Citrus Sinensis ID: 005933

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------67
Protein Sequence
MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPLSNEITISLIEGR
Secondary Structure (PSIPRED)
ccccccccccccEEEEEEcccccccccEEEEEEccccccEEEEEEccEEEEEEccccccEEEEcccccccccEEEEEEEcccEEEEEEEEEcccEEEEEEEcccccEEEEEEEcccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccEEEEEccccccccccEEEEccccHHHHHHHHcccccccccccccccccccEEEEccccccccEEccccccEEEEEccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHEEEcccccccccccccccccccccccccccccccEEHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHHHcccccccEEcccccccEEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccEEEEEcccccHHHHHcccccccccccEEEEEEEEEEEcccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccEEEccccccccccccccccccccccEEEEEEccc
Secondary Structure Prediction (SSPRO)
ccccccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEccccccccccEEEEEEEEcccEEEEEEEEEcccEEEEEEEccccEEEEEEEEcccccEEEEEEcccccccccccHcccccccEEcccccccccccccccccccHHHHcccccccccEEcccccccccccEEEEccccccccccEEEcccccHHHHHHHHHHcccEEEEEEEcccccccEEEEEEccHHHHHHcccccccEEEEEccHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccEcHHHHHHHHcccccccccccccccccEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEHEccHccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEcccHcccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHEccccccccccccccccHHHHHHHHHHccccHHHHcHHHcccccHHHHHHHHHHHHHHHHccccccccccEEEEEcccccccccccccEEEEEcccccccccccccccccccEEEEEEEccc
Coil and Loop (DISEMBL)
MKLGVNLVTGLKRFMSswksaddpaqdnyiyevdprgvpqavfrkgskikfragpwnglhwtgtpqlqpnpvytfeyvsneneVFYRFNLIKSSVLTMMVinpqgepqrlTWMEqtqkwapfvpfsglildqcdnyaLCGAYAICnmnsnsarceclegfvpkspsewdlldtsdgcirrtqldcehgdgflkresvklpdtsfsrvdkniSILACKELCskncsctayanadvrgggsgcllwfhDLIDMKVLSEGGQDLYIRMATSELdnfertkrrkkKKVVIIIICALLATGVILIGGFMYmrkkkrrdqgntvgsseldyidrgnrkenmelpmfdwntiadatdnfswknklgeggfgpvyrgmlteGQEIAVKRLSkssgqgveEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEylpnksleQFIFDVTRtkfldwskRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNvlldndmnpkisdfgmarafgvdqteantdrvvgtygymspeyaidGLFSVKSDVFSFGVLVLEIVCgkrnrgfyhadhhHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLcvqqrpedrpnmSSVVLMLsgerslpqpkqpgffternlpesesssskrklplsneITISLIEGR
Flexible Loop (DISEMBL)
MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLhwtgtpqlqpnPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDcehgdgflkresvklpdtsfsrvdKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMAtseldnfertkrrkkkkvVIIIICAllatgviliGGFMYMRkkkrrdqgntvgsseldyidrgnrkeNMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAfgvdqteantdrVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGErslpqpkqpgffternlpesesssskrklplsneitisliegr
Low Complexity Region (SEG)
MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTkrrkkkkvviiiiCALLATGVILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPLSNEITISLIEGR
Disordered region (IsUnstruct)
****VNLVTGLKRFMSSWK******QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMA*****************VVIIIICALLATGVILIGGFMYMR***************************MELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKR********VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQ**************************************************************
Disordered Region (DISOPRED)
MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILIGGFMYMRK**************************MELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF**********************ITISLIEGR
Disordered Region (DISEMBL)
MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILIGGFMYMRK***********SSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTE***************PLSNEITISLIEGR
Disordered Region (DISPRO)
**LGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILIGGFMYMRKKKRRD********************NMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERN*************PLSNEITISLIEG*
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYxxxxxxxxxxxxxxxxxxxxxVVIIIICALLATGVILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPLSNEITISLIEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	669	2.2.26 [Sep-21-2011]
O81832	783	G-type lectin S-receptor-	yes	no	0.926	0.791	0.548	0.0
O81833	815	G-type lectin S-receptor-	no	no	0.967	0.793	0.519	0.0
O81905	850	Receptor-like serine/thre	no	no	0.982	0.772	0.5	0.0
Q39086	843	Receptor-like serine/thre	no	no	0.979	0.776	0.490	0.0
Q9S972	847	Receptor-like serine/thre	no	no	0.977	0.772	0.482	0.0
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.989	0.794	0.466	1e-177
Q09092	857	Putative serine/threonine	N/A	no	0.982	0.766	0.466	1e-176
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.983	0.778	0.466	1e-175
P0DH86	853	G-type lectin S-receptor-	no	no	0.977	0.766	0.465	1e-164
O81906	849	G-type lectin S-receptor-	no	no	0.964	0.759	0.470	1e-164

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  734 bits (1894), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/671 (54%), Positives = 469/671 (69%), Gaps = 51/671 (7%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MK G+N VTGL RF++SW++ DDP+  NY  ++DP GVPQ   +K S + FR GPWNGL 
Sbjct: 162 MKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLR 221

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           +TG P L+PNP+Y +EYV  E EV+Y + L   SVLT M +NP G  QR TW++  Q W 
Sbjct: 222 FTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWN 281

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
            ++     ++D CD Y LCG+Y  CN+N + A C CL+GFV K+P  W   D S+GC+RR
Sbjct: 282 FYL---SAMMDSCDQYTLCGSYGSCNINESPA-CRCLKGFVAKTPQAWVAGDWSEGCVRR 337

Query: 181 TQLDCEHG-DGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGS 239
            +LDC  G DGFLK   +KLPDT  S  DKN+ +  CK++C +NC+C+AY+  D+R GG 
Sbjct: 338 VKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGK 397

Query: 240 GCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVIL 299
           GC+LWF DLID++  +E GQDLY+R+A+SE++  +R   R                    
Sbjct: 398 GCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESSRVSS----------------- 440

Query: 300 IGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLG 359
                                       R   +E++ELP  D +T+++AT  FS  NKLG
Sbjct: 441 ----------------------------RKQEEEDLELPFLDLDTVSEATSGFSAGNKLG 472

Query: 360 EGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD 419
           +GGFGPVY+G L  GQE+AVKRLS++S QGVEEFKNE+ LIAKLQHRNLV++LG C   +
Sbjct: 473 QGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEE 532

Query: 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479
           ERMLIYEY PNKSL+ FIFD  R + LDW KR +II+GIARG+LYLH+DSRLRIIHRDLK
Sbjct: 533 ERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLK 592

Query: 480 ASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFS 539
           ASNVLLD+DMN KISDFG+AR  G D+TEANT RVVGTYGYMSPEY IDG FS+KSDVFS
Sbjct: 593 ASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFS 652

Query: 540 FGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS-LSEALRC 598
           FGVLVLEIV G+RNRGF + +H  NLLGHAWR + ED++ E+ID++++ S + +SE LR 
Sbjct: 653 FGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRV 712

Query: 599 IQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPLS 658
           I +GLLCVQQ P+DRPNMS VVLMLS E  L  P+QPGFF ERNL  S++ S   ++P +
Sbjct: 713 IHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSN 772

Query: 659 NEITISLIEGR 669
           N  T+S+I+ R
Sbjct: 773 NFQTMSVIDPR 783

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  677 bits (1747), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/676 (51%), Positives = 466/676 (68%), Gaps = 29/676 (4%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKG--SKIKFRAGPWNG 58
           MKLG N  T ++  +SSWK+  DP+  ++   +D RG+PQ + RK   S   +R G WNG
Sbjct: 162 MKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNG 221

Query: 59  LHWTGTPQL-QPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQ 117
           L +TG P + + N ++ +++ S+  EV Y +   +  +++ +V+N  G+  R    +Q Q
Sbjct: 222 LSFTGAPAMGRENSLFDYKFTSSAQEVNYSWT-PRHRIVSRLVLNNTGKLHRFIQSKQNQ 280

Query: 118 KWAPFVPFSGLILDQCDNYALCGAYAICNMNS-NSARCECLEGFVPKSPSEWDLLDTSDG 176
               ++  +    D+CD Y++CGAYA+C +NS N+  C CL+GF PKS  +W++   + G
Sbjct: 281 ----WILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYG 336

Query: 177 CIRRTQLDCEHGDGFLKRESVKLPDTSFSRVD--KNISILACKELCSKNCSCTAYANADV 234
           C+     +CE  D F+K   +KLPDTS+S  D    +++  CK  CS NCSCTAYAN D+
Sbjct: 337 CVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDI 396

Query: 235 RGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLA 294
           R GG GCLLWF DL+DM+  S  GQD+YIRM       F + + + ++ V +++   +  
Sbjct: 397 REGGKGCLLWFGDLVDMREYSSFGQDVYIRMG------FAKIEFKGREVVGMVVGSVVAI 450

Query: 295 TGVILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSW 354
             V+++    + +K  +R +G            +G  +E+++LP+FD  TI+ ATD+FS+
Sbjct: 451 AVVLVVVFACFRKKIMKRYRGEN--------FRKGIEEEDLDLPIFDRKTISIATDDFSY 502

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
            N LG GGFGPVY+G L +GQEIAVKRLS +SGQGVEEFKNEV LIAKLQHRNLVRLLGC
Sbjct: 503 VNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGC 562

Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
           C   +E MLIYEY+PNKSL+ FIFD  R+  LDW KR  II G+ARG+LYLHQDSRLRII
Sbjct: 563 CIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRII 622

Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVK 534
           HRDLKA NVLLDNDMNPKISDFG+A++FG DQ+E++T+RVVGTYGYM PEYAIDG FSVK
Sbjct: 623 HRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVK 682

Query: 535 SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS-LS 593
           SDVFSFGVLVLEI+ GK NRGF HADH  NLLGH W++W EDR +E+ ++      S + 
Sbjct: 683 SDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIP 742

Query: 594 EALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKR 653
           E LRCI V LLCVQQ+PEDRP M+SVVLM   + SLP P QPGFFT RN+P+  SS S R
Sbjct: 743 EVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTNRNVPDISSSLSLR 802

Query: 654 KLPLSNEITISLIEGR 669
                NE++I++++GR
Sbjct: 803 S---QNEVSITMLQGR 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  669 bits (1725), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/696 (50%), Positives = 469/696 (67%), Gaps = 39/696 (5%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MKLG +  TG  RF+ SWKS DDP+  ++ ++++  G P+          +R+GPWNG+ 
Sbjct: 167 MKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIR 226

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           ++G P++QP     F + +++ EV Y F + KS V + + I+  G  QR TW+E  Q W 
Sbjct: 227 FSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWN 286

Query: 121 PF--VPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCI 178
            F   P      DQCD Y  CG Y  C+ N+ S  C C++GF P++P  W L D SDGC+
Sbjct: 287 QFWYAP-----KDQCDEYKECGVYGYCDSNT-SPVCNCIKGFKPRNPQVWGLRDGSDGCV 340

Query: 179 RRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGG 238
           R+T L C  GDGF++ + +KLPDT+ + VD+ I +  C++ C ++C+CTA+AN D+RG G
Sbjct: 341 RKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSG 400

Query: 239 SGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVV--IIIICALLATG 296
           SGC+ W  +L D++  ++GGQDLY+R+A ++L++    KR +  K++   I +  LL   
Sbjct: 401 SGCVTWTGELFDIRNYAKGGQDLYVRLAATDLED----KRNRSAKIIGSSIGVSVLLLLS 456

Query: 297 VILIGGFMYMRKKKR---------------RDQ-GNTVGSSELDYIDRGNRKENMELPMF 340
            I+   F++ RK+KR               RD   N V  S   +I R N  +++ELP+ 
Sbjct: 457 FIIF--FLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLM 514

Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
           ++  +A AT+NFS  NKLG+GGFG VY+G L +GQE+AVKRLSK+S QG +EFKNEV LI
Sbjct: 515 EFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLI 574

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
           A+LQH NLVRLL CC    E+MLIYEYL N SL+  +FD +R   L+W  R  II GIAR
Sbjct: 575 ARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIAR 634

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GLLYLHQDSR RIIHRDLKASN+LLD  M PKISDFGMAR FG D+TEANT +VVGTYGY
Sbjct: 635 GLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGY 694

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
           MSPEYA+DG+FS+KSDVFSFGVL+LEI+  KRN+GFY++D   NLLG  WR W E + LE
Sbjct: 695 MSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLE 754

Query: 581 LIDKSLDGSYSL---SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER-SLPQPKQPG 636
           +ID  +  S S     E LRCIQ+GLLCVQ+R EDRP MS V+LML  E  ++PQPK PG
Sbjct: 755 IIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPG 814

Query: 637 FFTERNLPESESSSSKRKLPLS---NEITISLIEGR 669
           +  ER+L +++SSSSK++   S   N+IT+S+++ R
Sbjct: 815 YCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  643 bits (1658), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/697 (49%), Positives = 463/697 (66%), Gaps = 42/697 (6%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MKLG +  TG  R + SWK+ DDP+   +  +++    P+        I +R+GPWNG+ 
Sbjct: 161 MKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMR 220

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           ++  P         + + +++ EV Y + + K+++ + + +N  G  QRLTW E TQ W 
Sbjct: 221 FSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWK 280

Query: 121 P--FVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCI 178
              + P      D CDNY +CG +  C+ NS    C C++GF P +   WDL D S GC+
Sbjct: 281 QLWYSP-----KDLCDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQAWDLRDGSAGCM 334

Query: 179 RRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGG 238
           R+T+L C+  DGF + + +KLPDT+ + VD+ I +  CKE C ++C+CTA+ANAD+R GG
Sbjct: 335 RKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGG 394

Query: 239 SGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVI 298
           SGC++W  +++DM+  ++GGQDLY+R+A +EL++    KR K +K    II + +   ++
Sbjct: 395 SGCVIWTREILDMRNYAKGGQDLYVRLAAAELED----KRIKNEK----IIGSSIGVSIL 446

Query: 299 LIGGFM----YMRKKKR------------RDQG---NTVGSSELDYIDRGNRKENMELPM 339
           L+  F+    + RK+KR            R Q    N V  S   Y  +  + E +ELP+
Sbjct: 447 LLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPL 506

Query: 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLL 399
            +   +A AT+NFS  NKLG+GGFG VY+G L +G+EIAVKRLSK S QG +EF NEV L
Sbjct: 507 LELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRL 566

Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
           IAKLQH NLVRLLGCC  + E+MLIYEYL N SL+  +FD TR+  L+W KR  II GIA
Sbjct: 567 IAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIA 626

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           RGLLYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMAR FG ++TEANT RVVGTYG
Sbjct: 627 RGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYG 686

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           YMSPEYA+DG+FS+KSDVFSFGVL+LEI+ GKRN+GFY+++   NLLG  WR W E   L
Sbjct: 687 YMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNEL 746

Query: 580 ELID----KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQ 634
           E++D     SL   +   E LRCIQ+GLLCVQ+R EDRP MSSV++ML  E + +PQPK+
Sbjct: 747 EIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKR 806

Query: 635 PGFFTERNLPESESSSSKRKLP--LSNEITISLIEGR 669
           PGF   R+  E++SSSS ++      N+IT+S+I+ R
Sbjct: 807 PGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  636 bits (1640), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/698 (48%), Positives = 460/698 (65%), Gaps = 44/698 (6%)

Query: 1   MKLGV-NLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGL 59
           MK+G  N   G  R + SWK+ DDP+  ++  ++   G P+        I +R+GPW G 
Sbjct: 165 MKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGN 224

Query: 60  HWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKW 119
            ++  P ++P       +  N  +V Y + + K+++ +++ ++  G  QRLTWME  Q W
Sbjct: 225 RFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSW 284

Query: 120 AP--FVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGC 177
               + P      D CDNY  CG Y  C+ N+ S  C C++GF P +  +  L D S GC
Sbjct: 285 KQLWYSP-----KDLCDNYKECGNYGYCDANT-SPICNCIKGFEPMN-EQAALRDDSVGC 337

Query: 178 IRRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGG 237
           +R+T+L C+  DGF++ + ++LPDT+ + VDK I +  C+E C K C+CTA+AN D+R G
Sbjct: 338 VRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNG 397

Query: 238 GSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGV 297
           GSGC++W   L D++  ++GGQDLY+R+A  +L++    KR K KK    II + +   +
Sbjct: 398 GSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLED----KRIKSKK----IIGSSIGVSI 449

Query: 298 ILIGGFM----YMRKKKR------------RDQG---NTVGSSELDYIDRGNRKENMELP 338
           +L+  F+    + RK+KR            R Q    N +  +   Y  + N+ + +ELP
Sbjct: 450 LLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELP 509

Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL 398
           + +W  +A AT+NFS  NKLG+GGFG VY+GML +G+EIAVKRLSK S QG +EF NEV 
Sbjct: 510 LMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVR 569

Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
           LIAKLQH NLVRLLGCC  + E+MLIYEYL N SL+  +FD TR+  L+W KR  II GI
Sbjct: 570 LIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGI 629

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           ARGLLYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMAR FG ++TEANT RVVGTY
Sbjct: 630 ARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTY 689

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS 578
           GYMSPEYA+DG+FS+KSDVFSFGVL+LEI+ GKRN+GFY+++   NLLG  WR W E + 
Sbjct: 690 GYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKE 749

Query: 579 LELID----KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPK 633
           LE++D     +L   +   E LRCIQ+GLLCVQ+R EDRP MSSV++ML  E + +PQPK
Sbjct: 750 LEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPK 809

Query: 634 QPGFFTERNLPESESSSSKRKLP--LSNEITISLIEGR 669
           +PGF   R+  E +SSSS ++      N++T+S+I+ R
Sbjct: 810 RPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  621 bits (1601), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 320/686 (46%), Positives = 441/686 (64%), Gaps = 24/686 (3%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           M+LG     GL R ++SWKS  DP   + I  ++ RG PQ +  KG    +R G W G  
Sbjct: 155 MRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYKGVTPWWRMGSWTGHR 214

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           W+G P++    ++   +V+NE+EV + + +  +SV+T  ++N  G   R TW+ + ++W 
Sbjct: 215 WSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVNETGTMHRFTWIARDKRWN 274

Query: 121 PF--VPFSGLILDQCDNYALCGAYAICNM-NSNSARCECLEGFVPKSPSEWDLLDTSDGC 177
            F  VP      +QCDNYA CG    C+  +S +  C CL GF PK P  W L D+S GC
Sbjct: 275 DFWSVP-----KEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPRHWFLRDSSGGC 329

Query: 178 IRRTQLD-CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANA--DV 234
            ++ +   C   DGF+K + +K+PDTS + VD NI++  CK+ C KNCSC AYA+A  + 
Sbjct: 330 TKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCSCVAYASAYHES 389

Query: 235 RGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLA 294
           + G  GCL W   ++D +     GQD YIR+   EL  + R     K++V++I+I  + A
Sbjct: 390 KRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRRVLLILISLIAA 449

Query: 295 TGVILIGGFMYMRKKKR----RDQGNTVGSSELDYID----RGNRKENMELPMFDWNTIA 346
             ++ +  F  +R++++    R           D+ +      ++  N ELP+FD NTI 
Sbjct: 450 VMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNRELPLFDLNTIV 509

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR 406
            AT+NFS +NKLG GGFGPVY+G+L    EIAVKRLS++SGQG+EEFKNEV LI+KLQHR
Sbjct: 510 AATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHR 569

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           NLVR+LGCC   +E+ML+YEYLPNKSL+ FIF   +   LDW KR +I+ GIARG+LYLH
Sbjct: 570 NLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLH 629

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
           QDSRLRIIHRDLKASN+LLD++M PKISDFGMAR FG +Q E  T RVVGT+GYM+PEYA
Sbjct: 630 QDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYA 689

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
           ++G FS+KSDV+SFGVL+LEI+ GK+N  F+  +   NL+GH W LW    + E+ID  +
Sbjct: 690 MEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVGHIWDLWENGEATEIIDNLM 747

Query: 587 DG-SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS-GERSLPQPKQPGFFTERNLP 644
           D  +Y   E ++CIQ+GLLCVQ+   DR +MSSVV+ML     +LP PK P F + R   
Sbjct: 748 DQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPAFTSARRRG 807

Query: 645 ESESSSSKRKLPLS-NEITISLIEGR 669
               +  K +  +S N++T S I+GR
Sbjct: 808 GENGACLKGQTGISVNDVTFSDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2

 Score =  619 bits (1595), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 327/701 (46%), Positives = 459/701 (65%), Gaps = 44/701 (6%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MKLG NL TGL RF++SW+S+DDP+  N+ Y+++ + +P+    + +    R+GPWNG+ 
Sbjct: 169 MKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIR 228

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           ++G P+ Q      + ++ N  EV Y F +  +S  + + +  +G  QRLTW    + W 
Sbjct: 229 FSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWN 288

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
            F  +S  +  QCD Y +CG YA C++N+ S  C C++GF P++  +WD    + GCIRR
Sbjct: 289 RF--WSSPVDPQCDTYIMCGPYAYCDVNT-SPVCNCIQGFNPRNIQQWDQRVWAGGCIRR 345

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
           TQL C  GDGF + + +KLP+T+ + VD++I +  CK+ C  +C+CTA+ANAD+R GGSG
Sbjct: 346 TQLSCS-GDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSG 404

Query: 241 CLLWFHDLIDMKVLSEG---GQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGV 297
           C++W   L D++  +     GQDLY+R+A +++      KR    K++ + +   ++  +
Sbjct: 405 CVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAK----KRNASGKIISLTVG--VSVLL 458

Query: 298 ILIGGFMYMRKKKR------------RDQG----NTVGSSELDYIDRGNRK-ENMELPMF 340
           +LI   ++ RK+KR            R+Q       V SS+ ++   G  K E +ELP+ 
Sbjct: 459 LLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREF--SGEYKFEELELPLI 516

Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
           +  T+  AT+NFS  NKLG+GGFG VY+G L +G+EIAVKRLSK+S QG +EF NEV LI
Sbjct: 517 EMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLI 576

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
           A+LQH NLV++LGCC   DE+MLIYEYL N SL+ ++F  TR   L+W++R  I  G+AR
Sbjct: 577 ARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVAR 636

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GLLYLHQDSR RIIHRDLK SN+LLD +M PKISDFGMAR F  D+TEANT +VVGTYGY
Sbjct: 637 GLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGY 696

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
           MSPEYA+ G+FS KSDVFSFGV+VLEIV GK+NRGFY+ D+ ++LL + W  W E R+LE
Sbjct: 697 MSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALE 756

Query: 581 LIDKSLDGSYSL-------SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQP 632
           ++D  +  S S         E L+CIQ+GLLCVQ+  E RP MSSVV M   E + +PQP
Sbjct: 757 IVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQP 816

Query: 633 KQPGFFTERNLPESESSSS----KRKLPLSNEITISLIEGR 669
           K PG+   R+  E + SSS    + +    N+ T S+I+ R
Sbjct: 817 KPPGYCVRRSPYELDPSSSWQCDENESWTVNQYTCSVIDAR 857

Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Brassica oleracea var. acephala (taxid: 3713)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  613 bits (1582), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 326/699 (46%), Positives = 441/699 (63%), Gaps = 41/699 (5%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MK G    +G+ R M+SW+S  DP   N  Y ++ RG PQ +  KG  + +R G W G  
Sbjct: 158 MKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMMMYKGLTLWWRTGSWTGQR 217

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           W+G P++    ++   +V+N +EV   + ++ +SV T MV+N  G  QR  W  + +KW 
Sbjct: 218 WSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVLNETGTLQRFRWNGRDKKW- 276

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSA-RCECLEGFVPKSPSEWDLLDTSDGCIR 179
             + F     D+CD Y  CG    C+  S     C CL G+ PK+P +W L D SDGC R
Sbjct: 277 --IGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPKTPRDWFLRDASDGCTR 334

Query: 180 -RTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANA--DVRG 236
            +    C   +GF K + VK+P+TS   VD NI++  C++ C KNCSC AYA+A  + + 
Sbjct: 335 IKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLKNCSCVAYASAYHESQD 394

Query: 237 GGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATG 296
           G  GCL W  +++D +     GQD Y+R+  SEL  +       KK++V+I+I  +    
Sbjct: 395 GAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGASGKKRLVLILISLIAVVM 454

Query: 297 VILIGGFMYMRKKKRRDQGN-------TVGSSELDYIDR------GNRKENMELPMFDWN 343
           ++LI    Y+RK+++R Q N       +   S  D  D        ++  + ELP+F+ +
Sbjct: 455 LLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFILEELEDKSRSRELPLFELS 514

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
           TIA AT+NF+++NKLG GGFGPVY+G+L  G EIAVKRLSKSSGQG+EEFKNEV LI+KL
Sbjct: 515 TIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKL 574

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           QHRNLVR+LGCC   +E+ML+YEYLPNKSL+ FIF   +   LDW KR  II GI RG+L
Sbjct: 575 QHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGIL 634

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLHQDSRLRIIHRDLKASNVLLDN+M PKI+DFG+AR FG +Q E +T+RVVGTYGYMSP
Sbjct: 635 YLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMSP 694

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
           EYA+DG FS+KSDV+SFGVL+LEI+ GKRN  FY  +   NL+ H W  W    ++E+ID
Sbjct: 695 EYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFY--EESLNLVKHIWDRWENGEAIEIID 752

Query: 584 KSL-DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER-SLPQPKQPGFFTER 641
           K + + +Y   E ++C+ +GLLCVQ+   DRP+MSSVV ML      LP PK P F   R
Sbjct: 753 KLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLGHNAIDLPSPKHPAFTAGR 812

Query: 642 -----------NLPESESSSSKRKLPLSNEITISLIEGR 669
                      N P  E+SS+       N++T++ ++GR
Sbjct: 813 RRNTKTGGSSDNWPSGETSST------INDVTLTDVQGR 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1

 Score =  580 bits (1495), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 326/701 (46%), Positives = 444/701 (63%), Gaps = 47/701 (6%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MKLG +   GL RF++SWKS+ DP+  +++++++  G+P+          +R+GPW+GL 
Sbjct: 168 MKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLPEFFGFTSFLEVYRSGPWDGLR 227

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           ++G  ++Q      + +  N  EV Y F +   +  + + IN  G  +   W    Q+W 
Sbjct: 228 FSGILEMQQWDDIIYNFTENREEVAYTFRVTDHNSYSRLTINTVGRLEGFMWEPTQQEWN 287

Query: 121 PF--VPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCI 178
            F  +P      D CD Y +CG YA C+M S S  C C++GF P SP +W   D +  C 
Sbjct: 288 MFWFMP-----KDTCDLYGICGPYAYCDM-STSPTCNCIKGFQPLSPQDWASGDVTGRCR 341

Query: 179 RRTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGG 238
           R+TQL C   D F +  ++K+P T+ + VDK I +  C+E C  +C+CTAYAN+D+R GG
Sbjct: 342 RKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKTHCNCTAYANSDIRNGG 400

Query: 239 SGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVI 298
           SGC++W  +  D++  +  GQDL++R+A +E    ER   R K   +II I  +L    I
Sbjct: 401 SGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFG--ERRTIRGKIIGLIIGISLMLVLSFI 458

Query: 299 LIGGFMYMRKKKRRDQGNTVGSSELDYIDR--------------GNRKENMELPMFD--- 341
           +   + + +KK++R +     ++ + Y DR              G R    E  +     
Sbjct: 459 I---YCFWKKKQKRARAT---AAPIGYRDRIQELIITNGVVMSSGRRLLGEEEDLELPLT 512

Query: 342 -WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
            + T+  AT+NFS  N LG GGFG VY+G L +GQEIAVKRLS+ S QG  EFKNEV LI
Sbjct: 513 EFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMSSQGTNEFKNEVRLI 572

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIA 459
           A+LQH NLVRLL CC   DE++LIYEYL N SL+  +F+ T++   L+W  R  II GIA
Sbjct: 573 ARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNKLNWQTRFSIINGIA 632

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           RGLLYLHQDSR +IIHRDLKASNVLLD +M PKISDFGMAR F  D+TEANT +VVGTYG
Sbjct: 633 RGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDETEANTRKVVGTYG 692

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           YMSPEYA++G+FSVKSDVFSFGVLVLEIV GKRNRGF+++   +NLLG+ W  W E + L
Sbjct: 693 YMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNNLLGYTWENWKEGKGL 752

Query: 580 ELIDKSLDGS------YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQP 632
           E++D  +  S      +   E LRCIQ+GLLCVQ+R EDRP MSSVVLML  E+  +PQP
Sbjct: 753 EIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQERAEDRPKMSSVVLMLGSEKGEIPQP 812

Query: 633 KQPGFFTER-NLPESESSSSKRKLPLS---NEITISLIEGR 669
           K+PG+   R +L  ++SSSS ++   S   N+IT+S+I  R
Sbjct: 813 KRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVSVINAR 853

Female specificity determinant of self-incompatibility.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  580 bits (1494), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 334/710 (47%), Positives = 435/710 (61%), Gaps = 65/710 (9%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKI-KFRAGPWNGL 59
           M++ VN  TG      SW+S  DP+  NY   VDP G P+ V  +G+K  K+R+G WN  
Sbjct: 164 MRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSA 223

Query: 60  HWTGTPQLQ--PNPVYTFEYVSNENE---VFYRFNLIKSSVLTMMVINPQGEPQRLTWME 114
            +TG P +    N +Y F+  S  +E   V++ +     SVL    +   G  + L W E
Sbjct: 224 IFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNE 283

Query: 115 QTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTS 174
             +KW  F         +CD Y  CG + IC+M  ++  C C+ G+   S   W     S
Sbjct: 284 TLKKWTKFQSEPD---SECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----S 335

Query: 175 DGCIRRTQLDCEHG-----DGFLKRESVKLPDTSFSRVDKN-ISILACKELCSKNCSCTA 228
            GC RRT L CE       D FL  +SVKLPD  F   + N +    C+E C +NCSC A
Sbjct: 336 RGCRRRTPLKCERNISVGEDEFLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNA 393

Query: 229 YANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIII 288
           Y+      GG GC++W  DL+D++    GG  L+IR+A SE+    +TK        I +
Sbjct: 394 YSLV----GGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVGENRKTK--------IAV 441

Query: 289 ICALLATGVILIGGFMYM--RKKKRRD-----------------------QGNTVGSSEL 323
           I A+L  GVILIG F  +  R K+++D                       +  +  S  +
Sbjct: 442 IVAVLV-GVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSV 500

Query: 324 DYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLS 383
           D +  G      ELP+F  N IA AT++F  +N+LG GGFGPVY+G+L +G+EIAVKRLS
Sbjct: 501 DIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLS 560

Query: 384 KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT 443
             SGQGV+EFKNE++LIAKLQHRNLVRLLGCC   +E+ML+YEY+PNKSL+ F+FD T+ 
Sbjct: 561 GKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQ 620

Query: 444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
             +DW  R  IIEGIARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFGMAR FG
Sbjct: 621 ALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFG 680

Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH 563
            +Q EANT RVVGTYGYMSPEYA++GLFSVKSDV+SFGVL+LEIV GKRN     +  H 
Sbjct: 681 GNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL-RSSEHG 739

Query: 564 NLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
           +L+G+AW L+T  RS EL+D  +  + S  EALRCI V +LCVQ    +RPNM+SV+LML
Sbjct: 740 SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLML 799

Query: 624 -SGERSLPQPKQPGFF-TERNLPESESS--SSKRKLPLSNEITISLIEGR 669
            S   +L  P+QP F  T RN  +   +  SS++ +  SNEIT +++ GR
Sbjct: 800 ESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	669
224122978	831	predicted protein [Populus trichocarpa]	0.982	0.790	0.635	0.0
224122974	729	predicted protein [Populus trichocarpa]	0.986	0.905	0.611	0.0
255587572	822	S-locus-specific glycoprotein S6 precurs	0.985	0.801	0.596	0.0
224122958	812	predicted protein [Populus trichocarpa]	0.979	0.806	0.604	0.0
224115106	755	predicted protein [Populus trichocarpa]	0.953	0.845	0.626	0.0
147799241	818	hypothetical protein VITISV_027305 [Viti	0.986	0.806	0.582	0.0
302143165	657	unnamed protein product [Vitis vinifera]	0.977	0.995	0.587	0.0
224122858	831	predicted protein [Populus trichocarpa]	0.989	0.796	0.583	0.0
302143143	910	unnamed protein product [Vitis vinifera]	0.962	0.707	0.586	0.0
302143132	2646	unnamed protein product [Vitis vinifera]	0.989	0.250	0.574	0.0

>gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa]

 Score =  861 bits (2225), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 420/661 (63%), Positives = 509/661 (77%), Gaps = 4/661 (0%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MK G N+VTGL R++SSWKS++DPAQ  + + +DPRG  Q +  +G KI +R G WNG  
Sbjct: 160 MKWGRNMVTGLDRYLSSWKSSNDPAQGEFTFRIDPRGNTQMLLMRGPKILYRTGTWNGYR 219

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           WTGTPQL+PN +YT+ ++S   E++Y+F+LI SSV + +V+N  G  QR TW+ +T  WA
Sbjct: 220 WTGTPQLEPNMLYTYGFISTATEMYYKFDLINSSVASRIVMNSSGAAQRFTWITRTNSWA 279

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
            F   S ++LDQCD+YALCGAY  CN+N     C CLEGF+PKSP +W + + SDGC+RR
Sbjct: 280 RF---SAVLLDQCDDYALCGAYGSCNVNKQPV-CACLEGFIPKSPKDWSIQEWSDGCVRR 335

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
           T+LDC+ GD FL+   VKLPD   S VD +  +  CK+LC KNCSC AYAN+D+RGGGSG
Sbjct: 336 TKLDCDKGDRFLQHGGVKLPDMIKSWVDTSKGLKECKDLCLKNCSCVAYANSDIRGGGSG 395

Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
           CLLWF +LID + L+ GGQDLYIR+A SEL N E+ +   KK++ II+   +   GV+++
Sbjct: 396 CLLWFDELIDTRELTTGGQDLYIRIAASELYNIEKNRSSDKKQLGIIVGTIITIVGVLVL 455

Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
              +Y R+KK + Q N   S   +Y D   RKE+MELP FD +TIA+ATDNFS +NKLGE
Sbjct: 456 AFILYARRKKLKKQANMKTSHLQNYEDEDQRKEDMELPTFDLSTIANATDNFSSRNKLGE 515

Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
           GGFG VY+G L EGQE+AVKRLSK+SGQG+ EFKNEV+LIAKLQHRNLV+LLGCC   DE
Sbjct: 516 GGFGSVYKGTLIEGQEVAVKRLSKNSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDE 575

Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
           R+LIYEY+PNKSL+ FIFD       DW     I+ GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 576 RILIYEYMPNKSLDYFIFDKKTRNSSDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKA 635

Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSF 540
           +NVLLDN MNPKISDFG+AR FG DQTEANT+++VGTYGYMSPEYA+DG FSVKSDVFSF
Sbjct: 636 ANVLLDNGMNPKISDFGLARTFGGDQTEANTNKIVGTYGYMSPEYAVDGFFSVKSDVFSF 695

Query: 541 GVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQ 600
           GVLVLEIV GK+NRGF H DHHHNLLGHAWRLW E   LELI++    S +LSE +RCI 
Sbjct: 696 GVLVLEIVSGKKNRGFNHPDHHHNLLGHAWRLWNEGMPLELINEPEQDSCTLSEIIRCIH 755

Query: 601 VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPLSNE 660
           VGLLCVQ+RPEDRPNMSSV++MLS   SLPQPKQPGFFTERNLPE ESSSS +K   +NE
Sbjct: 756 VGLLCVQKRPEDRPNMSSVIVMLSSGISLPQPKQPGFFTERNLPERESSSSNQKSFSTNE 815

Query: 661 I 661
           I
Sbjct: 816 I 816

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122974|ref|XP_002330410.1| predicted protein [Populus trichocarpa] gi|222871795|gb|EEF08926.1| predicted protein [Populus trichocarpa]

 Score =  829 bits (2142), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 409/669 (61%), Positives = 501/669 (74%), Gaps = 9/669 (1%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MK G NLVTGL R++S WKS+DDPA+ ++ + +DPRG  Q +  +G  I FR G WNG  
Sbjct: 70  MKWGKNLVTGLDRYISPWKSSDDPARGDFAFRLDPRGYNQMLLMRGLTILFRTGTWNGFR 129

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           W G P    N VY  ++VS  NE +YRF+L+ SS+ + +VI+P G PQRLTW+ QT  W 
Sbjct: 130 WGGVPDTVSNTVYREQFVSTPNESYYRFDLLNSSIPSRLVISPAGIPQRLTWIPQTNLWG 189

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
            +   S + +DQCD Y LCG   IC++N + A C CLE FVPK+P  W+  D   GC+RR
Sbjct: 190 SY---SVVQIDQCDTYTLCGVNGICSIN-DQAVCSCLESFVPKTPDRWNSQDWFGGCVRR 245

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
           TQL C +GDGFLK   VKLPD S S V+ ++S+  C ++C  NCSC AY+N+D+RGGGSG
Sbjct: 246 TQLGCNNGDGFLKHTGVKLPDMSDSWVNTSMSLNECGDMCLSNCSCVAYSNSDIRGGGSG 305

Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
           C LWF +L D K L +GG+DLYIRMA SEL     + RRK +++++ I+  + +  V+++
Sbjct: 306 CYLWFSELKDTKQLPQGGEDLYIRMAASEL---RISSRRKLRRIIVGIL--IPSVVVLVL 360

Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
           G  +YMR+K  R Q  T      +Y D  +RK+ MELP FD+ TI +ATD FS+  KLGE
Sbjct: 361 GLILYMRRKNPRRQAFTPSIRIENYKDESDRKDGMELPAFDFTTIENATDCFSFNKKLGE 420

Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
           GGFG VY+G L++GQEIAVKRLSK SGQG+ EFKNEV+LIAKLQHRNLV+LLGCC   +E
Sbjct: 421 GGFGSVYKGTLSDGQEIAVKRLSKDSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGNE 480

Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
           RMLIYEY+PNKSL+ FIFD T T  LDW  R  II GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 481 RMLIYEYMPNKSLDNFIFDQTNTNILDWQTRLNIIGGIARGLLYLHQDSRLRIIHRDLKA 540

Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSF 540
           SNVLLD+ MNPKISDFGMAR FG DQ EANT R+VGTYGYMSPEYA+DGLFS+KSDVFSF
Sbjct: 541 SNVLLDDSMNPKISDFGMARTFGGDQIEANTSRIVGTYGYMSPEYAVDGLFSIKSDVFSF 600

Query: 541 GVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQ 600
           GVLVLEIV  K+NRGF+H DH+HNLLGHAWRLW E R LEL++K +D S SLSE +RCIQ
Sbjct: 601 GVLVLEIVSAKKNRGFFHPDHNHNLLGHAWRLWNEGRPLELMNKKIDDSSSLSEVIRCIQ 660

Query: 601 VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPLSNE 660
           VGLLCVQQRPEDRP+MS+VV+MLS E SLPQPKQPGF+TER+  E E+SSS  +    N 
Sbjct: 661 VGLLCVQQRPEDRPSMSTVVVMLSSEISLPQPKQPGFYTERSFSEQETSSSSIRSASRNN 720

Query: 661 ITISLIEGR 669
           I+ ++ E R
Sbjct: 721 ISFTVFEPR 729

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis]

 Score =  825 bits (2132), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/689 (59%), Positives = 507/689 (73%), Gaps = 30/689 (4%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MKLG NL  GL R+++SWKS DDPAQ N+   +D RG PQ   +KG  ++ R+GPWNGL 
Sbjct: 144 MKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRGFPQLFMKKGDAVQVRSGPWNGLQ 203

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           +TG+PQL PNPV+ F +VSN++E++Y + L  +SV++ ++++ +G  +R  W+++TQ W 
Sbjct: 204 FTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVSRLIVSEKGALERHNWIDRTQSWT 263

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
            F  FS +  DQCD Y LCGAYA CN+NS    C CLEGFVPKSP++W   D SDGC+RR
Sbjct: 264 LF--FS-VPTDQCDTYLLCGAYASCNINSYPV-CSCLEGFVPKSPTDWSASDWSDGCVRR 319

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
           T+L C  GDGF K + +KLPDTS S VD ++ +  C+ +C +NCSC AYAN+D+RG  SG
Sbjct: 320 TELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCLRNCSCLAYANSDIRG--SG 377

Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
           CLLWF  LIDM+  +EGGQDLYIR+A SEL       +   K+V II+ C ++  G+  +
Sbjct: 378 CLLWFDHLIDMRKFTEGGQDLYIRIAASEL----AKGKSHGKRVAIIVSCLIIGMGMTAL 433

Query: 301 GGFMYMRKKKRRDQGNTV-----------------GSSELDYIDR---GNRKENMELPMF 340
           G  +Y RK+KR   G  V                 G ++  YI+       KE+ EL  F
Sbjct: 434 GSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKETYIENYGDNGAKEDTELIAF 493

Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
           D  TI +AT NFS  NKLGEGGFGPVY+G L +GQEIAVKRLS++SGQG +EFKNEV+LI
Sbjct: 494 DLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKRLSETSGQGGKEFKNEVILI 553

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
           A+LQHRNLV+LLGCC   DE+MLIYEY+PNKSL+ FIFD  R+  LDW    +II GIAR
Sbjct: 554 ARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKKRSMLLDWHMCFRIIGGIAR 613

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GLLYLHQDSRLRIIHRDLKASN+LLD DMNPKISDFG+AR FG DQ  ANT RVVGTYGY
Sbjct: 614 GLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLARTFGKDQNAANTKRVVGTYGY 673

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
           MSPEYA+DGLFSVKSDVFSFGVLVLEIV GKRNRGF H DH  NLLGHAWRLW E+R+LE
Sbjct: 674 MSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDHSLNLLGHAWRLWMEERALE 733

Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTE 640
           L DK     YS+S+ LRCIQVGLLCVQ+ P DRP+MS+VV+ML  E SLPQPKQPGF+TE
Sbjct: 734 LFDKFSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSAVVVMLGSESSLPQPKQPGFYTE 793

Query: 641 RNLPESESSSSKRKLPLSNEITISLIEGR 669
           R+  E++SS+SK ++   NEI+ +LIE R
Sbjct: 794 RDPFEADSSTSKERVWSRNEISSTLIEPR 822

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa]

 Score =  822 bits (2122), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 405/670 (60%), Positives = 494/670 (73%), Gaps = 15/670 (2%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MKLG NLVTGL  F+SSWK  ++PA   +   +D +G PQ + RK ++I +R G WNG +
Sbjct: 157 MKLGSNLVTGLNSFLSSWKGKENPAPGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQY 216

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           +TG P+L+P+P+YTFE+V N NEV+++F L  SSV + + + P G  Q  TW  QT  W 
Sbjct: 217 FTGFPELKPDPIYTFEFVFNRNEVYFKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDW- 275

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
               F+  ++D+C+NYALCGA A C+ NS S  C+CL+GF+ KSP+EW+  + + GCIRR
Sbjct: 276 --YVFATAVVDRCENYALCGANARCDSNS-SPVCDCLDGFIHKSPTEWNSQNWTGGCIRR 332

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
           T LDC   DGF     VKLPDTS S  D + S++ C+ LC +NCSC AYAN D RG GSG
Sbjct: 333 TPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSG 392

Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
           CL WF DLID + L+EGGQD+YIR+A S+       KR+KK    +I    +L + ++++
Sbjct: 393 CLRWFGDLIDTRRLAEGGQDIYIRLAASQSGVTGEKKRKKKTHAGVIGGAVILGSSILIL 452

Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
           G    +R++K R  GN        + DR  ++E MELPM D  TI  ATDNFS   KLGE
Sbjct: 453 GIVFCIRRRKHRKNGN--------FEDR--KEEEMELPMLDLTTIEHATDNFSSSKKLGE 502

Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
           GGFG VY+G L EGQEIAVKRLSKSSGQG+ EFKNEVLLIAKLQHRNLV+LLGCC   DE
Sbjct: 503 GGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDE 562

Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
           +MLIYEY+PN+SL+ FIFD TR KFLDWSKR  II+GIARGLLYLHQDSRLRIIHRD+KA
Sbjct: 563 KMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKA 622

Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSF 540
           SN+LLDN++NPKISDFG+AR FG DQTEANT RVVGTYGYMSPEYA+DG FSVKSDVFSF
Sbjct: 623 SNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSF 682

Query: 541 GVLVLEIVCGKRNRGFYHADHHH-NLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCI 599
           GVLVLEIV GK+NRGF H D++  NLLGHAW LW     LELID+    S + SEALRCI
Sbjct: 683 GVLVLEIVSGKKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELIDECFADSCTPSEALRCI 742

Query: 600 QVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPLSN 659
            V LLCVQQRPEDRPNMSSVVLML  E  LPQPKQPGFF   N PE ++SS+K +   +N
Sbjct: 743 HVALLCVQQRPEDRPNMSSVVLMLGSENPLPQPKQPGFFMGSNPPEKDTSSNKHQSHSAN 802

Query: 660 EITISLIEGR 669
           E+T++L++ R
Sbjct: 803 EVTVTLLQAR 812

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115106|ref|XP_002316941.1| predicted protein [Populus trichocarpa] gi|222860006|gb|EEE97553.1| predicted protein [Populus trichocarpa]

 Score =  821 bits (2121), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/645 (62%), Positives = 490/645 (75%), Gaps = 7/645 (1%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MK G NLVTGL R++SSWKSADDPA+ ++ + +DPRG  Q +  +G  I +R G WNG  
Sbjct: 117 MKWGKNLVTGLDRYISSWKSADDPARGDFTFRLDPRGYNQMLLMRGLTILYRTGIWNGFR 176

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           W G P+   N VY  ++VS   E +Y F+L+ SSV + +VINP   PQRLTW+ QT  W 
Sbjct: 177 WGGVPETISNTVYGEQFVSTATESYYTFDLLNSSVPSRLVINPSSIPQRLTWITQTNLWG 236

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
            +   S + +DQCD Y LCGA  IC+ NSN A C CLE F+P++P  W+  D S GC+RR
Sbjct: 237 SY---SVVQIDQCDTYTLCGANGICS-NSNGAVCSCLESFIPRTPESWNKQDWSGGCVRR 292

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
           TQL C++GDGFL+   VKLPD S S V+ ++S++ C+ +C  NCSC AY N+D+R G SG
Sbjct: 293 TQLGCKNGDGFLQITGVKLPDMSDSWVNTSMSLVECRNMCLSNCSCVAYGNSDIRRGASG 352

Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
           C LWF DL D K L  GGQDLYIRMA SEL  +E+    K+K+  III   + A  ++++
Sbjct: 353 CYLWFDDLWDTKHLPLGGQDLYIRMAASELSIYEKKSSSKRKRRRIIIGTLISAVVLLVL 412

Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYI-DRGNRKENMELPMFDWNTIADATDNFSWKNKLG 359
           G  +YMR++++  QG    S  +D + D   RK++MELP FD+ TI +ATD FS+ NKLG
Sbjct: 413 GFMLYMRRRRKTRQGKK--SIRIDNLKDESGRKDDMELPAFDFITIKNATDYFSYNNKLG 470

Query: 360 EGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD 419
           EGGFG VY+G LT+GQEIAVKRLSK+SGQG++EFKNEV+LIAKLQHRNLV+LLGCC   D
Sbjct: 471 EGGFGSVYKGTLTDGQEIAVKRLSKNSGQGLKEFKNEVILIAKLQHRNLVKLLGCCIEGD 530

Query: 420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK 479
           ERMLIYEY+PNKSL+ FIFD      LDW     II GIARGLLYLHQDSRLRIIHRDLK
Sbjct: 531 ERMLIYEYMPNKSLDNFIFDKKSRNLLDWQTHMNIIGGIARGLLYLHQDSRLRIIHRDLK 590

Query: 480 ASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFS 539
           ASNVLLDN MNPKISDFGMAR FG DQ EANT+R+VGTYGY+SPEYA+DGLFS+KSDVFS
Sbjct: 591 ASNVLLDNSMNPKISDFGMARIFGGDQIEANTNRIVGTYGYISPEYAVDGLFSIKSDVFS 650

Query: 540 FGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCI 599
           FGVLVLEIV GK+NRGFYH DH+HNLLGHAW+LW E R LEL+D ++D S SLSE LR I
Sbjct: 651 FGVLVLEIVSGKKNRGFYHPDHNHNLLGHAWKLWNEGRPLELMDITIDDSSSLSEILRHI 710

Query: 600 QVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLP 644
           QVGLLCVQQRP+DRP+MS+VV+MLS E SLPQPKQPGF+TERN P
Sbjct: 711 QVGLLCVQQRPDDRPSMSTVVVMLSSEISLPQPKQPGFYTERNFP 755

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera]

 Score =  817 bits (2110), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/669 (58%), Positives = 503/669 (75%), Gaps = 9/669 (1%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MK G N VTGL R++SSWKS DDP++ ++ Y +DP G PQ   R GS + FR+GPWNG+ 
Sbjct: 159 MKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIR 218

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           + G P+L+PNPV+ + +V NE E+++ + L+ SSVL+ +V+NP G  QRL W+ +T+ W 
Sbjct: 219 FNGFPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWN 278

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
            +   S    D CD+YALCGAY+ CN++  S RC C++GFVPK P +WD +D S+GC+R+
Sbjct: 279 VY---STAYKDDCDSYALCGAYSTCNIH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRK 334

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
           T LDC+ GDGF K   VKLPDT  S  ++++++  C  LC +NCSC+AY N+D++GGGSG
Sbjct: 335 TSLDCQKGDGFAKYSGVKLPDTRNSWFNESMNLKECASLCFRNCSCSAYTNSDIKGGGSG 394

Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
           CLLWF DLID+K  +E GQD YIRMA SELD   +  +R+   V  + I  ++   +++ 
Sbjct: 395 CLLWFGDLIDIKEFTENGQDFYIRMAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVT 454

Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
              +Y+ KK+ + +G T  ++E    +   R+E++ELP+F  +TI +AT NFS  NKLGE
Sbjct: 455 ---LYLLKKRLKRKGTTELNNE--GAETNERQEDLELPLFXLDTILNATHNFSRNNKLGE 509

Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
           GGFGPVY+GML +G+EIAVKRLSK S QG++EFKNEV+ I+KLQHRNLV+LLGCC   +E
Sbjct: 510 GGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEE 569

Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
           +MLIYEY+PNKSL  FIFD  ++  LDW KR  II GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 570 KMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKA 629

Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSF 540
            NVLLDN+MNP+ISDFGMAR+FG ++T A T RVVGTYGYMSPEYAIDG++SVKSDVFSF
Sbjct: 630 DNVLLDNEMNPRISDFGMARSFGGNETIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSF 689

Query: 541 GVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQ 600
           GVL LEI+ GKRNRGF H DH  NLLGHAW L+ E   LELID S+  +Y+ SE LR + 
Sbjct: 690 GVLXLEIISGKRNRGFNHPDHDLNLLGHAWTLYMEGTPLELIDASVGYTYNQSEVLRALN 749

Query: 601 VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPLSNE 660
           VGLLCVQ+ P+DRPNMSSVVLMLS E +LPQPK+PGFFTERN+ E++S   K  +   NE
Sbjct: 750 VGLLCVQRHPDDRPNMSSVVLMLSSEGALPQPKEPGFFTERNMLEADSLQCKHAVFSGNE 809

Query: 661 ITISLIEGR 669
            TI+++EGR
Sbjct: 810 HTITILEGR 818

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143165|emb|CBI20460.3| unnamed protein product [Vitis vinifera]

 Score =  809 bits (2089), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/672 (58%), Positives = 500/672 (74%), Gaps = 18/672 (2%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MK G N VTGL R++SSWK+ DDP+  N+ Y +DP G PQ + R GS + FR+GPWNGL 
Sbjct: 1   MKFGRNRVTGLDRYLSSWKTTDDPSIGNFTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLR 60

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           ++G PQL+PN VY++ ++ N+ E +Y F L+ SSV+T +V++P+G  QR TW+++T  W 
Sbjct: 61  FSGFPQLRPNSVYSYAFIFNDKETYYTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDW- 119

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
             + +S    D CD+YALCG Y IC +N  S +CEC++GF PK  S WD+ D SDGC+R 
Sbjct: 120 --ILYSSAQTDDCDSYALCGVYGICEIN-RSPKCECMKGFEPKFQSNWDMADWSDGCVRS 176

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
           T + C+  +GFLK   VKLPDT  S  ++++++  C  LC  NCSCTAY N+D+RGGGSG
Sbjct: 177 TPMVCQKSNGFLKYSGVKLPDTRNSWFNESMNLKECASLCLGNCSCTAYTNSDIRGGGSG 236

Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTK---RRKKKKVVIIIICALLATGV 297
           CLLWF DLID++  +E GQD YIRMA SELD F  T    +  K+K VI+   +++   +
Sbjct: 237 CLLWFGDLIDIREYTENGQDFYIRMAKSELDAFAMTNSGSKGAKRKWVIVSTVSIVGIIL 296

Query: 298 ILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNK 357
           + +   +Y+ +KKR           L   +   R+E++ELP+FD +TI +ATDNFS  NK
Sbjct: 297 LSLVLTLYVLRKKR-----------LRRKEINEREEDLELPLFDLDTILNATDNFSNDNK 345

Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           LGEGGFGPVY+GML +G+EIAVKRLSK S QG++EFKNEV  I+KLQHRNLV+LLGCC  
Sbjct: 346 LGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVKLLGCCIH 405

Query: 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD 477
            +E+MLIYEY+PNKSL+ FIFD  ++  LDW KR  II GIARGLLYLHQDSRLRIIHRD
Sbjct: 406 GEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRD 465

Query: 478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDV 537
           LKA NVLLDN+MNP+ISDFGMAR+F  +++EA T RVVGTYGYMSPEYAIDG++S+KSDV
Sbjct: 466 LKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGTYGYMSPEYAIDGVYSIKSDV 525

Query: 538 FSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALR 597
           FSFGVLVLEIV GKRNRGF H DH  NLLGHAW L+ E + LELID S+  S + SE LR
Sbjct: 526 FSFGVLVLEIVTGKRNRGFNHPDHALNLLGHAWTLYMEGKPLELIDASMGDSCNQSEVLR 585

Query: 598 CIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPL 657
            + VGLLCVQ+ P+DRP+MSSVVLMLS E +L QPK+PGFFTERN+ E  SS+SK  +  
Sbjct: 586 ALNVGLLCVQRSPDDRPSMSSVVLMLSSESALHQPKEPGFFTERNMLEGSSSASKHAIFS 645

Query: 658 SNEITISLIEGR 669
            NE TI+LIEGR
Sbjct: 646 GNEHTITLIEGR 657

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa]

 Score =  806 bits (2083), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/674 (58%), Positives = 509/674 (75%), Gaps = 12/674 (1%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MK G++ VTGL R+++SWKS  DP+   Y  ++DP G+PQ    +GS  +FR+GPWNGL 
Sbjct: 165 MKYGISFVTGLNRYLTSWKSPSDPSTGKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLR 224

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           ++G   L+PNP+YTFE+V N+ E++Y++ +  SSVL+ MV++P G  QR TW+++TQ W 
Sbjct: 225 FSGMINLKPNPIYTFEFVFNQEEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWT 284

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
            ++  +   +D CD +ALCGA+ +CN+N NS  C+CL+ F PKS  EW   D S GC+R+
Sbjct: 285 LYLTAN---MDNCDRFALCGAHGVCNIN-NSPACDCLKEFEPKSLEEWTAADWSQGCVRK 340

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
             LDC +G+GF+K   +K+PDT  S  +K I++  C+E+C KNCSCTAYAN DVR GGSG
Sbjct: 341 APLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSG 400

Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIII-CALLATGVIL 299
           C+LWF DLID++  +E GQD+YIR+A S +D  +  K R KK+V II+I  +L+A  ++ 
Sbjct: 401 CVLWFGDLIDIRQYNENGQDIYIRIAASVID--KPVKSRGKKRVRIIVIPVSLVAFSLLA 458

Query: 300 IGGFM-YMRKKKRRD---QGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWK 355
           +  F+ ++RK K++    +GN V + E D   + +R E++ELP+FD  T+ DAT+ FS  
Sbjct: 459 LCLFLRFLRKNKQQQLTREGNVVTNPEQDRT-KESRNEDLELPLFDLATLTDATNCFSIN 517

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           NKLG+GGFGPVY+G+L +GQEIAVKRLSK S QG+ EF+NEV+ IAKLQHRNLV+LLGCC
Sbjct: 518 NKLGQGGFGPVYKGILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCC 577

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
              +ERMLIYEY+PNKSL+ FIFD  R   LDW+KR  II GIARGLLYLHQDSRLRIIH
Sbjct: 578 IELEERMLIYEYMPNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIH 637

Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKS 535
           RDLKASN+LLD +MNPKISDFGMAR+FG D+T ANT R+VGTYGYMSPEYAIDGLFSVKS
Sbjct: 638 RDLKASNILLDYEMNPKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKS 697

Query: 536 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEA 595
           DVFSFGVLVLEIV G++NRGF HA+H  NLLGHAW L  E R L+LID+S+  +  +SE 
Sbjct: 698 DVFSFGVLVLEIVSGRKNRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIVDTCIISEV 757

Query: 596 LRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKL 655
           LR I+V LLCVQ+ PEDRP MS VVLMLS +  LPQPK+PGFFTER+L    SS+ K ++
Sbjct: 758 LRSIEVALLCVQKSPEDRPKMSIVVLMLSSDIVLPQPKEPGFFTERDLSNDSSSTIKHEI 817

Query: 656 PLSNEITISLIEGR 669
              NE+T +L+E R
Sbjct: 818 SSVNELTSTLLEAR 831

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143143|emb|CBI20438.3| unnamed protein product [Vitis vinifera]

 Score =  804 bits (2076), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/653 (58%), Positives = 495/653 (75%), Gaps = 9/653 (1%)

Query: 1   MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
           MK G N VTGL R++SSWKS DDP++ ++ Y +DP G PQ   R GS + FR+GPWNG+ 
Sbjct: 141 MKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIR 200

Query: 61  WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
           + G P+L+PNPV+ + +V NE E+++ + L+ SSVL+ +V+NP G  QRL W+ +T+ W 
Sbjct: 201 FNGFPELRPNPVFNYSFVFNEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWN 260

Query: 121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
            +   S    D CD+YALCGAY+ CN++  S RC C++GFVPK P +WD +D S+GC+R+
Sbjct: 261 VY---STAYKDDCDSYALCGAYSTCNIH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRK 316

Query: 181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
           T LDC+ GDGF+K   VKLPDT  S  ++++++  C  LC +NCSC+AY N+D++GGGSG
Sbjct: 317 TSLDCQKGDGFVKCSGVKLPDTRNSWFNESMNLKECASLCLRNCSCSAYTNSDIKGGGSG 376

Query: 241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTKRRKKKKVVIIIICALLATGVILI 300
           CLLWF DLID+K  +E GQD YIRMA SELD   +  +R+   V  + I  ++   +++ 
Sbjct: 377 CLLWFGDLIDVKEFTENGQDFYIRMAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVT 436

Query: 301 GGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGE 360
              +Y+ KK+ + +G T  ++E    +   R+E++ELP+FD +TI +AT NFS  NKLGE
Sbjct: 437 ---LYLLKKRLKRKGTTELNNE--GAETNERQEDLELPLFDLDTILNATHNFSRNNKLGE 491

Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE 420
           GGFGPVY+GML +G+EIAVKRLSK S QG++EFKNEV+ I+KLQHRNLV+LLGCC   +E
Sbjct: 492 GGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEE 551

Query: 421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA 480
           +MLIYEY+PNKSL  FIFD  ++  LDW KR  II GIARGLLYLHQDSRLRIIHRDLKA
Sbjct: 552 KMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKA 611

Query: 481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSF 540
            NVLLDN+MNP+ISDFGMAR+FG ++T+A T RVVGTYGYMSPEYAIDG++SVKSDVFSF
Sbjct: 612 DNVLLDNEMNPRISDFGMARSFGGNETQARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSF 671

Query: 541 GVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQ 600
           GVL+LEI+ GKRNRGF H DH  NLLGHAW L+ E   LELID S+  +Y+ SE LR + 
Sbjct: 672 GVLLLEIISGKRNRGFNHPDHDLNLLGHAWTLYMERTPLELIDASVGDTYNQSEVLRALN 731

Query: 601 VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKR 653
           VGLLCVQ+ P+DRPNMSSVVLMLS E +L QPK+PGFFTERN+ E++S   K 
Sbjct: 732 VGLLCVQRHPDDRPNMSSVVLMLSSEGALRQPKEPGFFTERNMLEADSLQCKH 784

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143132|emb|CBI20427.3| unnamed protein product [Vitis vinifera]

 Score =  800 bits (2065), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/679 (57%), Positives = 508/679 (74%), Gaps = 17/679 (2%)

Query: 1    MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
            MKLG N VTGL R++S+WKSADDP++ ++ Y +DPRG PQ + RKGS + FR+GPWNG+ 
Sbjct: 1975 MKLGRNTVTGLDRYLSAWKSADDPSKGDFTYRLDPRGYPQLILRKGSAVTFRSGPWNGVR 2034

Query: 61   WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
            ++G P+L PN +YT+E+V NE E+++R+ L+ SSV++ +V+NP G  QR+ W+++T  W 
Sbjct: 2035 FSGFPELGPNSIYTYEFVFNEKEMYFRYELVNSSVVSRLVLNPDGSKQRVNWIDRTNGW- 2093

Query: 121  PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
              + +S    D CD+YALCG Y ICN+N  S +CEC+EGFVPK  ++WD+ D S+GC+R 
Sbjct: 2094 --ILYSSAPKDDCDSYALCGVYGICNIN-RSPKCECMEGFVPKFQNDWDMADWSNGCVRS 2150

Query: 181  TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
            T LDC++G+GF+K   VKLPDT  S  ++++ ++ C  +C  NCSCTAY N D+R GGSG
Sbjct: 2151 TPLDCQNGEGFVKFSGVKLPDTRNSWFNRSMGLMECAAVCLSNCSCTAYTNLDIRDGGSG 2210

Query: 241  CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNF-ERTKRRKKKKVVIIIICALLATGVIL 299
            CLLWF DLID++  +E GQ++Y+RMA SEL    E     K KK   II+ ++ +  +IL
Sbjct: 2211 CLLWFGDLIDIREFNENGQEIYVRMAASELGGSKESGSNLKGKKRKWIIVGSVSSVVIIL 2270

Query: 300  IGGFM---YMRKKKRRDQGNTVGSSE------LDYIDRGNRKENMELPMFDWNTIADATD 350
            +  F+    ++ K++R +GN            + Y      KE+ +L +FD+ T++ AT+
Sbjct: 2271 VSLFLTLYLLKTKRQRKKGNNPYYMHHYVFRTMGYNLEVGHKEDSKLQLFDFATVSKATN 2330

Query: 351  NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
            +FS+ NKLGEGGFG VY+G+L EGQEIAVKRLSK SGQG++E KNEV+ IAKLQHRNLVR
Sbjct: 2331 HFSFDNKLGEGGFGLVYKGILQEGQEIAVKRLSKDSGQGLDELKNEVIYIAKLQHRNLVR 2390

Query: 411  LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
            LLGCC   +E+MLIYEY+ NKSL+ FIFD T++  LDW+KR  II GIARGLLYLHQDSR
Sbjct: 2391 LLGCCIHGEEKMLIYEYMSNKSLDSFIFDKTQSMELDWNKRFLIINGIARGLLYLHQDSR 2450

Query: 471  LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            LRIIHRDLKA N+LLD +M PKISDFGMAR+FG ++TEANT RVVGTYGYMSPEYAIDGL
Sbjct: 2451 LRIIHRDLKAGNILLDEEMAPKISDFGMARSFGGNETEANTKRVVGTYGYMSPEYAIDGL 2510

Query: 531  FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY 590
            +S KSDVFSFGVLVLEIV GKRNRGF H DH  NLLGHAW L+ E RS+ELID S+   +
Sbjct: 2511 YSTKSDVFSFGVLVLEIVSGKRNRGFSHPDHSLNLLGHAWTLYMEGRSMELIDSSVGDMH 2570

Query: 591  SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSS 650
             LS+ L  I VGLLCVQ  P+DRP+MSSVVLMLS + SLPQPK+PGFFT R   +++SSS
Sbjct: 2571 DLSQVLCSINVGLLCVQCSPDDRPSMSSVVLMLSSDSSLPQPKEPGFFTGR---KAQSSS 2627

Query: 651  SKRKLPLSNEITISLIEGR 669
              +     N +TI++++GR
Sbjct: 2628 GNQGPFSGNGVTITMLDGR 2646

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	669
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.559	0.477	0.619	5.1e-201
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.965	0.792	0.528	1.4e-183
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.986	0.776	0.496	1.3e-178
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.988	0.784	0.490	1.8e-172
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.986	0.779	0.479	1.5e-168
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.977	0.770	0.459	1.9e-147
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.979	0.777	0.427	5.3e-143
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.965	0.761	0.432	2.8e-137
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.980	0.790	0.427	5.8e-137
TAIR|locus:2197734	814	AT1G61370 [Arabidopsis thalian	0.947	0.778	0.419	7.9e-133

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1163 (414.5 bits), Expect = 5.1e-201, Sum P(2) = 5.1e-201
 Identities = 239/386 (61%), Positives = 295/386 (76%)

Query:   296 GVIL-IGGFMYMRKKKRRDQGNTV--GSSELDYIDR-----GNRK---ENMELPMFDWNT 344
             G IL  G  + +R+     Q   V   SSE++ + R      +RK   E++ELP  D +T
Sbjct:   398 GCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDT 457

Query:   345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
             +++AT  FS  NKLG+GGFGPVY+G L  GQE+AVKRLS++S QGVEEFKNE+ LIAKLQ
Sbjct:   458 VSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQ 517

Query:   405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
             HRNLV++LG C   +ERMLIYEY PNKSL+ FIFD  R + LDW KR +II+GIARG+LY
Sbjct:   518 HRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLY 577

Query:   465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
             LH+DSRLRIIHRDLKASNVLLD+DMN KISDFG+AR  G D+TEANT RVVGTYGYMSPE
Sbjct:   578 LHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPE 637

Query:   525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
             Y IDG FS+KSDVFSFGVLVLEIV G+RNRGF + +H  NLLGHAWR + ED++ E+ID+
Sbjct:   638 YQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDE 697

Query:   585 SLDGSYS-LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNL 643
             +++ S + +SE LR I +GLLCVQQ P+DRPNMS VVLMLS E  L  P+QPGFF ERNL
Sbjct:   698 AVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQPGFFNERNL 757

Query:   644 PESESSSSKRKLPLSNEITISLIEGR 669
               S++ S   ++P +N  T+S+I+ R
Sbjct:   758 LFSDTVSINLEIPSNNFQTMSVIDPR 783

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1781 (632.0 bits), Expect = 1.4e-183, P = 1.4e-183
 Identities = 358/677 (52%), Positives = 469/677 (69%)

Query:     1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKG--SKIKFRAGPWNG 58
             MKLG N  T ++  +SSWK+  DP+  ++   +D RG+PQ + RK   S   +R G WNG
Sbjct:   162 MKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNG 221

Query:    59 LHWTGTPQL-QPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQ 117
             L +TG P + + N ++ +++ S+  EV Y +   +  +++ +V+N  G+  R    +Q Q
Sbjct:   222 LSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTP-RHRIVSRLVLNNTGKLHRFIQSKQNQ 280

Query:   118 KWAPFVPFSGLILDQCDNYALCGAYAICNMNS-NSARCECLEGFVPKSPSEWDLLDTSDG 176
              W   +  +    D+CD Y++CGAYA+C +NS N+  C CL+GF PKS  +W++   + G
Sbjct:   281 -W---ILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYG 336

Query:   177 CIRRTQLDCEHGDGFLKRESVKLPDTSFSRVD-KN-ISILACKELCSKNCSCTAYANADV 234
             C+     +CE  D F+K   +KLPDTS+S  D KN +++  CK  CS NCSCTAYAN D+
Sbjct:   337 CVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDI 396

Query:   235 RGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLA 294
             R GG GCLLWF DL+DM+  S  GQD+YIRM  ++++   R               +++A
Sbjct:   397 REGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMVVG-------SVVA 449

Query:   295 TGVILIGGFMYMRKK-KRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFS 353
               V+L+  F   RKK  +R +G            +G  +E+++LP+FD  TI+ ATD+FS
Sbjct:   450 IAVVLVVVFACFRKKIMKRYRGEN--------FRKGIEEEDLDLPIFDRKTISIATDDFS 501

Query:   354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
             + N LG GGFGPVY+G L +GQEIAVKRLS +SGQGVEEFKNEV LIAKLQHRNLVRLLG
Sbjct:   502 YVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLG 561

Query:   414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
             CC   +E MLIYEY+PNKSL+ FIFD  R+  LDW KR  II G+ARG+LYLHQDSRLRI
Sbjct:   562 CCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRI 621

Query:   474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
             IHRDLKA NVLLDNDMNPKISDFG+A++FG DQ+E++T+RVVGTYGYM PEYAIDG FSV
Sbjct:   622 IHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSV 681

Query:   534 KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS-LDGSYSL 592
             KSDVFSFGVLVLEI+ GK NRGF HADH  NLLGH W++W EDR +E+ ++  L+ +  +
Sbjct:   682 KSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVI 741

Query:   593 SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSK 652
              E LRCI V LLCVQQ+PEDRP M+SVVLM   + SLP P QPGFFT RN+P+  SS S 
Sbjct:   742 PEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTNRNVPDISSSLSL 801

Query:   653 RKLPLSNEITISLIEGR 669
             R     NE++I++++GR
Sbjct:   802 RS---QNEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1734 (615.5 bits), Expect = 1.3e-178, P = 1.3e-178
 Identities = 344/693 (49%), Positives = 471/693 (67%)

Query:     1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQA-VFRKGSKIKFRAGPWNGL 59
             MKLG +  TG  RF+ SWKS DDP+  ++ ++++  G P+  ++ + S++ +R+GPWNG+
Sbjct:   167 MKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRM-YRSGPWNGI 225

Query:    60 HWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKW 119
              ++G P++QP     F + +++ EV Y F + KS V + + I+  G  QR TW+E  Q W
Sbjct:   226 RFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNW 285

Query:   120 APFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIR 179
               F  ++    DQCD Y  CG Y  C+ N++   C C++GF P++P  W L D SDGC+R
Sbjct:   286 NQFW-YAPK--DQCDEYKECGVYGYCDSNTSPV-CNCIKGFKPRNPQVWGLRDGSDGCVR 341

Query:   180 RTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGS 239
             +T L C  GDGF++ + +KLPDT+ + VD+ I +  C++ C ++C+CTA+AN D+RG GS
Sbjct:   342 KTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGS 401

Query:   240 GCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLATGVIL 299
             GC+ W  +L D++  ++GGQDLY+R+A ++L++ +R                LL + +I 
Sbjct:   402 GCVTWTGELFDIRNYAKGGQDLYVRLAATDLED-KRNRSAKIIGSSIGVSVLLLLSFIIF 460

Query:   300 IGGFMYMRKKKR---------------RDQ-GNTVGSSELDYIDRGNRKENMELPMFDWN 343
                F++ RK+KR               RD   N V  S   +I R N  +++ELP+ ++ 
Sbjct:   461 ---FLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFE 517

Query:   344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
              +A AT+NFS  NKLG+GGFG VY+G L +GQE+AVKRLSK+S QG +EFKNEV LIA+L
Sbjct:   518 EVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARL 577

Query:   404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
             QH NLVRLL CC    E+MLIYEYL N SL+  +FD +R   L+W  R  II GIARGLL
Sbjct:   578 QHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLL 637

Query:   464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
             YLHQDSR RIIHRDLKASN+LLD  M PKISDFGMAR FG D+TEANT +VVGTYGYMSP
Sbjct:   638 YLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSP 697

Query:   524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
             EYA+DG+FS+KSDVFSFGVL+LEI+  KRN+GFY++D   NLLG  WR W E + LE+ID
Sbjct:   698 EYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIID 757

Query:   584 KSLDGSYSL---SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFT 639
               +  S S     E LRCIQ+GLLCVQ+R EDRP MS V+LML  E + +PQPK PG+  
Sbjct:   758 PIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCL 817

Query:   640 ERNLPESESSSSKRKLPLS---NEITISLIEGR 669
             ER+L +++SSSSK++   S   N+IT+S+++ R
Sbjct:   818 ERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1676 (595.0 bits), Expect = 1.8e-172, P = 1.8e-172
 Identities = 339/691 (49%), Positives = 455/691 (65%)

Query:     1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
             MKLG +  TG  R + SWK+ DDP+   +  +++    P+        I +R+GPWNG+ 
Sbjct:   161 MKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMR 220

Query:    61 WTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWA 120
             ++  P         + + +++ EV Y + + K+++ + + +N  G  QRLTW E TQ W 
Sbjct:   221 FSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWK 280

Query:   121 PFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRR 180
                 +S    D CDNY +CG +  C+ NS    C C++GF P +   WDL D S GC+R+
Sbjct:   281 QLW-YSPK--DLCDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQAWDLRDGSAGCMRK 336

Query:   181 TQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSG 240
             T+L C+  DGF + + +KLPDT+ + VD+ I +  CKE C ++C+CTA+ANAD+R GGSG
Sbjct:   337 TRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSG 396

Query:   241 CLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLATGVILI 300
             C++W  +++DM+  ++GGQDLY+R+A +EL++ +R                LL + VI  
Sbjct:   397 CVIWTREILDMRNYAKGGQDLYVRLAAAELED-KRIKNEKIIGSSIGVSILLLLSFVIF- 454

Query:   301 GGFMYMRKKKR------------RDQG---NTVGSSELDYIDRGNRKENMELPMFDWNTI 345
                 + RK+KR            R Q    N V  S   Y  +  + E +ELP+ +   +
Sbjct:   455 --HFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEAL 512

Query:   346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
             A AT+NFS  NKLG+GGFG VY+G L +G+EIAVKRLSK S QG +EF NEV LIAKLQH
Sbjct:   513 ATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQH 572

Query:   406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
              NLVRLLGCC  + E+MLIYEYL N SL+  +FD TR+  L+W KR  II GIARGLLYL
Sbjct:   573 INLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYL 632

Query:   466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
             HQDSR RIIHRDLKASNVLLD +M PKISDFGMAR FG ++TEANT RVVGTYGYMSPEY
Sbjct:   633 HQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEY 692

Query:   526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK- 584
             A+DG+FS+KSDVFSFGVL+LEI+ GKRN+GFY+++   NLLG  WR W E   LE++D  
Sbjct:   693 AMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPI 752

Query:   585 ---SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTE 640
                SL   +   E LRCIQ+GLLCVQ+R EDRP MSSV++ML  E + +PQPK+PGF   
Sbjct:   753 NIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIG 812

Query:   641 RNLPESESSSSKRKLP--LSNEITISLIEGR 669
             R+  E++SSSS ++      N+IT+S+I+ R
Sbjct:   813 RSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1639 (582.0 bits), Expect = 1.5e-168, P = 1.5e-168
 Identities = 332/692 (47%), Positives = 452/692 (65%)

Query:     1 MKLGV-NLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGL 59
             MK+G  N   G  R + SWK+ DDP+  ++  ++   G P+        I +R+GPW G 
Sbjct:   165 MKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGN 224

Query:    60 HWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKW 119
              ++  P ++P       +  N  +V Y + + K+++ +++ ++  G  QRLTWME  Q W
Sbjct:   225 RFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSW 284

Query:   120 APFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIR 179
                  +S    D CDNY  CG Y  C+ N+ S  C C++GF P +  +  L D S GC+R
Sbjct:   285 KQLW-YSPK--DLCDNYKECGNYGYCDANT-SPICNCIKGFEPMN-EQAALRDDSVGCVR 339

Query:   180 RTQLDCEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGS 239
             +T+L C+  DGF++ + ++LPDT+ + VDK I +  C+E C K C+CTA+AN D+R GGS
Sbjct:   340 KTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGS 399

Query:   240 GCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLATGVIL 299
             GC++W   L D++  ++GGQDLY+R+A  +L++ +R                LL + +I 
Sbjct:   400 GCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLED-KRIKSKKIIGSSIGVSILLLLSFIIF 458

Query:   300 IGGFMYMRKKKR------------RDQG---NTVGSSELDYIDRGNRKENMELPMFDWNT 344
                  + RK+KR            R Q    N +  +   Y  + N+ + +ELP+ +W  
Sbjct:   459 ---HFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKA 515

Query:   345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
             +A AT+NFS  NKLG+GGFG VY+GML +G+EIAVKRLSK S QG +EF NEV LIAKLQ
Sbjct:   516 LAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQ 575

Query:   405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
             H NLVRLLGCC  + E+MLIYEYL N SL+  +FD TR+  L+W KR  II GIARGLLY
Sbjct:   576 HINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLY 635

Query:   465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
             LHQDSR RIIHRDLKASNVLLD +M PKISDFGMAR FG ++TEANT RVVGTYGYMSPE
Sbjct:   636 LHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPE 695

Query:   525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
             YA+DG+FS+KSDVFSFGVL+LEI+ GKRN+GFY+++   NLLG  WR W E + LE++D 
Sbjct:   696 YAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDP 755

Query:   585 ----SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFT 639
                 +L   +   E LRCIQ+GLLCVQ+R EDRP MSSV++ML  E + +PQPK+PGF  
Sbjct:   756 INIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCV 815

Query:   640 ERNLPESESSSSKRKLP--LSNEITISLIEGR 669
              R+  E +SSSS ++      N++T+S+I+ R
Sbjct:   816 GRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1440 (512.0 bits), Expect = 1.9e-147, P = 1.9e-147
 Identities = 322/701 (45%), Positives = 423/701 (60%)

Query:     1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKI-KFRAGPWNGL 59
             M++ VN  TG      SW+S  DP+  NY   VDP G P+ V  +G+K  K+R+G WN  
Sbjct:   164 MRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSA 223

Query:    60 HWTGTPQLQ--PNPVYTFEYVSNENE---VFYRFNLIKSSVLTMMVINPQGEPQRLTWME 114
              +TG P +    N +Y F+  S  +E   V++ +     SVL    +   G  + L W E
Sbjct:   224 IFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNE 283

Query:   115 QTQKWAPFVPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTS 174
               +KW  F         +CD Y  CG + IC+M  ++  C C+ G+   S   W     S
Sbjct:   284 TLKKWTKFQSEPD---SECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----S 335

Query:   175 DGCIRRTQLDCEHG-----DGFLKRESVKLPDTSFSRVDKN-ISILACKELCSKNCSCTA 228
              GC RRT L CE       D FL  +SVKLPD  F   + N +    C+E C +NCSC A
Sbjct:   336 RGCRRRTPLKCERNISVGEDEFLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNA 393

Query:   229 YANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXX 288
             Y+      GG GC++W  DL+D++    GG  L+IR+A SE+    +T            
Sbjct:   394 YSLV----GGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGV 449

Query:   289 XC----ALLATGVI----LIGGF--------MYMRKKKRRDQGNTVGSSELDYIDRGNRK 332
                   ALL         + G +        + +    +  +  +  S  +D +  G   
Sbjct:   450 ILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAV 509

Query:   333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE 392
                ELP+F  N IA AT++F  +N+LG GGFGPVY+G+L +G+EIAVKRLS  SGQGV+E
Sbjct:   510 NTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDE 569

Query:   393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC 452
             FKNE++LIAKLQHRNLVRLLGCC   +E+ML+YEY+PNKSL+ F+FD T+   +DW  R 
Sbjct:   570 FKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRF 629

Query:   453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
              IIEGIARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFGMAR FG +Q EANT 
Sbjct:   630 SIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTV 689

Query:   513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 572
             RVVGTYGYMSPEYA++GLFSVKSDV+SFGVL+LEIV GKRN     +  H +L+G+AW L
Sbjct:   690 RVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL-RSSEHGSLIGYAWYL 748

Query:   573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQ 631
             +T  RS EL+D  +  + S  EALRCI V +LCVQ    +RPNM+SV+LML  + + L  
Sbjct:   749 YTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAA 808

Query:   632 PKQPGFF-TERNLPESESS--SSKRKLPLSNEITISLIEGR 669
             P+QP F  T RN  +   +  SS++ +  SNEIT +++ GR
Sbjct:   809 PRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1398 (497.2 bits), Expect = 5.3e-143, P = 5.3e-143
 Identities = 297/695 (42%), Positives = 422/695 (60%)

Query:     1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
             M++ VN   G  R    WKS  DP+   Y   +DP G  + V  +G K K+R+GPWN   
Sbjct:   162 MRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAI 221

Query:    61 WTGTPQLQ--PNPVYTFEYVS---NENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQ 115
             +TG P +    N +Y F+  S    +  V++ +    SS      I P G  ++  W + 
Sbjct:   222 FTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKD 281

Query:   116 TQKW--APFVPFSGLILDQCDNYALCGAYAICNMNS--NSARCECLEGFVPKSPSEWDLL 171
              + W    + P +     +C+ Y  CG Y++C+ +   +S +C C++GF P    +W+  
Sbjct:   282 IRNWNLLQWKPST-----ECEKYNRCGNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNR 336

Query:   172 DTSDGCIRRTQLDCEHG------DGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCS 225
             D S GC RR  L+C         DGF   + +K+PD  F  V  + +   CK++C+++CS
Sbjct:   337 DFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPD--FGSVVLHNNSETCKDVCARDCS 394

Query:   226 CTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXX 285
             C AYA       G GC++W  DLIDM+    GG  + IR+A S+L   +           
Sbjct:   395 CKAYALVV----GIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGGGKENSTLWIIVFS 450

Query:   286 XXXXCALLATGVILIGGFMYMRKK---KRRD-------QGNTVGSSELDYIDRGNRKENM 335
                   LL   + ++  F    K    K++D       +     SS +  +  G++ +  
Sbjct:   451 VIGAF-LLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSPIKVLV-GDQVDTP 508

Query:   336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN 395
             +LP+F ++++A AT +F+ +NKLG+GGFG VY+G  +EG+EIAVKRLS  S QG+EEFKN
Sbjct:   509 DLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKN 568

Query:   396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
             E+LLIAKLQHRNLVRLLGCC   +E+ML+YEY+PNKSL++F+FD ++   LDW KR ++I
Sbjct:   569 EILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVI 628

Query:   456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
              GIARGLLYLH+DSRL+IIHRDLKASN+LLD +MNPKISDFGMAR F   Q  ANT RVV
Sbjct:   629 GGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVV 688

Query:   516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE 575
             GTYGYM+PEYA++G+FS KSDV+SFGVL+LEIV G++N  F   DH  +L+G+AW LW++
Sbjct:   689 GTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGYAWHLWSQ 747

Query:   576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQ 634
              ++ E+ID  +  +  ++EA+RCI VG+LC Q     RPNM SV+LML  + S LP P+Q
Sbjct:   748 GKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQ 807

Query:   635 PGFFTERNLPESESSSSKRKLPLSNEITISLIEGR 669
             P F +  N  + E +     +   N++T + I GR
Sbjct:   808 PTFHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 1344 (478.2 bits), Expect = 2.8e-137, P = 2.8e-137
 Identities = 294/679 (43%), Positives = 402/679 (59%)

Query:    12 KRFMSSWKSADDPAQDNYIYEVDPRGVPQA-VFRKGSKIKFRAGPWNGLHWTGTPQLQPN 70
             +   +SW S  DP+   Y   +DP    QA +++ G+   +R+G WNG+++ G P     
Sbjct:   182 RMLFTSWASETDPSPGRYALGLDPGNSGQAYIWKDGNVTYWRSGQWNGVNFIGIPW---R 238

Query:    71 PVYTFEYVSNENEV---FYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSG 127
             P+Y   +    + V   +Y +    +S L   V+ P G        + +Q W   V +  
Sbjct:   239 PLYRSGFTPAIDPVLGNYYTYTATNTS-LQRFVVLPNGTDICYMVRKSSQDWE-LVWYQP 296

Query:   128 LILDQCDNYALCGAYAICNMNSNS-ARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCE 186
                ++C+ YA CG  A C  + +  A+C CL+GF PK   +W+  + S GCIR   L CE
Sbjct:   297 S--NECEYYATCGPNAKCTASQDGKAKCTCLKGFHPKLQEQWNAGNWSQGCIRSPPLGCE 354

Query:   187 ---HGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLL 243
                 GDGFL   ++K PD S+  V        C+ +C  NCSC AY    V    +GCL 
Sbjct:   355 TNQSGDGFLPMGNIKWPDFSYW-VSTVGDEPGCRTVCLNNCSCGAY----VYTATTGCLA 409

Query:   244 WFHDLIDMKVLSEGGQDLYIRMATSELDN----FERTXXXXXXXXXXXXXCALL--ATGV 297
             W ++LIDM  L  G   L +++  SEL      ++               C LL    G 
Sbjct:   410 WGNELIDMHELQTGAYTLNLKLPASELRGHHPIWKIATIISAIVLFVLAACLLLWWKHGR 469

Query:   298 IL---IGGFMYMRKKKRRDQGNTVG---SSELDYIDRGNRKENMELPMFDWNTIADATDN 351
              +   + G    R    + Q N+     S  + + D     ++ EL ++  + I  AT N
Sbjct:   470 NIKDAVHGSWRSRHSSTQSQQNSAMLDISQSIRFDDDVEDGKSHELKVYSLDRIRTATSN 529

Query:   352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
             FS  NKLGEGGFGPVY G L  G+E+AVKRL ++SGQG+EEFKNEV+LIAKLQHRNLVRL
Sbjct:   530 FSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRL 589

Query:   412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
             LGCC  R+E++L+YEY+PNKSL+ F+F+  + + LDW KR  IIEGIARGLLYLH+DSRL
Sbjct:   590 LGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRL 649

Query:   472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
             R++HRDLKASN+LLD DM PKISDFGMAR FG DQ + NT+RVVGT+GYMSPEYA++G+F
Sbjct:   650 RVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIF 709

Query:   532 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS 591
             SVKSDV+ FGVL+LEI+ GKR   F+  +   N+ G+AWR W ED + ELID  +  S S
Sbjct:   710 SVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCS 769

Query:   592 LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNLPESESSS 650
             + + LRCI + LLCVQ   ++RP++ +V+LMLS + S LP P+ P         ES  SS
Sbjct:   770 VRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLMLRGREIESSKSS 829

Query:   651 SKRKLPLSNEITISLIEGR 669
              K +      +T++ + GR
Sbjct:   830 EKDRSHSIGTVTMTQLHGR 848

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1341 (477.1 bits), Expect = 5.8e-137, P = 5.8e-137
 Identities = 293/686 (42%), Positives = 404/686 (58%)

Query:     1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLH 60
             M L  +  TG    + SWKS  DP+   Y   + P   P+ V  K   + +R+GPWNG +
Sbjct:   158 MSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQY 217

Query:    61 WTGTPQLQPNPVYTFEY-VSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKW 119
             + G P +    +  FE  +S++N      +   +++L   +++ +G   +  W    Q+W
Sbjct:   218 FIGLPNMDYR-INLFELTLSSDNRGSVSMSYAGNTLLYHFLLDSEGSVFQRDWNVAIQEW 276

Query:   120 APFVPFSGLILDQCDNYALCGAYAICNMNSNSAR-CECLEGFVPKSPSEWDLLDTSDGCI 178
               ++        +CD YA CG +A C  N  S   C C+ GF P+S +EW+  + + GC+
Sbjct:   277 KTWLKVPST---KCDTYATCGQFASCRFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCV 333

Query:   179 RRTQLDCEH---------GDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAY 229
             R+  L CE           DGF++ + +K+P     R   N     C E C KNCSCTAY
Sbjct:   334 RKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNP-QRSGANEQ--DCPESCLKNCSCTAY 390

Query:   230 ANADVRGGGSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXX 289
             +  D RG   GCLLW  +L+DM+  S  G   YIR+A SE    +RT             
Sbjct:   391 S-FD-RG--IGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFK--KRTNRSIVITVTLLVG 444

Query:   290 CALLATGVIL-IGGFMYMRKKKRRDQGNTVGSSELDYIDRG----NRKENMELPMFDWNT 344
               L A  V+L +      R+K R  +        L   D G    N+ +  ELP+F++  
Sbjct:   445 AFLFAGTVVLALWKIAKHREKNRNTRLLNERMEALSSNDVGAILVNQYKLKELPLFEFQV 504

Query:   345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
             +A AT+NFS  NKLG+GGFG VY+G L EG +IAVKRLS++SGQGVEEF NEV++I+KLQ
Sbjct:   505 LAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQ 564

Query:   405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
             HRNLVRLLG C   +ERML+YE++P   L+ ++FD  + + LDW  R  II+GI RGL+Y
Sbjct:   565 HRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMY 624

Query:   465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
             LH+DSRL+IIHRDLKASN+LLD ++NPKISDFG+AR F  ++ E +T RVVGTYGYM+PE
Sbjct:   625 LHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPE 684

Query:   525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
             YA+ GLFS KSDVFS GV++LEIV G+RN  FY+   + NL  +AW+LW     + L+D 
Sbjct:   685 YAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDP 744

Query:   585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNL 643
              +      +E  RC+ VGLLCVQ    DRP++++V+ MLS E S LP+PKQP F   R  
Sbjct:   745 VIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGT 804

Query:   644 PESESSSSKRKLPLSNEITISLIEGR 669
              E ESS         N ++++ I GR
Sbjct:   805 SEVESSGQSDPRASINNVSLTKITGR 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)]

 Score = 1302 (463.4 bits), Expect = 7.9e-133, P = 7.9e-133
 Identities = 282/672 (41%), Positives = 397/672 (59%)

Query:    12 KRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNP 71
             KR +SSWK+  DP+   ++ E+  +  PQ    +GS+  +R GPW  + +TG P++  + 
Sbjct:   167 KRVLSSWKNPTDPSPGEFVAELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSH 226

Query:    72 VYTFEY----VSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSG 127
             V  F+      +    + Y     ++S L+   +   G   ++ W      W   +    
Sbjct:   227 VSKFDISQDVAAGTGSLTYSLER-RNSNLSYTTLTSAGS-LKIIW-NNGSGWVTDLEAP- 282

Query:   128 LILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSPSEWDLLDTSDGCIRRTQLDCE- 186
               +  CD Y  CG + +C + SN  +CECL+GFVPKS  EW+  + + GC+RRT L C+ 
Sbjct:   283 --VSSCDVYNTCGPFGLC-IRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDV 339

Query:   187 ---------HGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGG 237
                      +GD F    +VK PD  F      I+   C++ C  NCSCTA++  +    
Sbjct:   340 NSSATAQANNGDIFDIVANVKPPD--FYEYLSLINEEDCQQRCLGNCSCTAFSYIEQ--- 394

Query:   238 GSGCLLWFHDLIDMKVLSEGGQDLYIRMATSELDNFERTXXXXXXXXXXXXXCALLATGV 297
               GCL+W  +L+D+     GG+ L IR+A+SEL    R                     +
Sbjct:   395 -IGCLVWNRELVDVMQFVAGGETLSIRLASSELAGSNRVKIIVASIVSISVFM------I 447

Query:   298 ILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNK 357
             ++   + Y R K +++  N +         R   K   ++  FD  TI   T+NFS +NK
Sbjct:   448 LVFASYWYWRYKAKQNDSNPIPLETSQDAWREQLKPQ-DVNFFDMQTILTITNNFSMENK 506

Query:   358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
             LG+GGFGPVY+G L +G+EIA+KRLS +SGQG+EEF NE++LI+KLQHRNLVRLLGCC  
Sbjct:   507 LGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIE 566

Query:   418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD 477
              +E++LIYE++ NKSL  FIFD T+   LDW KR +II+GIA GLLYLH+DS LR++HRD
Sbjct:   567 GEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRD 626

Query:   478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDV 537
             +K SN+LLD +MNPKISDFG+AR F   Q +ANT RVVGT GYMSPEYA  G+FS KSD+
Sbjct:   627 MKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDI 686

Query:   538 FSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALR 597
             ++FGVL+LEI+ GKR   F   +    LL  AW  W E    +L+D+ +  S S SE  R
Sbjct:   687 YAFGVLLLEIITGKRISSFTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSGSESEVAR 746

Query:   598 CIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSSKRKLPL 657
             C+Q+GLLC+QQ+  DRPN++ V+ ML+    LP+PKQP F  +  + ES+S S  + +  
Sbjct:   747 CVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKPKQPVFAMQ--VQESDSES--KTMYS 802

Query:   658 SNEITISLIEGR 669
              N IT + I GR
Sbjct:   803 VNNITQTAIVGR 814

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O81832	Y4729_ARATH	2, ., 7, ., 1, 1, ., 1	0.5484	0.9267	0.7918	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.01340036 hypothetical protein (831 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	669
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-34
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	1e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-28
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-28
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-27
pfam08276	66	pfam08276, PAN_2, PAN-like domain	4e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-26
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-24
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-24
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	7e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-22
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-21
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-21
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-20
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-20
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-20
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-17
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-09
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-08
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	4e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd00129	80	cd00129, PAN_APPLE, PAN/APPLE-like domain; present	4e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.003
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.003
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  181 bits (461), Expect = 2e-52
 Identities = 97/278 (34%), Positives = 135/278 (48%), Gaps = 36/278 (12%)

Query: 357 KLGEGGFGPVYRGMLT-----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVR 410
           KLGEG FG VY+G L      +  E+AVK L +  S Q +EEF  E  ++ KL H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           LLG CT  +  M++ EY+P   L  ++    R K L  S        IARG+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYAI 527
              IHRDL A N L+  ++  KISDFG++R    D  + +  +V G      +M+PE   
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGHAWRLWTEDRSLELIDKS 585
           +G F+ KSDV+SFGVL+ EI       G   Y    +  +L +      +   L      
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIF----TLGEEPYPGMSNAEVLEYL----KKGYRLPKPPNC 229

Query: 586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
               Y L   L+C         + PEDRP  S +V +L
Sbjct: 230 PPELYKL--MLQCW-------AEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  179 bits (457), Expect = 8e-52
 Identities = 91/278 (32%), Positives = 128/278 (46%), Gaps = 33/278 (11%)

Query: 355 KNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNL 408
             KLGEG FG VY+G L      +  E+AVK L + +S Q +EEF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V+LLG CT  +   ++ EY+    L  ++        L  S        IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ-TEANTDRVVGTYGYMSPEYAI 527
                IHRDL A N L+  ++  KISDFG++R    D        ++     +M+PE   
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLK 176

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGHAWRLWTEDRSLELIDKS 585
           +G F+ KSDV+SFGVL+ EI       G   Y    +  +L +          L      
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIF----TLGEQPYPGMSNEEVLEYL----KNGYRLPQPPNC 228

Query: 586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
               Y L   L+C         + PEDRP  S +V +L
Sbjct: 229 PPELYDL--MLQCW-------AEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (441), Expect = 4e-50
 Identities = 71/194 (36%), Positives = 108/194 (55%), Gaps = 11/194 (5%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           LGEGGFG VY       G+++A+K + K  S   +EE   E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
              +   L+ EY    SL+  + +      L   +  +I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 476 RDLKASNVLLDND-MNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSV 533
           RDLK  N+LLD+D    K++DFG+++    D++   T  +VGT  YM+PE  +  G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 534 KSDVFSFGVLVLEI 547
           KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  172 bits (439), Expect = 2e-49
 Identities = 91/296 (30%), Positives = 127/296 (42%), Gaps = 63/296 (21%)

Query: 356 NKLGEGGFGPVYRGMLTEGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVR 410
            KLGEG FG VY+G L        E+AVK L +  S +  ++F  E  ++ KL H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLY 464
           LLG CT  +   L+ EY+    L  ++      F       L           IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG----- 519
           L      + +HRDL A N L+  D+  KISDFG++R         +      T G     
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYHADHHHNLLGHAWRL 572
           +M+PE   DG+F+ KSDV+SFGVL+ EI         G  N                   
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------------------ 214

Query: 573 WTEDRSLELIDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
                  E+++    G          + L   ++ L C Q  PEDRP  S +V  L
Sbjct: 215 -------EVLEYLRKGYRLPKPEYCPDELY--ELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (414), Expect = 7e-46
 Identities = 75/203 (36%), Positives = 107/203 (52%), Gaps = 17/203 (8%)

Query: 357 KLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVR 410
           KLGEG FG VY+G L         ++AVK L + +  +  EEF  E  ++ KL H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           LLG CT  +   ++ EY+P   L  F+      + L      Q+   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG---YMSPEYAI 527
              +HRDL A N L+  ++  KISDFG++R   + + +    R  G      +M+PE   
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKR-GGGKLPIKWMAPESLK 177

Query: 528 DGLFSVKSDVFSFGVLVLEIVCG 550
           DG F+ KSDV+SFGVL+ EI   
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  162 bits (413), Expect = 1e-45
 Identities = 76/261 (29%), Positives = 111/261 (42%), Gaps = 24/261 (9%)

Query: 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLLG 413
            KLGEG FG VY     + G+ +A+K + K   +   E    E+ ++ KL+H N+VRL  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D+  L+ EY     L   +    +   L   +    +  I   L YLH      I
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGI 118

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           +HRDLK  N+LLD D + K++DFG+AR     +        VGT  YM+PE  +   +  
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGYGK 175

Query: 534 KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS 593
             D++S GV++ E++ GK     +  D     L                D S        
Sbjct: 176 AVDIWSLGVILYELLTGKP---PFPGDDQLLELFKKIGKPKPPFPPPEWDIS-------P 225

Query: 594 EALRCIQVGLLCVQQRPEDRP 614
           EA   I+  LL     PE R 
Sbjct: 226 EAKDLIR-KLLVKD--PEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  161 bits (410), Expect = 3e-45
 Identities = 72/199 (36%), Positives = 105/199 (52%), Gaps = 12/199 (6%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           KLG G FG VY+      G+ +AVK L K S   +  +  + E+ ++ +L H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               +D   L+ EY     L  ++   +R   L   +  +I   I RGL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL-FS 532
           IHRDLK  N+LLD +   KI+DFG+A+      +   T   VGT  YM+PE  + G  + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177

Query: 533 VKSDVFSFGVLVLEIVCGK 551
            K DV+S GV++ E++ GK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  144 bits (366), Expect = 4e-39
 Identities = 71/214 (33%), Positives = 111/214 (51%), Gaps = 27/214 (12%)

Query: 353 SWK--NKLGEGGFGPVYRGMLTE-GQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRN 407
            W     LG G FG VY  +  + G+ +AVK   LS  S + +E  + E+ +++ LQH N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 408 LVRLLGCCTLRDERML-IY-EYLPNKSLEQFI--F-----DVTRTKFLDWSKRCQIIEGI 458
           +VR  G     ++  L I+ EY+   SL   +  F      V R     +++  QI+EG+
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR----KYTR--QILEGL 114

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           A    YLH      I+HRD+K +N+L+D+D   K++DFG A+  G  +T   T  V GT 
Sbjct: 115 A----YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
            +M+PE      +   +D++S G  V+E+  GK 
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  130 bits (328), Expect = 5e-34
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 15/204 (7%)

Query: 352 FSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           F    K+G+GGFG VY+      G+E+A+K +   S +  E+  NE+ ++ K +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI---IEGIARGLLYLHQ 467
             G    +DE  ++ E+    SL+  +   T           QI    + + +GL YLH 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTL----TESQIAYVCKELLKGLEYLHS 116

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
                IIHRD+KA+N+LL +D   K+ DFG++            + +VGT  +M+PE   
Sbjct: 117 ---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVIN 170

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGK 551
              +  K+D++S G+  +E+  GK
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score =  121 bits (305), Expect = 1e-32
 Identities = 41/116 (35%), Positives = 69/116 (59%), Gaps = 8/116 (6%)

Query: 51  FRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRL 110
           +R+GPWNG+ ++G P++Q    Y + +  N  EV+Y + +  +S+ + + ++ +G  +R 
Sbjct: 1   WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60

Query: 111 TWMEQTQKWAPF--VPFSGLILDQCDNYALCGAYAICNMNSNSARCECLEGFVPKS 164
           TW+  +Q W  F   P      DQCD Y  CG Y  C++N  S +C C++GFVPK+
Sbjct: 61  TWIPNSQDWNLFWSAP-----KDQCDVYGRCGPYGYCDVN-TSPKCNCIKGFVPKN 110

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  125 bits (315), Expect = 3e-32
 Identities = 70/200 (35%), Positives = 102/200 (51%), Gaps = 22/200 (11%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG G FG V+ G      ++AVK L K      E F  E  ++ KL+H  LV+L   C+
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 417 LRDERMLIYEYLPNKSLEQFIFD-----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
             +   ++ EY+   SL  F+       +   + +D +   QI EG+A    YL      
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA--AQIAEGMA----YLE---SR 122

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYAID 528
             IHRDL A N+L+  ++  KI+DFG+AR    D+  A      G      + +PE A  
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANY 178

Query: 529 GLFSVKSDVFSFGVLVLEIV 548
           G F++KSDV+SFG+L+ EIV
Sbjct: 179 GRFTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 3e-32
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 15/206 (7%)

Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRN 407
           N+   + +G G FG VY+G+ L  G  +A+K++S      + ++    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--CQIIEGIARGLLYL 465
           +V+ +G     D   +I EY  N SL Q I      KF  + +      +  + +GL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII-----KKFGPFPESLVAVYVYQVLQGLAYL 115

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H+     +IHRD+KA+N+L   D   K++DFG+A    ++    +   VVGT  +M+PE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEV 170

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                 S  SD++S G  V+E++ G 
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  126 bits (317), Expect = 1e-31
 Identities = 88/329 (26%), Positives = 136/329 (41%), Gaps = 25/329 (7%)

Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSK---SSGQGVEEFKNEVLLIAKLQH-R 406
           ++    KLGEG FG VY       + +A+K L+K   S  + VE F  E+ ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+L           L+ EY+   SLE  +  + R   L  S+   I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 467 QDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDR----VVGTYGYM 521
                 IIHRD+K  N+LLD +    K+ DFG+A+      + ++        VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 522 SPEYAIDGLF---SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS 578
           +PE  +       S  SD++S G+ + E++ G             +       +      
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233

Query: 579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF 638
                 S      +S+A   +   LL     P++R + SS +        L   K     
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKD--PKNRLSSSSDLSHD----LLAHLKLKESD 287

Query: 639 TERNLPESESSSSKRKLPLSNEITISLIE 667
               L   +S+  +  LP S E  IS + 
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLN 316

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  123 bits (311), Expect = 2e-31
 Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 39/293 (13%)

Query: 356 NKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
            +LGEG FG V            G+++AVK L+ S   Q   +F+ E+ ++  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 410 RLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLH 466
           +  G C     R   LI EYLP+ SL  ++    R +  ++  +       I +G+ YL 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT--EANTDRVVGTYGYMSPE 524
                R IHRDL A N+L++++   KISDFG+A+    D+             + Y +PE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH----------ADHHHNLLGHAWRLWT 574
                 FS  SDV+SFGV + E+                           ++     L  
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELF--TYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240

Query: 575 EDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 627
           E   L       D  Y L +         LC +  P+DRP+ + ++L++   R
Sbjct: 241 EGERLPRPPSCPDEVYDLMK---------LCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  121 bits (307), Expect = 5e-31
 Identities = 83/290 (28%), Positives = 126/290 (43%), Gaps = 59/290 (20%)

Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 407
            +    ++G+G FG VY        ++  +K   LS  S +  E+  NEV ++ KL H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKF-----LDWSKRCQIIEGIAR 460
           +++       + +  ++ EY     L Q I         F     LDW    Q+      
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQL----CL 114

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L YLH  SR +I+HRD+K  N+ L ++   K+ DFG+++        A T  VVGT  Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169

Query: 521 MSPE------YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT 574
           +SPE      Y      + KSD++S G ++ E+   K      H     NL         
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLK------HPFEGENL--------- 208

Query: 575 EDRSLELIDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
               LEL  K L G Y       S  LR +   LL  Q+ PE+RP+++ +
Sbjct: 209 ----LELALKILKGQYPPIPSQYSSELRNLVSSLL--QKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 6e-31
 Identities = 84/288 (29%), Positives = 121/288 (42%), Gaps = 54/288 (18%)

Query: 356 NKLGEGGFGPVYRGMLTE--GQEI--AVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVR 410
            +LG G FG V +G+     G+E+  AVK L +     G +EF  E  ++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFD---VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           L+G C   +  ML+ E  P   L +++     +  +   + + +      +A G+ YL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMS 522
                 +HRDL A NVLL N    KISDFGM+RA G             T G     + +
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
           PE    G FS KSDV+S+GV + E      K       A+                    
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------------------- 206

Query: 581 LIDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLS 624
            +   L+    L     C Q    + L C + RPEDRP  S +     
Sbjct: 207 -VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  121 bits (304), Expect = 9e-31
 Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 6/197 (3%)

Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           F+ + KLG G FG V+ G+      +A+K L        ++F+ EV  + +L+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
              C++ +   +I E +   SL  F+      + L  +    +   +A G+ YL +    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
             IHRDL A N+L+  D+  K++DFG+AR    D   ++  ++   Y + +PE A  G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 532 SVKSDVFSFGVLVLEIV 548
           S KSDV+SFG+L+ E+ 
Sbjct: 182 STKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  121 bits (305), Expect = 1e-30
 Identities = 76/214 (35%), Positives = 108/214 (50%), Gaps = 31/214 (14%)

Query: 358 LGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVR 410
           LGEG FG VY+G LT          +A+K L ++   +  +EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQIIEG 457
           LLG CT      +++EYL +  L +F+              D T    LD S    I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           IA G+ YL   S    +HRDL A N L+   +  KISDFG++R    D   A+  RV   
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADYYRVQSK 185

Query: 518 ----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                 +M PE  + G F+ +SD++SFGV++ EI
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  119 bits (301), Expect = 5e-30
 Identities = 68/232 (29%), Positives = 102/232 (43%), Gaps = 43/232 (18%)

Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-Q 404
           D+F +   +GEG F  V         +E A+K L K      + V+  K E  ++ +L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 405 HRNLVRLLGCCTLRDERML--IYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEG 457
           H  +++L    T +DE  L  + EY PN  L Q+I      D   T+F            
Sbjct: 61  HPGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAE 110

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV--- 514
           I   L YLH      IIHRDLK  N+LLD DM+ KI+DFG A+    + +  +       
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 515 ---------------VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                          VGT  Y+SPE   +      SD+++ G ++ +++ GK
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 2e-29
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 21/206 (10%)

Query: 358 LGEGGFGPVYRGMLT-EGQ----EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+   EG+     +A+K L + +  +  +E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT----KFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L  +  LI + +P   L  ++ +          L+W  +      IA+G+ YL +
Sbjct: 75  LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HRDL A NVL+    + KI+DFG+A+   VD+ E + +       +M+ E  +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 528 DGLFSVKSDVFSFGVLVLEIVC-GKR 552
             +++ KSDV+S+GV V E++  G +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  117 bits (296), Expect = 3e-29
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 23/213 (10%)

Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
            D  + +    K+GEG  G VY+      G+E+A+K++ +   Q  E   NE+L++   +
Sbjct: 15  GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCK 73

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSL----EQFIFDVTRTKFLDWSKRCQI---IEG 457
           H N+V       + DE  ++ EY+   SL     Q    +            QI      
Sbjct: 74  HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE---------PQIAYVCRE 124

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           + +GL YLH      +IHRD+K+ N+LL  D + K++DFG A     ++++ N+  VVGT
Sbjct: 125 VLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             +M+PE      +  K D++S G++ +E+  G
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 1e-28
 Identities = 66/197 (33%), Positives = 100/197 (50%), Gaps = 12/197 (6%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
             KLG G FG V+ G+      +AVK L K      ++F  E  ++ KL+H  L++L   
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
           CTL +   ++ E +   SL +++        L   +   +   +A G+ YL   +    I
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YI 125

Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYAIDGLF 531
           HRDL A NVL+  +   K++DFG+AR    D  EA      G      + +PE A+   F
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRF 181

Query: 532 SVKSDVFSFGVLVLEIV 548
           S+KSDV+SFG+L+ EIV
Sbjct: 182 SIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 29/234 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRG---MLTEGQE---IAVKRLSKSSGQGVEE-FKNEVLLIAK 402
           D    K +LGEG FG V+ G    L    +   +AVK L +++     + F+ E  L+  
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----------IFDVTRTKFLDWSKR 451
            QH N+V+  G CT  D  ++++EY+ +  L +F               +    L  S+ 
Sbjct: 65  FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
            QI   IA G++YL   +    +HRDL   N L+  D+  KI DFGM+R    D    + 
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDY 177

Query: 512 DRVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
            RV G       +M PE  +   F+ +SDV+SFGV++ EI    +   +  ++ 
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  113 bits (284), Expect = 6e-28
 Identities = 74/212 (34%), Positives = 108/212 (50%), Gaps = 28/212 (13%)

Query: 358 LGEGGFGPVYRGML-------TEGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 409
           LG G FG VY G         +    +AVK L K ++ Q  +EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----LDWSKRCQIIEGIARGLLYL 465
           +LLG C L + + +I E +    L  ++ D    +F    L   +   I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 466 HQDSRLRIIHRDLKASNVLL-----DNDMNPKISDFGMARAFGVDQTEANTDRVVGT--- 517
            Q   +  IHRDL A N L+     D D   KI DFG+AR    D  +++  R  G    
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEGLL 175

Query: 518 -YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
              +M+PE  +DG F+ +SDV+SFGVL+ EI+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  112 bits (282), Expect = 1e-27
 Identities = 81/297 (27%), Positives = 124/297 (41%), Gaps = 52/297 (17%)

Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQEIAVK---RLSKSSGQGVEEFKNEVLLI 400
             D+ +    LG G FG VY    RG   +  E+ V         S Q   +F  E L++
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIE 456
           +K  H+N+VRL+G    R  R ++ E +    L+ F+ +      R   L          
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMAR-AFGVDQTEANTD 512
            +A+G  YL ++     IHRD+ A N LL         KI+DFGMAR  +          
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG-G 179

Query: 513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYHADHHHNL 565
           R +    +M PE  +DG+F+ K+DV+SFGVL+ EI         G+ N+           
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----------- 228

Query: 566 LGHAWRLWTEDRSLELIDKS--LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
                        +E +     LD        +   ++   C Q  PEDRPN ++++
Sbjct: 229 -----------EVMEFVTGGGRLDPPKGCPGPV--YRIMTDCWQHTPEDRPNFATIL 272

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 2e-27
 Identities = 77/271 (28%), Positives = 120/271 (44%), Gaps = 51/271 (18%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+G FG V      + G+  A+K L K      + VE    E  +++++ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 414 CCTLRDERML--IYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
               + E  L  + EY P   L     ++  F   R +F  ++   +I+  +     YLH
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YA--AEIVLALE----YLH 110

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
               L II+RDLK  N+LLD D + K++DFG+A+    + +  NT    GT  Y++PE  
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVL 165

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
           +   +    D +S GVL+ E++ GK    FY  D                   E+ +K L
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP--FYAEDRK-----------------EIYEKIL 206

Query: 587 DGSY----SLSEALRCIQVGLLCVQQRPEDR 613
                    LS   R +  GLL  Q+ P  R
Sbjct: 207 KDPLRFPEFLSPEARDLISGLL--QKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score =  103 bits (260), Expect = 4e-27
 Identities = 37/67 (55%), Positives = 51/67 (76%), Gaps = 1/67 (1%)

Query: 185 CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLW 244
           C  GDGFL+  ++KLPDT+ + VD++I +  C++ C  NCSCTAYA AD+R GGSGCL+W
Sbjct: 1   CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59

Query: 245 FHDLIDM 251
             +L+DM
Sbjct: 60  TGELVDM 66

Length = 66

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  110 bits (277), Expect = 5e-27
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 37/211 (17%)

Query: 357 KLGEGGFGPVYRGML-TEGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
            LG+G  G VY+      G+  A+K++      +  ++   E+  +   +   +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 415 ----CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC-----QIIEGIAR----G 461
                 +     ++ EY+   SL   +            K+       ++  IAR    G
Sbjct: 68  FYKEGEIS----IVLEYMDGGSLADLL------------KKVGKIPEPVLAYIARQILKG 111

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L YLH      IIHRD+K SN+L+++    KI+DFG+++   ++ T    +  VGT  YM
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYM 167

Query: 522 SPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK 551
           SPE  I G  +S  +D++S G+ +LE   GK
Sbjct: 168 SPE-RIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 1e-26
 Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 19/197 (9%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
              +G+G FG V  G    GQ++AVK L K      + F  E  ++  L+H NLV+LLG 
Sbjct: 11  GATIGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII--EGIARGLLYLHQDSRLR 472
               +   ++ EY+   SL  ++    R      +   Q+     +  G+ YL +     
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI---TLAQQLGFALDVCEGMEYLEEK---N 122

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY--GYMSPEYAIDGL 530
            +HRDL A NVL+  D+  K+SDFG+A+       EA+  +  G     + +PE   +  
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKK 175

Query: 531 FSVKSDVFSFGVLVLEI 547
           FS KSDV+SFG+L+ EI
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  108 bits (272), Expect = 2e-26
 Identities = 83/267 (31%), Positives = 130/267 (48%), Gaps = 40/267 (14%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG G FG V+ G      ++A+K L K      E F  E  L+ +LQH  LVRL    T
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 417 LRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
            ++   +I EY+ N SL  F+       +T  K +D +   QI EG+A    ++    R 
Sbjct: 72  -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA--AQIAEGMA----FIE---RK 121

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
             IHRDL+A+N+L+   +  KI+DFG+AR    ++  A  +       + +PE    G F
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTF 180

Query: 532 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS 591
           ++KSDV+SFG+L+ EIV   R                    +    + E+I ++L+  Y 
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIP------------------YPGMTNPEVI-QNLERGYR 221

Query: 592 LSEALRC----IQVGLLCVQQRPEDRP 614
           +     C     ++  LC +++PE+RP
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 4e-26
 Identities = 81/283 (28%), Positives = 137/283 (48%), Gaps = 47/283 (16%)

Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V RG L    +    +A+K L + SS +   +F  E  ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T     M+I EY+ N SL++F+      KF    +   ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFL-RENDGKF-TVGQLVGMLRGIASGMKYL---SEMN 126

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------YMSPEYA 526
            +HRDL A N+L+++++  K+SDFG++R         +++    T G      + +PE  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLE------DSEATYTTKGGKIPIRWTAPEAI 180

Query: 527 IDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
               F+  SDV+SFG+++ E++  G+R    Y            W +  +D     + K+
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERP---Y------------WDMSNQD-----VIKA 220

Query: 586 LDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLMLS 624
           ++  Y L   + C     Q+ L C Q+   +RP  S +V  L 
Sbjct: 221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 8e-26
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 38/217 (17%)

Query: 352 FSWKNKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFK----NEVLLIAKLQ 404
           +    KLGEG +G VY+      G+ +A+K  RL        E        E+ L+ +L+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELK 56

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKR--CQIIEGIARG 461
           H N+V+LL       +  L++EY  +  L++++ D        +  K    Q++ G+A  
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLA-- 112

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             Y H     RI+HRDLK  N+L++ D   K++DFG+ARAFG+      T  VV T  Y 
Sbjct: 113 --YCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWYR 165

Query: 522 SPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE       Y+     +V  D++S G +  E++ GK
Sbjct: 166 APEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  106 bits (266), Expect = 1e-25
 Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 8/202 (3%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           + TD  + K+KLG G +G VY G+  +    +AVK L K     VEEF  E  ++ +++H
Sbjct: 4   ERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKH 61

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            NLV+LLG CT      +I E++   +L  ++ +  R + ++      +   I+  + YL
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYL 120

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            + +    IHRDL A N L+  +   K++DFG++R    D   A+         + +PE 
Sbjct: 121 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPES 176

Query: 526 AIDGLFSVKSDVFSFGVLVLEI 547
                FS+KSDV++FGVL+ EI
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  105 bits (264), Expect = 2e-25
 Identities = 72/197 (36%), Positives = 102/197 (51%), Gaps = 16/197 (8%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG G FG V+ G      ++AVK L K     V+ F  E  L+  LQH  LVRL    T
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 417 LRDERMLIYEYLPNKSLEQFIFD-----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
             +   +I EY+   SL  F+       V   K +D+S +      IA G+ Y+    R 
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---RK 122

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
             IHRDL+A+NVL+   +  KI+DFG+AR    ++  A  +       + +PE    G F
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGSF 181

Query: 532 SVKSDVFSFGVLVLEIV 548
           ++KSDV+SFG+L+ EIV
Sbjct: 182 TIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  105 bits (262), Expect = 3e-25
 Identities = 78/277 (28%), Positives = 134/277 (48%), Gaps = 40/277 (14%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           ++G G FG V+ G   E +++A+K + +      E+F  E  ++ KL H  LV+L G CT
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC--QIIEGIARGLLYLHQDSRLRII 474
            R    L++E++ +  L  ++    R +   +S+     +   +  G+ YL   +   +I
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYAIDGLF 531
           HRDL A N L+  +   K+SDFGM R    DQ  ++T    GT     + SPE      +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKY 178

Query: 532 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS 591
           S KSDV+SFGVL+ E+     + G               +   E+RS   + ++++  + 
Sbjct: 179 SSKSDVWSFGVLMWEVF----SEG---------------KTPYENRSNSEVVETINAGFR 219

Query: 592 LSEALRC----IQVGLLCVQQRPEDRPNMSSVVLMLS 624
           L +         ++   C ++RPEDRP+ S ++  L+
Sbjct: 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 4e-25
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 43/217 (19%)

Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEF----KNEVLLIAKLQHRNLVR 410
            ++GEG +G VY+      G+ +A+K++        E F      E+ L+ KL+H N+VR
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 411 LLGCCTLRDER--MLIYEYLPN--KSL---EQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           L    T + +    +++EY+ +    L    +  F  ++ K        Q++EG+     
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY----MKQLLEGLQ---- 114

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH +    I+HRD+K SN+L++ND   K++DFG+AR +    +   T+RV+ T  Y  P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170

Query: 524 E---------YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E           +        D++S G ++ E+  GK
Sbjct: 171 ELLLGATRYGPEV--------DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  104 bits (262), Expect = 4e-25
 Identities = 81/275 (29%), Positives = 113/275 (41%), Gaps = 27/275 (9%)

Query: 357 KLGEGGFGPVYRGMLTEGQ----EIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRL 411
           KLG+G FG V RG  +        +AVK L        +++F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
            G   L    M++ E  P  SL   +       FL  S  C     IA G+ YL      
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESK--- 116

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGV--DQTEANTDRVVGTYGYMSPEYAIDG 529
           R IHRDL A N+LL +D   KI DFG+ RA     D         V  + + +PE     
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTR 175

Query: 530 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS 589
            FS  SDV+ FGV + E+        F + +     L  +  L   D+  E +++     
Sbjct: 176 TFSHASDVWMFGVTLWEM--------FTYGEEPWAGLSGSQILKKIDKEGERLERPEACP 227

Query: 590 YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
                      V L C    P DRP  +++   L 
Sbjct: 228 ------QDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 70/224 (31%), Positives = 117/224 (52%), Gaps = 37/224 (16%)

Query: 352 FSW-KNKL-GEGGFGPVYRGM-LTEGQEIAVKRL---SKSSGQG-------VEEFKNEVL 398
           F W K +L G+G +G VY  + +T G+ +AVK++   +  +G+        V+  ++E+ 
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQ 453
            +  L H N+V+ LG  T  +   +  EY+P  S+   +     F+    +F       Q
Sbjct: 61  TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT----EQ 116

Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR--AFGVDQTEANT 511
           ++EG+A    YLH      I+HRDLKA N+L+D D   KISDFG+++      D  +  +
Sbjct: 117 VLEGLA----YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169

Query: 512 DRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKR 552
            +  G+  +M+PE  I      +S K D++S G +VLE+  G+R
Sbjct: 170 MQ--GSVFWMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  102 bits (257), Expect = 2e-24
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           F    KLGEG +G VY+ +  E GQ +A+K +     + ++E   E+ ++ +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDV--TRTKFLDWSKRCQIIEGIARGLLYLHQD 468
             G      +  ++ EY    S    + D+     K L   +   I+    +GL YLH  
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS- 117

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
              + IHRD+KA N+LL+ +   K++DFG++        + NT  V+GT  +M+PE   +
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQE 173

Query: 529 GLFSVKSDVFSFGVLVLEIVCGK 551
             ++ K+D++S G+  +E+  GK
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (256), Expect = 2e-24
 Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 22/204 (10%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLS-----KSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY G+ L +G   AVK +S     ++  + V++ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 412 LGCCTLRDERMLIY-EYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           LG     ++ + I+ E +P  SL + +  +       +    R QI+ G+     YLH  
Sbjct: 68  LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHDR 121

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY-AI 527
                +HRD+K +N+L+D +   K++DFGMA+        +      G+  +M+PE  A 
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGK 551
            G + + +D++S G  VLE+  GK
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 65/198 (32%), Positives = 96/198 (48%), Gaps = 14/198 (7%)

Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           LG G FG V+ G      ++A+K + + +    ++F  E  ++ KL H NLV+L G CT 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD 477
           +    ++ EY+ N  L  ++    R   L       +   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYAIDGLFSVK 534
           L A N L+  D   K+SDFG+AR    DQ  ++     GT     +  PE      FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181

Query: 535 SDVFSFGVLVLEI-VCGK 551
           SDV+SFGVL+ E+   GK
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  102 bits (255), Expect = 5e-24
 Identities = 68/201 (33%), Positives = 114/201 (56%), Gaps = 20/201 (9%)

Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+ +    A+K L++++G     EF +E L++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     L+ + +P+  L  ++ +    +     L+W  +      IA+G++YL +
Sbjct: 75  LGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HRDL A NVL+ +  + KI+DFG+AR    D+ E N D       +M+ E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
              F+ +SDV+S+GV + E++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 95.6 bits (238), Expect = 7e-24
 Identities = 41/89 (46%), Positives = 52/89 (58%), Gaps = 8/89 (8%)

Query: 181 TQLDCEHG---DGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGG 237
           T L+C      DGFLK   VKLPD + +     IS+  C+E C  NCSCTAYA  +   G
Sbjct: 1   TPLNCGGDGSTDGFLKLPDVKLPDNASA--ITAISLEECREACLSNCSCTAYAYNN---G 55

Query: 238 GSGCLLWFHDLIDMKVLSEGGQDLYIRMA 266
             GCLLW   L +++ LS GG  LY+R+A
Sbjct: 56  SGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  101 bits (253), Expect = 7e-24
 Identities = 72/226 (31%), Positives = 116/226 (51%), Gaps = 32/226 (14%)

Query: 357 KLGEGGFGPVYRGML------TEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +LGE  FG VY+G L       + Q +A+K L  K+ G   EEFK+E ++ ++LQH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQIIE 456
            LLG  T      +I+ Y  +  L +F+              D T    L+ +    I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR-AFGVDQTEANTDRVV 515
            IA G+ +L   S   ++H+DL   NVL+ + +N KISD G+ R  +  D  +   + ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV-------CGKRNR 554
               +MSPE  + G FS+ SD++S+GV++ E+        CG  N+
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  101 bits (253), Expect = 1e-23
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 17/200 (8%)

Query: 358 LGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 413 GCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           G C     R   L+ EYLP  SL  ++      + LD  K       I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GS 126

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG---TYGYMSPEYAI 527
            R +HRDL   N+L++++   KI DFG+ +    D+ E    R  G    + Y +PE   
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLT 184

Query: 528 DGLFSVKSDVFSFGVLVLEI 547
           +  FSV SDV+SFGV++ E+
Sbjct: 185 ESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 30/213 (14%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQG---------VEEFKNEVLLIAKLQHRN 407
           +G G FG VY GM  + G+ +AVK++   S            ++    E+ L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGL 462
           +V+ LG     D   +  EY+P  S+   +     F+ T  +          +  I +GL
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD--QTEANTDR--VVGTY 518
            YLH      IIHRD+K +N+L+DN    KISDFG+++    +   T+ N  R  + G+ 
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            +M+PE      ++ K+D++S G LV+E++ GK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  100 bits (250), Expect = 1e-23
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 7/205 (3%)

Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
             ++     KLG G FG V+ G      ++AVK L K      E F  E  ++ KL+H  
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LV+L    +  +   ++ EY+   SL  F+ D    + L       +   +A G+ Y+  
Sbjct: 63  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE- 119

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
             R+  IHRDL+++N+L+ + +  KI+DFG+AR    ++  A          + +PE A+
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKR 552
            G F++KSDV+SFG+L+ E+V   R
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  100 bits (250), Expect = 1e-23
 Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 35/282 (12%)

Query: 351 NFSWKNKLGEGGFGPVYRGML-TEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 407
           +F   NK+G+G FG V++ +   + +  A+K+  LSK + +  EE  +E  ++AKL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           ++R       + +  ++ EY  N  L + +  + R + L   +  +    I  GL +LH 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               +I+HRD+K+ N+ LD   N KI D G+A+    +   ANT  +VGT  Y+SPE   
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCE 174

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD 587
           D  ++ KSDV++ GV++ E   GK                H +     +    LI K + 
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGK----------------HPFDA---NNQGALILKIIR 215

Query: 588 GSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
           G +       S+ L   Q+   C+ +    RP+   ++   S
Sbjct: 216 GVFPPVSQMYSQQL--AQLIDQCLTKDYRQRPDTFQLLRNPS 255

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 4e-23
 Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 37/272 (13%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLLGCC 415
           K+G+G FG VY+G+L    E+AVK    +    +  +F  E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKF--LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
             +    ++ E +P  SL  F+    R K   L   K  Q+    A G+ YL   +    
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL----RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMAR--AFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
           IHRDL A N L+  +   KISDFGM+R    G+        ++     + +PE    G +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRY 172

Query: 532 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS 591
           + +SDV+S+G+L+ E         F   D         +   +  ++ E I+      Y 
Sbjct: 173 TSESDVWSYGILLWET--------FSLGD-------TPYPGMSNQQTRERIES----GYR 213

Query: 592 LSEALRC----IQVGLLCVQQRPEDRPNMSSV 619
           +     C     ++ L C    PE+RP+ S +
Sbjct: 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 99.2 bits (247), Expect = 5e-23
 Identities = 74/205 (36%), Positives = 104/205 (50%), Gaps = 26/205 (12%)

Query: 358 LGEGGFGPV--YRGMLTE---GQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVRL 411
           LGEG FG V  Y         G+ +AVK L +  GQ     +K E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 412 LGCCTLRDER--MLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
            GCC+ +  +   LI EY+P  SL  ++    +   + L +++  QI EG+A    YLH 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQ--QICEGMA----YLHS 125

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ----TEANTDRVVGTYGYMSP 523
                 IHRDL A NVLLDND   KI DFG+A+A            + D  V  Y   + 
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---AV 179

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIV 548
           E   +  FS  SDV+SFGV + E++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 12/199 (6%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVRLLG 413
           K+GEG +G VY+      G+ +A+K++               E+ L+ +L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + +  L++E++ +  L + I D  R + L  S     +  + +GL + H      I
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-DGLFS 532
           +HRDLK  N+L++ +   K++DFG+AR+FG       T  VV T  Y +PE  + D  +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 533 VKSDVFSFGVLVLEIVCGK 551
              D++S G +  E++  +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 98.6 bits (245), Expect = 6e-23
 Identities = 77/267 (28%), Positives = 128/267 (47%), Gaps = 40/267 (14%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG G FG V+     +  ++AVK + K     VE F  E  ++  LQH  LV+L    T
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 417 LRDERMLIYEYLPNKSLEQFIFD-----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
            ++   +I E++   SL  F+           K +D+S +      IA G+ ++ Q +  
Sbjct: 72  -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN-- 122

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
             IHRDL+A+N+L+   +  KI+DFG+AR    ++  A  +       + +PE    G F
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGSF 180

Query: 532 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS 591
           ++KSDV+SFG+L++EIV   R                    +    + E+I ++L+  Y 
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP------------------YPGMSNPEVI-RALERGYR 221

Query: 592 LSEALRCIQ----VGLLCVQQRPEDRP 614
           +     C +    + + C + RPE+RP
Sbjct: 222 MPRPENCPEELYNIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 99.2 bits (247), Expect = 6e-23
 Identities = 61/209 (29%), Positives = 112/209 (53%), Gaps = 10/209 (4%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  + +  GQE+A+K+++       E   NE+L++ +
Sbjct: 13  SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N+V  L    + DE  ++ EYL   SL     DV     +D  +   +     + L
Sbjct: 73  NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHRD+K+ N+LL  D + K++DFG       +Q++ +T  +VGT  +M+
Sbjct: 129 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E+V G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 7e-23
 Identities = 77/289 (26%), Positives = 126/289 (43%), Gaps = 47/289 (16%)

Query: 358 LGEGGFGPVYRGML----TEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LGEG FG V  G L        ++AVK  +L   +   +EEF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 412 LGCC-TLRDER-----MLIYEYLPNKSLEQFIFDV---TRTKFLDWSKRCQIIEGIARGL 462
           +G C      +     M+I  ++ +  L  F+         + L      + +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA-FGVD---QTEANTDRVVGTY 518
            YL   S    IHRDL A N +L  DM   ++DFG+++  +  D   Q       V    
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 179

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH---NLLGHAWRLWTE 575
            +++ E   D +++ KSDV++FGV + EI    R +  Y    +H   + L H  RL   
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA--TRGQTPYPGVENHEIYDYLRHGNRL--- 234

Query: 576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
            +  + +D+  D  YS             C +  P+DRP  + +  +L 
Sbjct: 235 KQPEDCLDELYDLMYS-------------CWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 8e-23
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 37/215 (17%)

Query: 358 LGEGGFGPVYRGML------TEGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVR 410
           LG+G FG VY G+            +A+K +++++      EF NE  ++ +    ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 411 LLGCCTLRDERMLIYEYL-------------PNKSLEQFIFDVTRTKFLDWSKRCQIIEG 457
           LLG  +     +++ E +             P       +   T  KF+  +      E 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA-----AE- 127

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           IA G+ YL      + +HRDL A N ++  D+  KI DFGM R    D  E +  R  G 
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180

Query: 518 ----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                 +M+PE   DG+F+ KSDV+SFGV++ E+ 
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 31/210 (14%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKR-----LSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+G FG VY    +  G+E+AVK+      S  + + V   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLY 464
            GC    +   +  EY+P  S++  +         VTR K+       QI+EG+     Y
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTR-----QILEGVE----Y 119

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR---AFGVDQTEANTDRVVGTYGYM 521
           LH +    I+HRD+K +N+L D+  N K+ DFG ++         T   +  V GT  +M
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWM 174

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           SPE      +  K+DV+S G  V+E++  K
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 80/280 (28%), Positives = 128/280 (45%), Gaps = 53/280 (18%)

Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           NK+G G FG VY  + L  G+ +AVK  R+  +  + ++E  +E+ ++  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 413 GCCTLRDERMLIY-EYLPNKSLEQF-----IFD--VTRTKFLDWSKRCQIIEGIARGLLY 464
           G   +  E++ I+ EY    +LE+      I D  V R   L      Q++EG+A    Y
Sbjct: 66  GV-EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL------QLLEGLA----Y 114

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD--RVVGTYGYMS 522
           LH      I+HRD+K +N+ LD++   K+ DFG A     + T    +   + GT  YM+
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171

Query: 523 PEYAIDGLFSVK---SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL-----GHAWRLWT 574
           PE    G        +D++S G +VLE+  GKR       D+   ++     GH   +  
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL--DNEFQIMFHVGAGHKPPIPD 229

Query: 575 EDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP 614
                     S +G   L            C++  P+ RP
Sbjct: 230 SL------QLSPEGKDFLD----------RCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 80/271 (29%), Positives = 138/271 (50%), Gaps = 36/271 (13%)

Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLS----KSSGQG--VEEFKNEVLLIAKLQHRNLV 409
           LG G F   Y  R + T G  +AVK+++     SS Q   VE  + E+ L+A+L H +++
Sbjct: 8   LGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 410 RLLGCCTLRDERMLIY-EYLPNKSLEQFIFDVTRTKFLDWSKRCQI--IEGIARGLLYLH 466
           R+LG  T  D    ++ E++   S+   +     +K+  + +   I   E + RGL YLH
Sbjct: 67  RMLG-ATCEDSHFNLFVEWMAGGSVSHLL-----SKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 467 QDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFGVDQTEAN--TDRVVGTYGYMSP 523
           ++   +IIHRD+K +N+L+D+     +I+DFG A       T A     +++GT  +M+P
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
           E      +    DV+S G +++E+   K     ++A+ H N L   +++ +   +  + +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLALIFKIASATTAPSIPE 234

Query: 584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRP 614
                   LS  LR   V L C++ +PEDRP
Sbjct: 235 -------HLSPGLR--DVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 98.3 bits (244), Expect = 1e-22
 Identities = 62/209 (29%), Positives = 114/209 (54%), Gaps = 10/209 (4%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           +I D    ++   K+G+G  G V+  + +  GQE+A+K+++       E   NE+L++ +
Sbjct: 13  SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           L++ N+V  L    + DE  ++ EYL   SL     DV     +D ++   +     + L
Sbjct: 73  LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHRD+K+ NVLL  D + K++DFG       +Q++ +T  +VGT  +M+
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E+V G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 69/274 (25%), Positives = 128/274 (46%), Gaps = 44/274 (16%)

Query: 352 FSWKNKLGEGGFGPVYRGM-LTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           F+    +G+G FG VY+ +     Q +A+K   L ++  + +E+ + E+  +++ +   +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61

Query: 409 VRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
            +  G   L+  ++ +I EY    S      D+ +   LD +    I+  +  GL YLH+
Sbjct: 62  TKYYGS-FLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           +     IHRD+KA+N+LL  + + K++DFG++       ++ NT   VGT  +M+PE   
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIK 171

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK--- 584
              +  K+D++S G+  +E+  G+      H                  R L LI K   
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHP----------------MRVLFLIPKNNP 215

Query: 585 -SLDG---SYSLSEALRCIQVGLLCVQQRPEDRP 614
            SL+G   S    + +        C+ + P++RP
Sbjct: 216 PSLEGNKFSKPFKDFVSL------CLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 71/227 (31%), Positives = 120/227 (52%), Gaps = 16/227 (7%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLG 413
           K+GEG +G VY+G     GQ +A+K++  +S  +GV      E+ L+ +LQH N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                    LI+E+L +  L++++  + + +++D       +  I +G+L+ H     R+
Sbjct: 67  VLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRV 122

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFS 532
           +HRDLK  N+L+DN    K++DFG+ARAFG+      T  VV T  Y +PE  +    +S
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLLGSPRYS 180

Query: 533 VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW---TED 576
              D++S G +  E+      +  +H D   + L   +R+    TED
Sbjct: 181 TPVDIWSIGTIFAEMAT---KKPLFHGDSEIDQLFRIFRILGTPTED 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 24/210 (11%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLS------KSSGQGVEEFKNEVLLIAKLQHRNLV 409
             LG+G +G VY G+  +GQ IAVK++        ++ +  E+ + EV L+  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 410 RLLGCCTLRDERMLIY-EYLPNKSLEQFI--FD-VTRTKFLDWSKRCQIIEGIARGLLYL 465
           + LG C L D  + I+ E++P  S+   +  F  +    F  ++K  QI++G+A    YL
Sbjct: 66  QYLGTC-LDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK--QILDGVA----YL 118

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF---GVDQTEANTDRVV-GTYGYM 521
           H +    ++HRD+K +NV+L  +   K+ DFG AR     G+  T +N  + + GT  +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE   +  +  KSD++S G  V E+  GK
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 10/200 (5%)

Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE--EFKNEVLLIAKLQHRNLVRLL 412
             +G+G FG V +    ++G+ +  K +   +    E  +  +EV ++ +L+H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 413 GCCTLRD-ERMLIY-EYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLLYLH--Q 467
                R  + + I  EY     L Q I    +  K+++     +I+  +   L   H   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D    ++HRDLK +N+ LD + N K+ DFG+A+  G D + A T   VGT  YMSPE   
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLN 183

Query: 528 DGLFSVKSDVFSFGVLVLEI 547
              +  KSD++S G L+ E+
Sbjct: 184 HMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 23/206 (11%)

Query: 358 LGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVR 410
           LG G FG V+    +G+  EG E  + VK L K+  + ++ EF+ E+ +  KL H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLY 464
           LLG C   +   +I EY     L+QF+       +  +   L   ++  +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG---YM 521
           L   S  R +HRDL A N L+ +    K+S   +++    D   +   ++        ++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALIPLRWL 185

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEI 547
           +PE   +  FS KSDV+SFGVL+ E+
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 96.7 bits (240), Expect = 2e-22
 Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 7/196 (3%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 72  -EEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185

Query: 537 VFSFGVLVLEIVCGKR 552
           V+SFG+L+ E+    R
Sbjct: 186 VWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 96.6 bits (240), Expect = 4e-22
 Identities = 78/280 (27%), Positives = 138/280 (49%), Gaps = 42/280 (15%)

Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V+RG+L   G++   +A+K L    + +  ++F +E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS--KRCQIIEGIARGLLYLHQDSR 470
           G  T     M+I EY+ N +L++++    R    ++S  +   ++ GIA G+ YL   S 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSSYQLVGMLRGIAAGMKYL---SD 125

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG--YMSPEYAID 528
           +  +HRDL A N+L+++++  K+SDFG++R    D  E       G     + +PE    
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 529 GLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD 587
             F+  SDV+SFG+++ E++  G+R                    W  D S   + K+++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP------------------YW--DMSNHEVMKAIN 224

Query: 588 GSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
             + L   + C     Q+ L C QQ    RP    +V +L
Sbjct: 225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 96.7 bits (240), Expect = 5e-22
 Identities = 60/209 (28%), Positives = 112/209 (53%), Gaps = 10/209 (4%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  + +  GQE+A+K+++       E   NE+L++ +
Sbjct: 13  SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++ N+V  L    + DE  ++ EYL   SL     DV     +D  +   +     + L
Sbjct: 73  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHRD+K+ N+LL  D + K++DFG       +Q++ +T  +VGT  +M+
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E+V G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.8 bits (238), Expect = 5e-22
 Identities = 68/194 (35%), Positives = 102/194 (52%), Gaps = 19/194 (9%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
            +GEG FG V +G  T GQ++AVK +        + F  E  ++ KL H+NLVRLLG   
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68

Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           L +   ++ E +   +L  F+   TR + L    +  Q    +A G+ YL      +++H
Sbjct: 69  LHNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 476 RDLKASNVLLDNDMNPKISDFGMARA--FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           RDL A N+L+  D   K+SDFG+AR    GVD ++           + +PE      FS 
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFSS 176

Query: 534 KSDVFSFGVLVLEI 547
           KSDV+S+GVL+ E+
Sbjct: 177 KSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 96.2 bits (239), Expect = 5e-22
 Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)

Query: 355 KNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           K +LGEG FG V+      +L E  +  +AVK L ++S    ++F+ E  L+  LQH+++
Sbjct: 10  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFI-FDVTRTKFLDWSK-----------RCQIIE 456
           VR  G CT     ++++EY+ +  L +F+       K L   +              I  
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            IA G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D    +  RV G
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGG 182

Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                  +M PE  +   F+ +SD++SFGV++ EI
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 95.3 bits (237), Expect = 9e-22
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 19/203 (9%)

Query: 358 LGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           LG+G +G VY       Q  IA+K + +   + V+    E+ L + L+HRN+V+ LG  +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII----EGIARGLLYLHQDSRLR 472
                 +  E +P  SL      + R+K+       Q I    + I  GL YLH     +
Sbjct: 76  ENGFFKIFMEQVPGGSLS----ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQ 128

Query: 473 IIHRDLKASNVLLDNDMNP-KISDFGMA-RAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
           I+HRD+K  NVL++      KISDFG + R  G++     T+   GT  YM+PE    G 
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGP 185

Query: 531 --FSVKSDVFSFGVLVLEIVCGK 551
             +   +D++S G  ++E+  GK
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 37/275 (13%)

Query: 358 LGEGGFGP--VYR----GMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+G FG   +YR      L   +E+ + RLS+       +  NE+++++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64

Query: 412 LGCCTLRDERMLI-YEYLPNKSLEQFIFDVTRTKFLDWSKRCQI--IEGIARGLLYLHQD 468
                + D  +LI  EY    +L   I    R K   + +   +  +  I   + Y+H+ 
Sbjct: 65  YNH-FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               I+HRD+K  N+ L      K+ DFG+++  G + + A T  VVGT  YMSPE    
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQG 175

Query: 529 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG 588
             ++ KSD+++ G ++ E++  KR    + A    N L    ++   + +          
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRT---FDAT---NPLNLVVKIVQGNYTPV------VS 223

Query: 589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
            YS       I +    +QQ PE RP    V+   
Sbjct: 224 VYSSE----LISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 94.8 bits (235), Expect = 2e-21
 Identities = 58/209 (27%), Positives = 111/209 (53%), Gaps = 10/209 (4%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++ N+V  L    + DE  ++ EYL   SL     DV     +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHRD+K+ N+LL  D + K++DFG       +Q++ +   +VGT  +M+
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMA 184

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 94.0 bits (234), Expect = 4e-21
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)

Query: 358 LGEGGFGPVYRGML------TEGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-QHRNLV 409
           LGEG FG V +          E   +AVK L   ++ + + +  +E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG------------ 457
            LLG CT      ++ EY  + +L  F+    R      S                    
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRA-RRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 458 --IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTEANTD-R 513
             +ARG+ +L      + IHRDL A NVL+  D   KI+DFG+AR    +D     T+ R
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           +     +M+PE   D +++ +SDV+SFGVL+ EI 
Sbjct: 196 L--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 93.5 bits (232), Expect = 5e-21
 Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 25/212 (11%)

Query: 357 KLGEGGFGPVYRGML-----TEGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVR 410
           +LGE  FG +Y+G L        Q +A+K L   ++ Q   EF+ E  L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIF--------------DVTRTKFLDWSKRCQIIE 456
           LLG  T      +++EYL    L +F+               D T    LD      I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA-FGVDQTEANTDRVV 515
            IA G+ YL   S    +H+DL A N+L+   ++ KISD G++R  +  D        ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
               +M PE  + G FS  SD++SFGV++ EI
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 93.8 bits (233), Expect = 5e-21
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 29/224 (12%)

Query: 350 DNFSWKNKLGEGGFGPVY----RGMLTEGQE-------------IAVKRLSKSSGQGVE- 391
              ++K KLGEG FG V+     GM     +             +AVK L + + +    
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--------FDVTRT 443
           +F  E+ ++++L+  N++RLL  C   D   +I EY+ N  L QF+         +    
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
             + +S    +   IA G+ YL   S L  +HRDL   N L+  +   KI+DFGM+R   
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                    R V    +MS E  + G F+  SDV++FGV + EI
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 28/223 (12%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QH 405
           D T  F     +GEG +G VY+    +  ++   ++        EE K E  ++ K   H
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62

Query: 406 RNLVRLLGC------CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ------ 453
            N+    G           D+  L+ E     S    + D+ +       KR +      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIAY 117

Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           I+    RGL YLH++   ++IHRD+K  N+LL  +   K+ DFG++    +D T    + 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNT 172

Query: 514 VVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            +GT  +M+PE        D  +  +SDV+S G+  +E+  GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 92.0 bits (228), Expect = 9e-21
 Identities = 64/196 (32%), Positives = 106/196 (54%), Gaps = 7/196 (3%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G      ++A+K L K      E F  E  ++ KL+H  LV L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ E++   SL  F+ +    K+L   +   +   IA G+ Y+    R+  IHR
Sbjct: 72  -EEPIYIVTEFMGKGSLLDFLKE-GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ +++  KI+DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185

Query: 537 VFSFGVLVLEIVCGKR 552
           V+SFG+L+ E+V   R
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 79/290 (27%), Positives = 126/290 (43%), Gaps = 61/290 (21%)

Query: 351 NFSWKNKLGEGGFGPVYR-GMLTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 407
           +F    KLG+G +G VY+   L++ Q  A+K   L   S +  E+  NE+ ++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 408 LVR-----LLGC--CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL-----DWSKRCQII 455
           ++      L G   C        + EY P   L + I    + + L      W    Q+ 
Sbjct: 61  IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL- 112

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
               RGL  LH+    +I+HRDLK++N+LL  +   KI D G+++   + +  A T   +
Sbjct: 113 ---LRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT--QI 162

Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE 575
           GT  YM+PE      +S KSD++S G L+ E+                      +    E
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA--------------------TFAPPFE 202

Query: 576 DRSL-ELIDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
            RS+ +L  K   G Y       S+ L         +Q +P+ RPN   +
Sbjct: 203 ARSMQDLRYKVQRGKYPPIPPIYSQDL--QNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 31/280 (11%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQ 404
             NF  + K+G+G F  VY+ + L +G+ +A+K++        +  ++   E+ L+ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL-----DWSKRCQIIEGIA 459
           H N+++ L      +E  ++ E      L + I    + K L      W    Q+     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
             L ++H     RI+HRD+K +NV +      K+ D G+ R F    T A++  +VGT  
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           YMSPE   +  ++ KSD++S G L+ E+   +    FY         G    L++  + +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FY---------GDKMNLYSLCKKI 220

Query: 580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
           E  D     +   SE LR   +   C+   PE RP++S V
Sbjct: 221 EKCDYPPLPADHYSEELR--DLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 35/211 (16%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLG 413
           K+GEG +G VY+      G+ +A+K++  ++  +GV      E+ L+ +L H N+VRLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC------------QIIEGIARG 461
                ++  L++E+L          D+   K++D S               Q+++GIA  
Sbjct: 66  VVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA-- 113

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             Y H     R++HRDLK  N+L+D +   K++DFG+ARAFGV      T  VV T  Y 
Sbjct: 114 --YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYR 166

Query: 522 SPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +    +S   D++S G +  E+V  +
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 35/222 (15%)

Query: 355 KNKLGEGGFGPVY-----------------RGMLTEGQEIAVKRLSKSSGQGV-EEFKNE 396
             KLGEG FG V+                          +AVK L   +     E+F  E
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--------FDVTRTKFLDW 448
           V ++++L   N+ RLLG CT+     +I EY+ N  L QF+             +K L +
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 449 SKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR-AFGVD-- 505
           S    +   IA G+ YL     L  +HRDL   N L+  +   KI+DFGM+R  +  D  
Sbjct: 130 STLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186

Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
           + +    R      +M+ E  + G F+ KSDV++FGV + EI
Sbjct: 187 RVQG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 73/223 (32%), Positives = 113/223 (50%), Gaps = 30/223 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYR----GMLTEGQE----IAVKRLS-KSSGQGVEEFKNEVLLI 400
           D       LGEG FG V R    G+     +    +AVK L   ++ + + +  +E+ L+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +F+           FD+T+   + L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
            +         +ARG+ YL  +SR R IHRDL A NVL+  D   KI+DFG+AR  GV  
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHD 186

Query: 507 TEANTDRVVGTY--GYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            +       G     +M+PE   D +++ +SDV+SFG+L+ EI
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 31/219 (14%)

Query: 358 LGEGGFGPVYRGMLTEGQ------EIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVR 410
           LGEG FG V +      +       +AVK L +++    + +  +E  L+ ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFI------------FDVTRTKFLDWSKRCQIIE-- 456
           L G C+     +LI EY    SL  F+             D  R      +   + +   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 457 -------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
                   I+RG+ YL   + ++++HRDL A NVL+      KISDFG++R    + +  
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
              +      +M+ E   D +++ +SDV+SFGVL+ EIV
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 62/201 (30%), Positives = 112/201 (55%), Gaps = 20/201 (9%)

Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 75  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HRDL A NVL+    + KI+DFG+A+  G D+ E + +       +M+ E  +
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 31/225 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM---LTEGQE---IAVKRLSK-SSGQGVEEFKNEVLLIAK 402
           +N  +   +G+G FG V++     L   +    +AVK L + +S     +F+ E  L+A+
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----------------- 445
             H N+V+LLG C +     L++EY+    L +F+   +                     
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 446 --LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR-AF 502
             L  +++  I + +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R  +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             D  +A+ +  +    +M PE      ++ +SDV+++GV++ EI
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 90.8 bits (225), Expect = 4e-20
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 28/218 (12%)

Query: 355 KNKLGEGGFGPV----------YRGMLTEGQE-----IAVKRL-SKSSGQGVEEFKNEVL 398
           K KLGEG FG V          + G      +     +AVK L +  +     +F  E+ 
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKF--------LDWS 449
           ++++L++ N++RLLG C   D   +I EY+ N  L QF+      + F        +  +
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
               +   IA G+ YL   + L  +HRDL   N L+ N    KI+DFGM+R         
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
              R V    +M+ E  + G F+  SDV++FGV + E+
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQG-VEEFKNEVLLIAKLQ 404
           D  + F+   ++G+G FG VY+G+    +E+ A+K +     +  +E+ + E+ ++++  
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
              + R  G      +  +I EYL   S      D+ +   L+ +    I+  I +GL Y
Sbjct: 61  SPYITRYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDY 116

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH +   R IHRD+KA+NVLL    + K++DFG+A      Q + NT   VGT  +M+PE
Sbjct: 117 LHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPE 171

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                 +  K+D++S G+  +E+  G+
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 90.5 bits (224), Expect = 6e-20
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 27/217 (12%)

Query: 351 NFSWKNKLGEGGFGPVYRG----MLTEGQEI--AVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
           N   K +LGEG FG V+      +  E  +I  AVK L  +S    ++F  E  L+  LQ
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI----------FDVTRTKFLDWSKRCQI 454
           H ++V+  G C   D  ++++EY+ +  L +F+           +  R   L  S+   I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
            + IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +  RV
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 178

Query: 515 VG----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            G       +M PE  +   F+ +SDV+S GV++ EI
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.7 bits (223), Expect = 7e-20
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 18/206 (8%)

Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
             +G G    VY  + L   +++A+KR  L K     V+E + EV  +++  H N+V+  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----LDWSKRCQIIEGIARGLLYLHQD 468
               + DE  L+  YL   SL     D+ ++ +    LD +    +++ + +GL YLH +
Sbjct: 66  TSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEYA 526
            +   IHRD+KA N+LL  D + KI+DFG++ +   G D+T       VGT  +M+PE  
Sbjct: 122 GQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 527 IDGL-FSVKSDVFSFGVLVLEIVCGK 551
                +  K+D++SFG+  +E+  G 
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 89.7 bits (223), Expect = 7e-20
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 38/212 (17%)

Query: 356 NKLGEGGFGPVYRGML--TEGQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVR 410
            +LG G  G V + +L    G+ +AVK +     +     K    E+ ++ K     +V 
Sbjct: 7   GELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVG 63

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ----------IIEGIAR 460
             G      +  +  EY+   SL++ +            K  Q          I   + +
Sbjct: 64  FYGAFYNNGDISICMEYMDGGSLDKIL------------KEVQGRIPERILGKIAVAVLK 111

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GL YLH   + +IIHRD+K SN+L+++    K+ DFG++    V+ + A T   VGT  Y
Sbjct: 112 GLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSY 165

Query: 521 MSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           M+PE  I G  +SVKSD++S G+ ++E+  G+
Sbjct: 166 MAPE-RIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 90.2 bits (224), Expect = 9e-20
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 12/206 (5%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM---LTEGQ---EIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N S+   LG G FG V       L++     ++AVK L   +     E   +E+ +++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
           L  H N+V LLG CT+    ++I EY     L  F+    R  FL           +A+G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKG 153

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +L   +    IHRDL A NVLL +    KI DFG+AR    D              +M
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEI 547
           +PE   + +++ +SDV+S+G+L+ EI
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 63/201 (31%), Positives = 111/201 (55%), Gaps = 20/201 (9%)

Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + +G+ +    A+K L + +S +  +E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     L+ + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 75  LGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
              +R++HRDL A NVL+ +  + KI+DFG+AR   +D+TE + D       +M+ E  +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
              F+ +SDV+S+GV V E++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 13/194 (6%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V  G      ++A+K + + S    +EF  E  ++ KL H  LV+L G CT
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            +    ++ EY+ N  L  ++ +  +      S+  ++ + +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYAIDGLFSV 533
           DL A N L+D+    K+SDFG++R    D+  ++    VG+     +  PE  +   FS 
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180

Query: 534 KSDVFSFGVLVLEI 547
           KSDV++FGVL+ E+
Sbjct: 181 KSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 63/212 (29%), Positives = 115/212 (54%), Gaps = 25/212 (11%)

Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNL 408
           NF    KLGEG +  VY+G   T G+ +A+K +   + +G       E+ L+ +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFI--------FDVTRTKFLDWSKRCQIIEGIAR 460
           VRL       ++ ML++EY+ +K L++++         D    K   +    Q+++GIA 
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTY----QLLKGIA- 114

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
              + H++   R++HRDLK  N+L++     K++DFG+ARAFG+     + + V  T  Y
Sbjct: 115 ---FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWY 166

Query: 521 MSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK 551
            +P+  +    +S   D++S G ++ E++ G+
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 19/206 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           DNF    K+GEG  G V      + G+++AVK++     Q  E   NEV+++   QH N+
Sbjct: 22  DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V +     + DE  ++ E+L   +L      VT T+ ++  +   +   + + L +LH  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLAVLKALSFLHAQ 134

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR---VVGTYGYMSPEY 525
               +IHRD+K+ ++LL +D   K+SDFG        Q      R   +VGT  +M+PE 
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEV 186

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +  + D++S G++V+E+V G+
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 64/216 (29%), Positives = 91/216 (42%), Gaps = 33/216 (15%)

Query: 351 NFSWKNKLGEGGFGPV----YRGMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL 403
           +F     +G+G FG V     R      +  A+K ++K        V    NE  ++ +L
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57

Query: 404 QHRNLVRLLGCCTLRDER--MLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIE 456
            H  LV L    + +DE    L+ + L    L     ++  F   + KF         I 
Sbjct: 58  NHPFLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WIC 107

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            I   L YLH      IIHRD+K  N+LLD   +  I+DF +A        +  T    G
Sbjct: 108 EIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSG 161

Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
           T GYM+PE      +SV  D +S GV   E + GKR
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 27/206 (13%)

Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G+G FG VY G L  ++GQ+I  AVK L++ +  + VE+F  E +++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C L  E   +++  Y+ +  L  FI   T       + +  I  G  +A+G+ YL   
Sbjct: 63  GIC-LPSEGSPLVVLPYMKHGDLRNFIRSETHNP----TVKDLIGFGLQVAKGMEYLASK 117

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE--YA 526
              + +HRDL A N +LD     K++DFG+AR    D  +     V    G   P    A
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 527 IDGL----FSVKSDVFSFGVLVLEIV 548
           ++ L    F+ KSDV+SFGVL+ E++
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 22/212 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVE-EFKNEVLLIAKLQHRN 407
           +     ++LGEG  G V +  L     I A+K ++      ++ +   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 408 LVRLLGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRC------QIIEGIA 459
           +V+  G         +    EY    SL     D    K      R       +I E + 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVL 115

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           +GL YLH     +IIHRD+K SN+LL      K+ DFG++         A T    GT  
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSF 168

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           YM+PE      +S+ SDV+S G+ +LE+   +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 38/297 (12%)

Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGFG V    +   G+  A K+L K      +G +   NE  ++ K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               +D+  L+   +    L+  I++V    F +        + I  GL +LHQ    RI
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---RRI 116

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           ++RDLK  NVLLD+  N +ISD G+A      +         GT GYM+PE     ++  
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDF 173

Query: 534 KSDVFSFGVLVLEIVCGK---RNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY 590
             D F+ G  + E++ G+   R R                    + R+LE+  +  D   
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-----------LKRRTLEMAVEYPD--- 219

Query: 591 SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESE 647
             S   + +   LL   + PE R        +     S  + ++   F + N    E
Sbjct: 220 KFSPEAKDLCEALLQ--KDPEKR--------LGCRGGSADEVREHPLFKDLNWRRLE 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 58/288 (20%)

Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V  G L   G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M++ EY+ N SL+ F+      F V +           ++ GIA G+ YL 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL--------VGMLRGIASGMKYL- 122

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------Y 520
             S +  +HRDL A N+L+++++  K+SDFG++R    D   A T     T G      +
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIRW 175

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
            +PE      F+  SDV+S+G+++ E++  G+R                 W +  +D   
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---------------WEMSNQD--- 217

Query: 580 ELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
             + K+++  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 218 --VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 13/203 (6%)

Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFK-NEVLLIAKLQHR 406
           NF    K+GEG +G VY+      G+ +A+K  RL   + +GV      E+ L+ +L H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + H
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
                R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE  
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 172

Query: 527 IDG-LFSVKSDVFSFGVLVLEIV 548
           +    +S   D++S G +  E+V
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 30/216 (13%)

Query: 355 KNKLGEGGFGPVYRGM------LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           K +LGEG FG V+           +   +AVK L   +    ++F+ E  L+  LQH ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQII 455
           V+  G C   D  ++++EY+ +  L +F+                     L  S+   I 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
             IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +  RV 
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182

Query: 516 G----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
           G       +M PE  +   F+ +SDV+SFGV++ EI
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 80/303 (26%), Positives = 145/303 (47%), Gaps = 44/303 (14%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQG-VEEFKNEVLLIAKLQ 404
           D  + F+   K+G+G FG V++G+    Q++ A+K +     +  +E+ + E+ ++++  
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 405 HRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
              + +  G   L+D ++ +I EYL   S      D+     LD ++   I+  I +GL 
Sbjct: 61  SPYVTKYYGS-YLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLD 115

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH + +   IHRD+KA+NVLL      K++DFG+A    +  T+   +  VGT  +M+P
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAP 170

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
           E      +  K+D++S G+  +E+  G+      H++ H              + L LI 
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPP----HSELH------------PMKVLFLIP 214

Query: 584 K----SLDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGF 637
           K    +L+G+YS  L E +        C+ + P  RP       +L  +  +   K+  +
Sbjct: 215 KNNPPTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKE---LLKHKFIVRFAKKTSY 265

Query: 638 FTE 640
            TE
Sbjct: 266 LTE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 88.5 bits (219), Expect = 4e-19
 Identities = 80/314 (25%), Positives = 142/314 (45%), Gaps = 64/314 (20%)

Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEG---QEIAVKRLSKSSGQG-VEEF 393
           P+ +WN I        +++ +GEG FG V +  + +     + A+KR+ + + +    +F
Sbjct: 2   PVLEWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 54

Query: 394 KNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVT 441
             E+ ++ KL  H N++ LLG C  R    L  EY P+ +L  F+           F + 
Sbjct: 55  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114

Query: 442 RT--KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
            +    L   +       +ARG+ YL Q    + IHRDL A N+L+  +   KI+DFG++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171

Query: 500 RAFGVDQTEANTDRVVGTYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEIV-------CG 550
           R       E    + +G     +M+ E     +++  SDV+S+GVL+ EIV       CG
Sbjct: 172 RG-----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226

Query: 551 KRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRP 610
                 Y        L   +RL          +K L+    + + +R       C +++P
Sbjct: 227 MTCAELYEK------LPQGYRL----------EKPLNCDDEVYDLMR------QCWREKP 264

Query: 611 EDRPNMSSVVLMLS 624
            +RP+ + +++ L+
Sbjct: 265 YERPSFAQILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 87.2 bits (216), Expect = 4e-19
 Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 23/199 (11%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++A+K +++ +    E+F  E  ++ KL H  LV+L G CT
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC--QIIEGIARGLLYLHQDSRLRII 474
            +    ++ E++ N  L  ++    R +    SK     + + +  G+ YL ++S    I
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122

Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------YMSPEYAID 528
           HRDL A N L+ +    K+SDFGM R + +D      D    + G      +  PE    
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR-YVLD------DEYTSSSGAKFPVKWSPPEVFNF 175

Query: 529 GLFSVKSDVFSFGVLVLEI 547
             +S KSDV+SFGVL+ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 5e-19
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 17/200 (8%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQH---RNLVRLL 412
           +G G +G VYRG     G+ +A+K ++  +    V + + EV L+++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 413 GCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           G   L+  R+ +I EY    S+   +    +   +       II  +   L Y+H+    
Sbjct: 69  GS-YLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG-- 121

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-L 530
            +IHRD+KA+N+L+ N  N K+ DFG+A     + ++ +T   VGT  +M+PE   +G  
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKY 178

Query: 531 FSVKSDVFSFGVLVLEIVCG 550
           +  K+D++S G+ + E+  G
Sbjct: 179 YDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 87.3 bits (216), Expect = 6e-19
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 20/203 (9%)

Query: 358 LGEGGFGPVY------RGMLTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           LGEG FG V        G  T G+++AVK L  +S G  + + K E+ ++  L H N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 411 LLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQ 467
             G CT        LI E+LP+ SL++++    R K  ++  ++ +    I +G+ YL  
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL-- 125

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT--EANTDRVVGTYGYMSPEY 525
            SR + +HRDL A NVL++++   KI DFG+ +A   D+       D     + Y +PE 
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183

Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
            I   F + SDV+SFGV + E++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 58/281 (20%)

Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRLLGCCT 416
           LG+G FG V++G L +   +AVK   +   Q ++ +F +E  ++ +  H N+V+L+G CT
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE---GIARGLLYLHQDSRLRI 473
            R    ++ E +P      F+      K  D  K  Q+++     A G+ YL   +    
Sbjct: 63  QRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-------YMSPEYA 526
           IHRDL A N L+  +   KISDFGM+R           D +  + G       + +PE  
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--------QEDDGIYSSSGLKQIPIKWTAPEAL 166

Query: 527 IDGLFSVKSDVFSFGVLVLEI----VCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
             G +S +SDV+S+G+L+ E     VC                    +   T  ++ E +
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVC-------------------PYPGMTNQQAREQV 207

Query: 583 DKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSV 619
           +K     Y +S   +C     +V   C   +PE+RP  S +
Sbjct: 208 EK----GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 86.6 bits (214), Expect = 8e-19
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQG-VEEFKNEVLLIAKLQ 404
           D  + F+   ++G+G FG V++G+    Q++ A+K +     +  +E+ + E+ ++++  
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
              + +  G      +  +I EYL   S      D+ R    D  +   +++ I +GL Y
Sbjct: 61  SPYVTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDY 116

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH + +   IHRD+KA+NVLL    + K++DFG+A      Q + NT   VGT  +M+PE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPE 171

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                 +  K+D++S G+  +E+  G+
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 35/208 (16%)

Query: 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-----------EVLLIAKL 403
            KLGEG +  VY+    E G+ +A+K++       + E K            E+ L+ +L
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQEL 59

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++ LL     +    L++E++    LE+ I D           +  ++    RGL 
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKD-KSIVLTPADIKSYMLM-TLRGLE 116

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH      I+HRDLK +N+L+ +D   K++DFG+AR+FG       T +VV T  Y +P
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYRAP 171

Query: 524 EYAIDGLFSVKS-----DVFSFGVLVLE 546
           E     LF  +      D++S G +  E
Sbjct: 172 EL----LFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 13/206 (6%)

Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGFG V    M   G+  A K+L+K      +G E    E  ++AK+  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRLR 472
               + +  L+   +    L   I++V          + C     I  GL +LHQ    R
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           II+RDLK  NVLLDND N +ISD G+A      Q++  T    GT G+M+PE      + 
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYD 175

Query: 533 VKSDVFSFGVLVLEIVCGK---RNRG 555
              D F+ GV + E++  +   R RG
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARG 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 20/201 (9%)

Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG V++G+ + EG  I    A+K +   SG Q  +E  + +L +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C       L+ +  P  SL   +      +   + L+W  +      IA+G+ YL +
Sbjct: 75  LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HR+L A N+LL +D   +I+DFG+A     D  +           +M+ E  +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
            G ++ +SDV+S+GV V E++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 28/212 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHR 406
           D +    K+GEG +G VY+       E IA+K++  +   +GV      E+ L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD----WSKRCQIIEG----I 458
           N+VRL           L++EYL          D+   K +D    ++K  ++I+     I
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYL----------DLDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGT 517
            RG+ Y H     R++HRDLK  N+L+D   N  K++DFG+ARAFG+      T  VV T
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-T 166

Query: 518 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIV 548
             Y +PE  +    +S   D++S G +  E+V
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 31/278 (11%)

Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHR 406
           NF  + K+G G F  VYR   L + + +A+K++        +  ++   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD-----WSKRCQIIEGIARG 461
           N+++ L      +E  ++ E      L Q I    + K L      W    Q+   +   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
               H  SR R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           SPE   +  ++ KSD++S G L+ E+           A       G    L++  + +E 
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM-----------AALQSPFYGDKMNLFSLCQKIEQ 222

Query: 582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
            D     +   SE LR  ++  +C+   P+ RP++  V
Sbjct: 223 CDYPPLPTEHYSEKLR--ELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 15/209 (7%)

Query: 347 DATDNFSWK--NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
           D   N  W+   +LG+G FG VY+    E G   A K +   S + +E++  E+ ++A  
Sbjct: 7   DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC 66

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H  +V+LLG      +  ++ E+ P  +++  + ++ R   L   +   I   +   L 
Sbjct: 67  NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQ 124

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH    ++IIHRDLKA NVLL  D + K++DFG++ A  V +T    D  +GT  +M+P
Sbjct: 125 YLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS-AKNV-KTLQRRDSFIGTPYWMAP 179

Query: 524 EYAI-----DGLFSVKSDVFSFGVLVLEI 547
           E  +     D  +  K+D++S G+ ++E+
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 31/278 (11%)

Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHR 406
           NF  + K+G G F  VYR   L +G  +A+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD-----WSKRCQIIEGIARG 461
           N+++        +E  ++ E      L + I    + K L      W    Q+   +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
               H  SR R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           SPE   +  ++ KSD++S G L+ E+        FY         G    L++  + +E 
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFY---------GDKMNLYSLCKKIEQ 222

Query: 582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
            D     S   SE LR  Q+  +C+   PE RP+++ V
Sbjct: 223 CDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 19/205 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           +++    ++G G +G VY+       E+ A+K +    G   E  + E+ ++ + +H N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR----GLLY 464
           V   G    RD+  ++ EY    SL Q I+ VTR    +       I  + R    GL Y
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLSE-----LQIAYVCRETLKGLAY 116

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH+      IHRD+K +N+LL  D + K++DFG++    +  T A     +GT  +M+PE
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPE 171

Query: 525 YA---IDGLFSVKSDVFSFGVLVLE 546
            A     G +  K D+++ G+  +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 17/212 (8%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRL-----SKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+G FG VY    +  G+E+A K++     S  + + V   + E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 412 LGCCTLRDERML--IYEYLPNKSL-EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
            GC   R E+ L    EY+P  S+ +Q       T+ +      QI+EG++    YLH +
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS----YLHSN 125

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTEANTDRVVGTYGYMSPEYAI 527
               I+HRD+K +N+L D+  N K+ DFG ++    +  +      V GT  +MSPE   
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA 559
              +  K+DV+S G  V+E++  K     Y A
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 67/199 (33%), Positives = 104/199 (52%), Gaps = 21/199 (10%)

Query: 357 KLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVRL 411
           ++G G FG VY  R + T  + +A+K++S S  Q  E++++   EV  + +L+H N +  
Sbjct: 22  EIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
            GC        L+ EY    + +  I +V + K L   +   I  G  +GL YLH   R 
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHSHER- 136

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE--YAID- 528
             IHRD+KA N+LL      K++DFG A       + AN+   VGT  +M+PE   A+D 
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGTPYWMAPEVILAMDE 188

Query: 529 GLFSVKSDVFSFGVLVLEI 547
           G +  K DV+S G+  +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 27/219 (12%)

Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD--------WSKRC 452
            +    ++VRLLG  +     ++I E +    L+ ++  + R +  +          K  
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVQAPPSLKKMI 122

Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
           Q+   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 175

Query: 513 RVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
           R  G       +MSPE   DG+F+  SDV+SFGV++ EI
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.3 bits (211), Expect = 7e-18
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 39/213 (18%)

Query: 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRLLG 413
           N++G G  G VY+ +    G+  A+K +  +    V  +   E+ ++  + H N+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 414 CCTLRDERMLIYEYLPNKSL-------EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
                 E  ++ E++   SL       EQF+ DV R          QI+ GIA    YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----------QILSGIA----YLH 185

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY- 525
              R  I+HRD+K SN+L+++  N KI+DFG++R   + QT    +  VGT  YMSPE  
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSPERI 240

Query: 526 -------AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                  A DG      D++S GV +LE   G+
Sbjct: 241 NTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 83.5 bits (206), Expect = 8e-18
 Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 34/277 (12%)

Query: 358 LGEGGFGPVYRGMLTEGQEI---AVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LGEG FG V  G L +   I   AVK  +++  +   +E+F +E + + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 413 GCCTLRDER------MLIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGL 462
           G C    E       ++I  ++ +  L  F+   +R     ++L      + +  IA G+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            YL   S    IHRDL A N +L+ +MN  ++DFG+++                   +++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
            E   D +++ KSDV+SFGV + EI    R +  Y    +  +    +    +   L+  
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEI--ATRGQTPYPGVENSEI----YDYLRQGNRLKQP 236

Query: 583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
              LDG YSL  +         C    P+DRP+  ++
Sbjct: 237 PDCLDGLYSLMSS---------CWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 13/207 (6%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  D +    +LG+G FG VY+      G   A K +   S + +E+F  E+ ++++ +H
Sbjct: 2   NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V L       ++  ++ E+    +L+  + ++ R   L   +   +   +   L +L
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     ++IHRDLKA N+LL  D + K++DFG++ A     T    D  +GT  +M+PE 
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKS-TLQKRDTFIGTPYWMAPEV 174

Query: 526 AI-----DGLFSVKSDVFSFGVLVLEI 547
                  D  +  K+D++S G+ ++E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 84.3 bits (208), Expect = 9e-18
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)

Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           K+GEG  G V        G+++AVK +     Q  E   NEV+++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
            + +E  ++ E+L   +L   +        L+  +   + E + + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKS 535
           RD+K+ ++LL  D   K+SDFG       D  +  +  +VGT  +M+PE      +  + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198

Query: 536 DVFSFGVLVLEIVCGK 551
           D++S G++V+E+V G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCT 416
           +G G +G VY+G   +  ++A  ++   +G   EE K E+ ++ K   HRN+    G   
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 417 ------LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
                 + D+  L+ E+    S+   I + T+   L       I   I RGL +LHQ   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI--- 527
            ++IHRD+K  NVLL  +   K+ DFG++    +D+T    +  +GT  +M+PE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 528 --DGLFSVKSDVFSFGVLVLEIVCG 550
             D  +  KSD++S G+  +E+  G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 85/302 (28%), Positives = 133/302 (44%), Gaps = 57/302 (18%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKL-Q 404
           ++  +++ +GEG FG V R M+  +G ++  A+K L + +S     +F  E+ ++ KL  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKF---------LDWSKR 451
           H N++ LLG C  R    +  EY P  +L  F+       T   F         L   + 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
            Q    +A G+ YL   S  + IHRDL A NVL+  ++  KI+DFG++R       E   
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG-----EEVYV 173

Query: 512 DRVVGTYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEIV-------CGKRNRGFYHADHH 562
            + +G     +M+ E     +++ KSDV+SFGVL+ EIV       CG      Y     
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK--- 230

Query: 563 HNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 622
              L   +R       +E      D  Y L            C + RP +RP  + + + 
Sbjct: 231 ---LPQGYR-------MEKPRNCDDEVYELMRQ---------CWRDRPYERPPFAQISVQ 271

Query: 623 LS 624
           LS
Sbjct: 272 LS 273

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 17/202 (8%)

Query: 358 LGEGGFGPVYRGMLTEGQ------EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           +G G FG V+       Q      +I V++++K      +   NE  ++  L H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                     M++ EY P  +L ++I        LD      I+    + LL LH     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDED---TILHFFVQILLALHHVHTK 120

Query: 472 RIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            I+HRDLK  N+LLD + M  KI DFG+++     +++A T  VVGT  Y+SPE      
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYT--VVGTPCYISPELCEGKP 177

Query: 531 FSVKSDVFSFGVLVLEIVCGKR 552
           ++ KSD+++ G ++ E+   KR
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 31/209 (14%)

Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSG-QGVEEFK-NEVLLIAKLQ---HRNLV 409
            ++GEG +G VY+   L  G+ +A+K++      +G+      E+ L+ +L+   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 410 RLLGCC-TLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           RLL  C   R +R     L++E++ ++ L  ++    +      + +  ++  + RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDF 122

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH     RI+HRDLK  N+L+ +D   KI+DFG+AR +  +   A T  VV T  Y +PE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLWYRAPE 176

Query: 525 ------YAIDGLFSVKSDVFSFGVLVLEI 547
                 YA      V  D++S G +  E+
Sbjct: 177 VLLQSSYA----TPV--DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 73/285 (25%), Positives = 130/285 (45%), Gaps = 50/285 (17%)

Query: 358 LGEGGFGPVYRGMLT----EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V RG L         +A+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M+I E++ N +L+ F+      F V +           ++ GIA G+ YL 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--------VGMLRGIAAGMKYL- 122

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG---TYGYMSP 523
             S +  +HRDL A N+L+++++  K+SDFG++R    D ++      +G      + +P
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
           E      F+  SDV+S+G+++ E++  G+R                 W +  +D     +
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---------------WDMSNQD-----V 220

Query: 583 DKSLDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVVLML 623
             +++  Y L   + C     Q+ L C Q+    RP    +V  L
Sbjct: 221 INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 13/196 (6%)

Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +LG G FG V +G   M  +  ++A+K L   + + V +E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G C   +  ML+ E      L +F+    +   +  S   +++  ++ G+ YL   +   
Sbjct: 62  GVCE-AEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY--GYMSPEYAIDGL 530
            +HRDL A NVLL N    KISDFG+++A G D +     R  G +   + +PE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174

Query: 531 FSVKSDVFSFGVLVLE 546
           FS +SDV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 357 KLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           K+GEG  G V   + TE   G+++AVK++     Q  E   NEV+++    H N+V +  
Sbjct: 29  KIGEGSTGIVC--IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
              + DE  ++ E+L   +L      VT T+ ++  +   +   + R L YLH      +
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLSVLRALSYLHNQG---V 139

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRD+K+ ++LL +D   K+SDFG      V +       +VGT  +M+PE      +  
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 534 KSDVFSFGVLVLEIVCGK 551
           + D++S G++V+E++ G+
Sbjct: 198 EVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 12/200 (6%)

Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLG 413
           K+GEG +G V++    E  EI A+KR+      +GV      E+ L+ +L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                 +  L++EY  ++ L+++ FD      +D       +  + +GL + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFS 532
           +HRDLK  N+L++ +   K++DFG+ARAFG+      +  VV T  Y  P+      L+S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 178

Query: 533 VKSDVFSFGVLVLEIVCGKR 552
              D++S G +  E+    R
Sbjct: 179 TSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)

Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           DNF    K+GEG  G V    + + G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V +     + DE  ++ E+L   +L      VT T+ ++  +   +   + + L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLKALSVLHAQ 135

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               +IHRD+K+ ++LL +D   K+SDFG      V +       +VGT  +M+PE    
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISR 190

Query: 529 GLFSVKSDVFSFGVLVLEIVCGK 551
             +  + D++S G++V+E+V G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 78/311 (25%), Positives = 138/311 (44%), Gaps = 68/311 (21%)

Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEG-----QEIAVKRLSKSSGQ-GVEEFKNEVL 398
           IA + D  +  + L EG FG ++ G+L +      +E+ VK +   + +  V     E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 399 LIAKLQHRNLVRLLGCCT-LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG 457
           L+  L H+N++ +L  C    +   ++Y Y+   +L+ F+            ++C++ E 
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL------------QQCRLGEA 108

Query: 458 -----------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
                            IA G+ YLH   +  +IH+D+ A N ++D ++  KI+D  ++R
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Query: 501 -AFGVDQ--TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 557
             F +D      N +R V    +M+ E  ++  +S  SDV+SFGVL+ E++         
Sbjct: 166 DLFPMDYHCLGDNENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT-------- 214

Query: 558 HADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDR 613
                   LG     + E    E+     DG Y L++ + C      V   C    PE+R
Sbjct: 215 --------LGQT--PYVEIDPFEMAAYLKDG-YRLAQPINCPDELFAVMACCWALDPEER 263

Query: 614 PNMSSVVLMLS 624
           P+ S +V  L+
Sbjct: 264 PSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 13/191 (6%)

Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG    
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 418 RDERMLIY-EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
               + I  EY+   SL  ++    R+  L      +    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL A NVL+  D   K+SDFG+ +     +  +  D       + +PE   +  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181

Query: 537 VFSFGVLVLEI 547
           V+SFG+L+ EI
Sbjct: 182 VWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)

Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLS-KSSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 192 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.9 bits (202), Expect = 5e-17
 Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 43/232 (18%)

Query: 354 WKNKLGEGGFGPVYRGMLTEGQE-----------------IAVKRL-SKSSGQGVEEFKN 395
           +K KLGEG FG V+   +   Q+                 +AVK L   ++     +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD-------- 447
           EV ++++L+  N++RLLG C   D   +I EY+ N  L QF+   +     D        
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDA 125

Query: 448 -----------WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496
                      +S    +   IA G+ YL   S L  +HRDL   N L+  ++  KI+DF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182

Query: 497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           GM+R            R V    +M+ E  + G F+  SDV++FGV + EI+
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 81.6 bits (202), Expect = 8e-17
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 24/212 (11%)

Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRL---SKSSGQGVEEFKNEVLLIAKLQHR 406
            F   N++GEG +G VYR   T   EI A+K++   ++  G  +   + E+ L+  L+H 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66

Query: 407 NLVRLLGCCTLR--DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           N+V L      +  D   L+ EY   + L   + ++    F +   +C ++  + RGL Y
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTP-FSESQVKC-LMLQLLRGLQY 123

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH++    IIHRDLK SN+LL +    KI+DFG+AR +G+      T +VV T  Y +PE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV-TLWYRAPE 178

Query: 525 YAIDGLFSVKS-----DVFSFGVLVLEIVCGK 551
                L    +     D+++ G ++ E++  K
Sbjct: 179 L----LLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 10/201 (4%)

Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRN 407
            +    K+GEG FG +Y     ++ +   +K   L+K   +  E  K EV+L+AK++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           +V             ++ EY     L + I       F +       ++ I+ GL ++H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ-ISLGLKHIHD 119

Query: 468 DSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
               +I+HRD+K+ N+ L  N M  K+ DFG+AR        A T   VGT  Y+SPE  
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEIC 174

Query: 527 IDGLFSVKSDVFSFGVLVLEI 547
            +  ++ K+D++S G ++ E+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.8 bits (199), Expect = 8e-17
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 13/197 (6%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           +LG+G FG VY+    E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
              +   ++ E+    +++  + ++ R   L   +   + +     L YLH++   +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-----DGL 530
           RDLKA N+L   D + K++DFG++      +T    D  +GT  +M+PE  +     D  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 531 FSVKSDVFSFGVLVLEI 547
           +  K+DV+S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 81.6 bits (201), Expect = 9e-17
 Identities = 66/218 (30%), Positives = 110/218 (50%), Gaps = 36/218 (16%)

Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL------LIAKLQ------- 404
           LGEG FG V   ++ E   I   + +K     V+  K++        L+++++       
Sbjct: 20  LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS-KRCQIIE------- 456
           H+N++ LLG CT      ++ EY    +L +++    R   +D+S   C++ E       
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 457 ------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR-AFGVDQTEA 509
                  +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR    +D  + 
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 193 TTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 28/206 (13%)

Query: 361 GGFGPVY--RGMLTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLGCC 415
           G +G V+  +   T G   A+K + K+       V++   E  ++++ Q   +V+L    
Sbjct: 4   GAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62

Query: 416 TLRDERMLIYEYLPN---KSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
             +    L+ EYLP     SL + +   D    +          I  I   L YLH    
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHS--- 111

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFG------MARAFGVDQTEANTDRVVGTYGYMSPE 524
             IIHRDLK  N+L+D++ + K++DFG      + R   ++  E    R+VGT  Y++PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCG 550
             +    S   D +S G ++ E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 33/212 (15%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRL-----SKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+G FG VY     + G+E+AVK++     S  + + V   + E+ L+  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 412 LGCCTLRD--ERML--IYEYLPNKSLEQ-------FIFDVTRTKFLDWSKRCQIIEGIAR 460
            GC  LRD  ER L    E++P  S++           +VTR     +++  QI+EG+  
Sbjct: 70  YGC--LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK----YTR--QILEGV-- 119

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTEANTDRVVGTYG 519
              YLH +    I+HRD+K +N+L D+  N K+ DFG ++    +  +      V GT  
Sbjct: 120 --SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +MSPE      +  K+D++S G  V+E++  K
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 29/206 (14%)

Query: 358 LGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG GGFG V    + ++ +  A+K + K         E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 414 CCTLRDER---MLIYEYLPNKSLEQFIFDVTRT--KFLDWSKR---CQIIEGIARGLLYL 465
             T +D++   ML+ EY     L    + + R    F +++ R     ++        YL
Sbjct: 60  -RTFKDKKYIYMLM-EYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFE----YL 109

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H      II+RDLK  N+LLD++   K+ DFG A+     Q    T    GT  Y++PE 
Sbjct: 110 H---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEI 163

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
            ++  +    D +S G+L+ E++ G+
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.7 bits (207), Expect = 1e-16
 Identities = 86/354 (24%), Positives = 152/354 (42%), Gaps = 37/354 (10%)

Query: 279 RKKKKVVIIIICALLATGVILIGGFMYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELP 338
           RK       I C L A  V+ +  F ++  + R +        EL  ++  N     EL 
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN-------LELKRVE--NEDGTWELQ 673

Query: 339 MFDWN-----TIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKSSGQGVEE 392
            FD       TI D   +   +N +  G  G  Y+G  +  G +  VK ++  +     E
Sbjct: 674 FFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733

Query: 393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC 452
             +    + KLQH N+V+L+G C       LI+EY+  K+L + + +      L W +R 
Sbjct: 734 IAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRR 783

Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
           +I  GIA+ L +LH      ++  +L    +++D    P +    +      D     + 
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842

Query: 513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 572
                  Y++PE       + KSD++ FG++++E++ GK +        H +++  A R 
Sbjct: 843 ------AYVAPETRETKDITEKSDIYGFGLILIELLTGK-SPADAEFGVHGSIVEWA-RY 894

Query: 573 WTEDRSLEL-IDKSLDGSYSL--SEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
              D  L++ ID S+ G  S+  +E +  + + L C    P  RP  + V+  L
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 19/203 (9%)

Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAKLQHRN 407
           F+   ++G G FG VY        E+ A+K++S S  Q  E++++   EV  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
            +   GC        L+ EY    + +  + +V + K L   +   I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHK-KPLQEVEIAAITHGALQGLAYLHS 143

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
            +   +IHRD+KA N+LL      K++DFG A       + AN+   VGT  +M+PE  +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS--FVGTPYWMAPEVIL 194

Query: 528 ---DGLFSVKSDVFSFGVLVLEI 547
              +G +  K DV+S G+  +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 69/219 (31%), Positives = 111/219 (50%), Gaps = 36/219 (16%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRL---SKSSG---QGVEEFKNEVLLIAK 402
           D +   N++ EG +G VYR      G+ +A+K+L    +  G     + E    +LL  K
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI--NILL--K 60

Query: 403 LQHRNLVRL----LGCCTLRDERMLIYEYLPN--KSLEQFIFDVTRTKFLDWSKRC---Q 453
           LQH N+V +    +G  +  D+  ++ EY+ +  KSL     +  +  FL    +C   Q
Sbjct: 61  LQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSL----METMKQPFLQSEVKCLMLQ 114

Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           ++ G+A    +LH +    I+HRDLK SN+LL+N    KI DFG+AR +G    +  T  
Sbjct: 115 LLSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQL 166

Query: 514 VVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 551
           VV T  Y +PE  +    +S   D++S G +  E++  K
Sbjct: 167 VV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 50/200 (25%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           KLGEG FG VY+   +  G+ +A+K++   ++  G  +   + E+ ++ KL+H N+V L+
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLI 73

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIF---------DVT------RTKFLDWSKRC---QI 454
                     +  E       ++            D++        K  +   +C   Q+
Sbjct: 74  D---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF----------GV 504
           +EGI     YLH++    I+HRD+KA+N+L+DN    KI+DFG+AR +          G 
Sbjct: 125 LEGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 505 DQTEANTDRVVGTYGYMSPE 524
             T   T+ VV T  Y  PE
Sbjct: 178 GGTRKYTNLVV-TRWYRPPE 196

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 79/290 (27%), Positives = 138/290 (47%), Gaps = 50/290 (17%)

Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLV 409
           +LG+G FG VY G    + +G+    +AVK +++S S +   EF NE  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
           RLLG  +     +++ E + +  L+ ++  + R +  +   R         Q+   IA G
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---- 517
           + YL+     + +HRDL A N ++ +D   KI DFGM R    D  E +  R  G     
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
             +M+PE   DG+F+  SD++SFGV++ EI                +L    ++  + ++
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGLSNEQ 229

Query: 578 SLELIDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLML 623
            L+ +   +DG Y L +   C +    +  +C Q  P+ RP    +V +L
Sbjct: 230 VLKFV---MDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 4e-16
 Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 57/293 (19%)

Query: 358 LGEGGFGPVYRGMLTEG---QEIAVKRLSK-SSGQGVEEFKNEVLLIAKL-QHRNLVRLL 412
           +GEG FG V +  + +     + A+KR+ + +S     +F  E+ ++ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA-----RGLLYLHQ 467
           G C  R    L  EY P+ +L  F+    +++ L+      I    A     + LL+   
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 468 D--------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           D        S+ + IHRDL A N+L+  +   KI+DFG++R       E    + +G   
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 174

Query: 520 --YMSPEYAIDGLFSVKSDVFSFGVLVLEIV-------CGKRNRGFYHADHHHNLLGHAW 570
             +M+ E     +++  SDV+S+GVL+ EIV       CG      Y        L   +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LPQGY 228

Query: 571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
           RL  +  + +      D  Y L            C +++P +RP+ + +++ L
Sbjct: 229 RL-EKPLNCD------DEVYDLMRQ---------CWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.7 bits (196), Expect = 4e-16
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 19/208 (9%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAK 402
           D  + F   +++G G FG VY    +   E+ AVK++S S  Q  E++++   EV  + +
Sbjct: 18  DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           L+H N +   GC        L+ EY    + +  + +V + K L   +   I  G  +GL
Sbjct: 78  LKHPNTIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHK-KPLQEVEIAAITHGALQGL 134

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            YLH  +   +IHRD+KA N+LL      K++DFG A       + AN+   VGT  +M+
Sbjct: 135 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMA 185

Query: 523 PEYAI---DGLFSVKSDVFSFGVLVLEI 547
           PE  +   +G +  K DV+S G+  +E+
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 78.2 bits (192), Expect = 5e-16
 Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           ++F    ++G G +G VY+   +  G+  A+K +    G+     + E++++   +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V   G    RD+  +  E+    SL Q I+ VT    L  S+   +     +GL YLH  
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI- 527
            +   +HRD+K +N+LL ++ + K++DFG++    +  T A     +GT  +M+PE A  
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 528 --DGLFSVKSDVFSFGVLVLEI 547
              G ++   D+++ G+  +E+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 23/201 (11%)

Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK----LQHRNLV 409
           +LG G FG V +G   M    + +AVK L   +       K+E+L  A     L +  +V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           R++G C   +  ML+ E      L +F+    + K +      +++  ++ G+ YL + +
Sbjct: 60  RMIGICE-AESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
               +HRDL A NVLL      KISDFG+++A G D+   N  +      +    YA + 
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPEC 169

Query: 530 L----FSVKSDVFSFGVLVLE 546
           +    FS KSDV+SFGVL+ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 36/218 (16%)

Query: 358 LGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-Q 404
           LGEG FG V   ++ E             ++AVK L S ++ + + +  +E+ ++  + +
Sbjct: 26  LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS--KRCQIIEG----- 457
           H+N++ LLG CT      +I EY    +L +++    R   +++         E      
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 458 -------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTEA 509
                  +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR    +D  + 
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 199 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 19/198 (9%)

Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVRLL 412
           ++G G FG VY        E+ A+K++S S  Q  E++++   EV  + KL+H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           GC        L+ EY    + +  + +V + K L   +   +  G  +GL YLH  +   
Sbjct: 82  GCYLREHTAWLVMEYCLGSASD--LLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--- 135

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DG 529
           +IHRD+KA N+LL      K+ DFG A         A  +  VGT  +M+PE  +   +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEG 189

Query: 530 LFSVKSDVFSFGVLVLEI 547
            +  K DV+S G+  +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 17/204 (8%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK-NEVL-------LIAKLQHR 406
           + +LG+G FG VY  ++ + + +A +RL       V E   NE +       L++KL H 
Sbjct: 5   QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLLYL 465
            +V+       RD   +I EY   + L+  + ++  T K L  ++ C+    +  G+ Y+
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           HQ    RI+HRDLKA N+ L N++  KI DFG++R        A T    GT  YMSPE 
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVC 549
                +  KSD++S G ++ E+ C
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 76/268 (28%), Positives = 117/268 (43%), Gaps = 28/268 (10%)

Query: 357 KLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRLLGC 414
           ++G G FG V+ G L  +   +AVK   ++    ++ +F  E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
           CT +    ++ E +       F+   T    L   +  Q++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 475 HRDLKASNVLLDNDMNPKISDFGMAR--AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           HRDL A N L+      KISDFGM+R    GV  +     ++     + +PE    G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174

Query: 533 VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR-SLELIDKSLDGSYS 591
            +SDV+SFG+L+ E            A  + NL     R   E    L   +   D  Y 
Sbjct: 175 SESDVWSFGILLWEAFS-------LGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYR 227

Query: 592 LSEALRCIQVGLLCVQQRPEDRPNMSSV 619
           L E          C +  P  RP+ S+V
Sbjct: 228 LMER---------CWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 17/204 (8%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRL-----SKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY     + G+E+AVK++     S+ + + V   + E+ L+  L+H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 412 LGCCTLRDERML--IYEYLPNKSL-EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
            GC    +E+ L    EY+P  S+ +Q       T+ +      QI++G++    YLH +
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS----YLHSN 125

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMA-RAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               I+HRD+K +N+L D+  N K+ DFG + R   +  +      V GT  +MSPE   
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGK 551
              +  K+DV+S    V+E++  K
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 39/99 (39%), Positives = 62/99 (62%), Gaps = 6/99 (6%)

Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
           +I   +  GL YL+  +  RI+HRD+K SN+L+++    K+ DFG++    +  + A+T 
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE--LINSIADT- 161

Query: 513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
             VGT  YMSPE    G ++VKSDV+S G+ ++E+  GK
Sbjct: 162 -FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 72/210 (34%), Positives = 101/210 (48%), Gaps = 35/210 (16%)

Query: 358 LGEGGFGPVYRGMLTE----GQEIAVKRLSKS---SGQGVE--EFKNEVLLIAKLQHRNL 408
           LG+G FG V   ML E     +  A+K L K        VE    +  VL +A  +H  L
Sbjct: 3   LGKGSFGKV---MLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFL 58

Query: 409 VRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARG 461
             L   CT + +  L +  EYL    L   I     FD  R +F       +II G    
Sbjct: 59  THLF--CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA----AEIICG---- 108

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L +LH+     II+RDLK  NVLLD D + KI+DFGM +     + +A+T    GT  Y+
Sbjct: 109 LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYI 163

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE      ++   D +SFGVL+ E++ G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 18/175 (10%)

Query: 357 KLGEGGFGPVYR-GMLTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           ++GEG  G V++      G+ +A+K+  L +  G    +   E+  +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 414 CCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARGLLYLHQDS 469
                     L+ EY+P+  L + + D  R    +   +     +++G+A    Y+H   
Sbjct: 67  V-FPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVKSYMRMLLKGVA----YMHA-- 117

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
              I+HRDLK +N+L+  D   KI+DFG+AR F  ++    + + V T  Y +PE
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 75/283 (26%), Positives = 128/283 (45%), Gaps = 48/283 (16%)

Query: 358 LGEGGFGPVYRG--MLTEGQE--IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LG G FG + RG   L   +E  +A+  L    S +    F  E L + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           G  T  +  M++ EY+ N +L+ F+      +   + +       ++ G+A G+ YL   
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL--- 123

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA--NTDRVVGTYGYMSPEYA 526
           S +  +H+ L A  VL+++D+  KIS F   +    D++EA   T        + +PE  
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 527 IDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
               FS  SDV+SFG+++ E++  G+R                 W +  +D     + K+
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPY---------------WDMSGQD-----VIKA 220

Query: 586 LDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVVLMLS 624
           ++  + L     C     Q+ L C Q+   +RP  S +  +LS
Sbjct: 221 VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)

Query: 356 NKLGEGGFGPVYRG--MLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           +KLGEG +  VY+G   LT+   +A+K  RL    G      + EV L+  L+H N+V L
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                      L++EYL +K L+Q++ D   +  +   K    +  + RGL Y H   R 
Sbjct: 70  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK--LFLFQLLRGLNYCH---RR 123

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL- 530
           +++HRDLK  N+L++     K++DFG+ARA  +  T+  ++ VV T  Y  P+  +    
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTD 181

Query: 531 FSVKSDVFSFGVLVLEIVCGK 551
           +S + D++  G +  E+  G+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 14/199 (7%)

Query: 355 KNKLGEGGFGPVYRGMLT--EGQEI--AVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLV 409
              +GEG FG VY+G+    E ++I  AVK     +   V E+F  E  ++ +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 410 RLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +L+G  T  +  + ++ E  P   L  ++        LD +        ++  L YL   
Sbjct: 71  KLIGVIT--ENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
              R +HRD+ A NVL+ +    K+ DFG++R    D++     +      +M+PE    
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINF 182

Query: 529 GLFSVKSDVFSFGVLVLEI 547
             F+  SDV+ FGV + EI
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)

Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+GGFG V        G +   +++  KR+ K  G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                 +D   L+   +    L+  I+ +    F +  +       I  GL  LHQ+   
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDLHQE--- 121

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
           RI++RDLK  N+LLD+  + +ISD G+A      QT       VGT GYM+PE   +  +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERY 178

Query: 532 SVKSDVFSFGVLVLEIVCGK 551
           +   D ++ G L+ E++ G+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 77.8 bits (191), Expect = 2e-15
 Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 42/247 (17%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---EVLL 399
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+   Q +   K    E+ L
Sbjct: 11  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRL 69

Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ-- 453
           +  ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ  
Sbjct: 70  LKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKL 117

Query: 454 -------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
                  +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 169

Query: 507 TEANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 565
           T+      V T  Y +PE  ++ + ++   D++S G ++ E++ G   R  +    H + 
Sbjct: 170 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQ 226

Query: 566 LGHAWRL 572
           L    RL
Sbjct: 227 LKLILRL 233

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 25/205 (12%)

Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVRL 411
            +GEG +G V +      G+ +A+K+  +S     E+ K     EV ++ +L+H N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
                 +    L++EY+    LE              +   W    Q+++ IA    Y H
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW----QLLQAIA----YCH 117

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
                 IIHRD+K  N+L+      K+ DFG ARA         TD V  T  Y +PE  
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELL 173

Query: 527 I-DGLFSVKSDVFSFGVLVLEIVCG 550
           + D  +    DV++ G ++ E++ G
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNLVRL 411
           LG+G FG V    L E G+  AVK L K        VE    E  +L +A+  H  L +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
             C    D    + E++    L   +F + +++  D ++       I   L++LH     
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
            II+RDLK  NVLLD++ + K++DFGM +    +    +T    GT  Y++PE   + L+
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAPEILQEMLY 173

Query: 532 SVKSDVFSFGVLVLEIVCG 550
               D ++ GVL+ E++CG
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 41/218 (18%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS----SGQGVEEFKNEVLLIAKLQ 404
           D+F +   LG G FG V         +  A+K LSK+      Q VE   NE  ++  ++
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 405 HRNLVRLLGCCTLRDERML--IYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEG 457
           H  LV L G  + +D+  L  + EY+P   L   +     F     +F            
Sbjct: 60  HPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--------AAQ 109

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +   L YLH    L I++RDLK  N+LLD+D   KI+DFG A+     + +  T  + GT
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161

Query: 518 YGYMSPEYAIDGLFSVK-----SDVFSFGVLVLEIVCG 550
             Y++PE     +   K      D ++ G+L+ E++ G
Sbjct: 162 PEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 18/204 (8%)

Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           ++    ++G G +G VY+   L  G+  AVK +    G      + E+ ++ + +H N+V
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI---IEGIARGLLYLH 466
              G    R++  +  EY    SL Q I+ VT           QI        +GL YLH
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPL-----SELQIAYVCRETLQGLAYLH 123

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
              ++   HRD+K +N+LL ++ + K++DFG+A    +  T A     +GT  +M+PE A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAPEVA 178

Query: 527 I---DGLFSVKSDVFSFGVLVLEI 547
               +G ++   D+++ G+  +E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)

Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+GGFG V        G +   +++  KRL K SG+ +   + E+L   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                 +    L+   +    L+  I++V   + L+  +       I  G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
            I++RD+K  NVLLD+  N ++SD G+  A  +   +  T R  GT GYM+PE   +  +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQR-AGTNGYMAPEILKEEPY 171

Query: 532 SVKSDVFSFGVLVLEIVCGK 551
           S   D F+ G  + E+V G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 39/212 (18%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVRLLG 413
           +G G +G V     T+ G+++A+K+LS+   Q     K    E+ L+  + H N++ LL 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 414 CCTLRDERMLIYEYLPNKSLEQF--IFDVT-----------RTKFLDWSKRCQIIEGIAR 460
             T            P  SLE F  ++ VT           + + L       ++  I R
Sbjct: 82  VFT------------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR 129

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T+      V T  Y
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWY 181

Query: 521 MSPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 551
            +PE  ++ +   ++ D++S G ++ E++ GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 356 NKLGEGGFGPVYRG--MLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
            KLGEG +  V++G   LTE   +A+K  RL    G      + EV L+  L+H N+V L
Sbjct: 12  EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                      L++EYL +K L+Q++ D      +   K    +  I RGL Y H   R 
Sbjct: 70  HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVK--IFLYQILRGLAYCH---RR 123

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-DGL 530
           +++HRDLK  N+L++     K++DFG+ARA  V  T+  ++ VV T  Y  P+  +    
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSE 181

Query: 531 FSVKSDVFSFGVLVLEIVCGK 551
           +S + D++  G +  E+  G+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 20/223 (8%)

Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
           D + + D    F     +G G +G VY+G   +  ++A  ++   +    EE K E+ ++
Sbjct: 7   DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66

Query: 401 AKL-QHRNLVRLLGCCTLR------DERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRC 452
            K   HRN+    G    +      D+  L+ E+    S+   + +        DW    
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--A 124

Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
            I   I RGL +LH     ++IHRD+K  NVLL  +   K+ DFG++    +D+T    +
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRN 179

Query: 513 RVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCG 550
             +GT  +M+PE        D  +  +SD++S G+  +E+  G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 38/272 (13%)

Query: 358 LGEGGFGPVYRGMLTE----GQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           +GEG FG   R +L +     Q+ A+K  RL KSS   VE+ + E +L+AK++H N+V  
Sbjct: 8   VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                      ++ EY     L Q I       F + +     ++ +  G+ ++H+    
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ-MCLGVQHIHEK--- 119

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
           R++HRD+K+ N+ L  +   K+ DFG AR        A T   VGT  Y+ PE   +  +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPY 177

Query: 532 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS 591
           + KSD++S G ++ E+   K           H    ++W+         LI K   GSY 
Sbjct: 178 NNKSDIWSLGCILYELCTLK-----------HPFQANSWK--------NLILKVCQGSYK 218

Query: 592 LSEALRCIQVGLLCVQ---QRPEDRPNMSSVV 620
              +    ++  L  Q   + P  RP+ ++++
Sbjct: 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 28/209 (13%)

Query: 358 LGEGGFGPVYRGMLTE--GQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLG 413
           +G G FG V + ML +  G  +AVKR+ S    +  +    ++ ++ +      +V+  G
Sbjct: 12  IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 414 CCTLRDERMLIYEYLPNKSLEQF---IFDVTRTKFLDWSKRCQIIEGIA----RGLLYLH 466
               R+    I   L + SL++F   +++V ++   +     +I+  IA    + L YL 
Sbjct: 71  A-LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLK 124

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE-- 524
           ++  L+IIHRD+K SN+LLD + N K+ DFG++    VD   A T R  G   YM+PE  
Sbjct: 125 EE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSI-AKT-RDAGCRPYMAPERI 179

Query: 525 --YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
              A DG + V+SDV+S G+ + E+  GK
Sbjct: 180 DPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 42/285 (14%)

Query: 358 LGEGGFGPVYR-------GMLTEGQEIAVKRLS-----KSSGQGVEEFKNEVLLIAK-LQ 404
           LG G FG VY+         L   +EI V   +     +   + + +  +EV +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSL-EQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           H N+VR        D   ++ + +    L E F     + +     +   I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH++ R  I+HRDL  +N++L  D    I+DFG+A+     Q E+    VVGT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTILYSCP 182

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
           E   +  +  K+DV++FG ++ ++        FY  +                  L L  
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMC--TLQPPFYSTN-----------------MLSLAT 223

Query: 584 KSLDGSYS-LSEALRCIQVGLL---CVQQRPEDRPNMSSVVLMLS 624
           K ++  Y  L E +    V  +   C+    E RP++  V  M+S
Sbjct: 224 KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 66/209 (31%), Positives = 93/209 (44%), Gaps = 33/209 (15%)

Query: 358 LGEGGFGPVYRGMLTE----GQEIAVKRLSKS---SGQGVEEFKNE--VLLIAKLQHRNL 408
           LG+G FG V   +L E     +  AVK L K        VE    E  VL +A  +H  L
Sbjct: 3   LGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            +L  C   +D    + EY+    L         FD  R +F            I  GL 
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--------IVLGLQ 110

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR-AFGVDQTEANTDRVVGTYGYMS 522
           +LH+     II+RDLK  NVLLD++ + KI+DFGM +       T   T    GT  Y++
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIA 164

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +    D ++ GVL+ E++ G+
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 39/193 (20%)

Query: 357 KLGEGGFGPVYRGMLTE---GQEIAVKRL--SKSSGQGVEEFK-NEVLLIAKLQHRNLVR 410
            +G G +G VY+        G+E A+K+    K    G+ +    E+ L+ +L+H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 411 LLGCCTLRDERMLIY------EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR---- 460
           L+    L      +Y      E+     L Q I      KF   +KR  I   + +    
Sbjct: 67  LVEVF-LEHADKSVYLLFDYAEH----DLWQII------KFHRQAKRVSIPPSMVKSLLW 115

Query: 461 ----GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVD-QTEANT 511
               G+ YLH +    ++HRDLK +N+L+  +       KI D G+AR F    +  A+ 
Sbjct: 116 QILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 512 DRVVGTYGYMSPE 524
           D VV T  Y +PE
Sbjct: 173 DPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 58/217 (26%), Positives = 111/217 (51%), Gaps = 31/217 (14%)

Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFK----NEVLLIAKL 403
           D F    ++GEG +G VY  R   T G+ +A+K++   + +  E F      E+ ++ +L
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRLDNEK--EGFPITAIREIKILRQL 63

Query: 404 QHRNLVRLLGCCTLRDERM----------LIYEYLPNKSLEQFIFDVTRTKFLDWSKR-- 451
            HRN+V L    T + + +          L++EY+     +  +  +  +  + +S+   
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHI 118

Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
              ++ +  GL Y H+ + L   HRD+K SN+LL+N    K++DFG+AR +  +++   T
Sbjct: 119 KSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 512 DRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEI 547
           ++V+ T  Y  PE  + +  +    DV+S G ++ E+
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 19/198 (9%)

Query: 361 GGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVRLLGCC 415
           G FG VY     + G   A+K L KS      +  N      +++ + +   + +L    
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
             +D   L+ EYL        I         DW+   Q I  +  G+  LHQ     IIH
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWA--KQYIAEVVLGVEDLHQRG---IIH 120

Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVK- 534
           RD+K  N+L+D   + K++DFG++R    ++      + VGT  Y++PE  I G+   K 
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDKM 173

Query: 535 SDVFSFGVLVLEIVCGKR 552
           SD +S G ++ E + G  
Sbjct: 174 SDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 74/280 (26%), Positives = 127/280 (45%), Gaps = 51/280 (18%)

Query: 357 KLGEGGFGPVYRGML----TEGQEIAVKRL--SKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           K+GEG FG   + +L     +G++  +K +  SK S +  EE + EV +++ ++H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-----LDWSKRCQIIEGIARGLLYL 465
                       ++ +Y     L + I       F     LDW  +      I   L ++
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHV 117

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     +I+HRD+K+ N+ L  D   K+ DFG+AR        A T   +GT  Y+SPE 
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
             +  ++ KSD+++ G ++ E+   K      HA    N+               L+ K 
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK------HAFEAGNM-------------KNLVLKI 213

Query: 586 LDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
           + GSY       S  LR +   L   ++ P DRP+++S++
Sbjct: 214 IRGSYPPVSSHYSYDLRNLVSQLF--KRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 3e-14
 Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 20/200 (10%)

Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN--EVLLIAKLQ-HRNLVRLL 412
           +LG+G FG VY     E  E+ A+K++ K      EE  N  EV  + KL  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                 DE   ++EY+   +L Q + D     F +   R  II  I +GL ++H   +  
Sbjct: 65  EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIH---KHG 119

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN---TDRVVGTYGYMSPEYAI-D 528
             HRDLK  N+L+      KI+DFG+AR     +  +    TD  V T  Y +PE  +  
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRAPEILLRS 173

Query: 529 GLFSVKSDVFSFGVLVLEIV 548
             +S   D+++ G ++ E+ 
Sbjct: 174 TSYSSPVDIWALGCIMAELY 193

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 26/216 (12%)

Query: 352 FSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQH 405
           F+    LG+G FG V    L       Q++AVK L     S   +EEF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 406 RNLVRLLGCCTLRDER------MLIYEYLPNKSLEQFIF--DVTRTKF-LDWSKRCQIIE 456
            N+++L+G       +      M+I  ++ +  L  F+    +    F L      + + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA-FGVD---QTEANTD 512
            IA G+ YL   S    IHRDL A N +L+ +M   ++DFG+++  +  D   Q  A+  
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
            V     +++ E   D +++  SDV++FGV + EI+
Sbjct: 178 PV----KWLALESLADNVYTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)

Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFK---NEVLLIAKLQHRNLVRLL 412
           ++G+GG+G V+     +  EI A+KR+ KS    + E +    E  ++   +   LV+LL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGIARGLLYLHQDSRL 471
                 +   L  EY+P       +        L +   R  + E     +  LH    L
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFE-AVDALH---EL 120

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
             IHRDLK  N L+D   + K++DFG+++      T AN+  VVG+  YM+PE      +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMAPEVLRGKGY 175

Query: 532 SVKSDVFSFGVLVLEIVCG 550
               D +S G ++ E +CG
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 38/195 (19%)

Query: 374 GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN 430
           GQ +A+K+LS+   Q V   K    E++L+  + H+N++ LL   T            P 
Sbjct: 41  GQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT------------PQ 87

Query: 431 KSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARGLLYLHQDSRLRIIHRD 477
           KSLE+F  DV     L  +  CQ+I+              +  G+ +LH      IIHRD
Sbjct: 88  KSLEEFQ-DVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRD 143

Query: 478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL-FSVKSD 536
           LK SN+++ +D   KI DFG+AR  G       T  VV  Y Y +PE  I G+ +    D
Sbjct: 144 LKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE-VILGMGYKENVD 199

Query: 537 VFSFGVLVLEIVCGK 551
           ++S G ++ E++ G 
Sbjct: 200 IWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ---HRNLVR 410
           ++G G +G VY+      G  +A+K +   + +         EV L+ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 411 LLG-CCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
           L+  C T R +R     L++E++ ++ L  ++ D      L       ++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H +    I+HRDLK  N+L+ +    K++DFG+AR +           VV T  Y +PE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEV 178

Query: 526 AIDGLFSVKSDVFSFGVLVLEI 547
            +   ++   D++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 57/223 (25%), Positives = 110/223 (49%), Gaps = 23/223 (10%)

Query: 357 KLGEGGFGPVY--RGMLTEGQEIAVKRL---SKSSGQGVEEFKNEVLL--IAKLQHRNLV 409
           ++GEG +G V+  R +   G+ +A+KR+   +   G  +   +   +L  +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 410 RLLGCCTL-RDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           RL   CT+ R +R     L++E++ ++ L  ++  V        + +  + + + RGL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 125

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH     R++HRDLK  N+L+ +    K++DFG+AR +     +     VV T  Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 567
             +   ++   D++S G +  E+    R +  +      + LG
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLG 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 72.8 bits (179), Expect = 7e-14
 Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 32/208 (15%)

Query: 358 LGEGGFGPVYRGMLTE----GQEIAVKRLSKS---SGQGVEEFKNE--VLLIA-KLQHRN 407
           LG G FG V   +L E    G+  A+K L K    +   VE    E  +   A   +H  
Sbjct: 7   LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLL 463
           LV L  C    D    + EY     L   I    F   R  F      C ++     GL 
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY---AACVVL-----GLQ 115

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR-AFGVDQTEANTDRVVGTYGYMS 522
           YLH++   +I++RDLK  N+LLD +   KI+DFG+ +   G       T    GT  +++
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLA 169

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           PE   +  ++   D +  GVL+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 26/205 (12%)

Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVRL 411
            +GEG +G V +    E GQ +A+K+  +S     +  K     E+ ++ +L+H NLV L
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65

Query: 412 LGCCTLRDERMLIYEYLPN---KSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           +     +    L++E++ +     LE++    D +R +   +    QI+ GI     + H
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF----QILRGIE----FCH 117

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
             +   IIHRD+K  N+L+      K+ DFG AR       E  TD  V T  Y +PE  
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELL 172

Query: 527 I-DGLFSVKSDVFSFGVLVLEIVCG 550
           + D  +    D+++ G LV E++ G
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 68/207 (32%), Positives = 97/207 (46%), Gaps = 29/207 (14%)

Query: 358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVE--EFKNEVLLIAKLQHRNLVRL 411
           LG+G FG V+   L    Q  A+K L K        VE    +  VL +A  +H  L  L
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61

Query: 412 LGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLY 464
              CT + +  L +  EYL    L   I     FD+ R  F      C        GL +
Sbjct: 62  Y--CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC--------GLQF 111

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      I++RDLK  N+LLD D + KI+DFGM +   +   +A T    GT  Y++PE
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPE 166

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
             +   ++   D +SFGVL+ E++ G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 19/225 (8%)

Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEEFKNEV 397
           M    ++ D TD +     +G+G +G VY+     +G   AVK L   S    EE + E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRT-KFLDWSK 450
            ++  L  H N+V+  G     D+ +     L+ E     S+ + +  +    + LD + 
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129

Query: 451 RCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN 510
              I+ G   GL +LH +   RIIHRD+K +N+LL  +   K+ DFG++      +   N
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186

Query: 511 TDRVVGTYGYMSPEY-----AIDGLFSVKSDVFSFGVLVLEIVCG 550
           T   VGT  +M+PE        D  +  + DV+S G+  +E+  G
Sbjct: 187 TS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.8 bits (177), Expect = 1e-13
 Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 48/222 (21%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---------EVLLIAKL- 403
             KLG+G +G V++ +    +E+ A+K++        + F+N         E++ + +L 
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELG 64

Query: 404 QHRNLVRLLGCCTLRDERM----LIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGI 458
            H N+V+LL    ++ E      L++EY+     E  +  V R   L D  KR  I+  +
Sbjct: 65  DHPNIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQL 116

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV---- 514
            + L Y+H  S   +IHRDLK SN+LL++D   K++DFG+AR+   +  E   + V    
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLTDY 172

Query: 515 VGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 551
           V T  Y +PE     L          D++S G ++ E++ GK
Sbjct: 173 VATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 37/211 (17%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVRLLGC 414
           +G G +G V     T   Q++AVK+LS+     +   +   E+ L+  ++H N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 415 CTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ---------IIEGIARG 461
            T            P  S+E F  ++ VT     D +   +CQ         +I  + RG
Sbjct: 83  FT------------PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L Y+H      IIHRDLK SNV ++ D   +I DFG+AR     Q +      V T  Y 
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYR 182

Query: 522 SPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +PE  ++ + ++   D++S G ++ E++ GK
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.0 bits (175), Expect = 3e-13
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 69/230 (30%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN---------EVLLIAKLQHRN 407
           +G G +G V   +    G+++A+K++S         F +         E+ L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFDVTRT---------KFLDWSKRCQ 453
           ++ LL             + L   S E F     + ++  T         + L      Q
Sbjct: 61  IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT-DDHIQ 106

Query: 454 -IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-- 510
             +  I RGL YLH      +IHRDLK SN+L++++ + KI DFG+AR    D+ E    
Sbjct: 107 YFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 511 TDRVVGTYGYMSPE---------YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           T+ VV T  Y +PE          AI        D++S G +  E++  K
Sbjct: 164 TEYVV-TRWYRAPELLLSSSRYTKAI--------DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 68/220 (30%), Positives = 97/220 (44%), Gaps = 28/220 (12%)

Query: 358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVE--EFKNEVLLIAKLQHRNLVRL 411
           LG+G FG V    L  +G+  AVK L K        VE    +  VL +A  ++  L  L
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTHL 61

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
                 ++    + E+L    L   I     FD+ R  F      C        GL +LH
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--------GLQFLH 113

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
                 II+RDLK  NV+LD D + KI+DFGM +        A+T    GT  Y++PE  
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEIL 168

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
               ++   D +SFGVL+ E++ G+     +H D    L 
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSP---FHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+GGFG V        G +   + +  KR+ K  G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                 +D   L+   +    L+  I+++    F +        E I  GL  LH+++  
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHREN-- 122

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR-VVGTYGYMSPEYAIDGL 530
             ++RDLK  N+LLD+  + +ISD G+A    V   E  + R  VGT GYM+PE   +  
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPEVLNNQR 177

Query: 531 FSVKSDVFSFGVLVLEIVCGK 551
           +++  D +  G L+ E++ G+
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 39/104 (37%), Positives = 60/104 (57%), Gaps = 11/104 (10%)

Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
           +I   I + L YLH  S+L +IHRD+K SNVL++ +   K+ DFG++  + VD      D
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSVAKTID 163

Query: 513 RVVGTYGYMSPEYAIDGL-----FSVKSDVFSFGVLVLEIVCGK 551
              G   YM+PE  I+       + VKSDV+S G+ ++E+  G+
Sbjct: 164 --AGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 41/193 (21%)

Query: 356 NKLGEGGFGPVY--RGMLTEGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
            K+G+G FG V+  R   T  Q +A+K++   ++  G  +   + E+ ++  L+H N+V 
Sbjct: 18  AKIGQGTFGEVFKARHKKT-KQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN 75

Query: 411 LLGCCT--------LRDERMLIYEY--------LPNKSLEQFIFDVTRTKFLDWSKRCQI 454
           L+  C          +    L++E+        L NK+++   F ++  K        ++
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIK--------KV 124

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN---T 511
           ++ +  GL Y+H   R +I+HRD+KA+N+L+  D   K++DFG+ARAF + +       T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 512 DRVVGTYGYMSPE 524
           +RVV T  Y  PE
Sbjct: 182 NRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+GGFG V        G +   +++  KR+ K  G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-IARGLLYLHQDSR 470
                 +D   L+   +    L+  I+++    F +  +R       I  GL  LH   R
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--ERAVFYAAEITCGLEDLH---R 120

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR-VVGTYGYMSPEYAIDG 529
            RI++RDLK  N+LLD+  + +ISD G+A    V+  E  T R  VGT GYM+PE   + 
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNE 176

Query: 530 LFSVKSDVFSFGVLVLEIVCGK 551
            ++   D +  G L+ E++ GK
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 358 LGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+GGFG V        G +   +++  KR+ K  G+ +    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                 +D   L+   +    L+  I+++    F D  +       +  GL  L ++   
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDLQRE--- 121

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR-VVGTYGYMSPEYAIDGL 530
           RI++RDLK  N+LLD+  + +ISD G+A    V   E  T R  VGT GYM+PE   +  
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEK 177

Query: 531 FSVKSDVFSFGVLVLEIVCGK 551
           ++   D +  G L+ E++ G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 356 NKLGEGGFGPVYRG--MLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           +KLGEG +  V++G   LTE   +A+K  RL    G      + EV L+  L+H N+V L
Sbjct: 11  DKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTL 68

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                      L++EYL +  L+Q++ +      +   K    +  + RGL Y H   + 
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVK--IFMFQLLRGLSYCH---KR 122

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL- 530
           +I+HRDLK  N+L++     K++DFG+ARA  V  T+  ++ VV T  Y  P+  +    
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTE 180

Query: 531 FSVKSDVFSFGVLVLEIVCGK 551
           +S   D++  G ++ E+  G+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 48/215 (22%)

Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ-HRNLVRL 411
            K+GEG F  V +      G+  A+K + K   + +E+  N  E+  + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 412 L--------GCCTLRDE--RMLIYE-------YLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
           +        G   L  E   M +YE        LP K ++ +++              Q+
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMY--------------QL 109

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
           +    + L ++H++    I HRD+K  N+L+ +D   K++DFG  R  G+      T+  
Sbjct: 110 L----KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTE-Y 158

Query: 515 VGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIV 548
           + T  Y +PE  + DG +  K D+++ G +  EI+
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 27/282 (9%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIA---VKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
           +++G G FG V  G    G   A   VK L  S+       F  EV    +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ--IIEGIARGLLYLHQDS 469
           LG C      +L+ E+ P   L+ ++            K     +   +A GLL+LHQ  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-- 527
               IH DL   N  L  D++ KI D+G+A     +      D       +++PE     
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 528 -DGLFSVK----SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
              L        S+++S GV + E+           +D    +L    R    ++ ++L 
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQVVR----EQDIKLP 231

Query: 583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
              LD  YS     R  +V   C    PE RP    V  +L+
Sbjct: 232 KPQLDLKYS----DRWYEVMQFCWLD-PETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 13/199 (6%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKLQHRNLVRLLG 413
           KLGEG +  VY+G+    GQ +A+K +S  + +GV  F    E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               ++    ++EY+ +  L Q++  +     L        +  + RGL Y+H      I
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYM--IQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHI 124

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL-FS 532
           +HRDLK  N+L+      K++DFG+ARA  +     +++ V  T  Y  P+  +    +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182

Query: 533 VKSDVFSFGVLVLEIVCGK 551
              D++  G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 21/213 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKR-LSKSSGQGVEEFK-NEVLLIAKLQHR 406
           D +    K+GEG +G VY+      G+ +A+K+   +   +G+      E+ L+  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 407 N-LVRLLGCCTLRDER-----MLIYEYLPNKSLEQFIFDVTRTKF---LDWSKRCQIIEG 457
             +VRLL    + ++       L++EYL +  L++F+ D         L        +  
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQ 118

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVG 516
           + +G+ + H   +  ++HRDLK  N+L+D      KI+D G+ RAF +   ++ T  +V 
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV- 173

Query: 517 TYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIV 548
           T  Y +PE  +    +S   D++S G +  E+ 
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 30/190 (15%)

Query: 375 QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434
           + +A+K+LS+        F+N+    AK  +R LV L+ C   ++   L+  + P KSLE
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99

Query: 435 QFIFDVTRTKFLDWSKRCQIIE-------------GIARGLLYLHQDSRLRIIHRDLKAS 481
           +F       + +D +  CQ+I+              +  G+ +LH      IIHRDLK S
Sbjct: 100 EFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 155

Query: 482 NVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 541
           N+++ +D   KI DFG+AR  G   +   T  VV  Y Y +PE  +   +    D++S G
Sbjct: 156 NIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVG 212

Query: 542 VLVLEIVCGK 551
            ++ E++ G 
Sbjct: 213 CIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 22/102 (21%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG--------MARAFGVDQTEA 509
           + RGL YL +  + +I+HRD+K SN+L+++    K+ DFG        MA +F       
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------- 158

Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                VGT  YMSPE      ++V+SD++S G+ ++E+  G+
Sbjct: 159 -----VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 13/205 (6%)

Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHR 406
           D++    KLGEG +  VY+G     G+ +A+K  RL +  G      + E  L+  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V L      ++   L++EY+ +  L Q++         +  K    +  + RGL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVK--LFLFQLLRGLSYIH 120

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
           Q     I+HRDLK  N+L+ +    K++DFG+ARA  V  +   ++ VV T  Y  P+  
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVL 175

Query: 527 IDGL-FSVKSDVFSFGVLVLEIVCG 550
           +    +S   D++  G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 24/204 (11%)

Query: 358 LGEGGFGPVY--RGMLTE--GQEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQHRNLVRL 411
           LG+G FG V+  R +     GQ  A+K L K++ +  +    K E  ++A++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 412 LGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
                   +  LI ++L    L     ++ +F     KF         +  +A  L +LH
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALDHLH 115

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
               L II+RDLK  N+LLD + + K++DFG+++   +D  E       GT  YM+PE  
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVV 170

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCG 550
                +  +D +SFGVL+ E++ G
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.5 bits (165), Expect = 5e-12
 Identities = 56/239 (23%), Positives = 106/239 (44%), Gaps = 38/239 (15%)

Query: 343 NTIADATDNFSWKNK-LGEGGFGPVYRGMLT-EGQEIAVKRL--------SKSSGQGVEE 392
           N     ++ +  K   LGEG +G V +   T  G+ +A+K++             Q V  
Sbjct: 1   NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60

Query: 393 FK------NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL 446
                    E+ ++ +++H N++ L+      D   L+ + +    L++ + D  + +  
Sbjct: 61  CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVD-RKIRLT 117

Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD- 505
           +   +C I+  I  GL  LH+      +HRDL  +N+ +++    KI+DFG+AR +G   
Sbjct: 118 ESQVKC-ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPP 173

Query: 506 ------------QTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK 551
                       + E  T +VV T  Y +PE  +    +    D++S G +  E++ GK
Sbjct: 174 YSDTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 19/208 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           D+      +G G FG V+       +   A+K ++       +  +   NE  ++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 406 RNLVRLLGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
             ++RL    T  D+R L  + EY+P   L  F +     +F + +      E I   L 
Sbjct: 61  PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALE 115

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH      I++RDLK  N+LLD + + K++DFG A+    D+T      + GT  Y++P
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT----LCGTPEYLAP 167

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E       +   D ++ G+L+ E++ G 
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 51/169 (30%), Positives = 74/169 (43%), Gaps = 21/169 (12%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +ARG+ +L   SR + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI--VCGKRNRGFYHADHHHNLLGHAWRLWTE 575
             +M+PE   D +++ +SDV+SFGVL+ EI  +      G    +     L    R+   
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP 298

Query: 576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
           + +   I                  + L C    PEDRP  S +V +L 
Sbjct: 299 EYATPEI----------------YSIMLDCWHNNPEDRPTFSELVEILG 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 28/215 (13%)

Query: 358 LGEGGFGPVYRGMLTE---GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG+G FG V   ++ E   G+  A+K L K    +   V     E  ++   +H  L  L
Sbjct: 3   LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 412 LGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
                 +D    + EY+    L      + +F   RT+F            I   L YLH
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE--------IVSALDYLH 112

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
                +I++RDLK  N++LD D + KI+DFG+ +    D     T    GT  Y++PE  
Sbjct: 113 SG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVL 167

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
            D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 55/233 (23%)

Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLVRL 411
           +G G FG V+  R     GQ  A+K L KS      Q +   + E  ++A      +V+L
Sbjct: 9   IGRGAFGEVWLVR-DKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66

Query: 412 LGCCTLRDERML--IYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
               + +DE  L  + EY+P   L      + +F     +F            IA  +L 
Sbjct: 67  Y--YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-----------IAELVLA 113

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA------------------------- 499
           L    +L  IHRD+K  N+L+D D + K++DFG+                          
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 500 RAFGVDQTEANTDR--VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
                D  +        VGT  Y++PE      + ++ D +S GV++ E++ G
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 58/283 (20%)

Query: 358 LGEGGFGPV----YRGMLTEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQHRNLVR- 410
           +G+G +G V    +R   T+G++  +K+L+   +S +  +  + E  L+++L+H N+V  
Sbjct: 8   VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 411 -------------LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG 457
                        ++G C   D        L +K  EQ    +   + ++W  +      
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGD--------LYHKLKEQKGKLLPENQVVEWFVQ------ 110

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           IA  L YLH+     I+HRDLK  NV L      K+ D G+AR        A+T  ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
             YMSPE   +  ++ KSDV++ G  V E+   K      HA +  ++    +R+  E +
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK------HAFNAKDMNSLVYRI-IEGK 218

Query: 578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
              L     D S  L E +      +L   +RPE RP++ S++
Sbjct: 219 ---LPPMPKDYSPELGELIA----TMLS--KRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 53/149 (35%), Positives = 77/149 (51%), Gaps = 12/149 (8%)

Query: 357 KLGEGGFGPVYRGM--LTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           KLGEG +  VY+G   LT GQ +A+K  RL    G      + E  L+  L+H N+V L 
Sbjct: 12  KLGEGSYATVYKGRSKLT-GQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                +    L++EYL +  L+Q++ D      L        +  + RGL Y HQ    R
Sbjct: 70  DIIHTKKTLTLVFEYL-DTDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---R 123

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARA 501
           ++HRDLK  N+L+      K++DFG+ARA
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARA 152

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 31/207 (14%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +G G  G V     T  G  +AVK+LS+        F+N+    AK  +R LV LL C  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVN 78

Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARGLL 463
            ++   L+  + P KSLE+F  DV     L  +  CQ+I               +  G+ 
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQ-DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 137

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           +LH      IIHRDLK SN+++ +D   KI DFG+AR    +     T  VV  Y Y +P
Sbjct: 138 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAP 191

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E  +   +    D++S G ++ E+V G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 42/225 (18%)

Query: 344 TIADATDNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLL 399
           T+ + T+ +     +G G FG V   R  LT GQ +A+K++ K  S+    +    E+ L
Sbjct: 4   TVFEITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKL 62

Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIY-----------EYLPNKSLE-QFIFDVTRTKFLD 447
           +  L+H N++ L            IY             L ++ LE QFI       FL 
Sbjct: 63  LKHLRHENIISL--SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI-----QYFL- 114

Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                QI+    RGL Y+H      ++HRDLK SN+L++ + + KI DFG+AR     Q 
Sbjct: 115 ----YQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QD 159

Query: 508 EANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 551
              T  V   Y Y +PE  +    + V+ D++S G +  E++ GK
Sbjct: 160 PQMTGYVSTRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN----EVLLIAKLQHRNLVRLL 412
           +GEG +G V +    E +EI A+K+   S     EE K     E+ ++  L+  N+V L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                R +  L++EY+    LE  + +           R  I + I + + + H++    
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKND--- 120

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           I+HRD+K  N+L+ ++   K+ DFG AR    + + AN    V T  Y SPE  +   + 
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 533 VKSDVFSFGVLVLEIVCGK 551
              D++S G ++ E+  G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 21/210 (10%)

Query: 351 NFSWKNKLGEGGFGPVYRGMLTE--GQE--IAVKRLSKS---SGQGVEEFKNEVLLIAKL 403
           +F++   LG+G FG V   ML E  G +   A+K L K        VE    E  ++A L
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLA-L 56

Query: 404 QHRN--LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
             +   L +L  C    D    + EY+    L   I  V   KF +        E IA G
Sbjct: 57  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAE-IAIG 113

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L +LH      II+RDLK  NV+LD + + KI+DFGM +          T    GT  Y+
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT--FCGTPDYI 168

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE      +    D ++FGVL+ E++ G+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSS---GQGVEEFKNE--VLLIAKLQHRNLVRL 411
           LG+G FG V    L    E+ A+K L K        V+    E  +L +A  +H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
             C   +D    + EY+    L   +F + R++  D  +       +   L++LH+    
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG-- 116

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
            +I+RDLK  N+LLD + + K++DFGM +  G+      T    GT  Y++PE   +  +
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILN-GVTTTTFCGTPDYIAPEILQELEY 173

Query: 532 SVKSDVFSFGVLVLEIVCGK 551
               D ++ GVL+ E++ G+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 47/232 (20%)

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           LL +H      +IHRD+K++N+LL ++   K+ DFG ++ +    ++       GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           +PE      +S K+D+FS GVL+ E++  KR   F   +                   E+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP--FDGENME-----------------EV 253

Query: 582 IDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRP------NMSSVVLMLSGERSLP 630
           + K+L G Y     S+S  ++ I   LL     P+ RP      NM    L +SG   + 
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLLNMPICKLFISGLLEIV 311

Query: 631 QPKQPGFFTE------RNLPESESS--SSKRKLPLSNE------ITISLIEG 668
           Q  QPGF         R + +++      +R++    E       + +++EG
Sbjct: 312 Q-TQPGFSGPLRDTISRQIQQTKQLLQVERRRIVRQMEESLSTAASTTILEG 362

Length = 496

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 19/158 (12%)

Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYE-----YLPNKSLEQFIFDVTRTKFLDWSK 450
           E +L+  + H +++R+           L+        LP+ S + + +   R++ L   +
Sbjct: 107 EAMLLQNVNHPSVIRMK--------DTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158

Query: 451 RCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN 510
              I + I  GL YLH     RIIHRD+K  N+ +++     I D G A+ F V      
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV--VAPA 212

Query: 511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
              + GT    +PE      ++ K+D++S G+++ E++
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 43/215 (20%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLL---IAKLQHR--NLVRL 411
           +G G  G VY+      G  +AVK++ ++   G +E    +L+   +    H    +V+ 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ--IIEGIA--------RG 461
            G   + D  + I   L +  L++              KR Q  I E I         + 
Sbjct: 80  YGY-FITDSDVFICMELMSTCLDKL------------LKRIQGPIPEDILGKMTVAIVKA 126

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L YL +     +IHRD+K SN+LLD   N K+ DFG++    VD ++A T R  G   YM
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS-GRLVD-SKAKT-RSAGCAAYM 181

Query: 522 SPEYAID-----GLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  ID       + +++DV+S G+ ++E+  G+
Sbjct: 182 APE-RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 20/212 (9%)

Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQE----IAVKRLSKSS----GQGVEEFKNEVLLIAK 402
           NF     LG G +G V+      G +     A+K L K++     +  E  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 403 LQHRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-IAR 460
           ++    +  L      D ++ LI +Y+    L  F     R +F +  +  QI  G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKE--QEVQIYSGEIVL 116

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L +LH   +L II+RD+K  N+LLD++ +  ++DFG+++ F  D+ E       GT  Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEY 172

Query: 521 MSPEYAI--DGLFSVKSDVFSFGVLVLEIVCG 550
           M+P+     DG      D +S GVL+ E++ G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 77/281 (27%), Positives = 129/281 (45%), Gaps = 27/281 (9%)

Query: 357 KLGEGGFGPVYRGMLTEG---QEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLL 412
           ++G G FG V  G +  G    ++ VK L  S+  Q   +F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL--DWSKRCQIIEGIARGLLYLHQDSR 470
           G CT     +L+ E+ P   L+ ++    + + +  D +   ++   IA GLL+LH+++ 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA--ID 528
              IH DL   N LL  D+  KI D+G++     +      D++     +++PE    + 
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 529 GLFSV-----KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
           G   V     +S+V+S GV + E+         + +D    +L +  R    ++ L+L  
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVR----EQQLKLPK 232

Query: 584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
             L     L  + R  +V   C  Q PE RP+   V L+LS
Sbjct: 233 PRL----KLPLSDRWYEVMQFCWLQ-PEQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 16/209 (7%)

Query: 358 LGEGGFGPV--YRGMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LG+G FG V   R   T G+  A+K L K    +   V     E  ++   +H  L  L 
Sbjct: 3   LGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                 D    + EY     L    F ++R +     +       I   L YLH      
Sbjct: 62  YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD--- 115

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           +++RD+K  N++LD D + KI+DFG+ +    D   A      GT  Y++PE   D  + 
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 533 VKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
              D +  GV++ E++CG+    FY+ DH
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 63.6 bits (154), Expect = 9e-11
 Identities = 59/187 (31%), Positives = 93/187 (49%), Gaps = 30/187 (16%)

Query: 375 QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434
           + +A+K+LS+        F+N+    AK  +R LV L+ C   ++   L+  + P KSLE
Sbjct: 43  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92

Query: 435 QFIFDVTRTKFLDWSKRCQIIE-------------GIARGLLYLHQDSRLRIIHRDLKAS 481
           +F  DV     L  +  CQ+I+              +  G+ +LH      IIHRDLK S
Sbjct: 93  EFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 148

Query: 482 NVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 541
           N+++ +D   KI DFG+AR  G   +   T  VV  Y Y +PE  +   +    D++S G
Sbjct: 149 NIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVG 205

Query: 542 VLVLEIV 548
            ++ E+V
Sbjct: 206 CIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 30/207 (14%)

Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-------EVLLIAKLQHRNL 408
           K+GEG +G V++    E GQ +A+K+  +S     E+          E+ ++ +L+H NL
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62

Query: 409 VRLLGCCTLRDERM-LIYEYLPN---KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           V L+     R  ++ L++EY  +     LE+        + +      +II    + + +
Sbjct: 63  VNLIEVFR-RKRKLHLVFEYCDHTVLNELEK------NPRGVPEHLIKKIIWQTLQAVNF 115

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
            H+      IHRD+K  N+L+      K+ DFG AR   +     +    V T  Y +PE
Sbjct: 116 CHK---HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPE 170

Query: 525 YAI-DGLFSVKSDVFSFGVLVLEIVCG 550
             + D  +    DV++ G +  E++ G
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 13/226 (5%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQ 404
           D    +   + +GEG +G V        G ++A+K++S    Q   +    E+ ++ + +
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK 61

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H N++ +L              Y+  + +E  ++ + +T+ L        +  I RGL Y
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKY 121

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV---VGTYGYM 521
           +H  +   ++HRDLK SN+LL+ + + KI DFG+AR    D    +T  +   V T  Y 
Sbjct: 122 IHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVATRWYR 176

Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
           +PE  ++     K+ D++S G ++ E++  +    F   D+ H L 
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL--FPGKDYLHQLN 220

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ 404
            +F  K+ +G G FG V   R   T G   A+K + KS   + + V  F+ E  +++   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF------IFDVTRTKFLDWSKRCQIIEGI 458
              + +L      +D   L+ EY P   L          FD    +F            +
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------L 108

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           A  +L +H   ++  +HRD+K  NVL+D   + K++DFG A     ++   N+   VGT 
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTP 167

Query: 519 GYMSPEY--AIDG----LFSVKSDVFSFGVLVLEIVCGK 551
            Y++PE    ++G     + V+ D +S GV+  E++ G+
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 31/212 (14%)

Query: 358 LGEGGFGPVYRGMLTE---------GQEIAVKR-LSKSSGQGVEEFKNEVLLIAKLQHRN 407
           LG+G F  +Y+G+L           GQE++V   +  S  +    F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LV+L G C +RDE +++ EY+    L+ F+        L W  +  + + +A  L YL  
Sbjct: 63  LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 468 DSRLRIIHRDLKASNVLL----DNDMNP---KISDFGMARAFGVDQTEANTDRVVGTYGY 520
               +++H ++   N+L+     N+      K+SD G+     V   E   +R+     +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----PW 170

Query: 521 MSPEYAIDGLFSVKS--DVFSFGVLVLEIVCG 550
           ++PE   +G  S+    D +SFG  +LEI   
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 37/90 (41%), Positives = 52/90 (57%), Gaps = 3/90 (3%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +ARG+ +L   SR + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 3/90 (3%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A+G+ +L   SR + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 33/95 (34%), Positives = 58/95 (61%), Gaps = 6/95 (6%)

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            + RGL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVG 164

Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           T  YMSPE      +SV+SD++S G+ ++E+  G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 24/219 (10%)

Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSK--SSGQGVEEFKNEVLL 399
            T+ +  + ++   ++G G +G V   +    G+++A+K+LS+   S    +    E+ L
Sbjct: 8   KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL 67

Query: 400 IAKLQHRNLVRLLGCCT---LRDERMLIYEYLPNKSLEQFIF-DVTRTKFLDWS--KRCQ 453
           +  +QH N++ LL   T     DE    Y  +P      ++  D+ +      S  K   
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP------YMQTDLQKIMGHPLSEDKVQY 121

Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           ++  +  GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR       +A    
Sbjct: 122 LVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTG 173

Query: 514 VVGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 551
            V T  Y +PE  ++ +   ++ D++S G ++ E++ GK
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 5/95 (5%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I RGL YLH      I+HRD+K  N+L++++   KI DFG+AR    D+++  T  VV  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 518 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y Y +PE  +    ++   D++S G +  E++  +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.3 bits (154), Expect = 3e-10
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 30/197 (15%)

Query: 374 GQEIAVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVRLLGCCTLRDERML-IYEYLP 429
           G E+A+K L   + +   +   F+ E  L A+L H N+V LL         +  ++EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 430 NKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484
            ++L + +          T  L      Q+++ +A      H      I+HRDLK  N++
Sbjct: 63  GRTLREVLAADGALPAGETGRL----MLQVLDALACA----HNQG---IVHRDLKPQNIM 111

Query: 485 L---DNDMNPKISDFGM------ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKS 535
           +       + K+ DFG+       R   V      T+ V+GT  Y +PE       +  S
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE-VLGTPTYCAPEQLRGEPVTPNS 170

Query: 536 DVFSFGVLVLEIVCGKR 552
           D++++G++ LE + G+R
Sbjct: 171 DLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 19/209 (9%)

Query: 351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL 403
           +F++   LG+G FG V   ML E     +  A+K L K        VE    E  ++A  
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57

Query: 404 QHRN-LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
                L +L  C    D    + EY+    L   I  V   KF +        E I+ GL
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAE-ISVGL 114

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH+     II+RDLK  NV+LD++ + KI+DFGM +   VD     T    GT  Y++
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGTPDYIA 169

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +    D +++GVL+ E++ G+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 9/105 (8%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VG 516
           I   L YLH      +++RDLK  N++LD D + KI+DFG+ +      ++  T +   G
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCG 157

Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
           T  Y++PE   D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 21/212 (9%)

Query: 358 LGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEF-----KNEVLLIAKLQHRNLV 409
           LG+G FG V   ++ E   G+  A+K L K      +E      +N VL  ++  H  L 
Sbjct: 3   LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFLT 58

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
            L       D    + EY     L    F ++R +     +       I   L YLH + 
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
              +++RDLK  N++LD D + KI+DFG+ +    D     T    GT  Y++PE   D 
Sbjct: 116 N--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDN 171

Query: 530 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
            +    D +  GV++ E++CG+    FY+ DH
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 32/95 (33%), Positives = 58/95 (61%), Gaps = 6/95 (6%)

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            + +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VG
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVG 164

Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           T  YMSPE      +SV+SD++S G+ ++E+  G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.7 bits (147), Expect = 7e-10
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 37/225 (16%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSK--SSGQGVEEFKNEVLLI 400
           TI +  D +    ++G G +G V   +    G ++A+K+L +   S    +    E+ L+
Sbjct: 9   TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK-------- 450
             ++H N++ LL   T            P+ SL++F   + V      D  K        
Sbjct: 69  KHMKHENVIGLLDVFT------------PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS 116

Query: 451 --RCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
             R Q ++  + +GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     QT
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QT 168

Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           ++     V T  Y +PE  ++ + ++   D++S G ++ E++ GK
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 18/211 (8%)

Query: 351 NFSWKNKLGEGGFGPVY----RGMLTEGQEIAVKRLSKSS----GQGVEEFKNE-VLLIA 401
           NF     LG G +G V+     G    G+  A+K L K++     +  E  + E  +L A
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
             +   LV L        +  LI +Y+     E F     R  F +   R  I E I   
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYV--NGGELFTHLYQREHFTESEVRVYIAE-IVLA 117

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L +LHQ   L II+RD+K  N+LLD++ +  ++DFG+++ F  ++ E       GT  YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173

Query: 522 SPEY--AIDGLFSVKSDVFSFGVLVLEIVCG 550
           +PE      G      D +S GVL  E++ G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 61.2 bits (148), Expect = 7e-10
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 3/90 (3%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +ARG+ +L   +    +HRDL A NVLL      KI DFG+AR    D    +       
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   D L++  SDV+S+G+L+ EI
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 59.9 bits (145), Expect = 8e-10
 Identities = 34/99 (34%), Positives = 56/99 (56%), Gaps = 7/99 (7%)

Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
           +I   + +GL YL     L+I+HRD+K SN+L++     K+ DFG++    +  + A T 
Sbjct: 99  RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ--LVNSIAKT- 152

Query: 513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
             VGT  YM+PE      + + SDV+S G+  +E+  G+
Sbjct: 153 -YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 28/210 (13%)

Query: 358 LGEGGFGPVYRGMLTE----GQ----EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           LG+G F  +++G+  E    G+    E+ +K L KS     E F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
              G C   DE +++ EY+   SL+ ++        + W  + ++ + +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 470 RLRIIHRDLKASNVLL-----DNDMNP---KISDFGMARAFGVDQTEANTDRVVGTYGYM 521
              + H ++ A NVLL         NP   K+SD G++    V   E   +R+     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT--VLPKEILLERI----PWV 171

Query: 522 SPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 550
            PE   +    S+ +D +SFG  + EI  G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 3/90 (3%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A+G+ +L   +    IHRD+ A NVLL +    KI DFG+AR    D            
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   D +++V+SDV+S+G+L+ EI
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQ--EIAVKRLSKSS---GQGVEEFKNEVLLIAKLQ 404
           ++F++   LG G FG V            +A+KR  KS     + V+   +E  ++  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR------CQIIEGI 458
           H   V L G  + +DE    Y YL    + +F+       FL  +KR      C     I
Sbjct: 90  HPFCVNLYG--SFKDES---YLYL----VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
                YL     L I++RDLK  N+LLD D   K++DFG A+       +  T  + GT 
Sbjct: 141 VLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTP 192

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y++PE  ++      +D ++ G+ + EI+ G
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 26/210 (12%)

Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFK-NEVLLIAKLQHR----N 407
           ++LG+G +G VY+ +    G  +A+K  RL       ++E K N++++   + H+     
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPY 60

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           +V   G   +     +  EY+   SL++       T+ +      +I   + +GL +L +
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY-- 525
           +    IIHRD+K +NVL++ +   K+ DFG++        + N    +G   YM+PE   
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIK 174

Query: 526 ----AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                 +  ++V+SDV+S G+ +LE+  G+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 15/158 (9%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Query: 518 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED 576
           +GYM+PE    G+ +   +D FS G ++ +++     RG      H     H     T  
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-----RGHSPFRQHKTKDKHEIDRMTLT 213

Query: 577 RSLELIDKSLDGSYSLSEAL--RCIQVGLLCVQQRPED 612
            ++EL D       SL E L  R +   L C+ +  ++
Sbjct: 214 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 66/249 (26%), Positives = 114/249 (45%), Gaps = 47/249 (18%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---------EVLLIAKLQHRN 407
           +G G +G V     +E  +++A+K+++ +       F N         E+ L+  L H N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65

Query: 408 LVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ-IIEGIARG 461
           ++ +                ++YE L +  L Q I     ++ L     CQ  +  + RG
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQII---RSSQTLS-DDHCQYFLYQLLRG 120

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L Y+H  +   ++HRDLK SN+LL+ + + KI DFG+AR    ++ +  T+ VV T  Y 
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRWYR 175

Query: 522 SPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE----- 575
           +PE  ++   ++   DV+S G +  E++   R   F   D+ H L     +L TE     
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL--GRKPLFPGKDYVHQL-----KLITELLGSP 228

Query: 576 -DRSLELID 583
            +  L  I 
Sbjct: 229 SEEDLGFIR 237

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 15/102 (14%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT--DRVV 515
           + RGL Y+H  +   +IHRDLK SN+L++ D   +I DFGMAR      TE        V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 516 GTYGYMSPEYAIDGLFSV-----KSDVFSFGVLVLEIVCGKR 552
            T  Y +PE     L S+       D++S G +  E++ G+R
Sbjct: 173 ATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 29/224 (12%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
           +++  D +D +     +G+G +G V++ +    G + AVK L        EE + E  ++
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68

Query: 401 AKLQ-HRNLVRLLGCCTLRDER-----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ- 453
             L  H N+V+  G    +D +      L+ E     S+   +       FL   +R + 
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEE 123

Query: 454 -----IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
                I+     GL +LH +   + IHRD+K +N+LL  +   K+ DFG++      +  
Sbjct: 124 PIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180

Query: 509 ANTDRVVGTYGYMSPEY-----AIDGLFSVKSDVFSFGVLVLEI 547
            NT   VGT  +M+PE       +D  +  + DV+S G+  +E+
Sbjct: 181 RNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 38/218 (17%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL---LG 413
           LG G  G V+  + ++  + +AVK++  +  Q V+    E+ +I +L H N+V++   LG
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 414 CCTLRDERML--------IY---EYLPN---KSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
                    +        +Y   EY+       LEQ        +   +    Q++    
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY----QLL---- 124

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEAN----TDRV 514
           RGL Y+H  +   ++HRDLK +NV ++  D+  KI DFG+AR   VD   ++    ++ +
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGL 179

Query: 515 VGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 551
           V  + Y SP   +      K+ D+++ G +  E++ GK
Sbjct: 180 VTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 3/94 (3%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           IA  +L L    +  I++RDLK  N+LLD   +  + DFG+++A   D    NT    GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159

Query: 518 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 550
             Y++PE  +D   ++   D +S GVLV E+ CG
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 53.1 bits (128), Expect = 2e-09
 Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 2/43 (4%)

Query: 629 LPQPKQPGFFTERNLPESESSSSKRKLPLS--NEITISLIEGR 669
           +PQPKQPGF   R+  E++SSSS ++      N++T+S+I+ R
Sbjct: 6   IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL--- 403
           +F++   LG+G FG V   ML E     +  A+K L K     +++   E  ++ K    
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLA 55

Query: 404 ---QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
              +   L +L  C    D    + EY+    L   I  V R K             IA 
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK---EPHAVFYAAEIAI 112

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GL +LH      II+RDLK  NV+LD++ + KI+DFGM +    D     T    GT  Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGTPDY 167

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           ++PE      +    D ++FGVL+ E++ G+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 34/271 (12%)

Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVRLLG 413
           +G G FG V        Q++ A+K LSK       +   F  E  ++A      +V+L  
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 109

Query: 414 CCTLRDERML--IYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
            C  +D++ L  + EY+P   L   +  +DV       W+K        A  +L L    
Sbjct: 110 -CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEVVLALDAIH 159

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT-EANTDRVVGTYGYMSPEY--- 525
            + +IHRD+K  N+LLD   + K++DFG      +D+T     D  VGT  Y+SPE    
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAVGTPDYISPEVLKS 217

Query: 526 -AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH----HHNLLGHAWRL-WTEDRSL 579
              DG +  + D +S GV + E++ G      ++AD     +  ++ H   L + ED  +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTP---FYADSLVGTYSKIMDHKNSLNFPEDVEI 274

Query: 580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRP 610
               K+L  ++     +R  + G+  ++Q P
Sbjct: 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVRLLGCC 415
           K+G G +G VY+    +G++     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 416 TLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY-----LHQD 468
               +R   L+++Y  +      I    R    +  K  Q+  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWH--IIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 469 SRLRIIHRDLKASNVLLDNDMNP-----KISDFGMARAFGVD-QTEANTDRVVGTYGYMS 522
               ++HRDLK +N+L+  +  P     KI+D G AR F    +  A+ D VV T+ Y +
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 523 PEYAIDGLFSVKS-DVFSFGVLVLEIV 548
           PE  +      K+ D+++ G +  E++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 8/94 (8%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Query: 518 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 550
           +GYM+PE    G  +   +D FS G ++ +++ G
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 25/209 (11%)

Query: 351 NFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHR 406
           +F     LG G FG V        G+  A+K L K      + V+    E  ++ +L H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 407 NLVRLLGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
            +V ++  C+ +DE  +  + E++     E F       +F +   +    E +     Y
Sbjct: 79  FIVNMM--CSFQDENRVYFLLEFVVGG--ELFTHLRKAGRFPNDVAKFYHAE-LVLAFEY 133

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR---VVGTYGYM 521
           LH      II+RDLK  N+LLDN  + K++DFG A+           DR   + GT  Y+
Sbjct: 134 LHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV--------PDRTFTLCGTPEYL 182

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +PE           D ++ GVL+ E + G
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLV 409
           LG+GG+G V++     G +     A+K L K+    + +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
            L+       +  LI EYL    L  F+       F++    C  +  I+  L +LHQ  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFME-DTACFYLSEISLALEHLHQ-- 118

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
              II+RDLK  N+LLD   + K++DFG+ +    + T  +T    GT  YM+PE  +  
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMAPEILMRS 175

Query: 530 LFSVKSDVFSFGVLVLEIVCG 550
                 D +S G L+ +++ G
Sbjct: 176 GHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 15/173 (8%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVRLL 412
           +G+G FG V       +G+  AVK L K +    +E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRL 471
                 D+   + +Y+    L    F + R + F +   R    E IA  L YLH    L
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
            II+RDLK  N+LLD+  +  ++DFG+ +  G+ +    T    GT  Y++PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE-GI-EHSKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D            
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   + +++ +SDV+S+G+L+ EI
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 24/205 (11%)

Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVRLLG 413
           +G G FG V        +++ A+K LSK       +   F  E  ++A      +V+L  
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL-- 108

Query: 414 CCTLRDERML--IYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
               +D++ L  + EY+P   L   +  +D+       W++        A  +L L    
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE----KWARFY-----TAEVVLALDAIH 159

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY---- 525
            +  IHRD+K  N+LLD   + K++DFG       +      D  VGT  Y+SPE     
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQ 218

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCG 550
             DG +  + D +S GV + E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 50.3 bits (120), Expect = 4e-08
 Identities = 26/81 (32%), Positives = 37/81 (45%), Gaps = 6/81 (7%)

Query: 186 EHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSK-NCSCTAYANADVRGGGSGCLLW 244
           +  D F++  + KLP  S   +    S+  C   C   NCSC ++       G  GCLLW
Sbjct: 1   KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTY---NNGTKGCLLW 56

Query: 245 -FHDLIDMKVLSEGGQDLYIR 264
               L D ++   GG DLY +
Sbjct: 57  SESSLGDARLFPSGGVDLYEK 77

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 3/90 (3%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A G+ +L   +    +HRDL A NVL+      KI DFG+AR    D    +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   + L++  SDV+SFG+L+ EI
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 54.7 bits (131), Expect = 6e-08
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVRLLGCC 415
           K+G G +G VY+    +G++     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 416 TLRDERM--LIYEYLPNKSLEQFIFDVT-----RTKFLDWSKRCQIIEGIARGLLYLHQD 468
               +R   L+++Y  +       F        +   L  S    ++  I  G+ YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 469 SRLRIIHRDLKASNVLLDNDMNP-----KISDFGMARAFGVD-QTEANTDRVVGTYGYMS 522
               ++HRDLK +N+L+  +  P     KI+D G AR F    +  A+ D VV T+ Y +
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 523 PEYAIDGLFSVKS-DVFSFGVLVLEIV 548
           PE  +      K+ D+++ G +  E++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 8/144 (5%)

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LV L  C        L+ EY+    L   +F + R + L           I   L +LH+
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
                II+RDLK  NVLLD D + K++D+GM +  G+   +  T    GT  Y++PE   
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD-TTSTFCGTPNYIAPEILR 169

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGK 551
              +    D ++ GVL+ E++ G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 54.3 bits (130), Expect = 9e-08
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  LV L  C         + EY+    L   +F + R + L           I+  L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH+     II+RDLK  NVLLD++ + K++D+GM +  G+   +  T    GT  Y++PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD-TTSTFCGTPNYIAPE 166

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                 +    D ++ GVL+ E++ G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 15/199 (7%)

Query: 358 LGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVRLL 412
           +G+G FG V      ++G   AVK L K +    +E  + +    +L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRL 471
                 ++   + +Y+    L    F + R + FL+   R    E +A  + YLH    L
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAE-VASAIGYLHS---L 115

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
            II+RDLK  N+LLD+  +  ++DFG+ +  GV+  E  T    GT  Y++PE      +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEP-EETTSTFCGTPEYLAPEVLRKEPY 173

Query: 532 SVKSDVFSFGVLVLEIVCG 550
               D +  G ++ E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 64/273 (23%), Positives = 116/273 (42%), Gaps = 56/273 (20%)

Query: 305 YMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWK--NKLGEGG 362
              K +  D+       E +     N  E+ +      N I + + N S+K  N +G G 
Sbjct: 24  GSGKFEMNDKKLD----EEERSHNNNAGEDEDEEKMIDNDI-NRSPNKSYKLGNIIGNGS 78

Query: 363 FGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK-LQHRNLVRLLGC----CT 416
           FG VY  + +   +++A+K++ +       ++KN  LLI K L H N++ L       C 
Sbjct: 79  FGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECF 133

Query: 417 LRDERML----IYEYLP-------------NKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
            ++E+ +    + E++P             N +L  F+  +   +             + 
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ-------------LC 180

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           R L Y+H      I HRDLK  N+L+D N    K+ DFG A+     Q   +    + + 
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS---YICSR 234

Query: 519 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 550
            Y +PE  +    ++   D++S G ++ E++ G
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 8/98 (8%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV--- 514
           I  GL Y+H  +   ++HRDLK  N+L++ D   KI DFG+AR F  +  E N   +   
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-NAGFMTEY 169

Query: 515 VGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 551
           V T  Y +PE  +      K+ DV+S G ++ E++  K
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 17/210 (8%)

Query: 351 NFSWKNKLGEGGFGPVYR----GMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAK 402
           NF     LG G +G V+          G+  A+K L K++     + VE  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 403 LQHRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
           ++    +  L      + ++ LI +Y+     E F     R  F +   R    E I   
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGG--EMFTHLYQRDNFSEDEVRFYSGE-IILA 117

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L +LH   +L I++RD+K  N+LLD++ +  ++DFG+++ F + + +  T    GT  YM
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173

Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
           +PE         K+ D +S G+L+ E++ G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 43/189 (22%), Positives = 81/189 (42%), Gaps = 25/189 (13%)

Query: 377 IAVKR--LSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE 434
           +AVK+  L   S + ++  + E++   +LQH N++  +    +  E  ++   +   S E
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87

Query: 435 QFIFDVTRTKFLDWSKR---CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP 491
             +    +T F +         I++ +   L Y+H       IHR +KAS++LL  D   
Sbjct: 88  DLL----KTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKV 140

Query: 492 KISDFGMARAFGVDQTEANTDRVVGTYG--------YMSPEYAIDGL--FSVKSDVFSFG 541
            +S    + +           RVV  +         ++SPE     L  ++ KSD++S G
Sbjct: 141 VLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197

Query: 542 VLVLEIVCG 550
           +   E+  G
Sbjct: 198 ITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 59/255 (23%), Positives = 109/255 (42%), Gaps = 37/255 (14%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIA---VKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLL 412
           ++G G FG V    +     +A   VK L  ++  +   EF  +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR-CQIIE------GIARGLLYL 465
           G C      +L++EY     L+ ++          W +R  Q++        IA G+ ++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA-FGVDQTEANTDRVVGTYGYMSPE 524
           H   +   +H DL   N  L +D+  K+ D+G+  + +  D  E   D+ V    +++PE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPE 171

Query: 525 YAI---DGLFSVK----SDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLWTED 576
                  GL + +    S+V++ GV + E+     +    Y       +L H  +    D
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP---YSHLSDREVLNHVIK----D 224

Query: 577 RSLELIDKSLDGSYS 591
           + ++L    L+  YS
Sbjct: 225 QQVKLFKPQLELPYS 239

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 37/98 (37%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN--TDRVVGT 517
           R L Y+H  +   + HRDLK  N+L + D   KI DFG+AR    D   A   TD  V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD-YVAT 169

Query: 518 YGYMSPEYAIDGLFSVKS----DVFSFGVLVLEIVCGK 551
             Y +PE    G F  K     D++S G +  E++ GK
Sbjct: 170 RWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I+  L +LH+     II+RDLK  NVLLD + + K++D+GM +  G+   +  T    GT
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDT-TSTFCGT 159

Query: 518 YGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIVCGK 551
             Y++PE     D  FSV  D ++ GVL+ E++ G+
Sbjct: 160 PNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 32/148 (21%), Positives = 59/148 (39%), Gaps = 17/148 (11%)

Query: 353 SWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-- 409
           S    L  G    VY   L    E   +K     S +   + + EV ++  L  + L   
Sbjct: 1   SSIKLLKGGLTNRVYL--LGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVP 56

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           ++L          L+ E++  ++L++   +  +    +     Q+ E +A+    LHQ  
Sbjct: 57  KVLASGESDGWSYLLMEWIEGETLDEVS-EEEKEDIAE-----QLAELLAK----LHQLP 106

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFG 497
            L + H DL   N+L+D+     I D+ 
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 8/156 (5%)

Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
           E  ++  + H ++++L G  T      LI   LP    + + +   +   +       I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN-IAICDILAIE 188

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
             + R + YLH++   RIIHRD+KA N+ +++  +  + DFG A  F VD          
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244

Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           GT    +PE      +    D++S G+++ E+    
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 41/173 (23%), Positives = 68/173 (39%), Gaps = 39/173 (22%)

Query: 396 EVLLIAKLQHRNLVRLLG--------CCTLRDERMLIYEYLPNKS---LEQFIFDVTRTK 444
           E+ ++  + HR ++ L+         C  +   +  ++ Y+       LEQ I       
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAIT------ 189

Query: 445 FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
                    I   +   L YLH      IIHRD+K  N+ LD   N  + DFG A     
Sbjct: 190 ---------IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC---- 233

Query: 505 DQTEANTDRV-----VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
            + +A+ D        GT    SPE      +  K+D++S G+++ E+     
Sbjct: 234 -KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 13/113 (11%)

Query: 438 FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497
           FD++R +F             A  L  L    +  +I+RDLK  N+LLD   +  + DFG
Sbjct: 90  FDLSRARFY-----------TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138

Query: 498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           + +    D  + NT    GT  Y++PE  +   ++   D ++ GVL+ E++ G
Sbjct: 139 LCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.0 bits (124), Expect = 7e-07
 Identities = 46/180 (25%), Positives = 87/180 (48%), Gaps = 23/180 (12%)

Query: 379 VKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI---YEYLPNKSLEQ 435
           + +  K+  +   + +NE+L + +L H N++++           +I   Y++     L  
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYS 251

Query: 436 FIFDVTRTKFLDWSKRC------QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM 489
           F++D    +  DW  R        I++ +   + Y+H     ++IHRD+K  N+ L+ D 
Sbjct: 252 FMYD----EAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304

Query: 490 NPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE-YAIDGLFSVKSDVFSFGVLVLEIV 548
              + DFG A  F   + EA     VGT    SPE  A DG   + +D++S G+++L+++
Sbjct: 305 KIVLGDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 19/201 (9%)

Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVRLL 412
           +G+G FG V        ++  AVK L K +    +E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRL 471
                 D+   + +Y+    L    + + R + FL+   R    E IA  L YLH    L
Sbjct: 63  FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAE-IASALGYLHS---L 115

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN--TDRVVGTYGYMSPEYAIDG 529
            I++RDLK  N+LLD+  +  ++DFG+ +    +  E N  T    GT  Y++PE     
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 530 LFSVKSDVFSFGVLVLEIVCG 550
            +    D +  G ++ E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 50.6 bits (122), Expect = 9e-07
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 15/149 (10%)

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLL 463
           + N ++L    T     +LI +Y+ +  L    FD+ + +  L  ++  +II  +   L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            LH   +  IIH D+K  NVL D   +   + D+G+ +  G   T +  D   GT  Y S
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG---TPSCYD---GTLDYFS 174

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      + V  D ++ GVL  E++ GK
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 9e-07
 Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 68/244 (27%)

Query: 358 LGEGGFGPVYR--GMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRL 411
           +G G FG V R       G   A+K+L KS      Q V   + E  ++A+  +  +V+L
Sbjct: 9   IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKL 66

Query: 412 LGCCTLRDER--MLIYEYLPNKSL-------EQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
               + +DE    LI EYLP   +       + F  + TR  F            IA  +
Sbjct: 67  Y--YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR--FY-----------IAETI 111

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG----------VDQTEANTD 512
           L +    +L  IHRD+K  N+LLD   + K+SDFG+               +     +  
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 513 R--------------------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLE 546
                                       VGT  Y++PE  +   ++ + D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 547 IVCG 550
           ++ G
Sbjct: 232 MLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 6/99 (6%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           IA  +L +H   +L  +HRD+K  NVLLD + + +++DFG       D T   +   VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGT 166

Query: 518 YGYMSPEY--AID---GLFSVKSDVFSFGVLVLEIVCGK 551
             Y+SPE   A++   G +  + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 24/177 (13%)

Query: 417 LRDERML--IYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
            +D+R L  + EY+P   L   +  +DV       W++        A  +L L     + 
Sbjct: 112 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYT-----AEVVLALDAIHSMG 162

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY----AID 528
            IHRD+K  N+LLD   + K++DFG       +      D  VGT  Y+SPE       D
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGD 221

Query: 529 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
           G +  + D +S GV + E++ G      ++AD   +L+G   ++     SL   D +
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTP---FYAD---SLVGTYSKIMNHKNSLTFPDDN 272

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 15/210 (7%)

Query: 358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEV----LLIAKLQHRNLVRLL 412
           +G+G FG V       +G+  AVK L K      +E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                 ++   + +++    L    F + R +     +       IA  L YLH    + 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           I++RDLK  N+LLD+  +  ++DFG+ +  G+ Q++  T    GT  Y++PE      + 
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTT-FCGTPEYLAPEVIRKQPYD 174

Query: 533 VKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
              D +  G ++ E++ G     FY  D  
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP--FYCRDVA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 83/264 (31%)

Query: 350 DNFSWKNKLGEGGFGPV-YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           ++F     +G+G FG V        G+  A+K L KS     E FK + L   K +   L
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAERDVL 55

Query: 409 --------VRLLGCCTLRDERML--IYEYLPNKSL-------EQFIFDVTRTKFLDWSKR 451
                   V L    + +D + L  I E+LP   L       + F  DVTR  F      
Sbjct: 56  AESDSPWVVSLY--YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR--FY----- 106

Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--------- 502
                 +A  +L +    +L  IHRD+K  N+L+D   + K+SDFG++  F         
Sbjct: 107 ------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160

Query: 503 -------------------GVDQ---TEANTDRV--------------VGTYGYMSPEYA 526
                               VD    T ++ D++              VGT  Y++PE  
Sbjct: 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF 220

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCG 550
           +   +  + D +S G ++ E + G
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.4 bits (117), Expect = 6e-06
 Identities = 68/260 (26%), Positives = 110/260 (42%), Gaps = 66/260 (25%)

Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN-----EVLLIAKLQHRNLVR- 410
           K+G G FG V+       QE    +    S +G++E +      EV ++ +L+H+N+VR 
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 411 --------------LLGCCTLRDERMLIYE--YLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
                         L+  C   D    I +   +  K  E  I D+TR          Q+
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR----------QL 127

Query: 455 IEGIARGLLYLHQ----DSRLRIIHRDLKASNVLLD-------------NDMN----PKI 493
           +  +A    Y H      +  R++HRDLK  N+ L              N++N     KI
Sbjct: 128 LHALA----YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 494 SDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV--KSDVFSFGVLVLEIVCGK 551
            DFG+++  G+   E+     VGT  Y SPE  +    S   KSD+++ G ++ E+  GK
Sbjct: 184 GDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Query: 552 RNRGFYHADHHHNLLGHAWR 571
               F+ A++   L+    R
Sbjct: 241 TP--FHKANNFSQLISELKR 258

Length = 1021

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 6/99 (6%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A  +L +    +L  +HRD+K  NVLLD + + +++DFG       D T   ++  VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGT 166

Query: 518 YGYMSPEY--AID---GLFSVKSDVFSFGVLVLEIVCGK 551
             Y+SPE   A++   G +  + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 52/227 (22%), Positives = 97/227 (42%), Gaps = 45/227 (19%)

Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-SGQGV--EEFKNEVLLIAKLQHRNLVRLL 412
            +G+GG G VY        + +A+K++ +  S   +  + F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---------------WSKRCQIIEG 457
             C+  D       Y+   +L+  +  V + + L                + K C  IE 
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE- 127

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-ANTD---- 512
                 Y+H  S+  ++HRDLK  N+LL       I D+G A    +++ +  + D    
Sbjct: 128 ------YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 513 -----------RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                      ++VGT  YM+PE  +    S  +D+++ GV++ +++
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

 Score = 42.3 bits (99), Expect = 4e-05
 Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 13/84 (15%)

Query: 185 CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKN---CSCTAYANADVRGGGSGC 241
           C+     L + ++K+  T  +  D       C   C KN    SC A+  A  R     C
Sbjct: 5   CKSAGTTLIKIALKIKTTKANTAD------ECANRCEKNGLPFSCKAFVFAKARK---QC 55

Query: 242 LLW-FHDLIDMKVLSEGGQDLYIR 264
           L + F+ +  ++     G DLY  
Sbjct: 56  LWFPFNSMSGVRKEFSHGFDLYEN 79

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.6 bits (108), Expect = 8e-05
 Identities = 45/179 (25%), Positives = 71/179 (39%), Gaps = 36/179 (20%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSGQGVEEFKNEVLL----- 399
           D+F    KLGEG FG VY+  L         +  +K+ +   G  VE + NE +      
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189

Query: 400 -IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL------EQFIFDVTRTKFLD----- 447
             A   +  L  +       DE  L++ Y    +L      ++F ++V            
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 448 --WSKRCQIIEGIARGLLY----LHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMA 499
               +  +II+ I R +L+    LH      I+HRD+K  N++        KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 8e-05
 Identities = 20/46 (43%), Positives = 31/46 (67%), Gaps = 3/46 (6%)

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
           I  +A  L YLH+     IIHRDLK  N+L+ N+ + K++DFG+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 6/87 (6%)

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY--AI 527
           +L  +HRD+K  N+L+D + + +++DFG       D T   +   VGT  Y+SPE   A+
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAM 178

Query: 528 D---GLFSVKSDVFSFGVLVLEIVCGK 551
           +   G +  + D +S GV + E++ G+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 24/81 (29%), Positives = 45/81 (55%)

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
           +++HRDLK++N+ L      K+ DFG ++ +    +        GT  Y++PE      +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 532 SVKSDVFSFGVLVLEIVCGKR 552
           S K+D++S GV++ E++   R
Sbjct: 249 SKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 35/198 (17%)

Query: 374 GQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK 431
           G  + V+   L   + + ++  +NEV+L    +H N++      T      +I  ++   
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 432 SLEQFIFDVTRTKFLDWSKRC---QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND 488
           S    +    +T F +         I+ G  RGL YLHQ+     IHR++KAS++L    
Sbjct: 85  SANSLL----KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHIL---- 133

Query: 489 MNPKISDFGMARAFGVDQTEA---NTDRVVGTYGY----------MSPEYAIDGL--FSV 533
               IS  G+    G+    +   N  +    Y +          +SPE     L  ++V
Sbjct: 134 ----ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNV 189

Query: 534 KSDVFSFGVLVLEIVCGK 551
           KSD++S G+   E+  G+
Sbjct: 190 KSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 63/280 (22%)

Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
           +T  F   + LGEG FG V      + +E    ++ ++  +   + K E+  + K++  +
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----LDW-------SKR--CQI 454
                     R   M I  Y  N++    I      K+    LDW       S R   QI
Sbjct: 187 PAD-------RFPLMKIQRYFQNETGHMCI---VMPKYGPCLLDWIMKHGPFSHRHLAQI 236

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNP-------------KISDFGM 498
           I      L Y H  + L ++H DLK  N+L+   D  ++P             +I D G 
Sbjct: 237 IFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 558
                 D+  + T  +V T  Y SPE  +   +   +D++S G ++ E+  GK     Y 
Sbjct: 295 C----CDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL---LY- 345

Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRC 598
            D H NL             L L++K+L G      A RC
Sbjct: 346 -DTHDNL-----------EHLHLMEKTL-GRLPSEWAGRC 372

Length = 467

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 20/154 (12%)

Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG G FG V      + + + A+K L K        V   K E  ++A+  +  +VRL  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 414 CCTLRDERMLIYEYLPNKSLEQF-----IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
               +D    + +Y+P   +        IF     +F            IA     +   
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY-----------IAELTCAVESV 117

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
            ++  IHRD+K  N+L+D D + K++DFG+   F
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 36/180 (20%), Positives = 76/180 (42%), Gaps = 20/180 (11%)

Query: 380 KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG----CCTLRDERMLIYEYLPNKSLEQ 435
           K+  K     ++  +NE+  + ++   N++++ G             LI EY     L +
Sbjct: 52  KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111

Query: 436 FIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKIS 494
            +    + K L +  +  +     +GL  L++  ++    +++L + + L+  +   KI 
Sbjct: 112 VL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKII 165

Query: 495 DFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS---VKSDVFSFGVLVLEIVCGK 551
             G+ +       +      V    Y S +   D +FS   +K D++S GV++ EI  GK
Sbjct: 166 CHGLEKILSSPPFKN-----VNFMVYFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 34/126 (26%), Positives = 55/126 (43%), Gaps = 33/126 (26%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTE-------- 508
           IA  +L +    +L  IHRD+K  N+LLD+  + K+SDFG+        +TE        
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 509 ---------ANTDR---------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 544
                     N+ R                VGT  Y++PE  +   ++   D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 545 LEIVCG 550
            E++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.2 bits (94), Expect = 0.003
 Identities = 48/244 (19%), Positives = 90/244 (36%), Gaps = 61/244 (25%)

Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           +G G FG V      +   + A+K L K+           K E  ++A+  +  +V+L  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 414 CCTLRDERMLIYEYLPNKSLEQF-----IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
               +D    + +Y+P   +        IF+    +F         I  +   +  +H  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFY--------IAELTCAIESVH-- 118

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-------------------------- 502
            ++  IHRD+K  N+L+D D + K++DFG+   F                          
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 503 ---------------GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                                     +VGT  Y++PE  +   ++   D +S GV++ E+
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 548 VCGK 551
           + G+
Sbjct: 238 LVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 0.003
 Identities = 58/241 (24%), Positives = 94/241 (39%), Gaps = 67/241 (27%)

Query: 357 KLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKLQHRNLV 409
            LG+G  G V+   L      G+  A+K L K       + K    E  ++A L H  L 
Sbjct: 8   LLGKGDVGRVF---LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64

Query: 410 RLLGCCTLRDERMLIY--EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR------- 460
            L    + + E  L    +Y P   L    F + + +      +C + E +AR       
Sbjct: 65  TLY--ASFQTETYLCLVMDYCPGGEL----FRLLQRQ----PGKC-LSEEVARFYAAEVL 113

Query: 461 -GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA-------------------- 499
             L YLH    L I++RDLK  N+LL    +  +SDF ++                    
Sbjct: 114 LALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 500 -------RAFGVDQTEANTDRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVC 549
                       ++    ++  VGT  Y++PE  I G     +V  D ++ G+L+ E++ 
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAV--DWWTLGILLYEMLY 227

Query: 550 G 550
           G
Sbjct: 228 G 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 58/245 (23%), Positives = 98/245 (40%), Gaps = 57/245 (23%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           D+F     +G G FG V      + G   A+K L K+     + V   + E  ++ +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
             +V++    + +D+R   LI E+LP   +   +          T+F            I
Sbjct: 61  AWVVKMF--YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY-----------I 107

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTE--------- 508
           A  +L +    +L  IHRD+K  N+LLD   + K+SDFG+        +TE         
Sbjct: 108 AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167

Query: 509 --------ANTDR---------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL 545
                    N+ R                VGT  Y++PE  +   ++   D +S GV++ 
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 546 EIVCG 550
           E++ G
Sbjct: 228 EMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 38/154 (24%), Positives = 65/154 (42%), Gaps = 20/154 (12%)

Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG G FG V      +   + A+K L K    +   V   K E  ++A+  +  +V+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 414 CCTLRDERMLIYEYLPNKSLEQF-----IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
               +D    + +Y+P   +        +F     +F            IA   L +   
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY-----------IAELTLAIESV 117

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
            ++  IHRD+K  N+L+D D + K++DFG+   F
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 28/102 (27%), Positives = 52/102 (50%), Gaps = 16/102 (15%)

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT----EANTDR---- 513
           L YLH      I+HRDLK  N+L+ +  + K++DFG+++   +  T    E + ++    
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 514 -----VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
                V GT  Y++PE  +   +    D ++ G+++ E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	669
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
PRK10345	210	hypothetical protein; Provisional	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
smart00090	237	RIO RIO-like kinase.	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.5
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
KOG1243	690	consensus Protein kinase [General function predict	99.2
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.14
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.08
KOG3087	229	consensus Serine/threonine protein kinase [General	99.03
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.02
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.97
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.89
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.8
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.68
COG4248	637	Uncharacterized protein with protein kinase and he	98.67
PRK09902	216	hypothetical protein; Provisional	98.63
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.55
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.54
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.43
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.41
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.28
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.24
PF01636	239	APH: Phosphotransferase enzyme family This family	98.2
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.18
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.18
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.17
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	98.01
PLN02876	822	acyl-CoA dehydrogenase	97.92
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.89
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.89
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.88
PRK10593	297	hypothetical protein; Provisional	97.85
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.84
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.84
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.8
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.78
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.58
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.52
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.5
PRK05231	319	homoserine kinase; Provisional	97.48
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.37
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.31
PLN02236	344	choline kinase	97.25
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.21
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.12
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.01
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.88
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.82
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.69
PLN02756	418	S-methyl-5-thioribose kinase	96.67
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.63
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.5
PRK12396	409	5-methylribose kinase; Reviewed	96.45
KOG2270	520	consensus Serine/threonine protein kinase involved	96.41
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.83
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.82
PRK11768	325	serine/threonine protein kinase; Provisional	95.5
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.37
PTZ00384	383	choline kinase; Provisional	95.37

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-53  Score=447.65  Aligned_cols=290  Identities=44%  Similarity=0.751  Sum_probs=256.8

Q ss_pred             CCCCccHHHHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEE
Q 005933          336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC  415 (669)
Q Consensus       336 ~~~~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~  415 (669)
                      ....|++.++..+|++|+..+.||+|+||.||+|.+.+++.||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56679999999999999999999999999999999999999999988665443155699999999999999999999999


Q ss_pred             ecCC-cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEe
Q 005933          416 TLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS  494 (669)
Q Consensus       416 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  494 (669)
                      .+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999765444 89999999999999999999999998899999999999999999999999


Q ss_pred             ecCCCcccCCCccCcCcccc-cccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          495 DFGMARAFGVDQTEANTDRV-VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       495 Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      |||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+...+.....+..|++..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999654321  1111112 89999999999999999999999999999999999999887766566667899999999


Q ss_pred             ccccchhhcccccC-CCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          574 TEDRSLELIDKSLD-GSYSL-SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       574 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ......+++|+.+. +..+. .+...+..++.+|++.+|++||+|.||+++|+....
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99999999999987 55554 678889999999999999999999999999965543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=385.33  Aligned_cols=254  Identities=30%  Similarity=0.492  Sum_probs=211.2

Q ss_pred             CccCeeeecCccceEEEEeCCCcEEEEEEecccCcc--chHHHHHHHHHHHHhCCCceeEEEEEEecCC-cceEEEeecC
Q 005933          353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLP  429 (669)
Q Consensus       353 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~E~~~  429 (669)
                      .+.+.||+|+||+||+|.+.....||||++......  ..+.|.+|+.+|.+++|||||+++|+|.++. ..+||||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            344669999999999999985444999999754322  2669999999999999999999999999988 7999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeecCCCcccCCCccC
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla~~~~~~~~~  508 (669)
                      +|+|..+++.. +...+++..+++++.|||+||.|||+.++  ||||||||+||||+.++ ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            99999999764 56779999999999999999999999884  99999999999999997 99999999998754322  


Q ss_pred             cCcccccccCCccCchhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          509 ANTDRVVGTYGYMSPEYAI--DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~--~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      .......||+.|||||++.  ...|+.|+||||||++||||+||+.||.....      ...         ...++....
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~---------~~~v~~~~~  263 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQV---------ASAVVVGGL  263 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHH---------HHHHHhcCC
Confidence            2233368999999999999  56999999999999999999999999664332      111         111222223


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ....+...+..+..|+.+||+.||+.||++.+++.+|+..
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            3344444677889999999999999999999999999865

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=380.40  Aligned_cols=254  Identities=31%  Similarity=0.500  Sum_probs=215.4

Q ss_pred             CCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      +.+.++||+|.||.||.|.++....||+|.+... ....+.|.+|+.+|++|+|+|||+++|+|..++..+||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            3456899999999999999998889999999543 456688999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCc
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT  511 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  511 (669)
                      +|.++|.. ..+..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||+|+....+... ..
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~~  361 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-AS  361 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee-ec
Confidence            99999965 45567999999999999999999999999   999999999999999999999999999955433332 22


Q ss_pred             ccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      ....-+..|.|||.+..+.++.|||||||||+||||+| |+.|++..                ...+..+.++..-.-..
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m----------------sn~ev~~~le~GyRlp~  425 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM----------------SNEEVLELLERGYRLPR  425 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC----------------CHHHHHHHHhccCcCCC
Confidence            23445788999999999999999999999999999999 66664422                22233344444444455


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      +..++..+.+||..||+.+|++|||++.+...|+...
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            6678889999999999999999999999999997653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-44  Score=356.88  Aligned_cols=247  Identities=26%  Similarity=0.363  Sum_probs=208.9

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc-ceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-RMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~E~  427 (669)
                      +.+..+.||+|..|+|||+.++. ++.+|+|.+... .....+++.+|+++++..+||+||.++|.|..... ..|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            34446899999999999999864 888999999544 34557899999999999999999999999999984 9999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |++|||+.++..   .+.+++...-+|+.+|++||.|||+ ++   ||||||||+||||+..|++||+|||.+..+-.. 
T Consensus       160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            999999999954   3669999999999999999999996 66   999999999999999999999999999876433 


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                         ..+..+||..|||||-+.+..|+.++||||||++++|+.+|+.|+....+              ......++++...
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~--------------~~~~~~~Ll~~Iv  295 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP--------------PYLDIFELLCAIV  295 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC--------------CCCCHHHHHHHHh
Confidence               44557999999999999999999999999999999999999999765411              1123344444444


Q ss_pred             CCC---CCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          587 DGS---YSL-SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       587 ~~~---~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .+.   .+. ....++.+++..||+.||.+||++.|+++
T Consensus       296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            422   222 25568999999999999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-44  Score=374.18  Aligned_cols=245  Identities=26%  Similarity=0.391  Sum_probs=212.7

Q ss_pred             cCCCccCeeeecCccceEEEEe-CCCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..|...+.||+|||+.+|.++. ..|+.||+|++.+.   .....+.+.+||+|.+.|+|||||+++++|++.+..+||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688899999999999999997 77999999999764   3456778999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      |+|++++|.+++   ++.+.+++.++..++.||+.||.|||+++   |+|||||..|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            999999999999   36678999999999999999999999999   999999999999999999999999999987544


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .  ++....+||+.|.|||++.....+..+||||+|||+|-|+.|++||+...                   ..+.....
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------------------vkety~~I  230 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------------------VKETYNKI  230 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------------------HHHHHHHH
Confidence            3  34445899999999999999999999999999999999999999976422                   22222222


Q ss_pred             cCCC--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGS--YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....  ++........+||..+|+.+|.+|||+++|+.
T Consensus       231 k~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  231 KLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2222  22344556789999999999999999999995

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.9e-44  Score=388.27  Aligned_cols=260  Identities=30%  Similarity=0.462  Sum_probs=218.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      ..+....++||+|.||.||+|...      +..-||||.++..... ...+|++|++++..|+|||||+|+|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345666799999999999999953      3567999999876655 788999999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVT-------R----TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN  490 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~  490 (669)
                      ++|+|||..|+|.+||....       .    ..+|+..+.+.||.|||.||.||-++.   +|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999996421       1    233889999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHh
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA  569 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~  569 (669)
                      |||+|||+++.....++........-+++|||||.|+.++||.+||||||||+||||++ |+.|+....           
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-----------  710 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-----------  710 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----------
Confidence            99999999998766555544444566889999999999999999999999999999998 666643221           


Q ss_pred             hhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                           ++...+.+...-.-+.+..++..+.+||..||+..|++||+++||-..|+...
T Consensus       711 -----n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  711 -----NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             -----hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence                 22222333322223556678889999999999999999999999999997653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=352.56  Aligned_cols=201  Identities=30%  Similarity=0.521  Sum_probs=180.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..+|.+.++||+|+|++||+|+++. +..||||.+.+.  .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            4578888999999999999999764 899999999766  5566778899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC------cceEEeecCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND------MNPKISDFGMA  499 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~------~~~kl~Dfgla  499 (669)
                      |||.+|+|..+|+.   .+.+++..+..++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999953   446999999999999999999999999   9999999999999864      56899999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  558 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~  558 (669)
                      +.+..   .......+|++.|||||+++.+.|+.|+|+||+|++||+|++|+.||....
T Consensus       163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            98753   233445799999999999999999999999999999999999999976433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=355.36  Aligned_cols=247  Identities=26%  Similarity=0.432  Sum_probs=202.7

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-------cchHHHHHHHHHHHHhCCCceeEEEEEEecCC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD  419 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  419 (669)
                      ..+.|.+.+.||+|+||.|-+|... +|+.||||++++..-       .......+|+++|++|+|||||++.+++..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3467888999999999999999954 599999999976421       12234579999999999999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC---cceEEeec
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDF  496 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~Df  496 (669)
                      ..++||||++||.|.+++-   ..+.+.+..-..++.|++.|+.|||+.|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999984   4455777888899999999999999999   9999999999999766   67999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      |+|+..+   ....+...+||+.|.|||++.+..   +..+.|+||+||+||-+++|.+||.....+..           
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----------  389 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----------  389 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----------
Confidence            9999864   344566689999999999998764   33478999999999999999999774433321           


Q ss_pred             ccccchhhcccccCCCCC------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          574 TEDRSLELIDKSLDGSYS------LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                             +.+....+.+.      .+...+.+++|.+||..||++|||+.|+++
T Consensus       390 -------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  390 -------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                   11112222221      233567889999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-44  Score=341.98  Aligned_cols=253  Identities=26%  Similarity=0.416  Sum_probs=207.1

Q ss_pred             cCCCccCeeeecCccceEEEE-eCCCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEE-EEecCCc-ceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLG-CCTLRDE-RMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~lV  424 (669)
                      .+|.+.++||+|.||+||++. +.+|..||.|.+.-.  +....+....|+.+|++|+|||||++++ .+.++.+ +.||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468888999999999999999 567999999998632  3455678899999999999999999998 4555555 8899


Q ss_pred             EeecCCCCHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          425 YEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDS-RLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      ||++..|+|..++...++ .+.+++..+++++.|++.||..+|..- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999976544 456899999999999999999999842 234999999999999999999999999999998


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .....-  ....+||+.||+||.+.+.+|+.++||||+||++|||..-++||...      ++             .++-
T Consensus       179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~-------------~~L~  237 (375)
T KOG0591|consen  179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NL-------------LSLC  237 (375)
T ss_pred             cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cH-------------HHHH
Confidence            654433  33479999999999999999999999999999999999999996532      11             2222


Q ss_pred             ccccCCCC---C-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          583 DKSLDGSY---S-LSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       583 ~~~~~~~~---~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                      ...-++.+   + ...+..+..||..|+..||+.||+.-.+++.+
T Consensus       238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            22222222   2 34567889999999999999999855544444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=340.73  Aligned_cols=239  Identities=26%  Similarity=0.368  Sum_probs=203.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++.+.||+|+||.||.++.++ ++-+|+|++++.   .....+..++|..+|..++||.||+++-.|.+.+.++||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4689999999999999999999665 899999999764   234577889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      +||+.||.|..+|   .+.+.+++..+.-++.+|+.||.|||+.+   ||||||||+|||||.+|+++|+|||+++..-.
T Consensus       104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999   45566899999999999999999999999   99999999999999999999999999986422


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                        ....+...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+                   ..+..+.
T Consensus       178 --~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-------------------~~~~~~~  236 (357)
T KOG0598|consen  178 --DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-------------------VKKMYDK  236 (357)
T ss_pred             --CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-------------------HHHHHHH
Confidence              2233445799999999999999999999999999999999999999966432                   2222222


Q ss_pred             ccCCC---CCHHHHHHHHHHHHHhccCCCCCCC
Q 005933          585 SLDGS---YSLSEALRCIQVGLLCVQQRPEDRP  614 (669)
Q Consensus       585 ~~~~~---~~~~~~~~l~~li~~cl~~dP~~RP  614 (669)
                      .+.+.   .+.-...+.++++...|+.||++|.
T Consensus       237 I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  237 ILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            22222   1222345778999999999999995

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5e-42  Score=365.99  Aligned_cols=256  Identities=26%  Similarity=0.421  Sum_probs=216.7

Q ss_pred             CCCccCeeeecCccceEEEEeCC----CcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ...+.+.||.|.||.|++|.++-    ...||||.++.. .+....+|+.|+.||.+++||||++|.|+.+.....+||.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            45677899999999999999864    457999999765 3456789999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      |||+||+|+.||+.  +.+.+++.++..++++||.||.||.+.+   +|||||.++||||+.+..+|++|||+++.+..+
T Consensus       710 EyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999965  3356999999999999999999999998   999999999999999999999999999987555


Q ss_pred             ccCcCccccc--ccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          506 QTEANTDRVV--GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       506 ~~~~~~~~~~--gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .. .......  -+.+|.|||.+...++|.++||||||+++||.++ |++|+--                +.+.+....+
T Consensus       785 ~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd----------------mSNQdVIkaI  847 (996)
T KOG0196|consen  785 PE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----------------MSNQDVIKAI  847 (996)
T ss_pred             CC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc----------------cchHHHHHHH
Confidence            42 2222222  2678999999999999999999999999999776 8888321                2223333444


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      .....-+.+.+++..|.+||+.|||.|-.+||.+.+|+.+|+++..
T Consensus       848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            4444446677889999999999999999999999999999988644

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.7e-41  Score=323.23  Aligned_cols=264  Identities=20%  Similarity=0.314  Sum_probs=204.6

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      +.|+.+.++|+|++|.|||.+.++ |+.||||++.+..+  ...+-.++|+++|++|+|+|+|.++.+|.......||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            457778899999999999999876 99999999976533  335668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |++..-|+++-.   ...-++...+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+..  
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            999877766542   2233788999999999999999999999   99999999999999999999999999998753  


Q ss_pred             cCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh--------hhhcccc-
Q 005933          507 TEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WRLWTED-  576 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~-  576 (669)
                      .....+.++.|+.|+|||.+.+ ..|...+||||+||++.||++|++-++....-+....+...        ...+... 
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            3344556789999999999987 58999999999999999999999876544333222222111        1111111 


Q ss_pred             cchhhcccccCCCCCHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 RSLELIDKSLDGSYSLS-----EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....+.-+......+.+     ...-+++++..||+.||.+|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            01111111111111111     1235689999999999999999999873

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.9e-40  Score=347.06  Aligned_cols=260  Identities=27%  Similarity=0.411  Sum_probs=202.8

Q ss_pred             hcCCCccCeeeecCccceEEEEe------CCCcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeEEEEEEecCC-
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD-  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-  419 (669)
                      .++|.+.++||+|+||.||+|..      .+++.||||++..... .....+.+|+.++..+ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46789999999999999999974      2356899999865432 3356789999999999 8999999999887654 


Q ss_pred             cceEEEeecCCCCHHHHhhccCC---------------------------------------------------------
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTR---------------------------------------------------------  442 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  442 (669)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999864211                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCc
Q 005933          443 --TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY  520 (669)
Q Consensus       443 --~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y  520 (669)
                        ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134788899999999999999999998   999999999999999999999999999865332222222234456789


Q ss_pred             cCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHH
Q 005933          521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCI  599 (669)
Q Consensus       521 ~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  599 (669)
                      +|||++.+..++.++||||||++||||++ |..|+.......  ...    .......         ....+...+..+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~~---------~~~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDGT---------RMRAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcCC---------CCCCCCCCCHHHH
Confidence            99999999999999999999999999997 988865432111  000    0000000         0011222345688


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          600 QVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       600 ~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +|+.+||+.||++||++.++++.|+..
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=347.28  Aligned_cols=261  Identities=28%  Similarity=0.437  Sum_probs=210.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCCCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..+.+.+.+.||+|.||+||+|.+.  -.||||++...  ..+..+.|++|+..+++-+|.||+-++|+|..+.. .||+
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            3456778899999999999999997  57999999764  34567899999999999999999999999998887 9999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      .+++|-+|..+|+..+  ..++..+.+.||+|||+||.|||.++   |||||||..||||.+++.|||+|||++..-..-
T Consensus       467 qwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             hhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee
Confidence            9999999999996433  45888999999999999999999999   999999999999999999999999998754333


Q ss_pred             ccCcCcccccccCCccCchhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ..........|...|||||++..+   +|++++||||||+++|||++|..|+.....+..  +       |.-++-.-..
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--i-------fmVGrG~l~p  612 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--I-------FMVGRGYLMP  612 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--E-------EEecccccCc
Confidence            333334456678899999999754   799999999999999999999999763222211  1       1111111111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      |..   ......+..+.+|+..||..++++||.+.+|+.+|+....
T Consensus       613 d~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  613 DLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            111   1122345678899999999999999999999998876543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=334.78  Aligned_cols=257  Identities=27%  Similarity=0.388  Sum_probs=204.2

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCC--cceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--ERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~E  426 (669)
                      .++...+.||+|.||+||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|.....+  ...++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            456677999999999999999765 8999999987654334677999999999999999999999855555  5889999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecCCCcccCC-
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGV-  504 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~~~~-  504 (669)
                      |+++|+|.+++.....  .+++..+..+++||++||+|||+++   |+||||||+||||+. ++.+||+|||++..... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999965432  6999999999999999999999999   999999999999999 79999999999987654 


Q ss_pred             CccCcCcccccccCCccCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ...........||+.|||||++.++. ...++|||||||++.||+||++|+...  .   .......         .+..
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~---~~~~~~~---------~ig~  237 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--F---EEAEALL---------LIGR  237 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--c---chHHHHH---------HHhc
Confidence            12223344578999999999999643 345999999999999999999885432  0   0001111         1111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ....+.++...+....+++..|++.+|+.|||+.+++.-.--
T Consensus       238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            111123344455677899999999999999999999986543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=371.67  Aligned_cols=259  Identities=32%  Similarity=0.488  Sum_probs=211.5

Q ss_pred             cCCCccCeeeecCccceEEEEeCC--Cc----EEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE--GQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      ++..+.+.||+|.||.||.|...+  +.    .||||.+.+. +.+...+|..|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            355667899999999999999654  33    4999999765 4566789999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          423 LIYEYLPNKSLEQFIFDVT----RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                      |++|||++|+|..||.+.+    +...|+....+.++.|||+|+.||++.+   +|||||.++|+||+....+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999997652    2445899999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      |+.+...........-.-+..|||||.++++.++.|+|||||||+||||+| |..|++.....   .+...    +    
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~~----~----  917 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLLD----V----  917 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHHH----H----
Confidence            996654443333333355679999999999999999999999999999999 66675432211   00000    0    


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                         +-..++  ..+..++..+.+||..||+.+|++||++..++..+..+.
T Consensus       918 ---~~ggRL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  918 ---LEGGRL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             ---HhCCcc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence               011112  345567778889999999999999999999999887653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=344.62  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=208.1

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ...|...++||+|+.|.||.+.. ..++.||||++........+-+.+|+.+|+..+|+|||.++..+...++++.||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            34577778999999999999994 45899999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      |++|+|.+.+..    ..+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            999999999833    34899999999999999999999999   99999999999999999999999999988755443


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        .....+||+.|||||++....|.++.||||||+++.||+-|++|+-...+..      ..+.....+      .+  .
T Consensus       425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~ng------~P--~  488 (550)
T KOG0578|consen  425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNG------TP--K  488 (550)
T ss_pred             --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhhcC------CC--C
Confidence              3344799999999999999999999999999999999999999954322111      111111000      00  1


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      -..+......+.++..+||+.|+++||++.|+|+
T Consensus       489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            1122334567889999999999999999999996

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=328.00  Aligned_cols=262  Identities=24%  Similarity=0.385  Sum_probs=208.5

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .+.|++.++||.|..++||+|+. +.+..||||++.-. .....+.+..|+..+..++||||++++..|..+..+++||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46899999999999999999994 55899999999743 33447899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      ||.+||+.+++...-..+ +++..+..|++++++||.|||+++   .||||||+.||||+++|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999997655554 899999999999999999999999   9999999999999999999999999877654322


Q ss_pred             cC--cCcccccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          507 TE--ANTDRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       507 ~~--~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ..  ...+..+|++.|||||+++..  .|+.|+||||||++..||.+|..||.-+.+-.  .++..   +-  .....+.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~t---Lq--n~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLT---LQ--NDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHH---hc--CCCCCcc
Confidence            11  112457899999999997654  69999999999999999999999976544321  11111   00  0111111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...+...........+.+++..||+.||.+|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111111111122347789999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-39  Score=334.27  Aligned_cols=266  Identities=23%  Similarity=0.344  Sum_probs=205.8

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC--CcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  423 (669)
                      .+.|+..++||+|.||.||+++. .+|+.||+|+++...  +....-..+||.||++|+||||++|.+...+.  ...+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            45677789999999999999995 569999999997654  34456678999999999999999999998887  67899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |+|||+. +|..++.  ...-.+++.++..++.||+.||.|+|..+   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999976 7888773  33456899999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh-----hhccccc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-----RLWTEDR  577 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~~~  577 (669)
                      ...... .+..+-|..|.|||++.+. .|+.+.|+||.||||.||+.|++.+.....-.+...+....     ..|....
T Consensus       270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            544333 4456789999999999887 79999999999999999999998866544332222222111     1122111


Q ss_pred             ch--hhcccccCCCCCHHH-----HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SL--ELIDKSLDGSYSLSE-----ALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~--~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..  ..+.+...-.....+     +...++|+..+|..||.+|.|+.++++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11  111111000111111     235689999999999999999999986

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.3e-39  Score=334.44  Aligned_cols=266  Identities=27%  Similarity=0.413  Sum_probs=203.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-----------------CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-----------------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRL  411 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  411 (669)
                      ++|.+.++||+|+||.||++.+++                 +..||||.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999998542                 3469999986543 3345679999999999999999999


Q ss_pred             EEEEecCCcceEEEeecCCCCHHHHhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 005933          412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVT----------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH  475 (669)
Q Consensus       412 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  475 (669)
                      ++++.+.+..++||||+++|+|.+++....                ....+++..+++++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999985421                1234788999999999999999999998   999


Q ss_pred             ccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005933          476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG  555 (669)
Q Consensus       476 ~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~  555 (669)
                      |||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||+++..+.+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543332222233455788999999998899999999999999999998544333


Q ss_pred             CCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          556 FYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      +..... ...............      .......+...+..+.+|+.+||+.+|++|||+.+|.+.|+.
T Consensus       242 ~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTD-EQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCH-HHHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            322111 111111111110000      000011122344678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=336.67  Aligned_cols=250  Identities=27%  Similarity=0.370  Sum_probs=206.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  423 (669)
                      ..+|.+++.||+|+|++|++++.. .++.+|||++.+..   +...+-...|-.+|.+| .||.|++|+-.|.+...+++
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            467889999999999999999965 49999999997642   23345567788999999 89999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |+||.++|+|.++|.+   .+.+++.....++.+|+.||+|||+.|   ||||||||+|||||+++++||+|||.|+.+.
T Consensus       152 vLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999999954   466999999999999999999999999   9999999999999999999999999999885


Q ss_pred             CCccC---------cCc--ccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          504 VDQTE---------ANT--DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       504 ~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      .....         ...  ...+||-.|.+||++.+...++.+|+|+|||+||.|+.|++||-.....   .+.      
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liF------  296 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIF------  296 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHH------
Confidence            43222         111  3478999999999999999999999999999999999999996532211   000      


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         ..+.++     .-.++..-+..+.+|+.+.|-.||++|++.++|-+
T Consensus       297 ---qkI~~l-----~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  297 ---QKIQAL-----DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ---HHHHHh-----cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence               011111     11223333467789999999999999999999876

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.3e-39  Score=306.32  Aligned_cols=277  Identities=25%  Similarity=0.359  Sum_probs=212.4

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-cc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|...++||+|.||.||+|+.. +|+.||||++.... .+ ......+||+.|+.++|+||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35777799999999999999954 59999999996542 22 24567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      ||+ .+|...+.+  +...++..++..++.++++||+|||.+.   |+||||||.|+|++++|.+||+|||+++.+....
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 589999954  4566899999999999999999999999   9999999999999999999999999999986554


Q ss_pred             cCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc------h
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS------L  579 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~  579 (669)
                      .....  .+-|+.|.|||.+.+. .|+...||||.||++.||+-|.+-+....   +.+.+....+.+.....      .
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s---DidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS---DIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc---hHHHHHHHHHHcCCCCcccCcccc
Confidence            43332  3789999999999876 69999999999999999999987655433   33333333322221111      1


Q ss_pred             hhccc---c-----cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCcc
Q 005933          580 ELIDK---S-----LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF  638 (669)
Q Consensus       580 ~~~~~---~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~p~~~  638 (669)
                      ++.|.   .     .....-.......++|+..++..||.+|++++|++++= -....|.|..|...
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~l  296 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKL  296 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhC
Confidence            11111   1     00111123345668999999999999999999998653 22334555554443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=338.39  Aligned_cols=265  Identities=27%  Similarity=0.423  Sum_probs=215.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .+...+.++||+|-||.|.+.....+..||||.++... ....++|..|+++|.+|+||||++++|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34567789999999999999999888999999998654 44568999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      |++|+|..|+....-. .+......+|+.|||.||+||.+.+   ++||||.++|+|++.++++||+|||+++.+.....
T Consensus       617 mEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999999654222 2456677889999999999999998   99999999999999999999999999998776666


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .......+.+..|||||.+..+++|.++|||+||+++||+++  .+.|++....+   ..+.....++..+....     
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~-----  764 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQV-----  764 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcce-----
Confidence            655556777899999999999999999999999999999876  45554432221   12222222222111111     


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                       -...+.-++..+.+++++||..+.++||+++++...|..+
T Consensus       765 -~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 -VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             1123445667888999999999999999999999988654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=344.49  Aligned_cols=262  Identities=29%  Similarity=0.418  Sum_probs=210.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCC----cE-EEEEEecc---cCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEG----QE-IAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~----~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      .++..+.++||+|+||.||+|.+..+    .. ||||....   .......+|++|++++++++|||||+++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            45666779999999999999997542    23 89999874   345678899999999999999999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .+||||++.||+|+++|.+...  .++..+++.++.++|.||+|||+.+   ++||||.++|+|++.++.+||+|||+++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            9999999999999999965333  5999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      .-..  .........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+......      ..         ..
T Consensus       311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v---------~~  373 (474)
T KOG0194|consen  311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EV---------KA  373 (474)
T ss_pred             CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HH---------HH
Confidence            6431  1111112245789999999999999999999999999999999 67664432211      00         01


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP  632 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p  632 (669)
                      .++........+...+..+..++.+||+.+|++||+|.++.+.|+.......+
T Consensus       374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            11111222233445677888999999999999999999999999877554443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=335.73  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=206.6

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHH--HHHHHHHHHhC-CCceeEEEEEEecCC-cce
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQ-HRNLVRLLGCCTLRD-ERM  422 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~  422 (669)
                      ..++|.+.++||.|.||.||+|+.. +|..||||++++.... .++.  ++|+..|++|+ ||||+++..++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3467888999999999999999954 5899999999765433 3332  57999999998 999999999999988 899


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +|||||+. +|.+++.+  +...+++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+.+
T Consensus        87 fVfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            99999954 89999865  3778999999999999999999999999   999999999999999999999999999976


Q ss_pred             CCCccCcCcccccccCCccCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh-
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE-  580 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  580 (669)
                      ..   ....+.++.|+.|+|||++. .+.|+.+.|+|++|||++||.+-++.|+....-++   +.............+ 
T Consensus       161 ~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq---i~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  161 RS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ---IYKICEVLGTPDKDSW  234 (538)
T ss_pred             cc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH---HHHHHHHhCCCccccc
Confidence            43   23344578899999999986 56799999999999999999999988765433222   222222211111111 


Q ss_pred             ----hcccccCCCC------C-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          581 ----LIDKSLDGSY------S-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       581 ----~~~~~~~~~~------~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                          .+...++-.+      +     .....++.+++.+|++.||++|||+.|.++.
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                1111111111      1     1245688999999999999999999999974

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=335.25  Aligned_cols=251  Identities=23%  Similarity=0.365  Sum_probs=207.6

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc----Cc-cchHHHHHHHHHHHHhC-CCceeEEEEEEecCCc
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS----SG-QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDE  420 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~  420 (669)
                      ...+|.+.+.||+|.||.|++|... +++.||||++.+.    .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4568999999999999999999854 5899999977653    22 34556778999999999 9999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-cceEEeecCCC
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMA  499 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~Dfgla  499 (669)
                      .++||||+.+|+|.+++.+   .+.+.+....+++.||+.|++|||+.+   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   566888999999999999999999999   9999999999999999 99999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGL-FS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ....  .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|..||+...                   
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------------------  227 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------------------  227 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------------------
Confidence            8763  2334455679999999999999877 76 78999999999999999999976411                   


Q ss_pred             chhhcccccCCCCC--HHH-HHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          578 SLELIDKSLDGSYS--LSE-ALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       578 ~~~~~~~~~~~~~~--~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ...+......+.+.  ... ...+..|+.+||+.||..|+++.+++ .-...
T Consensus       228 ~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~  278 (370)
T KOG0583|consen  228 VPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWF  278 (370)
T ss_pred             HHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhh
Confidence            11111112222221  112 67889999999999999999999999 44333

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-38  Score=328.58  Aligned_cols=245  Identities=19%  Similarity=0.299  Sum_probs=198.3

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCccc---hHHHHHHHHHHHHhCCCceeEEEEEEec----CCcceEEEeec
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERMLIYEYL  428 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~E~~  428 (669)
                      ..||+|++|.||+|.. +|+.||||++.......   .+.|.+|+.++.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 48999999997653333   5778899999999999999999999876    34678999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      ++|+|.+++..   ...+++...+.++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.+.... 
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999953   34689999999999999999999985 5   7899999999999999999999999988653221 


Q ss_pred             CcCcccccccCCccCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          508 EANTDRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                          ....++..|+|||++.+  ..++.++|||||||++|||++|+.|+......   .+...            ++...
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~------------i~~~~  238 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDL------------IINKN  238 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHH------------HHhcC
Confidence                12467889999999976  68999999999999999999999997532211   11110            00011


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      .....+...+..+.+++.+||+.||++|||++++++.|+..+
T Consensus       239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            111222234567889999999999999999999999998754

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-38  Score=342.18  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=202.8

Q ss_pred             hcCCCccCeeeecCccceEEEEe------CCCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  420 (669)
                      .++|++.++||+|+||.||+++.      ..+..||||++.... ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34788899999999999999973      236689999986432 23456788999999999 89999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCC----------------------------------------------------------
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTR----------------------------------------------------------  442 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  442 (669)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999854211                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          443 --------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       443 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                                    ...+++..++.++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788999999999999999999998   999999999999999999999999999865433221


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      .......++..|+|||++.+..++.++||||||+++|||++ |..|+.......  ...    +.....         ..
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~----~~~~~~---------~~  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY----KMIKEG---------YR  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH----HHHHhC---------cc
Confidence            11222345678999999999999999999999999999998 777754322110  111    111100         00


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...+...+..+.+|+.+||+.||++||++.+|+++|+.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            11111224578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-38  Score=341.09  Aligned_cols=260  Identities=28%  Similarity=0.440  Sum_probs=203.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  420 (669)
                      .++|.+.+.||+|+||.||+++..      ++..||||++.... ......+.+|+.+++.+ +|+||+++++++.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357889999999999999998842      24579999996543 23456788999999999 89999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccC-----------------------------------------------------------
Q 005933          421 RMLIYEYLPNKSLEQFIFDVT-----------------------------------------------------------  441 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  441 (669)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999985321                                                           


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCccc
Q 005933          442 --------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR  513 (669)
Q Consensus       442 --------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  513 (669)
                              ....+++.++++++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788999999999999999999998   99999999999999999999999999976533222111222


Q ss_pred             ccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCH
Q 005933          514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSL  592 (669)
Q Consensus       514 ~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (669)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.|+.......  ..             ...+........+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~-------------~~~~~~~~~~~~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF-------------YKMVKRGYQMSRPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH-------------HHHHHcccCccCCC
Confidence            345678999999999999999999999999999997 998865332211  00             01111111111111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          593 SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       593 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..+..+.+++.+||+.||++||++.+|+++|+..
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2245788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=334.18  Aligned_cols=240  Identities=28%  Similarity=0.433  Sum_probs=200.3

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCHH
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE  434 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  434 (669)
                      ++-||.|+.|.||+|++. ++.||||+++.-.       ..+|+-|++|+|+||+.+.|+|......+||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            478999999999999997 7999999885322       35788899999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccc
Q 005933          435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV  514 (669)
Q Consensus       435 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  514 (669)
                      ++|   +....+.......+..+||.||.|||.+.   |||||||.-||||+.+..+||+|||.++.....   ......
T Consensus       201 ~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF  271 (904)
T KOG4721|consen  201 EVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF  271 (904)
T ss_pred             HHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence            999   34556888899999999999999999998   999999999999999999999999999876433   223347


Q ss_pred             cccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHH
Q 005933          515 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE  594 (669)
Q Consensus       515 ~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (669)
                      .||..|||||++.+.+.++|+|||||||+||||+||..|+.-.+..    .+.     |.      +-...+.-..+..+
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AII-----wG------VGsNsL~LpvPstc  336 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AII-----WG------VGSNSLHLPVPSTC  336 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeE-----Ee------ccCCcccccCcccC
Confidence            8999999999999999999999999999999999999985421110    000     00      00111222345566


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          595 ALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       595 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +..+.-|+..||+..|..||++.+++.-|+-.
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            77888999999999999999999999998643

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-38  Score=324.53  Aligned_cols=250  Identities=33%  Similarity=0.531  Sum_probs=194.1

Q ss_pred             ccCeeeecCccceEEEEeC-----CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          354 WKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +.+.||.|.||.||+|.+.     .+..|+||.+.... ....+.|.+|+..+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999987     26789999996533 33478999999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|.++|... ....+++..++.|+.||++||.|||+.+   ++|+||+++||+|++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999654 3456899999999999999999999998   99999999999999999999999999987633322


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      ............|+|||.+....++.++||||||+++|||++ |+.|+.....   ..+...             +....
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~-------------~~~~~  222 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEK-------------LKQGQ  222 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHH-------------HHTTE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccc-------------ccccc
Confidence            222333556789999999999999999999999999999999 6677432211   111111             11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                      ....+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1112223456688999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-39  Score=307.44  Aligned_cols=235  Identities=27%  Similarity=0.352  Sum_probs=200.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|+..+.||.|+||.|.+++.+. |..+|+|++.+..   -...+...+|..+|+.+.||+++++.+.+.+.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            3578889999999999999999765 8889999997653   23456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||.+||-|..++++   .+.+++..+..+|.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+.+. 
T Consensus       123 meyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-  195 (355)
T ss_pred             EeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence            999999999999954   455899999999999999999999999   9999999999999999999999999998753 


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                          ..+-..+||+.|+|||++....+..++|.|||||++|||+.|.+||....+                   ..+...
T Consensus       196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------------------~~iY~K  252 (355)
T KOG0616|consen  196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------------------IQIYEK  252 (355)
T ss_pred             ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------------------HHHHHH
Confidence                234458999999999999999999999999999999999999999654332                   223333


Q ss_pred             ccCC--CCCHHHHHHHHHHHHHhccCCCCCC
Q 005933          585 SLDG--SYSLSEALRCIQVGLLCVQQRPEDR  613 (669)
Q Consensus       585 ~~~~--~~~~~~~~~l~~li~~cl~~dP~~R  613 (669)
                      .+.+  .++..-...+.+|+...|+.|-..|
T Consensus       253 I~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            3333  2333344567788889999998888

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.6e-39  Score=332.92  Aligned_cols=244  Identities=25%  Similarity=0.394  Sum_probs=210.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+..  +...+.+.+|+++++.|+||||+.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            47888899999999999999965 48899999997654  3456779999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+.+ +|..+|.   ..+.++++.+..++.++++||.|||++.   |+|||+||+||||+..+.+|++|||+|+.+..  
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--  152 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--  152 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence            9977 9999994   4566999999999999999999999998   99999999999999999999999999998644  


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      .........||+.|||||++.+++|+..+|.||+||+||||.+|++||-                   ...+.+++..++
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-------------------a~si~~Lv~~I~  213 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-------------------ARSITQLVKSIL  213 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-------------------HHHHHHHHHHHh
Confidence            3334456789999999999999999999999999999999999999953                   223334444444


Q ss_pred             CCC--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          587 DGS--YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       587 ~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...  .+......+.+++...|+.||..|.+..+++.
T Consensus       214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            332  23355668899999999999999999999985

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=328.37  Aligned_cols=248  Identities=24%  Similarity=0.385  Sum_probs=208.1

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..|+..+.||+|.||.||+|.... ++.||+|++.-. .+...++.+.|+.+|.+++++||.+++|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            457777999999999999999654 899999999744 556678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +.+|++.+.|   +....+++..+.-++.++..||.|||.++   .+|||||+.||||..+|.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999998   34445588888899999999999999999   99999999999999999999999999987644333


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      .  ....+||+.|||||++....|+.|+||||||++.+||.+|.+|+.-.++.....+            +.+...+.+.
T Consensus       167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~  232 (467)
T KOG0201|consen  167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLD  232 (467)
T ss_pred             c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCccc
Confidence            2  2568999999999999988999999999999999999999999665444211111            1111122222


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                          ......+.+++..||+.||+.||++.++++
T Consensus       233 ----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  233 ----GDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ----cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                233456889999999999999999999985

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1e-37  Score=322.13  Aligned_cols=257  Identities=30%  Similarity=0.502  Sum_probs=206.6

Q ss_pred             cCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......|.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468888999999999999998643      2579999986443 234567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc
Q 005933          423 LIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM  489 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~  489 (669)
                      ++|||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999864321             145889999999999999999999998   99999999999999999


Q ss_pred             ceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhH
Q 005933          490 NPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH  568 (669)
Q Consensus       490 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~  568 (669)
                      .++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..|+......   .+   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~---  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV---  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH---
Confidence            999999999986543332223334456788999999998999999999999999999998 88885432211   11   


Q ss_pred             hhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                                ...+........+...+..+.+|+.+||+.+|++||++.+|++.|+.
T Consensus       236 ----------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 ----------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ----------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                      11111111112233445788999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=319.36  Aligned_cols=274  Identities=26%  Similarity=0.371  Sum_probs=207.6

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHH--hCCCceeEEEEEEecCC----cceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVRLLGCCTLRD----ERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~l  423 (669)
                      ....+.+.||+|.||.||||.+. ++.||||++..   +..+.|++|-.|...  ++|+||+++++.-....    +.+|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34556689999999999999997 59999999854   455678888888776  48999999999876655    7899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS------RLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      |+||.++|+|.++|.    ...++|....+|+..+++||+|||+.-      +++|+|||||++||||.+++++.|+|||
T Consensus       286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999994    345899999999999999999999753      4579999999999999999999999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccC-CCC-----chhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh-
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFS-----VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-  570 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t-----~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~-  570 (669)
                      +|..+............+||.+|||||++.+. .+.     .+.||||+|.+||||++..........++.+..+.... 
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99998877666666668999999999999765 222     36899999999999999765443222222222221111 


Q ss_pred             hhcccccchh-hcccccCCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 005933          571 RLWTEDRSLE-LIDKSLDGSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ  631 (669)
Q Consensus       571 ~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  631 (669)
                      ....-+++.+ ++....++.++.     ..+.-+.+.+..||..||+.|.|+.=|.+.+....-+..
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            0111111111 112222222221     234567899999999999999999999988877655443

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=345.68  Aligned_cols=263  Identities=26%  Similarity=0.326  Sum_probs=214.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCC-cEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEE-EEecC------C
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEG-QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLG-CCTLR------D  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g-~~~~~------~  419 (669)
                      .-++++.+.|.+|||+.||.+....+ ..||+|++-..++...+...+||.+|+.|+ |+|||.+++ .....      -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            44677889999999999999998775 999999998778888999999999999997 999999999 33221      3


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      +.+|+||||.+|+|-++|....+.. |++.++++|+.|+++|+++||... ++|||||||-+||||+.+++.||||||.|
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            5789999999999999997655555 999999999999999999999986 67999999999999999999999999998


Q ss_pred             cccCCCccCc-Cc------ccccccCCccCchhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh
Q 005933          500 RAFGVDQTEA-NT------DRVVGTYGYMSPEYA---IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  569 (669)
Q Consensus       500 ~~~~~~~~~~-~~------~~~~gt~~y~aPE~~---~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~  569 (669)
                      .-........ ..      -...-|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+...           
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-----------  262 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-----------  262 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence            7543222111 10      013358999999987   56789999999999999999999999976432           


Q ss_pred             hhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 005933          570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP  632 (669)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p  632 (669)
                              ...++.....-+........+.+||..||++||++||++.+|+..+-.+...+.|
T Consensus       263 --------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  263 --------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             --------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                    2223333332233346778899999999999999999999999988776554443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.1e-38  Score=325.85  Aligned_cols=254  Identities=23%  Similarity=0.293  Sum_probs=205.4

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ..++|++++.||+|+||.||+++-++ |..+|+|++++..   ....+..++|-.+|....+|.||+|+-.|.+.+.++|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45789999999999999999999665 9999999998763   4566788899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||++||++..+|   .+.+.|++.....++.+++.|+..||++|   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999   46677999999999999999999999999   9999999999999999999999999985331


Q ss_pred             CC----------------------ccCc----C-------------------cccccccCCccCchhhccCCCCchhhHH
Q 005933          504 VD----------------------QTEA----N-------------------TDRVVGTYGYMSPEYAIDGLFSVKSDVF  538 (669)
Q Consensus       504 ~~----------------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~t~~sDVw  538 (669)
                      ..                      ....    .                   ....+||+.|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                      0000    0                   0125699999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---
Q 005933          539 SFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN---  615 (669)
Q Consensus       539 S~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---  615 (669)
                      |||||+||||.|.+||....+.....-+......             +..+.......+..+||.+||. ||++|..   
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            9999999999999998765554332111111111             1111122223677899999998 9999976   


Q ss_pred             HHHHHH
Q 005933          616 MSSVVL  621 (669)
Q Consensus       616 ~~evl~  621 (669)
                      ++||-+
T Consensus       439 ~~EIK~  444 (550)
T KOG0605|consen  439 AEEIKK  444 (550)
T ss_pred             HHHHhc
Confidence            555543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.9e-38  Score=319.41  Aligned_cols=256  Identities=25%  Similarity=0.367  Sum_probs=202.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC----CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.+..... .....|.+|+.++..++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999864    367899999875432 335678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999998542  346899999999999999999999998   9999999999999999999999999876532


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+......   ..+...             
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~-------------  221 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAV-------------  221 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH-------------
Confidence            2111 11112334678999999999999999999999999999775 98886432211   111110             


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ........+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            00001112223456788999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-37  Score=320.35  Aligned_cols=259  Identities=26%  Similarity=0.417  Sum_probs=203.2

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      .+++|++.++||+|+||.||+|...      .+..||||++.... .....+|.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999853      25679999986432 2345578999999999999999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTR-------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                      .++||||+++++|.+++.....       ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999864322       234678899999999999999999988   999999999999999999999


Q ss_pred             eecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhh
Q 005933          494 SDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       494 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      +|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+......   ....    .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----F  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H
Confidence            99999876543322222222345778999999998899999999999999999999 67775432111   1110    0


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ......         ...+...+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            000000         01122234568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-37  Score=320.72  Aligned_cols=257  Identities=29%  Similarity=0.455  Sum_probs=205.9

Q ss_pred             cCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      ++|.+.+.||+|+||.||+|...+      ++.||||.+...... ..+.+.+|++++..++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            467888999999999999998643      478999998765444 4678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          423 LIYEYLPNKSLEQFIFDVT-----------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      +||||+++++|.+++....           ....+++..+..++.||+.||+|||+.+   ++|+||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999996432           2345789999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~  570 (669)
                      +|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+......   .....  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~--  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC--  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH--
Confidence            9999999976533222222223345788999999999999999999999999999998 98885422111   11111  


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                                 +........+...+..+.+++.+||+.+|++||++.||++.|+.
T Consensus       237 -----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 -----------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -----------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                       00001111122344678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=315.04  Aligned_cols=255  Identities=29%  Similarity=0.466  Sum_probs=205.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|++.+.||+|++|.||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688899999999999999998888899999986533 34678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999995433 345899999999999999999999998   999999999999999999999999999876422111


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       .......+..|+|||++.+..++.++||||||++++||++ |+.|+......   ....             .+.....
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~-------------~~~~~~~  222 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ-------------QVDQGYR  222 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH-------------HHHcCCC
Confidence             1111223467999999999999999999999999999999 88875422111   1110             0011101


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            11122334678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-37  Score=317.93  Aligned_cols=256  Identities=28%  Similarity=0.473  Sum_probs=210.8

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ...+|++.++||.|+||.||+|...+++.+|+|.+..........+..|+.+++.++|+||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34578889999999999999999988999999999776655677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++.+. ....+++..+..++.||++||.|||+.+   ++|+||+|+||+|++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999653 3345899999999999999999999998   99999999999999999999999999987543221


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      .  .....++..|+|||.+.+..++.++||||||+++++|++ |+.|+......   ..+..             +....
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~-------------~~~~~  221 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQ-------------ITAGY  221 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH-------------HHhCC
Confidence            1  112345678999999998899999999999999999998 78886432211   11111             11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            112233445678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-37  Score=316.41  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=206.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            3578899999999999999999888889999998543 334678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999998643 3345889999999999999999999988   999999999999999999999999999876432221


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       ......++..|+|||++....++.++||||||+++|+|++ |..|+......   ........             ...
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~-------------~~~  222 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQR-------------GYR  222 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHc-------------CCC
Confidence             1122345678999999998899999999999999999998 88886432111   11111100             000


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      .......+..+.+++.+||+.+|++||++++++++|+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11111234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2e-37  Score=315.10  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=202.1

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|++.+.||+|+||.||++.++++..+|+|.+... ....+.|.+|+.+++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457888999999999999999988889999988533 3345788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +|+|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999998542  235899999999999999999999998   999999999999999999999999998765322211 


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+.....   ...+......    .         ..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~----~---------~~  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRG----F---------RL  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCC----C---------CC
Confidence            1122345568999999988899999999999999999999 8888543221   1111111000    0         00


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            011112356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-37  Score=334.41  Aligned_cols=260  Identities=27%  Similarity=0.386  Sum_probs=204.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccCc-cchHHHHHHHHHHHHhC-CCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~  420 (669)
                      .++|.+.++||+|+||.||+|+...      +..||||++..... ...+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            4688899999999999999998531      34799999965433 33567999999999996 9999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCC----------------------------------------------------------
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTR----------------------------------------------------------  442 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  442 (669)
                      .+|||||+++|+|.++|.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998864210                                                          


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC
Q 005933          443 -----------------------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN  487 (669)
Q Consensus       443 -----------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~  487 (669)
                                                         ...+++..++.++.||++||.|||+.+   ++|+||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               124788889999999999999999998   999999999999999


Q ss_pred             CcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchh
Q 005933          488 DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLL  566 (669)
Q Consensus       488 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~  566 (669)
                      ++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.  ...
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence            99999999999986543322222223456788999999999999999999999999999997 888754321110  000


Q ss_pred             hHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          567 GHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                          .         .+........+...+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus       351 ----~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         351 ----N---------KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             ----H---------HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence                0         0000011111223356788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-37  Score=325.92  Aligned_cols=257  Identities=25%  Similarity=0.444  Sum_probs=202.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCc----EEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQ----EIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .+|++.+.||+|+||.||+|++. +++    .||||.+.... ....+++.+|+.+++.++||||++++|++... ...+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999864 333    48999986543 34467899999999999999999999999764 5789


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998542  345889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .............+..|+|||++.+..++.++||||||+++|||++ |+.|+......   .+.             ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~-------------~~~  224 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS-------------SIL  224 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH-------------HHH
Confidence            4332222222334678999999999999999999999999999997 88886432111   000             011


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ........+......+.+++.+||+.+|.+||++.+++..|.....
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         225 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            1111111122234567899999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.3e-37  Score=327.12  Aligned_cols=265  Identities=23%  Similarity=0.304  Sum_probs=203.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999976 48889999986543 2345679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999999853   345899999999999999999999853  3999999999999999999999999998765322 


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhh---------------
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR---------------  571 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~---------------  571 (669)
                         ......++..|+|||++.+..++.++|||||||++|||++|+.|+...........+.....               
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence               22335689999999999999999999999999999999999999754322111000000000               


Q ss_pred             ------------hcccccchhhcccccCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          572 ------------LWTEDRSLELIDKSLDGS----YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       572 ------------~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                                  ........++.+......    ........+.+|+.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                        000000000111111100    011234578899999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3e-37  Score=318.71  Aligned_cols=257  Identities=30%  Similarity=0.457  Sum_probs=203.2

Q ss_pred             cCCCccCeeeecCccceEEEEe-----CCCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|++.++||+|+||.||+|.+     ..+..||+|.+.... ......|.+|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4677889999999999999984     246789999986433 3345688999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc
Q 005933          424 IYEYLPNKSLEQFIFDVTR--------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM  489 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~  489 (669)
                      ||||+++++|.+++.....              ...+++.+++.++.|++.||.|||+.+   ++|+||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999853211              234789999999999999999999998   99999999999999999


Q ss_pred             ceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhH
Q 005933          490 NPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH  568 (669)
Q Consensus       490 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~  568 (669)
                      .+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+......   .+.  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~--  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVI--  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence            999999999987543332222333445678999999988889999999999999999998 87775422110   111  


Q ss_pred             hhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                                 +.+........+...+..+.+++.+||+.+|.+||++.+|++.|..
T Consensus       237 -----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 -----------EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -----------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                       1111111111122234578899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=298.56  Aligned_cols=265  Identities=23%  Similarity=0.277  Sum_probs=212.3

Q ss_pred             HhcCCCccCeeeecCccceEEEE-eCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-----cc
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----ER  421 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~  421 (669)
                      ..++|.+.++||+|||+-||.++ +.++..+|+|++.....++.+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35689999999999999999999 6678999999998777788899999999999999999999999875544     38


Q ss_pred             eEEEeecCCCCHHHHhhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      +|+++|...|||.+.+......+ .+++.+++.|+.+|++||++||+..+ +++||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999997655444 79999999999999999999999874 79999999999999999999999999987


Q ss_pred             ccCCCccCcC-------cccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          501 AFGVDQTEAN-------TDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       501 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      .....-....       -.....|..|.|||.+.   +...++++|||||||+||+|+.|..||+.......        
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg--------  249 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG--------  249 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--------
Confidence            6422111100       11245689999999884   45688999999999999999999999764222110        


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                           .-...+....+.-+.....+..+.+++.+|++.||.+||++.+++..++.+
T Consensus       250 -----SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  250 -----SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -----eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                 001111111111112223567889999999999999999999999998764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.6e-37  Score=369.00  Aligned_cols=263  Identities=24%  Similarity=0.437  Sum_probs=209.7

Q ss_pred             HhcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ....+...+.||+|+||.||+|+. .++..||||++.....    ....|++++++++|||||+++|+|.+.+..++|||
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            345677788999999999999997 4689999999864332    12356889999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++|+|.+++.      .++|.++.+++.|||+||+|||.....+|+||||||+||+++.++.+++. |+.......  
T Consensus       764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            999999999994      28999999999999999999997655669999999999999999888875 665543211  


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                          .....++..|+|||++.+..++.++|||||||++|||++|+.|++.... ....+..+.............+++.+
T Consensus       835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence                1123678899999999999999999999999999999999999743222 22334444444343334444555555


Q ss_pred             CC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          587 DG--SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       587 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ..  ..+..+...+.+++.+||+.+|++||+|+||++.|+....
T Consensus       910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            33  2345666788999999999999999999999999987644

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=331.39  Aligned_cols=253  Identities=21%  Similarity=0.340  Sum_probs=203.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||.||+|+... ++.||||++.+..   ......+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            368899999999999999999764 8999999997542   234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999943   345899999999999999999999998   99999999999999999999999999976432 


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                          ......|+..|+|||++.+..++.++|||||||++|||++|..|+........   .... ..+.     ..+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i-~~~~-----~~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---WENL-KYWK-----ETLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---HHHH-Hhcc-----ccccCC
Confidence                22345789999999999999999999999999999999999999754322111   1000 0000     000000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ............+.+++.+||+.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000011234567899999999999999999999964

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=325.11  Aligned_cols=245  Identities=21%  Similarity=0.259  Sum_probs=199.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||.||++... +++.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999976 58999999986432   234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999843   345899999999999999999999998   999999999999999999999999998765321


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.|+......   .+...            +....
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~------------i~~~~  214 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEK------------ILAGK  214 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH------------HHhCC
Confidence                 22356899999999999989999999999999999999999996532211   00100            00000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVLM  622 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  622 (669)
                      .  .++......+.+++.+||+.||.+||+     ++++++.
T Consensus       215 ~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 L--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             c--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            1  112222456789999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-38  Score=331.27  Aligned_cols=254  Identities=27%  Similarity=0.390  Sum_probs=213.7

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      -|.+++.||.|+.|.|-+|++. +|+.+|||++.+.   .......+.+|+.+|+.+.|||++++++++++..+++||.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            4677899999999999999964 5999999999765   23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++|-|.++|   .+.+.+++.+..+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|..-   .
T Consensus        93 yv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe---~  163 (786)
T KOG0588|consen   93 YVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE---V  163 (786)
T ss_pred             ecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---c
Confidence            99999999999   45677999999999999999999999999   999999999999999999999999999763   2


Q ss_pred             cCcCcccccccCCccCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      ........+|.+.|.|||++++.+|. .++||||.|||||.|++|+.||+                   .+.+..++.+.
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-------------------DdNir~LLlKV  224 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-------------------DDNIRVLLLKV  224 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-------------------CccHHHHHHHH
Confidence            23334457899999999999999875 68999999999999999999965                   22333444444


Q ss_pred             cCCCCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HhcCCCCCCCC
Q 005933          586 LDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGERSLPQP  632 (669)
Q Consensus       586 ~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~p  632 (669)
                      -.+.+.  -..+.++.+|+.+|+..||+.|.|++||++  .|.+...++.+
T Consensus       225 ~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  225 QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            444333  334568899999999999999999999997  45555554443

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=331.08  Aligned_cols=242  Identities=26%  Similarity=0.383  Sum_probs=208.2

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcc
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDER  421 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~  421 (669)
                      ...++|.+.++||+|+||.|+++..+. ++.+|||.+++.   .++..+..+.|..++.... ||.|+.++.+|...+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            345789999999999999999999765 889999999876   3566788899999988885 99999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+.||++..+    .+...+++..+..++..|+.||+|||+++   |||||||.+|||||.+|.+||+|||+++.
T Consensus       445 ~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            999999999994333    34566999999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      --  .....+...+||+.|||||++.+..|+.++|.|||||+||||+.|+.||...                   +..++
T Consensus       518 ~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-------------------dEee~  576 (694)
T KOG0694|consen  518 GM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-------------------DEEEV  576 (694)
T ss_pred             cC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-------------------CHHHH
Confidence            32  1334566789999999999999999999999999999999999999996543                   33345


Q ss_pred             cccccCC--CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 005933          582 IDKSLDG--SYSLSEALRCIQVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       582 ~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~  616 (669)
                      .+..+..  .++.-.+.+.+.|+.++|..+|++|..+
T Consensus       577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            5555543  3455566788999999999999999876

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.7e-37  Score=320.08  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=206.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|+.++.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46888899999999999999842      245689999876665667789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          424 IYEYLPNKSLEQFIFDVT----------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                      ||||+++++|.+++....          +...+++..++.++.||+.||+|||+.+   ++||||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999986432          2235899999999999999999999998   999999999999999999999


Q ss_pred             eecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhh
Q 005933          494 SDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       494 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      +|||++................++..|+|||++.+..++.++||||||++++||++ |..|+......   .....    
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~----  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIEC----  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----
Confidence            99999986543322222233445778999999998899999999999999999998 88875432211   01100    


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ......         ...+...+..+.+|+.+||+.+|.+||++.+|+..|+...
T Consensus       235 i~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         235 ITQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            000000         0111123356889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-37  Score=315.15  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=204.6

Q ss_pred             cCCCccCeeeecCccceEEEEeCC----CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|++.+.||+|+||.||+|.+..    ...||||.+.... ......|.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578889999999999999999753    4579999986543 33456789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||++..+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999998542  346899999999999999999999988   99999999999999999999999999987642


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..|+......   ......             .
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~-------------~  222 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV-------------E  222 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH-------------H
Confidence            222222222344678999999998899999999999999999998 88775322111   111000             0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .......+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       223 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0001111223356788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-37  Score=320.49  Aligned_cols=260  Identities=28%  Similarity=0.438  Sum_probs=208.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .+|.+.+.||+|+||.||++...      ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35778899999999999999843      355699999876655556789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc
Q 005933          424 IYEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN  490 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~  490 (669)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999996432             1235899999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHh
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA  569 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~  569 (669)
                      ++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+.......   ...  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~--  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE--  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence            99999999976543332222333456788999999999999999999999999999998 888854322211   111  


Q ss_pred             hhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                        ........         ..+...+..+.+++.+||+.+|++||++.+|+++|+....
T Consensus       237 --~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 --CITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             --HHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence              11111100         1112234578899999999999999999999999988744

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-37  Score=318.60  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=199.3

Q ss_pred             CCccCeeeecCccceEEEEe-CCCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          352 FSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      |.+.+.||+|+||.||++.. .+++.||||.+.+..   ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66789999999999999996 468999999986432   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|..++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.++|+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999998885432 335899999999999999999999998   9999999999999999999999999998653221 


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.|+...........+   ...        +..  ..
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~--------~~~--~~  221 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRR--------VKE--DQ  221 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHH--------hhc--cc
Confidence              123356899999999999999999999999999999999999997643221110000   000        000  00


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      ...+...+..+.+|+.+||+.||++||+     ++++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            1122223456789999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.4e-37  Score=313.99  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=204.5

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .+|.+.++||+|++|.||+|...+ ++.||+|.+... .....++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            357788999999999999999754 889999998643 344678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++... ....+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999998543 2345899999999999999999999988   999999999999999999999999999876432221


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      . ......+..|+|||.+.+..++.++||||||+++|||++ |..|+.....+   ..    +..         +.....
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~----~~~---------~~~~~~  223 (263)
T cd05052         161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QV----YEL---------LEKGYR  223 (263)
T ss_pred             c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHH---------HHCCCC
Confidence            1 112234568999999999999999999999999999998 88886432211   11    111         111111


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...+...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            12222344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-37  Score=320.61  Aligned_cols=265  Identities=21%  Similarity=0.267  Sum_probs=200.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.+.||+|+||.||+++.+ +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999976 48899999986542  3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|..+..   ....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2345899999999999999999999998   9999999999999999999999999998753322


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh--------hhhc-cccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WRLW-TEDR  577 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~--------~~~~-~~~~  577 (669)
                      . .......++..|+|||++.+..++.++|||||||++|||++|+.|+...........+...        ...+ ....
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 1223356899999999999989999999999999999999999987643221110000000        0000 0000


Q ss_pred             chhhcccccCCCC------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLELIDKSLDGSY------SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ......+......      ....+..+.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000000      0112346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.3e-37  Score=319.37  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=198.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|.+.++||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56889999999999999999965 58999999986443 23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++ +|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            975 898888532  345789999999999999999999998   9999999999999999999999999987643221 


Q ss_pred             CcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh-----hhcccccc---
Q 005933          508 EANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-----RLWTEDRS---  578 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~---  578 (669)
                       .......++..|+|||++.+ ..++.++|||||||++|||++|++|+...........+....     ..+.....   
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence             12233567899999999875 568999999999999999999999976433221111110000     00000000   


Q ss_pred             -hhhcccccCCCC----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 -LELIDKSLDGSY----SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 -~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       .....+......    .......+.+++.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             000000000000    0112346789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=341.67  Aligned_cols=252  Identities=17%  Similarity=0.217  Sum_probs=203.3

Q ss_pred             CCCccCeeeecCccceEEEEeCC--CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .|.+.+.||+|+||.||++....  ++.||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            48888999999999999998543  6788999875555455567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          429 PNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       429 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      ++|+|.+++... .....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988643 33456899999999999999999999998   99999999999999999999999999987643332


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+......   .+..            .+..... 
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~------------~~~~~~~-  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQ------------QVLYGKY-  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH------------HHHhCCC-
Confidence            22334467899999999999999999999999999999999999996432110   0000            0000000 


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...+...+..+.+++.+||+.+|++||++.+++.
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            0112223457889999999999999999999874

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.7e-37  Score=310.94  Aligned_cols=248  Identities=27%  Similarity=0.396  Sum_probs=196.8

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      ++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999975 58999999876443 33456799999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCccc
Q 005933          434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR  513 (669)
Q Consensus       434 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  513 (669)
                      .+++..  ....+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999853  2345899999999999999999999998   99999999999999999999999999876432211111111


Q ss_pred             ccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCH
Q 005933          514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSL  592 (669)
Q Consensus       514 ~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (669)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..|+.......                ....+........+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----------------TREAIEQGVRLPCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----------------HHHHHHcCCCCCCcc
Confidence            223457999999999999999999999999999998 777754221110                011111111112222


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          593 SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       593 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..+..+.+++.+||+.+|++||++.+|+++|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            33457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.3e-37  Score=316.46  Aligned_cols=271  Identities=26%  Similarity=0.420  Sum_probs=202.4

Q ss_pred             cCCCccCeeeecCccceEEEEeC-----CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecC--Ccce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~  422 (669)
                      .+|.+.+.||+|+||.||++...     ++..||||++........+.+.+|+.+++.++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            47888899999999999999843     4789999999766666677899999999999999999999987543  4578


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +|+||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++..+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998532  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccCcC-cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhh-hcccccchh
Q 005933          503 GVDQTEAN-TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR-LWTEDRSLE  580 (669)
Q Consensus       503 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  580 (669)
                      ........ .....++..|+|||++.+..++.++||||||++++||++|..+......... ........ ........+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhcccccccccchHHHHH
Confidence            43222111 1112234569999999988999999999999999999998765321110000 00000000 000000011


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .+........+...+..+.+|+.+||+.+|++|||+.+|+..|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111111111223345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-37  Score=328.95  Aligned_cols=244  Identities=23%  Similarity=0.266  Sum_probs=199.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|.+.+.||+|+||.||++... +++.||||++.+..   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999976 48999999986532   234567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++......
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999853   345889999999999999999999998   999999999999999999999999999865322


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.|+......   ...    ..        +....
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~----~~--------i~~~~  231 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIY----EK--------ILAGR  231 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHH----HH--------HhcCC
Confidence                 12356899999999999999999999999999999999999996432110   000    00        00111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      +  ..+......+.+++.+||+.||.+||+     +++++.
T Consensus       232 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        232 L--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             c--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1  111122346789999999999999997     677764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-37  Score=327.00  Aligned_cols=241  Identities=23%  Similarity=0.296  Sum_probs=195.2

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      +.||+|+||.||++... +|+.||||++.+..   ......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999965 58999999987532   234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCc
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT  511 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  511 (669)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99998843   456899999999999999999999998   999999999999999999999999998753211  1222


Q ss_pred             ccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCC
Q 005933          512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS  591 (669)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (669)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.|+......   .....            +....  ..++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~------------~~~~~--~~~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL------------ILMEE--IRFP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHH------------HHcCC--CCCC
Confidence            3457899999999999999999999999999999999999996422111   00000            00000  1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          592 LSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       592 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      ......+.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            23345688999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=327.10  Aligned_cols=254  Identities=28%  Similarity=0.428  Sum_probs=212.1

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .+..+.++||.|.+|.||.|+|+. .-.||||.++ .+....++|+.|..+|+.++|||+|+|+|+|+.+..++||+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            456677999999999999999976 6789999995 45567899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ..|+|.++|.+..+ ..++.-..+.+|.||+.||.||...+   +|||||.++|.||.++..+||+|||+++++..+...
T Consensus       346 ~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             cCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence            99999999976543 44777888999999999999999998   999999999999999999999999999987554433


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      .. ....-++.|.|||-+.-..++.|+|||+|||+||||.| |..|++..+                .....+++.....
T Consensus       422 AH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----------------lSqVY~LLEkgyR  484 (1157)
T KOG4278|consen  422 AH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVYGLLEKGYR  484 (1157)
T ss_pred             cc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----------------HHHHHHHHhcccc
Confidence            22 22334678999999999999999999999999999998 555543211                1122333333333


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      -..+..++..+.+||++||+.+|.+||++.|+-+.++.
T Consensus       485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            34455678899999999999999999999999887763

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=315.07  Aligned_cols=267  Identities=26%  Similarity=0.396  Sum_probs=212.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--------------cchHHHHHHHHHHHHhCCCceeEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--------------QGVEEFKNEVLLIAKLQHRNLVRLL  412 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~  412 (669)
                      ..++|++.+.||+|.||.|-+|... +++.||||++.+...              ...+...+||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4578999999999999999999954 589999999965311              1245788999999999999999999


Q ss_pred             EEEecC--CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc
Q 005933          413 GCCTLR--DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN  490 (669)
Q Consensus       413 g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~  490 (669)
                      .+..++  +..+||+||+..|.+...=   .....+++.++.+++++++.||+|||.++   ||||||||+|+||+++|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence            998665  5689999999998876543   22223899999999999999999999999   999999999999999999


Q ss_pred             eEEeecCCCcccCCC---ccCcCcccccccCCccCchhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 005933          491 PKISDFGMARAFGVD---QTEANTDRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH  563 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~  563 (669)
                      +||+|||.+..+...   .........+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-        
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~--------  320 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF--------  320 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc--------
Confidence            999999998876322   1122233478999999999998743    3568999999999999999999943        


Q ss_pred             chhhHhhhhcccccchhhcccccCCCC----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC--CCCCCCCCCc
Q 005933          564 NLLGHAWRLWTEDRSLELIDKSLDGSY----SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER--SLPQPKQPGF  637 (669)
Q Consensus       564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~--~~~~p~~p~~  637 (669)
                                 .+...++.++.++...    ..+....+.+|++++|+.||+.|.+..+|.....-..  .-+.+.+|..
T Consensus       321 -----------~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~  389 (576)
T KOG0585|consen  321 -----------DDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPSS  389 (576)
T ss_pred             -----------cchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCccc
Confidence                       3344455555554432    2234568889999999999999999999987765543  3445556655


Q ss_pred             cc
Q 005933          638 FT  639 (669)
Q Consensus       638 ~~  639 (669)
                      +.
T Consensus       390 c~  391 (576)
T KOG0585|consen  390 CS  391 (576)
T ss_pred             ce
Confidence            54

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.2e-37  Score=311.19  Aligned_cols=252  Identities=26%  Similarity=0.437  Sum_probs=202.0

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|.+.+.||+|+||.||+|...++..+|||.+... ....+.|.+|+.++.+++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            457788999999999999999877778999988643 3345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999998543  235899999999999999999999998   999999999999999999999999998765332211 


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......   ......             ......
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~-------------~~~~~~  220 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV-------------SQGLRL  220 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH-------------hcCCCC
Confidence            1122345678999999998889999999999999999998 88886432211   011000             000000


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..+...+..+.+++.+||+.+|.+||++.+|+..|+
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            111123467889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-37  Score=310.81  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=202.0

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      .+|++.+.||+|+||.||++..+++..+|+|.+.+.. .....|.+|+.+++.++|+||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3577889999999999999998877889999985432 344678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++....... .
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~  156 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T  156 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence            99999998542  236899999999999999999999998   99999999999999999999999999876532211 1


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   .....             +......
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~-------------~~~~~~~  220 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVES-------------VSAGYRL  220 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHH-------------HHcCCcC
Confidence            1112234567999999999999999999999999999999 78776432211   11100             1111111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            122234567889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=324.40  Aligned_cols=240  Identities=20%  Similarity=0.283  Sum_probs=192.0

Q ss_pred             eeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      ||+|+||.||++...+ ++.||+|++.+.   .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999999764 889999998653   234456788999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCccc
Q 005933          434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR  513 (669)
Q Consensus       434 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  513 (669)
                      .+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            999853   345899999999999999999999998   9999999999999999999999999987532211  22334


Q ss_pred             ccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHH
Q 005933          514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS  593 (669)
Q Consensus       514 ~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (669)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.|+......   ...   ..         ......  ..+..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~---~~---------~~~~~~--~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMY---RK---------ILQEPL--RFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHH---HH---------HHcCCC--CCCCc
Confidence            57899999999999999999999999999999999999996532110   000   00         000000  12222


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          594 EALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       594 ~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ....+.+++.+||+.||++||++.++.+.
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~  244 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEI  244 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence            34567899999999999999865433333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.3e-37  Score=324.89  Aligned_cols=260  Identities=28%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeEEEEEEecC-C
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR-D  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~  419 (669)
                      .++|++.+.||+|+||.||+|...      .++.||+|++..... ...+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357889999999999999999742      257899999865432 3346788899999999 899999999988654 5


Q ss_pred             cceEEEeecCCCCHHHHhhccCC---------------------------------------------------------
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTR---------------------------------------------------------  442 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  442 (669)
                      ..++++||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999999853221                                                         


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCcc
Q 005933          443 -TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM  521 (669)
Q Consensus       443 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  521 (669)
                       ...+++..+.+++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125899999999999999999999998   9999999999999999999999999998764333222233345677899


Q ss_pred             CchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHH
Q 005933          522 SPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQ  600 (669)
Q Consensus       522 aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  600 (669)
                      |||++.+..++.++|||||||+||||++ |..|+.......   ..   ...         +........+......+.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~---~~~---------~~~~~~~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EF---CRR---------LKEGTRMRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HH---HHH---------HhccCCCCCCccCCHHHHH
Confidence            9999999999999999999999999998 888864321110   00   000         0000111112223457889


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          601 VGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       601 li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ++.+||+.+|++||++.++++.|+..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.2e-38  Score=324.53  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=212.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc-ceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-RMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~  425 (669)
                      ++|...+++|+|+||.++..+.+ ++..+|+|.+.-.  .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999998865 4788999988643  44456688999999999999999999999999999 99999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      +|++||+|.+.|.+.+ ...+++..+..++.||+.|+.|||+..   |+|||||+.|||++.+..+||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999996543 567899999999999999999999877   999999999999999999999999999987654


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .  ......+||+.||.||++.+.+|..|+|||||||++|||++-+++|...+                   ...++-..
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-------------------m~~Li~ki  218 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-------------------MSELILKI  218 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-------------------hHHHHHHH
Confidence            4  23445799999999999999999999999999999999999998865432                   22222222


Q ss_pred             cC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          586 LD---GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       586 ~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ..   .+.+......+..++..|++.+|+.||++.+++..
T Consensus       219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            22   23455567789999999999999999999999975

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-36  Score=313.42  Aligned_cols=257  Identities=30%  Similarity=0.467  Sum_probs=202.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      +++|.+.+.||+|++|.||+|.+.+      +..||+|.+.... ......|..|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678899999999999999999753      5679999886443 23346789999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc---ceEEe
Q 005933          422 MLIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKIS  494 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~  494 (669)
                      ++||||+++++|.+++.....    ...+++..+++++.||+.||+|||+.+   ++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865321    235899999999999999999999998   99999999999998754   59999


Q ss_pred             ecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhc
Q 005933          495 DFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       495 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      |||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..|+......   .+.       
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~-------  231 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVM-------  231 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH-------
Confidence            9999987633222111222334568999999999999999999999999999997 88876532211   111       


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                            +.+........+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       232 ------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 ------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                  111111111222333467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.7e-37  Score=322.86  Aligned_cols=264  Identities=22%  Similarity=0.316  Sum_probs=201.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999976 48889999886543 2345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||+.+  .++|+||||+|||++.++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999853   345889999999999999999999752  2999999999999999999999999998764221 


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh--------------
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL--------------  572 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~--------------  572 (669)
                         ......++..|+|||++.+..++.++|||||||++|||++|+.|+..................              
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence               122356889999999999889999999999999999999999997643221110000000000              


Q ss_pred             ------ccc-----ccchhhcccccCCC---CC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 ------WTE-----DRSLELIDKSLDGS---YS-LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ------~~~-----~~~~~~~~~~~~~~---~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                            ...     .....+.+......   .+ ......+.+|+.+||+.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                  000     00000111111110   00 012346789999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-36  Score=315.63  Aligned_cols=257  Identities=27%  Similarity=0.430  Sum_probs=203.3

Q ss_pred             CCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... ....++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      235789998865432 335678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCC
Q 005933          424 IYEYLPNKSLEQFIFDVT---------------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN  482 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~N  482 (669)
                      |+||+.+++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999985421                     1235889999999999999999999988   9999999999


Q ss_pred             EEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005933          483 VLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH  561 (669)
Q Consensus       483 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~  561 (669)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+....+. 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986533322222223345678999999988899999999999999999998 88886432111 


Q ss_pred             ccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                        .+.             +.+........+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       237 --~~~-------------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         237 --RLF-------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             --HHH-------------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence              111             11111111112223345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.5e-37  Score=315.37  Aligned_cols=257  Identities=27%  Similarity=0.425  Sum_probs=203.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      +++.+.++||+|+||.||++...      ++..+|+|.+..........|.+|+.+++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999742      356899999876666667789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          424 IYEYLPNKSLEQFIFDVTR------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      ||||+++++|.+++.....            ...+++..++.++.||+.||+|||+.+   ++|+||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            134889999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~  570 (669)
                      ||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |.+|+......   ...    
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAI----  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHH----
Confidence            9999999876533222122222345678999999999999999999999999999998 88775321111   000    


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                               ...........+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       235 ---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         235 ---------ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ---------HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                     0000000011112234567899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.3e-37  Score=316.82  Aligned_cols=256  Identities=29%  Similarity=0.448  Sum_probs=202.1

Q ss_pred             CCCccCeeeecCccceEEEEeCC------CcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      +|.+.++||+|+||.||+|...+      ++.||||++...... ..+.+..|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46677899999999999998642      578999999754332 34678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc
Q 005933          424 IYEYLPNKSLEQFIFDV-------------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN  490 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~  490 (669)
                      ++||+.+++|.+++...             .....+++..+..++.|++.||.|||+.+   ++||||||.||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999998421             11235888999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHh
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA  569 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~  569 (669)
                      +||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......   ...   
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~---  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVI---  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---
Confidence            99999999886543322222233455778999999998899999999999999999998 76664422111   111   


Q ss_pred             hhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                                +.+........+...+..+.+++..||+.+|++||++++|++.|+.
T Consensus       237 ----------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 ----------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                      1111111112223345668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=311.42  Aligned_cols=256  Identities=25%  Similarity=0.384  Sum_probs=201.0

Q ss_pred             CCccCeeeecCccceEEEEeCC----CcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc-----
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-----  420 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----  420 (669)
                      |.+.+.||+|+||.||+|....    +..||||++....  ......+.+|+..++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999999643    3679999986532  2345689999999999999999999999876554     


Q ss_pred             -ceEEEeecCCCCHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeec
Q 005933          421 -RMLIYEYLPNKSLEQFIFDVT---RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF  496 (669)
Q Consensus       421 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  496 (669)
                       .++|+||+++++|..++....   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999999985432   2346899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhccc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      |+++................+..|+|||.+.+..++.++||||||+++|||++ |..|+.....   ..+....      
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~------  228 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL------  228 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH------
Confidence            99987643332222222344678999999988899999999999999999999 7777543211   1111111      


Q ss_pred             ccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                             ........+...+..+.+++.+||+.||++||++.+|+..|+..
T Consensus       229 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 -------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   00001112223445788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-36  Score=313.78  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=200.2

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCc----EEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQ----EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|.+..... ....++..|+.+++.++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46788899999999999999964 344    478887754322 33467888898999999999999999875 456789


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ++||+++|+|.+++..  ....+++..+..++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999954  2345899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..|+........                .+++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------------~~~~  224 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV----------------PDLL  224 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHH
Confidence            3332223334556788999999998999999999999999999998 8888643221110                0111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ........+...+..+.+++.+||+.+|++||++.|+++.|.....
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         225 EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1000001111123467789999999999999999999999977543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.6e-37  Score=339.14  Aligned_cols=258  Identities=21%  Similarity=0.287  Sum_probs=205.3

Q ss_pred             HHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCC---
Q 005933          346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD---  419 (669)
Q Consensus       346 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---  419 (669)
                      ....++|.+.+.||+|+||+||++... +++.||||++...  .......+.+|+.++..++|+|++++...+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            334579999999999999999999854 5899999998654  2344567889999999999999999988775433   


Q ss_pred             -----cceEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          420 -----ERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       420 -----~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                           ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+   |+||||||+||||+.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 257999999999999998643 23456899999999999999999999998   999999999999999999999


Q ss_pred             eecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          494 SDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       494 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+......   .+..   .  
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~---~--  256 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMH---K--  256 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHH---H--
Confidence            9999998765433333334567899999999999999999999999999999999999996532110   0000   0  


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                             ..... ....+...+..+.+++.+||+.+|++||++.+++..
T Consensus       257 -------~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 -------TLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -------HhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                   00000 011222344678899999999999999999999863

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.5e-37  Score=316.97  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=206.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD  419 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  419 (669)
                      ..++|++.+.||+|+||.||++....      ...+|+|.+.... .....++.+|+.++..+ +|+||+++++++...+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34578888999999999999998642      3679999987532 23456788999999999 7999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc
Q 005933          420 ERMLIYEYLPNKSLEQFIFDV-------------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD  486 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~  486 (669)
                      ..++||||+++|+|..++...             .....+++..++.++.||+.||.|||+.+   |+|+||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998542             22356899999999999999999999988   99999999999999


Q ss_pred             CCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccch
Q 005933          487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNL  565 (669)
Q Consensus       487 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~  565 (669)
                      +++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.......    
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  242 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  242 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence            999999999999987644332222222345678999999998999999999999999999997 877754221110    


Q ss_pred             hhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          566 LGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                         ..         ..+........+...+..+.+|+.+||+.+|++|||+.++++.|+..
T Consensus       243 ---~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 ---LF---------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             ---HH---------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence               00         11111111122233456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=306.04  Aligned_cols=267  Identities=23%  Similarity=0.336  Sum_probs=209.0

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEec-----CC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-----RD  419 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~  419 (669)
                      ....|...+.||+|++|.|..++.. +|+.||||++...  .....++..+|+.+|+.++|+||+.+++.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3455666789999999999999975 4899999999743  33456788999999999999999999998865     34


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++|+|+| ..+|...+   +.+..|+..++..++.||++||.|+|+.+   ++||||||.|+|++.+..+||+|||+|
T Consensus       100 DvYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            579999999 66899988   34455999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh------
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL------  572 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~------  572 (669)
                      +...........+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|++-|...+.-.+..++......      
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            98765534444566889999999999865 47999999999999999999999998776554443333222111      


Q ss_pred             --cccccchhhcccccC-CCCCHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 --WTEDRSLELIDKSLD-GSYSLS-----EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 --~~~~~~~~~~~~~~~-~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        .........+..... ...+..     .....++|+.+||..||.+|+|++|.++
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence              111111112221111 111211     2346789999999999999999999986

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.8e-37  Score=323.00  Aligned_cols=242  Identities=24%  Similarity=0.315  Sum_probs=195.6

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      +.||+|+||.||++... +++.||||++.+.   .......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999965 5899999999754   2334567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCc
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT  511 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  511 (669)
                      +|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            99988843   346899999999999999999999998   999999999999999999999999998753221  1122


Q ss_pred             ccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCC
Q 005933          512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS  591 (669)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (669)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.|+......   ....    ..        ...  ....+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~----~~--------~~~--~~~~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LI--------LME--DIKFP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHH----Hh--------ccC--CccCC
Confidence            3357899999999999999999999999999999999999996532211   0000    00        000  00122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 005933          592 LSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM  622 (669)
Q Consensus       592 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  622 (669)
                      ......+.+++.+||+.||++||     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            22345678999999999999997     88988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.1e-37  Score=324.28  Aligned_cols=265  Identities=21%  Similarity=0.314  Sum_probs=195.6

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-----cce
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----ERM  422 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~  422 (669)
                      +|++.++||+|+||.||+|+.. +++.||||++....  .....++.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999965 58999999986432  233457889999999999999999999885433     479


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||||+. ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68988884   3345899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCcc-CcCcccccccCCccCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh--------hh
Q 005933          503 GVDQT-EANTDRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WR  571 (669)
Q Consensus       503 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~--------~~  571 (669)
                      ..... ........++..|+|||++.+  ..++.++|||||||++|||++|++|+...........+...        ..
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221 112234578999999999876  67899999999999999999999987543221110000000        00


Q ss_pred             hcccccchhhcccccC-CCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          572 LWTEDRSLELIDKSLD-GSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       572 ~~~~~~~~~~~~~~~~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ........+.+..... ...+.     .....+.+++.+||+.||++||+++|+++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000011100000 00010     123467899999999999999999999863

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2e-36  Score=310.48  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=197.2

Q ss_pred             CCccCeeeecCccceEEEEeCCC-c--EEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecC------Cc
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTEG-Q--EIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------DE  420 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~  420 (669)
                      |.+.++||+|+||.||+|.+.+. .  .||+|.+...  .....+.+..|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            35678999999999999997653 2  6899988653  234467889999999999999999999987532      24


Q ss_pred             ceEEEeecCCCCHHHHhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          421 RMLIYEYLPNKSLEQFIFDV---TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      .++|+||+++|+|.+++...   .....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999987432   12345899999999999999999999988   9999999999999999999999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      +++................+..|+|||.+.+..++.++||||||+++|||++ |+.|+.....   ..+..    .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD----YLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcC
Confidence            9987643322111222345678999999999999999999999999999999 7777543211   11111    11111


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ..         ...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       231 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NR---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            00         01112234567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.1e-36  Score=307.09  Aligned_cols=253  Identities=27%  Similarity=0.486  Sum_probs=202.5

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|++.++||+|++|.||++..+++..||+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            4688899999999999999998888899999986533 24567999999999999999999999875 456899999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++..+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            99999998643 2345899999999999999999999998   999999999999999999999999999865332211 


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....   ......             +......
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~-------------~~~~~~~  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQ-------------VERGYRM  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH-------------HHcCCCC
Confidence            1112335668999999988899999999999999999999 7877643211   111111             1111111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2223345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-36  Score=314.85  Aligned_cols=265  Identities=26%  Similarity=0.391  Sum_probs=200.6

Q ss_pred             cCCCccCeeeecCccceEEEEeCC---------------CcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE---------------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLG  413 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g  413 (669)
                      ++|++.++||+|+||.||++....               ...||||.++.. .....+.|.+|++++.+++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578899999999999999987542               235899998654 2334567999999999999999999999


Q ss_pred             EEecCCcceEEEeecCCCCHHHHhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEE
Q 005933          414 CCTLRDERMLIYEYLPNKSLEQFIFDVT---------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL  484 (669)
Q Consensus       414 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIl  484 (669)
                      ++...+..++||||+++++|.+++....         ....+++..++.++.|++.||+|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999985421         1124788999999999999999999998   999999999999


Q ss_pred             EcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 005933          485 LDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN  564 (669)
Q Consensus       485 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~  564 (669)
                      +++++.+||+|||++..+.............++..|+|||++.+..++.++||||||++++||+++..+.++..... ..
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-EQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-HH
Confidence            99999999999999976543222222223445678999999998999999999999999999998543322221111 11


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      .+......+....      .......+...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus       241 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1111111110000      00000111123457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6e-37  Score=322.76  Aligned_cols=241  Identities=23%  Similarity=0.312  Sum_probs=194.3

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      +.||+|+||.||++... +|+.||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999965 5899999999754   2334567788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCc
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT  511 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  511 (669)
                      +|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++.......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99988843   346899999999999999999999998   9999999999999999999999999987532211  122


Q ss_pred             ccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCC
Q 005933          512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS  591 (669)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (669)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.|+......   .....            ......  ..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~------------~~~~~~--~~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFEL------------ILMEEI--RFP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH------------HhcCCC--CCC
Confidence            3356899999999999999999999999999999999999996532211   00000            000000  112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          592 LSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       592 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      ......+.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            22345678999999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-36  Score=317.51  Aligned_cols=264  Identities=27%  Similarity=0.396  Sum_probs=207.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC--------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecC
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR  418 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  418 (669)
                      .++|.+.+.||+|+||.||++...        ++..||+|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888899999999999999741        24579999986432 34467899999999999 899999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                      ...++||||+++++|.+++.....             ...+++.+++.++.||++||.|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999965321             235788999999999999999999998   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  564 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~  564 (669)
                      +.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+......   .
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E  247 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---H
Confidence            9999999999999987644333222333445678999999998899999999999999999998 66664322111   0


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ  631 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  631 (669)
                          ........         .....+...+..+.+++.+||+.+|++||++.++++.|+.+..+..
T Consensus       248 ----~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         248 ----LFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             ----HHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence                01111100         0111122344678899999999999999999999999987655543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=311.80  Aligned_cols=258  Identities=25%  Similarity=0.417  Sum_probs=205.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|.+.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578889999999999999999653      4689999986443 23456788999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEe
Q 005933          422 MLIYEYLPNKSLEQFIFDVTR-------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS  494 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  494 (669)
                      ++||||+++++|.+++.....       ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999864322       234789999999999999999999988   9999999999999999999999


Q ss_pred             ecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhc
Q 005933          495 DFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       495 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      |||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......   ....    ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~----~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLK----FV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHH----HH
Confidence            9999886543322222233456788999999998899999999999999999998 88876432211   1111    11


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...         .....+...+..+.+++.+||+.+|++|||+.+++..|+.
T Consensus       235 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 IDG---------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            000         0111222235678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.3e-36  Score=307.47  Aligned_cols=253  Identities=26%  Similarity=0.458  Sum_probs=202.0

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|++.++||+|+||.||+|...+...||+|++... ....++|.+|+.+++.++|+||+++++++. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            568899999999999999999877778999998643 234568999999999999999999999874 456899999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +|+|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||++..+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            99999999543 2345799999999999999999999998   999999999999999999999999999765432221 


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||++.+..++.++||||||+++|||++ |..|+......   .....             +......
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~-------------~~~~~~~  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ-------------VERGYRM  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHH-------------HhcCCCC
Confidence            1122345678999999988899999999999999999999 77775432111   11100             0000011


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ..+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            1223345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-36  Score=313.37  Aligned_cols=267  Identities=29%  Similarity=0.421  Sum_probs=202.7

Q ss_pred             CCccCeeeecCccceEEEEe-----CCCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecC--CcceE
Q 005933          352 FSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERML  423 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  423 (669)
                      |.+.+.||+|+||+||++..     .+++.||+|.+..... .....|.+|+.+++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988653     3578899999865432 3457788999999999999999999988664  35789


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++++|.+++..    ..+++..+..++.|+++||.|||+.+   ++|+||||+|||++.++.++|+|||++....
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999853    24899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccCcC-cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEAN-TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ....... .....++..|+|||.+.+..++.++||||||++++||++|..|+....... .................+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence            3222111 122345667999999998899999999999999999999998854322110 11111111011111111222


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +.......+...+..+.+++.+||+.+|++||++++|+++|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            22222222333456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-37  Score=325.64  Aligned_cols=263  Identities=22%  Similarity=0.318  Sum_probs=207.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC--CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|.+.+.||+|+||.||+|....  +..||+|++.+.   .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3578899999999999999998643  368999998653   23345678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999953   345899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|..|+......   ....   .         +..
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~---~---------i~~  242 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQ---K---------ILE  242 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHH---H---------Hhc
Confidence            21     22357899999999999989999999999999999999999997532211   0000   0         111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH--hcC-------CCCCCCCCCCCccc
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM--LSG-------ERSLPQPKQPGFFT  639 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~--L~~-------~~~~~~p~~p~~~~  639 (669)
                      ...  ..+......+.+++.+||+.||++|+     +++++++.  +.+       ...++.|..|.+..
T Consensus       243 ~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~  310 (340)
T PTZ00426        243 GII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN  310 (340)
T ss_pred             CCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence            111  11222234678999999999999995     89988764  221       12445566666543

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-36  Score=312.60  Aligned_cols=259  Identities=24%  Similarity=0.389  Sum_probs=206.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-----CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEec-CCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~  421 (669)
                      .++|.+.+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.+++.++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678899999999999999999765     7889999986443 3346778999999999999999999998766 4678


Q ss_pred             eEEEeecCCCCHHHHhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeec
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRT-----KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF  496 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  496 (669)
                      ++++||+++++|.+++......     ..+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654332     56899999999999999999999988   999999999999999999999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhccc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      |+++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.|+....+   ..+...    ...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY----LKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHH----HHc
Confidence            99986543332222223455778999999998899999999999999999999 8888643221   111111    000


Q ss_pred             ccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                               ..........+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       235 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         235 ---------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             ---------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                     000011122345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.6e-36  Score=313.67  Aligned_cols=264  Identities=29%  Similarity=0.435  Sum_probs=204.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-----------------CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-----------------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVR  410 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  410 (669)
                      ..+|++.++||+|+||.||++...+                 +..||+|.+.... ....+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999998643                 2458999987543 334678999999999999999999


Q ss_pred             EEEEEecCCcceEEEeecCCCCHHHHhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCC
Q 005933          411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVT--------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN  482 (669)
Q Consensus       411 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~N  482 (669)
                      +++++..++..++|+||+++++|.+++....        ....+++..++.++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999996533        1236899999999999999999999998   9999999999


Q ss_pred             EEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 005933          483 VLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHAD  560 (669)
Q Consensus       483 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt--G~~p~~~~~~~  560 (669)
                      |+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++  +..|+....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence            9999999999999999886543332222333456788999999998899999999999999999998  444433211  


Q ss_pred             CccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          561 HHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                       ....+......+......      .....+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       239 -~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 -DQQVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -hHHHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             111111111111111100      001112223457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.5e-36  Score=314.12  Aligned_cols=263  Identities=24%  Similarity=0.331  Sum_probs=197.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|.+.++||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 588999999865432 234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+. ++|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            995 678777743  3345889999999999999999999998   9999999999999999999999999987543221


Q ss_pred             cCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc-------
Q 005933          507 TEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS-------  578 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  578 (669)
                        .......++..|+|||++.+ ..++.++|||||||++|||++|+.||.....  ....+............       
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence              12233567899999999875 4588999999999999999999999764321  11111111110000000       


Q ss_pred             --hhhcccccC--CCCCH-------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 --LELIDKSLD--GSYSL-------SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 --~~~~~~~~~--~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        .........  .....       .....+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence              000000000  00000       01245779999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.8e-36  Score=308.45  Aligned_cols=259  Identities=22%  Similarity=0.360  Sum_probs=206.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+...   .......+.+|+.+++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999965 5899999987542   2233457899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      ||+++++|.+++.... ....+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999886433 2345889999999999999999999998   99999999999999999999999999887543


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......    .......          +..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~----------~~~  222 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK----------IEQ  222 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH----------Hhc
Confidence            221  122346788999999999888999999999999999999999985321111    1111100          000


Q ss_pred             ccCCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          585 SLDGS-YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       585 ~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ..... .....+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            00111 11233467889999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-37  Score=308.63  Aligned_cols=257  Identities=23%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-----cceEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----ERMLI  424 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV  424 (669)
                      .|...+++|.|+||.||+|++.+ ++.||||+.-...+    --..|+.+|+.++|||||+|+-+|....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            45556899999999999999765 79999999854332    2246899999999999999998885433     23589


Q ss_pred             EeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-cceEEeecCCCccc
Q 005933          425 YEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAF  502 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~Dfgla~~~  502 (669)
                      ||||+. +|.+++... ..+..++...+.-+..||.+||+|||+.+   |+||||||+|+|||.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 888888643 23455777888889999999999999988   9999999999999965 99999999999987


Q ss_pred             CCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .....   ...+..++.|+|||.+.+. .|+.+.||||.||++.||+-|++-|...+..+.   +....+.+......++
T Consensus       177 ~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ---L~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  177 VKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ---LVEIIKVLGTPTREDI  250 (364)
T ss_pred             ccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence            43322   2345679999999999876 799999999999999999999998776444333   3332333222222111


Q ss_pred             ---cc-------cccCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 ---ID-------KSLDG-----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ---~~-------~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         -.       +.+..     -.....+.+..+++.++|+.+|.+|.++.|++.
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence               11       11111     122334568899999999999999999999985

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-36  Score=313.08  Aligned_cols=260  Identities=26%  Similarity=0.435  Sum_probs=202.7

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      ..++|++.++||+|+||.||+|...+      +..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            35689999999999999999997542      45799998864432 234568899999999999999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTR-------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                      .++||||+++|+|.+++.....       ...+++..+..++.||+.||.|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964321       234677889999999999999999998   999999999999999999999


Q ss_pred             eecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhh
Q 005933          494 SDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       494 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......   ....    .
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~----~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK----F  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----H
Confidence            99999886533222222222345678999999999999999999999999999998 66664321110   0100    0


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                              +.+.. ....+...+..+.+++.+||+.+|++||++.++++.|...
T Consensus       234 --------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 --------VMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             --------HHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                    00000 0011222346788999999999999999999999999775

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.1e-36  Score=306.61  Aligned_cols=246  Identities=28%  Similarity=0.447  Sum_probs=195.1

Q ss_pred             eeeecCccceEEEEeC---CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          357 KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      +||+|+||.||+|.++   ++..+|+|++.....  ...+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999753   478899999864432  34568999999999999999999999885 45678999999999


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc-C
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA-N  510 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~  510 (669)
                      +|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||||.||+++.++.+||+|||++.......... .
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843   345899999999999999999999998   9999999999999999999999999998764332211 1


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS  589 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (669)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+......   ...             +.+.......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~-------------~~i~~~~~~~  218 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVT-------------QMIESGERME  218 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH-------------HHHHCCCCCC
Confidence            112234578999999988889999999999999999998 88886532211   111             1111111112


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          590 YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       590 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      .+...+..+.+++.+||+.||++||++.+|...|++
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            222345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.7e-36  Score=325.31  Aligned_cols=260  Identities=26%  Similarity=0.402  Sum_probs=203.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCc-cchHHHHHHHHHHHHhC-CCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~  420 (669)
                      .++|.+.++||+|+||.||+|++.      .++.||||++..... ...+.++.|+.++..+. ||||+++++++.....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            346778899999999999999864      246899999975433 23457899999999997 9999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCC----------------------------------------------------------
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTR----------------------------------------------------------  442 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  442 (669)
                      .++|+||+++|+|.++++....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999864321                                                          


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          443 -------------------------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       443 -------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                                                           ...+++..++.++.||+.||+|||+.+   ++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                 124678889999999999999999988   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  564 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~  564 (669)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......   .
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---~  349 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---E  349 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---H
Confidence            9999999999999986532222111222356788999999998899999999999999999998 77775432111   0


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..   ..         .+........+...+..+.+|+.+||+.+|.+||++++|+..|+..
T Consensus       350 ~~---~~---------~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 QF---YN---------AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HH---HH---------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            00   00         0011111111222346788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-36  Score=313.56  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=194.0

Q ss_pred             cCCCccCeeeecCccceEEEEeC--CCcEEEEEEecccC--ccchHHHHHHHHHHHHh---CCCceeEEEEEEec-----
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL---QHRNLVRLLGCCTL-----  417 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----  417 (669)
                      ++|++.+.||+|+||.||++...  +++.||||++....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  36889999986432  22344667788887776   69999999999853     


Q ss_pred             CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       418 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      ....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            345789999996 68999885432 345899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc---
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT---  574 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~---  574 (669)
                      ++......   .......++..|+|||.+.+..++.++|||||||++|||++|++|+.......   .+........   
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~  229 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG  229 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence            99765322   22334568999999999998899999999999999999999999876432211   1111110000   


Q ss_pred             cccchh---hcccccC--CCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          575 EDRSLE---LIDKSLD--GSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       575 ~~~~~~---~~~~~~~--~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ......   +......  ...+.     .....+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000000   0000000  00011     12345679999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.6e-36  Score=312.87  Aligned_cols=263  Identities=26%  Similarity=0.402  Sum_probs=201.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-----------------CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-----------------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRL  411 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  411 (669)
                      ++|++.++||+|+||.||++...                 ++..||+|++.... .....+|.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999998532                 24468999987543 3345789999999999999999999


Q ss_pred             EEEEecCCcceEEEeecCCCCHHHHhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCE
Q 005933          412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTR--------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNV  483 (669)
Q Consensus       412 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NI  483 (669)
                      ++++...+..++||||+++++|.+++.....        ...+++..+..++.||+.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999865321        234788899999999999999999998   99999999999


Q ss_pred             EEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 005933          484 LLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADH  561 (669)
Q Consensus       484 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt--G~~p~~~~~~~~  561 (669)
                      |++.++.++|+|||++..+..............+..|+|||....+.++.++|||||||++|||++  |..|+...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence            999999999999999986543322222222344678999999988899999999999999999998  55554322111 


Q ss_pred             ccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                        .........+.....      ......+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus       241 --~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 --QVIENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             --HHHHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence              111111111110000      0000112223467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.3e-36  Score=315.27  Aligned_cols=240  Identities=27%  Similarity=0.354  Sum_probs=189.8

Q ss_pred             CeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||+|...+ ++.||||++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999754 7889999987532   23345566677777654 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999998843   345899999999999999999999998   9999999999999999999999999997642222  22


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.|+......   .....   .         ..  .....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~---i---------~~--~~~~~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDS---I---------LN--DRPHF  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHH---H---------Hc--CCCCC
Confidence            33457899999999999999999999999999999999999996532211   11100   0         00  01112


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMS-SVV  620 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  620 (669)
                      +......+.+++.+||+.+|++||++. +++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            222345678999999999999999976 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.9e-36  Score=310.73  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=203.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCc----EEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQ----EIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      .++|++.++||+|+||+||+|.+. +++    .||+|++.... ......+.+|+.++..++|+||+++++++.. ....
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            357888899999999999999853 344    48999986543 3345678899999999999999999999875 4578


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +++||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++.+
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999998542  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..|+......   .+.             ..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~-------------~~  223 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIP-------------DL  223 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH-------------HH
Confidence            43322222222344678999999999999999999999999999998 88875432111   010             01


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP  630 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  630 (669)
                      +........+...+..+.+++.+||+.||++||++.+++..|+.....|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            1111111112223456789999999999999999999999998775554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3e-36  Score=317.70  Aligned_cols=244  Identities=25%  Similarity=0.373  Sum_probs=193.1

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHH---HHhCCCceeEEEEEEecCCcceEE
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLI---AKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      |.+.+.||+|+||.||++... +++.||||++.+..   ....+.+..|+.++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567899999999999999965 48999999997532   23445677777665   456799999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|..++.    ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999998873    245899999999999999999999998   99999999999999999999999999875322


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .  ........|+..|+|||++.+..++.++|||||||++|||++|+.|+......   .....            +...
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~------------i~~~  216 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDS------------IVND  216 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHH------------HHhC
Confidence            1  12223457899999999999999999999999999999999999996532211   11100            0000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      .  ...+...+..+.+++.+||+.||++||     ++.++++
T Consensus       217 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         217 E--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            0  011222345678999999999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.5e-36  Score=314.73  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=202.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC--------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD  419 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  419 (669)
                      ++|.+.+.||+|+||.||++...        ....+|+|.+.... .....++..|+.++..+ +|+||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            57899999999999999999853        23579999987542 33456788999999999 7999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD  486 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~  486 (669)
                      ..++||||+++|+|.+++.....             ...+++.++++++.||+.||+|||+.+   ++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence            99999999999999999965321             235899999999999999999999988   99999999999999


Q ss_pred             CCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccch
Q 005933          487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNL  565 (669)
Q Consensus       487 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~  565 (669)
                      .++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+.....+   . 
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~-  250 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E-  250 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---H-
Confidence            999999999999876533221111222234568999999999899999999999999999998 77775422111   0 


Q ss_pred             hhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          566 LGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                         ....         +........+...+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       251 ---~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         251 ---LFKL---------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             ---HHHH---------HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence               0000         101111111223345778999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.2e-36  Score=314.72  Aligned_cols=259  Identities=29%  Similarity=0.450  Sum_probs=201.8

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-C--cEEEEEEeccc-CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-G--QEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478889999999999999999754 3  35788888643 333456789999999999 799999999999999999999


Q ss_pred             EeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          425 YEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      +||+++++|.+++....             ....+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999996422             1235889999999999999999999988   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~  570 (669)
                      ||+|||++......   ........+..|+|||++....++.++|||||||++|||++ |..|+......   ...    
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~----  228 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELY----  228 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----
Confidence            99999998643211   11111223557999999998899999999999999999997 88886432211   010    


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP  630 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  630 (669)
                               +.+........+...+..+.+|+.+||+.+|.+||++.++++.|+......
T Consensus       229 ---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         229 ---------EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             ---------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                     001111111122223456889999999999999999999999988764433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.8e-36  Score=311.32  Aligned_cols=258  Identities=26%  Similarity=0.450  Sum_probs=202.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|++.+.||+|+||.||++...      ++..||+|.+.... .....++.+|+.+++.++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888999999999999999864      46789999986543 23456799999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCC
Q 005933          422 MLIYEYLPNKSLEQFIFDVT-------------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN  482 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~N  482 (669)
                      ++|+||+++++|.+++....                   ....+++..++.++.||+.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999996421                   1234788999999999999999999998   9999999999


Q ss_pred             EEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005933          483 VLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH  561 (669)
Q Consensus       483 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~  561 (669)
                      |+++.++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876533322122222344667999999998899999999999999999997 76664321110 


Q ss_pred             ccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                        ....    ......        . ...+...+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus       240 --~~~~----~~~~~~--------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 --EVIY----YVRDGN--------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --HHHH----HHhcCC--------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              1110    000000        0 01122234678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5e-36  Score=305.60  Aligned_cols=254  Identities=29%  Similarity=0.467  Sum_probs=203.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .+.|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.+++.++|+|++++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35788899999999999999999889999999986433 34578999999999999999999999874 56789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++... ....+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999998543 3346899999999999999999999988   999999999999999999999999999765422211


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       ......++..|+|||++....++.++||||||++++||++ |+.|+......   .....             +.....
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~-------------~~~~~~  221 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQN-------------LERGYR  221 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHH-------------HHcCCC
Confidence             1122345678999999998899999999999999999999 88886532211   11100             001111


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...+...+..+.+++.+||+.+|++||++++++..|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11122234568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-36  Score=304.60  Aligned_cols=255  Identities=29%  Similarity=0.471  Sum_probs=205.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|.+.++||+|+||.||++..++++.||||.+... ....+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            4688999999999999999999888889999998643 334578999999999999999999999999889999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++... ....+++..+..++.+|+.||.|||+.+   ++|+||||+||++++++.++|+|||++..+..... 
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-  158 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence            999999999543 2345899999999999999999999998   99999999999999999999999999887643211 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      ........+..|+|||.+.+..++.++||||||++++||++ |+.|+......   ......             .....
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~-------------~~~~~  222 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQV-------------ERGYR  222 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-------------HcCCC
Confidence            11112234568999999998899999999999999999998 88886432111   111110             00011


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            11122224578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-36  Score=323.39  Aligned_cols=259  Identities=18%  Similarity=0.198  Sum_probs=195.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..+|.+.++||+|+||.||++... .++.||||...      ...+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999965 48899999753      24578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +. ++|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...... 
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            95 688888743   345899999999999999999999998   9999999999999999999999999997532211 


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC----ccchhhHhhhhccc--------
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH----HHNLLGHAWRLWTE--------  575 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~--------  575 (669)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-......    ....+.........        
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            122234578999999999999999999999999999999999997743211100    00001000000000        


Q ss_pred             --ccchhhc----ccccC--CCC-C----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          576 --DRSLELI----DKSLD--GSY-S----LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       576 --~~~~~~~----~~~~~--~~~-~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ....+..    .....  ... .    ...+..+.+|+.+||+.||++|||++|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              0000000    00000  000 0    123457889999999999999999999985

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.7e-36  Score=301.76  Aligned_cols=247  Identities=27%  Similarity=0.400  Sum_probs=197.8

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCHH
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE  434 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  434 (669)
                      +.||+|+||.||+|...+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            47999999999999988899999999875543 23457889999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccc
Q 005933          435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV  514 (669)
Q Consensus       435 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  514 (669)
                      +++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            998532  345899999999999999999999998   999999999999999999999999998754322211 11112


Q ss_pred             cccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHH
Q 005933          515 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS  593 (669)
Q Consensus       515 ~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (669)
                      .++..|+|||++....++.++||||||+++|||++ |..|+......   .....             +........+..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~-------------~~~~~~~~~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQ-------------VEKGYRMSCPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH-------------HHcCCCCCCCCC
Confidence            34567999999998899999999999999999998 88886432111   00000             000111112223


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          594 EALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       594 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      .+..+.+++.+|++.+|++||++.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            4567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-36  Score=303.90  Aligned_cols=250  Identities=28%  Similarity=0.429  Sum_probs=204.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|++.+.||.|++|.||++... ++.||||.+..... ..+++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999976 78999999965543 5678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999985432 236899999999999999999999998   99999999999999999999999999987532211 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                          ....+..|+|||.+....++.++||||||++++||++ |..|+......   .+....             .....
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~-------------~~~~~  217 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHV-------------EKGYR  217 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH-------------hcCCC
Confidence                2234668999999998899999999999999999997 88875432111   111110             00001


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...+...+..+.+++.+||+.+|++||++.+++.+|+.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            11122234678899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-36  Score=319.31  Aligned_cols=241  Identities=24%  Similarity=0.337  Sum_probs=193.7

Q ss_pred             CeeeecCccceEEEEe----CCCcEEEEEEeccc----CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          356 NKLGEGGFGPVYRGML----TEGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++||+|+||.||++..    ..++.||||++.+.    .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999985    34789999998653    223345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++..   .+.+.+..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            999999999843   445788899999999999999999998   9999999999999999999999999987532211 


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       .......|+..|+|||++.+..++.++||||||+++|||++|+.|+......   ...            ..+..... 
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~------------~~~~~~~~-  217 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTI------------DKILKGKL-  217 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHH------------HHHHcCCC-
Confidence             1223356899999999999888999999999999999999999996532211   000            01111111 


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                       ..+......+.+++.+||+.+|++||     ++.+++.
T Consensus       218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             11222345678999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-37  Score=326.17  Aligned_cols=253  Identities=23%  Similarity=0.319  Sum_probs=203.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|.+.+.||+|+||+||++... +++.||||++.+..   ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999976 58999999997532   244567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999543   56899999999999999999999988   999999999999999999999999999865433


Q ss_pred             c---------------------------cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005933          506 Q---------------------------TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  558 (669)
Q Consensus       506 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~  558 (669)
                      .                           .........||..|+|||++.+..++.++|||||||+||||++|+.|+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0012234568999999999999999999999999999999999999965432


Q ss_pred             CCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 005933          559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-MSSVVLM  622 (669)
Q Consensus       559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  622 (669)
                      ...      ...+....       ...+........+..+.+++.+|++ +|.+||+ +.++++.
T Consensus       235 ~~~------~~~~i~~~-------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQE------TYNKIINW-------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHH------HHHHHhcc-------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            110      00000000       0001101111135677899999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-35  Score=303.95  Aligned_cols=259  Identities=24%  Similarity=0.382  Sum_probs=208.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|++|.||+|... +++.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999987 6899999988642   2234678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      ||+++++|.+++.... ....+++.+++.++.+|++||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999986532 3455899999999999999999999998   99999999999999999999999999876533


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ...  ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.....    ......          +.+..
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~----------~~~~~  222 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC----------KKIEK  222 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHH----------hhhhc
Confidence            221  12234678899999999988999999999999999999999998643221    111000          00000


Q ss_pred             ccCCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          585 SLDGSYSL-SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       585 ~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ......+. ..+..+.+++.+||+.+|++||++.+|+++|+...
T Consensus       223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            01111121 33457889999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-36  Score=322.53  Aligned_cols=248  Identities=25%  Similarity=0.364  Sum_probs=193.7

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|+..++||+|+||.||+++.. +++.||||++..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999965 589999999865432 3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|....       ..++..+..++.||+.||.|||+.+   |+||||||+||||++++.+||+|||++..+.... 
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            9999986532       3567788899999999999999998   9999999999999999999999999998753221 


Q ss_pred             CcCcccccccCCccCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          508 EANTDRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                       .......|+..|+|||++..     ...+.++|||||||++|||++|+.||..........+...             +
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~-------------~  288 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA-------------I  288 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------H
Confidence             11233578999999998743     2345689999999999999999999763221111000000             0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ...............+.+|+.+||+.||++||++.|+++.
T Consensus       289 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        289 CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000111122334578899999999999999999999874

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.9e-36  Score=312.82  Aligned_cols=258  Identities=28%  Similarity=0.444  Sum_probs=203.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  420 (669)
                      .++|.+.+.||+|+||.||++...      .+..||||++.... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357889999999999999999742      25579999986543 23456789999999999 79999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++||||+.+|+|.+++.... ...+++.++..++.||+.||+|||+.+   ++|+||||+|||++.++.++|+|||++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999985422 334899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      .+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.......  ..    .         
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~----~---------  254 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KF----Y---------  254 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HH----H---------
Confidence            6543322112222345778999999999999999999999999999998 888854221110  00    0         


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      +.+........+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         255 KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            0111111111111224578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.7e-36  Score=306.32  Aligned_cols=255  Identities=22%  Similarity=0.371  Sum_probs=201.2

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|++.++||+|+||.||+|+. .+++.||+|++..........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35789999999999999999996 45889999999765555566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++..+.....
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            999999999843   345899999999999999999999998   99999999999999999999999999986532211


Q ss_pred             CcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          508 EANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                        ......++..|+|||.+.   ...++.++||||||+++|||++|+.|+....+....  .     .....   ....+
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~-----~~~~~---~~~~~  229 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F-----LMSKS---NFQPP  229 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--e-----eeecC---CCCCC
Confidence              122346788999999884   345788999999999999999999885322111100  0     00000   00000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                      ...  .....+..+.+++.+||+.+|++||+++++++.|
T Consensus       230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            010  0112245788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-36  Score=296.39  Aligned_cols=277  Identities=24%  Similarity=0.329  Sum_probs=206.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc-c-hHHHHHHHHHHHHhCCCceeEEEEEEec--CCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ-G-VEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l  423 (669)
                      .++|+.+++|++|.||.||+|+.+ +++.||+|+++...+. + .-..++||.+|.+++|||||.+-.+...  -+..++
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            457888999999999999999976 4889999999654321 1 2345789999999999999999887644  356899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||++. +|..++....  .++...++..+..|+++|++|||.+.   |+|||||++|+|+++.|.+||+|||+|+.++
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999976 8999996554  45888999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc-----
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR-----  577 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  577 (669)
                      ....  .....+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++.+.....   .+.+....+......     
T Consensus       229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE---~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE---IDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch---HHHHHHHHHHhCCCccccCC
Confidence            5422  23446789999999999887 599999999999999999999988664332   233333322221111     


Q ss_pred             ---chhhcc---------cccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCc
Q 005933          578 ---SLELID---------KSLDGSYSLS-EALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGF  637 (669)
Q Consensus       578 ---~~~~~~---------~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~p~~  637 (669)
                         ....+.         ..+...+... ....-.+|+...|..||++|.|++|.|.-= --...|.|..|.+
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~-~F~e~P~p~~P~~  375 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE-YFRETPLPIDPSM  375 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc-ccccCCCCCChhh
Confidence               111110         0011111111 123456888899999999999999987531 1234444444444

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.1e-37  Score=322.51  Aligned_cols=252  Identities=22%  Similarity=0.279  Sum_probs=199.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|.+.+.||+|+||.||++... +++.||||++....   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999965 58999999997542   234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999999543  245899999999999999999999998   999999999999999999999999999875432


Q ss_pred             ccCcCcccccccCCccCchhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          506 QTEANTDRVVGTYGYMSPEYAI------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ... ......+++.|+|||++.      ...++.++|||||||++|||++|+.|+.......   ..   ......    
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~---~~i~~~----  224 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---TY---NNIMNF----  224 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---HH---HHHHcC----
Confidence            221 222346899999999986      4567899999999999999999999965322110   00   000000    


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         ...+........+..+.+|+..|++ +|++||++.+++.
T Consensus       225 ---~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 ---QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ---CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence               0001101111234567889999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.8e-36  Score=306.46  Aligned_cols=256  Identities=27%  Similarity=0.462  Sum_probs=202.9

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-C---cEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-G---QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|+..+.||+|+||.||+|.... +   ..+|+|.+.... ....+.+.+|+.++..++|+|++++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            467888999999999999999753 3   379999986542 33456799999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++..  ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999854  2356899999999999999999999998   99999999999999999999999999886543


Q ss_pred             CccCcC-cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          505 DQTEAN-TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       505 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ...... ......+..|+|||++....++.++||||||+++|||++ |..|+......   ...    ...         
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~----~~i---------  223 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVM----KAI---------  223 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH----HHH---------
Confidence            222111 111223457999999998889999999999999999997 99886432211   111    111         


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ............+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         224 NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00111111223346788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-36  Score=325.93  Aligned_cols=253  Identities=20%  Similarity=0.298  Sum_probs=195.8

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .|.+.+.||+|+||+||+|... +++.||||++.+..   ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999965 48899999996532   3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999853   345889999999999999999999998   9999999999999999999999999976432110


Q ss_pred             cC---------------------------------------------cCcccccccCCccCchhhccCCCCchhhHHHHH
Q 005933          507 TE---------------------------------------------ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFG  541 (669)
Q Consensus       507 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G  541 (669)
                      ..                                             .......||..|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00                                             001234689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHH--hccCCCCCCCCHHHH
Q 005933          542 VLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLL--CVQQRPEDRPNMSSV  619 (669)
Q Consensus       542 ~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ev  619 (669)
                      |++|||++|+.|+........   .   ......       ...+...........+.+++.+  |+..+|..||++.++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~---~---~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTET---Q---LKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHH---H---HHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            999999999999754321110   0   000000       0000001111223456677776  556677779999999


Q ss_pred             HHH
Q 005933          620 VLM  622 (669)
Q Consensus       620 l~~  622 (669)
                      +..
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-35  Score=303.00  Aligned_cols=253  Identities=27%  Similarity=0.457  Sum_probs=201.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|.+.++||+|++|.||++....+..+|+|.+... ....+.+.+|+.+++.++|+|++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            468888999999999999999887778999987543 234567899999999999999999999875 456889999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++......... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999999643 2345899999999999999999999998   999999999999999999999999999765332211 


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......   ......    .         .....
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~---------~~~~~  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQV----E---------RGYRM  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----H---------cCCCC
Confidence            1122345678999999998899999999999999999999 88775432111   111110    0         00011


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ..+...+..+.+++.+||+.+|++||++++|+++|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1122335678899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.5e-36  Score=318.30  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=197.5

Q ss_pred             CCCccCeeeecCccceEEEEe----CCCcEEEEEEecccC----ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcc
Q 005933          351 NFSWKNKLGEGGFGPVYRGML----TEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  421 (669)
                      +|++.++||+|+||.||++..    .+++.||+|++.+..    ....+.+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999885    358899999986532    23356788899999999 599999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999843   345899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      +..... .......||..|+|||++.+. .++.++|||||||++|||++|+.|+...........+   ...        
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~~~--------  222 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---SRR--------  222 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---HHH--------
Confidence            532222 122235789999999999865 4788999999999999999999997543221111111   000        


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      +..  .....+......+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 ILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             Hhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            000  01112222345678999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.6e-36  Score=302.68  Aligned_cols=250  Identities=27%  Similarity=0.379  Sum_probs=203.4

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.+.||+|++|.||+++.. +++.|++|.+...  .......+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777899999999999999975 4899999998643  334567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999999653 2456899999999999999999999988   99999999999999999999999999886543222


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||++.+..++.++||||||++++||++|+.|+......   ....            ..... ..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~------------~~~~~-~~  218 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALIL------------KIIRG-VF  218 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH------------HHHcC-CC
Confidence              122346788999999999999999999999999999999999996533210   0000            00000 01


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            11222344678899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.4e-36  Score=322.25  Aligned_cols=201  Identities=24%  Similarity=0.346  Sum_probs=174.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||+||++... +++.||||++.+..   ......+..|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999865 48999999997532   234467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   .+.+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   356899999999999999999999998   999999999999999999999999998764321


Q ss_pred             ccC---------------------------------cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 005933          506 QTE---------------------------------ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR  552 (669)
Q Consensus       506 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~  552 (669)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123578999999999999999999999999999999999999


Q ss_pred             CCCC
Q 005933          553 NRGF  556 (669)
Q Consensus       553 p~~~  556 (669)
                      |+..
T Consensus       235 Pf~~  238 (363)
T cd05628         235 PFCS  238 (363)
T ss_pred             CCCC
Confidence            9753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-37  Score=306.69  Aligned_cols=245  Identities=23%  Similarity=0.397  Sum_probs=208.4

Q ss_pred             cCCCccCeeeecCccceEEEEe-CCCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      -+|++.+.||+|.+|.|-++.. ..|+.||||.+++.   +++..-.+.+||+||..|+||||++++.+|...+...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4688889999999999999995 66999999999765   4455667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||..+|.|.+++.   +.+.|++.+..++++||.+|+.|+|.+.   ++|||||.+|||||.++++||+|||++-.+.. 
T Consensus       133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~-  205 (668)
T KOG0611|consen  133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD-  205 (668)
T ss_pred             EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence            9999999999994   4566999999999999999999999998   99999999999999999999999999977532 


Q ss_pred             ccCcCcccccccCCccCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                        .......+|++-|.+||++.+.+|. +..|-|||||+||-|+.|..||+..+                   -..++..
T Consensus       206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-------------------hk~lvrQ  264 (668)
T KOG0611|consen  206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-------------------HKRLVRQ  264 (668)
T ss_pred             --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-------------------HHHHHHH
Confidence              2334457899999999999999885 78999999999999999999976422                   1223333


Q ss_pred             ccCCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          585 SLDGSYS-LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       585 ~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .-.+.+. .+.+....-||.|||..+|++|.|+.+|..-
T Consensus       265 Is~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  265 ISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             hhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            3333322 2334566789999999999999999999874

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=325.18  Aligned_cols=252  Identities=22%  Similarity=0.288  Sum_probs=198.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||.||++... +++.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999975 48999999996532   234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999853   345899999999999999999999998   999999999999999999999999998754321


Q ss_pred             ccCc------------------------------------CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh
Q 005933          506 QTEA------------------------------------NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC  549 (669)
Q Consensus       506 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt  549 (669)
                      ....                                    ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0112468999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 005933          550 GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN---MSSVVL  621 (669)
Q Consensus       550 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  621 (669)
                      |..|+......   ....   .....       ...+...........+.+++.+|+. +|.+|++   +.++++
T Consensus       235 G~~Pf~~~~~~---~~~~---~i~~~-------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQ---ETYR---KIINW-------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHH---HHHH---HHHcC-------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99997532211   0000   00000       0000000111223467788889986 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-36  Score=302.77  Aligned_cols=250  Identities=34%  Similarity=0.498  Sum_probs=203.4

Q ss_pred             CeeeecCccceEEEEeCC----CcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||++....    +..|++|.+...... ..+.+.+|+.++..++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999764    788999999765433 368899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          431 KSLEQFIFDVTR------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       431 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      ++|.+++.....      ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965422      366999999999999999999999988   99999999999999999999999999987654


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ...........++..|+|||.+....++.++||||||++++||++ |..|+......   .+...    ...        
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~--------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEY----LRK--------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHc--------
Confidence            332222334567889999999998899999999999999999999 58876543111   11110    000        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                       ......+...+..+.+++.+||+.+|++||++.+++..|+
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             0111122233567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=300.99  Aligned_cols=248  Identities=28%  Similarity=0.411  Sum_probs=198.5

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCHH
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE  434 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  434 (669)
                      ++||+|+||.||++...+++.||+|.+...... ....+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998754433 5678999999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccc
Q 005933          435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV  514 (669)
Q Consensus       435 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  514 (669)
                      +++...  ...+++..++.++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998542  235789999999999999999999998   999999999999999999999999999765322221111122


Q ss_pred             cccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHH
Q 005933          515 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS  593 (669)
Q Consensus       515 ~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (669)
                      ..+..|+|||.+.+..++.++||||||+++|||++ |..|+.......                ....+........+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----------------TRERIESGYRMPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----------------HHHHHhcCCCCCCCcc
Confidence            33567999999998899999999999999999999 777654322110                0011111111112223


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          594 EALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       594 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      .+..+.+++.+||+.+|++||++.||++.|+
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-36  Score=302.15  Aligned_cols=253  Identities=22%  Similarity=0.273  Sum_probs=207.6

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||.|..|+||++.+.+ +..+|+|++.+..   .....+...|-+||+.++||.++.|++.+..+...+|||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            467778999999999999999876 6899999998753   445667888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      |||+||+|..++++ +..+.+++..+..++.+|+-||+|||-.|   ||+|||||+||||.++|++.|+||.|+..+...
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999998854 45667999999999999999999999999   999999999999999999999999986543110


Q ss_pred             ----------------------------------c--------------------cCcCcccccccCCccCchhhccCCC
Q 005933          506 ----------------------------------Q--------------------TEANTDRVVGTYGYMSPEYAIDGLF  531 (669)
Q Consensus       506 ----------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~  531 (669)
                                                        .                    ........+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                              0                    0112234679999999999999999


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCC
Q 005933          532 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPE  611 (669)
Q Consensus       532 t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  611 (669)
                      +.++|.|+|||+||||+.|..||........               ...++...+.-......+..+.+||.+.|..||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            9999999999999999999999765433211               1222222222222224456889999999999999


Q ss_pred             CCCC----HHHHHH
Q 005933          612 DRPN----MSSVVL  621 (669)
Q Consensus       612 ~RPs----~~evl~  621 (669)
                      +|..    +.||-+
T Consensus       378 kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhccccchHHhhc
Confidence            9998    777764

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.7e-36  Score=316.96  Aligned_cols=241  Identities=27%  Similarity=0.367  Sum_probs=193.0

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCC-ceeEEEEEEecCCcceEEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHR-NLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~  425 (669)
                      +|++.+.||+|+||.||+|.... ++.||||++.+.   .....+.+..|+.++..++|+ +|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47888999999999999999764 789999998753   234456788899999999765 6888999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999998843   345889999999999999999999998   999999999999999999999999998753211


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                        ........|+..|+|||++.+..++.++|||||||++|||++|+.|+......   .....            +... 
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~------------i~~~-  216 (324)
T cd05587         155 --GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQS------------IMEH-  216 (324)
T ss_pred             --CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH------------HHcC-
Confidence              11223456899999999999999999999999999999999999997532211   11100            0000 


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  616 (669)
                       ....+......+.+++.+||+.+|.+||+.
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             011122234567899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.9e-36  Score=307.22  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=200.9

Q ss_pred             CCCccCeeeecCccceEEEEeCC-C---cEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-G---QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .|.+.+.||+|+||.||+|.+.. +   ..||||.+... ......+|..|+.+++.++||||+++++++..+...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46788999999999999999753 3   36999998654 3344678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++...  .+.+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999998542  345899999999999999999999998   999999999999999999999999998765432


Q ss_pred             ccCcCccccc---ccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          506 QTEANTDRVV---GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       506 ~~~~~~~~~~---gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ..........   .+..|+|||.+....++.++||||||+++|||++ |..|+......   ......            
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i------------  224 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI------------  224 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH------------
Confidence            2211111111   2457999999999999999999999999999886 88885422111   111110            


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                       ........+...+..+.+++.+||+.+|.+||++.+|+.+|+..
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 -EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             00001111223345678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.1e-36  Score=316.86  Aligned_cols=236  Identities=27%  Similarity=0.412  Sum_probs=190.0

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||++..+ +++.||||++.+.   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999976 4889999998653   234456778898888877 699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++......  ...
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence            999998843   345899999999999999999999998   999999999999999999999999998753221  112


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.|+......   .....    .        .....  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~----i--------~~~~~--~~  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEA----I--------LNDEV--VY  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHH----H--------hcCCC--CC
Confidence            23457899999999999999999999999999999999999997532211   11100    0        00000  11


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~  616 (669)
                      +......+.+++.+||+.||++||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            11234567899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.7e-36  Score=317.55  Aligned_cols=241  Identities=24%  Similarity=0.378  Sum_probs=193.1

Q ss_pred             CeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||+|.... ++.||||++.+.   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999764 789999998753   233456678899998876 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      ++|...+..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999988843   345889999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+......   .....            +.....  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~------------i~~~~~--~~  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFES------------ILHDDV--LY  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHH------------HHcCCC--CC
Confidence            23356899999999999999999999999999999999999997543211   11110            000000  11


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRP-------NMSSVVL  621 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~  621 (669)
                      +......+.+++.+||+.||++||       ++.++++
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            112235678999999999999999       7888874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.6e-36  Score=305.29  Aligned_cols=259  Identities=23%  Similarity=0.349  Sum_probs=206.3

Q ss_pred             cCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||.||++.. .+++.+|||.+....   .....++.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999996 468999999876432   234568899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      ||+++++|.+++.... ....+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999986432 3456899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ...  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+.....+    ..... +..     ...   
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~-----~~~---  223 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKI-----EQC---  223 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHh-hhh-----hcC---
Confidence            221  122346788999999999889999999999999999999999986422111    00000 000     000   


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..........+..+.+++.+||+.+|++||||.+|+++++..
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            000011112445788999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-35  Score=304.57  Aligned_cols=254  Identities=28%  Similarity=0.406  Sum_probs=192.3

Q ss_pred             CeeeecCccceEEEEeCC---CcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      +.||+|+||.||+|...+   +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998653   45799998865432 33457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          432 SLEQFIFDVT--RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       432 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +|.+++....  ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999996432  2234677888899999999999999998   9999999999999999999999999987543322222


Q ss_pred             CcccccccCCccCchhhccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          510 NTDRVVGTYGYMSPEYAIDG-------LFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~-------~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.|+......   .......    .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYTV----REQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHh----hcccCCC
Confidence            22334567889999998642       35789999999999999996 99886532211   1111100    0001111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..+    .........+.+++..|+ .+|++|||+.+|++.|+
T Consensus       231 ~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKP----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCC----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111    111122345778999998 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-35  Score=302.27  Aligned_cols=247  Identities=26%  Similarity=0.425  Sum_probs=194.1

Q ss_pred             eeeecCccceEEEEeC---CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCC
Q 005933          357 KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKS  432 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  432 (669)
                      .||+|+||.||+|.+.   .+..||+|++..... ...+.|.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999864   356799999865433 33567999999999999999999999885 457899999999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc-Cc
Q 005933          433 LEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA-NT  511 (669)
Q Consensus       433 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~  511 (669)
                      |.+++..  ....+++..+++++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+....... ..
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999853  2346899999999999999999999998   9999999999999999999999999998654332211 11


Q ss_pred             ccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      ....++..|+|||.+....++.++||||||+++|||++ |..|+......   ..             ...+........
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~-------------~~~~~~~~~~~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EV-------------MSFIEQGKRLDC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HH-------------HHHHHCCCCCCC
Confidence            12233578999999988889999999999999999996 88885432111   00             011111111122


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      +...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            23345678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-36  Score=319.57  Aligned_cols=241  Identities=24%  Similarity=0.310  Sum_probs=193.6

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      +.||+|+||.||++... +++.||+|++.+.   .......+..|+.++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999964 5899999999753   2234567788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      +|..++.   +...+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.+||+|||++.......  ..
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            9998884   33468999999999999999999997 57   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+.....+.   ...    ..        ....  ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~----~i--------~~~~--~~~  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE----LI--------LMEE--IRF  215 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHH----HH--------hcCC--CCC
Confidence            233568999999999999999999999999999999999999964322110   000    00        0000  011


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      +......+.+++.+||+.||++|+     ++.++++
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            222345678999999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.6e-36  Score=312.93  Aligned_cols=241  Identities=27%  Similarity=0.364  Sum_probs=193.9

Q ss_pred             CeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||++.... ++.||||++.+.   .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999764 789999999754   233456778899999888 699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   ++||||||+||++++++.+||+|||++.......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999998843   345899999999999999999999998   9999999999999999999999999986532111  12


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.|+......   .....            +....  ...
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~------------i~~~~--~~~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQS------------ILEDE--VRY  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHH------------HHcCC--CCC
Confidence            22356899999999999999999999999999999999999997532211   11100            00000  011


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNM-----SSVVL  621 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  621 (669)
                      +...+..+.+++.+||+.||++||++     .+++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            22234567899999999999999999     88865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-36  Score=308.47  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=200.5

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      +|++.+.||+|+||.||++... +++.||||++....   ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999965 58999999986532   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999988543 2345899999999999999999999998   9999999999999999999999999987653221


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                         ......++..|+|||++.+..++.++||||||+++|||++|+.|+........   ....         ...+.. .
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~---------~~~~~~-~  220 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEV---------ERRVKE-D  220 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHH---------HHHhhh-c
Confidence               12234688999999999988999999999999999999999999764322110   0000         000000 0


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM  622 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  622 (669)
                      ....+...+..+.+|+.+||+.||++||     ++.++++.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            1112223455678999999999999999     78888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.4e-36  Score=312.68  Aligned_cols=240  Identities=27%  Similarity=0.354  Sum_probs=190.6

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||++... +++.||||.+....   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999976 48899999997532   23455677788888765 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            999998843   345889999999999999999999998   999999999999999999999999998743211  112


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+......   .+....    .        ..  ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~----~--------~~--~~~~  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESI----R--------VD--TPHY  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH----H--------hC--CCCC
Confidence            23456899999999999999999999999999999999999996532211   111000    0        00  0111


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMS-SVV  620 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  620 (669)
                      +......+.+++.+||+.||++||++. +++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            112345678999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-35  Score=312.07  Aligned_cols=259  Identities=29%  Similarity=0.409  Sum_probs=202.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC--------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD  419 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  419 (669)
                      ++|.+.++||+|+||.||++...        ....+|+|.+.... ......+..|+.++..+ +||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57888999999999999999742        24579999986432 33456789999999999 6999999999999989


Q ss_pred             cceEEEeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD  486 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~  486 (669)
                      ..++||||+++|+|.+++....             ....+++.++..++.||+.||.|||+.+   ++|+||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999996532             1245899999999999999999999998   99999999999999


Q ss_pred             CCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccch
Q 005933          487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNL  565 (669)
Q Consensus       487 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~  565 (669)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......   .+
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~  245 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---EL  245 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence            999999999999986543222121222234567999999999899999999999999999999 77775422111   11


Q ss_pred             hhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          566 LGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ..    .....         .....+...+..+.+++.+||+.+|++||++.++++.|....
T Consensus       246 ~~----~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         246 FK----LLREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             HH----HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            11    00000         001112233456779999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=303.24  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=201.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-----cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-----QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|.+.+.||+|++|.||++... +++.||+|.+.....     ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999965 589999999864321     234578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999999853   345889999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCccCcC-cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEAN-TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ....... .....++..|+|||++.+..++.++||||||+++|||++|+.|+.....  .    .....         ..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~----~~~~~---------~~  220 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--M----AAIFK---------IA  220 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--H----HHHHH---------Hh
Confidence            3221111 1335578899999999998999999999999999999999998542111  0    00000         00


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ........+......+.+++.+||+.+|++||++.+++..
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            1111112222344567899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.9e-36  Score=299.64  Aligned_cols=264  Identities=25%  Similarity=0.357  Sum_probs=203.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc--chHHHHHHHHHHHHhCCCc-eeEEEEEEecCC------
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRD------  419 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------  419 (669)
                      ..|...++||+|.+|+||+|+.. +|+.||+|+++-..++  ......+|+.++++|+|+| |+++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34555688999999999999954 5899999999755432  3456789999999999999 999999998877      


Q ss_pred             cceEEEeecCCCCHHHHhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                      ..++|+||++ -+|..++...... ..++...+..+..||++||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            6789999995 5899999765432 34677889999999999999999999   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      |+.+..+...  ....+.|..|.|||++.+. .|+...||||+||+++||+++++.|.....   ...+....+......
T Consensus       167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPN  241 (323)
T ss_pred             HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCC
Confidence            9976543322  4446789999999999987 799999999999999999999888765443   233333332222111


Q ss_pred             ---chh---hcccc--cCC---CCCHHH-----HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          578 ---SLE---LIDKS--LDG---SYSLSE-----ALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       578 ---~~~---~~~~~--~~~---~~~~~~-----~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                         ...   +.+..  ...   ..+...     .....+++.+||+.+|..|.|++.++..
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               111   11111  000   011111     1367899999999999999999999875

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-35  Score=306.85  Aligned_cols=246  Identities=28%  Similarity=0.377  Sum_probs=195.1

Q ss_pred             eeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      ||+|+||+||++... +++.||+|.+.+..   ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999965 58899999986532   22346778899999999999999999999999999999999999999


Q ss_pred             HHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcc
Q 005933          434 EQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD  512 (669)
Q Consensus       434 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  512 (669)
                      ..++.... ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            98875432 3456899999999999999999999998   99999999999999999999999999976543222  223


Q ss_pred             cccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCH
Q 005933          513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSL  592 (669)
Q Consensus       513 ~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (669)
                      ...++..|+|||++.+..++.++||||||+++|||++|+.|+.........  . ...        .......  ...+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~-~~~--------~~~~~~~--~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--K-ELK--------QRILNDS--VTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--H-HHH--------HhhcccC--CCCcc
Confidence            357899999999999999999999999999999999999997543221100  0 000        0000100  01222


Q ss_pred             HHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          593 SEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       593 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      ..+..+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            3456788999999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.6e-36  Score=311.55  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=198.9

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-Cc--EEEEEEeccc-CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|++.+.||+|+||.||+|.+.. +.  .+|+|.+... .......+.+|+.++.++ +|+||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            478888999999999999999653 44  4688877543 234456889999999999 899999999999999999999


Q ss_pred             EeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          425 YEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      |||+++++|.+++....             ....+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999996432             1235889999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~  570 (669)
                      ||+|||++......   ........+..|+|||++.+..++.++||||||++++||++ |..|+......   ....   
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~---  234 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE---  234 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH---
Confidence            99999998642111   11111234567999999988889999999999999999998 88885422111   1110   


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                       .         +........+...+..+.+|+.+||+.+|++||++.++++.|+..
T Consensus       235 -~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         235 -K---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             -H---------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             0         000001111122345678999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9e-36  Score=307.42  Aligned_cols=271  Identities=28%  Similarity=0.424  Sum_probs=205.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-----CCcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEec--CCcc
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDER  421 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~  421 (669)
                      +.|.+.+.||+|+||.||++.+.     .+..||||.+...... ..+.|.+|+.+++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999854     3688999999755443 56789999999999999999999999877  5578


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999543  235899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ....... .......++..|+|||.+.+..++.++||||||++++||++|..|+........ ................+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-RMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc-cccccccccccHHHHHH
Confidence            6432221 111123445679999999988999999999999999999999988543221110 00000000000001111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .+........+...+..+.+++.+||+.+|++||+|.||+++|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111112223346788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.1e-36  Score=315.33  Aligned_cols=243  Identities=23%  Similarity=0.324  Sum_probs=191.2

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||++... +++.||+|++.+.   .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999975 4789999999754   223456678899988877 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+|+.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            999988843   345899999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc--chhhHhhhhcccccchhhcccccCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH--NLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+.........  ....+.....        ....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~~~--~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEKQ--I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--------hcCC--C
Confidence            23357899999999999999999999999999999999999997542221111  1111111110        0000  1


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~  616 (669)
                      ..+......+.+++.+||+.||++||++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1222334567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-35  Score=302.20  Aligned_cols=240  Identities=20%  Similarity=0.338  Sum_probs=188.6

Q ss_pred             CeeeecCccceEEEEeCC-------------CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          356 NKLGEGGFGPVYRGMLTE-------------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      +.||+|+||.||+|+...             ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998542             2358999886655555668899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc-------eEEee
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-------PKISD  495 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~-------~kl~D  495 (669)
                      +||||+++++|..++..  +...+++..+++++.||++||+|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999998843  2345899999999999999999999998   999999999999987664       89999


Q ss_pred             cCCCcccCCCccCcCcccccccCCccCchhhc-cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhc
Q 005933          496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       496 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      ||++......      ....++..|+|||.+. +..++.++|||||||++|||++ |..|+.......       .....
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFY  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHH
Confidence            9998654221      2245678899999887 4678999999999999999984 766643211100       00000


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      .         ...  ....+....+.+|+.+||+.||++||++.+|++.|+
T Consensus       223 ~---------~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 E---------GQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             h---------cCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0         000  011122356789999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.4e-36  Score=315.60  Aligned_cols=241  Identities=27%  Similarity=0.366  Sum_probs=193.0

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      +|.+.+.||+|+||.||++.... ++.||||++.+..   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            47788999999999999999764 7899999987542   23345677788888877 5899999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999998843   345889999999999999999999998   999999999999999999999999998753221


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .  .......|++.|+|||++.+..++.++|||||||++|||++|+.|+......   .+...            +....
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~------------i~~~~  217 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS------------IMEHN  217 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHH------------HHhCC
Confidence            1  1223457899999999999999999999999999999999999997532211   11111            00100


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  616 (669)
                        ..++......+.+++.+||+.+|.+|++.
T Consensus       218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              11222334567899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.8e-36  Score=316.59  Aligned_cols=260  Identities=28%  Similarity=0.398  Sum_probs=199.1

Q ss_pred             hcCCCccCeeeecCccceEEEEe------CCCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecC-C
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR-D  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~  419 (669)
                      .++|.+.+.||+|+||.||+|..      .+++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35789999999999999999973      347889999996543 23456788999999999 689999999988654 4


Q ss_pred             cceEEEeecCCCCHHHHhhccCC---------------------------------------------------------
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTR---------------------------------------------------------  442 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  442 (669)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            57899999999999999853210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCccccc
Q 005933          443 -------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV  515 (669)
Q Consensus       443 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  515 (669)
                             ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124688889999999999999999998   9999999999999999999999999988653322212222234


Q ss_pred             ccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHH
Q 005933          516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE  594 (669)
Q Consensus       516 gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (669)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+.......  ...    ......         .....+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~---------~~~~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEG---------TRMRAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhcc---------CCCCCCCCC
Confidence            5678999999999899999999999999999997 887754321110  000    000000         000111112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          595 ALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       595 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ...+.+++..||+.+|++||++.+|++.|+..
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            34678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.6e-36  Score=308.07  Aligned_cols=271  Identities=25%  Similarity=0.402  Sum_probs=201.8

Q ss_pred             cCCCccCeeeecCccceEEEEe-----CCCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecC--Ccc
Q 005933          350 DNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER  421 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~  421 (669)
                      ..|.+.+.||+|+||.||++..     .++..||+|.+.... ......+.+|+.+++.++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4567889999999999999984     347889999986543 33456899999999999999999999998775  567


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998532  235899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      +...... .......++..|+|||++.+..++.++||||||+++|||++++.|........ ..................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-LKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh-hhhcccccccccHHHHHH
Confidence            6433221 11223456778999999998899999999999999999999876532110000 000000000000000000


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .+........+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000001111222356789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-35  Score=313.28  Aligned_cols=262  Identities=26%  Similarity=0.392  Sum_probs=204.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC--------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD  419 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  419 (669)
                      .+|.+.+.||+|+||.||++...        ....||+|.+.... ....+++.+|+.++.++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        12368999886432 33467899999999999 7999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD  486 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~  486 (669)
                      ..++|+||+++|+|.+++....             ....+++..++.++.||+.||+|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986432             2235889999999999999999999998   99999999999999


Q ss_pred             CCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccch
Q 005933          487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNL  565 (669)
Q Consensus       487 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~  565 (669)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....+   . 
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~-  244 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---E-  244 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH---H-
Confidence            999999999999986543222222222334567999999999999999999999999999998 77775322111   0 


Q ss_pred             hhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCC
Q 005933          566 LGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP  630 (669)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  630 (669)
                         ......         .......+...+..+.+++.+||+.+|++||++.+++..|+......
T Consensus       245 ---~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         245 ---LFKLLK---------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ---HHHHHH---------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence               001110         00111112233457889999999999999999999999998775433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-35  Score=303.98  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=202.0

Q ss_pred             cCCCccCeeeecCccceEEEEeC----CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .+|.+.+.||+|+||.||+|...    .+..+|+|.+.... ....+.|.+|+.++..++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999864    23479999986533 23456889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++...  ...+++.+++.++.|++.||+|||+.+   ++|+||||+|||++.++.++|+|||++..+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999542  345899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccCcC-cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          505 DQTEAN-TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       505 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ...... .....++..|+|||.+.+..++.++||||||+++||+++ |..|+......   .......    .       
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~-------  224 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE----E-------  224 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh----C-------
Confidence            322111 111223567999999998899999999999999999886 88885432211   1111110    0       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                        ......+...+..+.+++.+|++.+|.+||+|.++++.|+..
T Consensus       225 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 --GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence              000111222345678999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.7e-36  Score=315.13  Aligned_cols=248  Identities=21%  Similarity=0.324  Sum_probs=195.1

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||++... +++.||||++.+.   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999975 4889999999753   223456788999999998 699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++..   .+.+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++......  ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            999988843   356899999999999999999999998   999999999999999999999999998742111  122


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc--cchhhHhhhhcccccchhhcccccCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH--HNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+........  ..........        +.....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~--  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQI--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCCC--
Confidence            2345789999999999999999999999999999999999999864332211  1111111111        111111  


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPN------MSSVVL  621 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~  621 (669)
                      ..+......+.+++.+||+.||.+||+      +.++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            112223456789999999999999997      667763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.4e-35  Score=304.03  Aligned_cols=251  Identities=20%  Similarity=0.327  Sum_probs=198.0

Q ss_pred             cCCCccCeeeecCccceEEEEe-CCCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999996 45889999998654 233456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+...  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999997653       3688889999999999999999998   999999999999999999999999999765322  


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||++.+..++.++||||||+++|+|++|+.|+...................        .+....
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~  218 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI--------VDEDPP  218 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH--------hccCCC
Confidence              1223578899999999999999999999999999999999999975422211110000000000        000000


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ..........+.+++.+||+.+|++||+++++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00111233567899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2e-35  Score=311.67  Aligned_cols=243  Identities=23%  Similarity=0.311  Sum_probs=192.3

Q ss_pred             CeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||++.... ++.||||++.+..   ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999754 7899999997542   23456788999999888 699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            999988843   345899999999999999999999998   999999999999999999999999998753211  112


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|+..|+|||++.+..++.++|||||||+||||++|+.|+....................        ....  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~--~~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------EKPI--RI  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------hCCC--CC
Confidence            2345789999999999999999999999999999999999999864333222221111111111        0000  11


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~  616 (669)
                      +...+..+.+++.+||+.||++||++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            22233567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=324.23  Aligned_cols=253  Identities=21%  Similarity=0.254  Sum_probs=196.0

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|.+.++||+|+||.||++... +++.||||++.+.   .....+.+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999865 5899999998653   2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853   345889999999999999999999998   999999999999999999999999998643211


Q ss_pred             ccC-----------c----------------------------------CcccccccCCccCchhhccCCCCchhhHHHH
Q 005933          506 QTE-----------A----------------------------------NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSF  540 (669)
Q Consensus       506 ~~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~  540 (669)
                      ...           .                                  ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000           0                                  0012468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCC---CCHH
Q 005933          541 GVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDR---PNMS  617 (669)
Q Consensus       541 G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~  617 (669)
                      ||++|||++|..||......   ......   .....       .+.-.........+.+++.+|++ +|.+|   |++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~---~~~~~i---~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSH---ETYRKI---INWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHH---HHHHHH---HccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999999997532221   111000   00000       00000011123467789999997 66665   5999


Q ss_pred             HHHHH
Q 005933          618 SVVLM  622 (669)
Q Consensus       618 evl~~  622 (669)
                      +++..
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.8e-35  Score=300.79  Aligned_cols=249  Identities=29%  Similarity=0.431  Sum_probs=199.1

Q ss_pred             CeeeecCccceEEEEeCC--C--cEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE--G--QEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+..|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999999753  2  3699999976655 567789999999999999999999999988 888999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC-c
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-A  509 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  509 (669)
                      ++|.+++.+... ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999965332 56899999999999999999999998   999999999999999999999999999876432211 1


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||.+.+..++.++||||||++++||++ |..|+......   ........            .....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~------------~~~~~  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDK------------EGERL  220 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh------------cCCcC
Confidence            1223456788999999999999999999999999999998 99885422111   11100000            00001


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            112223467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-35  Score=300.08  Aligned_cols=248  Identities=26%  Similarity=0.389  Sum_probs=198.0

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEe-cCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT-LRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~E~~  428 (669)
                      ++|.+.+.||+|+||.||++... +..||+|.+...  ...+.+.+|+.+++.++|+|++++++++. .++..++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            47888899999999999999876 788999998543  23567899999999999999999999764 456689999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++... ....+++..++.++.||+.||+|||+.+   ++||||||+||++++++.+||+|||++.......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999998542 2345889999999999999999999998   9999999999999999999999999987543221  


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                         .....+..|+|||++.+..++.++||||||+++|||++ |+.|+.....   ..+...             +.....
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~-------------~~~~~~  217 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR-------------VEKGYK  217 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH-------------HhcCCC
Confidence               12234568999999998899999999999999999997 8887542211   001100             000011


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            11122335678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=300.75  Aligned_cols=249  Identities=32%  Similarity=0.472  Sum_probs=196.0

Q ss_pred             CeeeecCccceEEEEeCC----CcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      ++||+|+||.||+|+...    +..+|+|.+..... ...+++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999998532    36899999875543 24568899999999999999999999875 5568999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      ++|.+++...   ..+++..+..++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++.+........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999999542   36899999999999999999999998   99999999999999999999999999987643322111


Q ss_pred             -cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          511 -TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       511 -~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......   .......    ...         ..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~---------~~  217 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGE---------RL  217 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCC---------cC
Confidence             111223567999999998899999999999999999998 88886533211   1111110    000         00


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ..+...+..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            112223456789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.7e-36  Score=324.71  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=196.0

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .+|++.++||+|+||.||++... +++.||||++.+..   ......+.+|+.+++.++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999965 48999999986532   234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999943   345888999999999999999999998   999999999999999999999999997533210


Q ss_pred             cc-----------------------------------------CcCcccccccCCccCchhhccCCCCchhhHHHHHHHH
Q 005933          506 QT-----------------------------------------EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV  544 (669)
Q Consensus       506 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l  544 (669)
                      ..                                         ........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            00                                         0001124689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCC---CHHHHHH
Q 005933          545 LEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP---NMSSVVL  621 (669)
Q Consensus       545 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~  621 (669)
                      |||++|+.|+........   .... ..+.         ..............+.+++.+|+ .+|.+|+   ++.+++.
T Consensus       235 yell~G~~Pf~~~~~~~~---~~~i-~~~~---------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         235 YEMLVGQPPFLADTPAET---QLKV-INWE---------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eehhhCCCCCCCCCHHHH---HHHH-hccC---------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            999999999754322110   0000 0000         00000111122345667777766 5999999   8888885


Q ss_pred             H
Q 005933          622 M  622 (669)
Q Consensus       622 ~  622 (669)
                      -
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-35  Score=309.08  Aligned_cols=264  Identities=22%  Similarity=0.303  Sum_probs=201.4

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.++||+|+||.||++... ++..+|+|.+..... ....++.+|++++.+++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999965 478899998865432 3346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      +++++|.+++..   ...+++..+..++.||++||.|||+ .+   ++|+||||+|||++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            999999999953   3558999999999999999999997 45   999999999999999999999999998754221 


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc-----------
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE-----------  575 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-----------  575 (669)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.....................           
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence               123356789999999998888999999999999999999999987533211111101000000000           


Q ss_pred             ------ccchhhcccccCC---CCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          576 ------DRSLELIDKSLDG---SYS-LSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       576 ------~~~~~~~~~~~~~---~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                            ....+..+.....   ..+ ......+.+++.+||+.+|++||++.+|++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                  0000111111100   000 01234688999999999999999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-36  Score=318.98  Aligned_cols=238  Identities=24%  Similarity=0.289  Sum_probs=191.3

Q ss_pred             CeeeecCccceEEEEe----CCCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          356 NKLGEGGFGPVYRGML----TEGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      +.||+|+||.||++..    .+|+.||+|++.+...  .....+..|+.++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6899999999999874    3588999999975422  234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999999843   345899999999999999999999998   9999999999999999999999999987643221  1


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS  589 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (669)
                      ......|+..|+|||++.+..++.++||||||+++|||++|+.|+......   .....            +.....  .
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~------------i~~~~~--~  216 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTM------------ILKAKL--G  216 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHH------------HHcCCC--C
Confidence            222357899999999999888999999999999999999999996532211   11100            000000  1


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 005933          590 YSLSEALRCIQVGLLCVQQRPEDRPNMSS  618 (669)
Q Consensus       590 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e  618 (669)
                      .+...+..+.+++.+||+.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            12223456789999999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=320.59  Aligned_cols=252  Identities=30%  Similarity=0.405  Sum_probs=209.0

Q ss_pred             CCCccCeeeecCccceEEEEeCC--Cc--EEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE--GQ--EIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ...+.++||+|.||.|++|.|..  |+  .||||.+...... ....|++|+.+|.+|+|+|+++|+|+..+ ....+|+
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            34456899999999999999864  43  5899999765443 68899999999999999999999999987 7789999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      |..+.|||.+.|.+ ..+..+-......++.|||.||.||..+.   +|||||.++|+||-....+||+||||.+.+...
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999987 45566888999999999999999999998   999999999999999999999999999988654


Q ss_pred             ccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          506 QTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       506 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ... .......-...|+|||.+....++.++|||+|||+||||+++ +.|+.                -.....+.+.+|
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~----------------G~~g~qIL~~iD  329 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV----------------GCRGIQILKNID  329 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC----------------CCCHHHHHHhcc
Confidence            332 233334457789999999999999999999999999999994 44421                122233444555


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                      ..-.-..+..++.++++++..||..+|.+||++..|...+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            3333355677889999999999999999999999997443

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=327.49  Aligned_cols=251  Identities=29%  Similarity=0.425  Sum_probs=209.3

Q ss_pred             ccCeeeecCccceEEEEe-CCC----cEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          354 WKNKLGEGGFGPVYRGML-TEG----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..++||+|+||+||+|.+ ++|    -+||||++... ..+...+++.|+.+|.+|+|||+++|+|+|.... ..||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            458999999999999995 333    46899988654 4456789999999999999999999999998766 8899999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      |+.|+|.++++.  .+..+-.+..+.|..|||+||.|||++.   ++||||.++||||.....+||.|||+++.+..+..
T Consensus       779 mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  779 MPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             cccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999965  3345888999999999999999999988   99999999999999999999999999999877766


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      +.......-.+.|||-|.+....|+.++|||||||++||++| |..|+.....++                +.+++...-
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~ge  917 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGE  917 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhccc
Confidence            665555556788999999999999999999999999999988 777754332222                222222222


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +-+.+.-.+.++..++.+||..|++.||+++++...+...
T Consensus       918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            2344556778899999999999999999999999877654

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-35  Score=299.60  Aligned_cols=252  Identities=28%  Similarity=0.449  Sum_probs=200.9

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.... .....|.+|+++++.++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4677889999999999999998778899999886432 335679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++...  ...+++..+..++.+++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......... 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            99999998532  345789999999999999999999998   999999999999999999999999998765322111 


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......   .....             +......
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~-------------~~~~~~~  220 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVET-------------INAGFRL  220 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH-------------HhCCCCC
Confidence            1122334678999999998899999999999999999998 88875432111   11100             0000000


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..+...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            011112457889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1e-35  Score=311.52  Aligned_cols=264  Identities=22%  Similarity=0.346  Sum_probs=197.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999975 47889999986543 23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++ +|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+||+|+.++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 888877442  345889999999999999999999998   99999999999999999999999999876432221


Q ss_pred             CcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh--------hhhcccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WRLWTEDRS  578 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~  578 (669)
                        ......++..|+|||++.+ ..++.++||||||+++|||++|++|+...........+...        |........
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              1223467889999999865 46899999999999999999999997644322111111110        000000000


Q ss_pred             hhhcc-cccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 LELID-KSLDG----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 ~~~~~-~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..... +....    .........+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000 00000    000112346789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.2e-35  Score=307.02  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..+|++.+.||+|++|.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            357888899999999999999964 5899999999766555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++..    ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999999842    34789999999999999999999998   99999999999999999999999999876432221


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||.+.+..++.++|||||||++|+|++|+.|+....+..  .+. .   .... ..     ..+ 
T Consensus       172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~-~---~~~~-~~-----~~~-  236 (296)
T cd06654         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY-L---IATN-GT-----PEL-  236 (296)
T ss_pred             --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHH-H---HhcC-CC-----CCC-
Confidence              1223467889999999998889999999999999999999999965322111  000 0   0000 00     000 


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ..+......+.+++.+||+.+|++||++.++++
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             111223356789999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-35  Score=312.95  Aligned_cols=237  Identities=22%  Similarity=0.295  Sum_probs=186.6

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHH-HHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVL-LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999975 48899999986532   223344555554 57889999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      ++|...+..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+|+.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            999988843   345888999999999999999999998   999999999999999999999999998753211  122


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+......   ....            .+....+  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~------------~i~~~~~--~~  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD------------NILHKPL--QL  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH------------HHhcCCC--CC
Confidence            23456899999999999989999999999999999999999996432110   0000            0011111  12


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMS  617 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~  617 (669)
                      +......+.+++.+||+.+|++||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            223345678999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.2e-36  Score=323.96  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=193.4

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .|++.++||+|+||.||+|+.. +++.||||++.+..   ......+.+|+.+++.++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999965 48899999986532   2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999999853   345889999999999999999999998   9999999999999999999999999975431100


Q ss_pred             c---------------------------------------------CcCcccccccCCccCchhhccCCCCchhhHHHHH
Q 005933          507 T---------------------------------------------EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFG  541 (669)
Q Consensus       507 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G  541 (669)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001224689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHH
Q 005933          542 VLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN---MSS  618 (669)
Q Consensus       542 ~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~e  618 (669)
                      |+||||++|+.|+....+...   .   ......       ...+...........+.+++.+++ .+|++|++   +.+
T Consensus       236 vil~elltG~~Pf~~~~~~~~---~---~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLET---Q---MKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHH---H---HHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            999999999999754322100   0   000000       000100111112345567777765 49999997   777


Q ss_pred             HHH
Q 005933          619 VVL  621 (669)
Q Consensus       619 vl~  621 (669)
                      ++.
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-35  Score=312.01  Aligned_cols=240  Identities=27%  Similarity=0.381  Sum_probs=190.6

Q ss_pred             CeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||+|.... ++.||||++....   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999764 7899999987542   23445667788888764 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|.+++..   ...+++.++..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999999853   345889999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+......   .+....    .      ...    ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i----~------~~~----~~~  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSI----R------MDN----PCY  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHH----H------hCC----CCC
Confidence            23356899999999999999999999999999999999999996532211   111000    0      000    111


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMS-SVV  620 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  620 (669)
                      +......+.+++.+||+.+|++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            112334678999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6e-36  Score=321.53  Aligned_cols=261  Identities=21%  Similarity=0.286  Sum_probs=197.5

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-----cce
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----ERM  422 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~  422 (669)
                      +|++.++||+|+||.||++... +++.||||++....  ....+++.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999964 58999999986532  234567889999999999999999999998776     789


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +|+||+. ++|.+.+.   ....+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 57887773   3456899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch--
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL--  579 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  579 (669)
                      ..... .......++..|+|||++.+. .++.++|||||||++|||++|+.||........   +.............  
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~  229 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAM  229 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence            33222 122234678899999999875 579999999999999999999999764332211   11111110000000  


Q ss_pred             --------hhcccccCC--------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          580 --------ELIDKSLDG--------SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       580 --------~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                              ..+......        .........+.+|+.+||+.||++|||+.|++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                    000000000        0111124567899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-35  Score=300.26  Aligned_cols=254  Identities=27%  Similarity=0.433  Sum_probs=203.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|.+.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.+++.++|+|++++.+++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4678889999999999999999888888999988643 3345788999999999999999999999887 7789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++... ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999999543 2345889999999999999999999988   999999999999999999999999999765332211


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       ......++..|+|||++....++.++||||||+++|+|++ |..|+......   .....    ..         ....
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~---------~~~~  221 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LE---------RGYR  221 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----Hh---------CCCC
Confidence             1122345677999999998889999999999999999999 88886432111   11100    00         0001


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...+...+..+.+++.+||+.+|++||++.+++.+|+.
T Consensus       222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11122334568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2e-35  Score=302.49  Aligned_cols=250  Identities=32%  Similarity=0.499  Sum_probs=197.4

Q ss_pred             CeeeecCccceEEEEeCC-------CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          356 NKLGEGGFGPVYRGMLTE-------GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +.||+|+||.||+|+..+       ++.+|||.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999999653       2579999886543 24467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-----ceEEeecCC
Q 005933          428 LPNKSLEQFIFDVT----RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-----NPKISDFGM  498 (669)
Q Consensus       428 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-----~~kl~Dfgl  498 (669)
                      +++++|.+++....    ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996432    2344789999999999999999999988   99999999999999877     899999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      +.................+..|+|||++.++.++.++||||||+++|||++ |+.|+......   .....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~---------  225 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH---------  225 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH---------
Confidence            876543322222223345678999999999999999999999999999998 88886432111   11100         


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                          +........+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       226 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 ----VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ----HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                0000011112233567789999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-35  Score=319.33  Aligned_cols=262  Identities=19%  Similarity=0.266  Sum_probs=200.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeC---CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT---EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..+|.+.++||+|+||.||++...   .++.||||.+...     ..+.+|+.+++.++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999853   3678999987542     34568999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      |++. ++|.+++   .....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.++|+|||++..+...
T Consensus       166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9995 6888887   23456899999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc-------ccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE-------DRS  578 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~  578 (669)
                      ..........||..|+|||++....++.++|||||||++|||++|+.|+...........+....+....       ...
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            3333334467899999999999999999999999999999999999997543332211111111110000       000


Q ss_pred             hh------hcccccCCCCCH-------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          579 LE------LIDKSLDGSYSL-------SEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       579 ~~------~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ..      ............       .....+.+++.+||+.||++||++.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00      000000111111       123467789999999999999999999875

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.7e-36  Score=314.85  Aligned_cols=237  Identities=22%  Similarity=0.291  Sum_probs=187.2

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHH-HHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVL-LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||+||++... +++.||||++.+..   .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999975 58999999986532   223345555555 56778999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999998843   446899999999999999999999998   999999999999999999999999998753211  122


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+......   ....            .+.....  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~------------~i~~~~~--~~  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYD------------NILNKPL--RL  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHHH------------HHHcCCC--CC
Confidence            33456899999999999999999999999999999999999996532111   0000            0011111  11


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMS  617 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~  617 (669)
                      +...+..+.+++.+||+.||.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            112345678999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.3e-35  Score=302.20  Aligned_cols=254  Identities=25%  Similarity=0.357  Sum_probs=188.9

Q ss_pred             CeeeecCccceEEEEeCC---CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      ++||+|+||.||+|....   ...+|+|.+.... ......|.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999998543   4578888875443 234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          432 SLEQFIFDVTR--TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       432 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999965432  233567888999999999999999998   9999999999999999999999999987543222111


Q ss_pred             CcccccccCCccCchhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          510 NTDRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..|+......   ..+...   .. ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~-~~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQV---VR-EQDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHH---hh-ccCccC
Confidence            1223445678999998743       356889999999999999999 66665422111   111110   00 001111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..+    ..+...+..+.+++..|+ .||++||++++|+++|.
T Consensus       231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111    112223345667888888 59999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=315.25  Aligned_cols=258  Identities=27%  Similarity=0.426  Sum_probs=210.6

Q ss_pred             eeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCHHH
Q 005933          357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ  435 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  435 (669)
                      +||+|.+|+||.|+..+ ...+|||-+........+-+..||.+.++|+|.|||+++|.+.+++..-|.||..+||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999765 56799999988777778889999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-CCcceEEeecCCCcccCCCccCcCcc
Q 005933          436 FIFDVTRTKFL--DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTD  512 (669)
Q Consensus       436 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~  512 (669)
                      +|..  .=+++  ++.++-.+.+||++||.|||++.   |||||||-+||||+ -.|.+||+|||.++.+.  .....+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccc
Confidence            9953  33445  78889999999999999999999   99999999999996 57899999999998763  2233344


Q ss_pred             cccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          513 RVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       513 ~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      ...||..|||||++..+  .|..++|||||||++.||.||++||-.......              .+..+--....++.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------------AMFkVGmyKvHP~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------------AMFKVGMYKVHPPI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------------hhhhhcceecCCCC
Confidence            57899999999999766  589999999999999999999999643222111              00111111234456


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HhcCCCCCCCCCCC
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGERSLPQPKQP  635 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~p~~p  635 (669)
                      +.+....+..+|++|+.+||.+||+++++++  +|......+.|+.+
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls  847 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS  847 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence            6777889999999999999999999999986  45444344444443

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.2e-35  Score=303.98  Aligned_cols=247  Identities=25%  Similarity=0.327  Sum_probs=192.6

Q ss_pred             eeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      ||+|+||.||++..+ +|+.||+|.+....   ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999965 48999999986432   12234566799999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCccc
Q 005933          434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR  513 (669)
Q Consensus       434 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  513 (669)
                      .+++... ....+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            9888543 2334889999999999999999999998   9999999999999999999999999987653321   1223


Q ss_pred             ccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHH
Q 005933          514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS  593 (669)
Q Consensus       514 ~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (669)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.|+.........  ......         .....+.. ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~---------~~~~~~~~-~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRR---------TLEDEVKF-EHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHH---------hhcccccc-cccc
Confidence            46889999999999989999999999999999999999996532211110  000000         00000000 0011


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          594 EALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       594 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                      .+..+.+|+.+||+.||++||+++|+++.+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            244678999999999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-35  Score=302.93  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=198.0

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecC------
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR------  418 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------  418 (669)
                      .+++.|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888999999999999999975 48899999986543 3456788999999998 699999999998753      


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                      ...++||||+.+++|.+++... ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            3578999999999999998642 3345899999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      +.......  .......++..|+|||++.     +..++.++|||||||++|||++|+.|+.......      ......
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------~~~~~~  229 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIP  229 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------HHHHHh
Confidence            87653221  1223456889999999986     3468889999999999999999999864322110      000000


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      . ..        .........+..+.+++.+||+.+|.+||++.+++.
T Consensus       230 ~-~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 R-NP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             c-CC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0 00        000011122346789999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.1e-36  Score=314.53  Aligned_cols=239  Identities=21%  Similarity=0.295  Sum_probs=187.9

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHH-HHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVL-LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||++... +|+.||||++.+.   .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 5899999998653   2233445556655 46778999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++.   +...+++..+..++.||+.||.|||+.+   |+||||||+||||++++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            99998884   3456899999999999999999999998   999999999999999999999999998753211  122


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+......   ....   .         +....+  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~---~---------~~~~~~--~~  215 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYD---N---------ILHKPL--VL  215 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHH---H---------HHcCCc--cC
Confidence            23457899999999999999999999999999999999999996432111   0100   0         001011  11


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMSSV  619 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev  619 (669)
                      .......+.+++.+|++.+|.+||++.+.
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            11234567789999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-35  Score=302.50  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=198.3

Q ss_pred             CCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccch--HHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      |++.+.||+|+||+||++.... ++.||+|++........  .....|+.++.+++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4577899999999999999765 67899999976543322  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++.   +...+++..++.++.||++||.+||+.+   ++|+||||+||+++.++.++|+|||.+...  ....
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence            9999999995   3456899999999999999999999998   999999999999999999999999998764  1122


Q ss_pred             cCcccccccCCccCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      .......++..|+|||++. +..++.++||||+|+++++|++|..|+.............   ...    ...... .. 
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~----~~~~~~-~~-  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KIL----KRPLPS-SS-  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHH----HTHHHH-HT-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcc----cccccc-cc-
Confidence            2334467789999999998 8889999999999999999999998865331111100000   000    000000 00 


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       .........+.+++.+||+.||++||++.++++
T Consensus       224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000111267889999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.7e-36  Score=320.03  Aligned_cols=254  Identities=21%  Similarity=0.245  Sum_probs=199.7

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ..++|++.++||+|+||.||++... +++.||+|++.+.   .......+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568999999999999999999975 4889999998643   22334567899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999999843    24788889999999999999999998   9999999999999999999999999998653


Q ss_pred             CCccCcCcccccccCCccCchhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      .... .......|++.|+|||++.+.    .++.++|||||||++|||++|+.|+......   ...   .......   
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~---~~i~~~~---  263 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTY---SKIMDHK---  263 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHH---HHHHcCC---
Confidence            3221 122335789999999998654    4788999999999999999999997532211   000   0000000   


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPED--RPNMSSVVLM  622 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  622 (669)
                          ..+.-......+..+.+++.+||+.+|++  ||++.+++..
T Consensus       264 ----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 ----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                00100111123457789999999999988  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=312.23  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=207.7

Q ss_pred             cCCCccCeeeecCccceEEEEeCC---C--cEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE---G--QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      +...+.+.||+|.||.||+|+..+   |  -.||||.-+.. ..+..+.|+.|..+|++++||||++++|+|.+ ...+|
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            455566889999999999999543   3  35899988763 44568899999999999999999999999975 56899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |||.++-|-|..+|..  +...|+......++.||+.||+|||+..   ++||||.++||||.+...+||+|||+++.+.
T Consensus       468 vmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999999954  4445889999999999999999999998   9999999999999999999999999999886


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ........ ...-+..|||||.+.-.+++.++|||.|||.+|||+. |..||-....                .+..-.+
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI~~i  605 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVIGHI  605 (974)
T ss_pred             ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceEEEe
Confidence            55443333 3456789999999999999999999999999999987 7788543221                1111122


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...-..+.+..++..+..|+.+||+++|.+||++.++...|+.
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence            2222335567788899999999999999999999999877653

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-35  Score=300.90  Aligned_cols=249  Identities=28%  Similarity=0.455  Sum_probs=193.6

Q ss_pred             CeeeecCccceEEEEeCC-Cc--EEEEEEeccc-CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||+|.+.+ +.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999764 33  5788888643 234556889999999999 799999999999999999999999999


Q ss_pred             CCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          431 KSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       431 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      |+|.+++....             ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1234789999999999999999999988   9999999999999999999999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      ++......   ........+..|+|||++....++.++||||||++++||++ |..|+......   ....    ..   
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~----~~---  224 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE----KL---  224 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHH----HH---
Confidence            98632211   11111233567999999988899999999999999999997 88886422111   0110    00   


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                            ........+...+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus       225 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         225 ------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                  00000011122334678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=303.46  Aligned_cols=255  Identities=27%  Similarity=0.436  Sum_probs=202.1

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-Cc----EEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ----EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .+|.+.+.||+|+||.||+|.+++ +.    .||+|.+..... ....++.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467888999999999999999653 33    589998865543 345788999999999999999999999987 78899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998542  335899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ............++..|+|||.+....++.++||||||++++||++ |+.|+.......   +.             ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~-------------~~~  224 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IP-------------DLL  224 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HH-------------HHH
Confidence            3322222222234568999999988899999999999999999998 998865322111   11             111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ........+......+.+++.+||..+|.+||++.++++.|+..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         225 EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11111111222345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-35  Score=324.33  Aligned_cols=260  Identities=21%  Similarity=0.326  Sum_probs=191.7

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecC--------
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--------  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------  418 (669)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999975 48899999885432    2345799999999999999999876432        


Q ss_pred             CcceEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeec
Q 005933          419 DERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDF  496 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Df  496 (669)
                      ...++||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999975 677766432 34456899999999999999999999998   99999999999999664 7999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      |+++.+....   ......+++.|+|||++.+. .++.++|||||||+||||++|.+||.......   .+.........
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~~~  289 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRIIQVLGT  289 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence            9998653222   12235678999999998764 68999999999999999999999975432211   11111111110


Q ss_pred             ccchhh--c-----c--------cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          576 DRSLEL--I-----D--------KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       576 ~~~~~~--~-----~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .....+  .     +        ..+...++...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000000  0     0        00000111123457889999999999999999999984

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.3e-35  Score=334.31  Aligned_cols=259  Identities=19%  Similarity=0.277  Sum_probs=200.7

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.++||+|+||.||+|... +++.||||++.....   ...++|.+|+.+++.++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999975 489999999875422   23567999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          426 EYLPNKSLEQFIFDVTR--------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      ||+++++|.+++.....        ...+++..++.++.||++||+|||+.+   |+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211        233567788999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccC----------------cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005933          498 MARAFGVDQTE----------------ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH  561 (669)
Q Consensus       498 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~  561 (669)
                      ++.........                .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99875211100                01122468999999999999999999999999999999999999965321110


Q ss_pred             ccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhcC
Q 005933          562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP-NMSSVVLMLSG  625 (669)
Q Consensus       562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~  625 (669)
                         .. ..         .....+. ........+..+.+++.+||+.||++|| +++++++.|+.
T Consensus       239 ---i~-~~---------~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 ---IS-YR---------DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             ---hh-hh---------hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               00 00         0000000 0000112335678999999999999996 56667776654

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-35  Score=318.85  Aligned_cols=253  Identities=21%  Similarity=0.242  Sum_probs=198.4

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      ...++|++.+.||+|+||.||++.... ++.||+|++.+.   .......+.+|+.+++.++||||+++++++..++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            345789999999999999999999764 889999998642   2233456889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+||||++++.+||+|||++..+
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999999999999843    24788999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCccCcCcccccccCCccCchhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      ..... .......||+.|+|||++...    .++.++|||||||+||||++|+.||......   ...            
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~------------  256 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTY------------  256 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHH------------
Confidence            32211 122345789999999999754    3788999999999999999999997532211   000            


Q ss_pred             hhhcccc--cCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 005933          579 LELIDKS--LDGSYSLSEALRCIQVGLLCVQQRPED--RPNMSSVVLM  622 (669)
Q Consensus       579 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  622 (669)
                      ..+++..  +...........+.+++..|++.++.+  ||++.|+++.
T Consensus       257 ~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         257 SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1111110  111111122456778899999866544  8999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.4e-35  Score=299.33  Aligned_cols=255  Identities=25%  Similarity=0.338  Sum_probs=199.0

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      +++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            4556666689999999999999965 478899999876666667789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecCCCcccCCC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVD  505 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~~~~~  505 (669)
                      |+++++|.+++.........++..+..++.||+.||+|||+.+   |+|+||||+||+++. ++.++|+|||++......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            9999999999964322212378889999999999999999988   999999999999986 679999999998765322


Q ss_pred             ccCcCcccccccCCccCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      .  .......++..|+|||++....  ++.++||||||+++|+|++|+.|+........   ...  ..         ..
T Consensus       163 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~--~~---------~~  226 (268)
T cd06624         163 N--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMF--KV---------GM  226 (268)
T ss_pred             C--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHh--hh---------hh
Confidence            1  1122345788999999986653  78899999999999999999998643211100   000  00         00


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .......+......+.+++.+||+.+|.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00111122233456889999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-35  Score=319.54  Aligned_cols=193  Identities=21%  Similarity=0.294  Sum_probs=167.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..+|.+.+.||+|+||.||++.... ++.||||...      ...+.+|+.++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999999765 7889999642      23467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +. ++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 688888743  2346899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN  553 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p  553 (669)
                      ........||..|+|||++.+..++.++|||||||+||||++|..+
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~  361 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS  361 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCC
Confidence            2222345789999999999999999999999999999999998765

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.3e-35  Score=299.03  Aligned_cols=249  Identities=26%  Similarity=0.424  Sum_probs=199.3

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc---------chHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ---------GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      +|.+.+.||+|++|.||+|... +++.||+|.+......         ..+.+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677899999999999999964 4889999988654322         23568899999999999999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++|+||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999943   345889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCccC----cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          501 AFGVDQTE----ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       501 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      ........    .......++..|+|||.+.+..++.++||||||+++|+|++|+.|+......      ....      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~------  222 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIF------  222 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHH------
Confidence            76422111    1112345788999999999888999999999999999999999996532110      0000      


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         .... ......+...+..+.+++.+||+.+|.+||++.++++
T Consensus       223 ---~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         223 ---KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence               0000 1111222234567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.9e-35  Score=303.01  Aligned_cols=265  Identities=25%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.+.||+|++|.||+|... +++.||||++....  ......+.+|+.++..++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999975 58999999986432  23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      ++ ++|.+++........+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 689888865555567899999999999999999999998   99999999999999999999999999876533221


Q ss_pred             CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh-----hhhcccccchhh
Q 005933          508 EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA-----WRLWTEDRSLEL  581 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~  581 (669)
                        ......++..|+|||++.+. .++.++||||||++++||++|+.|+...............     ...+........
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence              12234568899999988654 5789999999999999999999886532211100000000     000000000000


Q ss_pred             ccccc----CCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSL----DGS---YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~----~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .....    ...   ........+.+++.+||+.||++|||+.+|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000    000   00112346679999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=298.09  Aligned_cols=278  Identities=22%  Similarity=0.319  Sum_probs=204.8

Q ss_pred             CCCCCCccHHHHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHH--hCCCceeEE
Q 005933          334 NMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVRL  411 (669)
Q Consensus       334 ~~~~~~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l  411 (669)
                      ..++|.+--.+   ...+..+.+.||+|.||+||+|.+. |+.||||++....+   +.+.+|.++++.  |+|+||+.+
T Consensus       198 GSGlplLVQRT---iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgF  270 (513)
T KOG2052|consen  198 GSGLPLLVQRT---IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGF  270 (513)
T ss_pred             CCCchhHhHHh---hhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhh
Confidence            34454433333   3457888999999999999999998 89999999965443   455666666665  599999999


Q ss_pred             EEEEecCC----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCceeccCCCCC
Q 005933          412 LGCCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-----DSRLRIIHRDLKASN  482 (669)
Q Consensus       412 ~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiH~Dikp~N  482 (669)
                      ++.-..+.    +++||++|.+.|||.++|..    ..++....++++..+|.||++||.     ++++.|.|||||++|
T Consensus       271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN  346 (513)
T KOG2052|consen  271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN  346 (513)
T ss_pred             hhccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence            98875554    57899999999999999943    558999999999999999999994     477889999999999


Q ss_pred             EEEcCCcceEEeecCCCcccCCC--ccCcCcccccccCCccCchhhccCC----CC--chhhHHHHHHHHHHHHhCC---
Q 005933          483 VLLDNDMNPKISDFGMARAFGVD--QTEANTDRVVGTYGYMSPEYAIDGL----FS--VKSDVFSFGVLVLEIVCGK---  551 (669)
Q Consensus       483 Ill~~~~~~kl~Dfgla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~t--~~sDVwS~G~~l~elltG~---  551 (669)
                      |||.+++.+.|+|+|||-.....  ......+..+||.+|||||++.+.-    +.  ..+||||||.++||+....   
T Consensus       347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g  426 (513)
T KOG2052|consen  347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG  426 (513)
T ss_pred             EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence            99999999999999999876544  2344456789999999999996542    11  2599999999999997632   


Q ss_pred             -------CCCCCCCCCCccchhhHhhhhcccccchhhcccccCC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          552 -------RNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG-SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       552 -------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                             .||.  +.-+...-...    ..+..-.+-+.+.+.. -.+.+....+.+||..||..+|..|-|+--+-+.|
T Consensus       427 gi~eey~~Pyy--d~Vp~DPs~ee----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl  500 (513)
T KOG2052|consen  427 GIVEEYQLPYY--DVVPSDPSFEE----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL  500 (513)
T ss_pred             CEehhhcCCcc--cCCCCCCCHHH----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence                   2211  11000000000    1111111111222221 23345677889999999999999999999998888


Q ss_pred             cCCCC
Q 005933          624 SGERS  628 (669)
Q Consensus       624 ~~~~~  628 (669)
                      .++..
T Consensus       501 ~~l~~  505 (513)
T KOG2052|consen  501 AKLSN  505 (513)
T ss_pred             HHHhc
Confidence            77654

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.9e-35  Score=302.56  Aligned_cols=239  Identities=21%  Similarity=0.305  Sum_probs=186.6

Q ss_pred             eeeecCccceEEEEeCC-------------------------CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEE
Q 005933          357 KLGEGGFGPVYRGMLTE-------------------------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL  411 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  411 (669)
                      .||+|+||.||+|.+..                         ...|++|++..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998521                         23589998865544455678899999999999999999


Q ss_pred             EEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc--
Q 005933          412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM--  489 (669)
Q Consensus       412 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~--  489 (669)
                      ++++......++||||+++|+|..++..  ..+.+++..+..++.||++||+|||+.+   |+||||||+|||+++.+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999999853  2346889999999999999999999988   99999999999998644  


Q ss_pred             -----ceEEeecCCCcccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCCc
Q 005933          490 -----NPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHH  562 (669)
Q Consensus       490 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~ell-tG~~p~~~~~~~~~  562 (669)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 3799999987643211      12346778999998876 56899999999999999995 68877543221110


Q ss_pred             cchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          563 HNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                         .             .......  ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       231 ---~-------------~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ---E-------------RFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---H-------------HHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence               0             0000000  011112246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.9e-36  Score=317.34  Aligned_cols=197  Identities=24%  Similarity=0.365  Sum_probs=170.9

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhC-C-----CceeEEEEEEecCCcceE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-H-----RNLVRLLGCCTLRDERML  423 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~l  423 (669)
                      +|++.+.||+|.||.|.++... +++.||||++++ ...-.++...|+.+|..|+ |     -|+|+++++|...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7899999999999999999965 599999999954 3445677788999999997 4     389999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc--ceEEeecCCCcc
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM--NPKISDFGMARA  501 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~--~~kl~Dfgla~~  501 (669)
                      |+|.+ ..+|.++|.... ...++...+..|+.||+.||.+||+.+   |||+||||+||||.+..  .+||+|||.++.
T Consensus       266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99999 459999996543 344899999999999999999999998   99999999999997543  799999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  558 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~  558 (669)
                      ....     ...+..++.|+|||++.+.+|..+.||||||||++||++|.+.|+...
T Consensus       341 ~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  341 ESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            4322     125678999999999999999999999999999999999987765433

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.5e-35  Score=298.38  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=201.1

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      +|++.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999965 5899999998643 2334678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++... ....+++..++.++.||+.||.|||+.+   ++|+||||+||++++++.++|+|||++..+..... 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999988532 3345789999999999999999999998   99999999999999999999999999876533211 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                       ......++..|+|||++.+..++.++||||||+++|+|++|..|+......   ....   ... ...         ..
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~---~~~-~~~---------~~  218 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLIL---KVC-QGS---------YK  218 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHH---HHh-cCC---------CC
Confidence             122356788999999999889999999999999999999999996532110   0000   000 000         00


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ..+...+..+.+++.+||+.||++||++.+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1122234567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.5e-35  Score=296.76  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=202.7

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      ++|++.+.||+|+||.||+|...+ ++.+++|.+.....  .+++.+|+++++.++|+||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578899999999999999999875 78999999865432  678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999853  2356899999999999999999999998   99999999999999999999999999887543221 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                       ......++..|+|||++.+..++.++||||||+++++|++|+.|+.........  .     ....     .....+  
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~-----~~~~-----~~~~~~--  219 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F-----MIPN-----KPPPTL--  219 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h-----hhcc-----CCCCCC--
Confidence             222345788999999999889999999999999999999999986543221100  0     0000     000000  


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..+......+.+++.+||+.+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            111223356889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-36  Score=282.79  Aligned_cols=248  Identities=26%  Similarity=0.351  Sum_probs=206.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++++.||+|-||.||.|+.+. +-.||+|++.+.   ..+...++.+|+++-..|+||||++++++|.+....+|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            4689999999999999999999654 778999999764   234457899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      +||..+|+|...|.+ .+...+++.....++.|+|.||.|+|..+   ++||||||+|+|++..+.+||+|||-+..-. 
T Consensus       101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999953 34556888999999999999999999998   9999999999999999999999999876421 


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                         .......+||..|.|||...+...+...|+|++|++.||++.|.+||+.....   ..+.            ++...
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYk------------rI~k~  237 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYK------------RIRKV  237 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHH------------HHHHc
Confidence               22334578999999999999999999999999999999999999997643311   1110            11111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  -.++...+..+.++|.+|+..+|.+|.+..|++.
T Consensus       238 ~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  238 D--LKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             c--ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence            1  1223334457789999999999999999999875

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.3e-35  Score=306.77  Aligned_cols=257  Identities=28%  Similarity=0.462  Sum_probs=199.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCc----EEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQ----EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|...+.||+|+||.||+|.+. ++.    .||+|.+..... ....++.+|+.+++.++||||+++++++... ...+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56778899999999999999864 343    578998865432 2344788999999999999999999998654 5679


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ++||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999998532  335889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   ...             +++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~-------------~~~  224 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIP-------------DLL  224 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH-------------HHH
Confidence            3322222223445678999999998999999999999999999997 88875422111   111             011


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ........+...+..+.+++..||..+|++||++.++++.|+....
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         225 EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1000001111234567899999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-35  Score=302.16  Aligned_cols=240  Identities=23%  Similarity=0.402  Sum_probs=189.8

Q ss_pred             CeeeecCccceEEEEeCC--------CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          356 NKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999998643        234888888665555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc--------eEEeecCCC
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--------PKISDFGMA  499 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~--------~kl~Dfgla  499 (669)
                      +++|+|..++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999543  235899999999999999999999998   999999999999987765        699999988


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCccchhhHhhhhccccc
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK-RNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      .....      .....++..|+|||++.+. .++.++||||||+++|||++|. .|+.......   ..           
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~-----------  215 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KL-----------  215 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HH-----------
Confidence            65422      1224577889999999864 5799999999999999999995 4432211100   00           


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                        .....  ....+......+.+++.+||+.+|++|||++++++.|+
T Consensus       216 --~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         216 --QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              00000  11122223356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-35  Score=301.04  Aligned_cols=247  Identities=25%  Similarity=0.406  Sum_probs=201.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999976 48899999986543 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++...    .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+.... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999998532    6899999999999999999999998   9999999999999999999999999998764332 


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       .......++..|+|||++.+..++.++||||||+++|+|++|+.|+....+..   ...             .+.....
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~-------------~~~~~~~  215 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLF-------------LIPKNNP  215 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHH-------------HhhhcCC
Confidence             12233567889999999999899999999999999999999999975332110   000             0000011


Q ss_pred             CCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLS-EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...... .+..+.+++.+||+.+|++||+++++++
T Consensus       216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            111111 3456789999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-35  Score=297.61  Aligned_cols=238  Identities=22%  Similarity=0.423  Sum_probs=188.5

Q ss_pred             CeeeecCccceEEEEeCCCc-----------EEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          356 NKLGEGGFGPVYRGMLTEGQ-----------EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...|.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999986533           5788877544333 6789999999999999999999999988 778999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-------ceEEeecC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-------NPKISDFG  497 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-------~~kl~Dfg  497 (669)
                      |||+++|+|.+++....  ..+++..+..++.||+.||+|||+.+   |+|+||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999996432  26899999999999999999999988   99999999999999887       79999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCccchhhHhhhhcc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWT  574 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG-~~p~~~~~~~~~~~~~~~~~~~~~  574 (669)
                      ++.....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+........   .    ..+.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~----~~~~  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---E----RFYQ  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---H----HHHh
Confidence            9886532      1223466789999999876  789999999999999999995 555432211100   0    0000


Q ss_pred             cccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          575 EDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                              .   ....+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       221 --------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 --------D---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --------c---CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    0   00011111267889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.2e-35  Score=310.89  Aligned_cols=241  Identities=27%  Similarity=0.389  Sum_probs=192.2

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~  425 (669)
                      +|++.+.||+|+||.||++... +++.||||++.+..   ....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999965 48899999987532   234567788999998885 577888999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|..++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999999843   345899999999999999999999998   999999999999999999999999998754222


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .  .......|+..|+|||++.+..++.++|||||||++|||++|+.|+......   .....            +....
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~------------i~~~~  217 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQS------------IMEHN  217 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH------------HHhCC
Confidence            1  1223356899999999999999999999999999999999999996532211   11100            11100


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  616 (669)
                      .  ..+......+.+++.+||+.+|.+|++.
T Consensus       218 ~--~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 V--SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             C--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            1  1122234567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.5e-35  Score=299.86  Aligned_cols=256  Identities=27%  Similarity=0.389  Sum_probs=202.0

Q ss_pred             cCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      ++|++.+.||+|+||.||+|..+      +.+.|++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888899999999999999964      2467999988654433 4678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeec
Q 005933          423 LIYEYLPNKSLEQFIFDVTRT------KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF  496 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  496 (669)
                      +||||+++++|.+++......      ..+++..+..++.||+.||+|||+.+   ++|+||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999654322      25899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhccc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      |++........ .......++..|+|||.+.+..++.++||||||+++++|++ |..|+......   ......      
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~------  231 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL------  231 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH------
Confidence            99875432211 12223355678999999988889999999999999999999 66665321110   111000      


Q ss_pred             ccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                            ....+....+...+..+.+++.+||+.+|++||++.+++..|.
T Consensus       232 ------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 ------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                  0000001112233457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.9e-35  Score=295.84  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=202.8

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|+..+.||.|+||.||.+... +++.+++|.+...  ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5788899999999999999854 4889999988643  334567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999985432 355899999999999999999999988   99999999999999999999999999886543332


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||.+.+..++.++||||||++++||++|..|+......   ...   .         .+......
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~---~---------~~~~~~~~  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLV---V---------KIVQGNYT  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHH---H---------HHHcCCCC
Confidence              223356889999999998888999999999999999999999886432111   000   0         00000000


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                       ......+..+.+++.+||+.+|++||++.++++.+
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence             11122345688999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.2e-35  Score=305.65  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=197.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57888999999999999999975 48899999986443 33345778999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      ++ ++|.+++...  ...+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5898888542  345889999999999999999999998   99999999999999999999999999876432221


Q ss_pred             CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc---cccchhhcc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT---EDRSLELID  583 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  583 (669)
                        ......++..|+|||++.+. .++.++||||||+++|||++|++|+........   .........   .......+.
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhc
Confidence              12234568899999998754 578899999999999999999998764332111   111111000   000000000


Q ss_pred             ---------cccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 ---------KSLDG----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ---------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                               +....    ......+..+.+|+.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                     00000    000112346789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-35  Score=297.32  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=203.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      ++|++.+.||.|+||.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999975 47889999997666566788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+....  
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  155 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--  155 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence            999999998542  245899999999999999999999998   9999999999999999999999999987653321  


Q ss_pred             cCcccccccCCccCchhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          509 ANTDRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .......++..|+|||.+...   .++.++||||||+++|||++|+.|+.......  ......     .   .......
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~~-----~---~~~~~~~  225 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLIS-----K---SNFPPPK  225 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-----h---ccCCCcc
Confidence            112235678899999999877   88999999999999999999999865322110  000000     0   0000000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +  ......+..+.+++.+||+.+|.+||++.+|+.
T Consensus       226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0  112234567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.6e-35  Score=298.62  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=199.9

Q ss_pred             CCCccCeeeecCccceEEEEeCCCcEEEEEEecccC------ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS------GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      +|.+.+.||+|+||.||+|...+++.+|||.+....      ......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467889999999999999998889999999886432      12235688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      +||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999943   245789999999999999999999988   99999999999999999999999999876532


Q ss_pred             Cc----cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          505 DQ----TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       505 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ..    .........++..|+|||++.+..++.++||||||+++++|++|+.|+.......  ....    ...      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~----~~~------  222 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY----IGA------  222 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH----hhh------
Confidence            11    1112223568889999999998889999999999999999999999865321110  0000    000      


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ........+......+.+++.+||+.+|++||++.+++.
T Consensus       223 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 --HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              000011122234466789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.6e-35  Score=302.74  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=200.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .+.|++.++||+|+||.||+|.... ++.|++|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            3578889999999999999999765 899999999776666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|..++.+.  ...+++..+..++.||+.+|+|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            9999999887432  345899999999999999999999988   9999999999999999999999999987542221 


Q ss_pred             CcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          508 EANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                       .......++..|+|||++.     ...++.++|||||||++|||++|..|+......      ....... ...     
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~-----  231 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSE-----  231 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHh-cCC-----
Confidence             1122356788999999984     345788999999999999999999986432211      0000000 000     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .+..  ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         232 PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000  111223456789999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.4e-35  Score=302.40  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=198.8

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      .|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+.+++.++|||++++++++..++..++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            35677899999999999999764 78889999876655567789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|..++..  ....+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++.......  .
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            9999998753  2346899999999999999999999998   9999999999999999999999999987643221  1


Q ss_pred             CcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          510 NTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ......++..|+|||++.     +..++.++|||||||++|||++|++|+......   ...   ..... ..     ..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~---~~~~~-~~-----~~  226 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVL---LKIAK-SE-----PP  226 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHH---HHHhh-cC-----CC
Confidence            223356889999999984     345788999999999999999999886432110   000   00000 00     00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .+  ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         227 TL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00  1111234568899999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-35  Score=312.32  Aligned_cols=241  Identities=22%  Similarity=0.275  Sum_probs=187.6

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHH-HHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVL-LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999976 47889999986532   222334444444 56788999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      ++|..++..   ...+.+..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            999999843   345788889999999999999999998   999999999999999999999999998753221  122


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+......   .....            +.....  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~------------i~~~~~--~~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDN------------ILNKPL--QL  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHH------------HHhCCc--CC
Confidence            33457899999999999999999999999999999999999996532211   11000            000001  11


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....+..+.+++.+||+.+|.+||++.+.+.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            1223456789999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.1e-35  Score=297.73  Aligned_cols=250  Identities=28%  Similarity=0.379  Sum_probs=190.6

Q ss_pred             CeeeecCccceEEEEeCC----CcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEec-CCcceEEEeecC
Q 005933          356 NKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDERMLIYEYLP  429 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~~~  429 (669)
                      +.||+|+||.||+|.+.+    ...||+|++... .....+.+.+|+.+++.++|||++++++++.. +...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998542    457999998543 23346788999999999999999999998754 556789999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC-
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-  508 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  508 (669)
                      +++|.+++...  ...+++..++.++.||++||.|||+.+   ++||||||+|||+++++.+||+|||+++.+...... 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998542  234678888999999999999999988   999999999999999999999999999765322111 


Q ss_pred             -cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          509 -ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-RNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       509 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                       .......++..|+|||.+.+..++.++||||||+++|||++|. +|+....   ...+...   ....          .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~---~~~~----------~  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVY---LLQG----------R  219 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH---HhcC----------C
Confidence             1112234567899999998889999999999999999999964 4433211   1111111   0000          0


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ....+...+..+.+++.+||+.+|++||++.+|+..|+..
T Consensus       220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0011112235688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1e-34  Score=298.99  Aligned_cols=248  Identities=25%  Similarity=0.404  Sum_probs=202.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..|+..++||.|+||.||+|... +++.||||.+.... ......+.+|+.+++.++|+||+++++++..+...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35677789999999999999975 48899999986543 34567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++..    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998842    35889999999999999999999988   99999999999999999999999999976533221


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.|+....+...                ...+.....
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------------~~~~~~~~~  218 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV----------------LFLIPKNNP  218 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH----------------hhhhhcCCC
Confidence              22234678899999999988999999999999999999999998653221100                001111111


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .......+..+.+++.+||+.+|++||++.+++..
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            22333456778899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.8e-35  Score=301.14  Aligned_cols=252  Identities=22%  Similarity=0.391  Sum_probs=199.2

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      ++|.+.+.||+|+||.||++... +++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            47788899999999999999965 58899999987655555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++..   .+.+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+....  
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            99999999843   346899999999999999999999998   9999999999999999999999999987653221  


Q ss_pred             cCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          509 ANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .......++..|+|||++.   ...++.++|||||||++|+|++|..|+....+..  ...    .....    ......
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~----~~~~~----~~~~~~  230 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALF----LMTKS----NFQPPK  230 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHH----hhhcc----CCCCCc
Confidence            1223456889999999974   4568899999999999999999998854222110  000    00000    000000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....  ...+..+.+++.+||+.+|++||++.+|++
T Consensus       231 ~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 LKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0000  112345789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.4e-35  Score=302.40  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..+|.+.+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            468999999999999999999964 6999999999765555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++.+    ..+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999999843    34789999999999999999999998   99999999999999999999999999876533221


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+........  +..    .....      .+.. 
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~----~~~~~------~~~~-  235 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IATNG------TPEL-  235 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee----eccCC------CCCC-
Confidence              12234678899999999998999999999999999999999998643221110  000    00000      0000 


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             111223355779999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.2e-35  Score=297.70  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=199.8

Q ss_pred             CCCccCeeeecCccceEEEEeCC--CcEEEEEEeccc----------CccchHHHHHHHHHHHH-hCCCceeEEEEEEec
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLSKS----------SGQGVEEFKNEVLLIAK-LQHRNLVRLLGCCTL  417 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~  417 (669)
                      +|++.+.||+|+||.||+|....  ++.+|||.+...          ......++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999765  788999987532          22234567788888875 799999999999999


Q ss_pred             CCcceEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcCCcceEEee
Q 005933          418 RDERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISD  495 (669)
Q Consensus       418 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~D  495 (669)
                      .+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999988542 234568999999999999999999996 55   99999999999999999999999


Q ss_pred             cCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc
Q 005933          496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       496 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      ||++.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......      ....     
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~-----  223 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLAT-----  223 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHH-----
Confidence            99998654322   233456888999999999888999999999999999999999885422110      0000     


Q ss_pred             ccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                          ...............+..+.+++.+||+.||++||++.|+..+|+
T Consensus       224 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 ----KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ----HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                000000000011122356889999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.3e-35  Score=298.26  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=197.8

Q ss_pred             CCccCeeeecCccceEEEEeC----CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCC------
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------  419 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------  419 (669)
                      |.+.+.||+|+||.||+|.+.    .++.||||++...  .....+++.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999853    3688999998654  2334667899999999999999999999886543      


Q ss_pred             cceEEEeecCCCCHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeec
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVT---RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF  496 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  496 (669)
                      ..++++||+++|+|..++....   +...+++..+++++.||+.||+|||+.+   |+|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2368899999999998875322   2234789999999999999999999988   999999999999999999999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhccc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |++|+.....   ..+.....    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----K  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----c
Confidence            99987643322222223345678999999998899999999999999999999 7777542211   11111110    0


Q ss_pred             ccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..         ....+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus       231 ~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GN---------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00         0011122345788999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.2e-35  Score=302.66  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=199.5

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4556688999999999999965 47889999986443 344567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++.    ...+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+..... 
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            9999999883    245899999999999999999999988   99999999999999999999999999876543221 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                       ......++..|+|||++.+..++.++||||||++++||++|+.|+....+..   ...             .+......
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~-------------~~~~~~~~  219 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF-------------LIPKNSPP  219 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh-------------hhhcCCCC
Confidence             1223457889999999999899999999999999999999999864322111   000             00000111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ......+..+.+++.+||+.+|++||++.+++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            1222344568899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-34  Score=299.69  Aligned_cols=264  Identities=21%  Similarity=0.310  Sum_probs=199.4

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.+.||+|++|.||+|... +++.||+|++....  ....+.+.+|+.+++.++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999976 48999999986432  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|..++.   ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999999988773   3345899999999999999999999988   9999999999999999999999999998764322


Q ss_pred             cCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh--------hhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW--------RLWTEDR  577 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  577 (669)
                      .  ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+................        ..+....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1223457789999999876 468899999999999999999999875432211110000000        0000000


Q ss_pred             c-hhhcccccCCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 S-LELIDKSLDGSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~-~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      . .....+......+.     ..+..+.+++.+||+.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0 00000000000011     12356789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.9e-35  Score=301.32  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=192.0

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHh---CCCceeEEEEEEecC-----C
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKL---QHRNLVRLLGCCTLR-----D  419 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~-----~  419 (669)
                      +|++.+.||+|+||.||++... +++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999976 488999999865322  2234566788777766   699999999988642     3


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            47899999974 8888885432 344899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc--
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR--  577 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--  577 (669)
                      .......   ......++..|+|||++.+..++.++|||||||++|||++|++|+.......   .............  
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED  229 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence            8653221   1223467889999999998899999999999999999999999865332211   1111111000000  


Q ss_pred             -ch---hhcccccCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 -SL---ELIDKSLDG-------SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 -~~---~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ..   .........       .........+.+++.+||+.||++|||+.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             00   000000000       000122346789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.6e-35  Score=301.71  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=197.6

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      |+..+.||+|+||.||++... +++.||||.+.....   .....+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999965 588999999865322   2235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            99999999885432 235899999999999999999999988   9999999999999999999999999987643221 


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.|+..........   ......         .. ..
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~---------~~-~~  221 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLV---------KE-VQ  221 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhh---------hh-hh
Confidence              1223468999999999999999999999999999999999999975422111000   000000         00 00


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      ...+......+.+|+..||+.||++|||     +.|+++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            0111122346789999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.5e-35  Score=302.99  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=202.2

Q ss_pred             cCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .+|++.+.||.|++|.||+|.. .+++.|+||.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688999999999999999995 458999999987655556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|..++..    ..+++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            99999998843    34899999999999999999999998   99999999999999999999999999876533221 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                       ......++..|+|||.+.+..++.++|||||||++|+|++|+.|+........      ....... ..     ..+  
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~-~~-----~~~--  235 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATN-GT-----PEL--  235 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc-CC-----ccc--
Confidence             12234678899999999988899999999999999999999998643221110      0000000 00     000  


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            111223346778999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5e-35  Score=312.89  Aligned_cols=260  Identities=23%  Similarity=0.273  Sum_probs=195.3

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-----
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----  419 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----  419 (669)
                      ..++|++.+.||+|+||.||++... +++.||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999965 4899999998653  2334567889999999999999999999986543     


Q ss_pred             -cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          420 -ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       420 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                       ..++||||+++ +|...+.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46899999975 5655552     23788899999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc--
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED--  576 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--  576 (669)
                      ++.....   .......++..|+|||++.+..++.++|||||||++|+|++|+.|+.......   ............  
T Consensus       170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~  243 (359)
T cd07876         170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGTPSA  243 (359)
T ss_pred             ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCcH
Confidence            9754221   12233568899999999999999999999999999999999999976432111   000000000000  


Q ss_pred             -----------------------cchhhcccccCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          577 -----------------------RSLELIDKSLDG---SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       577 -----------------------~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                                             ...+........   .........+.+|+.+||+.||++|||+.|++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                                   000000000000   0011123467899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-34  Score=293.53  Aligned_cols=251  Identities=35%  Similarity=0.530  Sum_probs=199.6

Q ss_pred             CCccCeeeecCccceEEEEeCC-----CcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      |++.+.||.|+||.||++...+     +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999999764     388999999655433 5678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854222 22899999999999999999999998   999999999999999999999999999876443


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ...... ...++..|+|||.+.+..++.++||||||+++++|++ |..|+.....   .......             ..
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~-------------~~  219 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL-------------KK  219 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH-------------hc
Confidence            221111 2336789999999988889999999999999999998 6666443111   1111100             00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                      ......+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            000111122455788999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.6e-35  Score=316.72  Aligned_cols=252  Identities=21%  Similarity=0.281  Sum_probs=195.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||.||++... +++.||||++...   .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999975 4899999998643   2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999843   345899999999999999999999998   999999999999999999999999998754221


Q ss_pred             ccC---------------------------------cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 005933          506 QTE---------------------------------ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR  552 (669)
Q Consensus       506 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~  552 (669)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00113468999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 005933          553 NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN---MSSVVL  621 (669)
Q Consensus       553 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  621 (669)
                      |+....+..   ....   ....       ...+.-.........+.+++.+++. +|++|++   +.++++
T Consensus       235 Pf~~~~~~~---~~~~---i~~~-------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         235 PFCSETPQE---TYRK---VMNW-------KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCHHH---HHHH---HHcC-------CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            975432211   0000   0000       0000000011123456778888764 9999996   555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-34  Score=308.89  Aligned_cols=191  Identities=22%  Similarity=0.317  Sum_probs=164.2

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ...+|.+.+.||+|+||.||+|.... ++.||+|+....      ....|+.++++++|+||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            45689999999999999999999764 778999975332      23569999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      ++. ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            995 688888743  3456899999999999999999999998   999999999999999999999999998753211 


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN  553 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p  553 (669)
                        .......||..|+|||++.+..++.++|||||||++|||+++..+
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence              122235689999999999999999999999999999999986554

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.1e-35  Score=298.79  Aligned_cols=254  Identities=23%  Similarity=0.353  Sum_probs=200.4

Q ss_pred             cCCCccCeeeecCccceEEEEeCC----CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|.+.++||+|+||.||+|...+    ...||||...... ....+.+.+|+.+++.++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            467888999999999999999643    3469999886554 3456789999999999999999999998865 567899


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999542  235899999999999999999999988   99999999999999999999999999886543


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..... .....++..|+|||.+....++.++||||||++++||++ |..|+......   ......    ....      
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~~------  225 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI----ENGE------  225 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCC------
Confidence            32111 112234568999999988889999999999999999986 99886432211   111110    0000      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                         ....+...+..+.+++.+|+..+|++||++.+++..|+..
T Consensus       226 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         226 ---RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               0011223345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.7e-35  Score=295.33  Aligned_cols=247  Identities=28%  Similarity=0.427  Sum_probs=197.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|.+.+.||+|+||.||++.. .++.||+|.+...  ...+.+.+|+.++..++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999985 5788999998543  2346789999999999999999999998654 5799999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......    
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            99999999643 2345899999999999999999999988   999999999999999999999999998754221    


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                       ......+..|+|||.+.+..++.++||||||+++|||++ |+.|+......   .....             +......
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~-------------~~~~~~~  216 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKEC-------------VEKGYRM  216 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHH-------------HhCCCCC
Confidence             112234568999999998899999999999999999998 88875432211   11100             0001111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ..+...+..+.+++.+||+.+|++||++.+++..|+.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1122234677899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-35  Score=301.18  Aligned_cols=253  Identities=23%  Similarity=0.400  Sum_probs=201.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|++.++||.|++|.||++... ++..||+|.+........+.|..|+.++++++|+||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            457889999999999999999975 5899999998766556677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++.+.  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            9999999998542  345899999999999999999999998   9999999999999999999999999987643221 


Q ss_pred             CcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          508 EANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                       .......++..|+|||.+.     ...++.++||||||+++|||++|+.|+......   ...   ... ....     
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~---~~~-~~~~-----  224 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVL---LKI-LKSE-----  224 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHH---HHH-hcCC-----
Confidence             1223356788999999985     345778999999999999999999986532211   000   000 0000     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .+.+  ..+...+..+.+++.+||+.+|.+||++.++++-
T Consensus       225 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0000  0111223467899999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.7e-35  Score=300.95  Aligned_cols=255  Identities=23%  Similarity=0.345  Sum_probs=203.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999965 48899999886543 33467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      +++++|.+++..   .+.+++..+..++.+++.||.|||+ .+   ++|+||+|+||++++++.++|+|||++...... 
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            999999998843   3458999999999999999999997 45   999999999999999999999999998654221 


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-----cchhhHhhhhcccccchhh
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH-----HNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  581 (669)
                         ......++..|+|||++.+..++.++|||||||++|+|++|+.|+........     ..+.....         ..
T Consensus       158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~  225 (284)
T cd06620         158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ---------QI  225 (284)
T ss_pred             ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH---------HH
Confidence               12235689999999999888999999999999999999999999764332211     00011100         00


Q ss_pred             cccccCCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          582 IDKSLDGSYS-LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       582 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..... ...+ ...+..+.+++.+||+.||++||++.|+++..-
T Consensus       226 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         226 VQEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             hhccC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            00000 0111 123456889999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.6e-35  Score=312.02  Aligned_cols=260  Identities=23%  Similarity=0.282  Sum_probs=195.6

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-----
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----  419 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----  419 (669)
                      ..++|.+.+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999965 48899999987542  234567889999999999999999999886443     


Q ss_pred             -cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          420 -ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       420 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                       ..++||||+++ +|...+.     ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             46899999975 5666652     23788999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc---
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE---  575 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---  575 (669)
                      ++.....   .......++..|+|||++.+..++.++|||||||++|||++|+.|+........   ..........   
T Consensus       166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  239 (355)
T cd07874         166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCP  239 (355)
T ss_pred             cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence            9764322   122335689999999999999999999999999999999999999754321110   0000000000   


Q ss_pred             -------ccchhhcc---------------ccc---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          576 -------DRSLELID---------------KSL---DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       576 -------~~~~~~~~---------------~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                             ......+.               ..+   ...........+.+++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   00000000               000   000111123467899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.8e-34  Score=295.21  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=194.0

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-----ccchHHHHHHHHHHHHhCCCceeEEEEEEecC--Ccc
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER  421 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~  421 (669)
                      .+|...+.||+|+||.||++... ++..||+|++....     ......+.+|+.+++.++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999975 48999999886432     12345788999999999999999999988653  557


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++++||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999853   335889999999999999999999988   99999999999999999999999999876


Q ss_pred             cCCCcc-CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQT-EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      +..... ........++..|+|||++.+..++.++||||||+++|||++|+.|+......      ...         ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~---------~~  220 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAI---------FK  220 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHH---------HH
Confidence            533211 11222345788999999999888999999999999999999999986532110      000         00


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..........+......+.+++ +||..+|++||+++||+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1000111122222234455666 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.7e-35  Score=301.15  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=200.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999976 5899999988653 233456889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      +++++|..++........+++..+..++.||+.||.|||+. +   ++|+||||+||+++.++.++|+|||++..+... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            99999999986543345689999999999999999999974 5   999999999999999999999999998765322 


Q ss_pred             cCcCcccccccCCccCchhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                         ......++..|+|||.+.+.      .++.++|||||||++|+|++|+.|+......   ......         ..
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~---------~~  221 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQL---------SA  221 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHH---------HH
Confidence               12234578899999998554      3588999999999999999999996432111   111000         00


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .... .....+......+.+++.+||+.+|++||++.+++.
T Consensus       222 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         222 IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1110 111223334567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-34  Score=294.66  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=204.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+.+++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999965 58899999986532 33567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++........+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999965444456899999999999999999999998   99999999999999999999999999877644332


Q ss_pred             Cc--CcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          508 EA--NTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       508 ~~--~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ..  ......++..|+|||++... .++.++||||||++++||++|+.|+.......  ...    +....      ...
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~----~~~~~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLM----LTLQN------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHH----HHhcC------CCC
Confidence            21  22335688899999999877 78999999999999999999999965322110  000    00000      000


Q ss_pred             ccCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSY-SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...... ....+..+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111100 0123456789999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-34  Score=299.61  Aligned_cols=262  Identities=23%  Similarity=0.369  Sum_probs=201.4

Q ss_pred             HHHHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEe---
Q 005933          342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCT---  416 (669)
Q Consensus       342 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~---  416 (669)
                      +..+..+.++|++.+.||+|+||.||++... +++.+|+|.+... .....++.+|+.++..+ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3455567889999999999999999999975 4889999987543 22346788999999999 6999999999884   


Q ss_pred             --cCCcceEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          417 --LRDERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       417 --~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                        .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++||||||+||++++++.++|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              345689999999999999988542 23456889999999999999999999998   999999999999999999999


Q ss_pred             eecCCCcccCCCccCcCcccccccCCccCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhH
Q 005933          494 SDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH  568 (669)
Q Consensus       494 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~  568 (669)
                      +|||++........  ......++..|+|||++..     ..++.++|||||||++|||++|+.|+........  +   
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~---  238 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--L---  238 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--H---
Confidence            99999876532211  2223468899999999853     4578899999999999999999998653221100  0   


Q ss_pred             hhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                       ... .....     ..+  ..+......+.+++.+||+.+|++||++.||++.+
T Consensus       239 -~~~-~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         239 -FKI-PRNPP-----PTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -hhc-cccCC-----Ccc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             000 00000     000  00111234688999999999999999999998743

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=310.28  Aligned_cols=240  Identities=23%  Similarity=0.290  Sum_probs=184.9

Q ss_pred             eeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHh---CCCceeEEEEEEecCCcceEEEeecCC
Q 005933          358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL---QHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      ||+|+||+||++... +++.||||++.+..   ......+..|..++..+   +||||+++++.+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999975 48999999986432   22334556677777665   699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.++|+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            999998843   455899999999999999999999998   9999999999999999999999999987532211  22


Q ss_pred             cccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS  589 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (669)
                      .....||..|+|||++.+. .++.++|||||||++|||++|+.|+......   ...    .......      ..+.  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~----~~i~~~~------~~~~--  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMY----RNIAFGK------VRFP--  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHH----HHHHcCC------CCCC--
Confidence            2345789999999999765 4899999999999999999999996432111   000    0000000      0000  


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCC----CHHHHHH
Q 005933          590 YSLSEALRCIQVGLLCVQQRPEDRP----NMSSVVL  621 (669)
Q Consensus       590 ~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~  621 (669)
                       .......+.+++.+||+.||.+||    ++.++++
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             011234677999999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-34  Score=294.67  Aligned_cols=246  Identities=24%  Similarity=0.365  Sum_probs=200.3

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.+.||+|+||.+|++... +++.||+|.+...  .....+++.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999965 5899999998643  233456889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988542 2335789999999999999999999988   99999999999999999999999999976533221


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||++.+..++.++||||||+++++|++|+.|+......                   +.+...+.
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------------------~~~~~~~~  215 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------------------NLVLKIIR  215 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-------------------HHHHHHhc
Confidence              122345788899999999889999999999999999999999885422110                   11111111


Q ss_pred             C---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 G---SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +   ..+......+.+++.+||+.+|++||++.+|++
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         216 GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1   122233457889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-34  Score=293.56  Aligned_cols=247  Identities=27%  Similarity=0.410  Sum_probs=199.6

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-----ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      +|+..+.||+|++|.||+|+.. +++.|++|.+....     .+..+.+.+|+.+++.++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677799999999999999976 68999999986543     23456789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      +||+++++|.+++..   ...+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999853   345889999999999999999999998   99999999999999999999999999876533


Q ss_pred             CccCcCcccccccCCccCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|+|++|+.|+.....      ..........        
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~--------  217 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRS--------  217 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhc--------
Confidence            22   223456788999999987776 89999999999999999999999653221      0010000000        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ......+......+.+++.+||+.+|++||++.+++.
T Consensus       218 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         218 -KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             0001112223466789999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.2e-35  Score=302.98  Aligned_cols=264  Identities=22%  Similarity=0.341  Sum_probs=198.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.++||+|+||.||++..+ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999999976 489999999865432  235678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|..+...   ...+++..++.++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887632   334899999999999999999999998   9999999999999999999999999987653322


Q ss_pred             cCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-chhhHhh-------hhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH-NLLGHAW-------RLWTEDR  577 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~-~~~~~~~-------~~~~~~~  577 (669)
                        .......++..|+|||++.+ ..++.++||||||++++||++|++|+......... .+.....       ..+....
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence              22233567889999999875 45788999999999999999999886532211100 0000000       0000000


Q ss_pred             ch-hhcccccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SL-ELIDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~-~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .. ....+......     ....+..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00 00000000000     1122456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.7e-34  Score=298.69  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=196.7

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      |+..+.||+|+||+||++... +++.||+|.+....   ......+.+|+.+++.++|+|++++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566789999999999999965 58899999986432   22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999998885432 345899999999999999999999998   9999999999999999999999999987643221 


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||++.+..++.++||||||+++|||++|..|+........   .......        ....  .
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~--------~~~~--~  221 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRR--------VLET--E  221 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHh--------hhcc--c
Confidence              12234689999999999989999999999999999999999999653221100   0000000        0000  0


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      .......+..+.+|+..||+.+|++||+     +.+++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            0112223346789999999999999999     566665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.4e-34  Score=292.35  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=199.3

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-cceEEEe
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-ERMLIYE  426 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~E  426 (669)
                      +|++.+.||+|++|.||++.... ++.||+|++....  ....+.+.+|+.++++++|+|++++++.+...+ ..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            47888999999999999999654 7889999986432  334567899999999999999999999876444 5789999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++... ....+++.++..++.+++.||++||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998643 3345899999999999999999999998   9999999999999999999999999998653322


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                        .......++..|+|||++.+..++.++||||||+++++|++|+.|+......      .......         ...+
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~---------~~~~  219 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRII---------EGKL  219 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH---------hcCC
Confidence              1223356788999999999999999999999999999999999886532111      0000000         0000


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                       ...+...+..+.+++.+||+.+|++||++.+++..
T Consensus       220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             11222344578899999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.7e-35  Score=313.91  Aligned_cols=259  Identities=21%  Similarity=0.231  Sum_probs=199.2

Q ss_pred             HHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCC
Q 005933          344 TIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD  419 (669)
Q Consensus       344 ~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  419 (669)
                      .+....++|++.+.||+|+||.||++... +++.||+|++.+.   .......+.+|+.+++.++||||+++++.+..+.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            33445689999999999999999999976 4889999998642   2233456788999999999999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++||||+++|+|.+++..    ..++...+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            99999999999999999843    24788899999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      ..+..... .......||+.|+|||++...    .++.++|||||||++|||++|+.|+......      .........
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~  262 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNH  262 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcC
Confidence            87532211 122345789999999998754    3788999999999999999999997532211      000010000


Q ss_pred             ccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 005933          576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPED--RPNMSSVVLML  623 (669)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  623 (669)
                      ..       .+...........+.+++.+||+..+.+  ||++.++++..
T Consensus       263 ~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         263 KN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            00       0000111123456778999999844443  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-34  Score=300.19  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=197.8

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc-----chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ-----GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      +|.+.+.||+|++|.||+|... +++.||||.+......     ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777899999999999999975 5899999999754322     345677899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+ +++|.+++....  ..+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999995422  36899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc------
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR------  577 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------  577 (669)
                      ...  ......++..|+|||.+.+ ..++.++||||||++++||++|.+++.....   ...+...........      
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD---IDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc---HHHHHHHHHHcCCCchhhhhh
Confidence            221  1222356788999998865 4678999999999999999999776543221   111111111100000      


Q ss_pred             ---chhhcccccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          578 ---SLELIDKSLDGSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       578 ---~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                         .............+     ......+.+++.+||+.+|++||++.|++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence               00000000001111     1224578899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.9e-35  Score=321.57  Aligned_cols=265  Identities=20%  Similarity=0.248  Sum_probs=192.7

Q ss_pred             HHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCC------CceeEEEEEEe
Q 005933          344 TIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH------RNLVRLLGCCT  416 (669)
Q Consensus       344 ~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~~~  416 (669)
                      ++...+++|.+.++||+|+||+||++... .++.||||+++... .....+..|+.++..++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999965 47889999986432 234556778888887765      45889999887


Q ss_pred             cC-CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCc-----
Q 005933          417 LR-DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDM-----  489 (669)
Q Consensus       417 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~-----  489 (669)
                      .. .+.++|||++ +++|.+++.+   ...+++..+..++.||+.||.|||++ +   |+||||||+||||+.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence            65 4678999988 7788888843   34689999999999999999999974 7   99999999999998765     


Q ss_pred             -----------ceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005933          490 -----------NPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  558 (669)
Q Consensus       490 -----------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~  558 (669)
                                 .+||+|||++....     .......||..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                       49999999875422     12234678999999999999999999999999999999999999986433


Q ss_pred             CCCccchhhHhhh----hcc----cccchhhccccc--CCC------------C---CHHHHHHHHHHHHHhccCCCCCC
Q 005933          559 ADHHHNLLGHAWR----LWT----EDRSLELIDKSL--DGS------------Y---SLSEALRCIQVGLLCVQQRPEDR  613 (669)
Q Consensus       559 ~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~--~~~------------~---~~~~~~~l~~li~~cl~~dP~~R  613 (669)
                      .......+.....    .+.    .....++.+...  ...            .   .......+.+|+.+||+.||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            2211111110000    000    000000000000  000            0   00113457799999999999999


Q ss_pred             CCHHHHHH
Q 005933          614 PNMSSVVL  621 (669)
Q Consensus       614 Ps~~evl~  621 (669)
                      ||++|+++
T Consensus       430 ~ta~e~L~  437 (467)
T PTZ00284        430 LNARQMTT  437 (467)
T ss_pred             CCHHHHhc
Confidence            99999986

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.8e-34  Score=300.63  Aligned_cols=196  Identities=25%  Similarity=0.402  Sum_probs=160.4

Q ss_pred             cCeeeecCccceEEEEeC---CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEec--CCcceEEEeecC
Q 005933          355 KNKLGEGGFGPVYRGMLT---EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERMLIYEYLP  429 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~  429 (669)
                      .++||+|+||.||+|...   +++.||+|.+....  ....+.+|+.++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999964   46789999986432  23567889999999999999999998854  345789999986


Q ss_pred             CCCHHHHhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE----cCCcceEEeecCCC
Q 005933          430 NKSLEQFIFDVT------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMA  499 (669)
Q Consensus       430 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~Dfgla  499 (669)
                       ++|..++....      ....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             47877764221      2235889999999999999999999998   9999999999999    45678999999999


Q ss_pred             cccCCCcc-CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005933          500 RAFGVDQT-EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGF  556 (669)
Q Consensus       500 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~  556 (669)
                      +.+..... ........+|..|+|||++.+. .++.++||||+||++|||++|++|+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            87643322 1223346789999999999774 589999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.4e-34  Score=294.07  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=196.1

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC-----ccchHHHHHHHHHHHHhCCCceeEEEEEEecC--Ccc
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER  421 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~  421 (669)
                      .+|.+.+.||+|+||.||+|...+ ++.||||.+....     ....+.+.+|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            478889999999999999999754 8999999875321     12346788999999999999999999998764  356


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            799999999999999853   244788999999999999999999998   99999999999999999999999999886


Q ss_pred             cCCCcc-CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQT-EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+......     . ..         .+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~-~~---------~~  220 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----A-AI---------FK  220 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----H-HH---------HH
Confidence            532211 11223346888999999998888999999999999999999999986422110     0 00         00


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..........+......+.+++.+|+. +|++||++++|++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            111111122333445567889999985 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-34  Score=310.98  Aligned_cols=260  Identities=22%  Similarity=0.267  Sum_probs=196.0

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC------
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------  418 (669)
                      ..++|.+.+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999965 48899999987542  33456788999999999999999999987543      


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                      ...++||||+++ +|...+.     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            346899999975 6776663     23788999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc--
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED--  576 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--  576 (669)
                      ++.....   .......++..|+|||++.+..++.++|||||||++|||++|+.||........   ...........  
T Consensus       173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~  246 (364)
T cd07875         173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCP  246 (364)
T ss_pred             ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence            9765322   122335689999999999999999999999999999999999999754322111   10000000000  


Q ss_pred             --------c---------------chhhccccc---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          577 --------R---------------SLELIDKSL---DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       577 --------~---------------~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                              .               ...+.....   ...........+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                    0               000000000   000111123467899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=306.93  Aligned_cols=255  Identities=20%  Similarity=0.247  Sum_probs=194.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||.||++... +++.||||++.+.   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999965 4899999998642   2234566889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999999532  345889999999999999999999998   999999999999999999999999998765332


Q ss_pred             ccCcCcccccccCCccCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          506 QTEANTDRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      .. .......|++.|+|||++..     ..++.++|||||||++|||++|+.|+......   ...   ...........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~~---~~i~~~~~~~~  228 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETY---GKIMNHKEHFQ  228 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HHH---HHHHcCCCccc
Confidence            21 11223468999999999863     45788999999999999999999996432111   000   00100000000


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccC--CCCCCCCHHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQ--RPEDRPNMSSVVLM  622 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~  622 (669)
                           +. ......+..+.+++.+|+..  ++..||++.+++..
T Consensus       229 -----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 -----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                 00 00111234567788887754  33347899988865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-34  Score=302.24  Aligned_cols=256  Identities=19%  Similarity=0.258  Sum_probs=200.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|.+.+.||+|+||.||++.... ++.||+|.+....   ....+.+.+|+.++..++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368889999999999999999764 7899999986543   234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999943   345899999999999999999999988   999999999999999999999999998642111


Q ss_pred             ccC-------------cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          506 QTE-------------ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       506 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      ...             .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....   ..+...   .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~---~  228 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQ---V  228 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---H
Confidence            110             011124568889999999988999999999999999999999998642211   111100   0


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      .. .   ....    .......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       229 ~~-~---~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         229 IS-D---DIEW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             Hh-c---ccCC----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            00 0   0000    00111234567899999999999999998777777755

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.9e-34  Score=293.12  Aligned_cols=254  Identities=22%  Similarity=0.352  Sum_probs=188.1

Q ss_pred             CeeeecCccceEEEEeCCC---cEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          356 NKLGEGGFGPVYRGMLTEG---QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      ++||+|+||.||+|...++   ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999985443   346677665433 334678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          432 SLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       432 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      +|.+++..... ...+++..+..++.||+.||+|||+.+   ++|+||||+|||++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999965322 244677788899999999999999988   99999999999999999999999999864322211122


Q ss_pred             cccccccCCccCchhhcc-------CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          511 TDRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwS~G~~l~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+....   .........    ......+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~----~~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DREVLNHVI----KDQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----hhcccccC
Confidence            233567889999998753       2457899999999999999975 55543211   111111111    11111222


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ++.+    .......+.+++..|| .+|++||++++|++.|.
T Consensus       231 ~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222    1123346778888999 67999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.7e-35  Score=332.55  Aligned_cols=255  Identities=21%  Similarity=0.319  Sum_probs=196.9

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecC--Ccce
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERM  422 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~  422 (669)
                      ..++|.+.++||+|+||+||++.... +..||+|.+...  .......|..|+.++..|+|||||++++++...  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            45689999999999999999999754 778999988643  233456789999999999999999999988553  4588


Q ss_pred             EEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCceeccCCCCCEEEcC----------
Q 005933          423 LIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSR----LRIIHRDLKASNVLLDN----------  487 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiH~Dikp~NIll~~----------  487 (669)
                      |||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999996532 23569999999999999999999998542    24999999999999964          


Q ss_pred             -------CcceEEeecCCCcccCCCccCcCcccccccCCccCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005933          488 -------DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  558 (669)
Q Consensus       488 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~G~~l~elltG~~p~~~~~  558 (669)
                             .+.+||+|||++..+....   ......+|+.|+|||++.+  ..++.++|||||||+||||++|+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   2358999999998653322   1233578999999999864  458899999999999999999999964321


Q ss_pred             CCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  ...++.    .         +....... ....+..+.+|+..||+.+|.+||++.|++.
T Consensus       248 ~--~~qli~----~---------lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 N--FSQLIS----E---------LKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             c--HHHHHH----H---------HhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            1  101110    0         00000000 0112456889999999999999999999983

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=284.91  Aligned_cols=245  Identities=26%  Similarity=0.385  Sum_probs=198.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecc--cCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      +++|++-+.||+|.|+.|++.... +|+.+|+|++..  -.....+++.+|+.|-+.|+||||++|.....+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467888899999999999998854 599999998753  23447788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEeecCCCccc
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAF  502 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~Dfgla~~~  502 (669)
                      |+|+|++|..-|-.   .-..++..+-..++||+.||.|+|.++   |+|||+||+|++|-+   ..-+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999765532   244678888899999999999999999   999999999999953   345999999999987


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      +   .....-...||++|||||++...+|+..+|||+.||+||-|+.|.+||...+   .                .++.
T Consensus       164 ~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~----------------~rly  221 (355)
T KOG0033|consen  164 N---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---Q----------------HRLY  221 (355)
T ss_pred             C---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---H----------------HHHH
Confidence            6   2233345789999999999999999999999999999999999999954211   1                1111


Q ss_pred             ccccCCCCC------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 DKSLDGSYS------LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .....+.+.      ........+|+.+||..||.+|.|+.|.+.
T Consensus       222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            112221111      122346679999999999999999998874

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.2e-34  Score=303.89  Aligned_cols=199  Identities=19%  Similarity=0.261  Sum_probs=164.9

Q ss_pred             ccCeeeec--CccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          354 WKNKLGEG--GFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       354 ~~~~lg~G--~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      +.++||+|  +|++||++... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78899999965 58999999986542  233457788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc-
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT-  507 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~-  507 (669)
                      ++|+|.+++.... ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.++++||+.+........ 
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999985432 234899999999999999999999998   99999999999999999999999986544321110 


Q ss_pred             ----CcCcccccccCCccCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005933          508 ----EANTDRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGF  556 (669)
Q Consensus       508 ----~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~G~~l~elltG~~p~~~  556 (669)
                          ........++..|+|||++.+  ..++.++|||||||++|||++|+.|+..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                011122356778999999976  4689999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.7e-34  Score=291.95  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=205.9

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.+.||+|++|.||+++... ++.|+||++..... .....+.+|+.++..++|+|++++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368889999999999999999775 99999999876544 4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      +++++|.+++...   ..+++..++.++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999543   568999999999999999999999 88   9999999999999999999999999988764332


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      ..  .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...............            .. ..
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~------------~~-~~  219 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CD-GP  219 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH------------hc-CC
Confidence            22  12356788999999999999999999999999999999999996543321111111110            00 01


Q ss_pred             CCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          587 DGSYSLS-EALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       587 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ....+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1111222 45678899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-34  Score=300.56  Aligned_cols=195  Identities=26%  Similarity=0.414  Sum_probs=159.5

Q ss_pred             CeeeecCccceEEEEeCC---CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEec--CCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~~  430 (669)
                      .+||+|+||.||+|...+   +..||+|.+....  ....+.+|+.+++.++||||+++++++..  ....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            689999999999999653   5789999986432  23567899999999999999999998854  4567899999875


Q ss_pred             CCHHHHhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE----cCCcceEEeecCCCc
Q 005933          431 KSLEQFIFDV------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMAR  500 (669)
Q Consensus       431 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~Dfgla~  500 (669)
                       +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             777766421      12235889999999999999999999998   9999999999999    566799999999998


Q ss_pred             ccCCCccC-cCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005933          501 AFGVDQTE-ANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGF  556 (669)
Q Consensus       501 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~  556 (669)
                      ........ .......+|..|+|||++.+. .++.++|||||||++|||++|++|+..
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            76433221 223345789999999998764 589999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=304.56  Aligned_cols=250  Identities=23%  Similarity=0.299  Sum_probs=209.2

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc---cchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcce
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~  422 (669)
                      ..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+...   ...+.+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            45689999999999999999999776 99999999976543   34578999999999998 999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC----cceEEeecCC
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND----MNPKISDFGM  498 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~----~~~kl~Dfgl  498 (669)
                      +|||++.||.|.+.+...    .+++.....++.||+.++.|||+.+   ++||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999654    2899999999999999999999998   9999999999999643    4799999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      +.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..........              
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------------  248 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------------  248 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------------
Confidence            998654   445566899999999999999999999999999999999999999965433221111              


Q ss_pred             hhhcccc--cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          579 LELIDKS--LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       579 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                       .+....  .....-......+.+++..++..||..|+++.++++-
T Consensus       249 -~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 -AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence             111111  1111112234567899999999999999999999983

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-34  Score=306.34  Aligned_cols=255  Identities=20%  Similarity=0.239  Sum_probs=195.2

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999975 4788999998652   2233456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542  345889999999999999999999998   999999999999999999999999999765432


Q ss_pred             ccCcCcccccccCCccCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          506 QTEANTDRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      .. .......|+..|+|||++.+     ..++.++||||||++||||++|+.|+......   ...   ...........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~---~~i~~~~~~~~  228 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETY---GKIMNHEERFQ  228 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HHH---HHHHcCCCccc
Confidence            21 11223568999999999875     46788999999999999999999996532211   000   00000000000


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPED--RPNMSSVVLM  622 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  622 (669)
                           + .......+..+.+++.+|+..++++  |++++++++.
T Consensus       229 -----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 -----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                 0 0001112456778999988866544  4678888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.3e-34  Score=294.06  Aligned_cols=255  Identities=26%  Similarity=0.405  Sum_probs=197.7

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc----------cchHHHHHHHHHHHHhCCCceeEEEEEEecCC
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG----------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD  419 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  419 (669)
                      +|.+.+.||+|+||.||+|... +++.||||.+.....          ...+.+..|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667899999999999999864 589999998753211          12346788999999999999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998543   56899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ................++..|+|||.+....  ++.++||||||++++||++|..|+.....      ........... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKR-  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccc-
Confidence            7653322222233356788999999987654  88999999999999999999998642111      11111110000 


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                          ....+........+..+.+++.+||+.+|++||++.+|++.
T Consensus       229 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 ----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                00001111111234678899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-34  Score=305.47  Aligned_cols=255  Identities=18%  Similarity=0.231  Sum_probs=194.5

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|.+.++||+|+||.||+++.+. ++.+|+|++.+.   .......+..|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            468889999999999999999765 788999998642   2223456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542  345899999999999999999999998   999999999999999999999999998764322


Q ss_pred             ccCcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          506 QTEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.|+......      ..............
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcccc
Confidence            11 1222357899999999986     346889999999999999999999996532111      11111100000000


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPED--RPNMSSVVLM  622 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  622 (669)
                           . .......+..+.+++.+|+..++++  ||++.++++.
T Consensus       229 -----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 -----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                 0 0001122456778888888654444  6889998765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3e-34  Score=297.56  Aligned_cols=262  Identities=25%  Similarity=0.355  Sum_probs=201.8

Q ss_pred             ccHHHHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEec
Q 005933          340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL  417 (669)
Q Consensus       340 ~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~  417 (669)
                      +....+..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344555567889999999999999999999975 58899999985432 2346778899999999 79999999999875


Q ss_pred             C-----CcceEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          418 R-----DERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       418 ~-----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      .     ...++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            4     3579999999999999988542 23456899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL  566 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~  566 (669)
                      ||+|||++........  ......++..|+|||.+...     .++.++|||||||++|||++|+.|+.......  .+ 
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~-  242 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TL-  242 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HH-
Confidence            9999999886533221  12234678899999998643     36889999999999999999999865322110  00 


Q ss_pred             hHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          567 GHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         .... .....     .+  ..+......+.+++.+||+.+|++||++.++++
T Consensus       243 ---~~~~-~~~~~-----~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         243 ---FKIP-RNPPP-----TL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ---HHHh-cCCCC-----CC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               0000 00000     00  011122346889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=298.35  Aligned_cols=262  Identities=22%  Similarity=0.328  Sum_probs=200.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.+.||+|++|.||+|... +++.||||++...  .....+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999976 4889999988643  23345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |++++.|..++.   +...+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877776653   2344899999999999999999999998   9999999999999999999999999988764433


Q ss_pred             cCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh-----------cc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL-----------WT  574 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~  574 (669)
                      . .......++..|+|||++.+. .++.++||||||+++|+|++|++|+.......   .+......           +.
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcc
Confidence            2 122335678899999999888 88999999999999999999998865322111   00000000           00


Q ss_pred             cccch---hhcccc----cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          575 EDRSL---ELIDKS----LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       575 ~~~~~---~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .....   +.....    .....+...+..+.+++.+||+.+|++||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000   000000    000011122567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.3e-34  Score=293.23  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=201.0

Q ss_pred             CCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCc------cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          351 NFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      +|+..+.||+|++|.||++.. .+++.||+|.+.....      ...+.+..|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999996 4589999999864321      135678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeecCCCccc
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAF  502 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla~~~  502 (669)
                      |+||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++ .++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   346889999999999999999999998   99999999999998776 6999999998776


Q ss_pred             CCCccC--cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          503 GVDQTE--ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       503 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ......  .......++..|+|||.+.+..++.++||||+|+++++|++|..|+........   ....         .+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~---------~~  222 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALI---------FK  222 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHH---------HH
Confidence            433211  112234678899999999888899999999999999999999998653221111   0000         01


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..........+......+.+++.+||+.+|++||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            11111112233344567889999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=300.14  Aligned_cols=253  Identities=23%  Similarity=0.276  Sum_probs=201.5

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|.+.+.||+|++|.||++...+ ++.||||.+.....   ...+.+..|+.++..++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999999764 89999999976432   24567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+.+++|.+++.. .....+++..+..++.||++||+|||+.+   ++|+||||+||+|+.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999999853 23456899999999999999999999998   999999999999999999999999998764322


Q ss_pred             ccC---------------------------cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005933          506 QTE---------------------------ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  558 (669)
Q Consensus       506 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~  558 (669)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01123467889999999998899999999999999999999999965322


Q ss_pred             CCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 005933          559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN----MSSVVL  621 (669)
Q Consensus       559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  621 (669)
                      ....               .................+..+.+++.+||+.+|++||+    +.+++.
T Consensus       237 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDET---------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHH---------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1100               01111111111111124567899999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.7e-34  Score=293.34  Aligned_cols=248  Identities=26%  Similarity=0.419  Sum_probs=199.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +-|.+.++||+|+||.||+|... ++..||||.+.... ......+.+|+.++.+++||||+++++++..+...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34677899999999999999865 58899999886432 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++..    ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            999999999842    35899999999999999999999988   9999999999999999999999999987653321 


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       .......++..|+|||.+.+..++.++||||||+++++|++|..|+......   ...             ..+.....
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~-------------~~~~~~~~  218 (277)
T cd06641         156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVL-------------FLIPKNNP  218 (277)
T ss_pred             -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHH-------------HHHhcCCC
Confidence             1122346788999999999888999999999999999999999886432111   000             00000001


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .......+..+.+++.+||+.+|++||++.+++..
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11222334567899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.3e-34  Score=296.13  Aligned_cols=262  Identities=21%  Similarity=0.309  Sum_probs=200.2

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.+.||+|++|.||+|... +|+.||||++....  ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999975 58999999987543  33457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      + +++|.+++....  ..+++.++..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999985433  55899999999999999999999998   99999999999999999999999999887643321


Q ss_pred             CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc---h----
Q 005933          508 EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS---L----  579 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~----  579 (669)
                       .......++..|+|||.+.+. .++.++||||+|++++||++|.+++.....   ...+............   .    
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence             122335688899999998654 468999999999999999999776543221   1111111111100000   0    


Q ss_pred             ----hhcccccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          580 ----ELIDKSLDGSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       580 ----~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                          ..+........+     ......+.+++.+||+.+|++||++++++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                000000000000     1223678899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.1e-35  Score=308.91  Aligned_cols=258  Identities=24%  Similarity=0.322  Sum_probs=194.5

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC-----
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----  418 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----  418 (669)
                      ...++|.+.+.||+|+||.||++... +++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999964 58899999986532  22345678899999999999999999987543     


Q ss_pred             -CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          419 -DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       419 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                       ...++++|++ +++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468899988 788988773    245899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc-
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE-  575 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-  575 (669)
                      +++.....     .....++..|+|||++.+ ..++.++|||||||++|+|++|+.|+......   ..+......... 
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~  235 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVVGTP  235 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence            99865322     223568999999999877 57899999999999999999999987532211   011100000000 


Q ss_pred             ----------ccchhhcccccCCCCCH--------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          576 ----------DRSLELIDKSLDGSYSL--------SEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       576 ----------~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                                ......+.. +. ..+.        .....+.+++.+||+.||++|||+.|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         236 SPEVLKKISSEHARKYIQS-LP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CHHHHHhcchhhHHHHhhc-cc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                      000000000 00 0000        012346799999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=295.85  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=206.5

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..-|.+.+.||+|.|..|-+++. -.|..||||++.+..  ......+..|++.|+.++|||||+|+.+......++||.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34577779999999999999884 469999999998753  334568899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE-cCCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll-~~~~~~kl~Dfgla~~~~~  504 (669)
                      |.-++|+|.++|.+...  -+.+....+++.||+.|+.|+|+..   +|||||||+||.+ .+-|-+||.|||++-.+.+
T Consensus        97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999976544  3899999999999999999999999   9999999999976 5678999999999977654


Q ss_pred             CccCcCcccccccCCccCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ...   ....+|...|-|||++.+..|. ++.||||||||||-|++|++||.-..                   ..+.+.
T Consensus       172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-------------------DSETLT  229 (864)
T KOG4717|consen  172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-------------------DSETLT  229 (864)
T ss_pred             cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-------------------chhhhh
Confidence            332   3346899999999999999886 67999999999999999999965322                   122222


Q ss_pred             cccCC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          584 KSLDG--SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       584 ~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ..++-  ..+.....+|.+||..||..||++|.+.++|+..
T Consensus       230 mImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  230 MIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            22222  3445567799999999999999999999999864

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.7e-34  Score=295.40  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=200.0

Q ss_pred             cHHHHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEec-
Q 005933          341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL-  417 (669)
Q Consensus       341 ~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-  417 (669)
                      +..++....+.|++.+.||+|+||.||+|... +++.+|+|++.... ....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34445556678999999999999999999974 48899999985433 3446788999999998 69999999999853 


Q ss_pred             -----CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceE
Q 005933          418 -----RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK  492 (669)
Q Consensus       418 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  492 (669)
                           ....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45679999999999999998543 2345788899999999999999999998   99999999999999999999


Q ss_pred             EeecCCCcccCCCccCcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhh
Q 005933          493 ISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG  567 (669)
Q Consensus       493 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~  567 (669)
                      |+|||++.......  .......++..|+|||.+.     ...++.++||||||+++|||++|..|+........  .. 
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~-  236 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LF-  236 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hh-
Confidence            99999987653211  1223356888999999886     34678899999999999999999998643221100  00 


Q ss_pred             HhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          568 HAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                  ...............+..+.+++.+||+.||.+||++.|++.
T Consensus       237 ------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 ------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                        000000000011123457889999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.7e-34  Score=291.06  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=200.5

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEec--CCcceEEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERMLIY  425 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~  425 (669)
                      +|++.+.||.|+||.||++... +++.||+|++....  ....+++.+|+.+++.++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999964 58899999986432  3345678899999999999999999998764  34578999


Q ss_pred             eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          426 EYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      ||+++++|.+++.... ....+++..++.++.||+.||.|||..+  ..+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999999986532 2456899999999999999999999332  233999999999999999999999999999876


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .....  ......++..|+|||.+.+..++.++||||||+++++|++|+.|+.....   ....             +.+
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~-------------~~~  222 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA-------------SKI  222 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH-------------HHH
Confidence            43322  12234688999999999998899999999999999999999998654321   1111             011


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ........+...+..+.+++.+||+.+|++||++.+|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         223 KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1111112233445678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-34  Score=300.74  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=198.3

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            333478999999999999965 4889999998765555667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      ++|.+++..    ..+++..+..++.||+.||+|||+.+   ++||||||+||++++++.++|+|||++.......  ..
T Consensus       104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~  174 (292)
T cd06658         104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK  174 (292)
T ss_pred             CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence            999998832    34889999999999999999999998   9999999999999999999999999987653222  11


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......   .....         ....+...+..  
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~---------~~~~~~~~~~~--  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRR---------IRDNLPPRVKD--  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---------HHhcCCCcccc--
Confidence            22356789999999998889999999999999999999999986432111   00000         00011111111  


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .......+.+++.+||+.+|.+|||++++++.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11223467789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.3e-34  Score=293.92  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=201.7

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.+.||+|++|.||++... +++.||+|++.... .....++.+|+.+++.++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777899999999999999976 58999999987653 34556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      +++++|.+++....  ..+++..+..++.|++.||+|||+ .+   ++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999986432  568999999999999999999999 77   9999999999999999999999999987653221


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      ..    ...++..|+|||.+.+..++.++||||||+++++|++|+.|+........ .........         .... 
T Consensus       156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~---------~~~~-  220 (265)
T cd06605         156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYI---------VNEP-  220 (265)
T ss_pred             hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHH---------hcCC-
Confidence            11    15678899999999999999999999999999999999998654321111 111111000         0000 


Q ss_pred             CCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          587 DGSYSLS-EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       587 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....+.. ....+.+++.+||+.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            0011111 3456889999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-34  Score=299.05  Aligned_cols=267  Identities=22%  Similarity=0.311  Sum_probs=198.1

Q ss_pred             CCCccCeeeecCccceEEEEeCC---CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecC--Ccce
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERM  422 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~  422 (669)
                      +|.+.++||+|+||.||+|....   ++.||||.+....   ....+.+.+|+.++..++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999754   7899999997633   44457788999999999999999999999888  7899


Q ss_pred             EEEeecCCCCHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC----CcceEEeec
Q 005933          423 LIYEYLPNKSLEQFIFDVTR--TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----DMNPKISDF  496 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~----~~~~kl~Df  496 (669)
                      +||||+++ +|.+++.....  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 66666643222  236899999999999999999999998   999999999999999    999999999


Q ss_pred             CCCcccCCCcc-CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc------hhhH
Q 005933          497 GMARAFGVDQT-EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN------LLGH  568 (669)
Q Consensus       497 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~------~~~~  568 (669)
                      |++..+..... ........++..|+|||++.+. .++.++||||||+++++|++|++|+..........      .+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1223345678899999988764 58899999999999999999999976543332000      0000


Q ss_pred             hhhhcccc------------cchhhcccccCCCCC---H--------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          569 AWRLWTED------------RSLELIDKSLDGSYS---L--------SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       569 ~~~~~~~~------------~~~~~~~~~~~~~~~---~--------~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....+...            ......+.......+   .        .....+.+++.+||+.||++|||+.|++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000000            000000000000111   0        22346889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.9e-34  Score=289.79  Aligned_cols=248  Identities=25%  Similarity=0.349  Sum_probs=199.4

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.+.||+|++|.||++... +++.+|||.+...  .......+.+|+.+++.++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999965 5889999998654  233467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-cceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~Dfgla~~~~~~~  506 (669)
                      +++++|.+++... ....+++..+..++.+++++|.|||+.+   ++|+||+|+||+++.+ ..++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999642 2345899999999999999999999998   9999999999999855 468999999998754322


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                         ......++..|+|||.+.+..++.++||||||+++++|++|+.|+......   ......            ... .
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~------------~~~-~  217 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI------------MSG-T  217 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH------------Hhc-C
Confidence               122356788999999999888999999999999999999999886432211   011000            000 0


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            01112223456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.7e-34  Score=289.71  Aligned_cols=250  Identities=27%  Similarity=0.443  Sum_probs=200.4

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|.+.+.||+|+||.||+|... +++.|++|.+.....  ...+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999965 589999999876544  3678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++..   ...+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999853   345789999999999999999999998   99999999999999999999999999887643322


Q ss_pred             CcC--cccccccCCccCchhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          508 EAN--TDRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       508 ~~~--~~~~~gt~~y~aPE~~~~~~---~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ...  .....++..|+|||++.+..   .+.++||||||++++||++|+.|+......  ..   .......        
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~---~~~~~~~--------  221 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQ---IMFHVGA--------  221 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HH---HHHHHhc--------
Confidence            111  22356788999999998766   889999999999999999999997532211  00   0000000        


Q ss_pred             ccccCCCCCH--HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 DKSLDGSYSL--SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ......+.  .....+.+++.+||+.+|++||++.+++.
T Consensus       222 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 --GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              00011111  12456779999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-33  Score=291.11  Aligned_cols=260  Identities=23%  Similarity=0.294  Sum_probs=200.4

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecC--CcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~  425 (669)
                      ++|...++||.|++|.||++... +++.+|+|.+..... ....++.+|+++++.++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36778899999999999999975 488999999875433 3457799999999999999999999998654  3679999


Q ss_pred             eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      ||+++++|.+++.... ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999999875422 3455889999999999999999999998   99999999999999999999999999875432


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ..    .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ ...... ..........+.+ 
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~-  230 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELL-SYIVNMPNPELKD-  230 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHH-HHHhcCCchhhcc-
Confidence            21    1234568899999999999999999999999999999999999764422111 111110 0000001111100 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..  ......+..+.+++.+||+.+|++|||+.|+++
T Consensus       231 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00  001123457889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-34  Score=295.05  Aligned_cols=262  Identities=25%  Similarity=0.360  Sum_probs=196.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.+.||+|++|.||+|... +++.||||.+..... .....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999976 589999999865432 2335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +.+ +|.+++...  ...+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 899988543  236899999999999999999999998   99999999999999999999999999875432211


Q ss_pred             CcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh------
Q 005933          508 EANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE------  580 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  580 (669)
                      .  .....++..|+|||++.+ ..++.++||||||+++|||++|+.|+.....  ....+...++.........      
T Consensus       159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence            1  122346788999999875 4588999999999999999999988753321  1111111111100000000      


Q ss_pred             ---hcc--------cccCCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 ---LID--------KSLDGS-YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ---~~~--------~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         ...        ..+... ........+.+++.+||+.+|++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               000        000000 01111256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.7e-34  Score=295.72  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=194.8

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.++||+|+||.||+++.. +|+.||+|++....  ......+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999975 58999999986432  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      ++ ++|.+++..  ....+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+.....
T Consensus        81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 578777743  2345899999999999999999999998   99999999999999999999999999986543221


Q ss_pred             CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc------chh
Q 005933          508 EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR------SLE  580 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~  580 (669)
                        ......++..|+|||++.+. .++.++||||||+++|||++|..|+....  .....+....+......      ...
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhh
Confidence              12234568899999998765 47899999999999999999988842211  11111111111000000      000


Q ss_pred             hccccc----CCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 LIDKSL----DGS-----YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ~~~~~~----~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..+...    ...     ........+.+++.+||+.||.+|||+++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000000    000     00112356789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.4e-35  Score=277.74  Aligned_cols=247  Identities=25%  Similarity=0.380  Sum_probs=199.1

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-----c---cchHHHHHHHHHHHHh-CCCceeEEEEEEe
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-----G---QGVEEFKNEVLLIAKL-QHRNLVRLLGCCT  416 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-----~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~  416 (669)
                      ..-.+|...+.||+|..+.|-+...+ .|...|+|++....     +   .-.+.-..|+.||+++ -||+|+++.+++.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34467888899999999999988865 48899999885321     1   1234456799999998 5999999999999


Q ss_pred             cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeec
Q 005933          417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF  496 (669)
Q Consensus       417 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  496 (669)
                      .+...++|+|.|+.|.|.++|   ...-.++++...+|+.|+..|+.|||..+   |+||||||+|||+|++.++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            999999999999999999999   44556899999999999999999999999   999999999999999999999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      |+++.+...   ......+||++|+|||.+.-      ..|+...|+|++||++|-|+.|.+||-  +-.          
T Consensus       168 GFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRk----------  232 (411)
T KOG0599|consen  168 GFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRK----------  232 (411)
T ss_pred             ceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHH----------
Confidence            999986433   33445799999999999853      358889999999999999999999932  110          


Q ss_pred             hhcccccchhhcccccCCCCC--H----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          571 RLWTEDRSLELIDKSLDGSYS--L----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~--~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       .      .-++...+.+.+.  .    +......+||.+||+.||.+|.|++|+++
T Consensus       233 -Q------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 -Q------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -H------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence             0      0111112222222  1    22346789999999999999999999985

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-34  Score=292.49  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=199.6

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCC-----
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD-----  419 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-----  419 (669)
                      ..+++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            34678999999999999999999975 478999999865433 457899999999999 6999999999997654     


Q ss_pred             -cceEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          420 -ERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       420 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             3799999999999999986432 2456899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      ++.......  .......++..|+|||++..     ..++.++||||||+++++|++|+.|+......  ..+.    ..
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~  230 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALF----KI  230 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHH----Hh
Confidence            987653221  12233568889999998753     34678999999999999999999996532111  0000    00


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ....     ...+  ..+......+.+++.+||+.||++|||+.++++
T Consensus       231 -~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 -PRNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -hccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             0000     0000  111223457889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.1e-34  Score=295.82  Aligned_cols=244  Identities=25%  Similarity=0.315  Sum_probs=199.2

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|++|.||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999976 48999999986532   234567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+|+.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999854   356899999999999999999999988   999999999999999999999999998875432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                           .....++..|+|||.+.+...+.++||||||+++|+|++|+.|+......   ...    ..        .....
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~--------~~~~~  214 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIY----EK--------ILEGK  214 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HH--------HhcCC
Confidence                 22346788999999998888999999999999999999999986532210   000    00        00000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                        ...+......+.+++.+||+.+|.+||     +++|++.
T Consensus       215 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 --VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              111222346788999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=291.31  Aligned_cols=247  Identities=24%  Similarity=0.415  Sum_probs=197.9

Q ss_pred             CCCccCeeeecCccceEEEEe-CCCcEEEEEEeccc-CccchHHHHHHHHHHHHhC---CCceeEEEEEEecCCcceEEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .|++.+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.+++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467789999999999999996 45899999998654 3345678899999999997   999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++..    ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998843    36899999999999999999999998   999999999999999999999999998876433


Q ss_pred             ccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ..  ......++..|+|||.+.++ .++.++||||||+++|+|++|..|+........   ..    .....     ..+
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~----~~~~~-----~~~  220 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MM----LIPKS-----KPP  220 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hh----ccccC-----CCC
Confidence            21  12234688899999998754 578999999999999999999999753221110   00    00000     000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .+..   ...+..+.+++.+||+.||++||++.+++.
T Consensus       221 ~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 RLED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1110   013456889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.2e-34  Score=293.27  Aligned_cols=250  Identities=23%  Similarity=0.348  Sum_probs=192.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHH-HHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLL-IAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++.... .....++..|+.+ ++.++|||++++++++..+...++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999976 58999999986543 2234456666665 566689999999999999999999999


Q ss_pred             ecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          427 YLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       427 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |++ |+|.+++... .....+++..++.++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6888887543 2345689999999999999999999987 6   99999999999999999999999999886532


Q ss_pred             CccCcCcccccccCCccCchhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAID----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ..   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+......     .....         .
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~---------~  219 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLK---------Q  219 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHH---------H
Confidence            11   1222457889999998865    45688999999999999999999986421110     00000         0


Q ss_pred             hcccccCCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 LIDKSLDGSYS-LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .... .....+ ...+..+.+++.+||+.+|++||++.+++.
T Consensus       220 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         220 VVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000 000111 112456889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-33  Score=285.82  Aligned_cols=251  Identities=27%  Similarity=0.424  Sum_probs=204.8

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecC--CcceEEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLIY  425 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~  425 (669)
                      +|.+.+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999976 589999999865542  4577899999999999999999999999988  8899999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++...   ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998543   27899999999999999999999988   999999999999999999999999998876443


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      ..........++..|+|||.+.....+.++||||||+++++|++|..|+....     ......+..         ....
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~---------~~~~  220 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKI---------GSSG  220 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhc---------cccC
Confidence            32112334567889999999988889999999999999999999999965433     111111111         1101


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .....+...+..+.+++.+|++.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            111222233567889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.1e-34  Score=298.46  Aligned_cols=248  Identities=24%  Similarity=0.357  Sum_probs=198.3

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      |....+||+|+||.||++... +++.||||.+........+.+.+|+.++..++|||++++++++..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334468999999999999965 5899999998765555567889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      ++|.+++..    ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....  .
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            999998732    45899999999999999999999998   99999999999999999999999999875533221  1


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....++..|+|||++.+..++.++||||||++++||++|+.|+......   ...   .. .....     ....  ..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~---~~-~~~~~-----~~~~--~~  239 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM---KR-LRDSP-----PPKL--KN  239 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HH-HhccC-----CCCc--cc
Confidence            22356889999999999889999999999999999999999986532211   000   00 00000     0000  00


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .......+.+++.+||+.+|++||+++++++.
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11123457899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-33  Score=285.12  Aligned_cols=247  Identities=28%  Similarity=0.452  Sum_probs=202.5

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      +|++.+.||+|++|.||++... +++.+++|++..........+.+|+.+++.++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677899999999999999976 588999999976655567889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999985432  46899999999999999999999988   99999999999999999999999999877543321  


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS  589 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (669)
                       .....++..|+|||.+.+..++.++||||||+++++|++|+.|+.......   .....    .         ......
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~---------~~~~~~  216 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFKI----A---------TNGPPG  216 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHH----H---------hcCCCC
Confidence             334567889999999998889999999999999999999998865322110   00000    0         000001


Q ss_pred             CCHH--HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          590 YSLS--EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       590 ~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....  .+..+.+++.+||+.||++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111  1456889999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.3e-33  Score=291.47  Aligned_cols=262  Identities=25%  Similarity=0.375  Sum_probs=199.1

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      +|++.++||.|++|.||+|+.. +++.||||.+..... .....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999976 488999999875533 33567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++ +|.+++........+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88888865444456899999999999999999999998   99999999999999999999999999976533211 


Q ss_pred             cCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc---cccc------
Q 005933          509 ANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT---EDRS------  578 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~------  578 (669)
                       ......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+.......   ..........   ....      
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcC
Confidence             12234567889999988664 57899999999999999999999865432211   1111000000   0000      


Q ss_pred             hhhcccccC------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 LELIDKSLD------GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 ~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .........      .......+..+.+++.+|++.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000000      0001122456789999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.6e-33  Score=292.04  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=197.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999965 589999999865433 33456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+. ++|.+++..  ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 677776643  2345788889999999999999999998   999999999999999999999999998764322


Q ss_pred             ccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc-------
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR-------  577 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  577 (669)
                      ..  ......++..|+|||++.+. .++.++||||||+++|||++|+.|+......  ...+...+..+....       
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence            11  12234568899999998764 5788999999999999999999987543221  111111111111000       


Q ss_pred             ------chhhcccccCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 ------SLELIDKSLDGS-----YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                            ............     ........+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                  000000000000     00112456789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-33  Score=293.17  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=202.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|.+.+.||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            367888999999999999999864 5889999998655555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++.+    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999843    34789999999999999999999998   99999999999999999999999998876533222


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......++..|+|||.+....++.++||||||+++|+|++|+.|+...........      ...        .....
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~--------~~~~~  234 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT--------NGTPE  234 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhc--------CCCCC
Confidence              22234678899999999888899999999999999999999999753222111000      000        00000


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ...+...+..+.+++.+||+.+|.+||++.+++..
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01111234467899999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-33  Score=293.67  Aligned_cols=264  Identities=24%  Similarity=0.308  Sum_probs=197.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecC--CcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV  424 (669)
                      ++|++.+.||+|++|.||+|..+ +++.+|+|.+.....  .....+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888899999999999999976 488999999864432  2234678899999999999999999998877  889999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||++ ++|.+++...  ...+++..+..++.||+.||+|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 4899888542  236899999999999999999999998   99999999999999999999999999887643


Q ss_pred             CccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhH--------hhhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH--------AWRLWTE  575 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~  575 (669)
                      ...  ......++..|+|||.+.+. .++.++||||||++++||++|..|+...........+..        .|..+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            321  12234568889999998765 468999999999999999999998764332111000000        0000000


Q ss_pred             ------ccchhhcccccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          576 ------DRSLELIDKSLDGSYSLS-EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       576 ------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                            ..........+...++.. ....+.+++.+||+.+|++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  000000000111111111 2456789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-33  Score=293.35  Aligned_cols=263  Identities=22%  Similarity=0.295  Sum_probs=194.4

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCc-----
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDE-----  420 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~-----  420 (669)
                      ++|++.+.||+|+||.||+|... +++.||||.+....  ......+.+|+.+++.+. |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999975 58999999886542  223467889999999995 6999999999877665     


Q ss_pred             ceEEEeecCCCCHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecC
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTR--TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFG  497 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfg  497 (669)
                      .++||||+++ +|.+++.....  ...+++..++.++.||++||.|||+.+   ++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78888754332  346899999999999999999999998   999999999999998 8899999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      ++..+.....  ......++..|+|||++.+ ..++.++||||||+++|+|++|..|+.......   ............
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ---QLLHIFKLLGTP  231 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence            9876533221  1122356788999998865 457899999999999999999998865422111   000000000000


Q ss_pred             cc------hhhcccccCCC--------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 RS------LELIDKSLDGS--------YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 ~~------~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..      ...........        ........+.+++.+||+.+|.+||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00      00000000000        00122456789999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=303.67  Aligned_cols=244  Identities=28%  Similarity=0.415  Sum_probs=195.4

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc---chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ---GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .|+-++.||.|+||.||.+... +.+.||||+++-...+   ...++..|+..|++++|||++.+-||+......+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4566689999999999999954 5788999999765444   45678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      || -||-.+++.-  ..+++.+.++..|+.+.+.||+|||+++   .||||||+.||||++.|.|||+|||.|....+  
T Consensus       107 YC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             HH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            99 4576776632  3456889999999999999999999999   99999999999999999999999999876533  


Q ss_pred             cCcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          507 TEANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                          .+..+||+.|||||++.   .+.|+-++||||||++..||.-.++|.=  .    .+.......... ..     .
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF--n----MNAMSALYHIAQ-Ne-----s  242 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--N----MNAMSALYHIAQ-NE-----S  242 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc--C----chHHHHHHHHHh-cC-----C
Confidence                33479999999999986   4579999999999999999999988821  1    111111111000 00     0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +.+   ...+-...+.+++..||+.=|.+|||.++++.
T Consensus       243 PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  243 PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            011   12344567889999999999999999998875

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-33  Score=291.21  Aligned_cols=247  Identities=24%  Similarity=0.363  Sum_probs=198.2

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      |...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+|++++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444579999999999999964 5889999998655555567789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      ++|.+++..    ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++........  .
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~  171 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R  171 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence            999999854    45899999999999999999999998   99999999999999999999999998875532211  1


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....++..|+|||.+.+..++.++||||||++++||++|+.|+....+      ....... ...     ....+.  .
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~-~~~-----~~~~~~--~  237 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRI-RDN-----LPPKLK--N  237 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHH-Hhc-----CCCCCc--c
Confidence            2234678899999999988899999999999999999999998643211      0000000 000     000010  1


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....+..+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            1123457889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1e-33  Score=292.36  Aligned_cols=261  Identities=23%  Similarity=0.341  Sum_probs=195.8

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.+.||.|++|.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999975 58999999886432  23346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +. ++|.+++... ....+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||++..+.....
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 6898888543 3356899999999999999999999998   99999999999999999999999999876533221


Q ss_pred             CcCcccccccCCccCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc---------
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR---------  577 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  577 (669)
                        ......++..|+|||++.+.. ++.++||||||+++|||++|+.|+.......  ... ..........         
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLF-RIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHH-HHHHHhCCCChhhhhhhhH
Confidence              122235678899999887654 6889999999999999999999875432111  111 0000000000         


Q ss_pred             chh---hcccccCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLE---LIDKSLDG---SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~---~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..+   ........   .........+.+++.+||+.||++||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000   00000000   000112345679999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=285.03  Aligned_cols=246  Identities=25%  Similarity=0.408  Sum_probs=205.4

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      -|.++++||+|++|.||++.+++ |..||||.+..  +...+++..|+.++++.+.|++|+++|.+.....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            36677999999999999999775 99999999754  4467889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      .|+..+.+.  .++++|++.++..+++..++||+|||...   -+|||||+.||||+-+|.+||+|||.|-.+-.  +-.
T Consensus       112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA  184 (502)
T KOG0574|consen  112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA  184 (502)
T ss_pred             CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence            999999995  45677999999999999999999999987   89999999999999999999999999976532  223


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS  589 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (669)
                      ..+...||+.|||||++..-.|..++||||||+...||..|++|+.-.++-...                -++.....+.
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI----------------FMIPT~PPPT  248 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI----------------FMIPTKPPPT  248 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee----------------EeccCCCCCC
Confidence            344578999999999999999999999999999999999999996543321110                0111111111


Q ss_pred             C--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          590 Y--SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       590 ~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +  +..-...+-+++..||-..|++|-|+.++++
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            2  2233457889999999999999999998876

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-33  Score=286.97  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=199.3

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.+.||+|+||.||++..+. +..||+|.+....  ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            47788999999999999999764 8899999986532  23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla~~~~~~~  506 (669)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++ .++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999998543 2235799999999999999999999998   99999999999999885 56999999988764322


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      .  ......++..|+|||++.+..++.++||||||++++||++|..|+......      .....         ......
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~---------~~~~~~  219 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLK---------ICQGYF  219 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH---------HhcccC
Confidence            1  122346788999999998888999999999999999999999986432111      01100         001011


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      . ......+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 A-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             C-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0 1112234568899999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.9e-33  Score=290.81  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=203.8

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      +.++.|++.+.||+|++|.||+|..+ +++.|++|++..... ....+.+|+++++.++|+|++++++++...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34667888899999999999999987 589999999865443 5678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999996532  36899999999999999999999988   999999999999999999999999988654322


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      ..  ......++..|+|||++.+..++.++||||||+++|+|++|+.|+.......   ...   .         .....
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~---~---------~~~~~  232 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALF---L---------ITTKG  232 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H---------HHhcC
Confidence            11  1223457789999999988889999999999999999999999865322110   000   0         00000


Q ss_pred             cCC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          586 LDG-SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       586 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ... ......+..+.+++.+||+.+|.+||++.+++..
T Consensus       233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            000 0011134568899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=290.42  Aligned_cols=260  Identities=23%  Similarity=0.354  Sum_probs=196.9

Q ss_pred             CCccCeeeecCccceEEEEeCC-CcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC--CcceEEEe
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLIYE  426 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E  426 (669)
                      |++.++||+|++|.||+|+..+ ++.+|+|++....  ......+.+|+.+++.++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            5677899999999999999764 8899999997653  33456788999999999999999999999888  78999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++ +|.+++...  ...+++..++.++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888888432  246899999999999999999999998   9999999999999999999999999998764432


Q ss_pred             cCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc---cccchhh-
Q 005933          507 TEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT---EDRSLEL-  581 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-  581 (669)
                      . .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......   ..........   ....... 
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence            1 11223456788999998765 468899999999999999999998865433211   1111111000   0000000 


Q ss_pred             -------ccc------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 -------IDK------SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 -------~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                             ...      .+........+..+.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                   000      0000000112457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.1e-33  Score=293.75  Aligned_cols=248  Identities=27%  Similarity=0.376  Sum_probs=194.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .+.|.+.+.||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+.+++.++|||++++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888899999999999999975 589999999864332   3345788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      +||+. |+|.+++..  ....+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 577776643  2345899999999999999999999998   99999999999999999999999999875432


Q ss_pred             CccCcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .      ....++..|+|||++.   ...++.++||||||+++|||++|+.|+......      .......        
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~--------  227 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA--------  227 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHh--------
Confidence            1      2245778999999874   456889999999999999999999885422110      0000000        


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                       ............+..+.+++.+||+.+|++||++.+++...
T Consensus       228 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         228 -QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             -cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence             00000001112345688999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.7e-33  Score=294.31  Aligned_cols=267  Identities=22%  Similarity=0.341  Sum_probs=194.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc-----
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-----  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----  420 (669)
                      .++|++.++||+|+||.||++... +++.||||.+....  ......+.+|+.++++++||||+++++++.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357899999999999999999975 48999999886432  2233456789999999999999999999876544     


Q ss_pred             ---ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          421 ---RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       421 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                         .++||||+.+ +|.+.+..  ....+++.+++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence               4999999964 78877743  2345899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccC--cCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc
Q 005933          498 MARAFGVDQTE--ANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT  574 (669)
Q Consensus       498 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~  574 (669)
                      ++..+......  .......++..|+|||.+.+. .++.++||||||+++|||++|..|+...........+........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99876433221  112234578889999988765 478899999999999999999988654332211111111110000


Q ss_pred             -----cccchhhccccc-CCCC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          575 -----EDRSLELIDKSL-DGSY---------SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       575 -----~~~~~~~~~~~~-~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                           ........+... ....         .......+.+++.+||+.||.+||+++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                 000000000000 0000         0011245678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=290.29  Aligned_cols=260  Identities=23%  Similarity=0.333  Sum_probs=195.5

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      |++.+.||.|++|.||+|... +|+.||||++....  ......+.+|+.+++.++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567799999999999999965 59999999986543  223467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      + ++|.+++.... ...+++..++.++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 68999885432 245899999999999999999999988   99999999999999999999999999976532221 


Q ss_pred             cCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc---------cc
Q 005933          509 ANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED---------RS  578 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  578 (669)
                       ......++..|+|||++.+. .++.++||||||+++|+|++|+.|+........  ... ..+.....         ..
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFR-IFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChHHhhhhhhc
Confidence             11223567889999988764 578999999999999999999998654322110  000 00000000         00


Q ss_pred             hhhcccccCC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 LELIDKSLDG------SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 ~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .+........      ......+..+.+++.+||+.+|.+||+++|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000000      001112356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.9e-34  Score=289.88  Aligned_cols=247  Identities=26%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      +|++.+.||.|+||.||++... +++.||+|.+.+..   ....+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999976 48999999997542   2346789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999843   256899999999999999999999998   9999999999999999999999999988654322


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|..|+............    .         .... .
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~---------~~~~-~  217 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----A---------KQET-A  217 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----H---------Hhcc-c
Confidence               223356788999999999888999999999999999999999996643322110000    0         0000 1


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNM--SSVV  620 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  620 (669)
                      ....+...+..+.+++.+||+.||.+||++  +|++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            112223344778899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-34  Score=297.11  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=204.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecc--cCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ...|++.++||+||.+.||++...+.+.+|+|++..  .+.+...-|.+|+..|.+|+ |.+|++|++|-..++.+++||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            457999999999999999999998889999998753  45567889999999999995 999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||- ..+|..+|.+.. .....| .+..+..|++.|+.++|+++   |||.||||.|.|+-+ |.+||+|||+|..+..+
T Consensus       440 E~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            986 458999995432 222334 78889999999999999999   999999999999864 78999999999998888


Q ss_pred             ccCcCcccccccCCccCchhhccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGL-----------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT  574 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~  574 (669)
                      .+.-.....+||..||+||.+....           .+.++||||+|||||+|+.|++||+.+.     +.+        
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~--------  579 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI--------  579 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH--------
Confidence            7777777889999999999985432           5578999999999999999999965321     111        


Q ss_pred             cccchhhcccccCCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          575 EDRSLELIDKSLDGSYSL-SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       .....+.++...-.++. .....+++++..||+.||++||++.++|+
T Consensus       580 -aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 -AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence             11223333322222221 12233899999999999999999999986

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.4e-33  Score=293.52  Aligned_cols=263  Identities=26%  Similarity=0.367  Sum_probs=195.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecC--CcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  423 (669)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999975 489999999864322  2234567899999999999999999998765  45799


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999974 888888543  256899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc--cc--
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED--RS--  578 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~--  578 (669)
                      ....  ......++..|+|||.+.+ ..++.++||||||+++|||++|++|+......   ..+..........  ..  
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhch
Confidence            3221  1222345778999999875 46789999999999999999999987533221   1111111100000  00  


Q ss_pred             ----hhhccc-ccCC-CC-C-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          579 ----LELIDK-SLDG-SY-S-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       579 ----~~~~~~-~~~~-~~-~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                          ...... .+.. .. .     ......+.+++.+||+.||++|||+.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                000000 0000 00 0     0124466789999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=303.88  Aligned_cols=251  Identities=23%  Similarity=0.412  Sum_probs=202.0

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      +.|.|...||-|+||.||+++.++ +--.|-|++...+....+.|+-||+||+.+.||+||+|++.|...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            456677899999999999999876 3445778887777888999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      .||-.+.++....  ..|++.++.-++.|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+...  ..+.
T Consensus       112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTR  184 (1187)
T ss_pred             CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc--hhHH
Confidence            9999999986543  45999999999999999999999999   999999999999999999999999987643  2222


Q ss_pred             cCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          509 ANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ...+...||+.|||||+.+     +.+|..++||||||++|.||..+.+|..-.      +......+ ........++.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllK-iaKSePPTLlq  257 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLK-IAKSEPPTLLQ  257 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHH-HhhcCCCcccC
Confidence            3344578999999999874     568999999999999999999999883211      11100000 11111111111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                             +..-...+.++..+||..||+.||++.++++
T Consensus       258 -------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 -------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                   1223456789999999999999999999986

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.9e-33  Score=283.77  Aligned_cols=242  Identities=24%  Similarity=0.322  Sum_probs=194.9

Q ss_pred             eeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      ||.|++|.||+++... ++.||+|.+.+..   ....+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999764 8999999986542   23456799999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCccc
Q 005933          434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR  513 (669)
Q Consensus       434 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  513 (669)
                      .+++..   ...+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999943   344899999999999999999999988   9999999999999999999999999998764332   1223


Q ss_pred             ccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHH
Q 005933          514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS  593 (669)
Q Consensus       514 ~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (669)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....+.    ....         ............+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~---------~~~~~~~~~~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIY---------NDILKGNGKLEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHH---------HHHhccCCCCCCCcc
Confidence            467889999999988889999999999999999999999965433211    0000         011111111122223


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          594 EALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       594 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      .+..+.+++.+||+.+|++||+     ++|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            3567899999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-34  Score=303.06  Aligned_cols=244  Identities=24%  Similarity=0.390  Sum_probs=193.4

Q ss_pred             cCeeeecCccceEEEEeCC-CcEEEEEEec--c--cCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc--ceEEEee
Q 005933          355 KNKLGEGGFGPVYRGMLTE-GQEIAVKRLS--K--SSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE--RMLIYEY  427 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lV~E~  427 (669)
                      ..+||+|+|-+||+|.+.. |-.||=-.++  +  ......++|..|+.+|+.|+||||++++.++.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            4789999999999999754 6666533221  1  234556899999999999999999999999988766  6789999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~~~~~~  506 (669)
                      |..|+|..++.+.   +.++...+..|++||++||.|||++. +||||||||-+||||+. .|.|||+|+|||.......
T Consensus       125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999543   45788899999999999999999987 57999999999999985 5899999999998864322


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                          .....||+.|||||... ..|.+.+||||||+.++||+|+..|+.--                  ....++..+..
T Consensus       201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC------------------~n~AQIYKKV~  257 (632)
T KOG0584|consen  201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC------------------TNPAQIYKKVT  257 (632)
T ss_pred             ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh------------------CCHHHHHHHHH
Confidence                23378999999999886 88999999999999999999999985421                  11122222222


Q ss_pred             CCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HhcCC
Q 005933          587 DGSYS----LSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGE  626 (669)
Q Consensus       587 ~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~  626 (669)
                      .+-.+    .-....+.++|.+|+.. .++|||+.|+|.  +|...
T Consensus       258 SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  258 SGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             cCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            22111    11235678999999999 999999999995  45443

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=299.59  Aligned_cols=263  Identities=21%  Similarity=0.306  Sum_probs=195.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-----cc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----ER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~  421 (669)
                      +++|++.++||+|+||.||+|+.. +|+.||||++.... ......+..|+.+++.++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            568999999999999999999964 58999999986432 334567889999999999999999998875543     47


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++|+||+.+ +|.+++.    ...+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999974 7777763    345899999999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCccC-cCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc---
Q 005933          502 FGVDQTE-ANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED---  576 (669)
Q Consensus       502 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---  576 (669)
                      ....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+......   .............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHH
Confidence            5332211 12233567899999998765 46899999999999999999999987532211   1111110101000   


Q ss_pred             cchhhcccc-------c--CCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          577 RSLELIDKS-------L--DGSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       577 ~~~~~~~~~-------~--~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ....+....       .  ....+.     .....+.+++.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000       0  000111     123468899999999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.8e-33  Score=290.36  Aligned_cols=254  Identities=27%  Similarity=0.383  Sum_probs=197.5

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .|...+.||+|+||.||+++.. ++..||+|.+.....   .....+.+|+.+++.++|+|++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4667789999999999999965 588999999865422   234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+. |+|.+++..  ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus       106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            997 477777643  2345899999999999999999999998   99999999999999999999999999865432  


Q ss_pred             cCcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          507 TEANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                          .....++..|+|||++.   .+.++.++||||||+++|||++|+.|+......   ....            ....
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~------------~~~~  238 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY------------HIAQ  238 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHH------------HHHh
Confidence                12346788999999974   456889999999999999999999885421110   0000            0000


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ  631 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  631 (669)
                      ...........+..+.+++.+||+.+|.+||++.++++.+......+.
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence            000001111234567899999999999999999999987655444333

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.7e-33  Score=290.08  Aligned_cols=264  Identities=22%  Similarity=0.324  Sum_probs=196.0

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC----
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----  419 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----  419 (669)
                      ...++|++.+.||+|+||.||+|..+. ++.||||++....  ......+.+|+.+++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            345789999999999999999999764 8899999986543  233457788999999999999999999987655    


Q ss_pred             ------cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          420 ------ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       420 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                            ..++|+||+++ +|..++..  ....+++..+..++.||+.||+|||+.+   |+|+||+|+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 67666643  2345899999999999999999999998   999999999999999999999


Q ss_pred             eecCCCcccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          494 SDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       494 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      +|||++........ .......++..|+|||.+.+. .++.++|||||||+++||++|++|+.......   .+....+.
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRL  233 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH
Confidence            99999986543221 111223457789999988654 57899999999999999999998865322111   11111111


Q ss_pred             ccccc---chhh--------ccc------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 WTEDR---SLEL--------IDK------SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ~~~~~---~~~~--------~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .....   ...+        .+.      ...... ...+..+.+++.+||+.+|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000   0000        000      000000 012457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.5e-33  Score=283.37  Aligned_cols=249  Identities=25%  Similarity=0.350  Sum_probs=202.5

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.++||+|++|.||++... +++.+|+|.+....  .....++..|+.+++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999865 58899999986542  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      +++++|.+++.+.. ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999986532 2356899999999999999999999998   999999999999999999999999999876433 


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                         ......++..|+|||.+.+..++.++|+||||++++||++|+.|+......   .+.             ..+....
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~-------------~~~~~~~  217 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLR-------------YKVQRGK  217 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH-------------HHHhcCC
Confidence               222345788999999999999999999999999999999999986532211   000             0001111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ....+......+.+++.+|++.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            112223445678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.7e-33  Score=286.88  Aligned_cols=246  Identities=25%  Similarity=0.374  Sum_probs=196.1

Q ss_pred             eeecCccceEEEEeCC-CcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      ||+|+||.||+++... ++.+++|.+.....   ...+.+.+|+.++++++||||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999875 99999999865433   4567889999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc------
Q 005933          434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT------  507 (669)
Q Consensus       434 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~------  507 (669)
                      .+++...   ..+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9999543   36899999999999999999999998   99999999999999999999999999876433221      


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      ........++..|+|||.+.....+.++||||||+++++|++|..|+.......   ...   .         .......
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~---------~~~~~~~  219 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQ---N---------ILNGKIE  219 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H---------HhcCCcC
Confidence            112233567889999999988889999999999999999999999865322110   000   0         0000010


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      .......+..+.+++.+||+.+|++||++.++.+.|+
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            0001112467789999999999999999977776664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-33  Score=281.03  Aligned_cols=247  Identities=28%  Similarity=0.430  Sum_probs=201.1

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  ...+.+.+|++++.+++|+|++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 478999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998432   56899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      .  .....++..|+|||.+.+..++.++||||||+++++|++|..|+.....      ....+....          ...
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~~----------~~~  216 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIVQ----------DDH  216 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc----------cCC
Confidence            1  2335678899999999888889999999999999999999988642211      000001000          001


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...+...+..+.+++.+||+.+|++||++.+++.
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1122223457789999999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.4e-33  Score=297.15  Aligned_cols=260  Identities=25%  Similarity=0.290  Sum_probs=196.4

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecC------
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------  418 (669)
                      ..++|++.+.||+|+||.||++... +++.||||++.+.  .......+.+|+.+++.++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999965 5899999998653  223446778899999999999999999988643      


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                      ...++||||+. ++|.+.+..     .++...+..++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            34689999996 488877732     1888999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc---
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE---  575 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---  575 (669)
                      ++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.|+........   ..........   
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  238 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---WNKIIEQLGTPSD  238 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence            986533221   2234578899999999999999999999999999999999998754321110   0000000000   


Q ss_pred             ----------------------ccchhhcccccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          576 ----------------------DRSLELIDKSLDG----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       576 ----------------------~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                                            ....++....+..    ......+..+.+++.+||+.||++||++.|++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                                  0000000000000    0011234567899999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.3e-33  Score=285.51  Aligned_cols=257  Identities=20%  Similarity=0.284  Sum_probs=191.0

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhC-CCceeEEEEEEecC--CcceEEEe
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLR--DERMLIYE  426 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~E  426 (669)
                      |.+.++||+|+||.||+|... +++.||+|+++.... ........|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567789999999999999965 589999999875422 22234457888898885 99999999999887  88999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |++ ++|.+++..  +...+++..+..++.||+.||+|||+.+   ++|+||+|+||+++. +.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 578777743  2346899999999999999999999998   999999999999999 999999999998653322


Q ss_pred             cCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc-----------
Q 005933          507 TEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT-----------  574 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----------  574 (669)
                      .   .....++..|+|||.+.. ..++.++|||||||++|||++|..|+.......   .+........           
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence            1   123457889999997654 567889999999999999999999875432211   1111111000           


Q ss_pred             cccchhhcccccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          575 EDRSLELIDKSLDG----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       575 ~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .........+....    ......+..+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000000000000    001123567899999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-33  Score=282.71  Aligned_cols=250  Identities=25%  Similarity=0.372  Sum_probs=196.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc-----CccchHHHHHHHHHHHHhCCCceeEEEEEEecC--Ccc
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER  421 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~  421 (669)
                      .+|.+.+.||+|+||.||+|... +++.||+|.+...     .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999965 4899999987532     223456889999999999999999999998764  357


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++|+||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999843   344789999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCcc-CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQT-EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ...... ........++..|+|||++.+..++.++||||||++++||++|+.|+......   ..            ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~------------~~~  220 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AA------------IFK  220 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HH------------HHH
Confidence            533211 11122356788999999999888999999999999999999999996422110   00            011


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..........+......+.+++.+||+ +|..||++.+++.
T Consensus       221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            111111122333344568899999999 5799999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=8e-33  Score=284.80  Aligned_cols=244  Identities=27%  Similarity=0.355  Sum_probs=191.8

Q ss_pred             eeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      ||+|+||+||++... +|+.||+|.+....   ......+..|+.+++.++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 58999999986432   23345678899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCccc
Q 005933          434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR  513 (669)
Q Consensus       434 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  513 (669)
                      .+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            999864332 35899999999999999999999998   999999999999999999999999998765331   12223


Q ss_pred             ccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHH
Q 005933          514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS  593 (669)
Q Consensus       514 ~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (669)
                      ..++..|+|||++.+..++.++||||||+++++|++|+.|+...........+..            .... .....+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------~~~~-~~~~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR------------RTLE-MAVEYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh------------cccc-ccccCCcc
Confidence            4577899999999888899999999999999999999999653322111000000            0000 00111222


Q ss_pred             HHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          594 EALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       594 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      ....+.+++.+||+.+|++||     ++.+++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            355788999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.1e-33  Score=288.58  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=193.7

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|...++||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556689999999999999965 48999999986543 234567899999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          428 LPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       428 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      +.. +|.++...  ......+++..+..++.+++.||+|||+. +   ++||||||+||+++.++.++|+|||++..+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55554321  12335689999999999999999999975 6   99999999999999999999999999876532


Q ss_pred             CccCcCcccccccCCccCchhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ...   .....++..|+|||++.+.   .++.++||||||+++|||++|+.|+....     ........... ..    
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~----  227 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GD----  227 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CC----
Confidence            211   1223578899999999776   68999999999999999999999965332     11111111000 00    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                       .+.+........+..+.+++.+||+.+|++||++.+|+..
T Consensus       228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0111111112345578899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=287.36  Aligned_cols=259  Identities=22%  Similarity=0.323  Sum_probs=197.9

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      |.+.+.||+|++|.||++... +++.+++|++.....  .....+..|+.+++.++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999975 588999999865433  24567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++ +|.+++...  ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 888887542  256899999999999999999999998   9999999999999999999999999988764433  


Q ss_pred             cCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc---ccchhhcc-
Q 005933          509 ANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE---DRSLELID-  583 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-  583 (669)
                      .......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+.......   .+.........   ........ 
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhh
Confidence            112234577889999999877 78999999999999999999998865332211   11000000000   00000000 


Q ss_pred             ----------cccC--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 ----------KSLD--GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ----------~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                ....  .......+..+.+++.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      0000  0011123457889999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.9e-33  Score=281.06  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=203.7

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|.+.+.||.|++|.||++... +++.||+|++.....  .....+..|+++++.++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999976 589999999875433  4567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986532 2366899999999999999999999998   9999999999999999999999999998754332


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                        .......++..|+|||.+.+..++.++||||+|+++++|++|+.|+......   .+...   .         ... .
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~---~---------~~~-~  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALK---I---------LKG-Q  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHH---H---------hcC-C
Confidence              1223356788999999999889999999999999999999999986533211   11100   0         000 0


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....+......+.+++.+||+.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11112233457889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.2e-33  Score=296.31  Aligned_cols=264  Identities=22%  Similarity=0.352  Sum_probs=197.4

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCC--cc
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD--ER  421 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~--~~  421 (669)
                      ..++|++.+.||+|+||.||+|... +++.+|||++...  .......+..|+.+++++ +|+||+++++++...+  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567889999999999999999976 4889999988543  233445678899999999 9999999999986543  57


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||++ ++|..++..    ..+++..+..++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 589888843    26889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccC---cCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc----
Q 005933          502 FGVDQTE---ANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW----  573 (669)
Q Consensus       502 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~----  573 (669)
                      +......   .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+.......   .........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~  233 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPS  233 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence            6433221   12233568889999998765 467889999999999999999999875332211   111000000    


Q ss_pred             -------ccccchhhcccccCCC-CC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          574 -------TEDRSLELIDKSLDGS-YS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       574 -------~~~~~~~~~~~~~~~~-~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                             .......++....... ..     ...+..+.+++.+||+.+|++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                   0000111111100000 00     1124578899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-32  Score=283.51  Aligned_cols=242  Identities=24%  Similarity=0.293  Sum_probs=186.6

Q ss_pred             eeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHH---hCCCceeEEEEEEecCCcceEEEeecC
Q 005933          357 KLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAK---LQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      .||+|+||.||++... +++.+|+|.+.+...   .....+.+|..++..   .+|||++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 489999998865321   222334555544444   379999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++..   .+.+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999998843   345899999999999999999999998   9999999999999999999999999987543221   


Q ss_pred             CcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                       .....++..|+|||.+.+ ..++.++|||||||+++||++|..|+.......... +   ...          ......
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~---~~~----------~~~~~~  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I---DRM----------TLTVNV  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-H---HHH----------hhcCCc
Confidence             123468999999999864 568899999999999999999999975332211100 0   000          000111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM  622 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  622 (669)
                      ..+...+..+.+++.+||+.||++||     +++++++.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            12223446788999999999999999     59999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-32  Score=285.86  Aligned_cols=262  Identities=24%  Similarity=0.316  Sum_probs=194.5

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.+.||+|++|.||+|... +++.||+|.+....  ....+.+.+|+.+++.++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999976 58899999986542  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecCCCcccCCC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVD  505 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~~~~~  505 (669)
                      |++ ++|.+++... ....+++..+..++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 5787777432 2233678889999999999999999998   999999999999985 567999999999765332


Q ss_pred             ccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc-------
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR-------  577 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  577 (669)
                      .  .......++..|+|||++.+. .++.++||||||+++|+|++|+.|+......   ..+...........       
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhcccc
Confidence            1  112234568899999998764 5789999999999999999999987543221   11111100000000       


Q ss_pred             --chhhcc--cccCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 --SLELID--KSLDGS----YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 --~~~~~~--~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ......  +.....    ........+.+++.+|++.+|++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000000  000000    01112345789999999999999999999986

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-33  Score=296.64  Aligned_cols=262  Identities=21%  Similarity=0.300  Sum_probs=196.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-----c
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----E  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~  420 (669)
                      .++|.+.+.||+|+||+||++... +++.||||.+...  .......+.+|+.+++.++|+||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457899999999999999999965 5899999998653  2334567788999999999999999999876542     4


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++|+||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 68888874   3356899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh-------
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL-------  572 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~-------  572 (669)
                      ......  .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+.......   ........       
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~  231 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE  231 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence            653321  12223467889999998865 468899999999999999999999875332111   01100000       


Q ss_pred             ----cccccchhhcccccCCC------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          573 ----WTEDRSLELIDKSLDGS------YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       573 ----~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                          .........+.......      .....+..+.+++.+||+.+|++||+++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                00001111111000000      011234567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-33  Score=311.00  Aligned_cols=269  Identities=20%  Similarity=0.279  Sum_probs=187.0

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC--CcEEEEEE--------------ec---ccCccchHHHHHHHHHHHHhCCCce
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKR--------------LS---KSSGQGVEEFKNEVLLIAKLQHRNL  408 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni  408 (669)
                      ..++|.+.++||+|+||+||++.+..  +..+++|.              +.   .........+.+|+.+++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987542  22222221              11   1122234578899999999999999


Q ss_pred             eEEEEEEecCCcceEEEeecCCCCHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc
Q 005933          409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR--TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD  486 (669)
Q Consensus       409 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~  486 (669)
                      +++++++...+..++|+|++. ++|.+++.....  ........+..++.||+.||.|||+.+   |+||||||+||||+
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999985 567776643211  122345677889999999999999998   99999999999999


Q ss_pred             CCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCCccch
Q 005933          487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNL  565 (669)
Q Consensus       487 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p-~~~~~~~~~~~~  565 (669)
                      .++.+||+|||+++.+..... .......|+..|+|||++.+..++.++|||||||++|||++|..+ +..........+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999987643222 122235789999999999999999999999999999999998754 222111111111


Q ss_pred             hhHhhhh------ccc--ccchhhcccccCCC--CC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          566 LGHAWRL------WTE--DRSLELIDKSLDGS--YS-------LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       566 ~~~~~~~------~~~--~~~~~~~~~~~~~~--~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .......      +..  ....+.++......  ..       ...+..+.+++.+||+.||.+|||+.|++.
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1110000      000  00000110000000  00       011235677899999999999999999986

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-33  Score=282.48  Aligned_cols=244  Identities=24%  Similarity=0.273  Sum_probs=188.6

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHH-HHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLI-AKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.||+|++|.||+|... +++.||||.+.+...   .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999975 489999999865432   2223344555444 445899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      ++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999843   345899999999999999999999998   99999999999999999999999999875432      


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..|+......   ...    ........      ......
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~~------~~~~~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVF----DNILSRRI------NWPEEV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhccc------CCCCcc
Confidence            22345788999999998888999999999999999999999996532211   000    00000000      000011


Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          591 SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       591 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ....+..+.+++.+||+.+|++||++.++.+.|+
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            1123467889999999999999998877766664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.4e-33  Score=296.82  Aligned_cols=267  Identities=21%  Similarity=0.322  Sum_probs=198.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEec----CCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~  421 (669)
                      .++|++.+.||+|++|.||++... +++.||+|++....  ......+.+|+.++..++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            468999999999999999999965 59999999987542  2345678889999999999999999988753    3457


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+. ++|.+++.   ....+++..+..++.||+.||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            89999995 68988883   3345899999999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCccC--cCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhH--------hh
Q 005933          502 FGVDQTE--ANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH--------AW  570 (669)
Q Consensus       502 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~--------~~  570 (669)
                      .......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+..        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432221  11123568889999999866 4688999999999999999999999753322111000000        00


Q ss_pred             hhcccccchhhccccc-CCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          571 RLWTEDRSLELIDKSL-DGSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .........+..+... ....+     ...+..+.+++.+||+.+|++||++.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000001111111000 00111     1234678999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=286.51  Aligned_cols=260  Identities=18%  Similarity=0.237  Sum_probs=183.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC----CcEEEEEEecccCccchH-----------HHHHHHHHHHHhCCCceeEEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVE-----------EFKNEVLLIAKLQHRNLVRLLG  413 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l~g  413 (669)
                      .++|.+.++||+|+||.||+|...+    +..+|+|+..........           ....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3689999999999999999999754    345666654322211111           1122334455668999999999


Q ss_pred             EEecCC----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc
Q 005933          414 CCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM  489 (669)
Q Consensus       414 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~  489 (669)
                      ++....    ..++++|++. .++.+.+..   ....++..+..++.|+++||+|||+.+   ++||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            776544    2367777764 356666532   223578889999999999999999998   99999999999999999


Q ss_pred             ceEEeecCCCcccCCCccC-----cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 005933          490 NPKISDFGMARAFGVDQTE-----ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN  564 (669)
Q Consensus       490 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~  564 (669)
                      .++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||+++||++|+.|+.......  .
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence            9999999999876322111     11223468999999999999999999999999999999999999976432211  1


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ........+    ...+....+.   ....+..+.+++..|++.+|++||++.++++.|+
T Consensus       242 ~~~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDF----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHH----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111110000    0011111110   1112456889999999999999999999998874

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=286.34  Aligned_cols=244  Identities=27%  Similarity=0.357  Sum_probs=201.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .+.|+.-+.||+||||.||..+.. +|+-+|.|.+.+.   .+.+....++|-.+|.+++.+.||.+--.+...+.++||
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            456888899999999999999865 4999999988643   344566788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      +..|.||+|.-+|.+..+ ..+++..+..++.+|+.||++||...   ||+|||||+|||||+.|+++|+|+|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999976554 56899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ..   .....+||.+|||||++.++.|+...|.|||||+||||+.|+.||-.....                ...+-++.
T Consensus       340 g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------------vk~eEvdr  400 (591)
T KOG0986|consen  340 GK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------------VKREEVDR  400 (591)
T ss_pred             CC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------------hhHHHHHH
Confidence            32   233458999999999999999999999999999999999999996432211                11112222


Q ss_pred             ccC---CCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 005933          585 SLD---GSYSLSEALRCIQVGLLCVQQRPEDRPN  615 (669)
Q Consensus       585 ~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs  615 (669)
                      ++.   ..++..-..++.+|....|+.||++|..
T Consensus       401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             HHhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            221   1233334457778888999999999953

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.2e-33  Score=287.47  Aligned_cols=243  Identities=23%  Similarity=0.341  Sum_probs=195.4

Q ss_pred             CeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCHH
Q 005933          356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLE  434 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  434 (669)
                      .+||+|+||.||++... +++.||||++..........+.+|+.+++.++|+|++++++++..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            68999999999999975 58999999986555555678999999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccc
Q 005933          435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV  514 (669)
Q Consensus       435 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  514 (669)
                      +++..    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  .....
T Consensus       106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~  176 (292)
T cd06657         106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL  176 (292)
T ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence            98732    34789999999999999999999998   99999999999999999999999999876533221  12335


Q ss_pred             cccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHH
Q 005933          515 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE  594 (669)
Q Consensus       515 ~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  594 (669)
                      .++..|+|||.+.+..++.++||||||+++|+|++|..|+......   ......    .     ......+..  ....
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~----~-----~~~~~~~~~--~~~~  242 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMI----R-----DNLPPKLKN--LHKV  242 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----H-----hhCCcccCC--cccC
Confidence            6788999999998888999999999999999999999986532111   000000    0     000111100  1122


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          595 ALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       595 ~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +..+.+++.+||+.+|.+||++.+++.
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            446788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.7e-32  Score=278.42  Aligned_cols=247  Identities=21%  Similarity=0.263  Sum_probs=189.4

Q ss_pred             HHHHhcCCCccCee--eecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCc
Q 005933          345 IADATDNFSWKNKL--GEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       345 l~~~~~~~~~~~~l--g~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  420 (669)
                      +....++|.+.+.+  |+|+||.||++..+ +++.+|+|.+.......     .|+.....+ +|||++++++.+...+.
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34445677777777  99999999999965 48889999986432211     122222222 69999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeecCCC
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMA  499 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla  499 (669)
                      .++||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++ .++|+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            9999999999999999843   237899999999999999999999998   99999999999999988 9999999998


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ......      ....++..|+|||++.+..++.++||||||++++||++|+.|+.....+. .........        
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~--------  222 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR--------  222 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh--------
Confidence            765322      12357889999999999899999999999999999999999976322111 011111000        


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-MSSVVL  621 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  621 (669)
                        .....  ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus       223 --~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        223 --QQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             --hcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence              00000  111134567889999999999999996 688873

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-32  Score=287.40  Aligned_cols=262  Identities=20%  Similarity=0.233  Sum_probs=191.1

Q ss_pred             ccCeeeecCccceEEEEeCCCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      +.+.+|.|+++.|+++.. +++.||||++...  .....+.+..|+.+++.++|+||+++++++...+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344555556655555555 5899999998754  3445678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc----
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT----  507 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~----  507 (669)
                      +|.+++.... ...+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||.+..+.....    
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999996432 234889999999999999999999998   99999999999999999999999998875532211    


Q ss_pred             -CcCcccccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh----cccccchh
Q 005933          508 -EANTDRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL----WTEDRSLE  580 (669)
Q Consensus       508 -~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~  580 (669)
                       ........++..|+|||++...  .++.++||||||++++||++|+.|+......  ..........    ........
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence             1112234567789999998763  5889999999999999999999997532211  1111110000    00000000


Q ss_pred             -----------hcccc----cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          581 -----------LIDKS----LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       581 -----------~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                                 ..+..    ............+.+++.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                       00000    0011112233567899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.8e-32  Score=289.38  Aligned_cols=260  Identities=23%  Similarity=0.295  Sum_probs=190.9

Q ss_pred             Ceeeec--CccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEG--GFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G--~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      ..||+|  +||+||++... +++.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            467776  89999999975 59999999986432  23457889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc-
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA-  509 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  509 (669)
                      ++|.+++.... ...+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999986532 234889999999999999999999988   9999999999999999999999998654332111110 


Q ss_pred             ----CcccccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh-------------
Q 005933          510 ----NTDRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-------------  570 (669)
Q Consensus       510 ----~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~-------------  570 (669)
                          ......++..|+|||++.+.  .++.++||||||++++||++|+.|+.......  .......             
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence                01112345679999999764  47899999999999999999999975432110  0000000             


Q ss_pred             ---hhccc-----------cc-----chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          571 ---RLWTE-----------DR-----SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       571 ---~~~~~-----------~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         ..+..           ..     ...+....+...........+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               00000           00     00000111111122334567899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=272.72  Aligned_cols=277  Identities=22%  Similarity=0.334  Sum_probs=209.5

Q ss_pred             HHHHHHHhcCCCccCeeeecCccceEEEE-eCCCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCC
Q 005933          342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRD  419 (669)
Q Consensus       342 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~  419 (669)
                      +.++...++     +.||+|+++.|-..+ +.+|..+|||++.+.......+..+|++++.+.+ |+||++|+.+|+++.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            444544443     789999999999888 6779999999999888888999999999999996 999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc---eEEeec
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDF  496 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~Df  496 (669)
                      ..+||||-|.||+|..+|.   +.+.+++.++.++.++|+.||.|||..+   |.||||||+|||..+...   +||+||
T Consensus       150 ~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             eEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence            9999999999999999994   4556899999999999999999999999   999999999999976544   799999


Q ss_pred             CCCcccCC--Cc---cCcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchh
Q 005933          497 GMARAFGV--DQ---TEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL  566 (669)
Q Consensus       497 gla~~~~~--~~---~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~  566 (669)
                      .+..-...  +-   .......++|+..|||||+..     ...|..+.|.||||||||-|++|.+||...-+.+-    
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----  299 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----  299 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----
Confidence            88754321  11   112233477899999999873     23578899999999999999999999864333211    


Q ss_pred             hHhhhhcccccchhhcccccCCC--CCHHHH----HHHHHHHHHhccCCCCCCCCHHHHHH-----HhcCCCCCCCCC
Q 005933          567 GHAWRLWTEDRSLELIDKSLDGS--YSLSEA----LRCIQVGLLCVQQRPEDRPNMSSVVL-----MLSGERSLPQPK  633 (669)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~----~~l~~li~~cl~~dP~~RPs~~evl~-----~L~~~~~~~~p~  633 (669)
                      .|.....-...-..+...+..+.  ++..+.    ....+++...+-.|+.+|.++.+++.     +.....++|.|+
T Consensus       300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~  377 (463)
T KOG0607|consen  300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQ  377 (463)
T ss_pred             CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCc
Confidence            00000000011112222233333  333332    35568888889999999999999876     444445666554

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.6e-32  Score=284.24  Aligned_cols=255  Identities=23%  Similarity=0.320  Sum_probs=199.4

Q ss_pred             CCCccCeeeecCccceEEEEe----CCCcEEEEEEecccC----ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcc
Q 005933          351 NFSWKNKLGEGGFGPVYRGML----TEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  421 (669)
                      +|++.+.||+|++|.||++..    .+++.||||.+.+..    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467789999999999999984    247889999986432    23346788999999999 599999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999999843   345889999999999999999999988   99999999999999999999999999876


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      +...... ......++..|+|||.+.+..  .+.++||||||++++||++|..|+........  .......        
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~--------  223 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRR--------  223 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHH--------
Confidence            5433211 122345788999999987665  78899999999999999999999653221110  0000000        


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                       ....  ....+......+.+++.+||+.+|++|||+.++...|+.
T Consensus       224 -~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         224 -ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence             0000  011122234567899999999999999999999888865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=298.32  Aligned_cols=203  Identities=30%  Similarity=0.447  Sum_probs=176.1

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC------cceE
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------ERML  423 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l  423 (669)
                      +...+.||+|+||.||+|+.+ .|+.||||.+++.. ....+....|+++|++|+|+|||++++.-.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            444588999999999999965 59999999997643 345677889999999999999999999865543      5789


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc--CCc--ceEEeecCCC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDM--NPKISDFGMA  499 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~--~~~--~~kl~Dfgla  499 (669)
                      |||||.+|||+..|.+..+.--|++.+.+.++.+++.||.|||+++   |+||||||.||++-  .+|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999988888778999999999999999999999998   99999999999984  223  5799999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD  560 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~  560 (669)
                      +.+....   .....+||..|++||.... ..|+..+|.|||||++|+.+||..||.....+
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9875433   4556899999999999985 78999999999999999999999998765554

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.9e-33  Score=285.62  Aligned_cols=249  Identities=27%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|.+.+.||+|++|.||++... +++.||+|++.+.   .....+.+..|+.++++++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999976 5899999998653   2233567889999999998 99999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      ||++++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999954   346999999999999999999999998   99999999999999999999999999887643


Q ss_pred             CccC------------------cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchh
Q 005933          505 DQTE------------------ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL  566 (669)
Q Consensus       505 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~  566 (669)
                      ....                  .......++..|+|||.+....++.++||||||+++++|++|+.|+......   ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTF  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHH
Confidence            3221                  1223345788999999999888999999999999999999999986533210   000


Q ss_pred             hHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 005933          567 GHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNM----SSVVL  621 (669)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  621 (669)
                         .         ....  .....+...+..+.+++.+||+.+|.+||++    +++++
T Consensus       232 ---~---------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 ---Q---------KILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---H---------HHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               0         0000  1112222335678899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=310.44  Aligned_cols=259  Identities=29%  Similarity=0.411  Sum_probs=205.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC--------CcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeEEEEEEecC
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR  418 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  418 (669)
                      .++..+.+.||+|.||.|++|....        ...||||.++.... ...+.+..|+++|..+ +|+||+.++|+|...
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            3455666799999999999998541        45799999976533 4577899999999999 699999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVT-----------RT--KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                      +..++|+||++.|+|.+++...+           ..  ..++....+.++.|||.|++||++..   ++||||.++||||
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence            99999999999999999997654           01  23889999999999999999999998   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCc-CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEA-NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHH  563 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~  563 (669)
                      ..+..+||+|||+++......... ......-+..|||||.+....|+.++|||||||+||||++ |..|++....  . 
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~-  528 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--T-  528 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--H-
Confidence            999999999999999654433322 1111114566999999999999999999999999999999 5566432100  0 


Q ss_pred             chhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          564 NLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                                  ....+.+...-.-..+..+..++.++|+.||+.+|++||++.++++.|+.
T Consensus       529 ------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  529 ------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             ------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence                        11111222222223445556788899999999999999999999999987

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-32  Score=289.50  Aligned_cols=264  Identities=21%  Similarity=0.282  Sum_probs=194.9

Q ss_pred             hcCCCc-cCeeeecCccceEEEEeC-CCcEEEEEEecccCccc--------------hHHHHHHHHHHHHhCCCceeEEE
Q 005933          349 TDNFSW-KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQG--------------VEEFKNEVLLIAKLQHRNLVRLL  412 (669)
Q Consensus       349 ~~~~~~-~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  412 (669)
                      .++|.. .+.||+|+||+||+|... +++.||||.+.......              ...+.+|+.++..++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345653 467999999999999965 58999999986532211              12578899999999999999999


Q ss_pred             EEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceE
Q 005933          413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK  492 (669)
Q Consensus       413 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  492 (669)
                      +++...+..++||||+. ++|.+++.   ....+++.....++.||+.||.|||+.+   ++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999997 68998884   3345899999999999999999999998   99999999999999999999


Q ss_pred             EeecCCCcccCCCc------------cCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005933          493 ISDFGMARAFGVDQ------------TEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHA  559 (669)
Q Consensus       493 l~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~  559 (669)
                      |+|||++.......            .........++..|+|||.+.+. .++.++||||||++++||++|+.|+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999987654111            01111223467889999998765 478999999999999999999998754332


Q ss_pred             CCccchhhHhhhhcccccch---hh--------cccccCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          560 DHHHNLLGHAWRLWTEDRSL---EL--------IDKSLDG---SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       560 ~~~~~~~~~~~~~~~~~~~~---~~--------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .   ..+.............   ..        .......   .........+.+++.+||+.+|++||++.|++..
T Consensus       240 ~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        240 I---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             H---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1   1111111111100000   00        0000000   0001123567899999999999999999999964

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-32  Score=280.46  Aligned_cols=259  Identities=22%  Similarity=0.329  Sum_probs=193.0

Q ss_pred             CCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc--cchHHHHHHHHHHHHh---CCCceeEEEEEEecCCc-----
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKL---QHRNLVRLLGCCTLRDE-----  420 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----  420 (669)
                      |++.+.||+|+||.||+|+.+. ++.||||++.....  .....+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999875 89999999964322  2234567788877766   59999999999988776     


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .+++|||+.+ +|.+++.... ...+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 8988885432 235899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc--
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS--  578 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  578 (669)
                      .......   .....++..|+|||++.+..++.++||||||+++|||++|.+|+......   ..+............  
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHh
Confidence            7533221   12235688899999999999999999999999999999998886532211   111111000000000  


Q ss_pred             --------hhhcccccCCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 --------LELIDKSLDGS---YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 --------~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                              ...........   ........+.+++.+||+.||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                    00000000000   01122356789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=282.91  Aligned_cols=260  Identities=25%  Similarity=0.299  Sum_probs=194.8

Q ss_pred             CCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc-cchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEeec
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      |.+.+.||+|++|+||+|...+ ++.|+||++..... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5677999999999999999864 78999999865432 22334567999999999 999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence             889998885432 346899999999999999999999998   9999999999999999999999999997653221  


Q ss_pred             cCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc---------cc
Q 005933          509 ANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED---------RS  578 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  578 (669)
                       ......++..|+|||++.. ..++.++||||||++++||++|++|+........   ...........         ..
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhHhhh
Confidence             1223467889999998754 4578999999999999999999988654322111   00000000000         00


Q ss_pred             hhhcccccCCC--C-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          579 LELIDKSLDGS--Y-----SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       579 ~~~~~~~~~~~--~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ...+...+...  .     .......+.+++.+||+.+|++||+++|++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000000  0     00113578899999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-32  Score=291.67  Aligned_cols=262  Identities=22%  Similarity=0.317  Sum_probs=194.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------  419 (669)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++.+..  ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 58999999986532  233457889999999999999999999986543      


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999964 777665     134889999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc-----
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW-----  573 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~-----  573 (669)
                      .....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......   .+.......     
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  236 (342)
T cd07879         165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP  236 (342)
T ss_pred             cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence            76422     1223466888999999876 468899999999999999999999976432111   111111000     


Q ss_pred             ------ccccchhhccccc-CCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCCC
Q 005933          574 ------TEDRSLELIDKSL-DGSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGER  627 (669)
Q Consensus       574 ------~~~~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~  627 (669)
                            ............. .....     ......+.+++.+||+.||++||++.+++..  ++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                  0000000000000 00000     0123467899999999999999999999853  55543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-33  Score=276.82  Aligned_cols=264  Identities=24%  Similarity=0.334  Sum_probs=216.0

Q ss_pred             HHHHHHhcCCCccCeeeecCccceEEEEeC------CCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEE
Q 005933          343 NTIADATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCC  415 (669)
Q Consensus       343 ~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~  415 (669)
                      .++.....+++....+-+|.||.||.|++.      +.+.|.||.++.. +......++.|-..+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            344555677888889999999999999754      3456788877654 344577899999999999999999999998


Q ss_pred             ecC-CcceEEEeecCCCCHHHHhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc
Q 005933          416 TLR-DERMLIYEYLPNKSLEQFIF-----DVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM  489 (669)
Q Consensus       416 ~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~  489 (669)
                      .+. +..+.+|.++.-|+|..||.     +......++..+...++.|++.|++|||.++   +||.||.++|.+||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            765 45788999999999999997     4444556888899999999999999999999   99999999999999999


Q ss_pred             ceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhH
Q 005933          490 NPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH  568 (669)
Q Consensus       490 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~  568 (669)
                      ++||+|=.+++.+-+.+.....+....+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+.      
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------  507 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------  507 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------
Confidence            999999999998877777666667778899999999999999999999999999999988 7777443222211      


Q ss_pred             hhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                                ...+...-+-..+..++.++..++.-||...|++||+++|++.-|..
T Consensus       508 ----------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  508 ----------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ----------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                      11111111113355677889999999999999999999999998864

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3e-32  Score=282.44  Aligned_cols=251  Identities=23%  Similarity=0.311  Sum_probs=194.8

Q ss_pred             CCCccCeeeecCccceEEEEe----CCCcEEEEEEecccC----ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcc
Q 005933          351 NFSWKNKLGEGGFGPVYRGML----TEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  421 (669)
                      +|++.+.||+|+||.||++..    .+|+.||+|++....    ....+.+.+|+.++..+ +|+||+++.+++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999986    368999999986532    22346788999999999 599999999999998899


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++|+||+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++||||+|+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   345889999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCccCcCcccccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ....... ......++..|+|||.+...  .++.++||||||+++|+|++|..|+........  ..........     
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~-----  226 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILK-----  226 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhc-----
Confidence            5332211 12234578899999998753  467899999999999999999998653221111  0000000000     


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                            .....+......+.+++.+||+.+|++||     ++.+++.
T Consensus       227 ------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         227 ------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                  00112223345678999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.6e-32  Score=286.15  Aligned_cols=264  Identities=22%  Similarity=0.326  Sum_probs=197.6

Q ss_pred             HHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEec-CCcc
Q 005933          346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDER  421 (669)
Q Consensus       346 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~  421 (669)
                      ..++++|++.+.||+|+||.||++... +++.||||++.+..  ....+.+..|+.++..++||||+++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999965 68999999886432  2345678899999999999999999999866 4578


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++|+||+ +++|.+++.    ...+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 568988873    234788888999999999999999998   99999999999999999999999999875


Q ss_pred             cCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhh--------Hhhhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAWRL  572 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~--------~~~~~  572 (669)
                      ...     ......++..|+|||.+.+ ..++.++||||||+++++|++|+.|+...........+.        .....
T Consensus       158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            422     1123456788999998866 568999999999999999999999875432211000000        00000


Q ss_pred             cccccchhhccccc-CCCCCHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          573 WTEDRSLELIDKSL-DGSYSLS-----EALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       573 ~~~~~~~~~~~~~~-~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .......+++.... ....+..     ....+.+++.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00111111111110 1111111     23578899999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-33  Score=292.56  Aligned_cols=265  Identities=22%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-----cce
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-----ERM  422 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~  422 (669)
                      +|.+.+.||+|++|.||++.... ++.||||++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47888999999999999999764 8999999987643  345578999999999999999999999988775     789


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||||++ ++|.+++..   ...+++..+..++.||+.||+|||+.+   ++|+||||.|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 488888843   337899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCcc-CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh--------hhh
Q 005933          503 GVDQT-EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WRL  572 (669)
Q Consensus       503 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~--------~~~  572 (669)
                      ..... ........++..|+|||.+.+. .++.++||||||+++++|++|..|+...........+...        +..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            44321 1122334678899999999888 8899999999999999999999987543321110000000        000


Q ss_pred             cccccchhhcccccC-CCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          573 WTEDRSLELIDKSLD-GSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .........+..... ...+     ...+..+.+++.+||+.+|++||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000111111110000 0001     1124567899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-33  Score=292.84  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=206.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc--chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ...|.+.+.||+|.|+.|.+|+.. .+..||||.+.+..-.  ....+.+|+++|..|+|||||+++.+......+++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            457888999999999999999965 4999999999876433  3456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||..+|.+.+++.+.   +...+.....++.|+.+|++|||+++   |+|||||++||||+.+.++||+|||++..+.  
T Consensus       135 eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--  206 (596)
T KOG0586|consen  135 EYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD--  206 (596)
T ss_pred             EeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--
Confidence            999999999999543   33556888899999999999999999   9999999999999999999999999998874  


Q ss_pred             ccCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                       ........+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+..                   ...++-..
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-------------------~lk~Lr~r  266 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-------------------NLKELRPR  266 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-------------------ccccccch
Confidence             3334455789999999999998865 57999999999999999999996632                   22223333


Q ss_pred             ccCCCC--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          585 SLDGSY--SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       585 ~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .+.+.+  +..-..+|-+++.++|-.+|.+|++++++..-
T Consensus       267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            333322  22334578899999999999999999999764

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.5e-32  Score=284.04  Aligned_cols=253  Identities=21%  Similarity=0.368  Sum_probs=193.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC-ccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .++|++.+.||+|++|.||+|..+. ++.||||++.... .....++..|+.++..+. |+||+++++++......++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3578888999999999999999875 8999999997543 234456777887777775 999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      ||+. ++|.+++...  ...+++..+..++.||++||+|||+. +   ++||||+|+||++++++.+||+|||++..+..
T Consensus        94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9985 4777776442  23689999999999999999999974 6   99999999999999999999999999876532


Q ss_pred             CccCcCcccccccCCccCchhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ...   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.|+.....+  ...+   .+..... .  
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~~~~~~~-~--  236 (296)
T cd06618         168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVL---TKILQEE-P--  236 (296)
T ss_pred             CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHH---HHHhcCC-C--
Confidence            221   12235678899999987554    788999999999999999999996432111  0001   0111000 0  


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                         ..+  ......+..+.+++.+||+.||.+||++.++++.-
T Consensus       237 ---~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         237 ---PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             ---CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence               000  01112345688999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.1e-32  Score=285.00  Aligned_cols=248  Identities=28%  Similarity=0.385  Sum_probs=193.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      +.|...+.||+|+||.||+|+.. +++.+|+|.+...   ......++.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666789999999999999975 4788999998642   2233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+. |+|.+.+..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9996 578777643  2345899999999999999999999998   999999999999999999999999998764321


Q ss_pred             ccCcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                            ....++..|+|||.+.   ...++.++||||||+++|+|++|..|+......   ....            ...
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~------------~~~  227 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY------------HIA  227 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHHH------------HHh
Confidence                  2345788999999985   346788999999999999999999885322110   0000            000


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ...............+.+++.+||+.+|++||++.+++....
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             hcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            000000111233456789999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.1e-32  Score=285.00  Aligned_cols=267  Identities=22%  Similarity=0.289  Sum_probs=193.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCC------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------  419 (669)
                      .++|++.++||+|++|.||+|... +++.||||++.....  .....+.+|+++++.++|+||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999965 489999999864332  22356788999999999999999999875544      


Q ss_pred             --cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          420 --ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       420 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                        ..++|+||+.+ +|...+..  ....+++..+..++.||++||.|||+.+   ++|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35899999975 67666643  2346899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccCc---------CcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhh
Q 005933          498 MARAFGVDQTEA---------NTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG  567 (669)
Q Consensus       498 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~  567 (669)
                      ++..........         ......++..|+|||.+.+. .++.++||||||+++|||++|++|+...........+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998654322111         11234567889999988654 58899999999999999999998865322211111110


Q ss_pred             Hhhhhcccc------cchhhcccccCC--CCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          568 HAWRLWTED------RSLELIDKSLDG--SYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       568 ~~~~~~~~~------~~~~~~~~~~~~--~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .........      ............  ....     .....+.+++.+||+.+|++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000000000      000000000000  0000     11246789999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.6e-32  Score=278.24  Aligned_cols=241  Identities=24%  Similarity=0.308  Sum_probs=186.0

Q ss_pred             eeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHH---HHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          357 KLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLI---AKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      .||+|+||.||++... +++.||+|.+.+...   .....+..|..++   +...||||+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999965 488999999865421   1222344454443   34579999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|..++.   +...+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+...    
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----  150 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence            999999884   3456999999999999999999999988   999999999999999999999999998765322    


Q ss_pred             CcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||.+.++ .++.++||||||+++|||++|+.|+............    ..         . .....
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~---------~-~~~~~  216 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RM---------T-LTMAV  216 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HH---------h-hccCC
Confidence            12234689999999999754 6899999999999999999999996543221111000    00         0 00011


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      ..+...+..+.+++.+||+.+|.+||     ++.++++
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            12222346788999999999999999     9999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.8e-32  Score=281.88  Aligned_cols=244  Identities=27%  Similarity=0.399  Sum_probs=190.6

Q ss_pred             CCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      |...++||+|+||+||+|+.. +++.|++|++.....   .....+.+|+.+++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556688999999999999965 488999999865332   2345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +. ++|.+++..  ....+++.++..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....    
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            96 577777643  2345899999999999999999999998   9999999999999999999999999886432    


Q ss_pred             CcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          508 EANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                        ......++..|+|||++.   ...++.++||||||+++|||++|..|+......      ......... .       
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~-~-------  236 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-D-------  236 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhc-C-------
Confidence              122356788999999984   456888999999999999999999885422110      000000000 0       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                       .........+..+.+++.+||+.+|.+||++.+++..
T Consensus       237 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 -SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000111123457899999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-32  Score=290.02  Aligned_cols=268  Identities=22%  Similarity=0.306  Sum_probs=197.4

Q ss_pred             HHHHHHHhcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC
Q 005933          342 WNTIADATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR  418 (669)
Q Consensus       342 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  418 (669)
                      ..++....++|.+.+.||+|+||.||++.. .+++.||||++....  ....+.+.+|+.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345666789999999999999999999985 458999999986532  22356788899999999999999999988643


Q ss_pred             ------CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceE
Q 005933          419 ------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK  492 (669)
Q Consensus       419 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  492 (669)
                            ...+++++++ +++|.+++..    ..+++..+..++.||++||+|||+.+   ++||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  2356777776 7899888732    34899999999999999999999998   99999999999999999999


Q ss_pred             EeecCCCcccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhH---
Q 005933          493 ISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH---  568 (669)
Q Consensus       493 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~---  568 (669)
                      |+|||++.....     ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+...........+..   
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999876422     1223467889999999876 4688999999999999999999998753222110000000   


Q ss_pred             -----hhhhcccccchhh---cccccCCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          569 -----AWRLWTEDRSLEL---IDKSLDGSY---SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       569 -----~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                           .............   +.......+   .......+.+++.+|++.||.+||++.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                 0000000000000   000000000   00123467899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-32  Score=279.36  Aligned_cols=259  Identities=26%  Similarity=0.368  Sum_probs=196.9

Q ss_pred             CCccCeeeecCccceEEEEeCC-CcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      |++.+.||+|++|.||+|+... ++.||+|.+....  ....+.+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            4567899999999999999764 8999999997653  334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      + ++|.+++....  ..+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58999985432  45899999999999999999999998   99999999999999999999999999887543221 


Q ss_pred             cCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc---cccch---hh
Q 005933          509 ANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT---EDRSL---EL  581 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~  581 (669)
                       .......+..|+|||.+.+. .++.++||||||++++||++|.+|+.......   .+........   .....   .+
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccc
Confidence             22233457789999998776 88999999999999999999988865422111   1100000000   00000   00


Q ss_pred             --cccccCC----CC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 --IDKSLDG----SY---SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 --~~~~~~~----~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        .+.....    ..   .......+.+++.+||+.+|++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              0000000    00   0011457899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-32  Score=288.02  Aligned_cols=261  Identities=22%  Similarity=0.304  Sum_probs=195.4

Q ss_pred             HHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC--
Q 005933          345 IADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--  419 (669)
Q Consensus       345 l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--  419 (669)
                      +....++|.+.+.||+|+||.||++... ++..||||++....  ......+.+|+.+++.++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3345678999999999999999999954 58999999985432  223457889999999999999999999987654  


Q ss_pred             ----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEee
Q 005933          420 ----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD  495 (669)
Q Consensus       420 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  495 (669)
                          ..++||||+ +++|..++.    ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.++|+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                348999998 779988873    245899999999999999999999998   99999999999999999999999


Q ss_pred             cCCCcccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhh---
Q 005933          496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR---  571 (669)
Q Consensus       496 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~---  571 (669)
                      ||++......     .....++..|+|||.+.+ ..++.++||||||+++++|++|..|+......   ........   
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~  233 (343)
T cd07880         162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVTG  233 (343)
T ss_pred             cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence            9998764321     223456889999999876 46889999999999999999999987532211   00000000   


Q ss_pred             --------hcccccchhhcccccCC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          572 --------LWTEDRSLELIDKSLDG------SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       572 --------~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                              .................      .........+.+++.+|++.||++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                    00000000000000000      000112335789999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.8e-32  Score=291.13  Aligned_cols=264  Identities=21%  Similarity=0.299  Sum_probs=193.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecC---------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR---------  418 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---------  418 (669)
                      ..+|.+.+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367889999999999999999975 4889999998766656677899999999999999999999776543         


Q ss_pred             -----CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-CCcceE
Q 005933          419 -----DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPK  492 (669)
Q Consensus       419 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-~~~~~k  492 (669)
                           ...++|+||++ ++|.+++.    ...+++..+..++.||++||.|||+.+   ++||||||+||+++ +++.++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 58888873    235889999999999999999999998   99999999999998 456789


Q ss_pred             EeecCCCcccCCCccC-cCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh-
Q 005933          493 ISDFGMARAFGVDQTE-ANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA-  569 (669)
Q Consensus       493 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~-  569 (669)
                      |+|||++..+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.|+............... 
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999765332211 11123457889999998755 46888999999999999999999997533211100000000 


Q ss_pred             -------hhhcccccchhhcc-cccCCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          570 -------WRLWTEDRSLELID-KSLDGSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       570 -------~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                             ...... ....... .......+.     .....+.+++.+||+.||++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                   000000 0000000 000001111     12346789999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.6e-33  Score=309.20  Aligned_cols=253  Identities=27%  Similarity=0.414  Sum_probs=188.7

Q ss_pred             HHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEec------
Q 005933          346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL------  417 (669)
Q Consensus       346 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------  417 (669)
                      .+...+|+..+.||+||||.|||++.+ ||+.||||++.-. +........+|+.+|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456678999999999999999999976 7999999999754 34455678899999999999999999853211      


Q ss_pred             ------------------------------------------------------------------------C-------
Q 005933          418 ------------------------------------------------------------------------R-------  418 (669)
Q Consensus       418 ------------------------------------------------------------------------~-------  418 (669)
                                                                                              +       
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                    0       


Q ss_pred             ----------------------------------CcceEEEeecCCCCHHHHhhccCCCCCC-CHHHHHHHHHHHHHHHH
Q 005933          419 ----------------------------------DERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGIARGLL  463 (669)
Q Consensus       419 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l-~~~~~~~i~~~ia~~L~  463 (669)
                                                        ..++|=||||+..+|++++.+.   ... .....++++++|+.||+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHH
Confidence                                              0135668999888888888432   222 46778999999999999


Q ss_pred             HHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC----------------CccCcCcccccccCCccCchhhc
Q 005933          464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV----------------DQTEANTDRVVGTYGYMSPEYAI  527 (669)
Q Consensus       464 yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~  527 (669)
                      |+|+.+   ||||||||.|||||++..|||+|||+|.....                .......+..+||.-|+|||++.
T Consensus       712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            999999   99999999999999999999999999987210                01111234578999999999997


Q ss_pred             cC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC--CCCCHHHHHHHHHHH
Q 005933          528 DG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD--GSYSLSEALRCIQVG  602 (669)
Q Consensus       528 ~~---~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li  602 (669)
                      +.   +|+.|+|+||+||||+||+.   ||+...        ..+ ..     +..+-+..+.  ..+..++...-..+|
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--------ERa-~i-----L~~LR~g~iP~~~~f~~~~~~~e~slI  851 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--------ERA-SI-----LTNLRKGSIPEPADFFDPEHPEEASLI  851 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchH--------HHH-HH-----HHhcccCCCCCCcccccccchHHHHHH
Confidence            65   49999999999999999985   222110        000 00     0111111111  112233444557899


Q ss_pred             HHhccCCCCCCCCHHHHHH
Q 005933          603 LLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       603 ~~cl~~dP~~RPs~~evl~  621 (669)
                      .++++.||.+|||+.|+|.
T Consensus       852 ~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  852 RWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHhcCCCccCCCHHHHhh
Confidence            9999999999999999986

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.9e-32  Score=276.05  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=194.1

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc-----CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      +|.+.++||+|+||.||++.... +..+++|.+...     ......++..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998654 455666665432     122344677899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          425 YEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |||+++++|.+++... .....+++..++.++.|+++||.|||+.+   ++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988643 23456899999999999999999999998   999999999999975 569999999987653


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ....  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+....      .......         ...
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~---------~~~  219 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLR---------IVE  219 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHH---------HHc
Confidence            3221  2223457889999999988889999999999999999999998864211      1111000         000


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ......+...+..+.+++.+||+.+|++||++.++++
T Consensus       220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             0111223344567889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=316.81  Aligned_cols=257  Identities=26%  Similarity=0.350  Sum_probs=202.2

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .+-++.-..+||.|.||.||-++.. +|.-.|+|-+...  .........+|+.++..|+|||+|+++|+-.+.+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            3446667789999999999999954 5888999977543  234567788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      ||||++|+|.+++..   +.-+++.....+..|++.|++|||+++   ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1313 MEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999999843   333566666778899999999999999   99999999999999999999999999998755


Q ss_pred             Ccc--CcCcccccccCCccCchhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          505 DQT--EANTDRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       505 ~~~--~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ...  ....+...||+.|||||++.+.   .-.-++||||+||++.||+||++|....+.+-.   +.+.          
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IMy~---------- 1453 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IMYH---------- 1453 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HHhH----------
Confidence            421  2233457899999999999764   355689999999999999999999543322211   1000          


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                        +...-.++++......-.+++..||+.||++|.++.|+++.=-+
T Consensus      1454 --V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1454 --VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             --HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence              00011123343445566799999999999999999888765433

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.8e-32  Score=286.03  Aligned_cols=261  Identities=22%  Similarity=0.274  Sum_probs=191.0

Q ss_pred             CCCccCeeeecCccceEEEEeC-C--CcEEEEEEecccC--ccchHHHHHHHHHHHHh-CCCceeEEEEEEecC----Cc
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-E--GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR----DE  420 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~  420 (669)
                      +|.+.+.||+|+||.||++... .  +..||||++....  ....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999965 3  6789999986432  22356788999999999 599999999875433    34


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++++||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 68988884   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCccC--cCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhh------
Q 005933          501 AFGVDQTE--ANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR------  571 (669)
Q Consensus       501 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~------  571 (669)
                      .+......  .......++..|+|||++.+ ..++.++||||||+++++|++|++|+.......   .+.....      
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~  230 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD  230 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence            65432221  11233568899999998765 468999999999999999999998865432111   1110000      


Q ss_pred             -----hcccccchhhcccc-cCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          572 -----LWTEDRSLELIDKS-LDGSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       572 -----~~~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                           .............. ......     ......+.+++.+||+.||++||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 00000000000000 000000     112356889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.3e-31  Score=270.99  Aligned_cols=236  Identities=25%  Similarity=0.342  Sum_probs=191.7

Q ss_pred             eeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          358 LGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      ||+|+||.||++... +++.+|+|.+.+...   .....+..|+.+++.++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999976 489999999875432   2456889999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCccc
Q 005933          434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR  513 (669)
Q Consensus       434 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  513 (669)
                      .+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            999843   235899999999999999999999988   9999999999999999999999999987753322  12334


Q ss_pred             ccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHH
Q 005933          514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS  593 (669)
Q Consensus       514 ~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (669)
                      ..++..|+|||.+.+...+.++|+||||+++|+|++|+.|+.....   .....            .+...  ....+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~------------~~~~~--~~~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE------------KILKD--PLRFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH------------HHhcC--CCCCCCC
Confidence            5678899999999888899999999999999999999998643221   00000            00010  1112222


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHH
Q 005933          594 EALRCIQVGLLCVQQRPEDRPNMSS  618 (669)
Q Consensus       594 ~~~~l~~li~~cl~~dP~~RPs~~e  618 (669)
                      .+..+.+++.+||+.||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            3567789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=2.1e-31  Score=305.25  Aligned_cols=145  Identities=28%  Similarity=0.435  Sum_probs=130.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|.+.++||+|+||.||+|... +++.||||++....   ......+..|+.++..++|+||+++++++......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999976 58999999986532   223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      ||+.+++|.+++..   ...+++..++.++.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999853   345889999999999999999999988   9999999999999999999999999976

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.5e-32  Score=290.11  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=195.4

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc----
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE----  420 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----  420 (669)
                      ..++|++.+.||+|++|.||+|... +++.||||++...  .......+.+|+.+++.++|+|++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999976 4889999998643  22334667889999999999999999988766554    


Q ss_pred             --ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          421 --RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       421 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                        .++|+||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 6699998843    45899999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh-----
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL-----  572 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~-----  572 (669)
                      +......     .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......   .+......     
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~  236 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPD  236 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCC
Confidence            9865322     2234578889999998653 67899999999999999999999875322211   11100000     


Q ss_pred             ------cccccchhhcccccCC-CCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 ------WTEDRSLELIDKSLDG-SYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ------~~~~~~~~~~~~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                            +........+...... ...     ......+.+++.+||+.+|++|||+.+|+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                  0000000011100000 000     012457889999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.9e-33  Score=269.12  Aligned_cols=241  Identities=24%  Similarity=0.328  Sum_probs=197.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      -++|..+++||+|.||.|.+.+-+ .++.+|+|++++..   ......-+.|-++|+..+||.+..|--.|...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467888999999999999999965 48999999998753   34455667899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||..||.|.-+|   .+...+++.....+-..|+.||.|||+.+   |+.||||.+|.|||++|++||+|||+++.-  
T Consensus       247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--  318 (516)
T KOG0690|consen  247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--  318 (516)
T ss_pred             EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--
Confidence            9999999998888   44556888888889999999999999998   999999999999999999999999999752  


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      -.....+...+||+.|+|||++.+..|..+.|.|.+||++|||++|+.||...+.+.-..++.               -.
T Consensus       319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl---------------~e  383 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL---------------ME  383 (516)
T ss_pred             ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---------------hh
Confidence            223345566899999999999999999999999999999999999999965433222111110               00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRP  614 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  614 (669)
                      .+  .++.....+...|..-.|..||++|.
T Consensus       384 d~--kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 DL--KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence            11  22333344556777888999999995

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=3.8e-32  Score=262.95  Aligned_cols=203  Identities=27%  Similarity=0.395  Sum_probs=171.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-----CcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEec-CCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~  420 (669)
                      ...|+...+||+|.+|.||+++-++     ...+|||++.....  ......-+|+.+++.++|||++.|..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4578889999999999999997332     33799999865422  224567899999999999999999998877 777


Q ss_pred             ceEEEeecCCCCHHHHhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC----cceEEe
Q 005933          421 RMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND----MNPKIS  494 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~----~~~kl~  494 (669)
                      .++++||.+. +|...|+-  ..+.+.++...+..|+.||+.|+.|||++-   |+||||||.||||..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            8999999976 78777753  234467999999999999999999999998   9999999999999877    899999


Q ss_pred             ecCCCcccCCCccCc-CcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 005933          495 DFGMARAFGVDQTEA-NTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRG  555 (669)
Q Consensus       495 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~  555 (669)
                      |||+++.+...-..- ..+..+-|..|.|||.+.+. .||.+.|||+.|||+.||++-++.|-
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            999999986654433 45567789999999999887 69999999999999999999887654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-32  Score=285.23  Aligned_cols=240  Identities=24%  Similarity=0.299  Sum_probs=195.2

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .++.|.+...+|.|+|+.|-.+... +++..+||++.+..    .+-.+|+.++... +||||+++.+.+.++.+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3678888899999999999998854 48899999997652    2334567666665 6999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE-cCCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll-~~~~~~kl~Dfgla~~~~~  504 (669)
                      |.+.++-|.+.+...   . .....+..|+.+|+.|+.|||+++   ++||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~~---~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK---P-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhc---c-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999999888777432   2 222778889999999999999999   9999999999999 5899999999999987644


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .     ....+-|..|.|||++....+++++|+||||++||+|++|+.|+.....+                  .++...
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~  525 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTR  525 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHh
Confidence            3     33456789999999999999999999999999999999999996532211                  222333


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...+.+....+....+|+.+||+.||.+||+|.++..
T Consensus       526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            3333444445567789999999999999999999975

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.97  E-value=9.8e-32  Score=234.60  Aligned_cols=110  Identities=46%  Similarity=1.017  Sum_probs=106.1

Q ss_pred             EeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccCCCeEEEEeecCCCceeeeecccCcCc
Q 005933           51 FRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVPFSGLIL  130 (669)
Q Consensus        51 ~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~w~~~~~~w~~~~~~~~~~~  130 (669)
                      ||+|||||..|+|+|+|.....+.+.|+.+++|+||+|.+.++++++|++||.+|+++++.|+++++.|...|   .+|.
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~---~~p~   77 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFW---SAPK   77 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEE---Eecc
Confidence            8999999999999999999999999999999999999999999999999999999999999999999999999   8889


Q ss_pred             cCCCCCCCCCCCccccCCCCCCcccccCCCccCC
Q 005933          131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPKS  164 (669)
Q Consensus       131 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~  164 (669)
                      |+||+|+.||+||+|+.+ +.+.|+||+||+|++
T Consensus        78 d~Cd~y~~CG~~g~C~~~-~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   78 DQCDVYGFCGPNGICNSN-NSPKCSCLPGFEPKN  110 (110)
T ss_pred             cCCCCccccCCccEeCCC-CCCceECCCCcCCCc
Confidence            999999999999999876 678999999999985

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=255.58  Aligned_cols=249  Identities=21%  Similarity=0.354  Sum_probs=190.7

Q ss_pred             CCccCeeeecCccceEEEEeCC-CcEEEEEEecccC-ccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEeec
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      ...+..||.|.-|.|++.+... |..+|||.+.+.. .+..++++..+.++..-+ +|.||+.+|+|..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            3445789999999999999764 8999999998754 445677788888776664 899999999999999999999998


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      . ..++.++..  -.+++++..+-++...+++||.||.+.+  .|+|||+||+|||+|+.|++||+|||++-.+-...  
T Consensus       174 s-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--  246 (391)
T KOG0983|consen  174 S-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--  246 (391)
T ss_pred             H-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence            3 456666643  2345888888899999999999998865  59999999999999999999999999987653222  


Q ss_pred             cCcccccccCCccCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          509 ANTDRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                       ......|-..|||||-+.-   ..|..++||||||+.|+||.||+.|+..-..+.  ..+...   .. ..     .+.
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltkv---ln-~e-----PP~  314 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTKV---LN-EE-----PPL  314 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHHH---Hh-cC-----CCC
Confidence             2234568889999998853   368889999999999999999999966432221  111110   00 00     011


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +.+.  ..-...+++++..||+.|+.+||...++++
T Consensus       315 L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  315 LPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            1111  113457889999999999999999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-32  Score=269.26  Aligned_cols=260  Identities=19%  Similarity=0.220  Sum_probs=197.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhC-C-C----ceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-H-R----NLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~g~~~~~~~~  421 (669)
                      +++|.+...+|+|.||.|-...... +..||||+++. .....+..+-|+.+|+++. + |    -+|++.++|...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6899999999999999999998665 78999999854 3445667788999999994 2 2    378888999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC--------------
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------------  487 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~--------------  487 (669)
                      +||+|.+ |-|+.++|.. .+..+++..++..|+.|++++++|||+..   ++|-||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999998 6699999943 34456888999999999999999999998   999999999999831              


Q ss_pred             ------CcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005933          488 ------DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH  561 (669)
Q Consensus       488 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~  561 (669)
                            +..++|+|||.|..-...     ....+.|..|.|||++.+..++.++||||+||||+|+.+|...|......+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  334899999999864322     245788999999999999999999999999999999999988654332111


Q ss_pred             ccchhhH----------------hhhhcccccch-------hhcccccCC--------CCCHHHHHHHHHHHHHhccCCC
Q 005933          562 HHNLLGH----------------AWRLWTEDRSL-------ELIDKSLDG--------SYSLSEALRCIQVGLLCVQQRP  610 (669)
Q Consensus       562 ~~~~~~~----------------~~~~~~~~~~~-------~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP  610 (669)
                        .+..-                ..+.+....+.       .-.......        .....+...+++|+..||..||
T Consensus       317 --HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  317 --HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             --HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence              11100                00111111000       000000000        1122445678999999999999


Q ss_pred             CCCCCHHHHHH
Q 005933          611 EDRPNMSSVVL  621 (669)
Q Consensus       611 ~~RPs~~evl~  621 (669)
                      .+|+|+.|+++
T Consensus       395 ~~RiTl~EAL~  405 (415)
T KOG0671|consen  395 ARRITLREALS  405 (415)
T ss_pred             cccccHHHHhc
Confidence            99999999975

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=8.4e-31  Score=263.41  Aligned_cols=219  Identities=21%  Similarity=0.146  Sum_probs=174.4

Q ss_pred             cCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCHHHHhhc
Q 005933          361 GGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD  439 (669)
Q Consensus       361 G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  439 (669)
                      |.+|.||++... +++.||+|++....     .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999975 48999999986543     234455556666799999999999999999999999999999999854


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCC
Q 005933          440 VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG  519 (669)
Q Consensus       440 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  519 (669)
                         ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||.+..+...     .....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence               234899999999999999999999998   999999999999999999999999987654321     122345677


Q ss_pred             ccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHH
Q 005933          520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCI  599 (669)
Q Consensus       520 y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  599 (669)
                      |+|||.+....++.++||||+|+++|||++|..++......                 ...    ......+......+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~~----~~~~~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------INT----HTTLNIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------ccc----ccccCCcccCCHHHH
Confidence            99999998888999999999999999999998764321100                 000    000011122345678


Q ss_pred             HHHHHhccCCCCCCCCH
Q 005933          600 QVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       600 ~li~~cl~~dP~~RPs~  616 (669)
                      +++.+||+.||++||++
T Consensus       207 ~li~~~l~~dp~~R~~~  223 (237)
T cd05576         207 SLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHccCCHHHhcCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=258.35  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=194.7

Q ss_pred             HhcCCCcc-CeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEec----CCc
Q 005933          348 ATDNFSWK-NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL----RDE  420 (669)
Q Consensus       348 ~~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~  420 (669)
                      .+++|++. ++||-|--|.|-....+ +++++|+|++...     ....+|+++.-.. .|||||.+++++.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45667665 57999999999998866 4899999998532     4457888877666 59999999998854    345


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEeecC
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFG  497 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~Dfg  497 (669)
                      +++|||.|+||.|...+.+. ....+++.++..|..||+.|+.|||+.+   |.||||||+|+|...   +..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78899999999999999653 3455899999999999999999999999   999999999999964   5579999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      +|+.-   .........+.|+.|.|||++..++|....|+||+||++|-|++|.+||.-.++...           ..+.
T Consensus       210 FAK~t---~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-----------spgM  275 (400)
T KOG0604|consen  210 FAKET---QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGM  275 (400)
T ss_pred             ccccc---CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-----------ChhH
Confidence            99863   223444557889999999999999999999999999999999999999754333211           1111


Q ss_pred             chhhcccccCCCCCHHH----HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          578 SLELIDKSLDGSYSLSE----ALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ...+....  -.++.++    +....++|..+|..+|.+|.|+.+++.-
T Consensus       276 k~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  276 KRRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             HhHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            11111110  1222222    3466789999999999999999999864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-32  Score=269.36  Aligned_cols=239  Identities=28%  Similarity=0.366  Sum_probs=195.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  423 (669)
                      ..+|..+.+||+|+||.|.++.-+. .+.+|||++++..   ....+--+.|-++|+.. +-|.++++..+|..-+.+++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            3578889999999999999999664 6779999998753   23344556777888776 46789999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+.||+|--++.+   -+.+.+..+..+|.+||-||-+||+.+   |+.||||.+|||||.+|++||+|||+++.--
T Consensus       428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            9999999999988854   345778889999999999999999999   9999999999999999999999999997521


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                        .....+...+||+.|+|||++.-++|+.++|.|||||+||||+.|++||+..+.+                   ++..
T Consensus       502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-------------------elF~  560 (683)
T KOG0696|consen  502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------------------ELFQ  560 (683)
T ss_pred             --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HHHH
Confidence              2233445689999999999999999999999999999999999999997643322                   2222


Q ss_pred             cccC--CCCCHHHHHHHHHHHHHhccCCCCCCC
Q 005933          584 KSLD--GSYSLSEALRCIQVGLLCVQQRPEDRP  614 (669)
Q Consensus       584 ~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RP  614 (669)
                      ....  -.++...+.+...+....|..+|.+|.
T Consensus       561 aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  561 AIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            2222  245555666778888899999999993

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=3.9e-30  Score=257.80  Aligned_cols=236  Identities=28%  Similarity=0.368  Sum_probs=191.6

Q ss_pred             CccceEEEEeCC-CcEEEEEEecccCccc-hHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCHHHHhhc
Q 005933          362 GFGPVYRGMLTE-GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD  439 (669)
Q Consensus       362 ~fg~Vy~g~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  439 (669)
                      +||.||+|+..+ ++.+|+|++....... .+.+.+|+..+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999875 8999999997655544 78999999999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCC
Q 005933          440 VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG  519 (669)
Q Consensus       440 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  519 (669)
                      ..   .+++..++.++.+++.++.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            22   2889999999999999999999998   9999999999999999999999999998764332   2334567889


Q ss_pred             ccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHH--HHHH
Q 005933          520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS--EALR  597 (669)
Q Consensus       520 y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  597 (669)
                      |+|||.+....++.++||||||+++++|++|..|+....  ......             +.+...........  .+..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~-------------~~~~~~~~~~~~~~~~~~~~  216 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELF-------------KKIGKPKPPFPPPEWKISPE  216 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHH-------------HHHhccCCCCccccccCCHH
Confidence            999999998889999999999999999999998864321  110111             11110000000000  3457


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 005933          598 CIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       598 l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +.+++.+|++.+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.7e-32  Score=255.76  Aligned_cols=265  Identities=22%  Similarity=0.384  Sum_probs=199.4

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecC--------C
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--------D  419 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~  419 (669)
                      .|+-..+||+|.||.||+++.++ |+.||+|++--..+  .-.....+|+.+|..|+|+|++.++..|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            45555799999999999999654 88899987643222  2234668899999999999999998877432        3


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++|+.+++. +|..+|.+  ....++..++.++..++..||.|+|...   |+|||+||.|+||+.++.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence            47899999965 78888843  2345889999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCcc--CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh-----h
Q 005933          500 RAFGVDQT--EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-----R  571 (669)
Q Consensus       500 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~-----~  571 (669)
                      +.+.....  .......+-|..|++||.+.+. .|+++.|||.-||++.||+++.+-+..........++....     .
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            87754432  3344556779999999999876 69999999999999999999998765444433333333222     2


Q ss_pred             hcccccchhhcccccCCCCCH-------------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          572 LWTEDRSLELIDKSLDGSYSL-------------SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .|.+.+-..+....-.++.+.             .......+|+..++..||.+|+.+.+++.
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            344333333333321111111             01125678999999999999999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=258.97  Aligned_cols=262  Identities=22%  Similarity=0.333  Sum_probs=196.9

Q ss_pred             CCccHHHHHHHhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeEEEEE
Q 005933          338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRLLGC  414 (669)
Q Consensus       338 ~~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~  414 (669)
                      ..|+.+.+++       +..||.|+||+|+|-..+. |+..|||+++.... ....+++.|.+...+- +.||||+++|.
T Consensus        59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            3455555544       4789999999999999765 99999999976544 5677888888876555 69999999999


Q ss_pred             EecCCcceEEEeecCCCCHHHHhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceE
Q 005933          415 CTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK  492 (669)
Q Consensus       415 ~~~~~~~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  492 (669)
                      +-.++..++-||.| ..||+.+...  ..+...+++..+-+|+...+.||.||...-  .|||||+||+||||+..|.+|
T Consensus       132 ~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  132 LFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEe
Confidence            99999999999999 4577776532  234456899999999999999999998754  599999999999999999999


Q ss_pred             EeecCCCcccCCCccCcCcccccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          493 ISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       493 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      |+|||++-.+-..   .....-.|-..|||||-+...  .|..++||||||++|+|+.||..|+.-+..     ..+...
T Consensus       209 LCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~  280 (361)
T KOG1006|consen  209 LCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLC  280 (361)
T ss_pred             eecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHH
Confidence            9999998765221   122335678899999998644  488999999999999999999998553321     111111


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .. ..++...+    +......+....+.+++..|+..|-++||+..++..+
T Consensus       281 ~V-v~gdpp~l----~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  281 QV-VIGDPPIL----LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HH-HcCCCCee----cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11 11111111    0111123345678899999999999999999998753

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=272.55  Aligned_cols=242  Identities=26%  Similarity=0.366  Sum_probs=192.2

Q ss_pred             cCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCC
Q 005933          355 KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      .+.||.|.||+||-|+.. +|+.||||++.+.  ......++.+|+.||++++||.||.+.-.|+..+..+.|||-+.|-
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            378999999999999964 5999999999763  3445688999999999999999999999999999999999999655


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC---cceEEeecCCCcccCCCccC
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~Dfgla~~~~~~~~~  508 (669)
                      -|.-.|.  ...+.|++..-..++.||+.||.|||..+   |+|+||||+||||.+.   -++||+|||+|+.+..... 
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            5554442  34556888888899999999999999999   9999999999999653   4799999999998754332 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                        ....+||+.|+|||++.+..|...-|+||.|||+|--++|..||..  .++..+.+..+.-+              -+
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFM--------------yP  784 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFM--------------YP  784 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccc--------------cC
Confidence              3347899999999999999999999999999999999999988652  22222222111111              11


Q ss_pred             CCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHH
Q 005933          589 SYSLSE-ALRCIQVGLLCVQQRPEDRPNMSSVV  620 (669)
Q Consensus       589 ~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl  620 (669)
                      .-+..+ ....++||...||..-++|-+...-+
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            222222 34667888889999988888876654

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=295.52  Aligned_cols=256  Identities=22%  Similarity=0.252  Sum_probs=202.5

Q ss_pred             HHHHHHhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecC
Q 005933          343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR  418 (669)
Q Consensus       343 ~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  418 (669)
                      .++....++|.+++.||+|+||.|..++.+. ++.||+|++++-   ......-|..|-.+|..-+.+-|++++-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            3444556899999999999999999999764 889999999772   344567899999999999999999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                      ..+|+|||||+||+|-.+|.+.   ..+++..+..++..|+-||.-||+.|   +|||||||+|||||..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            9999999999999999999543   36899999999999999999999999   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      +-.+..+. .......+|||.|.+||++..     +.|...+|.||+||++|||+.|..||.....      ..--.+..
T Consensus       222 Clkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm  294 (1317)
T KOG0612|consen  222 CLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIM  294 (1317)
T ss_pred             HHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHh
Confidence            88765332 344556799999999999952     5689999999999999999999999653211      11000001


Q ss_pred             ccccchhhcccccCCCCC--HHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 005933          574 TEDRSLELIDKSLDGSYS--LSEALRCIQVGLLCVQQRPEDRPN---MSSVVL  621 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~  621 (669)
                      ....       .+  .+|  ...+....+||.+.+ -+|+.|-.   ++++-.
T Consensus       295 ~hk~-------~l--~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  295 NHKE-------SL--SFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN  337 (1317)
T ss_pred             chhh-------hc--CCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence            0000       11  122  223445667777655 47788877   777764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=265.61  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=197.0

Q ss_pred             hcCCCccCeeeecCccceEEEE-eCCCcEEEEEEec--ccCc-----cchHHHHHHHHHHHHhCCCceeEEEEEEecC-C
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS--KSSG-----QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-D  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~~~--~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~  419 (669)
                      .++|-++++||+|||+.||++. +.+.+.||||+-.  +...     ...+...+|..|.+.|.||.||++++++.-+ +
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            3567888999999999999999 4568899999753  2222     2235677899999999999999999998654 5


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc---CCcceEEeec
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDF  496 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~Df  496 (669)
                      .++-|+||++|.+|+-+|   ++.+.+++.++..|+.||+.||.||.+.. ++|||-||||.||||-   .-|.+||.||
T Consensus       542 sFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence            678999999999999999   45667999999999999999999999886 6799999999999995   4578999999


Q ss_pred             CCCcccCCCccC-----cCcccccccCCccCchhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhh
Q 005933          497 GMARAFGVDQTE-----ANTDRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG  567 (669)
Q Consensus       497 gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~  567 (669)
                      |+++.+..+...     ..+....||..|++||.+.-+    .++.|+||||.|||+|..+.|+.||+....  ...++.
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq  695 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ  695 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh
Confidence            999988655433     224457799999999988533    578899999999999999999999875332  222221


Q ss_pred             HhhhhcccccchhhcccccCCCCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 005933          568 HAWRLWTEDRSLELIDKSLDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSVV  620 (669)
Q Consensus       568 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl  620 (669)
                      +.       .+   +.. -.-.++  +........+|.+||++.-++|....++.
T Consensus       696 eN-------TI---lkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  696 EN-------TI---LKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hh-------ch---hcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            11       00   000 000111  11234567899999999999998777663

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=233.02  Aligned_cols=263  Identities=24%  Similarity=0.334  Sum_probs=195.3

Q ss_pred             CCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +|...++||+|.+|+||+|+..+ ++.||+|+++-.  ++.......+|+-+++.++|.|||++++....+....||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            34556899999999999999654 889999998754  333456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +.. +|..+...  -++.++.+....++.|+++||.++|+++   +.|||+||+|.||+.+|++||+|||+++.++.+..
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            954 77777643  3456899999999999999999999999   99999999999999999999999999998764432


Q ss_pred             CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCccchhhHhhhhccccc---chhhc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWTEDR---SLELI  582 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  582 (669)
                        -....+-|..|.+|.++.+. -|+...|+||-||++.|+... ++.|+..+.++...-+-+......++.   +..+.
T Consensus       157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence              12234568899999999876 589999999999999999874 444443333222111111111111111   22223


Q ss_pred             ccccCCCCCH----HH-H----HHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 DKSLDGSYSL----SE-A----LRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~~----~~-~----~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      |...-+.++.    .+ .    ..=+++....+.-+|..|.++++.++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            3222222221    11 1    12367778888889999999998765

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-30  Score=280.08  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=208.3

Q ss_pred             ccHHHHHHHhcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEec
Q 005933          340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL  417 (669)
Q Consensus       340 ~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~  417 (669)
                      ..++.+.+.++.|++.+.||.|.+|.||+++. ++++.+|||++... ....++...|+.+|+.+ .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            34455566778899999999999999999994 45899999998543 34457788899999988 59999999999854


Q ss_pred             -----CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceE
Q 005933          418 -----RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK  492 (669)
Q Consensus       418 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  492 (669)
                           +++++||||||.+||..+++.... ...+.|..+..|+..++.||++||...   ++|||||-.|||++.++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence                 568999999999999999997665 677999999999999999999999998   99999999999999999999


Q ss_pred             EeecCCCcccCCCccCcCcccccccCCccCchhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhh
Q 005933          493 ISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG  567 (669)
Q Consensus       493 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~  567 (669)
                      |+|||.+..+.  .+........||+.|||||++...     .|+..+|+||||++..||--|.+|+--.++-       
T Consensus       164 LvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------  234 (953)
T KOG0587|consen  164 LVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------  234 (953)
T ss_pred             Eeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------
Confidence            99999998763  333445557899999999999643     4777899999999999999999984322211       


Q ss_pred             HhhhhcccccchhhcccccCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          568 HAWRLWTEDRSLELIDKSLDG-----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       568 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                 ..+ -.+...     ..+..-...+.++|..||..|-++||++.++++
T Consensus       235 -----------raL-F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  235 -----------RAL-FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -----------hhh-ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                       111 111111     112334567889999999999999999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=8.6e-30  Score=284.92  Aligned_cols=259  Identities=20%  Similarity=0.253  Sum_probs=166.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-----CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEE------Ee
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC------CT  416 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~  416 (669)
                      ..++|.+.++||+|+||.||+|++.+     +..||||++......  +.+..|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999999754     689999987543211  111111  1111122222222111      24


Q ss_pred             cCCcceEEEeecCCCCHHHHhhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 005933          417 LRDERMLIYEYLPNKSLEQFIFDVTR-----------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK  479 (669)
Q Consensus       417 ~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dik  479 (669)
                      .....+|||||+.+++|.+++.....                 ........+..++.||+.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            56678999999999999999854211                 001123446679999999999999998   9999999


Q ss_pred             CCCEEEcC-CcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccC----------------------CCCchhh
Q 005933          480 ASNVLLDN-DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG----------------------LFSVKSD  536 (669)
Q Consensus       480 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~~sD  536 (669)
                      |+||||+. ++.+||+|||+++.+..... .......+++.|+|||.+...                      .+..++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 68999999999986543222 122345788999999976432                      2334669


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc----cchhhcccccCCC----CC--HHHHHHHHHHHHHhc
Q 005933          537 VFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED----RSLELIDKSLDGS----YS--LSEALRCIQVGLLCV  606 (669)
Q Consensus       537 VwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~----~~--~~~~~~l~~li~~cl  606 (669)
                      ||||||+||||+++..+.+.       .+...........    .....+.......    +.  ........+|+.+||
T Consensus       362 VwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            99999999999987654221       1110000000000    0000111110000    00  001123458999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 005933          607 QQRPEDRPNMSSVVL  621 (669)
Q Consensus       607 ~~dP~~RPs~~evl~  621 (669)
                      +.||++|||+.++++
T Consensus       435 ~~dP~kR~ta~e~L~  449 (566)
T PLN03225        435 RFKGRQRISAKAALA  449 (566)
T ss_pred             cCCcccCCCHHHHhC
Confidence            999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.5e-29  Score=276.04  Aligned_cols=261  Identities=20%  Similarity=0.263  Sum_probs=179.0

Q ss_pred             hcCCCccCeeeecCccceEEEEe-----------------CCCcEEEEEEecccCccchHH--------------HHHHH
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-----------------TEGQEIAVKRLSKSSGQGVEE--------------FKNEV  397 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~  397 (669)
                      .++|.+.++||+|+||.||+|.+                 ..++.||||++........++              +..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            57899999999999999999974                 235689999986543222223              34577


Q ss_pred             HHHHHhCCCce-----eEEEEEEec--------CCcceEEEeecCCCCHHHHhhccC---------------------CC
Q 005933          398 LLIAKLQHRNL-----VRLLGCCTL--------RDERMLIYEYLPNKSLEQFIFDVT---------------------RT  443 (669)
Q Consensus       398 ~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~  443 (669)
                      .++.+++|.++     ++++++|..        .+..+|||||+++++|.++++...                     ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77888877654     677787753        356799999999999999986421                     11


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCc
Q 005933          444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP  523 (669)
Q Consensus       444 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP  523 (669)
                      ..+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            23567889999999999999999998   999999999999999999999999999765332211 11123347899999


Q ss_pred             hhhccCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCCCC-Cc---cchhhHhhhhcccc
Q 005933          524 EYAIDGLF----------------------SVKSDVFSFGVLVLEIVCGKR-NRGFYHAD-HH---HNLLGHAWRLWTED  576 (669)
Q Consensus       524 E~~~~~~~----------------------t~~sDVwS~G~~l~elltG~~-p~~~~~~~-~~---~~~~~~~~~~~~~~  576 (669)
                      |.+.....                      ..+.||||+||++++|++|.. |+...... ..   .......|+.....
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98854321                      124699999999999999875 43211000 00   00000111111100


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHH
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRP---EDRPNMSSVVL  621 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~  621 (669)
                              ...-...........+|+.++|..+|   .+|+|++|+++
T Consensus       460 --------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 --------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             --------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                    00001111223566789999999766   78999999985

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=245.28  Aligned_cols=278  Identities=23%  Similarity=0.340  Sum_probs=213.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  423 (669)
                      ..+|.++..||+|++..|..++++. .+.+|+|++++.   ..+..+..+.|-.+..+. +||.+|.+..+|.....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            4678999999999999999999764 788999999764   445677788888887776 69999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |.||.++|+|--++   .++..|+++++..+...|+.||.|||+.+   ||.||||..|||||..|++||.|+|+++.- 
T Consensus       329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~-  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-  401 (593)
T ss_pred             EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-
Confidence            99999999986665   56667999999999999999999999999   999999999999999999999999998752 


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC-ccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH-HHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  582 (669)
                       -.....+...+||+.|.|||++.+..|....|.|++||+++||+.|+.||+....+. ..+.-++.....        +
T Consensus       402 -l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------l  472 (593)
T KOG0695|consen  402 -LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------L  472 (593)
T ss_pred             -CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------h
Confidence             122334556899999999999999999999999999999999999999998654332 122222221111        1


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCC------CHHHHH----------HHhcCCCCCCCCCCCCccccCCCCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP------NMSSVV----------LMLSGERSLPQPKQPGFFTERNLPE  645 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP------s~~evl----------~~L~~~~~~~~p~~p~~~~~~~~~~  645 (669)
                      ...+  ..+.....+...+...-|..||++|.      .++++-          .+|++ +++-.|-+|....+..+..
T Consensus       473 ekqi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq-k~v~ppf~p~i~~d~~l~~  548 (593)
T KOG0695|consen  473 EKQI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ-KQVLPPFQPQITDDYGLDN  548 (593)
T ss_pred             hhcc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh-cccCCCCCCccccccCccc
Confidence            1111  12223334556777888999999983      233332          23333 4445566777765554433

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.8e-29  Score=234.58  Aligned_cols=256  Identities=20%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             hcCCCccCeeeecCccceEEEE-eCCCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCC--cceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRD--ERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lV  424 (669)
                      .++|++.+++|+|-+++||.|. ..++++++||+++..   ..+.+.+|+.+|..|. ||||+++++...++.  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            5789999999999999999999 456899999998532   3467889999999997 999999999987765  46799


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-cceEEeecCCCcccC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFG  503 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~Dfgla~~~~  503 (669)
                      +||+++.+...+.      ..|+...+...+.++++||.|+|+.|   |+|||+||+|++||.. -.++|+|+|+|.+..
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999999888776      33777888999999999999999999   9999999999999964 579999999999876


Q ss_pred             CCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ....   .+..+.+..|.-||.+.+- .|...-|+|||||+|..|+..+.||  .++.+..+.+....+..........+
T Consensus       185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF--FhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc--cCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            5543   3345678889999999775 5888999999999999999999884  44444444444333333332222221


Q ss_pred             cc-------ccCC---CC---CH----------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 DK-------SLDG---SY---SL----------SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~~-------~~~~---~~---~~----------~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..       ....   ..   +.          -...+.++++...|..|..+|||++|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            11       1100   00   00          01246788999999999999999999853

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=272.58  Aligned_cols=246  Identities=28%  Similarity=0.381  Sum_probs=186.3

Q ss_pred             CCccCeeeecCccc-eEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeecC
Q 005933          352 FSWKNKLGEGGFGP-VYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       352 ~~~~~~lg~G~fg~-Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      |.-.+.+|.|.-|+ ||+|... |+.||||++-.   ...+...+|+..|+.- +|||||++++.-.+.+..+|..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44446788998886 7999986 89999999843   3345678899999988 59999999999999999999999994


Q ss_pred             CCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---C--cceEEeecCCCcccC
Q 005933          430 NKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---D--MNPKISDFGMARAFG  503 (669)
Q Consensus       430 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~--~~~kl~Dfgla~~~~  503 (669)
                       -+|++++... .......-...+.++.|+++||++||+.+   |+||||||+||||+.   +  .+++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5999999653 11111111345778899999999999988   999999999999975   2  579999999999887


Q ss_pred             CCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          504 VDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       504 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .+... .......||.+|+|||++....-+.++||||+||++|..++| .+||+-... .+.+++       ........
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-R~~NIl-------~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-RQANIL-------TGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-hhhhhh-------cCccceee
Confidence            65543 234567899999999999999989999999999999999987 778663211 001111       00000000


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                          +  ....++  ...+||.+|++++|..||++.+|+.
T Consensus       735 ----L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 ----L--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ----e--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence                0  001111  6779999999999999999999973

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=259.32  Aligned_cols=266  Identities=23%  Similarity=0.286  Sum_probs=211.2

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCc-EEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .++.....||-|+||.|-+...+... .+|+|++++.   .....+....|-.+|...+.|.||+++-.|.+....+++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566678999999999999977533 4899988653   3445677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      |-|-||.|...|.   ..+.++......++..+++|++|||.++   ||+|||||+|.+|+.+|-+||.|||+|+.+...
T Consensus       500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999994   4556888888899999999999999999   999999999999999999999999999987543


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .   .+-..+||+.|.|||++.+.....++|.||||+++|||++|.+||...++-...+++......             
T Consensus       574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-------------  637 (732)
T KOG0614|consen  574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-------------  637 (732)
T ss_pred             C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-------------
Confidence            3   334579999999999999999999999999999999999999997755443222222111111             


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHh-------cC--CCCCCCCCCCCccc
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVLML-------SG--ERSLPQPKQPGFFT  639 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L-------~~--~~~~~~p~~p~~~~  639 (669)
                        -.++........+|+.+.+..+|.+|..     +.+|-.--       ++  ...++.|-+|....
T Consensus       638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~  703 (732)
T KOG0614|consen  638 --IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN  703 (732)
T ss_pred             --hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence              1233344456778999999999999976     55554321       11  24566676766654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2e-28  Score=256.08  Aligned_cols=205  Identities=24%  Similarity=0.355  Sum_probs=174.2

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .-|..++.||-|+||+|.++.-.| ...+|+|.+++.+   +......++|-.||+.-+.+-||+|+-.|.+.+.+++||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457777899999999999998544 6779999997753   455677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      +|++||++-.+|.+   .+.+.+..+..++.++..|+++.|..|   +|||||||+|||||.+|++||.||||+.-+.-.
T Consensus       709 dYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            99999999999853   455788888888999999999999999   999999999999999999999999997644110


Q ss_pred             c--------------------cCc--------------------CcccccccCCccCchhhccCCCCchhhHHHHHHHHH
Q 005933          506 Q--------------------TEA--------------------NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL  545 (669)
Q Consensus       506 ~--------------------~~~--------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~  545 (669)
                      .                    .+.                    .....+||..|+|||++....++..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence            0                    000                    001266999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCC
Q 005933          546 EIVCGKRNRGFYHAD  560 (669)
Q Consensus       546 elltG~~p~~~~~~~  560 (669)
                      ||+.|+.||-...+.
T Consensus       863 em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPG  877 (1034)
T ss_pred             HHhhCCCCccCCCCC
Confidence            999999997655543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=4.2e-27  Score=229.85  Aligned_cols=211  Identities=35%  Similarity=0.576  Sum_probs=183.9

Q ss_pred             eeecCccceEEEEeCC-CcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCHHH
Q 005933          358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ  435 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  435 (669)
                      ||+|.+|.||++...+ ++.++||++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 899999998654332 35789999999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecCCCcccCCCccCcCcccc
Q 005933          436 FIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVDQTEANTDRV  514 (669)
Q Consensus       436 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~  514 (669)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            985432  45899999999999999999999998   999999999999999 89999999999986543321  12234


Q ss_pred             cccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHH
Q 005933          515 VGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLS  593 (669)
Q Consensus       515 ~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (669)
                      .+...|++||.+... ..+.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999887 888999999999999998                                              


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          594 EALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       594 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                        ..+.+++..|++.+|++||++.++++.|
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              5677899999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-27  Score=244.39  Aligned_cols=131  Identities=30%  Similarity=0.404  Sum_probs=111.7

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhC-----C---CceeEEEEEEec---
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----H---RNLVRLLGCCTL---  417 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~~---  417 (669)
                      .+|.+.++||.|.|++||++.... .+.||+|+. +......+..+.||++|++++     |   .+||+|+++|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVv-KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVV-KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEE-ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            578899999999999999999654 678999998 445556678899999999984     3   379999999854   


Q ss_pred             -CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          418 -RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       418 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                       +.+.++|+|++ |-+|..+|... ..+-++...+.+|++||+.||.|||...  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             56899999999 66888888543 3444899999999999999999999987  69999999999999

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=223.09  Aligned_cols=203  Identities=25%  Similarity=0.364  Sum_probs=166.5

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEeccc-CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .+.......||+|++|.|-+-++ .+|+..|+|++... ..+..++.++|+.+..+. .+|.+|.++|........++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            34444567899999999988885 45999999999755 345567788888876655 7999999999998889999999


Q ss_pred             eecCCCCHHHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |.| ..||+.+..+ ..+.+.+++..+-+||..+.+||.|||++-  .++|||+||+||||+.+|++|++|||.+-.+-.
T Consensus       125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            999 4588887654 345667999999999999999999999864  599999999999999999999999999876532


Q ss_pred             CccCcCcccccccCCccCchhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFY  557 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDVwS~G~~l~elltG~~p~~~~  557 (669)
                      .-   ......|-..|||||.+..+    .|+.++||||||+.+.||.+++.|++.+
T Consensus       202 Si---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  202 SI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             hh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            21   11124567889999998543    6889999999999999999999997643

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-28  Score=233.08  Aligned_cols=263  Identities=20%  Similarity=0.295  Sum_probs=191.5

Q ss_pred             CccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC-----CcceEE
Q 005933          353 SWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DERMLI  424 (669)
Q Consensus       353 ~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV  424 (669)
                      +..+.||-|+||.||..+.. +|+.||+|++...-  -...+.+.+|+++|..++|.|++..++...-.     ++.+.|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34589999999999999965 59999999986532  23457888999999999999999998876443     246778


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      +|.| ..+|...|   .....++...+.-++.||++||.|||+.+   |.||||||.|.|++++-.+||+|||+++.-..
T Consensus       136 TELm-QSDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELM-QSDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHH-Hhhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            8888 45777777   34455888888899999999999999999   99999999999999999999999999997544


Q ss_pred             CccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh--------hhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WRLWTE  575 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~  575 (669)
                      +.... ....+-|..|.|||++++. .|+.+.||||.||++.||+..+..|....+-....++...        .+..-+
T Consensus       209 d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            43332 3345678999999999986 6999999999999999999887766544443222222111        111111


Q ss_pred             ccchhhcccccCC-CC--------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          576 DRSLELIDKSLDG-SY--------SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       576 ~~~~~~~~~~~~~-~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                      +...-++...... ..        +.........+...++..||+.|.+.++.+.-+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            1111111111111 00        111123446677788999999999999888654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=6.3e-26  Score=224.97  Aligned_cols=198  Identities=33%  Similarity=0.470  Sum_probs=172.1

Q ss_pred             CCccCeeeecCccceEEEEeCC-CcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      |.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|+..+..++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999875 899999999765544 67889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++.....  .+++..+..++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+........ .
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            9999999854322  1789999999999999999999998   99999999999999999999999999887644321 1


Q ss_pred             CcccccccCCccCchhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005933          510 NTDRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIVCGKRNRG  555 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~-~~~~~t~~sDVwS~G~~l~elltG~~p~~  555 (669)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.|+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22335677889999998 66678889999999999999999999963

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=1.1e-27  Score=245.73  Aligned_cols=206  Identities=20%  Similarity=0.246  Sum_probs=174.3

Q ss_pred             HHHhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhC------CCceeEEEEEEecC
Q 005933          346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ------HRNLVRLLGCCTLR  418 (669)
Q Consensus       346 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~  418 (669)
                      +..-.+|.+....|+|-|++|..|.... |+.||||++.+.. -..+.=+.|+++|.+|+      ..|.++|+-.|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            3345688888999999999999999654 8899999996542 22344467999999996      34899999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-cceEEeecC
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFG  497 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~Dfg  497 (669)
                      +++|||+|-+ ..+|.++|.+..+..-|....+..++.|+.-||..|..-+   |+|.||||.||||++. ..+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence            9999999988 4589999998888888999999999999999999999988   9999999999999965 568999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD  560 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~  560 (669)
                      .|-.....    ....+.-+..|.|||++.+.+|....|+||.||.||||.||+..|+.....
T Consensus       583 SA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  583 SASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             cccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence            99765322    223345578899999999999999999999999999999999887654443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=6.2e-27  Score=228.41  Aligned_cols=259  Identities=24%  Similarity=0.274  Sum_probs=188.4

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecC------Cc
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------DE  420 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~  420 (669)
                      .+|.-+..+|.|.- .|-.+... .++.||+|++...  .....++..+|..++..++|+|+++++.+++-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45555677888877 44444432 4899999988654  234567788999999999999999999998544      35


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++|||+|. .+|..++.     -.++-.++.+|..|++.|++|||+.+   |+||||||+||+|..+..+||.|||+++
T Consensus        96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            789999994 58888874     23677889999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhh-------------
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG-------------  567 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~-------------  567 (669)
                      .-...   -....++.++.|.|||++.+..+.+.+||||+||++.||++|..-|...+.-+....+.             
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            63322   34556788999999999999999999999999999999999987665322111111110             


Q ss_pred             ---Hhhhhccccc------chhh-cccccCC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          568 ---HAWRLWTEDR------SLEL-IDKSLDG--SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       568 ---~~~~~~~~~~------~~~~-~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         .+..+.....      ..+. .|.....  ..+......+.+++.+||-.+|++|.++.++|+
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence               0000100000      0000 0000000  011122335678999999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=7.7e-27  Score=242.63  Aligned_cols=196  Identities=27%  Similarity=0.396  Sum_probs=167.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC--------ccchHHHHHHHHHHHHhC---CCceeEEEEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCT  416 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~  416 (669)
                      ...|...+.||+|+||.|+.++++. ...|+||.+.+..        ....-..-.||.||..|+   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3468899999999999999999876 5678999886531        112234567999999997   999999999999


Q ss_pred             cCCcceEEEeec-CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEee
Q 005933          417 LRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD  495 (669)
Q Consensus       417 ~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  495 (669)
                      +++..+|+||-. ++.+|.++|   ...+.+++.+...|++||+-|+++||+++   |+|||||-+||.|+.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence            999999999985 566888998   34556999999999999999999999999   99999999999999999999999


Q ss_pred             cCCCcccCCCccCcCcccccccCCccCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCC
Q 005933          496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNR  554 (669)
Q Consensus       496 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwS~G~~l~elltG~~p~  554 (669)
                      ||.+.....    ......+||..|.|||++.+.+|- ..-|||++|++||-++....|+
T Consensus       714 fgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            999876533    334558899999999999998875 5589999999999998877663

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=5.7e-27  Score=247.46  Aligned_cols=249  Identities=25%  Similarity=0.363  Sum_probs=200.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|++...+|.|.+|.|||++.. .++..|||+++-.......-...|+-+++..+||||+.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467888999999999999999965 4899999999877777788888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +.+|+|++..+   -.+++++.++..+++...+||+|||+.+   -+|||||-.|||+++.|.+|++|||.+..+.  .+
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit--at  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT--AT  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh--hh
Confidence            99999999873   4567999999999999999999999999   8999999999999999999999999986642  22


Q ss_pred             CcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          508 EANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      -.......||+.|||||+..   .+.|...+|||++|+...|+---++|.--.++-                +..-++..
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm----------------r~l~LmTk  229 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM----------------RALFLMTK  229 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH----------------HHHHHhhc
Confidence            23334578999999999873   567999999999999999987776662111110                00111111


Q ss_pred             ccCCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYS----LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..-.+..    ..-...+.+++..|+..+|++||+++.+++
T Consensus       230 S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  230 SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1111111    122346778999999999999999987764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-25  Score=214.14  Aligned_cols=252  Identities=19%  Similarity=0.328  Sum_probs=187.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEE-EecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGC-CTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~  425 (669)
                      .+.|.+.+.||+|.||.+-++.+.. .+.+++|.+.+.. ...++|.+|..---.| .|.||+.-++. |...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            3578888999999999999999765 7889999886543 3467888888765555 58999987654 56667778999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc--CCcceEEeecCCCcccC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDMNPKISDFGMARAFG  503 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~--~~~~~kl~Dfgla~~~~  503 (669)
                      ||++.|+|.+-+..    .-+.+....+++.|+++|+.|+|+.+   +||||||.+||||-  +..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999988733    33778888999999999999999999   99999999999994  34489999999987643


Q ss_pred             CCccCcCcccccccCCccCchhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      .     .......+..|.|||.....     ...+.+|||.||+++|.+++|..|..   .........+.|..|.....
T Consensus       175 ~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ---ka~~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 T-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ---KASIMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             c-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch---hhhccCchHHHHHHHhcccC
Confidence            2     22234456789999987432     35678999999999999999999954   22333334455555555444


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       579 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ..+.+..-      .-...+.++..+-+..+|++|-.+.++..+
T Consensus       247 ~~~P~~F~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  247 PALPKKFN------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             ccCchhhc------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            43322111      123456678888999999999555555443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=6.9e-25  Score=222.06  Aligned_cols=200  Identities=25%  Similarity=0.434  Sum_probs=167.1

Q ss_pred             HHHHhcCCCccCeeeecCccceEEEEeC----CCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCC
Q 005933          345 IADATDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRD  419 (669)
Q Consensus       345 l~~~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~  419 (669)
                      +....+.|...++||+|.|++||++++.    ..+.||+|.+...+  ...+..+|+++|..+. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445678899999999999999999954    36789999986543  3467899999999995 999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGM  498 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgl  498 (669)
                      ...+|+||++.....+++..      ++...+..++..+.+||+++|..|   ||||||||.|+|.+. .+.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999999844      678899999999999999999999   999999999999985 56789999999


Q ss_pred             CcccCCCc-------------c-----------------------------CcCcccccccCCccCchhhcc-CCCCchh
Q 005933          499 ARAFGVDQ-------------T-----------------------------EANTDRVVGTYGYMSPEYAID-GLFSVKS  535 (669)
Q Consensus       499 a~~~~~~~-------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~~s  535 (669)
                      |.......             .                             ........||++|.|||++.. ...++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            87211000             0                             000112559999999999865 4689999


Q ss_pred             hHHHHHHHHHHHHhCCCCCC
Q 005933          536 DVFSFGVLVLEIVCGKRNRG  555 (669)
Q Consensus       536 DVwS~G~~l~elltG~~p~~  555 (669)
                      ||||.|||++-+++++.||-
T Consensus       260 Diws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             ceeeccceeehhhccccccc
Confidence            99999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=2.7e-25  Score=260.92  Aligned_cols=196  Identities=20%  Similarity=0.234  Sum_probs=137.1

Q ss_pred             HhCC-CceeEEEEEE-------ecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 005933          402 KLQH-RNLVRLLGCC-------TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI  473 (669)
Q Consensus       402 ~l~h-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  473 (669)
                      .++| +||++++++|       ......++++|++ +++|.++|..  ....+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4556 5788888877       3334567788987 6699999953  2345899999999999999999999998   9


Q ss_pred             eeccCCCCCEEEcCCc-------------------ceEEeecCCCcccCCCcc--------------CcCcccccccCCc
Q 005933          474 IHRDLKASNVLLDNDM-------------------NPKISDFGMARAFGVDQT--------------EANTDRVVGTYGY  520 (669)
Q Consensus       474 iH~Dikp~NIll~~~~-------------------~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y  520 (669)
                      +||||||+||||+..+                   .+||+|||+++.......              ........+|+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            9999999999996544                   455666666543211000              0001113578889


Q ss_pred             cCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHH
Q 005933          521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQ  600 (669)
Q Consensus       521 ~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  600 (669)
                      +|||++.+..++.++|||||||+||||++|.+|+....     .....            +....+ .............
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~------------~~~~~~-~~~~~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSS------------LRHRVL-PPQILLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHH------------HHHhhc-ChhhhhcCHHHHH
Confidence            99999999999999999999999999999877632100     00000            000000 0111112334568


Q ss_pred             HHHHhccCCCCCCCCHHHHHH
Q 005933          601 VGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       601 li~~cl~~dP~~RPs~~evl~  621 (669)
                      ++.+||+.+|.+||+|.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            889999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=1.7e-23  Score=200.05  Aligned_cols=166  Identities=20%  Similarity=0.153  Sum_probs=122.6

Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN  510 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  510 (669)
                      |+|.+++..  +...+++.+++.++.||++||.|||+.+         ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            689999853  2446999999999999999999999876         999999999999999  99987653221    


Q ss_pred             cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC
Q 005933          511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY  590 (669)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (669)
                         ..++..|+|||++.+..++.++|||||||++|||++|+.|+......  ...+..........      ... ....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~------~~~-~~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPAD------DPR-DRSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccC------Ccc-cccc
Confidence               25789999999999999999999999999999999999986432211  11111100000000      000 0001


Q ss_pred             CHHHH--HHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          591 SLSEA--LRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       591 ~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      .....  ..+.+++.+||+.+|++||++.++++.+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            11112  258999999999999999999999988754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=4.5e-24  Score=203.32  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=194.1

Q ss_pred             CccCeeeecCccceEEEEeCCCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       353 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      .+..+|.+...|+.|+|++. |..+++|++...  .....+.|..|.-.|+.+.||||+.++|.|..+.++.++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34568899999999999997 667778887543  333457899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEe--ecCCCcccCCCccC
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS--DFGMARAFGVDQTE  508 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~--Dfgla~~~~~~~~~  508 (669)
                      |||..+|++. ..-..+..+..+++.+||+|++|||+..+. |.---|.++.|+||++.+++|+  |--++.        
T Consensus       272 gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsf--------  341 (448)
T KOG0195|consen  272 GSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSF--------  341 (448)
T ss_pred             hHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeee--------
Confidence            9999999653 344578889999999999999999998742 4445799999999999988874  322111        


Q ss_pred             cCcccccccCCccCchhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                       ........+.||+||.+...+   .-.++|+|||+++||||.|.+.||.-..+-               +.-..+.-..
T Consensus       342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm---------------ecgmkialeg  405 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM---------------ECGMKIALEG  405 (448)
T ss_pred             -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch---------------hhhhhhhhcc
Confidence             111234568899999997654   345799999999999999999997643321               1122333334


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      +....++.....+.+|+.-|+..||.+||.+..|+-+|++..
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            445566666778889999999999999999999999998653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.7e-22  Score=210.30  Aligned_cols=167  Identities=19%  Similarity=0.188  Sum_probs=130.0

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC--CCcEEEEEEeccc-----CccchHHHHHHHHHHHHhCCCceeEEEEEEecCC
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD  419 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  419 (669)
                      ...++|.+.+.||+|+||+||+|...  +++.||||++...     .......|.+|+++|++++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34568999999999999999999865  4778899987532     11235679999999999999999853322   24


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccC-CCCCEEEcCCcceEEeecCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Di-kp~NIll~~~~~~kl~Dfgl  498 (669)
                      ..+|||||+++++|....    ...      ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            679999999999996321    111      1467889999999999998   999999 99999999999999999999


Q ss_pred             CcccCCCccCcC------cccccccCCccCchhhccC
Q 005933          499 ARAFGVDQTEAN------TDRVVGTYGYMSPEYAIDG  529 (669)
Q Consensus       499 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  529 (669)
                      ++.+........      .....++..|+|||.+...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            997754322111      1245678889999998644

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=3.3e-21  Score=202.41  Aligned_cols=259  Identities=22%  Similarity=0.246  Sum_probs=192.7

Q ss_pred             CCCccCeeeecCccceEEEEeCCC--cEEEEEEecccCccchHHHHHHHHHHHHhCC----CceeEEEEEE-ecCCcceE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTEG--QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH----RNLVRLLGCC-TLRDERML  423 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l  423 (669)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|+.++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  5789998766544433478899999999973    6899999988 47778899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-----cceEEeecCC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-----MNPKISDFGM  498 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-----~~~kl~Dfgl  498 (669)
                      ||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|.+||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 789999875444 567999999999999999999999999   9999999999999854     4699999999


Q ss_pred             CcccC--CCcc----CcC--cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          499 ARAFG--VDQT----EAN--TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       499 a~~~~--~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      ++...  ....    ...  .....||..|.++....+...+.+.|+||++.++.|++.|..|.........   .....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~  250 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE  250 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence            99332  1111    111  2235699999999999999999999999999999999999987432221111   00000


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..    ........     .....+..+.++...+-..+..++|....+...|...
T Consensus       251 ~~----~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  251 KD----PRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HH----hhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            00    00000000     1112233444555555568999999999999887654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=6.1e-20  Score=191.64  Aligned_cols=261  Identities=30%  Similarity=0.386  Sum_probs=197.5

Q ss_pred             CCccCeeeecCccceEEEEeCCCcEEEEEEecccCcc---chHHHHHHHHHHHHhCCC-ceeEEEEEEecCCcceEEEee
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ---GVEEFKNEVLLIAKLQHR-NLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~E~  427 (669)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+.+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567789999999999999987  88999998765433   377899999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeecCCCcccCCCc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVDQ  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla~~~~~~~  506 (669)
                      +.+++|.+++........+.......++.|++.++.|+|..+   ++||||||+||+++..+ .++++|||.+..+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977643221136889999999999999999999999   99999999999999988 79999999998654433


Q ss_pred             cCc----CcccccccCCccCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-CccchhhHhhhhcccccc
Q 005933          507 TEA----NTDRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD-HHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       507 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  578 (669)
                      ...    ......++..|+|||.+.+   .......|+||+|++++++++|..|+...... ...............   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            221    3456789999999999987   57889999999999999999999984433221 000111111111000   


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       579 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                        .................+.+++..++..+|..|.++.+....
T Consensus       234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              000000000001223467789999999999999999987764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=6.7e-20  Score=179.93  Aligned_cols=200  Identities=22%  Similarity=0.309  Sum_probs=170.9

Q ss_pred             hcCCCccCeeeecCccceEEEE-eCCCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .-+|.++++||+|.||.++.|+ +-+++.||||.-..  .....++..|....+.|. .++|...+-+..++-+..||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3489999999999999999999 45699999998543  334567888999999985 7899999998899999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-----cceEEeecCCCcc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-----MNPKISDFGMARA  501 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-----~~~kl~Dfgla~~  501 (669)
                      .+ |-||.++..-+.+  .++.++++.+|.|++.-++|+|++.   +|.|||||+|.||...     ..+.|+|||+|+.
T Consensus       105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            98 7899998754443  3899999999999999999999999   9999999999999643     3589999999998


Q ss_pred             cCCCccCcC-----cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005933          502 FGVDQTEAN-----TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF  556 (669)
Q Consensus       502 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~  556 (669)
                      +....+...     .....||..||+--...+...+.+.|+=|||-+++..+-|..|+..
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            765444322     2346799999999999999999999999999999999999999544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3e-21  Score=215.52  Aligned_cols=251  Identities=20%  Similarity=0.257  Sum_probs=183.6

Q ss_pred             ccCeeeecCccceEEEEeC-CCcEEEEEEecc---cCcc---chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          354 WKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSK---SSGQ---GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~---~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ..+.+|.|.+|.|+..... ..+..+.|....   ....   ....+..|+.+-..+.|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4578999999977777633 233344443321   1111   11225567777788899999888777766666666699


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |++. +|..++.   ....+...++..+++|+..|+.|||+.+   |.|||||++|++++.++.+||+|||.+..+..+.
T Consensus       402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 9999983   3356888999999999999999999999   9999999999999999999999999998876655


Q ss_pred             cC--cCcccccccCCccCchhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          507 TE--ANTDRVVGTYGYMSPEYAIDGLFSV-KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       507 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~-~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..  ......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.|+............          .....-.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----------~~~~~~~  544 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----------NNYSDQR  544 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----------hcccccc
Confidence            54  5556788999999999999998876 589999999999999998885433322221100          0000000


Q ss_pred             cccCCC--CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGS--YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....+.  .....+.+.+.++.++|+.+|.+|.|+++|++
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000111  11123456789999999999999999999975

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=4.2e-20  Score=178.17  Aligned_cols=139  Identities=17%  Similarity=0.162  Sum_probs=108.6

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCcc--c-------hHH-----------------HHHHHHHHHHhCCCce
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ--G-------VEE-----------------FKNEVLLIAKLQHRNL  408 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni  408 (669)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4789999999999999888999999999653211  1       112                 2349999999987776


Q ss_pred             eEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceeccCCCCCEEEcC
Q 005933          409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL-HQDSRLRIIHRDLKASNVLLDN  487 (669)
Q Consensus       409 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dikp~NIll~~  487 (669)
                      .....+..  ...+|||||+++++|...+.   ....++...+..++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            43332221  23489999999987765532   234588999999999999999999 6888   99999999999998 


Q ss_pred             CcceEEeecCCCccc
Q 005933          488 DMNPKISDFGMARAF  502 (669)
Q Consensus       488 ~~~~kl~Dfgla~~~  502 (669)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=2e-20  Score=182.50  Aligned_cols=171  Identities=13%  Similarity=0.169  Sum_probs=133.5

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchH---H------HHHHHHHHHHhCCCceeEEEEEEecC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVE---E------FKNEVLLIAKLQHRNLVRLLGCCTLR  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~g~~~~~  418 (669)
                      ..++|.+.+.||.|+||.||.... ++..+|||.+.........   .      +.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            367899999999999999999665 5778999999754332222   2      68999999999999999998886543


Q ss_pred             --------CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc
Q 005933          419 --------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN  490 (669)
Q Consensus       419 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~  490 (669)
                              ...+|||||++|.+|.++..       ++.    ....+|+.+|..||+.+   ++|||++|.||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999988741       222    34569999999999999   99999999999999988 


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHH
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV  548 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ell  548 (669)
                      ++|+|||...........              ..++....+..++|+|+||+.+.-..
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999987654211110              11444556677999999999987653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=7.1e-20  Score=172.26  Aligned_cols=199  Identities=24%  Similarity=0.338  Sum_probs=166.4

Q ss_pred             hcCCCccCeeeecCccceEEEE-eCCCcEEEEEEecccCccchHHHHHHHHHHHHhCC-CceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ..+|.+.++||.|+||.+|.|. ..+|..||||.-+...  ...++..|..+...|++ ..|..+.-+..+.....+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4679999999999999999999 5679999999865433  34577889999999975 678888888889999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEeecCCCcccC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFG  503 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~Dfgla~~~~  503 (669)
                      .+ |-||.++..-..+.  ++..+++-++.|++.-++|+|.++   ++||||||+|.|..-   -..+.|+|||+++.+.
T Consensus        92 LL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 77999987544333  788899999999999999999999   999999999999863   3468999999999874


Q ss_pred             CCccCc-----CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005933          504 VDQTEA-----NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG  555 (669)
Q Consensus       504 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~  555 (669)
                      ...+..     ......||..|.+--...+-..+.+.|+=|+|.+|...--|..|+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ  222 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ  222 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence            433221     1234779999999888888888999999999999999999998854

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=4e-19  Score=171.97  Aligned_cols=140  Identities=19%  Similarity=0.210  Sum_probs=111.4

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCccc--------------------------hHHHHHHHHHHHHhCCCce
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG--------------------------VEEFKNEVLLIAKLQHRNL  408 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni  408 (669)
                      ...||+|++|.||+|...+|+.||||+++......                          ...+..|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            57899999999999998789999999987542110                          1224678999999999987


Q ss_pred             eEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcC
Q 005933          409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN  487 (669)
Q Consensus       409 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~  487 (669)
                      .....+...  ..+|||||++++++.....   ....++......++.|++.++.+||+ .+   |+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  3589999999886544321   22347788999999999999999999 88   99999999999999 


Q ss_pred             CcceEEeecCCCcccC
Q 005933          488 DMNPKISDFGMARAFG  503 (669)
Q Consensus       488 ~~~~kl~Dfgla~~~~  503 (669)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=4.6e-20  Score=205.18  Aligned_cols=253  Identities=20%  Similarity=0.254  Sum_probs=184.4

Q ss_pred             CCCccCeeeecCccceEEEEeCCCcEEEEEEecccC-ccchHHHHHHHHHHH--HhCCCceeEEEEEEecCCcceEEEee
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS-GQGVEEFKNEVLLIA--KLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~--~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++...+.||.+.|=.|.+++.++|. |+||++-+.. ....+.|.++++-++  .++|||.+++.-.-......+||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667799999999999999999887 9999987655 445666666555444  45899999988776677777888888


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc-
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ-  506 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~-  506 (669)
                      ..+ +|.+.|   ..+.++...+..-|+.|++.||..+|..+   |+|||||.+||||+.-.=+.|+||...+....+. 
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            854 777776   56677888999999999999999999999   9999999999999998889999998765432221 


Q ss_pred             cCcCc----ccccccCCccCchhhccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhh
Q 005933          507 TEANT----DRVVGTYGYMSPEYAIDG----------L-FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       507 ~~~~~----~~~~gt~~y~aPE~~~~~----------~-~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~  570 (669)
                      .+...    +....-..|+|||-+...          . .+++.||||+||+++||++ |+++|+...      ++  +.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~--aY  247 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LL--AY  247 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HH--hH
Confidence            22222    222334579999977431          2 6788999999999999998 466654211      11  11


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      +... ....+.+-..+.       ...++++++.|++.||+.|.++++.|+.-.+..
T Consensus       248 r~~~-~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  248 RSGN-ADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             hccC-ccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            1111 111111111111       126789999999999999999999999755543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=4.5e-19  Score=189.18  Aligned_cols=218  Identities=22%  Similarity=0.326  Sum_probs=162.6

Q ss_pred             HHHhCCCceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 005933          400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK  479 (669)
Q Consensus       400 l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dik  479 (669)
                      |+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+..  ....+++.....++++|++||+|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568899999999999999999999999999999999965  3455899999999999999999999876  12999999


Q ss_pred             CCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccC---C----CCchhhHHHHHHHHHHHHhCCC
Q 005933          480 ASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG---L----FSVKSDVFSFGVLVLEIVCGKR  552 (669)
Q Consensus       480 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~t~~sDVwS~G~~l~elltG~~  552 (669)
                      +.|.++|....+||+|||+.................-...|.|||.+.+.   .    .+.+.||||||++++||++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998765321111122223345679999999764   1    4678999999999999999999


Q ss_pred             CCCCCCCCCc-cchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          553 NRGFYHADHH-HNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       553 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      |++....... ..++....+     .......+.+...  .+....+..++..||..+|++||++++|-..++....
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9765332222 122222211     0111111111100  0223368899999999999999999999998876533

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=8.7e-19  Score=176.18  Aligned_cols=231  Identities=22%  Similarity=0.311  Sum_probs=150.9

Q ss_pred             CccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhC----------CCceeEEEEEEec-
Q 005933          353 SWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ----------HRNLVRLLGCCTL-  417 (669)
Q Consensus       353 ~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------h~niv~l~g~~~~-  417 (669)
                      ...+.||.|+++.||.++..+ ++++|||+....   .....+++++|.-....+.          |-.++-.++.... 
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            345789999999999999876 899999988543   3345677777776665532          2233333332211 


Q ss_pred             --------CC--------cceEEEeecCCCCHHHHhh---ccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecc
Q 005933          418 --------RD--------ERMLIYEYLPNKSLEQFIF---DVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD  477 (669)
Q Consensus       418 --------~~--------~~~lV~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D  477 (669)
                              ..        ..+++|+-+ .++|..++.   ...+ ...+....++.+..|+++.+++||..+   ++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence                    11        236788887 568888753   2222 223455667788899999999999999   99999


Q ss_pred             CCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhcc--------CCCCchhhHHHHHHHHHHHHh
Q 005933          478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID--------GLFSVKSDVFSFGVLVLEIVC  549 (669)
Q Consensus       478 ikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDVwS~G~~l~ellt  549 (669)
                      |+|+|++++.+|.+.|+||+.....+.....     ...+..|.+||....        -.++.+.|.|++|+++|.|++
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999877654321111     234578999997743        257889999999999999999


Q ss_pred             CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 005933          550 GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDR  613 (669)
Q Consensus       550 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  613 (669)
                      |..|++...+......                   .+ .... +.+..+..||..+|+.+|.+|
T Consensus       246 ~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999875443322111                   11 1233 556778899999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=3.6e-18  Score=163.16  Aligned_cols=182  Identities=21%  Similarity=0.146  Sum_probs=138.7

Q ss_pred             ccCeeeecCccceEEEEeCCCcEEEEEEecccCcc----chHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEeec
Q 005933          354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ----GVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      +...|++|+||+||.+.- .+.+++.+.+.....-    ....|.+|+++|++|+ |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999997766 5788888887554331    1225889999999995 5889999886    4569999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccC-CCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Di-kp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +|.+|...+..          ....++.|++.+|.++|+++   |+|||| ||.|||++.++.++|+|||++........
T Consensus        81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99998754310          12357789999999999999   999999 79999999999999999999986543221


Q ss_pred             C----cC-------cccccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhCCCC
Q 005933          508 E----AN-------TDRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRN  553 (669)
Q Consensus       508 ~----~~-------~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG~~p  553 (669)
                      .    ..       ......++.|++|+...-.  .--...+.++.|..+|.++|+..+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~  206 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVL  206 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCC
Confidence            1    00       0112357788888765332  233678999999999999999876

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.3e-18  Score=197.93  Aligned_cols=198  Identities=22%  Similarity=0.284  Sum_probs=158.2

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhC---CCceeEEEEEEecCCcceE
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l  423 (669)
                      ...+.|.|.+.||+|++|.||+|...+|+.||||+-+....-   +|.-=.+++.+|+   -+-|+.+.......+..+|
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            345678899999999999999999888999999987544321   1111112223333   2234444444556778899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-------CCcceEEeec
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-------NDMNPKISDF  496 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-------~~~~~kl~Df  496 (669)
                      |+||.+.|+|.+++.   ..+.++|.....++.|+++.+..||..+   |||+||||+|.||.       +...++|+||
T Consensus       772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence            999999999999995   5667999999999999999999999999   99999999999994       2346899999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN  553 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p  553 (669)
                      |.+..+..-..........+|-.+-.+|...+.++++++|.|.|+-+++-|+.|+.-
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999876554444455567789999999999999999999999999999999999864

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=3.1e-17  Score=159.76  Aligned_cols=135  Identities=20%  Similarity=0.281  Sum_probs=105.4

Q ss_pred             ccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHh-----CCCceeEEEEEEecCC---c-ceEE
Q 005933          354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-----QHRNLVRLLGCCTLRD---E-RMLI  424 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lV  424 (669)
                      -.+.||+|+||.||.  .++....+||++........+.+.+|+.++..+     .||||++++|++.++.   . ..+|
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            347999999999996  443333479988665445567899999999999     5799999999998874   2 2378


Q ss_pred             Eee--cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceeccCCCCCEEEcC----CcceEEeecC
Q 005933          425 YEY--LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL-LYLHQDSRLRIIHRDLKASNVLLDN----DMNPKISDFG  497 (669)
Q Consensus       425 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiH~Dikp~NIll~~----~~~~kl~Dfg  497 (669)
                      +||  ..+++|.+++.+    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  557999999943    124544  35677888777 9999999   999999999999974    3479999954


Q ss_pred             CC
Q 005933          498 MA  499 (669)
Q Consensus       498 la  499 (669)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.5e-18  Score=185.00  Aligned_cols=225  Identities=25%  Similarity=0.311  Sum_probs=176.1

Q ss_pred             eeeecCccceEEEE----eCCCcEEEEEEecccCcc--chHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEeecC
Q 005933          357 KLGEGGFGPVYRGM----LTEGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      .+|+|.+|.|++..    .+.|.-+|+|.+.+....  .......|-.++..++ ||.+|++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999998755    334778899988764321  1125667888899887 9999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +|.|...+   .+....++.....+...++-+++++|+.+   ++|||+|++||+++.+|++++.|||+++..-....  
T Consensus        81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            99998877   33444677777778889999999999999   99999999999999999999999999886422221  


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS  589 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (669)
                          .+||..|||||++.  ....++|.||||++.+||++|..|+..                   +....++..  ...
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------------~~~~~Il~~--~~~  205 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------------DTMKRILKA--ELE  205 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------------HHHHHHhhh--ccC
Confidence                28899999999998  567899999999999999999988542                   011111111  123


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCH
Q 005933          590 YSLSEALRCIQVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       590 ~~~~~~~~l~~li~~cl~~dP~~RPs~  616 (669)
                      .+........+++..+...+|..|--.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            444555667788888888899988755

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=1.2e-16  Score=157.51  Aligned_cols=134  Identities=20%  Similarity=0.280  Sum_probs=113.8

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCcc--------chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ--------GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      +.||+|++|.||+|.. .|..|+||+.......        ....+.+|+.++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999998 5788999986532211        124678899999999999988877777777889999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      +++++|.+++...      .. .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998432      12 78899999999999999998   99999999999999 78999999998864

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=1.4e-16  Score=158.97  Aligned_cols=144  Identities=16%  Similarity=0.174  Sum_probs=112.9

Q ss_pred             hcCCCccCeeeecCccceEEEE--eCCCcEEEEEEecccCcc------------------------chHHHHHHHHHHHH
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGM--LTEGQEIAVKRLSKSSGQ------------------------GVEEFKNEVLLIAK  402 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  402 (669)
                      ...|.+.+.||+|++|.||+|.  ..+|+.||||++......                        ....+..|+.++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458889999999999999998  567999999998643210                        01235689999999


Q ss_pred             hCCC--ceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCC
Q 005933          403 LQHR--NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA  480 (669)
Q Consensus       403 l~h~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp  480 (669)
                      +.+.  .+.++++.    ...++||||+++.+|...+.   ....+.......++.||+.+|.+||+.+  .++|+||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp  177 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE  177 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence            9753  34455543    23589999999988876542   2234556677899999999999999987  399999999


Q ss_pred             CCEEEcCCcceEEeecCCCccc
Q 005933          481 SNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       481 ~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=2e-16  Score=154.25  Aligned_cols=144  Identities=19%  Similarity=0.236  Sum_probs=113.6

Q ss_pred             HHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCcc----------------------chHHHHHHHHHHH
Q 005933          344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ----------------------GVEEFKNEVLLIA  401 (669)
Q Consensus       344 ~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  401 (669)
                      ++......|.+.+.||+|+||.||++...+|+.||||++......                      ....+..|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            444444458888999999999999999888999999987543210                      1123677899999


Q ss_pred             HhCCC--ceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 005933          402 KLQHR--NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK  479 (669)
Q Consensus       402 ~l~h~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dik  479 (669)
                      .+.|+  .++..++.    ...++||||+++++|......         .....++.+++.++.++|+.+   ++|+||+
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence            99877  45555542    456899999999999775420         235678899999999999988   9999999


Q ss_pred             CCCEEEcCCcceEEeecCCCcccC
Q 005933          480 ASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       480 p~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |.||++++++.++|+|||++..+.
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.69  E-value=2.1e-17  Score=129.29  Aligned_cols=66  Identities=52%  Similarity=1.094  Sum_probs=59.4

Q ss_pred             ccCCCceeEeecccCCCCcccccccccCHHHHHHHhhhcCCcccccccccCCCCceEEEeecccccc
Q 005933          185 CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDM  251 (669)
Q Consensus       185 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~C~C~a~~~~~~~~~~~~c~~~~~~l~~~  251 (669)
                      |+.+|+|+++++|++|++....++.++++++|++.||+||||+||+|.++. ++++|++|+++|+|+
T Consensus         1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL   66 (66)
T ss_pred             CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence            566799999999999999877776779999999999999999999998766 568999999999985

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=3.6e-16  Score=152.59  Aligned_cols=130  Identities=23%  Similarity=0.344  Sum_probs=106.9

Q ss_pred             eeeecCccceEEEEeCCCcEEEEEEecccCc--------cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .||+|+||.||+|.+ ++..|++|+......        ....++.+|+.++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 478899998643221        11356788999999999887665555566677789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++++|.+++....          ..++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999874311          078999999999999998   99999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=2.8e-16  Score=176.33  Aligned_cols=144  Identities=18%  Similarity=0.308  Sum_probs=116.0

Q ss_pred             HHHHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEE-ecccCc-------cchHHHHHHHHHHHHhCCCceeEEEE
Q 005933          342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKR-LSKSSG-------QGVEEFKNEVLLIAKLQHRNLVRLLG  413 (669)
Q Consensus       342 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g  413 (669)
                      +.........|...+.||+|+||+||+|.+... .+++|+ +.+...       ...+++.+|+.++..++|++++....
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            333333445566789999999999999997644 444443 222111       12356889999999999999998888


Q ss_pred             EEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       414 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                      ++......++||||+++++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ +++.++|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence            8887788899999999999999883           35679999999999999998   9999999999999 6789999


Q ss_pred             eecCCCcc
Q 005933          494 SDFGMARA  501 (669)
Q Consensus       494 ~Dfgla~~  501 (669)
                      +|||+++.
T Consensus       469 iDFGla~~  476 (535)
T PRK09605        469 IDFGLGKY  476 (535)
T ss_pred             EeCccccc
Confidence            99999975

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=3.7e-16  Score=157.06  Aligned_cols=197  Identities=20%  Similarity=0.246  Sum_probs=137.7

Q ss_pred             CCCceeEEEEEEec---------------------------CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHH
Q 005933          404 QHRNLVRLLGCCTL---------------------------RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE  456 (669)
Q Consensus       404 ~h~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  456 (669)
                      +|||||+++++|.+                           +...++||..++. +|++++..    ...+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence            59999999988754                           2245788887754 89988843    2256666777899


Q ss_pred             HHHHHHHHHHhCCCCCceeccCCCCCEEE--cCCc--ceEEeecCCCcccCCC----ccCcCcccccccCCccCchhhcc
Q 005933          457 GIARGLLYLHQDSRLRIIHRDLKASNVLL--DNDM--NPKISDFGMARAFGVD----QTEANTDRVVGTYGYMSPEYAID  528 (669)
Q Consensus       457 ~ia~~L~yLH~~~~~~iiH~Dikp~NIll--~~~~--~~kl~Dfgla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  528 (669)
                      |+++|+.|||.++   |.|||+|++||||  |+++  .+.|+|||.+-.....    ..........|.-.-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   9999999999998  4444  4688999987543221    11111223457778999998854


Q ss_pred             CC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHH
Q 005933          529 GL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVG  602 (669)
Q Consensus       529 ~~------~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  602 (669)
                      .+      .-.|+|.|+.|.+.||++....||.-. ++-..+.              ...+....+..+...+..+++++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~--------------r~Yqe~qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDT--------------RTYQESQLPALPSRVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCccccc-chheech--------------hhhhhhhCCCCcccCChHHHHHH
Confidence            32      225899999999999999988885421 1100000              00111112234445567788999


Q ss_pred             HHhccCCCCCCCCHHHHHHHh
Q 005933          603 LLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       603 ~~cl~~dP~~RPs~~evl~~L  623 (669)
                      ...|+.||++||+..-....|
T Consensus       491 ~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHhcCCccccCCccHHHhHH
Confidence            999999999999977666555

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=6.3e-17  Score=169.41  Aligned_cols=124  Identities=29%  Similarity=0.451  Sum_probs=108.9

Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..+|.|+++...+|.++|.........++...+.++.|++.|+.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            467899999999999999765666668899999999999999999   55   999999999999999999999999998


Q ss_pred             cccCCCc----cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh
Q 005933          500 RAFGVDQ----TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC  549 (669)
Q Consensus       500 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt  549 (669)
                      .......    .........||..||+||.+.+..|+.++||||||++|+|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8764433    1233455789999999999999999999999999999999987

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=9.7e-15  Score=134.93  Aligned_cols=135  Identities=21%  Similarity=0.221  Sum_probs=115.9

Q ss_pred             ccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCC--CceeEEEEEEecCCcceEEEeecCCC
Q 005933          354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      +.+.||+|.++.||++...+ ..++||.......  ...+..|+.++..++|  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999864 7899999865433  5688999999999976  58999999988888899999999987


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      .+..+          +......++.+++++|++||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          5566778899999999999997555699999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=1e-14  Score=140.78  Aligned_cols=135  Identities=20%  Similarity=0.277  Sum_probs=99.0

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCcc--chHH----------------------HHHHHHHHHHhCCC--ce
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ--GVEE----------------------FKNEVLLIAKLQHR--NL  408 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni  408 (669)
                      .+.||+|+||.||++...+++.||||++......  ....                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4789999999999999888999999998643211  1111                      13566666666543  34


Q ss_pred             eEEEEEEecCCcceEEEeecCCCCHHHH-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEc
Q 005933          409 VRLLGCCTLRDERMLIYEYLPNKSLEQF-IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLD  486 (669)
Q Consensus       409 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~  486 (669)
                      .+++++    ...++||||++++++... +....    .. .....++.+++.++.++|. .+   |+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            555543    346899999999543221 11100    11 5678899999999999999 77   99999999999999


Q ss_pred             CCcceEEeecCCCccc
Q 005933          487 NDMNPKISDFGMARAF  502 (669)
Q Consensus       487 ~~~~~kl~Dfgla~~~  502 (669)
                       ++.++|+|||.+...
T Consensus       150 -~~~~~liDfg~a~~~  164 (187)
T cd05119         150 -DGKVYIIDVPQAVEI  164 (187)
T ss_pred             -CCcEEEEECcccccc
Confidence             899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=1.8e-15  Score=169.15  Aligned_cols=212  Identities=21%  Similarity=0.253  Sum_probs=142.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|+..+.|..|++|.||..++++ .+.+|+|+- +..-.    +++   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc-ccchh----hhc---cccccCCccee------------------
Confidence            3578888999999999999999875 677888543 22110    000   22222233332                  


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                         |+=...+   +.-+.++.        +++.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+.+.......
T Consensus       136 ---gDc~tll---k~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLL---KNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhc---ccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               2323333   22233332        2378999999998   99999999999999999999999999875322111


Q ss_pred             -------------CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc
Q 005933          508 -------------EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT  574 (669)
Q Consensus       508 -------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~  574 (669)
                                   +......+||+.|.|||++....|...+|.|++|+|+||.+-|..||....++.   ++......  
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~visd--  273 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISD--  273 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhhh--
Confidence                         111234689999999999999999999999999999999999999976543332   11111000  


Q ss_pred             cccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 005933          575 EDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMS  617 (669)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  617 (669)
                               ......-+...+.+.++++.+.|+++|..|--..
T Consensus       274 ---------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  274 ---------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             ---------hccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence                     0001111223345778899999999999996433

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=4.7e-14  Score=141.11  Aligned_cols=134  Identities=21%  Similarity=0.281  Sum_probs=106.0

Q ss_pred             Ceee-ecCccceEEEEeCCCcEEEEEEecccC-------------ccchHHHHHHHHHHHHhCCCce--eEEEEEEecCC
Q 005933          356 NKLG-EGGFGPVYRGMLTEGQEIAVKRLSKSS-------------GQGVEEFKNEVLLIAKLQHRNL--VRLLGCCTLRD  419 (669)
Q Consensus       356 ~~lg-~G~fg~Vy~g~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~~  419 (669)
                      ..|| .||.|+||+.... +..++||++....             ......+.+|+.++..|+|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5788 8999999999886 7789999875321             1233568889999999998775  67777654432


Q ss_pred             c----ceEEEeecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEe
Q 005933          420 E----RMLIYEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS  494 (669)
Q Consensus       420 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  494 (669)
                      .    .++|+|++++ .+|.+++..    ..++..    .+.+|+.+|.+||+.+   |+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 699988743    234443    3578999999999999   9999999999999998999999


Q ss_pred             ecCCCcc
Q 005933          495 DFGMARA  501 (669)
Q Consensus       495 Dfgla~~  501 (669)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998865

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.50  E-value=2.1e-14  Score=115.85  Aligned_cols=72  Identities=24%  Similarity=0.381  Sum_probs=63.4

Q ss_pred             ccCCCceeEeecccCCCCcccccccccCHHHHHHHhhh---cCCcccccccccCCCCceEEEeeccc-ccceeccCCCce
Q 005933          185 CEHGDGFLKRESVKLPDTSFSRVDKNISILACKELCSK---NCSCTAYANADVRGGGSGCLLWFHDL-IDMKVLSEGGQD  260 (669)
Q Consensus       185 C~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---~C~C~a~~~~~~~~~~~~c~~~~~~l-~~~~~~~~~~~~  260 (669)
                      |....+|+++.+|++|++..      .++++|++.|++   ||||+||+|.+.   +.||++|.++| +++++...++.+
T Consensus         5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~   75 (80)
T cd00129           5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD   75 (80)
T ss_pred             eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence            55567899999999999873      689999999999   999999999753   35899999999 999998888999


Q ss_pred             EEEEe
Q 005933          261 LYIRM  265 (669)
Q Consensus       261 ~y~~~  265 (669)
                      +|+|.
T Consensus        76 Ly~r~   80 (80)
T cd00129          76 LYENK   80 (80)
T ss_pred             eEeEC
Confidence            99983

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=4.1e-15  Score=166.43  Aligned_cols=255  Identities=22%  Similarity=0.303  Sum_probs=187.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCC--CcEEEEEEecccC--ccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV  424 (669)
                      ..|.+.+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456677889999999998877633  5567777765543  233344555777777776 99999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceeccCCCCCEEEcCCc-ceEEeecCCCccc
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH-QDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAF  502 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla~~~  502 (669)
                      .||..++++.+.+.. ......+....-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999888731 11113455666788999999999999 777   99999999999999999 9999999999987


Q ss_pred             CC-CccCcCcccccc-cCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          503 GV-DQTEANTDRVVG-TYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       503 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      .. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|...........      ..|......
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~~~~  249 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSNKGR  249 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------eeecccccc
Confidence            66 444555556778 9999999999874 55678999999999999999999865443322100      001110000


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV  620 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  620 (669)
                        ....    .-..-.....++...++..+|..|.+.+++-
T Consensus       250 --~~~~----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 --FTQL----PWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             --cccC----ccccCChhhhhcccccccCCchhcccccccc
Confidence              0000    0011123455777788889999999988774

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=1e-12  Score=142.88  Aligned_cols=141  Identities=23%  Similarity=0.288  Sum_probs=100.1

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCccch----------------------------------------HHHH
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGV----------------------------------------EEFK  394 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  394 (669)
                      .+.||.|++|.||+|++++|+.||||+.+.......                                        -.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999854321100                                        0244


Q ss_pred             HHHHHHHHhC-----CCceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 005933          395 NEVLLIAKLQ-----HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR-GLLYLHQD  468 (669)
Q Consensus       395 ~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~  468 (669)
                      +|...+.++.     ++++.-.--+.......+|||||++|++|.++.......  +   .+.+++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence            5665555552     333322222223345679999999999998876421111  1   23456666666 47788988


Q ss_pred             CCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       469 ~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      +   ++|+|++|.||+++.++.++|+|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   9999999999999999999999999997653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.42  E-value=3.6e-13  Score=111.67  Aligned_cols=80  Identities=50%  Similarity=0.941  Sum_probs=66.9

Q ss_pred             cccccCC---CceeEeecccCCCCcccccccccCHHHHHHHhhhcCCcccccccccCCCCceEEEeecccccceeccCCC
Q 005933          182 QLDCEHG---DGFLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGG  258 (669)
Q Consensus       182 ~~~C~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~C~C~a~~~~~~~~~~~~c~~~~~~l~~~~~~~~~~  258 (669)
                      +++|...   +.|++++++++|++.+..  .+.++++|++.||+||+|+||+|.+   ++.+|++|..++.+.+.....+
T Consensus         2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~   76 (84)
T cd01098           2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG   76 (84)
T ss_pred             CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence            4568654   689999999999887653  6789999999999999999999975   3568999999999988766566


Q ss_pred             ceEEEEec
Q 005933          259 QDLYIRMA  266 (669)
Q Consensus       259 ~~~y~~~~  266 (669)
                      ..+|||++
T Consensus        77 ~~~yiKv~   84 (84)
T cd01098          77 GTLYLRLA   84 (84)
T ss_pred             cEEEEEeC
Confidence            88999974

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=1.3e-13  Score=135.84  Aligned_cols=206  Identities=21%  Similarity=0.234  Sum_probs=141.5

Q ss_pred             HHHHHHHHhCCCceeEEEEEEecC-----CcceEEEeecCCCCHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005933          395 NEVLLIAKLQHRNLVRLLGCCTLR-----DERMLIYEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQD  468 (669)
Q Consensus       395 ~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~  468 (669)
                      .-+.-|-.+-|-|||++..|+.+.     ....++.|||+.|+|..+|.+.+. +..+......+++.||..||.|||+-
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            334455667799999999887553     356889999999999999986443 44578888889999999999999997


Q ss_pred             CCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC---CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHH
Q 005933          469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV---DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL  545 (669)
Q Consensus       469 ~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~  545 (669)
                      . ++|+|+++..+-|++..++-+|+.- +.......   ...........+.++|.|||.-.....+.++|||+||+...
T Consensus       196 ~-PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  196 D-PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             C-CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence            6 6799999999999999999888742 11111110   11111122345678999999877777888999999999999


Q ss_pred             HHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          546 EIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       546 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ||.-+..-.......           ...+..+...+...-+        ..-+.++..|++..|..||+|.+++.
T Consensus       274 emailEiq~tnseS~-----------~~~ee~ia~~i~~len--------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  274 EMAILEIQSTNSESK-----------VEVEENIANVIIGLEN--------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHheeccCCCcce-----------eehhhhhhhheeeccC--------ccccCcCcccccCCCCCCcchhhhhc
Confidence            998876431111000           0001111111110000        11135677899999999999999874

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1.5e-11  Score=116.44  Aligned_cols=130  Identities=22%  Similarity=0.168  Sum_probs=98.6

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCcee-EEEEEEecCCcceEEEeecCCCCHH
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-RLLGCCTLRDERMLIYEYLPNKSLE  434 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~~gsL~  434 (669)
                      +.|+.|.++.||++... +..|+||....... ....+..|+.++..+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            67899999999999976 78899998754332 234568899999998765544 455443  33468999999998876


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          435 QFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       435 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ...           .....++.+++++|+.||+.+  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            430           011245678999999999987  23469999999999999 66899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=9e-12  Score=133.59  Aligned_cols=248  Identities=21%  Similarity=0.285  Sum_probs=178.0

Q ss_pred             CCCccCeeee--cCccceEEEEe--C-CCcEEEEEEecccC--ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcce
Q 005933          351 NFSWKNKLGE--GGFGPVYRGML--T-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       351 ~~~~~~~lg~--G~fg~Vy~g~~--~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  422 (669)
                      .|.+.+.+|.  |.+|.||++..  . ++..+|+|+-+...  ......=.+|+.....+ .|+|.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566788999  99999999997  3 47889999854332  23333445677777777 4999999888889999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceeccCCCCCEEEcCC-cceEEeecC
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFG  497 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~Dfg  497 (669)
                      +-.|++. .+|..+..  .....++...++.+..+...    ||.++|...   ++|-|+||.||++..+ ...+++|||
T Consensus       195 iqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            9999985 67877764  33344677778888888888    999999998   9999999999999999 889999999


Q ss_pred             CCcccCCCccCcC---cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc
Q 005933          498 MARAFGVDQTEAN---TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT  574 (669)
Q Consensus       498 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~  574 (669)
                      +...++.......   .....+...|++||.. ++.++..+|+|++|.++.+-.++.........        ..|....
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~~r  339 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQLR  339 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCccccc
Confidence            9988765442221   2234678889999976 45678999999999999999988765221100        0111111


Q ss_pred             cccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          575 EDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...   +.+     .+-..-..++..++..+++.+|..|++.+.+..
T Consensus       340 ~~~---ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  340 QGY---IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccc---Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            111   111     111111234445888899999999998877654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.20  E-value=2.1e-10  Score=124.21  Aligned_cols=234  Identities=18%  Similarity=0.198  Sum_probs=155.0

Q ss_pred             eCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHH
Q 005933          371 LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK  450 (669)
Q Consensus       371 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~  450 (669)
                      ..++.+|.|...............+-++.|+.++||||++++......+..+||+|.+.  .|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34588888888876665445677888999999999999999999999999999999874  46666643      23455


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCC
Q 005933          451 RCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL  530 (669)
Q Consensus       451 ~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  530 (669)
                      ...-+.||+.||.|||+.+  .++|++|....|+|+..|..||++|.++.......  ........-..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~--~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN--APAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC--cccccchhhhcccChhhcCccc
Confidence            6677899999999999766  49999999999999999999999998876532111  1112223334566777553322


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCC
Q 005933          531 FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRP  610 (669)
Q Consensus       531 ~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  610 (669)
                        -..|.|-||++++|++.|..+.........  .+        +....+...+.+. ..+...+. ..+++..|....+
T Consensus       182 --~s~D~~~Lg~li~el~ng~~~~~~~~~~~~--~i--------pk~~~~~~~k~~~-~~~~~r~n-~~~~~~~~~~~~g  247 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGSLLTKTDLSNTG--KI--------PKALIELYCKKLG-ATELKRPN-KLRFILECRLLGG  247 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcccCcchhhhccC--cc--------chhHHHHHHHHhc-cccccccc-hhhHHHHHHhccc
Confidence              457999999999999999332111000000  00        0000011100110 01111122 4566677777777


Q ss_pred             CCCCCHHHHHHHhcCCCCCC
Q 005933          611 EDRPNMSSVVLMLSGERSLP  630 (669)
Q Consensus       611 ~~RPs~~evl~~L~~~~~~~  630 (669)
                      -.|=.+-+++..|+...-..
T Consensus       248 ff~n~fvd~~~fLeel~lks  267 (690)
T KOG1243|consen  248 FFRNDFVDTLLFLEELRLKS  267 (690)
T ss_pred             cccchHHHHHHHHHhcccCc
Confidence            77777777777777665443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.19  E-value=9.4e-11  Score=129.01  Aligned_cols=144  Identities=17%  Similarity=0.225  Sum_probs=93.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCcc------------------------------c----hH---
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQ------------------------------G----VE---  391 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~------------------------------~----~~---  391 (669)
                      ..|+. +.||.|++|.||+|++++ |+.||||+++.....                              .    .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 789999999999999988 999999998643110                              0    01   


Q ss_pred             ---HHHHHHHHHHHhC----CCceeEEEEEEe-cCCcceEEEeecCCCCHHHHhhccCCC---CCCCHHHHHHHHHHHHH
Q 005933          392 ---EFKNEVLLIAKLQ----HRNLVRLLGCCT-LRDERMLIYEYLPNKSLEQFIFDVTRT---KFLDWSKRCQIIEGIAR  460 (669)
Q Consensus       392 ---~~~~E~~~l~~l~----h~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~  460 (669)
                         +|.+|+..+.+++    +.+.+.+=.++. .....+|||||++|+.|.++..-...+   ..+....+..++.|   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence               1344554444442    333333322222 245678999999999998753111111   01222222223333   


Q ss_pred             HHHHHHhCCCCCceeccCCCCCEEEcCCc----ceEEeecCCCcccCC
Q 005933          461 GLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFGMARAFGV  504 (669)
Q Consensus       461 ~L~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~Dfgla~~~~~  504 (669)
                          ++..+   ++|+|+||.||+++.++    .++++|||++..+..
T Consensus       276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                34455   99999999999999888    999999999887643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=4.3e-10  Score=111.36  Aligned_cols=142  Identities=18%  Similarity=0.251  Sum_probs=111.8

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCc-cchHHHHHHHHHHHHhCC--CceeEEEEEEecCC---cceEEEeecC
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRD---ERMLIYEYLP  429 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lV~E~~~  429 (669)
                      +.|+.|..+.||++...+|+.++||....... .....+..|+.++..+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999987778999999754332 245678999999999976  44677787776543   5689999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS----------------------------------------  469 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------  469 (669)
                      +.+|...+..    ..++...+..++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776521    34677788888889999999988531                                        


Q ss_pred             -------------CCCceeccCCCCCEEEcC--CcceEEeecCCCcc
Q 005933          470 -------------RLRIIHRDLKASNVLLDN--DMNPKISDFGMARA  501 (669)
Q Consensus       470 -------------~~~iiH~Dikp~NIll~~--~~~~kl~Dfgla~~  501 (669)
                                   ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         235799999999999998  66789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.14  E-value=8e-10  Score=105.89  Aligned_cols=137  Identities=12%  Similarity=0.110  Sum_probs=99.7

Q ss_pred             cCeeeecCccceEEEEeCC-------CcEEEEEEecccC------------c----------cchHHH----HHHHHHHH
Q 005933          355 KNKLGEGGFGPVYRGMLTE-------GQEIAVKRLSKSS------------G----------QGVEEF----KNEVLLIA  401 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~  401 (669)
                      ...||.|--+.||.|...+       +..+|||+.+...            +          .....+    +.|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998553       4799999874211            0          011223    37999999


Q ss_pred             HhCC--CceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceeccC
Q 005933          402 KLQH--RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL-HQDSRLRIIHRDL  478 (669)
Q Consensus       402 ~l~h--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Di  478 (669)
                      ++..  -++.+++++    ...+|||||+.+..+.....   +...++......+..+++.+|..| |..+   ++|+||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            9853  566677764    56789999997754422110   112345566778889999999999 7888   999999


Q ss_pred             CCCCEEEcCCcceEEeecCCCccc
Q 005933          479 KASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       479 kp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      ++.||+++ ++.+.|+|||.+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 468999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.08  E-value=1.6e-09  Score=100.17  Aligned_cols=131  Identities=21%  Similarity=0.327  Sum_probs=104.2

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEE-ecccCcc-------chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKR-LSKSSGQ-------GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~-~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..+++|+-+.+|.+.+. |.++++|. +++....       ...+-.+|+.++.+++--.|....=+..+++...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999875 44566663 3333221       234567899999999877776666677788899999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++|..|.+.+...          ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999988442          2567888888899999999   99999999999998775 99999999975

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.03  E-value=3.3e-09  Score=97.53  Aligned_cols=143  Identities=24%  Similarity=0.323  Sum_probs=109.5

Q ss_pred             ccCeeeecCccceEEEEeCCCcEEEEE-EecccCc-------cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          354 WKNKLGEGGFGPVYRGMLTEGQEIAVK-RLSKSSG-------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~~~~~vavK-~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ....|-+|+-+.|+++.+. |+..+|| ++.+..+       -...+.++|+++|.++.--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578999999999999987 6776666 4443322       23457789999999997666665555677778889999


Q ss_pred             eecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc---ceEEeecCCCcc
Q 005933          426 EYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKISDFGMARA  501 (669)
Q Consensus       426 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~Dfgla~~  501 (669)
                      ||+++ .++.+++....+....+ .....++..|-+.+.-||..+   |+|+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 47888886544433222 233688999999999999999   99999999999997655   458999999865

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.02  E-value=2.2e-10  Score=123.03  Aligned_cols=249  Identities=20%  Similarity=0.190  Sum_probs=174.8

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC--CCcEEEEEEecccCccchHH--HHHHHHHHHHh-CCCceeEEEEEEecCCcce
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSGQGVEE--FKNEVLLIAKL-QHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  422 (669)
                      ...+|..+..||.|.|+.|++....  ++..+++|.+.+.......+  -..|+.+...+ .|.|+++....+....+.+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4567888999999999999998744  47889999886654332222  24566666666 5899999888887788888


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-cceEEeecCCCcc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARA  501 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~Dfgla~~  501 (669)
                      +=-||++++++...+   .-...++...++++..|++.++.++|+..   ++|+|++|+||++..+ +..++.|||....
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            899999999887665   22234677888999999999999999887   9999999999999886 7889999998864


Q ss_pred             cCCCccCcCcccccccCCc-cCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQTEANTDRVVGTYGY-MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      +.....    .....+..| .+|+......+-.++|++|||.-+.|.+++..-..-                  ......
T Consensus       417 ~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~------------------~~~~~~  474 (524)
T KOG0601|consen  417 LAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES------------------GVQSLT  474 (524)
T ss_pred             cceecc----cccccccccccchhhccccccccccccccccccccccccCcccCcc------------------ccccee
Confidence            321111    111122334 355555666888999999999999999998653110                  000111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +..... ...+. ....+..+...++..++..||.+.++....+-.
T Consensus       475 i~~~~~-p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  475 IRSGDT-PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             eecccc-cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            111101 01111 114555677778899999999999887766544

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.97  E-value=1.5e-08  Score=106.56  Aligned_cols=169  Identities=21%  Similarity=0.299  Sum_probs=130.1

Q ss_pred             ccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEec----CCcceEEEeecCC-CCHHHH
Q 005933          363 FGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERMLIYEYLPN-KSLEQF  436 (669)
Q Consensus       363 fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~E~~~~-gsL~~~  436 (669)
                      -.+.|++.. .||..|++|+++....+....-..-+++++++.|+|+|++..++..    +...++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            356788884 4699999999965444444445567889999999999999988762    3457899999876 477777


Q ss_pred             hhcc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          437 IFDV------------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       437 l~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      .+..            .+...+++..+|.++.|+..||.++|+.|   +.-+-|.+++|+++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            6532            12334788999999999999999999999   88899999999999999999998887765433


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN  553 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p  553 (669)
                      +..                |-+   .--.+-|.=.||.+++.|.||...
T Consensus       446 d~~----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            321                001   112367999999999999999654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.89  E-value=2.7e-08  Score=100.80  Aligned_cols=140  Identities=21%  Similarity=0.145  Sum_probs=101.4

Q ss_pred             eeeecCccceEEEEeCCCcEEEEEEecccCcc-----------chHHHHHHHHHHHHhCCC--ceeEEEEEEec-----C
Q 005933          357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ-----------GVEEFKNEVLLIAKLQHR--NLVRLLGCCTL-----R  418 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~--niv~l~g~~~~-----~  418 (669)
                      .+-......|++..+ +|+.|.||+.......           ....+.+|...+..+...  ..+.++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344334444667766 4789999987433211           112478999999998543  34445666543     2


Q ss_pred             CcceEEEeecCCC-CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-------Ccc
Q 005933          419 DERMLIYEYLPNK-SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------DMN  490 (669)
Q Consensus       419 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-------~~~  490 (669)
                      ...+||+|++++. +|.+++.+.. ....+...+..++.+++..+.-||..+   |+|+|++++||||+.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3478999999986 8999984322 234566778899999999999999999   999999999999985       468


Q ss_pred             eEEeecCCCcc
Q 005933          491 PKISDFGMARA  501 (669)
Q Consensus       491 ~kl~Dfgla~~  501 (669)
                      +.|+||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=3e-08  Score=94.70  Aligned_cols=125  Identities=25%  Similarity=0.324  Sum_probs=83.1

Q ss_pred             ceEEEEeCCCcEEEEEEecccC--------------c------------cchHHHHHHHHHHHHhCCC--ceeEEEEEEe
Q 005933          365 PVYRGMLTEGQEIAVKRLSKSS--------------G------------QGVEEFKNEVLLIAKLQHR--NLVRLLGCCT  416 (669)
Q Consensus       365 ~Vy~g~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~g~~~  416 (669)
                      .||.|...+|..+|||+.+...              .            .......+|++.|.++...  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899999999999999874311              0            0123467899999999765  566776553 


Q ss_pred             cCCcceEEEeecC--CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          417 LRDERMLIYEYLP--NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY-LHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       417 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                         ...|||||++  +..+..+....     ++......++.+++..+.. +|..+   |+|+||.+.||+++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               5689999998  65555443211     1123455677778775555 57877   9999999999999988 9999


Q ss_pred             eecCCCccc
Q 005933          494 SDFGMARAF  502 (669)
Q Consensus       494 ~Dfgla~~~  502 (669)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.80  E-value=1.4e-09  Score=122.81  Aligned_cols=245  Identities=19%  Similarity=0.236  Sum_probs=164.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ..+.+.+.+-+-+|.++.++.+.-.. |...++|.....   .....+....+-.++-..++|-+++..--+.-.....|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            34677777888889999888766322 322233322111   11112222222223333455667766655666778899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |++|..+++|...|+..   +.++..-....+..+..+++|||...   +.|+|++|.|++...++..++.||++.....
T Consensus       882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            99999999999888543   23444445556677889999999987   8999999999999999999999998433211


Q ss_pred             CC-------------------------ccCc----CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005933          504 VD-------------------------QTEA----NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR  554 (669)
Q Consensus       504 ~~-------------------------~~~~----~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~  554 (669)
                      .-                         ....    ......+|..|.+||.+.+......+|.|++|++++|.++|.+|+
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            00                         0000    012356899999999999999999999999999999999999996


Q ss_pred             CCCCCCCccchhhHhhhhcccccchhhcccccCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 005933          555 GFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS-----YSLSEALRCIQVGLLCVQQRPEDRPNMS  617 (669)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~  617 (669)
                      ....+..                   .++..+...     .+........+++...+..+|.+|-.|.
T Consensus      1036 na~tpq~-------------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ-------------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhh-------------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            6433321                   222222221     1223345667888888889999997776

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.68  E-value=9.9e-08  Score=93.66  Aligned_cols=134  Identities=21%  Similarity=0.260  Sum_probs=96.4

Q ss_pred             CCccCeeeecCccceEEEEeCCCcEEEEEEeccc--------------------C--ccchHHHHHHHHHHHHhCCC--c
Q 005933          352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--------------------S--GQGVEEFKNEVLLIAKLQHR--N  407 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~h~--n  407 (669)
                      ..++++||.|--+.||.|..+.|.++|||.-+..                    +  .-.....++|+++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4567899999999999999999999999964211                    0  01233467899999999654  6


Q ss_pred             eeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC
Q 005933          408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN  487 (669)
Q Consensus       408 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~  487 (669)
                      +.+.+++    +...+||||+++-.|...-        ++....-.++..|+.-+.-+-..|   ++|+|+++-||+|++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            7676653    4568999999986665432        122233344444444444444556   999999999999999


Q ss_pred             CcceEEeecCCCc
Q 005933          488 DMNPKISDFGMAR  500 (669)
Q Consensus       488 ~~~~kl~Dfgla~  500 (669)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999996543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.67  E-value=4.8e-07  Score=93.16  Aligned_cols=263  Identities=15%  Similarity=0.105  Sum_probs=156.8

Q ss_pred             CccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEE------EecCCc-ceEE
Q 005933          353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGC------CTLRDE-RMLI  424 (669)
Q Consensus       353 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~------~~~~~~-~~lV  424 (669)
                      .....||+|+-+.+|..-  +-...+-|+.+........+..   ..|... .||-+-.-+.+      ....+. ..++
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            456789999999988533  2233456777665443322222   223332 45533221111      111222 4567


Q ss_pred             EeecCCC-CHHHHhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          425 YEYLPNK-SLEQFIFDV---TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       425 ~E~~~~g-sL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      |+.+++. ....++.-.   ..-...+|...+++++.+|.+.+.||.++   .+-+|+.++|+||++++.+.|.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            7777654 233333221   22345789999999999999999999999   8999999999999999999999865433


Q ss_pred             ccCCCccCcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCC-CCccchhh--Hhhh
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHA-DHHHNLLG--HAWR  571 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG-~~p~~~~~~-~~~~~~~~--~~~~  571 (669)
                      ..   .........+|...|.+||...     +..-+...|-|.||+++++++.| ++|+..... ....+..+  .+..
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            32   2223344578899999999764     33456789999999999999997 788764221 11111111  0111


Q ss_pred             hcccccchhhcccccCCCCCHHH-HHHHHHHHHHhccCC--CCCCCCHHHHHHHhcCC
Q 005933          572 LWTEDRSLELIDKSLDGSYSLSE-ALRCIQVGLLCVQQR--PEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~  626 (669)
                      .+........-....-...+.+. +..+..+..+|+...  +.-|||++.++..|...
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            11111110000000011222222 345667777787654  56899999998877543

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=7.7e-07  Score=85.56  Aligned_cols=139  Identities=14%  Similarity=0.157  Sum_probs=104.5

Q ss_pred             eeecCccceEEEEeCCCcEEEEEEecccC------ccchHHHHHHHHHHHHhCC--CceeEEEEEEecC----CcceEEE
Q 005933          358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSS------GQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLR----DERMLIY  425 (669)
Q Consensus       358 lg~G~fg~Vy~g~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~----~~~~lV~  425 (669)
                      -|+||-+.|+.-.+. |+.+-||+.....      ......|.+|+..|..|..  ..+.+++......    -..+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            356888899998776 4578999875221      3466789999999999953  3355555222221    2368999


Q ss_pred             eecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc--eEEeecCCCcc
Q 005933          426 EYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--PKISDFGMARA  501 (669)
Q Consensus       426 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~--~kl~Dfgla~~  501 (669)
                      |-+++ -+|.+++.+. .....+...+..++.+|+++++-||+.+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 5898887432 2234677888899999999999999999   999999999999986666  99999987664

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=4.3e-07  Score=88.86  Aligned_cols=122  Identities=27%  Similarity=0.303  Sum_probs=92.8

Q ss_pred             CcEEEEEEecccC-c------cchHHHHHHHHHHHHhCC--CceeEEEEEEecCC----cceEEEeecCCC-CHHHHhhc
Q 005933          374 GQEIAVKRLSKSS-G------QGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRD----ERMLIYEYLPNK-SLEQFIFD  439 (669)
Q Consensus       374 ~~~vavK~~~~~~-~------~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~  439 (669)
                      ++.+.+|.+.... .      -....+.+|...+..|..  -..++++++.....    ..+||+|++++. +|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            5566666543211 1      234568889999888853  44566777765533    358999999884 89999854


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc---ceEEeecCCCcc
Q 005933          440 VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKISDFGMARA  501 (669)
Q Consensus       440 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~Dfgla~~  501 (669)
                      ...   ++......++.+++..++-||+.+   |+|+|+++.|||++.+.   .+.|+||+.++.
T Consensus       112 ~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  112 WEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            222   566778899999999999999999   99999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.55  E-value=5.7e-07  Score=98.67  Aligned_cols=160  Identities=19%  Similarity=0.310  Sum_probs=103.1

Q ss_pred             CCCCccHHHHHHH------------hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccc--------------
Q 005933          336 ELPMFDWNTIADA------------TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG--------------  389 (669)
Q Consensus       336 ~~~~~~~~~l~~~------------~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~--------------  389 (669)
                      ..|.|+++.+...            -..|+ .+.|+.++-|.||+|++++|+.||||+.+..-...              
T Consensus       100 ~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~  178 (517)
T COG0661         100 RVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARL  178 (517)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHH
Confidence            4567777655442            23444 26899999999999999999999999875321110              


Q ss_pred             ----------------hH----------HHHHHHHHHHHhC-----CCceeEEEEEEecCCcceEEEeecCCCCHHHHhh
Q 005933          390 ----------------VE----------EFKNEVLLIAKLQ-----HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF  438 (669)
Q Consensus       390 ----------------~~----------~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  438 (669)
                                      .+          .+..|...+.+++     .+++.-.-=+........|+|||++|..+.+...
T Consensus       179 ~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~  258 (517)
T COG0661         179 IKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA  258 (517)
T ss_pred             HHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH
Confidence                            01          1334444444442     3333322223344567899999999999988853


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHH-HHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          439 DVTRTKFLDWSKRCQIIEGIARG-LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       439 ~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      -..  ..++.+.   ++..++++ +..+-..+   ++|.|.+|.||+++.++++.+.|||+...+..
T Consensus       259 l~~--~g~d~k~---ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         259 LKS--AGIDRKE---LAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHh--cCCCHHH---HHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222  2244333   33333332 22333345   99999999999999999999999999876543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.54  E-value=3.1e-08  Score=108.14  Aligned_cols=153  Identities=16%  Similarity=0.249  Sum_probs=102.6

Q ss_pred             HHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC-------cCcccccccCCccCchhhc
Q 005933          455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-------ANTDRVVGTYGYMSPEYAI  527 (669)
Q Consensus       455 ~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~  527 (669)
                      +.+++.||.|+|.+-  .+||++|.|++|.++..+..||+.|+++.........       ...........|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345569999999876  5999999999999999999999999987654331111       1111233467899999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhc
Q 005933          528 DGLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCV  606 (669)
Q Consensus       528 ~~~~t~~sDVwS~G~~l~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  606 (669)
                      +...+.++|+||+|+++|-+..|..+ +........     +...        ...+..-....+...+.++.+=+.+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~--------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFS--------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhh--------hcccccccccccccCcHHHHHHHHHHh
Confidence            98899999999999999999954433 222111111     1000        000100111122334556777778899


Q ss_pred             cCCCCCCCCHHHHHHH
Q 005933          607 QQRPEDRPNMSSVVLM  622 (669)
Q Consensus       607 ~~dP~~RPs~~evl~~  622 (669)
                      ..++.-||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999987776543

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.43  E-value=4.4e-07  Score=73.63  Aligned_cols=72  Identities=36%  Similarity=0.711  Sum_probs=56.8

Q ss_pred             CceeEeecccCCCCcccccccccCHHHHHHHhhh-cCCcccccccccCCCCceEEEee-cccccceeccCCCceEEEE
Q 005933          189 DGFLKRESVKLPDTSFSRVDKNISILACKELCSK-NCSCTAYANADVRGGGSGCLLWF-HDLIDMKVLSEGGQDLYIR  264 (669)
Q Consensus       189 ~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-~C~C~a~~~~~~~~~~~~c~~~~-~~l~~~~~~~~~~~~~y~~  264 (669)
                      ..|.+++++.+++..... ....++++|++.|++ +|+|.||.|..   ++.+|.+|. +.+.+.......+.++|.|
T Consensus         4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~   77 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK   77 (78)
T ss_pred             ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence            569999999999765433 346799999999999 99999999975   456899999 7777776555556667765

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.41  E-value=4.8e-06  Score=82.64  Aligned_cols=140  Identities=16%  Similarity=0.170  Sum_probs=86.6

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCc--eeEEEEEEecCCcceEEEeecCCCC-
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN--LVRLLGCCTLRDERMLIYEYLPNKS-  432 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~E~~~~gs-  432 (669)
                      .+||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            68999999999984   25567888875422  3456788999999986443  4677888777777889999999963 


Q ss_pred             HHHHhh------------------ccCC--CCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCceeccCC
Q 005933          433 LEQFIF------------------DVTR--TKFLDWSKRC-QIIE----------GIAR-GLLYLHQD-SRLRIIHRDLK  479 (669)
Q Consensus       433 L~~~l~------------------~~~~--~~~l~~~~~~-~i~~----------~ia~-~L~yLH~~-~~~~iiH~Dik  479 (669)
                      +...+.                  ....  .......... .+..          .+.. ...+|... ....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            221110                  0000  0001111100 0000          0111 11222211 23357999999


Q ss_pred             CCCEEEcCCcceEEeecCCCcc
Q 005933          480 ASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       480 p~NIll~~~~~~kl~Dfgla~~  501 (669)
                      |.||++++++ +.|+||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.28  E-value=1.5e-05  Score=77.87  Aligned_cols=152  Identities=18%  Similarity=0.204  Sum_probs=100.7

Q ss_pred             ccHHHHHHHhcCCCccCeeee---cCccceEEEEeCCCcEEEEEEecccCcc-------------------c-----hHH
Q 005933          340 FDWNTIADATDNFSWKNKLGE---GGFGPVYRGMLTEGQEIAVKRLSKSSGQ-------------------G-----VEE  392 (669)
Q Consensus       340 ~~~~~l~~~~~~~~~~~~lg~---G~fg~Vy~g~~~~~~~vavK~~~~~~~~-------------------~-----~~~  392 (669)
                      .++..+....+...+....|.   |--+.||+|.-.++..+|||+.......                   .     ...
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            455666666666666666665   4455799999888999999998543210                   0     112


Q ss_pred             HHHHHHHHHHhC--CCceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 005933          393 FKNEVLLIAKLQ--HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DS  469 (669)
Q Consensus       393 ~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~  469 (669)
                      ...|+.-|.++.  +-.+.+.+++.    ...|||||+....+-.-.   -+...+...+...+..++++.+.-|-. .+
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~  187 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEAG  187 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence            345777777774  44555555543    458999998654211100   011112223566777788888887776 55


Q ss_pred             CCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       470 ~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                         +||+||+.-|||+. ++.+.|+||+-+...
T Consensus       188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             ---cccccchhhheEEE-CCeEEEEECcccccc
Confidence               99999999999999 889999999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.24  E-value=1.1e-05  Score=78.05  Aligned_cols=137  Identities=18%  Similarity=0.198  Sum_probs=91.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHH---------HHHHHHHHhCC---CceeEEEEEE-
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK---------NEVLLIAKLQH---RNLVRLLGCC-  415 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~h---~niv~l~g~~-  415 (669)
                      ..+|.+.+.+-......|.+-..+ |+.+++|..+.......+.|+         +++..+..++.   ..+..++.+. 
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            467777777777777667666664 789999987654433333322         34444444432   2222222222 


Q ss_pred             ----ecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          416 ----TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       416 ----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                          ......+|||||++|..|.++..       ++.    .++..|+.++.-||+.|   ++|+|.+|.|+++++++ +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence                22344578999999988866541       222    35567888899999999   99999999999999655 9


Q ss_pred             EEeecCCCcc
Q 005933          492 KISDFGMARA  501 (669)
Q Consensus       492 kl~Dfgla~~  501 (669)
                      +++||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.20  E-value=1.2e-05  Score=80.03  Aligned_cols=143  Identities=23%  Similarity=0.251  Sum_probs=86.2

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCC--ceeEEEEEEecC---CcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLLGCCTLR---DERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~---~~~~lV~E~~~~  430 (669)
                      +.|+.|..+.||+....+ ..+++|.....  .....+..|+.++..+...  .+.+++......   ...+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            679999999999999887 69999997543  4567788999999888533  356777654333   235889999999


Q ss_pred             CCHHH----------------Hhh---cc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 005933          431 KSLEQ----------------FIF---DV-TRTKFLDWSK---------RCQI------------IEGIAR-GLLYLHQ-  467 (669)
Q Consensus       431 gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~-  467 (669)
                      ..+..                .+.   .. ..........         ....            ...+.+ .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            98887                111   11 1111111100         0000            111222 2333332 


Q ss_pred             ---CCCCCceeccCCCCCEEEc-CCcceEEeecCCCcc
Q 005933          468 ---DSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARA  501 (669)
Q Consensus       468 ---~~~~~iiH~Dikp~NIll~-~~~~~kl~Dfgla~~  501 (669)
                         ..+..++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence               2345699999999999999 666668999988753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.18  E-value=1.6e-05  Score=87.14  Aligned_cols=158  Identities=16%  Similarity=0.260  Sum_probs=98.0

Q ss_pred             CCCCccHHHHHHHh------------cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccc--------------
Q 005933          336 ELPMFDWNTIADAT------------DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG--------------  389 (669)
Q Consensus       336 ~~~~~~~~~l~~~~------------~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~--------------  389 (669)
                      ..|.++++++....            ..|+ .+.||.-+.|.||+|++++|+.||||+.+..-+..              
T Consensus       136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~  214 (538)
T KOG1235|consen  136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKV  214 (538)
T ss_pred             cCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHH
Confidence            45667776665432            2333 36899999999999999999999999875432110              


Q ss_pred             -----------------h------HHHHHHHHHHHH----hCCCc------eeEEEEEEecCCcceEEEeecCCCCHHHH
Q 005933          390 -----------------V------EEFKNEVLLIAK----LQHRN------LVRLLGCCTLRDERMLIYEYLPNKSLEQF  436 (669)
Q Consensus       390 -----------------~------~~~~~E~~~l~~----l~h~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~  436 (669)
                                       .      -+|..|.+-..+    +.|-+      |.+++  ........|+||||+|..+.+.
T Consensus       215 l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl  292 (538)
T KOG1235|consen  215 LQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDL  292 (538)
T ss_pred             HHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCH
Confidence                             0      013444443333    33555      22332  2223578999999999977766


Q ss_pred             hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC----CcceEEeecCCCcccC
Q 005933          437 IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----DMNPKISDFGMARAFG  503 (669)
Q Consensus       437 l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~----~~~~kl~Dfgla~~~~  503 (669)
                      -.-..  ..++...+..-+.++..-+-+  ..|   ++|+|-+|.||+++.    ++.+.+.|||+...+.
T Consensus       293 ~~i~~--~gi~~~~i~~~l~~~~~~qIf--~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  293 DAIDK--RGISPHDILNKLVEAYLEQIF--KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHHH--cCCCHHHHHHHHHHHHHHHHH--hcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            32111  124444433333333222222  223   999999999999984    6789999999987653

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.18  E-value=7.4e-06  Score=78.61  Aligned_cols=104  Identities=24%  Similarity=0.285  Sum_probs=84.3

Q ss_pred             HHHHHHHHHhCC-CceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 005933          394 KNEVLLIAKLQH-RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR  472 (669)
Q Consensus       394 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  472 (669)
                      .+|..+++.+++ +++++++|+|    ..++|.||...+++........+--..+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458889999976 6999999999    45889999987766432111112223689999999999999999999976666


Q ss_pred             ceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          473 IIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       473 iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      +...|++++|+-+++++++|++|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            89999999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.17  E-value=2.5e-05  Score=78.68  Aligned_cols=141  Identities=15%  Similarity=0.132  Sum_probs=87.6

Q ss_pred             CeeeecCc-cceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          356 NKLGEGGF-GPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       356 ~~lg~G~f-g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      +.|..|.. ..||+.... +..++||+.....   ...+..|+.++..+. +--+.+++++....+..++|||+++|.+|
T Consensus         4 ~~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555555 678998765 4788899875432   346778999998884 44566788887776778999999999887


Q ss_pred             HHHhh-------------------ccCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----
Q 005933          434 EQFIF-------------------DVTR-TKFLD--WSKRCQIIE--------------------GIARGLLYLHQ----  467 (669)
Q Consensus       434 ~~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~~L~yLH~----  467 (669)
                      .....                   .... .....  ....+....                    .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            64421                   0000 00011  000000000                    01111222211    


Q ss_pred             CCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       468 ~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      ...+.++|+|+.|.|||++.+..+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            123458999999999999998788999998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=98.01  E-value=6.6e-06  Score=58.86  Aligned_cols=44  Identities=55%  Similarity=0.828  Sum_probs=38.6

Q ss_pred             CCCCCCCCCCCccccCCCCCCCCCcccC--CCCCCcceeeeeeccC
Q 005933          626 ERSLPQPKQPGFFTERNLPESESSSSKR--KLPLSNEITISLIEGR  669 (669)
Q Consensus       626 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  669 (669)
                      ...+|.|++|+|+.++...+..++.+.+  ...++|++|+|.|+||
T Consensus         3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            4679999999999999887777776666  7799999999999998

; GO: 0004674 protein serine/threonine kinase activity

>PLN02876 acyl-CoA dehydrogenase

Probab=97.92  E-value=0.00014  Score=86.21  Aligned_cols=79  Identities=18%  Similarity=0.346  Sum_probs=58.8

Q ss_pred             cCeeeecCccceEEEEeCCC---cEEEEEEecccC-ccchHHHHHHHHHHHHhC-CCce--eEEEEEEecC---CcceEE
Q 005933          355 KNKLGEGGFGPVYRGMLTEG---QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQ-HRNL--VRLLGCCTLR---DERMLI  424 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV  424 (669)
                      .++|+.|.+..+|+....++   ..+++|+..... ......+.+|+.+++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            47789999999999887654   467888764322 123457889999999995 6654  7888888664   457899


Q ss_pred             EeecCCCCH
Q 005933          425 YEYLPNKSL  433 (669)
Q Consensus       425 ~E~~~~gsL  433 (669)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.89  E-value=0.00011  Score=73.48  Aligned_cols=73  Identities=16%  Similarity=0.273  Sum_probs=47.3

Q ss_pred             CeeeecCcc-ceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCC---ceeEEEEEEecCC---cceEEEeec
Q 005933          356 NKLGEGGFG-PVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR---NLVRLLGCCTLRD---ERMLIYEYL  428 (669)
Q Consensus       356 ~~lg~G~fg-~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~---~~~lV~E~~  428 (669)
                      +.|+.|+.. .||+.    +..+++|..+.  ......+..|++++..+...   .+.++++.....+   ..++|||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567777766 48874    24577786543  22345789999999888532   3445555443322   348899999


Q ss_pred             CCCCHH
Q 005933          429 PNKSLE  434 (669)
Q Consensus       429 ~~gsL~  434 (669)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.89  E-value=0.00016  Score=77.35  Aligned_cols=75  Identities=16%  Similarity=0.191  Sum_probs=56.0

Q ss_pred             CeeeecCccceEEEEeCCC-cEEEEEEeccc-------CccchHHHHHHHHHHHHhC---CCceeEEEEEEecCCcceEE
Q 005933          356 NKLGEGGFGPVYRGMLTEG-QEIAVKRLSKS-------SGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV  424 (669)
                      +.||.|.+..||+....+| +.|+||.-...       .....+++..|.+.|..+.   -.++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            6899999999999999877 58999985311       1234567888888888863   2456777766  44668999


Q ss_pred             EeecCCCC
Q 005933          425 YEYLPNKS  432 (669)
Q Consensus       425 ~E~~~~gs  432 (669)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.88  E-value=0.00025  Score=68.39  Aligned_cols=128  Identities=17%  Similarity=0.261  Sum_probs=91.5

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccC----------------ccchHHHHHHHHHHHHhC------CCceeEEE
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS----------------GQGVEEFKNEVLLIAKLQ------HRNLVRLL  412 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~  412 (669)
                      ...||+|+.-.||.  +++.....||++....                ....++..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46899999998886  4455677888876544                223567777887777666      78999999


Q ss_pred             EEEecCCcceEEEeecCCC------CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc
Q 005933          413 GCCTLRDERMLIYEYLPNK------SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD  486 (669)
Q Consensus       413 g~~~~~~~~~lV~E~~~~g------sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~  486 (669)
                      |+...+....+|+|.+.+.      +|.+++.    ...++. ...+.+.   .-..||-++.   |+.+|++|+||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence            9999999999999997542      5777773    223444 3333333   4445666666   99999999999996


Q ss_pred             CCc----ceEEee
Q 005933          487 NDM----NPKISD  495 (669)
Q Consensus       487 ~~~----~~kl~D  495 (669)
                      ...    .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            332    577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.85  E-value=0.00023  Score=73.85  Aligned_cols=76  Identities=13%  Similarity=0.106  Sum_probs=57.9

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCC---CceeEEEEEEecC---CcceEEEeec
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH---RNLVRLLGCCTLR---DERMLIYEYL  428 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~---~~~~lV~E~~  428 (669)
                      .+.||.|..+.||+....++ .+++|..+.  ......|..|...|+.|..   ..+.++++++..+   +..+||||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            46899999999999987655 466777432  1133688999999999953   4688889887543   5689999999


Q ss_pred             CCCCH
Q 005933          429 PNKSL  433 (669)
Q Consensus       429 ~~gsL  433 (669)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.84  E-value=0.00012  Score=67.63  Aligned_cols=128  Identities=21%  Similarity=0.253  Sum_probs=88.2

Q ss_pred             ccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeE-EEEEEecCCcceEEEeecCCCC
Q 005933          354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR-LLGCCTLRDERMLIYEYLPNKS  432 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lV~E~~~~gs  432 (669)
                      ..+.|++|.+|.||+|.+. |..+|+|+-..  +.....+..|+++|..++-.++.+ ++.+-    ..++.|||+.|-.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence            4578999999999999997 56899998643  344578889999999998666554 44332    3345599999988


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC-CCCEEEcCCcceEEeecCCCcc
Q 005933          433 LEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK-ASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       433 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dik-p~NIll~~~~~~kl~Dfgla~~  501 (669)
                      |.+.-...      +-.++.    .++..-.-|...+   |-|+.|. |..++|-.+..+.|+||..|..
T Consensus        99 L~~~~~~~------~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG------DRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc------cHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            88765321      223333    3444444455555   9999986 4444444444999999998874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.84  E-value=2.3e-06  Score=92.63  Aligned_cols=188  Identities=18%  Similarity=0.142  Sum_probs=133.4

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCc-eeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .-+...+.+++++.+.++|.+-.-.+....+.+...     ....-++++|.+++||| .++.++-+..++...+++++.
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            334444668899999999887543444445555332     44566889999999999 777777777777889999998


Q ss_pred             CCC-CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          429 PNK-SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       429 ~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      ..+ +-..-+.  .....+...+...+...-.+++++||+..   -+|+|    ||+..+ +..+..||+....+.... 
T Consensus       317 s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  317 STGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             cCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence            876 2111110  00111333344556677788999999875   58888    777665 678999999988765433 


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG  555 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~  555 (669)
                        ......+++.++|||+.....+....|+|++|+-..+|--|.+|..
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence              2334678999999999999999999999999998777777776643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.80  E-value=0.00021  Score=71.37  Aligned_cols=141  Identities=18%  Similarity=0.279  Sum_probs=83.3

Q ss_pred             CeeeecCccceEEEEeCC--CcEEEEEEecccCccchHHHHHHHHHHHHhCCCce-eEEEEEEecCCcceEEEeecCCCC
Q 005933          356 NKLGEGGFGPVYRGMLTE--GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYLPNKS  432 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gs  432 (669)
                      +.|..|-...+|+....+  +..|++|+....... .-...+|+.++..+...++ +++++...    ..+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567888889999998764  678999977543222 1233578889988854333 44444332    248999999977


Q ss_pred             HHHH--------------h---hccCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 005933          433 LEQF--------------I---FDVTRT--------KFLD-WSKRCQIIE----------------------GIARGLLY  464 (669)
Q Consensus       433 L~~~--------------l---~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~L~y  464 (669)
                      +...              +   +.....        .... +..+..+..                      .+...+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321              1   111111        1111 222212111                      11111111


Q ss_pred             ----HHhC-CCCCceeccCCCCCEEEcC-CcceEEeecCCCcc
Q 005933          465 ----LHQD-SRLRIIHRDLKASNVLLDN-DMNPKISDFGMARA  501 (669)
Q Consensus       465 ----LH~~-~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~  501 (669)
                          +... .+..++|+|+.+.|||++. ++.+.|+||..+..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence                2221 2345999999999999998 57899999988753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.78  E-value=0.00014  Score=73.90  Aligned_cols=139  Identities=16%  Similarity=0.094  Sum_probs=80.9

Q ss_pred             eeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCce-eEEEEEEecCCcceEEEeecCCCCHHH
Q 005933          357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYLPNKSLEQ  435 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~  435 (669)
                      .+..|-...+|+... +++.+++|+.........-...+|..+++.+....+ .++++...    ..+||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            456677889998874 477888987654332221245789999999864333 34444432    478999999876542


Q ss_pred             H-----------------hhccCC-CCCCCHHH-HHHHHHH---------HHHHHHHHHhC-----CCCCceeccCCCCC
Q 005933          436 F-----------------IFDVTR-TKFLDWSK-RCQIIEG---------IARGLLYLHQD-----SRLRIIHRDLKASN  482 (669)
Q Consensus       436 ~-----------------l~~~~~-~~~l~~~~-~~~i~~~---------ia~~L~yLH~~-----~~~~iiH~Dikp~N  482 (669)
                      -                 ++.... ...++... +.....+         +...+..+...     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 111111 11122221 1111111         11112222211     12358999999999


Q ss_pred             EEEcCCcceEEeecCCCcc
Q 005933          483 VLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       483 Ill~~~~~~kl~Dfgla~~  501 (669)
                      |++++++ +.|+||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.58  E-value=0.0005  Score=71.29  Aligned_cols=143  Identities=20%  Similarity=0.206  Sum_probs=87.1

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCC--ceeEEEEE------EecCCcceEEEe
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLLGC------CTLRDERMLIYE  426 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~------~~~~~~~~lV~E  426 (669)
                      .+.|..|....+|+.... +..+++|+...   ........|+.++..+.+.  .+.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            356777888899998765 45788898754   2345677788888888533  24455432      223445689999


Q ss_pred             ecCCCCHHH----H----------hhccCC--------CCCCCHHHHH----------HHHHHHHHHHHHHHhC----CC
Q 005933          427 YLPNKSLEQ----F----------IFDVTR--------TKFLDWSKRC----------QIIEGIARGLLYLHQD----SR  470 (669)
Q Consensus       427 ~~~~gsL~~----~----------l~~~~~--------~~~l~~~~~~----------~i~~~ia~~L~yLH~~----~~  470 (669)
                      +++|..+..    .          ++....        .....|....          .....+..++.++...    .+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999877532    1          111100        0111222111          0112233445555431    22


Q ss_pred             CCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          471 LRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       471 ~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ..++|+|+.|.||+++++..+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3599999999999999987789999987753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.52  E-value=0.00052  Score=79.81  Aligned_cols=196  Identities=18%  Similarity=0.145  Sum_probs=134.2

Q ss_pred             HHHHHHHHHHhCCCceeEEEEEEecCCcce----EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005933          393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERM----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD  468 (669)
Q Consensus       393 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~  468 (669)
                      ..-|+..+..+.|+|++.++.+-.+.....    +..|++..-++...+.   .-..++....+.+..++.+||+|+|+.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            345677788889999999999876654433    3457777777877773   345578888889999999999999998


Q ss_pred             CCCCceeccCCCC---CEEEcCCcceEEe--ecCCCcccCCCccCcCcccccccCCccCchhhccCCCCc--hhhHHHHH
Q 005933          469 SRLRIIHRDLKAS---NVLLDNDMNPKIS--DFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV--KSDVFSFG  541 (669)
Q Consensus       469 ~~~~iiH~Dikp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--~sDVwS~G  541 (669)
                      .   +.|.-+..+   +--++..+.+.++  ||+....+......   .....+..+.|||......+..  ..|+|.+|
T Consensus       306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence            6   566555555   5555666777777  88887765332221   1233456677888776665544  47999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          542 VLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       542 ~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..+..+..|..+...                      ...+...+......    ...+....|+..++++|+++.+++.
T Consensus       380 ll~~~~~~~~~i~~~----------------------~~~~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEK----------------------SAVPVSLLDVLSTS----ELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHHhhhhhcCccccc----------------------ccchhhhhccccch----hhhhhhhhhcchhhhhccchhhhhh
Confidence            999999998765211                      01111111111111    4556777899999999999999997


Q ss_pred             Hh
Q 005933          622 ML  623 (669)
Q Consensus       622 ~L  623 (669)
                      ..
T Consensus       434 ~~  435 (1351)
T KOG1035|consen  434 HP  435 (1351)
T ss_pred             ch
Confidence            55

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.50  E-value=0.0011  Score=63.48  Aligned_cols=125  Identities=26%  Similarity=0.424  Sum_probs=90.1

Q ss_pred             cCCCccCeeeecCc-cceEEEEeCCCcEEEEEEecc---cC--------c----------cchHHHHHHHHHHHHhC---
Q 005933          350 DNFSWKNKLGEGGF-GPVYRGMLTEGQEIAVKRLSK---SS--------G----------QGVEEFKNEVLLIAKLQ---  404 (669)
Q Consensus       350 ~~~~~~~~lg~G~f-g~Vy~g~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~E~~~l~~l~---  404 (669)
                      .+++..+.||.|.- |.||+..+. |+.+|||.+..   ..        .          .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78888999999999 999999997 78999999321   00        0          12345788999888885   


Q ss_pred             CCce--eEEEEEEecCC------------------cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 005933          405 HRNL--VRLLGCCTLRD------------------ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY  464 (669)
Q Consensus       405 h~ni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y  464 (669)
                      +.++  |+.+|+..-..                  ...||.||.+...            .+.    .+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4466  89999873321                  1356777765432            112    2345567777888


Q ss_pred             HHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       465 LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      +|..+   |+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99988   999999999986     4588999854

>PRK05231 homoserine kinase; Provisional

Probab=97.48  E-value=0.0015  Score=68.47  Aligned_cols=156  Identities=20%  Similarity=0.228  Sum_probs=85.5

Q ss_pred             HHHHHHHhcCCCc-----cCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCC--ceeEEEE-
Q 005933          342 WNTIADATDNFSW-----KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLLG-  413 (669)
Q Consensus       342 ~~~l~~~~~~~~~-----~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g-  413 (669)
                      ..++......|.+     .+.|+.|....+|+....+| .+++|+...   ...+....|+.++..|...  .+.+++. 
T Consensus         9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~   84 (319)
T PRK05231          9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVAR   84 (319)
T ss_pred             HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence            3444444445544     24567777789999887655 688898752   2234445566666666322  2334332 


Q ss_pred             -----EEecCCcceEEEeecCCCCHHH-----------Hh---hccCC--------CCCCCH-HHHHH------------
Q 005933          414 -----CCTLRDERMLIYEYLPNKSLEQ-----------FI---FDVTR--------TKFLDW-SKRCQ------------  453 (669)
Q Consensus       414 -----~~~~~~~~~lV~E~~~~gsL~~-----------~l---~~~~~--------~~~l~~-~~~~~------------  453 (669)
                           +....+..++++||++|..+..           .|   +....        ...+.| .....            
T Consensus        85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (319)
T PRK05231         85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA  164 (319)
T ss_pred             CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence                 1223456789999999875421           11   11110        001112 11111            


Q ss_pred             HH-HHHHHHHHHHHhC----CCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          454 II-EGIARGLLYLHQD----SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       454 i~-~~ia~~L~yLH~~----~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      .+ ..+...+..+...    -+..++|+|+.|.||+++.+...-|+||+.+..
T Consensus       165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            11 1111222333211    234599999999999999776668999998753

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.37  E-value=0.0013  Score=68.49  Aligned_cols=141  Identities=25%  Similarity=0.377  Sum_probs=85.4

Q ss_pred             CeeeecCccceEEEEeCC-------CcEEEEEEecccCccchHHHHHHHHHHHHhCCCce-eEEEEEEecCCcceEEEee
Q 005933          356 NKLGEGGFGPVYRGMLTE-------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~  427 (669)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|+.++..+....+ .++++++.    -.+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            456677777899988765       5789999975443 233455788888888854333 35555553    2368999


Q ss_pred             cCCCCHHHH-----------------hhccCCCC------CCC--HHHHHH--------------------------HHH
Q 005933          428 LPNKSLEQF-----------------IFDVTRTK------FLD--WSKRCQ--------------------------IIE  456 (669)
Q Consensus       428 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~  456 (669)
                      ++|.++...                 ++......      ..+  +..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776431                 11111110      010  111111                          112


Q ss_pred             HHHHHHHHHHh------CCCCCceeccCCCCCEEEcCC----cceEEeecCCCcc
Q 005933          457 GIARGLLYLHQ------DSRLRIIHRDLKASNVLLDND----MNPKISDFGMARA  501 (669)
Q Consensus       457 ~ia~~L~yLH~------~~~~~iiH~Dikp~NIll~~~----~~~kl~Dfgla~~  501 (669)
                      .+...+..|..      ..+..++|+|+.+.||+++++    +.+.|+||+.+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22233344432      234569999999999999985    8899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.31  E-value=0.0018  Score=66.37  Aligned_cols=74  Identities=22%  Similarity=0.280  Sum_probs=50.7

Q ss_pred             ccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhC---CCceeEEEEEEecCCcceEEEeecCC
Q 005933          354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      -.+.|+.|....+|+.. .+++.+.||.-.   ......|..|.+-|+.|.   -..+.+++++....+..+||+||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            34678989999999988 568899999875   334567899999999884   44678899998888888999999987


Q ss_pred             C
Q 005933          431 K  431 (669)
Q Consensus       431 g  431 (669)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            7

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.25  E-value=0.0027  Score=67.30  Aligned_cols=141  Identities=17%  Similarity=0.253  Sum_probs=84.8

Q ss_pred             CeeeecCccceEEEEeCC-----CcEEEEEEecccCccchHHHHHHHHHHHHhCCCcee-EEEEEEecCCcceEEEeecC
Q 005933          356 NKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-RLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~  429 (669)
                      +.|-.|-...+|+....+     ++.|++|+.........++ .+|..++..+...++. ++++++..+    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            456567778899987543     3689999886654444444 7899999988654444 556665332    5899998


Q ss_pred             CCCHHHH-----------------hhccC-C-CC-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 005933          430 NKSLEQF-----------------IFDVT-R-TK-FLDWSKRCQIIEGI-----------------ARGLLYL----HQ-  467 (669)
Q Consensus       430 ~gsL~~~-----------------l~~~~-~-~~-~l~~~~~~~i~~~i-----------------a~~L~yL----H~-  467 (669)
                      +.+|...                 ++... . .. ...+.++.++..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776421                 11111 0 01 11233333332211                 1112122    22 


Q ss_pred             CCCCCceeccCCCCCEEEcC-CcceEEeecCCCcc
Q 005933          468 DSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARA  501 (669)
Q Consensus       468 ~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~  501 (669)
                      ..+..++|+|+++.||++++ ++.+.|+||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22345899999999999986 47899999988753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.21  E-value=0.0085  Score=62.53  Aligned_cols=155  Identities=21%  Similarity=0.264  Sum_probs=88.8

Q ss_pred             HHHHHHhcCCCc-----cCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCC--ceeEEEEEE
Q 005933          343 NTIADATDNFSW-----KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLLGCC  415 (669)
Q Consensus       343 ~~l~~~~~~~~~-----~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~  415 (669)
                      +++....+.|.+     .+.++.|....+|+....++ .+++|+.....  ..+....|+.++..|...  .+.+++...
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~   86 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSR   86 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence            444444444544     35567777789999876544 67788764421  234556777888777432  244444321


Q ss_pred             ------ecCCcceEEEeecCCCCHHH-----------H---hhccCCC---------CCCCHHHHH------------HH
Q 005933          416 ------TLRDERMLIYEYLPNKSLEQ-----------F---IFDVTRT---------KFLDWSKRC------------QI  454 (669)
Q Consensus       416 ------~~~~~~~lV~E~~~~gsL~~-----------~---l~~~~~~---------~~l~~~~~~------------~i  454 (669)
                            ...+..++|+||++|..+..           .   ++.....         ....|....            ..
T Consensus        87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~  166 (307)
T TIGR00938        87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM  166 (307)
T ss_pred             CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence                  22345689999999865321           1   1111110         001121110            01


Q ss_pred             HHHHHHHHHHHHh----CCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          455 IEGIARGLLYLHQ----DSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       455 ~~~ia~~L~yLH~----~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      ...+.+.++++..    ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            1223344555543    223469999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.12  E-value=0.00045  Score=69.87  Aligned_cols=145  Identities=17%  Similarity=0.211  Sum_probs=97.7

Q ss_pred             ccHHHHHHHh---cCCCccCeeeecCccceEEEEeCCCcEEEEEEecc--c------------------Ccc--chHHHH
Q 005933          340 FDWNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSK--S------------------SGQ--GVEEFK  394 (669)
Q Consensus       340 ~~~~~l~~~~---~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~--~------------------~~~--~~~~~~  394 (669)
                      +++-.|....   .-++++++||-|--+.||.+...+|++.++|.-+-  .                  +..  +.-...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            4444443332   34678899999999999999999999999994310  0                  000  112345


Q ss_pred             HHHHHHHHhCC--CceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 005933          395 NEVLLIAKLQH--RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR  472 (669)
Q Consensus       395 ~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  472 (669)
                      .|+..|+.|..  --+.+.+++    +..++|||++.+-.|...-      ...+..+   +...+..-+.-|..+|   
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---  222 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---  222 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---
Confidence            68888888853  234455543    4568899999888776543      1123333   3333444455566677   


Q ss_pred             ceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          473 IIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       473 iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      +||+|+.--||+|++++.++++||--..
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999999996443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.01  E-value=0.0068  Score=62.67  Aligned_cols=137  Identities=18%  Similarity=0.244  Sum_probs=84.4

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecc--cCccchHHHHHHHHHHHHhCC--CceeEEEEEEecCC--cceEEEeec
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRD--ERMLIYEYL  428 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lV~E~~  428 (669)
                      .+.+..|..-.+|..... +++++|+ ...  ..........+|+.+++.+.-  .-+...++.|.++.  ..+.||+|.
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            344434444445555544 7888888 331  233345566778888888743  34556677777766  679999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHH-HHHHHHHHHHH-----------------------------------------
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQII-EGIARGLLYLH-----------------------------------------  466 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~~L~yLH-----------------------------------------  466 (669)
                      +|..+.+.+....      ..  .+++ ..+++.|+.||                                         
T Consensus       108 eGe~~~~~~~~~~------~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         108 EGEVVWSALPPES------LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             cceeccCcCCccc------ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            9854332221100      00  0111 23334444444                                         


Q ss_pred             ---------hC-----CCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          467 ---------QD-----SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       467 ---------~~-----~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                               ++     ++..++|+|+.+.||+++.+.-+-|.||+++..
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                     22     223699999999999999988899999999865

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.88  E-value=0.0089  Score=62.71  Aligned_cols=73  Identities=16%  Similarity=0.184  Sum_probs=49.8

Q ss_pred             eeeecCccceEEEEeCCC-cEEEEEEecc-------cCccchHHHHHHHHHHHHhC--CC-ceeEEEEEEecCCcceEEE
Q 005933          357 KLGEGGFGPVYRGMLTEG-QEIAVKRLSK-------SSGQGVEEFKNEVLLIAKLQ--HR-NLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       357 ~lg~G~fg~Vy~g~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~lV~  425 (669)
                      .||.|....||++..++| +.|+||.-..       ...-..++..-|...|....  -| .+++++.  .+++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999998754 6899996421       12344566677888887663  34 3444443  3456677999


Q ss_pred             eecCCC
Q 005933          426 EYLPNK  431 (669)
Q Consensus       426 E~~~~g  431 (669)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.82  E-value=0.007  Score=62.01  Aligned_cols=31  Identities=26%  Similarity=0.528  Sum_probs=25.8

Q ss_pred             CCceeccCCCCCEEEcCCcc-eEEeecCCCcc
Q 005933          471 LRIIHRDLKASNVLLDNDMN-PKISDFGMARA  501 (669)
Q Consensus       471 ~~iiH~Dikp~NIll~~~~~-~kl~Dfgla~~  501 (669)
                      ..++|+|++|.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.69  E-value=0.0013  Score=52.41  Aligned_cols=53  Identities=21%  Similarity=0.395  Sum_probs=38.3

Q ss_pred             eeEeecccCCCCcccccccccCHHHHHHHhhhcCCcccccccccCCCCceEEEeecc
Q 005933          191 FLKRESVKLPDTSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHD  247 (669)
Q Consensus       191 f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~C~C~a~~~~~~~~~~~~c~~~~~~  247 (669)
                      |..+.++.++........ ..+.++|++.|+.+|+|.||.|..   +...|+++...
T Consensus         6 ~~~~~~~~~~g~d~~~~~-~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~   58 (73)
T cd01100           6 FRQGSNVDFRGGDLSTVF-ASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE   58 (73)
T ss_pred             ccccCCCccccCCcceee-cCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence            334456777665554332 568999999999999999999974   24569987653

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.67  E-value=0.026  Score=60.38  Aligned_cols=73  Identities=12%  Similarity=0.114  Sum_probs=51.9

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEeccc----C---ccchHHHHHHHHHHHHhC---CCceeEEEEEEecCCcceEE
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS----S---GQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV  424 (669)
                      .+.||.|....||+.... +..++||+-...    .   .....+-..|...|..+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            468899999999998864 567999976411    1   124445555677776663   247888888876  557889


Q ss_pred             EeecCC
Q 005933          425 YEYLPN  430 (669)
Q Consensus       425 ~E~~~~  430 (669)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.63  E-value=0.017  Score=60.88  Aligned_cols=141  Identities=15%  Similarity=0.239  Sum_probs=82.3

Q ss_pred             CeeeecCccceEEEEeCC----CcEEEEEEecccCccchHHHHHHHHHHHHhCCCcee-EEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-RLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      +.|..|-...+|+....+    +..|++|+.........+ -.+|..+++.+..-++. ++++++..  .  +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeCC--c--EeehhhcC
Confidence            556667777889887543    247999987654433323 36799999998755553 55666532  2  58999987


Q ss_pred             CCHHHH-----------------hhccC-C--CCCCCHHHHHHHHHHH----------------------HHHHHH----
Q 005933          431 KSLEQF-----------------IFDVT-R--TKFLDWSKRCQIIEGI----------------------ARGLLY----  464 (669)
Q Consensus       431 gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~i----------------------a~~L~y----  464 (669)
                      .+|..-                 ++... .  ..+--|..+.++..++                      ..-+..    
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            765321                 11111 0  0111233332222221                      111111    


Q ss_pred             HHh-CCCCCceeccCCCCCEEEcC-CcceEEeecCCCcc
Q 005933          465 LHQ-DSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARA  501 (669)
Q Consensus       465 LH~-~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~  501 (669)
                      +.. ..+..++|.|+.+.||++++ ++.++++||+.|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111 12235899999999999975 57899999998754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.50  E-value=0.0064  Score=59.66  Aligned_cols=123  Identities=19%  Similarity=0.226  Sum_probs=61.1

Q ss_pred             CcEEEEEEecccCccchHHHHHHHHHHHHhCCCce-eEEEEEEecCCcceEEEeecCCCCHHHH-------h--------
Q 005933          374 GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYLPNKSLEQF-------I--------  437 (669)
Q Consensus       374 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~~-------l--------  437 (669)
                      ++.|+||+...... ..-.-..|..+++.+...++ .++++++..    .+|+||+++.+|..-       +        
T Consensus         2 ~~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            46788888755533 33455788999988865444 456665533    367799977664321       0        


Q ss_pred             --hc--c--CCCCCCCHHHHHHH--------------------------HHHHHHHHHHHHhC-CCCCceeccCCCCCEE
Q 005933          438 --FD--V--TRTKFLDWSKRCQI--------------------------IEGIARGLLYLHQD-SRLRIIHRDLKASNVL  484 (669)
Q Consensus       438 --~~--~--~~~~~l~~~~~~~i--------------------------~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIl  484 (669)
                        +.  .  .....--|..+.++                          ...+......|-.. .+..++|+|+.|.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              00  0  01111112222221                          11111112222111 1235899999999999


Q ss_pred             E-cCCcceEEeecCCCcc
Q 005933          485 L-DNDMNPKISDFGMARA  501 (669)
Q Consensus       485 l-~~~~~~kl~Dfgla~~  501 (669)
                      + +.++.++|+||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8899999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.45  E-value=0.0088  Score=63.50  Aligned_cols=74  Identities=12%  Similarity=0.109  Sum_probs=52.0

Q ss_pred             cCeeeecCccceEEEEeCC-CcEEEEEEecc------cCccchHHHHHHHHHHHHhC--CC-ceeEEEEEEecCCcceEE
Q 005933          355 KNKLGEGGFGPVYRGMLTE-GQEIAVKRLSK------SSGQGVEEFKNEVLLIAKLQ--HR-NLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~lV  424 (669)
                      .+.||.|...-||++.+.+ ++.|+||.-..      ...-..++..-|.+.|+...  -| ++++++.+  +++...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3689999999999999853 67899996421      22345677778888888763  34 34455543  45667889


Q ss_pred             EeecCC
Q 005933          425 YEYLPN  430 (669)
Q Consensus       425 ~E~~~~  430 (669)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.41  E-value=0.023  Score=58.77  Aligned_cols=140  Identities=20%  Similarity=0.188  Sum_probs=94.3

Q ss_pred             ccCeeeecCccceEEEEeCCCcEEEEEEecccC-------c-------------------cchHHHHHHHHHHHHhCCCc
Q 005933          354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS-------G-------------------QGVEEFKNEVLLIAKLQHRN  407 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~-------~-------------------~~~~~~~~E~~~l~~l~h~n  407 (669)
                      +...|..|--+.||.+.-.+|..+|||+++...       .                   ...-....|++-|.+|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            446788888899999999999999999874210       0                   01112456888888886444


Q ss_pred             eeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC
Q 005933          408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN  487 (669)
Q Consensus       408 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~  487 (669)
                      |.-.--..  -...+|||+|+..-.-   -.-.-+...++...+..+-.+++.-|.-|.+.+  .+||.||+--|+|+. 
T Consensus       228 IP~PePIl--Lk~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  228 IPCPEPIL--LKNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCCCcee--eecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence            32111111  1234789999853221   111122334677778888889999999888887  499999999999985 


Q ss_pred             CcceEEeecCCCcc
Q 005933          488 DMNPKISDFGMARA  501 (669)
Q Consensus       488 ~~~~kl~Dfgla~~  501 (669)
                      +|.+.|+|-+-+..
T Consensus       300 dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVE  313 (520)
T ss_pred             CCEEEEEEcccccc
Confidence            46889999876544

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.83  E-value=0.14  Score=53.30  Aligned_cols=64  Identities=14%  Similarity=0.251  Sum_probs=40.0

Q ss_pred             ceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCC--ceeEEEEE------EecCCcceEEEeecCCCCH
Q 005933          365 PVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLLGC------CTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       365 ~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~------~~~~~~~~lV~E~~~~gsL  433 (669)
                      .||+....+| .+++|+....    ...+..|+..+..|...  .+++++..      ...++..++|+|+++|.++
T Consensus        11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~   82 (313)
T TIGR02906        11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC   82 (313)
T ss_pred             cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence            4888776545 6889987422    24456677777777432  34444432      2235567899999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.82  E-value=0.078  Score=55.34  Aligned_cols=32  Identities=25%  Similarity=0.313  Sum_probs=28.3

Q ss_pred             CCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       470 ~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      +..++|+|+.++||+++.++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44699999999999999999999999988754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.50  E-value=0.46  Score=49.96  Aligned_cols=94  Identities=14%  Similarity=0.110  Sum_probs=56.9

Q ss_pred             CCccHHHHHHHhcCCCcc---C-eeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCC--ceeEE
Q 005933          338 PMFDWNTIADATDNFSWK---N-KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRL  411 (669)
Q Consensus       338 ~~~~~~~l~~~~~~~~~~---~-~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l  411 (669)
                      +..+...+.++.+.+.+.   + ..=.+.-..||+....++..+++|+.+ .......+...|+..+..|...  .++..
T Consensus         9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r-~~~~~~~~i~~E~~~l~~L~~~gipv~~p   87 (325)
T PRK11768          9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYR-PERWSDAQILEEHAFALELAEAEIPVVAP   87 (325)
T ss_pred             CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcC-cccCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            345556666665555432   1 222345567999998888899999874 3233456777888888877421  22222


Q ss_pred             E---E--EEecCCcceEEEeecCCCC
Q 005933          412 L---G--CCTLRDERMLIYEYLPNKS  432 (669)
Q Consensus       412 ~---g--~~~~~~~~~lV~E~~~~gs  432 (669)
                      .   |  ....++..+.|+++++|..
T Consensus        88 ~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         88 LAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            1   1  1223455778999998764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.37  E-value=0.26  Score=48.04  Aligned_cols=75  Identities=20%  Similarity=0.281  Sum_probs=54.8

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhC---CCceeEEEEEEecCCcceEEEeecCCCC
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLIYEYLPNKS  432 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~E~~~~gs  432 (669)
                      +++..|..-..|..... ..++.||+-   .......|.+|+.-|..|.   --.+.+++.+-....+.+||+||++-+.
T Consensus        22 ~~v~gG~inea~~v~dg-~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRDG-TDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeecC-CcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            45555555555555543 577888864   2334567888988887774   3568888999999999999999999877


Q ss_pred             HH
Q 005933          433 LE  434 (669)
Q Consensus       433 L~  434 (669)
                      ++
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            66

>PTZ00384 choline kinase; Provisional

Probab=95.37  E-value=0.2  Score=53.72  Aligned_cols=74  Identities=18%  Similarity=0.330  Sum_probs=46.2

Q ss_pred             CeeeecCccceEEEEeCCC--cE-----EEEEEecccCccchHHHHHHHHHHHHhCCCcee-EEEEEEecCCcceEEEee
Q 005933          356 NKLGEGGFGPVYRGMLTEG--QE-----IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-RLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~  427 (669)
                      +.|..|-...+|+....++  ..     |.++.......... .-.+|+.+++.+...++. ++++.+.    -.+|+||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            4566688888999876543  22     44443322222222 236789999999765554 5566654    2699999


Q ss_pred             cCCCCHH
Q 005933          428 LPNKSLE  434 (669)
Q Consensus       428 ~~~gsL~  434 (669)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	669
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-55
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-53
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-40
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-37
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-23
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-22
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-22
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-22
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-22
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-21
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-20
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-20
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-20
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-20
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-20
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-18
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-18
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-18
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-18
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-18
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-18
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-18
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-18
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-18
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-18
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-18
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-18
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-18
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-17
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-17
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-17
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-17
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-17
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-17
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-17
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-14
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-14
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-13
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-11
3soa_A	444	Full-Length Human Camkii Length = 444		6e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  211 bits (538), Expect = 8e-55,   Method: Compositional matrix adjust.
 Identities = 129/325 (39%), Positives = 185/325 (56%), Gaps = 13/325 (4%)
Query: 307 RKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPV 366
           R+KK +D    V + E   +  G      +L  F    +  A+DNFS KN LG GGFG V
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLG------QLKRFSLRELQVASDNFSNKNILGRGGFGKV 54
Query: 367 YRGMLTEGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425
           Y+G L +G  +AVKRL +   QG E +F+ EV +I+   HRNL+RL G C    ER+L+Y
Sbjct: 55  YKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 114
Query: 426 EYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484
            Y+ N S+   + +   ++  LDW KR +I  G ARGL YLH     +IIHRD+KA+N+L
Sbjct: 115 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 174
Query: 485 LDNDMNPKISDFGMARAFGVDQTEANTDRVV-GTYGYMSPEYAIDGLFSVKSDVFSFGVL 543
           LD +    + DFG+A+   +D  + +    V GT G+++PEY   G  S K+DVF +GV+
Sbjct: 175 LDEEFEAVVGDFGLAKL--MDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 232
Query: 544 VLEIVCGKRNRGFYHADHHHNLLGHAWR--LWTEDRSLELIDKSLDGSYSLSEALRCIQV 601
           +LE++ G+R        +  +++   W   L  E +   L+D  L G+Y   E  + IQV
Sbjct: 233 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQV 292
Query: 602 GLLCVQQRPEDRPNMSSVVLMLSGE 626
            LLC Q  P +RP MS VV ML G+
Sbjct: 293 ALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  207 bits (526), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 120/296 (40%), Positives = 172/296 (58%), Gaps = 7/296 (2%)
Query: 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVE-EFK 394
           +L  F    +  A+DNF  KN LG GGFG VY+G L +G  +AVKRL +   QG E +F+
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 395 NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQ 453
            EV +I+   HRNL+RL G C    ER+L+Y Y+ N S+   + +   ++  LDW KR +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           I  G ARGL YLH     +IIHRD+KA+N+LLD +    + DFG+A+   +D  + +   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDXHVXX 193
Query: 514 VV-GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR- 571
            V G  G+++PEY   G  S K+DVF +GV++LE++ G+R        +  +++   W  
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 572 -LWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 626
            L  E +   L+D  L G+Y   E  + IQV LLC Q  P +RP MS VV ML G+
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  163 bits (413), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 103/290 (35%), Positives = 167/290 (57%), Gaps = 9/290 (3%)
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE 392
           E+  +P+ D   + +AT+NF  K  +G G FG VY+G+L +G ++A+KR +  S QG+EE
Sbjct: 25  ESYRVPLVD---LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKR 451
           F+ E+  ++  +H +LV L+G C  R+E +LIY+Y+ N +L++ ++     T  + W +R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
            +I  G ARGL YLH  +   IIHRD+K+ N+LLD +  PKI+DFG+++  G +  + + 
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHL 197
Query: 512 DRVV-GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 570
             VV GT GY+ PEY I G  + KSDV+SFGV++ E++C +            NL   A 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
                 +  +++D +L          +     + C+    EDRP+M  V+
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  163 bits (412), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 103/290 (35%), Positives = 167/290 (57%), Gaps = 9/290 (3%)
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE 392
           E+  +P+ D   + +AT+NF  K  +G G FG VY+G+L +G ++A+KR +  S QG+EE
Sbjct: 25  ESYRVPLVD---LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKR 451
           F+ E+  ++  +H +LV L+G C  R+E +LIY+Y+ N +L++ ++     T  + W +R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
            +I  G ARGL YLH  +   IIHRD+K+ N+LLD +  PKI+DFG+++  G +  + + 
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHL 197
Query: 512 DRVV-GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 570
             VV GT GY+ PEY I G  + KSDV+SFGV++ E++C +            NL   A 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
                 +  +++D +L          +     + C+    EDRP+M  V+
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (409), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 159/299 (53%), Gaps = 27/299 (9%)
Query: 340 FDWNTIADATDNFSWK------NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE- 392
           F +  + + T+NF  +      NK+GEGGFG VY+G +     +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 73
Query: 393 ---FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS 449
              F  E+ ++AK QH NLV LLG  +  D+  L+Y Y+PN SL   +  +  T  L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
            RC+I +G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA        
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN----L 565
              R+VGT  YM+PE A+ G  + KSD++SFGV++LEI+      G    D H      L
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT-----GLPAVDEHREPQLLL 244
Query: 566 LGHAWRLWTEDRSLELIDKSLDGSYSLS-EALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
                    E    + IDK ++ + S S EA+    V   C+ ++   RP++  V  +L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  161 bits (408), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 159/299 (53%), Gaps = 27/299 (9%)
Query: 340 FDWNTIADATDNFSWK------NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE- 392
           F +  + + T+NF  +      NK+GEGGFG VY+G +     +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 73
Query: 393 ---FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS 449
              F  E+ ++AK QH NLV LLG  +  D+  L+Y Y+PN SL   +  +  T  L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
            RC+I +G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA        
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN----L 565
              R+VGT  YM+PE A+ G  + KSD++SFGV++LEI+      G    D H      L
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT-----GLPAVDEHREPQLLL 244
Query: 566 LGHAWRLWTEDRSLELIDKSLDGSYSLS-EALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
                    E    + IDK ++ + S S EA+    V   C+ ++   RP++  V  +L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  161 bits (407), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 108/299 (36%), Positives = 159/299 (53%), Gaps = 27/299 (9%)
Query: 340 FDWNTIADATDNFSWK------NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE- 392
           F +  + + T+NF  +      NK+GEGGFG VY+G +     +AVK+L+       EE 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 67
Query: 393 ---FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS 449
              F  E+ ++AK QH NLV LLG  +  D+  L+Y Y+PN SL   +  +  T  L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
            RC+I +G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA        
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN----L 565
              R+VGT  YM+PE A+ G  + KSD++SFGV++LEI+      G    D H      L
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT-----GLPAVDEHREPQLLL 238
Query: 566 LGHAWRLWTEDRSLELIDKSLDGSYSLS-EALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
                    E    + IDK ++ + S S EA+    V   C+ ++   RP++  V  +L
Sbjct: 239 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM--YSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 107/299 (35%), Positives = 153/299 (51%), Gaps = 27/299 (9%)
Query: 340 FDWNTIADATDNFSWK------NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE- 392
           F +  + + T+NF  +      NK GEGGFG VY+G +     +AVK+L+       EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 64
Query: 393 ---FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS 449
              F  E+ + AK QH NLV LLG  +  D+  L+Y Y PN SL   +  +  T  L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
            RC+I +G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA        
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN----L 565
              R+VGT  Y +PE A+ G  + KSD++SFGV++LEI+      G    D H      L
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIIT-----GLPAVDEHREPQLLL 235
Query: 566 LGHAWRLWTEDRSLELIDKSLDGSYSLS-EALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
                    E    + IDK  + + S S EA     V   C+ ++   RP++  V  +L
Sbjct: 236 DIKEEIEDEEKTIEDYIDKKXNDADSTSVEAX--YSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 122/240 (50%), Gaps = 16/240 (6%)
Query: 318 VGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI 377
           + ++E  Y       ++M++P  D N           K K+G G FG V+R     G ++
Sbjct: 15  IPTTENLYFQGAMDGDDMDIPWCDLNI----------KEKIGAGSFGTVHRAEW-HGSDV 63
Query: 378 AVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ 435
           AVK L +     + V EF  EV ++ +L+H N+V  +G  T      ++ EYL   SL +
Sbjct: 64  AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 436 FIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD 495
            +      + LD  +R  +   +A+G+ YLH +    I+HR+LK+ N+L+D     K+ D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG 555
           FG++R      T  ++    GT  +M+PE   D   + KSDV+SFGV++ E+   ++  G
Sbjct: 183 FGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 120/240 (50%), Gaps = 16/240 (6%)
Query: 318 VGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI 377
           + ++E  Y       ++M++P  D N           K K+G G FG V+R     G ++
Sbjct: 15  IPTTENLYFQGAMDGDDMDIPWCDLNI----------KEKIGAGSFGTVHRAEW-HGSDV 63
Query: 378 AVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ 435
           AVK L +     + V EF  EV ++ +L+H N+V  +G  T      ++ EYL   SL +
Sbjct: 64  AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 436 FIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD 495
            +      + LD  +R  +   +A+G+ YLH +    I+HRDLK+ N+L+D     K+ D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCD 182
Query: 496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG 555
           FG++R          +    GT  +M+PE   D   + KSDV+SFGV++ E+   ++  G
Sbjct: 183 FGLSRLKA--SXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 87  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 141
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAINYGTFTIKSD 200
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 201 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 245
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 246 --ELYQLMRLCWKERPEDRPTF 265

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 88  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 142
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAINYGTFTIKSD 201
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 202 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 246
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 247 --ELYQLMRLCWKERPEDRPTF 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 85  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 199 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 243
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 244 --ELYQLMRLCWKERPEDRPTF 263

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 79  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 237
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 238 --ELYQLMRLCWKERPEDRPTF 257

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 79  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 237
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 238 --ELYQLMRLCWKERPEDRPTF 257

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 81  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 135
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAINYGTFTIKSD 194
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 195 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 239
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 240 --ELYQLMRLCWKERPEDRPTF 259

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 84  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 138
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSD 197
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 198 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 242
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 243 --ELYQLMRLCWKERPEDRPTF 262

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 36/267 (13%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 417 LRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
            ++   +I EY+ N SL  F+       +T  K LD + +      IA G+ ++ + +  
Sbjct: 85  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 135
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
             IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTF 193
Query: 532 SVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS 589
           ++KSDV+SFG+L+ EIV   R    G  + +   N L   +R+   D   E         
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE--------- 243
Query: 590 YSLSEALRCIQVGLLCVQQRPEDRPNM 616
                     Q+  LC ++RPEDRP  
Sbjct: 244 -------ELYQLMRLCWKERPEDRPTF 263

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 80  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 134
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 194 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 238
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 239 --ELYQLMRLCWKERPEDRPTF 258

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 79  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 237
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 238 --ELYQLMRLCWKERPEDRPTF 257

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 89  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 143
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 203 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 247
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 248 --ELYQLMRLCWKERPEDRPTF 267

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 36/267 (13%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 417 LRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
            ++   +I EY+ N SL  F+       +T  K LD + +      IA G+ ++ + +  
Sbjct: 74  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 124
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
             IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F
Sbjct: 125 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTF 182
Query: 532 SVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS 589
           ++KSDV+SFG+L+ EIV   R    G  + +   N L   +R+   D   E         
Sbjct: 183 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE--------- 232
Query: 590 YSLSEALRCIQVGLLCVQQRPEDRPNM 616
                     Q+  LC ++RPEDRP  
Sbjct: 233 -------ELYQLMRLCWKERPEDRPTF 252

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 125/266 (46%), Gaps = 38/266 (14%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            +LG G FG V+ G      ++AVK L K     V+ F  E  L+  LQH  LVRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 416 TLRDERMLIYEYLPNKSLEQFIFD-----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           T  +   +I EY+   SL  F+       V   K +D+S +      IA G+ Y+    R
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---R 128
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
              IHRDL+A+NVL+   +  KI+DFG+AR    ++  A  +       + +PE    G 
Sbjct: 129 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGC 187
Query: 531 FSVKSDVFSFGVLVLEIVC-------GKRNRGFYHA--------------DHHHNLLGHA 569
           F++KSDV+SFG+L+ EIV        G+ N     A              D  ++++   
Sbjct: 188 FTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMC 247
Query: 570 WRLWTEDR-SLELIDKSLDGSYSLSE 594
           W+   E+R + + +   LD  Y+ +E
Sbjct: 248 WKEKAEERPTFDYLQSVLDDFYTATE 273

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 115/201 (57%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQ----EIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+     +A+K L++++G     EF +E L++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     L+ + +P+  L +++ +    +     L+W  +      IA+G++YL +
Sbjct: 106 LGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HRDL A NVL+ +  + KI+DFG+AR    D+ E N D       +M+ E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
              F+ +SDV+S+GV + E++
Sbjct: 216 YRKFTHQSDVWSYGVTIWELM 236

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 75  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           +L+A+N+L+ + ++ KI+DFG+AR    ++  A  +       + +PE    G F++KSD
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSD 188
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 189 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 233
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 234 --ELYQLMRLCWKERPEDRPTF 253

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 125/266 (46%), Gaps = 38/266 (14%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            KLG G FG V+ G      ++AVK L K     V+ F  E  L+  LQH  LVRL    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 416 TLRDERMLIYEYLPNKSLEQFIFD-----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           T  +   +I E++   SL  F+       V   K +D+S +      IA G+ Y+    R
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---R 127
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
              IHRDL+A+NVL+   +  KI+DFG+AR    ++  A  +       + +PE    G 
Sbjct: 128 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGC 186
Query: 531 FSVKSDVFSFGVLVLEIVC-------GKRNRGFYHA--------------DHHHNLLGHA 569
           F++KS+V+SFG+L+ EIV        G+ N     A              D  ++++   
Sbjct: 187 FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYDIMKMC 246
Query: 570 WRLWTEDR-SLELIDKSLDGSYSLSE 594
           W+   E+R + + +   LD  Y+ +E
Sbjct: 247 WKEKAEERPTFDYLQSVLDDFYTATE 272

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 115/201 (57%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQ----EIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+     +A+K L++++G     EF +E L++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     L+ + +P+  L +++ +    +     L+W  +      IA+G++YL +
Sbjct: 83  LGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HRDL A NVL+ +  + KI+DFG+AR    D+ E N D       +M+ E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
              F+ +SDV+S+GV + E++
Sbjct: 193 YRKFTHQSDVWSYGVTIWELM 213

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 108/208 (51%), Gaps = 25/208 (12%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRL----SKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           +G GGFG VYR     G E+AVK       +   Q +E  + E  L A L+H N++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
            C       L+ E+     L + +    +     ++W+ +      IARG+ YLH ++ +
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIV 127
Query: 472 RIIHRDLKASNVLL-----DNDMNP---KISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
            IIHRDLK+SN+L+     + D++    KI+DFG+AR +             G Y +M+P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAAGAYAWMAP 183
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +FS  SDV+S+GVL+ E++ G+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 128/262 (48%), Gaps = 26/262 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G  G V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    T
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +    IHR
Sbjct: 79  -QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+ + ++ KI+DFG+AR    D      +       + +PE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 537 VFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSE 594
           V+SFG+L+ EIV   R    G  + +   N L   +R+   D   E              
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPE-------------- 237
Query: 595 ALRCIQVGLLCVQQRPEDRPNM 616
                Q+  LC ++RPEDRP  
Sbjct: 238 --ELYQLMRLCWKERPEDRPTF 257

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 125/252 (49%), Gaps = 36/252 (14%)
Query: 335 MELPMFDWNTIAD----ATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLS- 383
           ME+P+ + +  A     +     +  +LGE  FG VY+G L       + Q +A+K L  
Sbjct: 7   MEMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 384 KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----- 438
           K+ G   EEF++E +L A+LQH N+V LLG  T      +I+ Y  +  L +F+      
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 439 --------DVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN 490
                   D T    L+      ++  IA G+ YL   S   ++H+DL   NVL+ + +N
Sbjct: 127 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLN 183
Query: 491 PKISDFGMAR-AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV- 548
            KISD G+ R  +  D  +   + ++    +M+PE  + G FS+ SD++S+GV++ E+  
Sbjct: 184 VKISDLGLFREVYAADYYKLLGNSLLPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
Query: 549 ------CGKRNR 554
                 CG  N+
Sbjct: 243 YGLQPYCGYSNQ 254

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 23/207 (11%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CTL     ++ EY+P  +L            LD+ + C   E  A  LLY+    
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNL------------LDYLRECNREEVTAVVLLYMATQI 139
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 140 SSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 198
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           +PE      FS+KSDV++FGVL+ EI 
Sbjct: 199 APESLAYNTFSIKSDVWAFGVLLWEIA 225

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 74  -EEPIXIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 187
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 188 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 247
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 248 ERPTFEYLQAFLEDYFTSTE 267

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 77  -EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 190
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 191 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 250
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 251 ERPTFEYLQAFLEDYFTSTE 270

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 115/226 (50%), Gaps = 32/226 (14%)
Query: 357 KLGEGGFGPVYRGML------TEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +LGE  FG VY+G L       + Q +A+K L  K+ G   EEF++E +L A+LQH N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQIIE 456
            LLG  T      +I+ Y  +  L +F+              D T    L+      ++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR-AFGVDQTEANTDRVV 515
            IA G+ YL   S   ++H+DL   NVL+ + +N KISD G+ R  +  D  +   + ++
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV-------CGKRNR 554
               +M+PE  + G FS+ SD++S+GV++ E+        CG  N+
Sbjct: 193 PI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 333 -EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 446
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 506
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 507 ERPTFEYLQAFLEDYFTSTE 526

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 -EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 363
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 423
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 424 ERPTFEYLQAFLEDYFTSTE 443

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 -EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 363
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 423
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 424 ERPTFEYLQAFLEDYFTSTE 443

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 74  QLLGVCTREPPFYIIIEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 121
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 122 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWT 180
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 233
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 234 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 263

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 78  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 125
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 126 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWT 184
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 237
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 238 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 78  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVSAVVLLYMATQI 125
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 126 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 184
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 237
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 238 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 267

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 81  -EEPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 194
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 254
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 255 ERPTFEYLQAFLEDYFTSTE 274

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 78  QLLGVCTREPPFYIIIEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 125
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 126 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 184
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 237
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 238 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 73  QLLGVCTREPPFYIIIEFM------------TYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 179
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 232
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 233 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 262

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 135/281 (48%), Gaps = 23/281 (8%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           +LG G FG V+ G      ++A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+ D    + L       +   +A G+ Y+    R+  IHR
Sbjct: 75  -EEPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+++N+L+ N +  KI+DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 188
Query: 537 VFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEAL 596
           V+SFG+L+ E+V   + R  Y   ++  +L    R +        +    D   SL E +
Sbjct: 189 VWSFGILLTELVT--KGRVPYPGMNNREVLEQVERGYR-------MPCPQDCPISLHELM 239
Query: 597 RCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK-QPG 636
                 + C ++ PE+RP    +   L    +  +P+ QPG
Sbjct: 240 ------IHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 77  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 124
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 183
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 236
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 237 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 266

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 -EEPIYIVGEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 363
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 423
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 424 ERPTFEYLQAFLEDYFTSTE 443

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 78  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 125
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 126 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 184
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 237
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 238 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 267

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 81  -EEPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKSD 194
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 254
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 255 ERPTFEYLQAFLEDYFTSTE 274

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 73  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 179
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 232
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 233 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 73  QLLGVCTREPPFYIIIEFM------------TYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 179
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 232
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 233 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 262

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 73  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 120
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 179
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 232
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 233 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 73  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 179
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 232
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 233 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 78  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 125
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 126 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 184
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 237
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 238 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 73  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 120
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 179
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 232
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 233 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 75  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 122
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 123 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 181
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 234
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 235 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 75  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 122
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 123 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 181
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 234
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 235 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 85
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 86  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 133
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 134 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 192
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 193 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 245
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 246 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 275

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++ N+V  L    + DE  ++ EYL   SL     DV     +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHRD+K+ N+LL  D + K++DFG       +Q++ +T  +VGT  +M+
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  -EEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 257
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 258 ERPTFEYLQAFLEDYFTSTE 277

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 74  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 121
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A          + 
Sbjct: 122 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWT 180
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 233
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 234 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 263

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 75  -EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 188
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 189 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 248
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 249 ERPTFEYLQAFLEDYFTSTE 268

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 73  -EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 186
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 187 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 246
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 247 ERPTFEYLQAFLEDYFTSTE 266

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G FG VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 71  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 119 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWT 177
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  +     + L  +D  +E
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDPSQVYELLEKDYRME 230
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 231 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 260

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  -EEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 197
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 257
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 258 ERPTFEYLQAFLEDYFTSTE 277

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  -EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 257
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 258 ERPTFEYLQAFLEDYFTSTE 277

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 75  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 122
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A          + 
Sbjct: 123 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWT 181
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 234
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 235 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 264

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  -EEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 257
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 258 ERPTFEYLQAFLEDYFTSTE 277

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 71  QLLGVCTREPPFYIIIEFM------------TYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 119 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWT 177
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  +     + L  +D  +E
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDPSQVYELLEKDYRME 230
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 231 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 260

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 132/273 (48%), Gaps = 39/273 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           ++   + KLG G FG V+     +  ++AVK + K     VE F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-----FLDWSKRCQIIEGIARGLLY 464
           +L    T ++   +I E++   SL  F+     +K      +D+S +      IA G+ +
Sbjct: 247 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 299
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           + Q +    IHRDL+A+N+L+   +  KI+DFG+AR    ++  A  +       + +PE
Sbjct: 300 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPE 355
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHH 563
               G F++KSDV+SFG+L++EIV   R                RG+         +  +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 415
Query: 564 NLLGHAWRLWTEDR-SLELIDKSLDGSYSLSEA 595
           N++   W+   E+R + E I   LD  Y+ +E+
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 73
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGME 131
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYEL 213

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 280 QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVSAVVLLYMATQI 327
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHR+L A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 386
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 439
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 440 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 469

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 125/260 (48%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ K++H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  -EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 257
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 258 ERPTFEYLQAFLEDYFTSTE 277

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 124/260 (47%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  -EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 257
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 258 ERPTFEYLQAFLEDYFTSTE 277

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++ N+V  L    + DE  ++ EYL   SL     DV     +D  +   +     + L
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 130
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHR++K+ N+LL  D + K++DFG       +Q++ +T  +VGT  +M+
Sbjct: 131 EFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 185
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E++ G+
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 73
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 131
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYEL 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 111/209 (53%), Gaps = 10/209 (4%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++ N+V  L    + DE  ++ EYL   SL     DV     +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHRD+K+ N+LL  D + K++DFG       +Q++ +   +VGT  +M+
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--EMVGTPYWMA 184
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 15  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 74
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 132
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 133 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYEL 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 42  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 159
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYEL 241

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 128
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYEL 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 9   HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 68
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 126
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 127 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYEL 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +   + TKF +  K   I    ARG+ YLH  S   IIH
Sbjct: 78  T-KPQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 131
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY---AIDGLFS 532
           RDLK++N+ L  D   KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 192 FQSDVYAFGIVLYELMTGQ 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 16  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 75
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 76  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 133
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 134 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 191 PESLTESKFSVASDVWSFGVVLYEL 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 10  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 69
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 127
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 128 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYEL 209

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 17  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 76
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 134
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 135 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYEL 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 128
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYEL 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 18  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 77
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 78  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 135
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 136 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 193 PESLTESKFSVASDVWSFGVVLYEL 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 111/209 (53%), Gaps = 10/209 (4%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++ N+V  L    + DE  ++ EYL   SL     DV     +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHRD+K+ N+LL  D + K++DFG       +Q++ +   +VGT  +M+
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMA 184
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 13/219 (5%)
Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVE 391
           +P    N       +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 74
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWS 449
           +F+ E+ ++  LQH N+V+  G C     R   LI EYLP  SL  ++      + +D  
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHI 132
Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
           K  Q    I +G+ YL      R IHRDL   N+L++N+   KI DFG+ +    D+   
Sbjct: 133 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 189
Query: 510 NTDRV-VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                      + +PE   +  FSV SDV+SFGV++ E+
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 319 QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVNAVVLLYMATQI 366
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHR+L A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 367 SSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWT 425
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  + L   + L  +D  +E
Sbjct: 426 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDLSQVYELLEKDYRME 478
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 479 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 508

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 124/260 (47%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 251 -EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+ R    ++  A          + +PE A+ G F++KSD
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 364
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 365 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 424
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 425 ERPTFEYLQAFLEDYFTSTE 444

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 13/219 (5%)
Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVE 391
           +P    N       +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 74
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWS 449
           +F+ E+ ++  LQH N+V+  G C     R   LI EYLP  SL  ++      + +D  
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHI 132
Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
           K  Q    I +G+ YL      R IHRDL   N+L++N+   KI DFG+ +    D+   
Sbjct: 133 KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 189
Query: 510 NTDRV-VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                      + +PE   +  FSV SDV+SFGV++ E+
Sbjct: 190 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 138/280 (49%), Gaps = 41/280 (14%)
Query: 358 LGEGGFGPVYRGML--TEGQE---IAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRL 411
           +G G FG VY+GML  + G++   +A+K L     +    +F  E  ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS--KRCQIIEGIARGLLYLHQDS 469
            G  +     M+I EY+ N +L++F+    R K  ++S  +   ++ GIA G+ YL   +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGMLRGIAAGMKYL---A 164
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG--YMSPEYAI 527
            +  +HRDL A N+L+++++  K+SDFG++R    D  EA      G     + +PE   
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD 587
              F+  SDV+SFG+++ E++     R ++   +H                   + K+++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT-YGERPYWELSNHE------------------VMKAIN 264
Query: 588 GSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
             + L   + C     Q+ + C QQ    RP  + +V +L
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 111/209 (53%), Gaps = 10/209 (4%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  M +  GQE+A+++++       E   NE+L++ +
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++ N+V  L    + DE  ++ EYL   SL     DV     +D  +   +     + L
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 130
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHRD+K+ N+LL  D + K++DFG       +Q++ +   +VGT  +M+
Sbjct: 131 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMA 185
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E++ G+
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 124/260 (47%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+    L  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  -EEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 257
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 258 ERPTFEYLQAFLEDYFTSTE 277

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 11/211 (5%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKSS---GQGVEEFKNEVLLI 400
           I +  ++F   N LG+G F  VYR   +  G E+A+K + K +      V+  +NEV + 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
            +L+H +++ L       +   L+ E   N  + +++ +  R K    ++    +  I  
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIIT 123
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           G+LYLH      I+HRDL  SN+LL  +MN KI+DFG+A    +   +  T  + GT  Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +SPE A      ++SDV+S G +   ++ G+
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 124/260 (47%), Gaps = 29/260 (11%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
             +   ++ EY+    L  F+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  -EEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSD 536
           DL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 197
Query: 537 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWTE 575
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 257
Query: 576 DR-SLELIDKSLDGSYSLSE 594
           +R + E +   L+  ++ +E
Sbjct: 258 ERPTFEYLQAFLEDYFTSTE 277

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
           +LLG CT      +I E++            T    LD+ + C   E  A  LLY+    
Sbjct: 71  QLLGVCTREPPFYIITEFM------------TYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 469 -------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
                   +   IHRDL A N L+  +   K++DFG++R    D   A+         + 
Sbjct: 119 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWT 177
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWTEDRSLE 580
           +PE      FS+KSDV++FGVL+ EI         Y    +  +     + L  +D  +E
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIAT-------YGMSPYPGIDPSQVYELLEKDYRME 230
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +   +  Y L  A         C Q  P DRP+ + +
Sbjct: 231 RPEGCPEKVYELMRA---------CWQWNPSDRPSFAEI 260

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +   + TKF +  K   I    ARG+ YLH  S   IIH
Sbjct: 90  T-KPQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE---YAIDGLFS 532
           RDLK++N+ L  D   KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 204 FQSDVYAFGIVLYELMTGQ 222

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 79  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 76  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 129
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 190 FQSDVYAFGIVLYELMTGQ 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 79  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 74  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 357 KLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 412 LGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
            G C     R   LI E+LP  SL +++      + +D  K  Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMSPEYAID 528
             R IHRDL   N+L++N+   KI DFG+ +    D+              + +PE   +
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 529 GLFSVKSDVFSFGVLVLEI 547
             FSV SDV+SFGV++ E+
Sbjct: 195 SKFSVASDVWSFGVVLYEL 213

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 40/279 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           ++   + KLG G FG V+     +  ++AVK + K     VE F  E  ++  LQH  LV
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 73
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGIARGLLY 464
           +L    T ++   +I E++   SL  F+           K +D+S +      IA G+ +
Sbjct: 74  KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 126
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           + Q +    IHRDL+A+N+L+   +  KI+DFG+AR    ++  A  +       + +PE
Sbjct: 127 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPE 182
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
               G F++KSDV+SFG+L++EIV     R  Y    +  ++                 +
Sbjct: 183 AINFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVI-----------------R 223
Query: 585 SLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSV 619
           +L+  Y +     C +    + + C + RPE+RP    +
Sbjct: 224 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYI 262

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 101 T-KPQLAIVTQWCEGSSLYHHLH-IIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 154
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 215 FQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLH-IIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 216 FQSDVYAFGIVLYELMTGQ 234

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 94  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 147
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 207
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 208 FQSDVYAFGIVLYELMTGQ 226

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 74  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 43  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG+AR    D   A T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 258
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T + +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLH-IIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 216 FQSDVYAFGIVLYELMTGQ 234

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T   +  ++ ++    SL   +   + TKF +  K   I    ARG+ YLH  S   IIH
Sbjct: 90  TA-PQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY---AIDGLFS 532
           RDLK++N+ L  D   KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 204 FQSDVYAFGIVLYELMTGQ 222

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 128
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHRDL   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYEL 210

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T   +  ++ ++    SL   +  +  TKF +  K   I    A+G+ YLH  S   IIH
Sbjct: 74  T-APQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFS 532
           RDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 533 VKSDVFSFGVLVLEIVCGK 551
            +SDV++FG+++ E++ G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 43  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 158 SGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 258
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 41  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 99
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 100 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 155
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 156 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 212
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 256
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 257 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 130/276 (47%), Gaps = 55/276 (19%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           ++   + KLG G FG V+     +  ++AVK + K     VE F  E  ++  LQH  LV
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 240
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-----FLDWSKRCQIIEGIARGLLY 464
           +L    T ++   +I E++   SL  F+     +K      +D+S +      IA G+ +
Sbjct: 241 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 293
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA---FGVDQTEANTDRVVGTYGYM 521
           + Q +    IHRDL+A+N+L+   +  KI+DFG+AR    F +  T              
Sbjct: 294 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT-------------- 336
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------AD 560
           +PE    G F++KSDV+SFG+L++EIV   R                RG+         +
Sbjct: 337 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 396
Query: 561 HHHNLLGHAWRLWTEDR-SLELIDKSLDGSYSLSEA 595
             +N++   W+   E+R + E I   LD  Y+ +E+
Sbjct: 397 ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 432

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 43  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 258
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 43  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 258
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 43  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 258
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  +  +LG+G FG V    Y  +    G+ +AVK+L  S+ + + +F+ E+ ++  LQH
Sbjct: 12  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 71
Query: 406 RNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            N+V+  G C     R   LI EYLP  SL  ++      + +D  K  Q    I +G+ 
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 129
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMS 522
           YL      R IHR+L   N+L++N+   KI DFG+ +    D+              + +
Sbjct: 130 YL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEI 547
           PE   +  FSV SDV+SFGV++ E+
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYEL 211

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 43  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 258
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 14  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 128
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 229
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 230 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 127/231 (54%), Gaps = 27/231 (11%)
Query: 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQG----- 389
           E P     T+AD  +   ++ ++G+GGFG V++G L + + + A+K L     +G     
Sbjct: 7   EFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 390 --VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
              +EF+ EV +++ L H N+V+L G   + +   ++ E++P   L   + D  +   + 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLD--KAHPIK 120
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMN----PKISDFGMARAF 502
           WS + +++  IA G+ Y+ Q+    I+HRDL++ N+ L + D N     K++DFG+++  
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 503 GVDQTEANTDRVVGTYGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIVCGK 551
              Q+  +   ++G + +M+PE   A +  ++ K+D +SF +++  I+ G+
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 136/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 31  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 89
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 90  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 145
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 146 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD- 246
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 247 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G   L   +EI+V   +   G   +   +F  E  ++ 
Sbjct: 43  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ EY+ N SL+ F+   D   T      +   ++ GIA
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG+ R    D   A T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 258
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 355 KNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           K +LGEG FG V+      +L E  +  +AVK L ++S    ++F+ E  L+  LQH+++
Sbjct: 17  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 76
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQII 455
           VR  G CT     ++++EY+ +  L +F+              DV     L   +   + 
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAVA 135
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
             +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R            R +
Sbjct: 136 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
               +M PE  +   F+ +SDV+SFGV++ EI
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEI 224

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 355 KNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           K +LGEG FG V+      +L E  +  +AVK L ++S    ++F+ E  L+  LQH+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQII 455
           VR  G CT     ++++EY+ +  L +F+              DV     L   +   + 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAVA 164
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
             +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R            R +
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
               +M PE  +   F+ +SDV+SFGV++ EI
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 126/231 (54%), Gaps = 27/231 (11%)
Query: 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQG----- 389
           E P     T+AD  +   ++ ++G+GGFG V++G L + + + A+K L     +G     
Sbjct: 7   EFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 390 --VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
              +EF+ EV +++ L H N+V+L G   + +   ++ E++P   L   + D  +   + 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLD--KAHPIK 120
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMN----PKISDFGMARAF 502
           WS + +++  IA G+ Y+ Q+    I+HRDL++ N+ L + D N     K++DFG ++  
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-- 177
Query: 503 GVDQTEANTDRVVGTYGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIVCGK 551
              Q+  +   ++G + +M+PE   A +  ++ K+D +SF +++  I+ G+
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 355 KNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           K +LGEG FG V+      +L E  +  +AVK L ++S    ++F+ E  L+  LQH+++
Sbjct: 23  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 82
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFLDWSKRCQII 455
           VR  G CT     ++++EY+ +  L +F+              DV     L   +   + 
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAVA 141
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
             +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R            R +
Sbjct: 142 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
               +M PE  +   F+ +SDV+SFGV++ EI
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEI 230

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            ++G G FG VY+G       + + ++   + +  + F+NEV ++ K +H N++  +G  
Sbjct: 42  TRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T +D   ++ ++    SL + +  V  TKF    +   I    A+G+ YLH  +   IIH
Sbjct: 102 T-KDNLAIVTQWCEGSSLYKHL-HVQETKF-QMFQLIDIARQTAQGMDYLHAKN---IIH 155
Query: 476 RDLKASNVLLDNDMNPKISDFGMA----RAFGVDQTEANTDRVVGTYGYMSPEYAI---D 528
           RD+K++N+ L   +  KI DFG+A    R  G  Q E  T    G+  +M+PE      +
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT----GSVLWMAPEVIRMQDN 211
Query: 529 GLFSVKSDVFSFGVLVLEIVCGK 551
             FS +SDV+S+G+++ E++ G+
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGE 234

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 112/198 (56%), Gaps = 11/198 (5%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLGC 414
           K+GEG +G VY+   ++G+ +A+KR+   +  +G+      E+ L+ +L H N+V L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
                   L++E++  K L++ + D  +T   D   +  + + + RG+ + HQ    RI+
Sbjct: 88  IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RIL 141
Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-DGLFSV 533
           HRDLK  N+L+++D   K++DFG+ARAFG+    + T  VV T  Y +P+  +    +S 
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLMGSKKYST 199
Query: 534 KSDVFSFGVLVLEIVCGK 551
             D++S G +  E++ GK
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 112/198 (56%), Gaps = 11/198 (5%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLGC 414
           K+GEG +G VY+   ++G+ +A+KR+   +  +G+      E+ L+ +L H N+V L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
                   L++E++  K L++ + D  +T   D   +  + + + RG+ + HQ    RI+
Sbjct: 88  IHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RIL 141
Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-DGLFSV 533
           HRDLK  N+L+++D   K++DFG+ARAFG+    + T  VV T  Y +P+  +    +S 
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPDVLMGSKKYST 199
Query: 534 KSDVFSFGVLVLEIVCGK 551
             D++S G +  E++ GK
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 126/231 (54%), Gaps = 27/231 (11%)
Query: 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQG----- 389
           E P     T+AD  +   ++ ++G+GGFG V++G L + + + A+K L     +G     
Sbjct: 7   EFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 390 --VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
              +EF+ EV +++ L H N+V+L G   + +   ++ E++P   L   + D  +   + 
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLD--KAHPIK 120
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMN----PKISDFGMARAF 502
           WS + +++  IA G+ Y+ Q+    I+HRDL++ N+ L + D N     K++DF +++  
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-- 177
Query: 503 GVDQTEANTDRVVGTYGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIVCGK 551
              Q+  +   ++G + +M+PE   A +  ++ K+D +SF +++  I+ G+
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 131/291 (45%), Gaps = 35/291 (12%)
Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSK---SSGQGVEEF 393
           P   +NT+A    NF  + K+G G F  VYR   L +G  +A+K++        +   + 
Sbjct: 24  PDMGYNTLA----NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC 79
Query: 394 KNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD-----W 448
             E+ L+ +L H N+++        +E  ++ E      L + I    + K L      W
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 449 SKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
               Q+   +       H  SR R++HRD+K +NV +      K+ D G+ R F    T 
Sbjct: 140 KYFVQLCSALE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 192
Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           A++  +VGT  YMSPE   +  ++ KSD++S G L+ E+        FY         G 
Sbjct: 193 AHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFY---------GD 239
Query: 569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
              L++  + +E  D     S   SE LR  Q+  +C+   PE RP+++ V
Sbjct: 240 KMNLYSLCKKIEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYV 288

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 30/279 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
             ++  ++G G FG V+ G      ++A+K + +      E+F  E  ++ KL H  LV+
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G C  +    L++E++ +  L  ++   T+           +   +  G+ YL + S 
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS- 123
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
             +IHRDL A N L+  +   K+SDFGM R    DQ  ++T        + SPE      
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 180
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY 590
           +S KSDV+SFGVL+ E+     + G               ++  E+RS   + + +   +
Sbjct: 181 YSSKSDVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGF 221
Query: 591 SLSE----ALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 625
            L +    +    Q+   C ++RPEDRP  S ++  L+ 
Sbjct: 222 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAA 260

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 27/217 (12%)
Query: 351 NFSWKNKLGEGGFGPVYRG----MLTEGQEI--AVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
           N   K +LGEG FG V+      +  E  +I  AVK L  +S    ++F  E  L+  LQ
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI----------FDVTRTKFLDWSKRCQI 454
           H ++V+  G C   D  ++++EY+ +  L +F+           +      L  S+   I
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
            + IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +  RV
Sbjct: 134 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 186
Query: 515 VG----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            G       +M PE  +   F+ +SDV+S GV++ EI
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 92/326 (28%), Positives = 151/326 (46%), Gaps = 55/326 (16%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD--------WSKRC 452
            +    ++VRLLG  +     ++I E +    L+ ++  + R    +         SK  
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVLAPPSLSKMI 141
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
           Q+   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 194
Query: 513 RVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           R  G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L  
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL-- 250
Query: 569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 628
             R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S
Sbjct: 251 --RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SS 293
Query: 629 LPQPKQPGF------FTERN-LPESE 647
           + +  +PGF      ++E N LPE E
Sbjct: 294 IKEEMEPGFREVSFYYSEENKLPEPE 319

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 92/325 (28%), Positives = 151/325 (46%), Gaps = 53/325 (16%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  R
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 195
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 250
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 251 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 294
Query: 630 PQPKQPGF------FTERN-LPESE 647
            +  +PGF      ++E N LPE E
Sbjct: 295 KEEMEPGFREVSFYYSEENKLPEPE 319

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 85  LGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 136
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 137 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 87  LGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 138
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 139 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 197 HRIYTHQSDVWSYGVTVWELM 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 84  LGIC-LTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 135
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 136 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 194 HRIYTHQSDVWSYGVTVWELM 214

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 84  LGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 135
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 136 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 194 HRIYTHQSDVWSYGVTVWELM 214

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 43  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ E + N SL+ F+   D   T      +   ++ GIA
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 258
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 89  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 140
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 141 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 199 HRIYTHQSDVWSYGVTVWELM 219

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 86  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 137
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 138 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELM 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 134
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 135 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 86  LGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 137
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 138 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELM 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 43  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ E + N SL+ F+   D   T      +   ++ GIA
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 158 SGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------------WEMSNQD- 258
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 83  LGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 134
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 135 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 85  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 136
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 137 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 83  LGIC-LTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 134
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 135 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 86  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 137
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 138 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELM 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 134
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 135 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSSG---QGVEEFKNEVLLIA 401
           DAT N S    +G G FG V  G L     +EI+V   +   G   +   +F  E  ++ 
Sbjct: 14  DAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIA 459
           +  H N++RL G  T     M++ E + N SL+ F+   D   T      +   ++ GIA
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI----QLVGMLRGIA 128
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-Y 518
            G+ YL   S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR 577
            + SPE      F+  SDV+S+G+++ E++  G+R                 W +  +D 
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER---------------PYWEMSNQD- 229
Query: 578 SLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
               + K++D  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 230 ----VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 90  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 141
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 142 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELM 220

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 86  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 137
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 138 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELM 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 93  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 144
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 145 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 203 HRIYTHQSDVWSYGVTVWELM 223

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 77  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 128
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 129 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 187 HRIYTHQSDVWSYGVTVWELM 207

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  R
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXR 189
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 244
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 245 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 288
Query: 630 PQPKQPGF 637
            +  +PGF
Sbjct: 289 KEEMEPGF 296

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 113/201 (56%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 108 LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 159
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 160 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 218 HRIYTHQSDVWSYGVTVWELM 238

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  R
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXR 180
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 235
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 236 -RFVMEGG---LLDKPDNCPDMLLELMR------MCWQYNPKMRPSFLEII------SSI 279
Query: 630 PQPKQPGF 637
            +  +PGF
Sbjct: 280 KEEMEPGF 287

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 142/314 (45%), Gaps = 64/314 (20%)
Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEG---QEIAVKRLSK-SSGQGVEEF 393
           P+ DWN I        +++ +GEG FG V +  + +     + A+KR+ + +S     +F
Sbjct: 10  PVLDWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 62
Query: 394 KNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVT 441
             E+ ++ KL  H N++ LLG C  R    L  EY P+ +L  F+           F + 
Sbjct: 63  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 122
Query: 442 RT--KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
            +    L   +       +ARG+ YL Q    + IHRDL A N+L+  +   KI+DFG++
Sbjct: 123 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 179
Query: 500 RAFGVDQTEANTDRVVGTYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEIV-------CG 550
           R       E    + +G     +M+ E     +++  SDV+S+GVL+ EIV       CG
Sbjct: 180 RG-----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 234
Query: 551 KRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRP 610
                 Y        L   +RL          +K L+    + + +R       C +++P
Sbjct: 235 MTCAELYEK------LPQGYRL----------EKPLNCDDEVYDLMR------QCWREKP 272
Query: 611 EDRPNMSSVVLMLS 624
            +RP+ + +++ L+
Sbjct: 273 YERPSFAQILVSLN 286

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 142/314 (45%), Gaps = 64/314 (20%)
Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEG---QEIAVKRLSK-SSGQGVEEF 393
           P+ DWN I        +++ +GEG FG V +  + +     + A+KR+ + +S     +F
Sbjct: 20  PVLDWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 72
Query: 394 KNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVT 441
             E+ ++ KL  H N++ LLG C  R    L  EY P+ +L  F+           F + 
Sbjct: 73  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132
Query: 442 RT--KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
            +    L   +       +ARG+ YL Q    + IHRDL A N+L+  +   KI+DFG++
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 189
Query: 500 RAFGVDQTEANTDRVVGTYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEIV-------CG 550
           R       E    + +G     +M+ E     +++  SDV+S+GVL+ EIV       CG
Sbjct: 190 RG-----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
Query: 551 KRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRP 610
                 Y        L   +RL          +K L+    + + +R       C +++P
Sbjct: 245 MTCAELYEK------LPQGYRL----------EKPLNCDDEVYDLMR------QCWREKP 282
Query: 611 EDRPNMSSVVLMLS 624
            +RP+ + +++ L+
Sbjct: 283 YERPSFAQILVSLN 296

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 115/218 (52%), Gaps = 28/218 (12%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQH 405
           ++  F    KLG G +  VY+G+  T G  +A+K +   S +G       E+ L+ +L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRTKFLDWSKRCQI 454
            N+VRL       ++  L++E++ N  L++++            ++   K+  W    Q+
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW----QL 117
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
           ++G+A    + H++   +I+HRDLK  N+L++     K+ DFG+ARAFG+     +++ V
Sbjct: 118 LQGLA----FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 515 VGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK 551
             T  Y +P+  +    +S   D++S G ++ E++ GK
Sbjct: 171 --TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA G+ YL +
Sbjct: 80  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAEGMNYL-E 131
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 132 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 189
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 190 HRIYTHQSDVWSYGVTVWELM 210

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 87  LGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 138
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E + +       +M+ E  +
Sbjct: 139 DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 197 HRIYTHQSDVWSYGVTVWELM 217

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 85  LGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 136
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E + +       +M+ E  +
Sbjct: 137 DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 85  LGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 136
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E + +       +M+ E  +
Sbjct: 137 DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 126/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+KL
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 204
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 265 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 295
Query: 619 VV 620
           ++
Sbjct: 296 IL 297

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 85  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 136
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E + +       +M+ E  +
Sbjct: 137 DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELM 215

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 10/201 (4%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           F    KLGEG +G VY+ +  E GQ +A+K++   S   ++E   E+ ++ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
             G      +  ++ EY    S+   I    R K L   +   I++   +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
           +R IHRD+KA N+LL+ + + K++DFG+A         A  + V+GT  +M+PE   +  
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 531 FSVKSDVFSFGVLVLEIVCGK 551
           ++  +D++S G+  +E+  GK
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 90  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 141
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E + +       +M+ E  +
Sbjct: 142 DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELM 220

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
             ++  ++G G FG V+ G      ++A+K + +      E+F  E  ++ KL H  LV+
Sbjct: 11  ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G C  +    L++E++ +  L  ++   T+           +   +  G+ YL +   
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 126
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
             +IHRDL A N L+  +   K+SDFGM R    DQ  ++T        + SPE      
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 183
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY 590
           +S KSDV+SFGVL+ E+     + G               ++  E+RS   + + +   +
Sbjct: 184 YSSKSDVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGF 224
Query: 591 SLSE----ALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
            L +    +    Q+   C ++RPEDRP  S ++  L+
Sbjct: 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 126/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+KL
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 218
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 279 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 309
Query: 619 VV 620
           ++
Sbjct: 310 IL 311

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
             ++  ++G G FG V+ G      ++A+K + +      E+F  E  ++ KL H  LV+
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G C  +    L++E++ +  L  ++   T+           +   +  G+ YL +   
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 123
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
             +IHRDL A N L+  +   K+SDFGM R    DQ  ++T        + SPE      
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 180
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY 590
           +S KSDV+SFGVL+ E+     + G               ++  E+RS   + + +   +
Sbjct: 181 YSSKSDVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGF 221
Query: 591 SLSE----ALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
            L +    +    Q+   C ++RPEDRP  S ++  L+
Sbjct: 222 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 259

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 134
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E + +       +M+ E  +
Sbjct: 135 DRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 112/211 (53%), Gaps = 11/211 (5%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFKNEVLLI 400
           N IAD  + F+   ++G+G FG V++G+    Q++ A+K +  + +   +E+ + E+ ++
Sbjct: 16  NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
           ++     + +  G      +  +I EYL   S      D+ R    D  +   +++ I +
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILK 131
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GL YLH + +   IHRD+KA+NVLL    + K++DFG+A      Q + NT   VGT  +
Sbjct: 132 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFW 186
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           M+PE      +  K+D++S G+  +E+  G+
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
             ++  ++G G FG V+ G      ++A+K + +      E+F  E  ++ KL H  LV+
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G C  +    L++E++ +  L  ++   T+           +   +  G+ YL +   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
             +IHRDL A N L+  +   K+SDFGM R    DQ  ++T        + SPE      
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 178
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY 590
           +S KSDV+SFGVL+ E+     + G               ++  E+RS   + + +   +
Sbjct: 179 YSSKSDVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGF 219
Query: 591 SLSE----ALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
            L +    +    Q+   C ++RPEDRP  S ++  L+
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  R
Sbjct: 134 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 186
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 241
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 242 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 285
Query: 630 PQPKQPGF 637
            +  +PGF
Sbjct: 286 KEEMEPGF 293

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  R
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 188
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 243
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 244 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 287
Query: 630 PQPKQPGF 637
            +  +PGF
Sbjct: 288 KEEMEPGF 295

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  R
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 182
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 237
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 238 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 281
Query: 630 PQPKQPGF 637
            +  +PGF
Sbjct: 282 KEEMEPGF 289

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 135/292 (46%), Gaps = 31/292 (10%)
Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNE 396
           +P    + + D ++  ++  ++G G FG V+ G      ++A+K + + S    ++F  E
Sbjct: 15  VPRGSLHMVIDPSE-LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEE 72
Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456
             ++ KL H  LV+L G C  +    L++E++ +  L  ++   T+           +  
Sbjct: 73  AEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCL 130
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            +  G+ YL +     +IHRDL A N L+  +   K+SDFGM R    DQ  ++T     
Sbjct: 131 DVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 187
Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED 576
              + SPE      +S KSDV+SFGVL+ E+     + G               ++  E+
Sbjct: 188 V-KWASPEVFSFSRYSSKSDVWSFGVLMWEVF----SEG---------------KIPYEN 227
Query: 577 RSLELIDKSLDGSYSLSE----ALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
           RS   + + +   + L +    +    Q+   C ++RPEDRP  S ++  L+
Sbjct: 228 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 279

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 143/309 (46%), Gaps = 48/309 (15%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD--------WSKRC 452
            +    ++VRLLG  +     ++I E +    L+ ++  + R    +         SK  
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVLAPPSLSKMI 131
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
           Q+   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 184
Query: 513 RVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           R  G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L  
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL-- 240
Query: 569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 628
             R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S
Sbjct: 241 --RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SS 283
Query: 629 LPQPKQPGF 637
           + +  +PGF
Sbjct: 284 IKEEMEPGF 292

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 139/285 (48%), Gaps = 27/285 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRN 407
           D++  +  +G G    V        +E +A+KR++    Q  ++E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVT-----RTKFLDWSKRCQIIEGIARGL 462
           +V       ++DE  L+ + L   S+   I  +      ++  LD S    I+  +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR--AFGVDQTEANTDRV-VGTYG 519
            YLH++ +   IHRD+KA N+LL  D + +I+DFG++   A G D T     +  VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 520 YMSPEY--AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
           +M+PE    + G +  K+D++SFG+  +E+  G      YH      +L     L  +  
Sbjct: 192 WMAPEVMEQVRG-YDFKADIWSFGITAIELATGA---APYHKYPPMKVL--MLTLQNDPP 245
Query: 578 SLE--LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
           SLE  + DK +   Y   ++ R  ++  LC+Q+ PE RP  + ++
Sbjct: 246 SLETGVQDKEMLKKY--GKSFR--KMISLCLQKDPEKRPTAAELL 286

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  R
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 189
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 244
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 245 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 288
Query: 630 PQPKQPGF 637
            +  +PGF
Sbjct: 289 KEEMEPGF 296

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  R
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 188
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 243
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 244 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 287
Query: 630 PQPKQPGF 637
            +  +PGF
Sbjct: 288 KEEMEPGF 295

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           L  G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 90  LGIC-LTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 141
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 142 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELM 220

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 139/285 (48%), Gaps = 27/285 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRN 407
           D++  +  +G G    V        +E +A+KR++    Q  ++E   E+  +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVT-----RTKFLDWSKRCQIIEGIARGL 462
           +V       ++DE  L+ + L   S+   I  +      ++  LD S    I+  +  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR--AFGVDQTEANTDRV-VGTYG 519
            YLH++ +   IHRD+KA N+LL  D + +I+DFG++   A G D T     +  VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 520 YMSPEY--AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
           +M+PE    + G +  K+D++SFG+  +E+  G      YH      +L     L  +  
Sbjct: 187 WMAPEVMEQVRG-YDFKADIWSFGITAIELATGAAP---YHKYPPMKVL--MLTLQNDPP 240
Query: 578 SLE--LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
           SLE  + DK +   Y   ++ R  ++  LC+Q+ PE RP  + ++
Sbjct: 241 SLETGVQDKEMLKKY--GKSFR--KMISLCLQKDPEKRPTAAELL 281

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           L  G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 134
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 135 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 358 LGEGGFGPVYRGML-----TEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LGEG FG V            G+++AVK L  +S G  + + K E+ ++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 412 LGCCTLR--DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
            G CT    +   LI E+LP+ SL++++        ++  ++ +    I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT--DRVVGTYGYMSPEYAI 527
           R + +HRDL A NVL++++   KI DFG+ +A   D+       DR    + Y +PE  +
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
              F + SDV+SFGV + E++
Sbjct: 203 QSKFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 358 LGEGGFGPVYRGML-----TEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LGEG FG V            G+++AVK L  +S G  + + K E+ ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 412 LGCCTLR--DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
            G CT    +   LI E+LP+ SL++++        ++  ++ +    I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 132
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT--DRVVGTYGYMSPEYAI 527
           R + +HRDL A NVL++++   KI DFG+ +A   D+       DR    + Y +PE  +
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
              F + SDV+SFGV + E++
Sbjct: 191 QSKFYIASDVWSFGVTLHELL 211

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           L  G FG VY+G+ + EG+++    A+K L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 90  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 141
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 142 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELM 220

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R    D  E +  R
Sbjct: 165 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 217
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 272
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 273 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 316
Query: 630 PQPKQPGF 637
            +  +PGF
Sbjct: 317 KEEMEPGF 324

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 18/189 (9%)
Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC----CT 416
           G FG V++  L   + +AVK       Q  +  + EV  +  ++H N+++ +G      +
Sbjct: 35  GRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-------S 469
           +  +  LI  +    SL  F+    +   + W++ C I E +ARGL YLH+D        
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
           +  I HRD+K+ NVLL N++   I+DFG+A  F   ++  +T   VGT  YM+PE  ++G
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLEG 207
Query: 530 LFSVKSDVF 538
             + + D F
Sbjct: 208 AINFQRDAF 216

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 142/314 (45%), Gaps = 64/314 (20%)
Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEG---QEIAVKRLSK-SSGQGVEEF 393
           P+ DWN I        +++ +GEG FG V +  + +     + A+KR+ + +S     +F
Sbjct: 17  PVLDWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 69
Query: 394 KNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVT 441
             E+ ++ KL  H N++ LLG C  R    L  EY P+ +L  F+           F + 
Sbjct: 70  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 129
Query: 442 RT--KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
            +    L   +       +ARG+ YL Q    + IHR+L A N+L+  +   KI+DFG++
Sbjct: 130 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLS 186
Query: 500 RAFGVDQTEANTDRVVGTYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEIV-------CG 550
           R       E    + +G     +M+ E     +++  SDV+S+GVL+ EIV       CG
Sbjct: 187 RG-----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 241
Query: 551 KRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRP 610
                 Y        L   +RL          +K L+    + + +R       C +++P
Sbjct: 242 MTCAELYEK------LPQGYRL----------EKPLNCDDEVYDLMR------QCWREKP 279
Query: 611 EDRPNMSSVVLMLS 624
            +RP+ + +++ L+
Sbjct: 280 YERPSFAQILVSLN 293

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 112/201 (55%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + EG+++    A+  L + +S +  +E  +E  ++A + + ++ RL
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     LI + +P   L  ++ +    +     L+W  +      IA+G+ YL +
Sbjct: 117 LGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYL-E 168
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
           D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E + +       +M+ E  +
Sbjct: 169 DRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 226
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
             +++ +SDV+S+GV V E++
Sbjct: 227 HRIYTHQSDVWSYGVTVWELM 247

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 203
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 264 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 294
Query: 619 VV 620
           ++
Sbjct: 295 IL 296

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 203
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 264 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 294
Query: 619 VV 620
           ++
Sbjct: 295 IL 296

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNE 396
           L   D + + D    F     +G G +G VY+G   +  ++A  ++   +G   EE K E
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE 70
Query: 397 VLLIAKL-QHRNLVRLLGCCT------LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS 449
           + ++ K   HRN+    G         + D+  L+ E+    S+   I + T+   L   
Sbjct: 71  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEE 129
Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
               I   I RGL +LHQ    ++IHRD+K  NVLL  +   K+ DFG++    +D+T  
Sbjct: 130 WIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVG 184
Query: 510 NTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCG 550
             +  +GT  +M+PE        D  +  KSD++S G+  +E+  G
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 204
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 265 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 295
Query: 619 VV 620
           ++
Sbjct: 296 IL 297

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 108 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 167
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 168 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 220
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 221 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 280
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 281 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 311
Query: 619 VV 620
           ++
Sbjct: 312 IL 313

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 83  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 142
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 143 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 195
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 196 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 255
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 256 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 286
Query: 619 VV 620
           ++
Sbjct: 287 IL 288

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 124/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A   R  G
Sbjct: 192 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGG 244
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 305 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 335
Query: 619 VV 620
           ++
Sbjct: 336 IL 337

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 218
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 279 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 309
Query: 619 VV 620
           ++
Sbjct: 310 IL 311

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 124/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 109 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 168
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A   R  G
Sbjct: 169 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGG 221
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 222 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 281
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 282 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 312
Query: 619 VV 620
           ++
Sbjct: 313 IL 314

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 98  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 157
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 158 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 210
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 211 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 270
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 271 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 301
Query: 619 VV 620
           ++
Sbjct: 302 IL 303

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 131/283 (46%), Gaps = 48/283 (16%)
Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V  G L   G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M+I EY+ N SL+ F+      F V +           ++ GI  G+ YL 
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL--------VGMLRGIGSGMKYL- 147
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-YGYMSPEY 525
             S +  +HRDL A N+L+++++  K+SDFGM+R    D   A T R       + +PE 
Sbjct: 148 --SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
                F+  SDV+S+G+++ E++  G+R                 W +  +D     + K
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMSNQD-----VIK 245
Query: 585 SLDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVVLML 623
           +++  Y L   + C     Q+ L C Q+   DRP    +V ML
Sbjct: 246 AIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 343 NTIADATD------NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEE 392
           N+I  ATD      N+  +  +G+G F  V   R +LT G+E+AVK + K+  +   +++
Sbjct: 2   NSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQK 60
Query: 393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC 452
              EV ++  L H N+V+L           L+ EY      E F + V   +  +   R 
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARA 118
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
           +  + I   + Y HQ     I+HRDLKA N+LLD DMN KI+DFG +  F V       D
Sbjct: 119 KFRQ-IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN---KLD 171
Query: 513 RVVGTYGYMSPEYAIDGLFSVKS------DVFSFGVLVLEIVCG 550
              G     SP YA   LF  K       DV+S GV++  +V G
Sbjct: 172 TFCG-----SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 117
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 118 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 177
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 178 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 230
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 231 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 290
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 291 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 321
Query: 619 VV 620
           ++
Sbjct: 322 IL 323

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 181
Query: 526 AI-DGLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           LG+G FG   +    E  E+ V K L +   +    F  EV ++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV-L 76
Query: 417 LRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
            +D+R+  I EY+   +L   I  +       WS+R    + IA G+ YLH    + IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR------------VVGTYGYMSP 523
           RDL + N L+  + N  ++DFG+AR    ++T+    R            VVG   +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIV 548
           E      +  K DVFSFG+++ EI+
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 124 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 178
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 526 AI-DGLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R  G
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGG 218
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 279 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 309
Query: 619 VV 620
           ++
Sbjct: 310 IL 311

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 113/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 173
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 30/278 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
             ++  ++G G FG V+ G      ++A+K + +      E+F  E  ++ KL H  LV+
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G C  +    L+ E++ +  L  ++   T+           +   +  G+ YL +   
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
             +IHRDL A N L+  +   K+SDFGM R    DQ  ++T        + SPE      
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSR 181
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY 590
           +S KSDV+SFGVL+ E+     + G               ++  E+RS   + + +   +
Sbjct: 182 YSSKSDVWSFGVLMWEVF----SEG---------------KIPYENRSNSEVVEDISTGF 222
Query: 591 SLSE----ALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
            L +    +    Q+   C ++RPEDRP  S ++  L+
Sbjct: 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 131/283 (46%), Gaps = 48/283 (16%)
Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V  G L   G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M+I EY+ N SL+ F+      F V +           ++ GI  G+ YL 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL--------VGMLRGIGSGMKYL- 132
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-YGYMSPEY 525
             S +  +HRDL A N+L+++++  K+SDFGM+R    D   A T R       + +PE 
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
                F+  SDV+S+G+++ E++  G+R                 W +  +D     + K
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMSNQD-----VIK 230
Query: 585 SLDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVVLML 623
           +++  Y L   + C     Q+ L C Q+   DRP    +V ML
Sbjct: 231 AIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 181
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 182 LLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 131/283 (46%), Gaps = 48/283 (16%)
Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V  G L   G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M+I EY+ N SL+ F+      F V +           ++ GI  G+ YL 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL--------VGMLRGIGSGMKYL- 126
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-YGYMSPEY 525
             S +  +HRDL A N+L+++++  K+SDFGM+R    D   A T R       + +PE 
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
                F+  SDV+S+G+++ E++  G+R                 W +  +D     + K
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGER---------------PYWDMSNQD-----VIK 224
Query: 585 SLDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVVLML 623
           +++  Y L   + C     Q+ L C Q+   DRP    +V ML
Sbjct: 225 AIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 110/223 (49%), Gaps = 32/223 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           DN      +G G +G VY+G L E + +AVK  S ++ Q     KN +  +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 410 RLLG-----CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           R +          R E +L+ EY PN SL +++   T     DW   C++   + RGL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAY 126
Query: 465 LHQD------SRLRIIHRDLKASNVLLDNDMNPKISDFGMA-RAFG---VDQTEANTDRV 514
           LH +       +  I HRDL + NVL+ ND    ISDFG++ R  G   V   E +   +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 515 --VGTYGYMSPEYAIDGLFSVKS--------DVFSFGVLVLEI 547
             VGT  YM+PE  ++G  +++         D+++ G++  EI
Sbjct: 187 SEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 173
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 173
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 142/308 (46%), Gaps = 46/308 (14%)
Query: 348 ATDNFSWKNKLGEGGFGPVY----RGMLTEGQE--IAVKRLSKSSGQGVE-EFKNEVLLI 400
           A +  +   +LG+G FG VY    +G++ +  E  +A+K +++++      EF NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF----DVTRTKFL---DWSKRCQ 453
            +    ++VRLLG  +     ++I E +    L+ ++     ++     L     SK  Q
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           +   IA G+ YL+ +   + +HRDL A N  +  D   KI DFGM R    D  E +  R
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYYR 182
Query: 514 VVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             G       +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 237
Query: 570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 629
            R   E     L+DK  +    L E +R      +C Q  P+ RP+   ++       S+
Sbjct: 238 -RFVMEGG---LLDKPDNCPDMLLELMR------MCWQYNPKMRPSFLEII------SSI 281
Query: 630 PQPKQPGF 637
            +  +PGF
Sbjct: 282 KEEMEPGF 289

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 109/201 (54%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEI----AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG VY+G+ + +G+ +    A+K L + +S +  +E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C L     L+ + +P   L   + +    +     L+W  +      IA+G+ YL  
Sbjct: 85  LGIC-LTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
              +R++HRDL A NVL+ +  + KI+DFG+AR   +D+TE + D       +M+ E  +
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
              F+ +SDV+S+GV V E++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELM 215

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 112/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            +LG G FG V  G      ++AVK + K      +EF  E   + KL H  LV+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           +      ++ EY+ N  L  ++   +  K L+ S+  ++   +  G+ +L      + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYAIDGLFS 532
           RDL A N L+D D+  K+SDFGM R    DQ  ++    VGT     + +PE      +S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFKYS 183
Query: 533 VKSDVFSFGVLVLEI 547
            KSDV++FG+L+ E+
Sbjct: 184 SKSDVWAFGILMWEV 198

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 147/307 (47%), Gaps = 44/307 (14%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFKNEVLLI 400
           N  AD  + F+   K+G+G FG V++G+    Q++ A+K +  + +   +E+ + E+ ++
Sbjct: 15  NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 401 AKLQHRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
           ++     + +  G   L+D ++ +I EYL   S      D+     LD ++   I+  I 
Sbjct: 75  SQCDSPYVTKYYGSY-LKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREIL 129
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           +GL YLH + +   IHRD+KA+NVLL      K++DFG+A      Q + N    VGT  
Sbjct: 130 KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPF 184
Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           +M+PE      +  K+D++S G+  +E+  G+      H++ H              + L
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP----HSELHPM------------KVL 228
Query: 580 ELIDK----SLDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 633
            LI K    +L+G+YS  L E +        C+ + P  RP       +L  +  L   K
Sbjct: 229 FLIPKNNPPTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKE---LLKHKFILRNAK 279
Query: 634 QPGFFTE 640
           +  + TE
Sbjct: 280 KTSYLTE 286

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 114/227 (50%), Gaps = 33/227 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYR----GMLT--EGQEIAVKRLSKSSGQGVE-EFKNEVLLIAK 402
           +N  +   +GEG FG V++    G+L       +AVK L + +   ++ +F+ E  L+A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV--------------TRTKF--- 445
             + N+V+LLG C +     L++EY+    L +F+  +              TR +    
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 446 ----LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR- 500
               L  +++  I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            +  D  +A+ +  +    +M PE      ++ +SDV+++GV++ EI
Sbjct: 224 IYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 146/303 (48%), Gaps = 44/303 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFKNEVLLIAKLQ 404
           D  + F+   K+G+G FG V++G+    Q++ A+K +  + +   +E+ + E+ ++++  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 405 HRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
              + +  G   L+D ++ +I EYL   S      D+     LD ++   I+  I +GL 
Sbjct: 64  SPYVTKYYGSY-LKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLD 118
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH + +   IHRD+KA+NVLL      K++DFG+A      Q + NT   VGT  +M+P
Sbjct: 119 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAP 173
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
           E      +  K+D++S G+  +E+  G+      H++ H              + L LI 
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPP----HSELHPM------------KVLFLIP 217
Query: 584 K----SLDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGF 637
           K    +L+G+YS  L E +        C+ + P  RP       +L  +  L   K+  +
Sbjct: 218 KNNPPTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKE---LLKHKFILRNAKKTSY 268
Query: 638 FTE 640
            TE
Sbjct: 269 LTE 271

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 146/303 (48%), Gaps = 44/303 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFKNEVLLIAKLQ 404
           D  + F+   K+G+G FG V++G+    Q++ A+K +  + +   +E+ + E+ ++++  
Sbjct: 24  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 83
Query: 405 HRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
              + +  G   L+D ++ +I EYL   S      D+     LD ++   I+  I +GL 
Sbjct: 84  SPYVTKYYGSY-LKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLD 138
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH + +   IHRD+KA+NVLL      K++DFG+A      Q + NT   VGT  +M+P
Sbjct: 139 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAP 193
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
           E      +  K+D++S G+  +E+  G+      H++ H              + L LI 
Sbjct: 194 EVIKQSAYDSKADIWSLGITAIELARGEPP----HSELHPM------------KVLFLIP 237
Query: 584 K----SLDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGF 637
           K    +L+G+YS  L E +        C+ + P  RP       +L  +  L   K+  +
Sbjct: 238 KNNPPTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKE---LLKHKFILRNAKKTSY 288
Query: 638 FTE 640
            TE
Sbjct: 289 LTE 291

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 125/302 (41%), Gaps = 68/302 (22%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV----TRTKFLDWSKRCQIIEGIA 459
            H+N+VR +G       R ++ E +    L+ F+ +     ++   L       +   IA
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            G  YL ++     IHRD+ A N LL         KI DFGMA+    D   A+  R  G
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRKGG 204
Query: 517 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYH------- 558
                  +M PE  ++G+F+ K+D +SFGVL+ EI          K N+           
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264
Query: 559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS 618
            D   N  G  +R+ T+                             C Q +PEDRPN + 
Sbjct: 265 MDPPKNCPGPVYRIMTQ-----------------------------CWQHQPEDRPNFAI 295
Query: 619 VV 620
           ++
Sbjct: 296 IL 297

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 358 LGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
           LGEG FG V            G+ +AVK L    G Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 412 LGCCTLRDER--MLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
            GCC  + E+   L+ EY+P  SL  ++    +   + L +++  QI EG+A    YLH 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ--QICEGMA----YLHS 135
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEY 525
                 IHR+L A NVLLDND   KI DFG+A+A   G +      D     + Y +PE 
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 191
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
             +  F   SDV+SFGV + E++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELL 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 358 LGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
           LGEG FG V            G+ +AVK L    G Q    +K E+ ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 412 LGCCTLRDER--MLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
            GCC  + E+   L+ EY+P  SL  ++    +   + L +++  QI EG+A    YLH 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ--QICEGMA----YLHA 135
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEY 525
                 IHR+L A NVLLDND   KI DFG+A+A   G +      D     + Y +PE 
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 191
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
             +  F   SDV+SFGV + E++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELL 214

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 92  PFFVKLY--FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +   S  SD+++ G ++ ++V G
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L  C   +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 97  PFFVKLYFC--FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 146
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 147 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           K+GEG  G V        G+++AVK +     Q  E   NEV+++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
            + +E  ++ E+L   +L     D+     L+  +   + E + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKS 535
           RD+K+ ++LL  D   K+SDFG       D  +     +VGT  +M+PE     L++ + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX--LVGTPYWMAPEVISRSLYATEV 222
Query: 536 DVFSFGVLVLEIVCGK 551
           D++S G++V+E+V G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/225 (32%), Positives = 107/225 (47%), Gaps = 33/225 (14%)
Query: 343 NTIADATD------NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEE 392
           N+IA   D      N+     +G+G F  V   R +LT G+E+A+K + K+  +   +++
Sbjct: 2   NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQK 60
Query: 393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDW-SKR 451
              EV ++  L H N+V+L           LI EY     +  ++    R K  +  SK 
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF 120
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
            QI+  +     Y HQ    RI+HRDLKA N+LLD DMN KI+DFG +  F V       
Sbjct: 121 RQIVSAVQ----YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKL 170
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKS------DVFSFGVLVLEIVCG 550
           D   G   Y +PE     LF  K       DV+S GV++  +V G
Sbjct: 171 DAFCGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N  +   LG G FG V        G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-------FDVTRTKFLDWSKRCQI 454
           L QH N+V LLG CT     ++I EY     L  F+        D    + L+       
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
              +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D         
Sbjct: 158 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 515 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                +M+PE   D +++V+SDV+S+G+L+ EI
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 176
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 355 KNKLGEGGFGPVYRGM------LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           K +LGEG FG V+           +   +AVK L   +    ++F+ E  L+  LQH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-------------LDWSKRCQII 455
           V+  G C   D  ++++EY+ +  L +F+                     L  S+   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
             IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +  RV 
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 192
Query: 516 G----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
           G       +M PE  +   F+ +SDV+SFGV++ EI
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 48/283 (16%)
Query: 358 LGEGGFGPVYRGMLT-EGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V  G L   G+    +A+K L    + +   +F  E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M++ EY+ N SL+ F+      F V +           ++ GI+ G+ YL 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQL--------VGMLRGISAGMKYL- 140
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT-YGYMSPEY 525
             S +  +HRDL A N+L+++++  K+SDFG++R    D   A T R       + +PE 
Sbjct: 141 --SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 198
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
                F+  SDV+S+G+++ E+V  G+R                 W +  +D     + K
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVSYGERPY---------------WEMTNQD-----VIK 238
Query: 585 SLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML 623
           +++  Y L   + C     Q+ L C Q+    RP    +V ML
Sbjct: 239 AVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 173
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +PE 
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 173
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 107/227 (47%), Gaps = 19/227 (8%)
Query: 329 GNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSG 387
            ++++N E     W     A ++F     LG+G FG VY     + + I A+K L K+  
Sbjct: 18  ASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL 72
Query: 388 Q--GVE-EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK 444
           +  GVE + + EV + + L+H N++RL G         LI EY P   L     ++ +  
Sbjct: 73  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLS 129
Query: 445 FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
             D  +    I  +A  L Y H     R+IHRD+K  N+LL +    KI+DFG    + V
Sbjct: 130 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSV 182
Query: 505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
               +  D + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 183 HAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 11/208 (5%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFKNEVLLIAKL 403
            D  + F+  +++G+G FG VY+G+    +E+ A+K +  + +   +E+ + E+ ++++ 
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC 74
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
               + R  G      +  +I EYL   S      D+ +   L+ +    I+  I +GL 
Sbjct: 75  DSPYITRYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLD 130
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH +   R IHRD+KA+NVLL    + K++DFG+A      Q + N    VGT  +M+P
Sbjct: 131 YLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAP 185
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E      +  K+D++S G+  +E+  G+
Sbjct: 186 EVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 18/213 (8%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N  +   LG G FG V        G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-------FDVTRTKFLDWSKRCQI 454
           L QH N+V LLG CT     ++I EY     L  F+        D    + L+       
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
              +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D         
Sbjct: 166 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 515 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                +M+PE   D +++V+SDV+S+G+L+ EI
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 46/282 (16%)
Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G  G V  G L   GQ    +A+K L    + +   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T     M++ EY+ N SL+ F+   T        +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------YMSPEYA 526
            +HRDL A NVL+D+++  K+SDFG++R    D   A T     T G      + +PE  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT-----TTGGKIPIRWTAPEAI 226
Query: 527 IDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
               FS  SDV+SFGV++ E++  G+R                 W +   D     +  S
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP---------------YWNMTNRD-----VISS 266
Query: 586 LDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVVLML 623
           ++  Y L   + C     Q+ L C  +    RP  S +V +L
Sbjct: 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 50/309 (16%)
Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
           +LG+G FG VY G    + +G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
           RLLG  +     +++ E + +  L+ ++  + R +  +   R         Q+   IA G
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---- 517
           + YL+     + +HRDL A N ++ +D   KI DFGM R    D  E +  R  G     
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLP 192
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
             +M+PE   DG+F+  SD++SFGV++ EI                +L    ++  + ++
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGLSNEQ 237
Query: 578 SLELIDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 633
            L+ +   +DG Y L +   C +    +  +C Q  P+ RP    +V +L  +     P+
Sbjct: 238 VLKFV---MDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 293
Query: 634 QPGFFTERN 642
              F +E N
Sbjct: 294 VSFFHSEEN 302

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 46/282 (16%)
Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G  G V  G L   GQ    +A+K L    + +   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T     M++ EY+ N SL+ F+   T        +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------YMSPEYA 526
            +HRDL A NVL+D+++  K+SDFG++R       E + D    T G      + +PE  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVL-----EDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 527 IDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
               FS  SDV+SFGV++ E++  G+R                 W +   D     +  S
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP---------------YWNMTNRD-----VISS 266
Query: 586 LDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVVLML 623
           ++  Y L   + C     Q+ L C  +    RP  S +V +L
Sbjct: 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +  D + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 111/207 (53%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L+ F+ D +    +        +  + +GL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+ ++   +  +GV      E+ L+ +L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+ ++   +  +GV      E+ L+ +L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E+L ++ L++F+ D +    +        +  + +GL + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 173
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKLQH 405
           +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      ++  L++E++ ++ L+ F+ D +    +        +  + +GL + 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 173
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVC 549
            +    +S   D++S G +  E+V 
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 116/239 (48%), Gaps = 23/239 (9%)
Query: 358 LGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVRL 411
           LGEG FG V            G+ +AVK L +  G  +   ++ E+ ++  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 412 LGCCTLRDER--MLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
            GCC  + E+   L+ EY+P  SL  ++    V   + L +++  QI EG+A    YLH 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQ--QICEGMA----YLHA 130
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEY 525
                 IHR L A NVLLDND   KI DFG+A+A   G +      D     + Y +PE 
Sbjct: 131 Q---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 186
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
             +  F   SDV+SFGV + E++    +    H      L+GH     T  R  EL+++
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTK-FTELIGHTQGQMTVLRLTELLER 244

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 50/309 (16%)
Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
           +LG+G FG VY G    + +G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
           RLLG  +     +++ E + +  L+ ++  + R +  +   R         Q+   IA G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---- 517
           + YL+     + +HRDL A N ++ +D   KI DFGM R    D  E +  R  G     
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLP 195
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
             +M+PE   DG+F+  SD++SFGV++ EI                +L    ++  + ++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGLSNEQ 240
Query: 578 SLELIDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 633
            L+ +   +DG Y L +   C +    +  +C Q  P+ RP    +V +L  +     P+
Sbjct: 241 VLKFV---MDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 296
Query: 634 QPGFFTERN 642
              F +E N
Sbjct: 297 VSFFHSEEN 305

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 351 NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           N+     +G+G F  V   R +LT G+E+A+K + K+  +   +++   EV ++  L H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDW-SKRCQIIEGIARGLLYL 465
           N+V+L           LI EY     +  ++    R K  +  SK  QI+  +     Y 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 127
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           HQ    RI+HRDLKA N+LLD DMN KI+DFG +  F V       D   G     SP Y
Sbjct: 128 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCG-----SPPY 176
Query: 526 AIDGLFSVKS------DVFSFGVLVLEIVCG 550
           A   LF  K       DV+S GV++  +V G
Sbjct: 177 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 111/207 (53%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L ++ L+ F+ D +    +        +  + +GL 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 118 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/239 (32%), Positives = 116/239 (48%), Gaps = 23/239 (9%)
Query: 358 LGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVRL 411
           LGEG FG V            G+ +AVK L +  G  +   ++ E+ ++  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 412 LGCCTLRDER--MLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
            GCC  + E+   L+ EY+P  SL  ++    V   + L +++  QI EG+A    YLH 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQ--QICEGMA----YLHA 129
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEY 525
                 IHR L A NVLLDND   KI DFG+A+A   G +      D     + Y +PE 
Sbjct: 130 Q---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APEC 185
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
             +  F   SDV+SFGV + E++    +    H      L+GH     T  R  EL+++
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTK-FTELIGHTQGQMTVLRLTELLER 243

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
              NT        +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 70  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 119
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 120 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 118/229 (51%), Gaps = 16/229 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L +  L++F+ D +    +        +  + +GL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 571
           E  +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 69  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 118
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 119 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 93  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 142
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 144/309 (46%), Gaps = 50/309 (16%)
Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
           +LG+G FG VY G    + +G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
           RLLG  +     +++ E + +  L+ ++  + R +  +   R         Q+   IA G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---- 517
           + YL+     + +HRDL A N ++ +D   KI DFGM R    D  E +  R  G     
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLP 195
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
             +M+PE   DG+F+  SD++SFGV++ EI                +L    ++  + ++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGLSNEQ 240
Query: 578 SLELIDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 633
            L+ +   +DG Y L +   C +    +  +C Q  P  RP    +V +L  +     P+
Sbjct: 241 VLKFV---MDGGY-LDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPE 296
Query: 634 QPGFFTERN 642
              F +E N
Sbjct: 297 VSFFHSEEN 305

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +  D + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 133/273 (48%), Gaps = 44/273 (16%)
Query: 343 NTIADATD--NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK-----RLSKSSGQGVEEFK 394
           +++AD     N+     LGEG FG V      T GQ++A+K      L+KS  QG    +
Sbjct: 4   SSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIE 61
Query: 395 NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
            E+  +  L+H ++++L      +DE +++ EY  N   E F + V R K  +   R + 
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN---ELFDYIVQRDKMSEQEAR-RF 117
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
            + I   + Y H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  + 
Sbjct: 118 FQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKT 170
Query: 515 -VGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 572
             G+  Y +PE     L++  + DV+S GV++  ++C                     RL
Sbjct: 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC--------------------RRL 210
Query: 573 WTEDRSLELIDKSL-DGSYSLSEALRCIQVGLL 604
             +D S+ ++ K++ +G Y+L + L     GL+
Sbjct: 211 PFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 243

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 118/229 (51%), Gaps = 16/229 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L +  L++F+ D +    +        +  + +GL 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 118
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 571
           E  +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 133/273 (48%), Gaps = 44/273 (16%)
Query: 343 NTIADATD--NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK-----RLSKSSGQGVEEFK 394
           +++AD     N+     LGEG FG V      T GQ++A+K      L+KS  QG    +
Sbjct: 5   SSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIE 62
Query: 395 NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
            E+  +  L+H ++++L      +DE +++ EY  N   E F + V R K  +   R + 
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN---ELFDYIVQRDKMSEQEAR-RF 118
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
            + I   + Y H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  + 
Sbjct: 119 FQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKT 171
Query: 515 -VGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 572
             G+  Y +PE     L++  + DV+S GV++  ++C                     RL
Sbjct: 172 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC--------------------RRL 211
Query: 573 WTEDRSLELIDKSL-DGSYSLSEALRCIQVGLL 604
             +D S+ ++ K++ +G Y+L + L     GL+
Sbjct: 212 PFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 244

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +LG G FG V +G   M  +  ++A+K L + + +   EE   E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G C   +  ML+ E      L +F+  V + + +  S   +++  ++ G+ YL + +   
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY--GYMSPEYAIDGL 530
            +HRDL A NVLL N    KISDFG+++A G D +   T R  G +   + +PE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189
Query: 531 FSVKSDVFSFGVLVLEIV 548
           FS +SDV+S+GV + E +
Sbjct: 190 FSSRSDVWSYGVTMWEAL 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 67  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 116
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 117 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 93  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 142
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 90  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 90  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 68  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 117
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 118 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 351 NFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  + ++LG+G FG V            G  +AVK+L  S      +F+ E+ ++  L  
Sbjct: 8   HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 67
Query: 406 RNLVRLLGCC--TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
             +V+  G      R E  L+ EYLP+  L  F+    R + LD S+       I +G+ 
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRAR-LDASRLLLYSSQICKGME 125
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG--YM 521
           YL   SR R +HRDL A N+L++++ + KI+DFG+A+   +D+ +    R  G     + 
Sbjct: 126 YL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DXXVVREPGQSPIFWY 181
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEI 547
           +PE   D +FS +SDV+SFGV++ E+
Sbjct: 182 APESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 90  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 92  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 92  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           + ++  +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV+
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G CT +    +I EY+ N  L  ++ ++ R +F    +  ++ + +   + YL     
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK-- 139
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            + +HRDL A N L+++    K+SDFG++R + +D  E ++        +  PE  +   
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSK 197
Query: 531 FSVKSDVFSFGVLVLEI 547
           FS KSD+++FGVL+ EI
Sbjct: 198 FSSKSDIWAFGVLMWEI 214

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 92  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 95  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 144
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 145 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 128/263 (48%), Gaps = 42/263 (15%)
Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKLQ 404
           N+     LGEG FG V      T GQ++A+K      L+KS  QG    + E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 62
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H ++++L      +DE +++ EY  N   E F + V R K  +   R +  + I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGN---ELFDYIVQRDKMSEQEAR-RFFQQIISAVEY 118
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMSP 523
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y +P
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 171
Query: 524 EYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
           E     L++  + DV+S GV++  ++C                     RL  +D S+ ++
Sbjct: 172 EVISGKLYAGPEVDVWSCGVILYVMLC--------------------RRLPFDDESIPVL 211
Query: 583 DKSL-DGSYSLSEALRCIQVGLL 604
            K++ +G Y+L + L     GL+
Sbjct: 212 FKNISNGVYTLPKFLSPGAAGLI 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 92  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 92  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 141
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 358 LGEGGFG--------PVYRGMLTEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 408
           LGEG FG        P   G    G+ +AVK L   +G Q    +K E+ ++  L H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 409 VRLLGCC--TLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLY 464
           ++  GCC         L+ EY+P  SL  ++    +   + L +++  QI EG+A    Y
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ--QICEGMA----Y 149
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMS 522
           LH       IHRDL A NVLLDND   KI DFG+A+A   G +      D     + Y +
Sbjct: 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-A 205
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIV 548
           PE   +  F   SDV+SFGV + E++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 74  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 123
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 124 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 128/263 (48%), Gaps = 42/263 (15%)
Query: 351 NFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKLQ 404
           N+     LGEG FG V      T GQ++A+K      L+KS  QG    + E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 66
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H ++++L      +DE +++ EY  N   E F + V R K  +   R +  + I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGN---ELFDYIVQRDKMSEQEAR-RFFQQIISAVEY 122
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMSP 523
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y +P
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 175
Query: 524 EYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
           E     L++  + DV+S GV++  ++C                     RL  +D S+ ++
Sbjct: 176 EVISGKLYAGPEVDVWSCGVILYVMLC--------------------RRLPFDDESIPVL 215
Query: 583 DKSL-DGSYSLSEALRCIQVGLL 604
            K++ +G Y+L + L     GL+
Sbjct: 216 FKNISNGVYTLPKFLSPGAAGLI 238

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E++ ++ L++F+ D +    +        +  + +GL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVC 549
           E  +    +S   D++S G +  E+V 
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 16/229 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L +  L+ F+ D +    +        +  + +GL 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLA 120
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 571
           E  +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 17/207 (8%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQHRN 407
           +   +KLG GG   VY    T    ++A+K +    +   + ++ F+ EV   ++L H+N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD---VTRTKFLDWSKRCQIIEGIARGLLY 464
           +V ++      D   L+ EY+   +L ++I     ++    ++++   QI++GI      
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTN--QILDGIKHA--- 127
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
                 +RI+HRD+K  N+L+D++   KI DFG+A+A   + +   T+ V+GT  Y SPE
Sbjct: 128 ----HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPE 182
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            A        +D++S G+++ E++ G+
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 89  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 138
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 139 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 89  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 138
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 139 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 145/303 (47%), Gaps = 44/303 (14%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFKNEVLLIAKLQ 404
           D  + F+   K+G+G FG V++G+    Q++ A+K +  + +   +E+ + E+ ++++  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 405 HRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
              + +  G   L+D ++ +I EYL   S      D+     LD ++   I+  I +GL 
Sbjct: 64  SPYVTKYYGSY-LKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLD 118
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH + +   IHRD+KA+NVLL      K++DFG+A      Q + N    VGT  +M+P
Sbjct: 119 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAP 173
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
           E      +  K+D++S G+  +E+  G+      H++ H              + L LI 
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGEPP----HSELHPM------------KVLFLIP 217
Query: 584 K----SLDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGF 637
           K    +L+G+YS  L E +        C+ + P  RP       +L  +  L   K+  +
Sbjct: 218 KNNPPTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKE---LLKHKFILRNAKKTSY 268
Query: 638 FTE 640
            TE
Sbjct: 269 LTE 271

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 117/229 (51%), Gaps = 16/229 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLS-KSSGQGVEEFK-NEVLLIAKL 403
           + +NF    K+GEG +G VY  R  LT G+ +A+K++   +  +GV      E+ L+ +L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N+V+LL      ++  L++E+L +  L+ F+ D +    +        +  + +GL 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLA 119
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV       + V  T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 174
Query: 524 EYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 571
           E  +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 220

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 XXKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 50/309 (16%)
Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
           +LG+G FG VY G    + +G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
           RLLG  +     +++ E + +  L+ ++  + R +  +   R         Q+   IA G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---- 517
           + YL+     + +HRDL A N ++ +D   KI DFGM R    D  E +  R  G     
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 195
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
             +M+PE   DG+F+  SD++SFGV++ EI                +L    ++  + ++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGLSNEQ 240
Query: 578 SLELIDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 633
            L+ +   +DG Y L +   C +    +  +C Q  P+ RP    +V +L  +     P+
Sbjct: 241 VLKFV---MDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 296
Query: 634 QPGFFTERN 642
              F +E N
Sbjct: 297 VSFFHSEEN 305

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 XXKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 145/309 (46%), Gaps = 50/309 (16%)
Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
           +LG+G FG VY G    + +G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
           RLLG  +     +++ E + +  L+ ++  + R +  +   R         Q+   IA G
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---- 517
           + YL+     + +HRDL A N ++ +D   KI DFGM R    D  E +  R  G     
Sbjct: 142 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 194
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
             +M+PE   DG+F+  SD++SFGV++ EI                +L    ++  + ++
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGLSNEQ 239
Query: 578 SLELIDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 633
            L+ +   +DG Y L +   C +    +  +C Q  P+ RP    +V +L  +     P+
Sbjct: 240 VLKFV---MDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 295
Query: 634 QPGFFTERN 642
              F +E N
Sbjct: 296 VSFFHSEEN 304

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 350 DNFSWKNKLGEGGFGP-VYRGMLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F   V    L   +E A+K L K        V     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 406 RNLVRLLGCCTLRDERMLIY--EYLPNKSLEQFI-----FDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L +   Y  N  L ++I     FD T T+F            I
Sbjct: 90  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------I 139
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y+SPE   +      SD+++ G ++ ++V G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 142/305 (46%), Gaps = 42/305 (13%)
Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
           +LG+G FG VY G    + +G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
           RLLG  +     +++ E + +  L+ ++  + R +  +   R         Q+   IA G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + YL+     + +HRDL A N ++ +D   KI DFGM R            + +    +M
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           +PE   DG+F+  SD++SFGV++ EI                +L    ++  + ++ L+ 
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGLSNEQVLKF 244
Query: 582 IDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGF 637
           +   +DG Y L +   C +    +  +C Q  P+ RP    +V +L  +     P+   F
Sbjct: 245 V---MDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSFF 300
Query: 638 FTERN 642
            +E N
Sbjct: 301 HSEEN 305

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           +LG+G FG VY+    E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
              +   ++ E+    +++  + ++ R   L  S+   + +     L YLH +   +IIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-----DGL 530
           RDLKA N+L   D + K++DFG++      +T    D  +GT  +M+PE  +     D  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 531 FSVKSDVFSFGVLVLEI 547
           +  K+DV+S G+ ++E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKLQH 405
           ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N++RL G         LI EY P  ++ + +  ++R    D  +    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYC 128
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R+IHRD+K  N+LL ++   KI+DFG    + V    +  D + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCG 550
               +   K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N  +   LG G FG V        G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
           L QH N+V LLG CT     ++I EY     L  F+    +++ L+      I    A  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTAST 163
Query: 462 LLYLHQDSRL----------RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
              LH  S++            IHRD+ A NVLL N    KI DFG+AR    D      
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                   +M+PE   D +++V+SDV+S+G+L+ EI
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 19/227 (8%)
Query: 329 GNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSG 387
            ++++N E     W     A ++F     LG+G FG VY     + + I A+K L K+  
Sbjct: 18  ASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL 72
Query: 388 Q--GVE-EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK 444
           +  GVE + + EV + + L+H N++RL G         LI EY P   L     ++ +  
Sbjct: 73  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLS 129
Query: 445 FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
             D  +    I  +A  L Y H     R+IHRD+K  N+LL +    KI+DFG    + V
Sbjct: 130 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSV 182
Query: 505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
               +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 183 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +LG G FG V +G   M  +  ++A+K L + + +   EE   E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G C   +  ML+ E      L +F+  V + + +  S   +++  ++ G+ YL + +   
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY--GYMSPEYAIDGL 530
            +HR+L A NVLL N    KISDFG+++A G D +   T R  G +   + +PE      
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 515
Query: 531 FSVKSDVFSFGVLVLEIV 548
           FS +SDV+S+GV + E +
Sbjct: 516 FSSRSDVWSYGVTMWEAL 533

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   + + +  +++    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   + + +  +++    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 30/285 (10%)
Query: 351 NFSWKNKLGEGGFGPV----YRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  + ++LG+G FG V    Y  +    G  +AVK+L  S      +F+ E+ ++  L  
Sbjct: 11  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 70
Query: 406 RNLVRLLGCC--TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
             +V+  G      R    L+ EYLP+  L  F+    R + LD S+       I +G+ 
Sbjct: 71  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRAR-LDASRLLLYSSQICKGME 128
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG--YM 521
           YL   SR R +HRDL A N+L++++ + KI+DFG+A+   +D+ +    R  G     + 
Sbjct: 129 YL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWY 184
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           +PE   D +FS +SDV+SFGV++ E+        F + D   +      R+   +R +  
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYEL--------FTYCDKSCSPSAEFLRMMGSERDVPA 236
Query: 582 IDKSLDGSYS---LSEALRCI----QVGLLCVQQRPEDRPNMSSV 619
           + + L+       L     C     ++  LC    P+DRP+ S++
Sbjct: 237 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N  +   LG G FG V        G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---------WSKR- 451
           L QH N+V LLG CT     ++I EY     L  F+   +R    D          S R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 452 -CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN 510
                  +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D     
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 511 TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                    +M+PE   D +++V+SDV+S+G+L+ EI
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 357 KLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           K+GEG  G V   + TE   G+++AVK++     Q  E   NEV+++    H N+V +  
Sbjct: 52  KIGEGSTGIV--CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
              + DE  ++ E+L   +L      VT T+ ++  +   +   + R L YLH      +
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLSVLRALSYLHNQG---V 162
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRD+K+ ++LL +D   K+SDFG      V +       +VGT  +M+PE      +  
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKXLVGTPYWMAPEVISRLPYGT 220
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + D++S G++V+E++ G+
Sbjct: 221 EVDIWSLGIMVIEMIDGE 238

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 19/227 (8%)
Query: 329 GNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSG 387
            ++++N E     W     A ++F     LG+G FG VY     + + I A+K L K+  
Sbjct: 9   ASKQKNEESKKRQW-----ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL 63
Query: 388 Q--GVE-EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK 444
           +  GVE + + EV + + L+H N++RL G         LI EY P   L     ++ +  
Sbjct: 64  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLS 120
Query: 445 FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
             D  +    I  +A  L Y H     R+IHRD+K  N+LL +    KI+DFG    + V
Sbjct: 121 KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSV 173
Query: 505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
               +    + GT  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 174 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 25/204 (12%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           K+GEG +G VY+     G+  A+K  RL K           E+ ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 415 CTLRDERMLIYEYLPNKSLEQFI-------FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
              +   +L++E+L ++ L++ +         VT   FL      Q++ GIA    Y H 
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA----YCHD 118
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HRDLK  N+L++ +   KI+DFG+ARAFG+      T  VV T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYRAPDVLM 173
Query: 528 -DGLFSVKSDVFSFGVLVLEIVCG 550
               +S   D++S G +  E+V G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 25/204 (12%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           K+GEG +G VY+     G+  A+K  RL K           E+ ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 415 CTLRDERMLIYEYLPNKSLEQFI-------FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
              +   +L++E+L ++ L++ +         VT   FL      Q++ GIA    Y H 
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA----YCHD 118
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HRDLK  N+L++ +   KI+DFG+ARAFG+      T  VV T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYRAPDVLM 173
Query: 528 -DGLFSVKSDVFSFGVLVLEIVCG 550
               +S   D++S G +  E+V G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAK 402
           D    FS   ++G G FG VY        E+ A+K++S S  Q  E++++   EV  + K
Sbjct: 51  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           L+H N ++  GC        L+ EY    + +  + +V + K L   +   +  G  +GL
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHK-KPLQEVEIAAVTHGALQGL 167
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            YLH  +   +IHRD+KA N+LL      K+ DFG A         A  +  VGT  +M+
Sbjct: 168 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMA 218
Query: 523 PEYAI---DGLFSVKSDVFSFGVLVLEIV 548
           PE  +   +G +  K DV+S G+  +E+ 
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 351 NFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  + ++LG+G FG V            G  +AVK+L  S      +F+ E+ ++  L  
Sbjct: 24  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 83
Query: 406 RNLVRLLGCC--TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
             +V+  G      R    L+ EYLP+  L  F+    R + LD S+       I +G+ 
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRAR-LDASRLLLYSSQICKGME 141
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG--YM 521
           YL   SR R +HRDL A N+L++++ + KI+DFG+A+   +D+ +    R  G     + 
Sbjct: 142 YL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWY 197
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEI 547
           +PE   D +FS +SDV+SFGV++ E+
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 351 NFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  + ++LG+G FG V            G  +AVK+L  S      +F+ E+ ++  L  
Sbjct: 12  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 71
Query: 406 RNLVRLLGCC--TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
             +V+  G      R    L+ EYLP+  L  F+    R + LD S+       I +G+ 
Sbjct: 72  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRAR-LDASRLLLYSSQICKGME 129
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG--YM 521
           YL   SR R +HRDL A N+L++++ + KI+DFG+A+   +D+ +    R  G     + 
Sbjct: 130 YL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWY 185
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEI 547
           +PE   D +FS +SDV+SFGV++ E+
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 27/206 (13%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI    R +  + + +  I  G  +A+G+ +L   
Sbjct: 99  GIC-LRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE--YA 526
           +  + +HRDL A N +LD     K++DFG+AR    D  +   D V    G   P    A
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 527 IDGL----FSVKSDVFSFGVLVLEIV 548
           ++ L    F+ KSDV+SFGVL+ E++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 27/206 (13%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI    R +  + + +  I  G  +A+G+ +L   
Sbjct: 98  GIC-LRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL--- 149
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE--YA 526
           +  + +HRDL A N +LD     K++DFG+AR    D  +   D V    G   P    A
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 527 IDGL----FSVKSDVFSFGVLVLEIV 548
           ++ L    F+ KSDV+SFGVL+ E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 27/206 (13%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI    R +  + + +  I  G  +A+G+ +L   
Sbjct: 96  GIC-LRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL--- 147
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE--YA 526
           +  + +HRDL A N +LD     K++DFG+AR    D  +   D V    G   P    A
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 527 IDGL----FSVKSDVFSFGVLVLEIV 548
           ++ L    F+ KSDV+SFGVL+ E++
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 27/206 (13%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI    R +  + + +  I  G  +A+G+ +L   
Sbjct: 103 GIC-LRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL--- 154
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE--YA 526
           +  + +HRDL A N +LD     K++DFG+AR    D  +   D V    G   P    A
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 527 IDGL----FSVKSDVFSFGVLVLEIV 548
           ++ L    F+ KSDV+SFGVL+ E++
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELM 236

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 121
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 27/206 (13%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI    R +  + + +  I  G  +A+G+ +L   
Sbjct: 99  GIC-LRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE--YA 526
           +  + +HRDL A N +LD     K++DFG+AR    D  +   D V    G   P    A
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 527 IDGL----FSVKSDVFSFGVLVLEIV 548
           ++ L    F+ KSDV+SFGVL+ E++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 126
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 27/206 (13%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI    R +  + + +  I  G  +A+G+ +L   
Sbjct: 157 GIC-LRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE--YA 526
           +  + +HRDL A N +LD     K++DFG+AR    D  +   D V    G   P    A
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 527 IDGL----FSVKSDVFSFGVLVLEIV 548
           ++ L    F+ KSDV+SFGVL+ E++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELM 290

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 258 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 25/204 (12%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           K+GEG +G VY+     G+  A+K  RL K           E+ ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 415 CTLRDERMLIYEYLPNKSLEQFI-------FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
              +   +L++E+L ++ L++ +         VT   FL      Q++ GIA    Y H 
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA----YCHD 118
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HRDLK  N+L++ +   KI+DFG+ARAFG+      T  +V T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRAPDVLM 173
Query: 528 -DGLFSVKSDVFSFGVLVLEIVCG 550
               +S   D++S G +  E+V G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 27/206 (13%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI    R +  + + +  I  G  +A+G+ +L   
Sbjct: 98  GIC-LRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMKFL--- 149
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE--YA 526
           +  + +HRDL A N +LD     K++DFG+AR    D  +   D V    G   P    A
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 527 IDGL----FSVKSDVFSFGVLVLEIV 548
           ++ L    F+ KSDV+SFGVL+ E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   +I+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN---EVLLIAK 402
           D    FS   ++G G FG VY        E+ A+K++S S  Q  E++++   EV  + K
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           L+H N ++  GC        L+ EY    + +  + +V + K L   +   +  G  +GL
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHK-KPLQEVEIAAVTHGALQGL 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            YLH  +   +IHRD+KA N+LL      K+ DFG A         A  +  VGT  +M+
Sbjct: 129 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMA 179
Query: 523 PEYAI---DGLFSVKSDVFSFGVLVLEIV 548
           PE  +   +G +  K DV+S G+  +E+ 
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           + ++  +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV+
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G CT +    +I EY+ N  L  ++ ++ R +F    +  ++ + +   + YL     
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK-- 139
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            + +HRDL A N L+++    K+SDFG++R    D+  ++         +  PE  +   
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSK 197
Query: 531 FSVKSDVFSFGVLVLEI 547
           FS KSD+++FGVL+ EI
Sbjct: 198 FSSKSDIWAFGVLMWEI 214

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 199 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 97  GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 148
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEXXSVHNKTGAKLPVKWMALES 207
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 117/222 (52%), Gaps = 23/222 (10%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSK---SSGQGVEEF 393
           MF  ++ A  +D +  +  LG+G FG V   +  +T GQE AVK +SK         E  
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESL 79
Query: 394 KNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR 451
             EV L+ +L H N+++L      +    L+ E      L    FD  ++R +F +    
Sbjct: 80  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA- 134
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTE 508
            +II  +  G+ Y+H++   +I+HRDLK  N+LL++   D N +I DFG++  F  + ++
Sbjct: 135 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASK 189
Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
              D+ +GT  Y++PE  + G +  K DV+S GV++  ++ G
Sbjct: 190 KMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 204 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           + ++  +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV+
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G CT +    +I EY+ N  L  ++ ++ R +F    +  ++ + +   + YL     
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK-- 124
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            + +HRDL A N L+++    K+SDFG++R + +D    ++        +  PE  +   
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 531 FSVKSDVFSFGVLVLEI 547
           FS KSD+++FGVL+ EI
Sbjct: 183 FSSKSDIWAFGVLMWEI 199

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I EY    +L +++           +D+ R   + +
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 201 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           + ++  +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV+
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G CT +    +I EY+ N  L  ++ ++ R +F    +  ++ + +   + YL     
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK-- 123
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            + +HRDL A N L+++    K+SDFG++R    D+  ++         +  PE  +   
Sbjct: 124 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSK 181
Query: 531 FSVKSDVFSFGVLVLEI 547
           FS KSD+++FGVL+ EI
Sbjct: 182 FSSKSDIWAFGVLMWEI 198

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           DNF    K+GEG  G V    + + G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 34  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V +     + DE  ++ E+L   +L      VT T+ ++  +   +   + + L  LH  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQ 146
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               +IHRD+K+ ++LL +D   K+SDFG      V +       +VGT  +M+PE    
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 201
Query: 529 GLFSVKSDVFSFGVLVLEIVCGK 551
             +  + D++S G++V+E+V G+
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 350 DNFSWKNKLGEGGFGPV-YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           DNF    K+GEG  G V    + + G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 154 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V +     + DE  ++ E+L   +L      VT T+ ++  +   +   + + L  LH  
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQ 266
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               +IHRD+K+ ++LL +D   K+SDFG      V +       +VGT  +M+PE    
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 321
Query: 529 GLFSVKSDVFSFGVLVLEIVCGK 551
             +  + D++S G++V+E+V G+
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           DNF    K+GEG  G V    + + G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 32  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V +     + DE  ++ E+L   +L      VT T+ ++  +   +   + + L  LH  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQ 144
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               +IHRD+K+ ++LL +D   K+SDFG      V +       +VGT  +M+PE    
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 199
Query: 529 GLFSVKSDVFSFGVLVLEIVCGK 551
             +  + D++S G++V+E+V G+
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           DNF    K+GEG  G V    + + G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V +     + DE  ++ E+L   +L      VT T+ ++  +   +   + + L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQ 135
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               +IHRD+K+ ++LL +D   K+SDFG      V +       +VGT  +M+PE    
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 190
Query: 529 GLFSVKSDVFSFGVLVLEIVCGK 551
             +  + D++S G++V+E+V G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           + ++  +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV+
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G CT +    +I EY+ N  L  ++ ++ R +F    +  ++ + +   + YL     
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK-- 124
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            + +HRDL A N L+++    K+SDFG++R    D+  ++         +  PE  +   
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSK 182
Query: 531 FSVKSDVFSFGVLVLEI 547
           FS KSD+++FGVL+ EI
Sbjct: 183 FSSKSDIWAFGVLMWEI 199

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           DNF    K+GEG  G V    + + G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 27  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V +     + DE  ++ E+L   +L      VT T+ ++  +   +   + + L  LH  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQ 139
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               +IHRD+K+ ++LL +D   K+SDFG      V +       +VGT  +M+PE    
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 194
Query: 529 GLFSVKSDVFSFGVLVLEIVCGK 551
             +  + D++S G++V+E+V G+
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 117/222 (52%), Gaps = 23/222 (10%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSK---SSGQGVEEF 393
           MF  ++ A  +D +  +  LG+G FG V   +  +T GQE AVK +SK         E  
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESL 97
Query: 394 KNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR 451
             EV L+ +L H N+++L      +    L+ E      L    FD  ++R +F +    
Sbjct: 98  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA- 152
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTE 508
            +II  +  G+ Y+H++   +I+HRDLK  N+LL++   D N +I DFG++  F  + ++
Sbjct: 153 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASK 207
Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
              D+ +GT  Y++PE  + G +  K DV+S GV++  ++ G
Sbjct: 208 KMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 361 GGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC----CT 416
           G FG V++  L     +AVK       Q  +  + E+     ++H NL++ +        
Sbjct: 26  GRFGCVWKAQLM-NDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-------- 468
           L  E  LI  +    SL  ++    +   + W++ C + E ++RGL YLH+D        
Sbjct: 84  LEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
            +  I HRD K+ NVLL +D+   ++DFG+A  F   +   +T   VGT  YM+PE  ++
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VLE 198
Query: 529 GLFSVKSDVF------SFGVLVLEIV 548
           G  + + D F      + G+++ E+V
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           DNF    K+GEG  G V    + + G+ +AVK++     Q  E   NEV+++   QH N+
Sbjct: 77  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V +     + DE  ++ E+L   +L      VT T+ ++  +   +   + + L  LH  
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQ 189
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               +IHRD+K+ ++LL +D   K+SDFG      V +       +VGT  +M+PE    
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISR 244
Query: 529 GLFSVKSDVFSFGVLVLEIVCGK 551
             +  + D++S G++V+E+V G+
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 135/294 (45%), Gaps = 49/294 (16%)
Query: 358 LGEGGFGPVYRG-MLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC-- 414
           +G GGFG V++     +G+   +KR+  ++    E+ + EV  +AKL H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 415 -----------CTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
                       + R +   ++   E+    +LEQ+I +  R + LD     ++ E I +
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITK 133
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           G+ Y+H     ++I+RDLK SN+ L +    KI DFG+  +    + +    R  GT  Y
Sbjct: 134 GVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXRSKGTLRY 187
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
           MSPE      +  + D+++ G+++ E++            H  +      + +T+ R   
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELL------------HVCDTAFETSKFFTDLRDGI 235
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQ 634
           + D       +L + L         + ++PEDRPN S ++  L+  +  P+  +
Sbjct: 236 ISDIFDKKEKTLLQKL---------LSKKPEDRPNTSEILRTLTVWKKSPEKNE 280

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           + ++  +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV+
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G CT +    +I EY+ N  L  ++ ++ R +F    +  ++ + +   + YL     
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK-- 130
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            + +HRDL A N L+++    K+SDFG++R    D+  ++         +  PE  +   
Sbjct: 131 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSK 188
Query: 531 FSVKSDVFSFGVLVLEI 547
           FS KSD+++FGVL+ EI
Sbjct: 189 FSSKSDIWAFGVLMWEI 205

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 117/222 (52%), Gaps = 23/222 (10%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSK---SSGQGVEEF 393
           MF  ++ A  +D +  +  LG+G FG V   +  +T GQE AVK +SK         E  
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESL 96
Query: 394 KNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR 451
             EV L+ +L H N+++L      +    L+ E      L    FD  ++R +F +    
Sbjct: 97  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA- 151
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTE 508
            +II  +  G+ Y+H++   +I+HRDLK  N+LL++   D N +I DFG++  F  + ++
Sbjct: 152 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASK 206
Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
              D+ +GT  Y++PE  + G +  K DV+S GV++  ++ G
Sbjct: 207 KMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           + ++  +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV+
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G CT +    +I EY+ N  L  ++ ++ R +F    +  ++ + +   + YL     
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRF-QTQQLLEMCKDVCEAMEYLESK-- 119
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            + +HRDL A N L+++    K+SDFG++R    D+  ++         +  PE  +   
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSK 177
Query: 531 FSVKSDVFSFGVLVLEI 547
           FS KSD+++FGVL+ EI
Sbjct: 178 FSSKSDIWAFGVLMWEI 194

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N  +   LG G FG V        G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRTKFLDWSK 450
           L QH N+V LLG CT     ++I EY     L  F+           ++ +       S 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 451 R--CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
           R        +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D   
Sbjct: 166 RDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                      +M+PE   D +++V+SDV+S+G+L+ EI
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 144/309 (46%), Gaps = 50/309 (16%)
Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
           +LG+G FG VY G    + +G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
           RLLG  +     +++ E + +  L+ ++  + R +  +   R         Q+   IA G
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---- 517
           + YL+     + +HR+L A N ++ +D   KI DFGM R    D  E +  R  G     
Sbjct: 144 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 196
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
             +M+PE   DG+F+  SD++SFGV++ EI                +L    ++  + ++
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGLSNEQ 241
Query: 578 SLELIDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 633
            L+ +   +DG Y L +   C +    +  +C Q  P  RP    +V +L  +     P+
Sbjct: 242 VLKFV---MDGGY-LDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPE 297
Query: 634 QPGFFTERN 642
              F +E N
Sbjct: 298 VSFFHSEEN 306

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           +LG+G FG VY+    E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
              +   ++ E+    +++  + ++ R   L  S+   + +     L YLH +   +IIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-----DGL 530
           RDLKA N+L   D + K++DFG++      +     D  +GT  +M+PE  +     D  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNT--RXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 531 FSVKSDVFSFGVLVLEI 547
           +  K+DV+S G+ ++E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYR----GMLTEGQ--EIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N  +   LG G FG V      G+   G   ++AVK L  K+     E   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----LDWSKRCQIIE- 456
           L  H N+V LLG CTL     LI+EY     L  ++    R KF    +++  + ++ E 
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL-RSKREKFSEDEIEYENQKRLEEE 163
Query: 457 ----------------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
                            +A+G+ +L   S    +HRDL A NVL+ +    KI DFG+AR
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
               D              +M+PE   +G++++KSDV+S+G+L+ EI
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 117/222 (52%), Gaps = 23/222 (10%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSK---SSGQGVEEF 393
           MF  ++ A  +D +  +  LG+G FG V   +  +T GQE AVK +SK         E  
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESL 73
Query: 394 KNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR 451
             EV L+ +L H N+++L      +    L+ E      L    FD  ++R +F +    
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA- 128
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTE 508
            +II  +  G+ Y+H++   +I+HRDLK  N+LL++   D N +I DFG++  F  + ++
Sbjct: 129 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASK 183
Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
              D+ +GT  Y++PE  + G +  K DV+S GV++  ++ G
Sbjct: 184 KMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 351 NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           N+     +G+G F  V   R +LT G+E+AVK + K+  +   +++   EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+L           L+ EY      E F + V   +  +   R +  + I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCH 130
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
           Q     I+HRDLKA N+LLD DMN KI+DFG +  F         D   G     SP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCG-----SPPYA 179
Query: 527 IDGLFSVKS------DVFSFGVLVLEIVCG 550
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 144/309 (46%), Gaps = 50/309 (16%)
Query: 357 KLGEGGFGPVYRGM---LTEGQ---EIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLV 409
           +LG+G FG VY G    + +G+    +AVK +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--------CQIIEGIARG 461
           RLLG  +     +++ E + +  L+ ++  + R +  +   R         Q+   IA G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---- 517
           + YL+     + +HR+L A N ++ +D   KI DFGM R    D  E +  R  G     
Sbjct: 143 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 195
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR 577
             +M+PE   DG+F+  SD++SFGV++ EI                +L    ++  + ++
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT---------------SLAEQPYQGLSNEQ 240
Query: 578 SLELIDKSLDGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 633
            L+ +   +DG Y L +   C +    +  +C Q  P  RP    +V +L  +     P+
Sbjct: 241 VLKFV---MDGGY-LDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFPE 296
Query: 634 QPGFFTERN 642
              F +E N
Sbjct: 297 VSFFHSEEN 305

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 98  GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 149
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 208
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELM 231

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAV-KRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           +LG+G FG VY+    E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
              +   ++ E+    +++  + ++ R   L  S+   + +     L YLH +   +IIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-----DGL 530
           RDLKA N+L   D + K++DFG++      +     D  +GT  +M+PE  +     D  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNT--RXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 531 FSVKSDVFSFGVLVLEI 547
           +  K+DV+S G+ ++E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 119
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E         K D++S GVL  E + GK
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 97  GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 148
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 207
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELM 230

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 90  GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 141
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 200
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELM 223

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEV 397
           D       LGEG FG V   +L E             ++AVK L S ++ + + +  +E+
Sbjct: 20  DRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 76
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR----- 451
            ++  + +H+N++ LLG CT      +I EY    +L +++    R   L++S       
Sbjct: 77  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNP 135
Query: 452 ---------CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
                          +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR  
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 192
Query: 503 -GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +D  +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 193 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 351 NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           N+     +G+G F  V   R +LT G+E+AVK + K+  +   +++   EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+L           L+ EY      E F + V   +  +   R +  + I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCH 130
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
           Q     I+HRDLKA N+LLD DMN KI+DFG +  F         D   G     SP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCG-----SPPYA 179
Query: 527 IDGLFSVKS------DVFSFGVLVLEIVCG 550
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 98  GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 149
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 208
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 93  GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 144
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 203
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELM 226

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 96  GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 147
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 206
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELM 229

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I  Y    +L +++           +D+ R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 116 GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 167
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 226
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELM 249

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 117 GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 168
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 227
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELM 250

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 358 LGEGGFGPVYRGML--TEGQEI--AVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG VY G L   +G++I  AVK L++ +  G V +F  E +++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 413 GCCTLRDE--RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--IARGLLYLHQD 468
           G C LR E   +++  Y+ +  L  FI + T       + +  I  G  +A+G+ YL   
Sbjct: 95  GIC-LRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKGMKYL--- 146
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
           +  + +HRDL A N +LD     K++DFG+AR    D+   +     G      +M+ E 
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 205
Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                F+ KSDV+SFGVL+ E++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELM 228

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N  +   LG G FG V        G+E     +AVK L S +     E   +E+ +++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--------------------FDVT 441
           L QH N+V LLG CT     ++I EY     L  F+                     D  
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 442 RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
             + L+          +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
              D              +M+PE   D +++V+SDV+S+G+L+ EI
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKLQH 405
           ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N++RL G         LI EY P  ++ + +  ++R    D  +    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYC 128
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R+IHRD+K  N+LL ++   KI+DFG    + V    +    + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCG 550
               +   K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI++FG    + V    +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 347 DATDNFSWK--NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
           D   N  W+   +LG+G FG VY+    E G   A K +   S + +E++  E+ ++A  
Sbjct: 6   DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H  +V+LLG      +  ++ E+ P  +++  + ++ R   L   +   +   +   L 
Sbjct: 66  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALN 123
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           +LH     RIIHRDLKA NVL+  + + +++DFG++      +T    D  +GT  +M+P
Sbjct: 124 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMAP 178
Query: 524 EYAI-----DGLFSVKSDVFSFGVLVLEI 547
           E  +     D  +  K+D++S G+ ++E+
Sbjct: 179 EVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEV 397
           D       LGEG FG V   +L E             ++AVK L S ++ + + +  +E+
Sbjct: 28  DRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 84
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR----- 451
            ++  + +H+N++ LLG CT      +I EY    +L +++    R   L++S       
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNP 143
Query: 452 ---------CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
                          +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR  
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 503 -GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +D  +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 201 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 355 KNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRL- 411
           K +LG GGFG V R +  + G+++A+K+  +  S +  E +  E+ ++ KL H N+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 412 -----LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
                L      D  +L  EY     L +++        L       ++  I+  L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 467 QDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           ++   RIIHRDLK  N++L      +  KI D G A+    DQ E  T+  VGT  Y++P
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGTLQYLAP 192
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
           E      ++V  D +SFG L  E + G R
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 347 DATDNFSWK--NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
           D   N  W+   +LG+G FG VY+    E G   A K +   S + +E++  E+ ++A  
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC 73
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H  +V+LLG      +  ++ E+ P  +++  + ++ R   L   +   +   +   L 
Sbjct: 74  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALN 131
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           +LH     RIIHRDLKA NVL+  + + +++DFG++      +T    D  +GT  +M+P
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMAP 186
Query: 524 EYAI-----DGLFSVKSDVFSFGVLVLEI 547
           E  +     D  +  K+D++S G+ ++E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 355 KNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRL- 411
           K +LG GGFG V R +  + G+++A+K+  +  S +  E +  E+ ++ KL H N+V   
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 412 -----LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
                L      D  +L  EY     L +++        L       ++  I+  L YLH
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 467 QDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           ++   RIIHRDLK  N++L      +  KI D G A+    DQ E  T+  VGT  Y++P
Sbjct: 140 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGTLQYLAP 193
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
           E      ++V  D +SFG L  E + G R
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEV 397
           D       LGEG FG V   +L E             ++AVK L S ++ + + +  +E+
Sbjct: 21  DRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 77
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR----- 451
            ++  + +H+N++ LLG CT      +I EY    +L +++    R   L++S       
Sbjct: 78  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNP 136
Query: 452 ---------CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
                          +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR  
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 193
Query: 503 -GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +D  +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 194 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEV 397
           D       LGEG FG V   +L E             ++AVK L S ++ + + +  +E+
Sbjct: 17  DRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 73
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR----- 451
            ++  + +H+N++ LLG CT      +I EY    +L +++    R   L++S       
Sbjct: 74  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNP 132
Query: 452 ---------CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
                          +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR  
Sbjct: 133 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 189
Query: 503 -GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +D  +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 190 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 103/216 (47%), Gaps = 16/216 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSS--GQGVE-EFKNEVLLIAKLQH 405
           D+F     LG+G FG VY     +   I A+K L KS    +GVE + + E+ + A L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N++RL      R    LI EY P   L +   ++ ++   D  +   I+E +A  L+Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYK---ELQKSCTFDEQRTATIMEELADALMYC 139
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     ++IHRD+K  N+LL      KI+DFG    + V         + GT  Y+ PE 
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPEM 192
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
               + + K D++  GVL  E++ G  N  F  A H
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVG--NPPFESASH 226

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 115/246 (46%), Gaps = 40/246 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     +  G +IAVK+LS+     +   +   E+ L+
Sbjct: 45  TIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL 104
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P  SLE+F  ++ VT     D +   +CQ   
Sbjct: 105 KHMKHENVIGLLDVFT------------PATSLEEFNDVYLVTHLMGADLNNIVKCQKLT 152
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 153 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 204
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
           +      V T  Y +PE  ++ + +++  D++S G ++ E++ G   R  +    H N L
Sbjct: 205 DDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG---RTLFPGTDHINQL 261
Query: 567 GHAWRL 572
               RL
Sbjct: 262 QQIMRL 267

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 125
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI++FG    + V    +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAV----KRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG V++G+ + EG+ I +    K +   SG Q  +   + +L I  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 412 LGCCTLRDERMLIYEYLPNKSL----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C       L+ +YLP  SL     Q    +     L+W  +      IA+G+ YL +
Sbjct: 99  LGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 151
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
                ++HR+L A NVLL +    +++DFG+A     D  +           +M+ E   
Sbjct: 152 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 528 DGLFSVKSDVFSFGVLVLEIVC 549
            G ++ +SDV+S+GV V E++ 
Sbjct: 209 FGKYTHQSDVWSYGVTVWELMT 230

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEV 397
           D       LGEG FG V   +L E             ++AVK L S ++ + + +  +E+
Sbjct: 69  DRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR----- 451
            ++  + +H+N++ LLG CT      +I EY    +L +++    R   L++S       
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNP 184
Query: 452 ---------CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
                          +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR  
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 503 -GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +D  +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 242 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAV----KRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRL 411
           LG G FG V++G+ + EG+ I +    K +   SG Q  +   + +L I  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 412 LGCCTLRDERMLIYEYLPNKSL----EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           LG C       L+ +YLP  SL     Q    +     L+W  +      IA+G+ YL +
Sbjct: 81  LGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 133
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
                ++HR+L A NVLL +    +++DFG+A     D  +           +M+ E   
Sbjct: 134 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 528 DGLFSVKSDVFSFGVLVLEIVC 549
            G ++ +SDV+S+GV V E++ 
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEV 397
           D       LGEG FG V   +L E             ++AVK L S ++ + + +  +E+
Sbjct: 28  DRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 84
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS------- 449
            ++  + +H+N++ LLG CT      +I EY    +L +++    R   L++S       
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEFSFNPSHNP 143
Query: 450 -------KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
                          +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR  
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 503 -GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +D  +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 201 HHIDXXKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 38/283 (13%)
Query: 358 LGEGGFGPVYRGMLTE----GQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           LGEG FG V  G L +      ++AVK  +L  SS + +EEF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 412 LGCCTLRDER-----MLIYEYLPNKSLEQFIFDV---TRTKFLDWSKRCQIIEGIARGLL 463
           LG C     +     M+I  ++    L  ++      T  K +      + +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YL   S    +HRDL A N +L +DM   ++DFG+++                   +++ 
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL---LGHAWRLWTEDRSLE 580
           E   D +++ KSDV++FGV + EI    R    Y    +H +   L H  RL   +  L 
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEI--ATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCL- 275
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
             D+  +  YS             C +  P DRP  S + L L
Sbjct: 276 --DELYEIMYS-------------CWRTDPLDRPTFSVLRLQL 303

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 357 KLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSS---------GQGVEEFK----NEVLLIAK 402
           KLG G +G V       G  E A+K + KS           + +E+F     NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           L H N+++L      +    L+ E+     L + I  + R KF D      I++ I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKF-DECDAANIMKQILSGI 159
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
            YLH+ +   I+HRD+K  N+LL+N    +N KI DFG++  F  D      DR +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDR-LGTAY 213
Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           Y++PE  +   ++ K DV+S GV++  ++CG
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 351 NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           N+     +G+G F  V   R +LT G+E+AV+ + K+  +   +++   EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+L           L+ EY      E F + V   +  +   R +  + I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCH 130
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
           Q     I+HRDLKA N+LLD DMN KI+DFG +  F         D   G     SP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDEFCG-----SPPYA 179
Query: 527 IDGLFSVKS------DVFSFGVLVLEIVCG 550
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 351 NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           N+     +G+G F  V   R +LT G+E+AVK + K+  +   +++   EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+L           L+ EY      E F + V   +  +   R +  + I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCH 130
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
           Q     I+HRDLKA N+LLD DMN KI+DFG +  F         D   G   Y +PE  
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDAFCGAPPYAAPE-- 182
Query: 527 IDGLFSVKS------DVFSFGVLVLEIVCG 550
              LF  K       DV+S GV++  +V G
Sbjct: 183 ---LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY     + + I A+K L K+  +  GVE + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     R+IHRD+K  N+LL +    KI+DFG    +      +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 134/307 (43%), Gaps = 62/307 (20%)
Query: 358 LGEGGFGPVYRG-MLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC-- 414
           +G GGFG V++     +G+   ++R+  ++    E+ + EV  +AKL H N+V   GC  
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 415 -----CTLRDERMLIYEYLPNKS----------------------LEQFIFDVTRTKFLD 447
                    D+ +   +Y P  S                      LEQ+I +  R + LD
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLD 134
Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                ++ E I +G+ Y+H     ++IHRDLK SN+ L +    KI DFG+  +    + 
Sbjct: 135 KVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL---KN 188
Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 567
           +    R  GT  YMSPE      +  + D+++ G+++ E++            H  +   
Sbjct: 189 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL------------HVCDTAF 236
Query: 568 HAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 627
              + +T+ R   + D       +L + L         + ++PEDRPN S ++  L+  +
Sbjct: 237 ETSKFFTDLRDGIISDIFDKKEKTLLQKL---------LSKKPEDRPNTSEILRTLTVWK 287
Query: 628 SLPQPKQ 634
             P+  +
Sbjct: 288 KSPEKNE 294

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVY--------RGMLTEGQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V         +    E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----------FDVTRT--KFL 446
             + +H+N++ LLG CT      +I  Y    +L +++           +D+ R   + +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVD 505
            +         +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    +D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 YYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           LG+G +G VY G  L+    IA+K + +   +  +    E+ L   L+H+N+V+ LG  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII----EGIARGLLYLHQDSRLR 472
                 +  E +P  SL   +    R+K+       Q I    + I  GL YLH +   +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 473 IIHRDLKASNVLLDNDMNP-KISDFGMA-RAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
           I+HRD+K  NVL++      KISDFG + R  G++     T+   GT  YM+PE    G 
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGP 199
Query: 531 --FSVKSDVFSFGVLVLEIVCGK 551
             +   +D++S G  ++E+  GK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 351 NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           N+     +G+G F  V   R +LT G+E+AV+ + K+  +   +++   EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+L           L+ EY      E F + V   +  +   R +  + I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQ-IVSAVQYCH 130
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
           Q     I+HRDLKA N+LLD DMN KI+DFG +  F         D   G     SP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCG-----SPPYA 179
Query: 527 IDGLFSVKS------DVFSFGVLVLEIVCG 550
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 358 LGEGGFGPVYRGMLT-EGQE---IAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V  G L   G+    +A+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M+I E++ N SL+ F+      F V +           ++ GIA G+ YL 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL--------VGMLRGIAAGMKYL- 151
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG---TYGYMSP 523
             + +  +HRDL A N+L+++++  K+SDFG++R    D ++      +G      + +P
Sbjct: 152 --ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
           E      F+  SDV+S+G+++ E++  G+R                 W +  +D     +
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPY---------------WDMTNQD-----V 249
Query: 583 DKSLDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVV 620
             +++  Y L   + C     Q+ L C Q+    RP    +V
Sbjct: 250 INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 291

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQ--GVE-EFKNEVLLIAKL 403
           A ++F     LG+G FG VY       + I A+K L K+  +  GVE + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++RL G         LI EY P  ++ +   ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALS 122
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H     ++IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLS--KSSGQGVEEFKNE 396
           F  N     +DN+  K +LG+G F  V R +  T G E A K ++  K S +  ++ + E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456
             +  KLQH N+VRL           L+++ +    L +   D+   +F   +     I+
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQ 135
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDR 513
            I   + Y H +    I+HR+LK  N+LL +       K++DFG+A    V+ +EA    
Sbjct: 136 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHG 189
Query: 514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
             GT GY+SPE      +S   D+++ GV++  ++ G     F+  D H
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQH 236

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 107/205 (52%), Gaps = 25/205 (12%)
Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V RG L   G++   +A+K L    + +   EF +E  ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M++ E++ N +L+ F+      F V +           ++ GIA G+ YL 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL--------VGMLRGIASGMRYLA 133
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG---TYGYMSP 523
           +   +  +HRDL A N+L+++++  K+SDFG++R    + ++      +G      + +P
Sbjct: 134 E---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIV 548
           E      F+  SD +S+G+++ E++
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVM 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 107/205 (52%), Gaps = 25/205 (12%)
Query: 358 LGEGGFGPVYRGML-TEGQE---IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V RG L   G++   +A+K L    + +   EF +E  ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M++ E++ N +L+ F+      F V +           ++ GIA G+ YL 
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL--------VGMLRGIASGMRYLA 135
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG---TYGYMSP 523
           +   +  +HRDL A N+L+++++  K+SDFG++R    + ++      +G      + +P
Sbjct: 136 E---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIV 548
           E      F+  SD +S+G+++ E++
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           LG+G +G VY G  L+    IA+K + +   +  +    E+ L   L+H+N+V+ LG  +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII----EGIARGLLYLHQDSRLR 472
                 +  E +P  SL   +    R+K+       Q I    + I  GL YLH +   +
Sbjct: 76  ENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 128
Query: 473 IIHRDLKASNVLLDNDMNP-KISDFGMA-RAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
           I+HRD+K  NVL++      KISDFG + R  G++     T+   GT  YM+PE    G 
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEIIDKGP 185
Query: 531 --FSVKSDVFSFGVLVLEIVCGK 551
             +   +D++S G  ++E+  GK
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGK 208

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 36/226 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEV 397
           D       LGEG FG V   +L E             ++AVK L S ++ + + +  +E+
Sbjct: 13  DRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDW-------- 448
            ++  + +H+N++ LLG CT      +I EY    +L +++    R   L++        
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNP 128
Query: 449 ------SKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
                          +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR  
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 503 -GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +D  +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 186 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 36/226 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEV 397
           D       LGEG FG V   +L E             ++AVK L S ++ + + +  +E+
Sbjct: 28  DRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 84
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDW-------- 448
            ++  + +H+N++ LLG CT      +I EY    +L +++    R   L++        
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNP 143
Query: 449 ------SKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
                          +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR  
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 503 -GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +D  +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 201 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 405
           +DN+  K +LG+G F  V R +  T G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+VRL           L+++ +    L +   D+   +F   +     I+ I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 121
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           H +    I+HR+LK  N+LL +       K++DFG+A    V+ +EA      GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
           PE      +S   D+++ GV++  ++ G     F+  D H
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQH 213

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNE--VLLIA 401
             DNF +   LG+G FG V    + E G   AVK L K        VE    E  +L +A
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
           +  H  L +L  C    D    + E++    L   +F + +++  D ++       I   
Sbjct: 81  R-NHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISA 136
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L++LH      II+RDLK  NVLLD++ + K++DFGM +  G+      T    GT  Y+
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNG-VTTATFCGTPDYI 191
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +PE   + L+    D ++ GVL+ E++CG
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           +G+G FG VY G       I +  + + +   ++ FK EV+   + +H N+V  +G C  
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD 477
                +I      ++L   + D      LD +K  QI + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY-----------MSPEYA 526
           LK+ NV  DN     I+DFG+    GV Q     D++    G+           +SP+  
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 527 IDGL-FSVKSDVFSFGVLVLEI 547
            D L FS  SDVF+ G +  E+
Sbjct: 215 EDKLPFSKHSDVFALGTIWYEL 236

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 405
           +DN+  K +LG+G F  V R +  T G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+VRL           L+++ +    L +   D+   +F   +     I+ I   + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           H +    I+HR+LK  N+LL +       K++DFG+A    V+ +EA      GT GY+S
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 174
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
           PE      +S   D+++ GV++  ++ G     F+  D H
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQH 212

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 82  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 181
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 405
           +DN+  K +LG+G F  V R +  T G E A K ++  K S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+VRL           L+++ +    L +   D+   +F   +     I+ I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 121
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           H +    I+HR+LK  N+LL +       K++DFG+A    V+ +EA      GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPGYLS 175
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
           PE      +S   D+++ GV++  ++ G     F+  D H
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQH 213

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 351 NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           N+     +G+G F  V   R +LT G+E+AVK + K+  +   +++   EV ++  L H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+L           L+ EY      E F + V      +   R +  + I   + Y H
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGWMKEKEARAKFRQ-IVSAVQYCH 123
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
           Q     I+HRDLKA N+LLD DMN KI+DFG +  F         D   G     SP YA
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCG-----SPPYA 172
Query: 527 IDGLFSVKS------DVFSFGVLVLEIVCG 550
              LF  K       DV+S GV++  +V G
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 72  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 96  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 144 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 195
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 196 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 36/226 (15%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-----------QEIAVKRL-SKSSGQGVEEFKNEV 397
           D       LGEG FG V   +L E             ++AVK L S ++ + + +  +E+
Sbjct: 28  DRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 84
Query: 398 LLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR----- 451
            ++  + +H+N++ LLG CT      +I EY    +L +++        L++S       
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QAREPPGLEYSYNPSHNP 143
Query: 452 ---------CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
                          +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR  
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 503 -GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +D  +  T+  +    +M+PE   D +++ +SDV+SFGVL+ EI
Sbjct: 201 HHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 95  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 143 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 194
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 195 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 96  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 144 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 195
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 196 DDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 72  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 172 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LSK     +   +   E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 88  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 136 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 187
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 188 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 21  TIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 81  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 180
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 81  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 180
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +     +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 26  TIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 86  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 133
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 134 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 185
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 186 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 87  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 135 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 186
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 187 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 82  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 181
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 340 FDWNTIADATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSK---SSGQGVEEFK 394
           F  ++ A  +D +  +  LG+G FG V   +  +T GQE AVK +SK         E   
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLL 74
Query: 395 NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRC 452
            EV L+ +L H N+ +L      +    L+ E      L    FD  ++R +F +     
Sbjct: 75  REVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDA-A 129
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEA 509
           +II  +  G+ Y H++   +I+HRDLK  N+LL++   D N +I DFG++  F   +   
Sbjct: 130 RIIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXK 186
Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +    +GT  Y++PE  + G +  K DV+S GV++  ++ G
Sbjct: 187 DK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 82  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HT 181
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 82  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 181
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 81  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 180
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 78  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 177
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 78  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HT 177
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 78  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 177
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 81  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 180
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 73  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 121 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 172
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 173 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 15  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 75  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 122
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 123 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 174
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 175 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 78  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 177
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYR--GMLTEGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+G FG V +    +T+ QE AVK ++K+S +         EV L+ KL H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                    ++ E      L    FD + + K        +II+ +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 473 IIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
           I+HRDLK  N+LL++   D + KI DFG++  F   Q     DR +GT  Y++PE  + G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDR-IGTAYYIAPE-VLRG 197
Query: 530 LFSVKSDVFSFGVLVLEIVCG 550
            +  K DV+S GV++  ++ G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 83  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 183 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 88  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 136 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 187
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 188 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 88  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 136 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 187
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 188 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQGVE-EFKNEVLL 399
           W    D  D + +++ LG G F  V        Q+ +A+K ++K + +G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGI 458
           + K++H N+V L           LI + +    L    FD +    F       ++I  +
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQV 125
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVL---LDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
              + YLH    L I+HRDLK  N+L   LD D    ISDFG+++   ++   +      
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           GT GY++PE      +S   D +S GV+   ++CG
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 87  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 135 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 186
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 187 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 96  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 144 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 195
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 196 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 72  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 99  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 147 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 198
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 199 DDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 95  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 143 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 194
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 195 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 14  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 74  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 121
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 122 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 173
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 174 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 99  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 147 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 198
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 199 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 73  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 121 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 172
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 173 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYR--GMLTEGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+G FG V +    +T+ QE AVK ++K+S +         EV L+ KL H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                    ++ E      L    FD + + K        +II+ +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 473 IIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
           I+HRDLK  N+LL++   D + KI DFG++  F   Q     DR +GT  Y++PE  + G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDR-IGTAYYIAPE-VLRG 197
Query: 530 LFSVKSDVFSFGVLVLEIVCG 550
            +  K DV+S GV++  ++ G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQGVE-EFKNEVLL 399
           W    D  D + +++ LG G F  V        Q+ +A+K ++K + +G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGI 458
           + K++H N+V L           LI + +    L    FD +    F       ++I  +
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQV 125
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVL---LDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
              + YLH    L I+HRDLK  N+L   LD D    ISDFG+++   ++   +      
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           GT GY++PE      +S   D +S GV+   ++CG
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQGVE-EFKNEVLL 399
           W    D  D + +++ LG G F  V        Q+ +A+K ++K + +G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGI 458
           + K++H N+V L           LI + +    L    FD +    F       ++I  +
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQV 125
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVL---LDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
              + YLH    L I+HRDLK  N+L   LD D    ISDFG+++   ++   +      
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           GT GY++PE      +S   D +S GV+   ++CG
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 356 NKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRLLG 413
            ++G G FG V+ G L  +   +AVK   ++    ++ +F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
            CT +    ++ E +       F+   T    L      Q++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMAR--AFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
           IHRDL A N L+      KISDFGM+R  A GV        +V     + +PE    G +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV--PVKWTAPEALNYGRY 292
Query: 532 SVKSDVFSFGVLVLE 546
           S +SDV+SFG+L+ E
Sbjct: 293 SSESDVWSFGILLWE 307

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQGVE-EFKNEVLL 399
           W    D  D + +++ LG G F  V        Q+ +A+K ++K + +G E   +NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGI 458
           + K++H N+V L           LI + +    L    FD +    F       ++I  +
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQV 125
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVL---LDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
              + YLH    L I+HRDLK  N+L   LD D    ISDFG+++   ++   +      
Sbjct: 126 LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTAC 179
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           GT GY++PE      +S   D +S GV+   ++CG
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 358 LGEGGFGPVYR--GMLTEGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+G FG V +    +T+ QE AVK ++K+S +         EV L+ KL H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                    ++ E      L    FD + + K        +II+ +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 473 IIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
           I+HRDLK  N+LL++   D + KI DFG++  F   Q     DR +GT  Y++PE  + G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDR-IGTAYYIAPE-VLRG 197
Query: 530 LFSVKSDVFSFGVLVLEIVCG 550
            +  K DV+S GV++  ++ G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 83  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
                  V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 51/305 (16%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           +G G FG V +      +++A+K++   S +  + F  E+  ++++ H N+V+L G C  
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 418 RDERMLIYEYLPNKSLEQFIFDV------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
            +   L+ EY    SL   +         T    + W  +C      ++G+ YLH     
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 125
Query: 472 RIIHRDLKASNVLL-DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            +IHRDLK  N+LL       KI DFG A      QT    ++  G+  +M+PE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFEGSN 180
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR-LW-----TEDRSLELIDK 584
           +S K DVFS+G+++ E++   R + F        + G A+R +W     T    ++ + K
Sbjct: 181 YSEKCDVFSWGIILWEVI--TRRKPF------DEIGGPAFRIMWAVHNGTRPPLIKNLPK 232
Query: 585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV-LMLSGERSLPQPKQP-GFFTERN 642
            ++   +             C  + P  RP+M  +V +M    R  P   +P  +  + +
Sbjct: 233 PIESLMT------------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 280
Query: 643 LPESE 647
           LP  E
Sbjct: 281 LPPGE 285

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 50/282 (17%)
Query: 358 LGEGGFGPVYRGMLT-EGQE---IAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V  G L   G+    +A+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M+I E++ N SL+ F+      F V +           ++ GIA G+ YL 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL--------VGMLRGIAAGMKYL- 125
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG---TYGYMSP 523
             + +  +HR L A N+L+++++  K+SDFG++R    D ++      +G      + +P
Sbjct: 126 --ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
           E      F+  SDV+S+G+++ E++  G+R                 W +  +D     +
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPY---------------WDMTNQD-----V 223
Query: 583 DKSLDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVV 620
             +++  Y L   + C     Q+ L C Q+    RP    +V
Sbjct: 224 INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 265

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 83  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
                  V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 127/298 (42%), Gaps = 48/298 (16%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQ------EIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N      LGEG FG V +      +       +AVK L + +S   + +  +E  ++ ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-------------KFLDWSK 450
            H ++++L G C+     +LI EY    SL  F+ +  +                LD   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 451 RCQIIEG--------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
              +  G        I++G+ YL   + ++++HRDL A N+L+      KISDFG++R  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH 561
             + +     +      +M+ E   D +++ +SDV+SFGVL+ EIV  G         + 
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             NLL    R+   D   E             E  R +   L C +Q P+ RP  + +
Sbjct: 261 LFNLLKTGHRMERPDNCSE-------------EMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 51/305 (16%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           +G G FG V +      +++A+K++   S +  + F  E+  ++++ H N+V+L G C  
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 418 RDERMLIYEYLPNKSLEQFIFDV------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
            +   L+ EY    SL   +         T    + W  +C      ++G+ YLH     
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 124
Query: 472 RIIHRDLKASNVLL-DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            +IHRDLK  N+LL       KI DFG A      QT    ++  G+  +M+PE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFEGSN 179
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR-LW-----TEDRSLELIDK 584
           +S K DVFS+G+++ E++   R + F        + G A+R +W     T    ++ + K
Sbjct: 180 YSEKCDVFSWGIILWEVI--TRRKPF------DEIGGPAFRIMWAVHNGTRPPLIKNLPK 231
Query: 585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV-LMLSGERSLPQPKQP-GFFTERN 642
            ++   +             C  + P  RP+M  +V +M    R  P   +P  +  + +
Sbjct: 232 PIESLMT------------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279
Query: 643 LPESE 647
           LP  E
Sbjct: 280 LPPGE 284

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 83  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
                  V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 131/288 (45%), Gaps = 58/288 (20%)
Query: 358 LGEGGFGPVYRGMLT----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G FG V  G L         +A+K L    + +   +F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFI------FDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           G  T     M++ E++ N +L+ F+      F V +           ++ GIA G+ YL 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL--------VGMLRGIAAGMRYL- 161
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------Y 520
             + +  +HRDL A N+L+++++  K+SDFG++R       E + + V  T G      +
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-----EDDPEAVYTTTGGKIPVRW 214
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
            +PE      F+  SDV+S+G+++ E++  G+R                 W +  +D   
Sbjct: 215 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------------YWDMSNQD--- 256
Query: 580 ELIDKSLDGSYSLSEALRCI----QVGLLCVQQRPEDRPNMSSVVLML 623
             + K+++  Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 257 --VIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 351 NFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           N+     +G+G F  V   R +LT G+E+AVK + K+  +   +++   EV +   L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+L           L+ EY      E F + V   +  +   R +  + I   + Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGG--EVFDYLVAHGRXKEKEARAKFRQ-IVSAVQYCH 130
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
           Q     I+HRDLKA N+LLD D N KI+DFG +  F         D   G   Y +PE  
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN---KLDAFCGAPPYAAPE-- 182
Query: 527 IDGLFSVKS------DVFSFGVLVLEIVCG 550
              LF  K       DV+S GV++  +V G
Sbjct: 183 ---LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 356 NKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVE-EFKNEVLLIAKLQHRNLVRLLG 413
            ++G G FG V+ G L  +   +AVK   ++    ++ +F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
            CT +    ++ E +       F+   T    L      Q++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMAR--AFGVDQTEANTDRVVGTYGYMSPEYAIDGLF 531
           IHRDL A N L+      KISDFGM+R  A GV        +V     + +PE    G +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEALNYGRY 292
Query: 532 SVKSDVFSFGVLVLE 546
           S +SDV+SFG+L+ E
Sbjct: 293 SSESDVWSFGILLWE 307

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +C    
Sbjct: 72  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCAKLT 119
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI D+G+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 127/298 (42%), Gaps = 48/298 (16%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQ------EIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N      LGEG FG V +      +       +AVK L + +S   + +  +E  ++ ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-------------KFLDWSK 450
            H ++++L G C+     +LI EY    SL  F+ +  +                LD   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 451 RCQIIEG--------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
              +  G        I++G+ YL   + ++++HRDL A N+L+      KISDFG++R  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH 561
             + +     +      +M+ E   D +++ +SDV+SFGVL+ EIV  G         + 
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             NLL    R+   D   E             E  R +   L C +Q P+ RP  + +
Sbjct: 261 LFNLLKTGHRMERPDNCSE-------------EMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 113/222 (50%), Gaps = 36/222 (16%)
Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQ-HRNLVRL 411
           KLG+G +G V++ +    G+ +AVK++    ++S      F+ E++++ +L  H N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 412 LGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           L      ++R   L+++Y+     E  +  V R   L+   +  ++  + + + YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAF------------GVDQTEANTD----- 512
              ++HRD+K SN+LL+ + + K++DFG++R+F             +++   N D     
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 513 --RVVGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 551
               V T  Y +PE  +      K  D++S G ++ EI+CGK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHR 406
           F +K  LG G F  V   +L E    G+  AVK + K + +G E   +NE+ ++ K++H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGLLYL 465
           N+V L       +   L+ + +    L    FD +    F        +I  +   + YL
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYL 136
Query: 466 HQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           H   R+ I+HRDLK  N+L    D +    ISDFG+++  G     +      GT GY++
Sbjct: 137 H---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA---CGTPGYVA 190
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           PE      +S   D +S GV+   ++CG
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DF +AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQ------EIAVKRLSK-SSGQGVEEFKNEVLLIAKL 403
           N      LGEG FG V +      +       +AVK L + +S   + +  +E  ++ ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-------------KFLDWSK 450
            H ++++L G C+     +LI EY    SL  F+ +  +                LD   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 451 RCQIIEG--------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
              +  G        I++G+ YL   + + ++HRDL A N+L+      KISDFG++R  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH 561
             + +     +      +M+ E   D +++ +SDV+SFGVL+ EIV  G         + 
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             NLL    R+   D   E             E  R +   L C +Q P+ RP  + +
Sbjct: 261 LFNLLKTGHRMERPDNCSE-------------EMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSKRCQ----- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +     
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 16/216 (7%)
Query: 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI--AVKRLSKSSGQGVEEFKNEV 397
           F  +T  D    ++ +N +G G +G V +  + +G  I  A K++ K   + V+ FK E+
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 398 LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG 457
            ++  L H N++RL        +  L+ E      L +    V   +    S   +I++ 
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE---RVVHKRVFRESDAARIMKD 131
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLL--DNDMNP-KISDFGMARAFGVDQTEANTDRV 514
           +   + Y H   +L + HRDLK  N L   D+  +P K+ DFG+A  F   +        
Sbjct: 132 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--- 185
Query: 515 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           VGT  Y+SP+  ++GL+  + D +S GV++  ++CG
Sbjct: 186 VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 113/253 (44%), Gaps = 26/253 (10%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVE--EFKNEVL 398
           I    ++F     LG+G FG V+     +  Q  A+K L K        VE    +  VL
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
            +A  +H  L  +      ++    + EYL    L   ++ +      D S+       I
Sbjct: 73  SLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 128
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
             GL +LH      I++RDLK  N+LLD D + KI+DFGM +   +   +A T+   GT 
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNEFCGTP 183
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL------ 572
            Y++PE  +   ++   D +SFGVL+ E++ G+     +H      L  H+ R+      
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELF-HSIRMDNPFYP 239
Query: 573 -WTEDRSLELIDK 584
            W E  + +L+ K
Sbjct: 240 RWLEKEAKDLLVK 252

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 138 KYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 142 KYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 138 KYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 356 NKLGEGGFGPVYRGM--LTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           +KLGEG +  VY+G   LT+   +A+K  RL    G      + EV L+  L+H N+V L
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 65
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                      L++EYL +K L+Q++ D      ++       +  + RGL Y H   R 
Sbjct: 66  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH---RQ 119
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL- 530
           +++HRDLK  N+L++     K++DFG+ARA  +       D  V T  Y  P+  +    
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTD 177
Query: 531 FSVKSDVFSFGVLVLEIVCGK 551
           +S + D++  G +  E+  G+
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 26  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 85
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 145
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 146 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 202
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 247

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 138 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 82
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 142
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 143 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 199
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 244

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 24  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 83
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 143
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 144 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 200
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 245

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 15  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 74
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 134
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 135 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 191
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 236

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 142 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 138 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 79
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 139
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 140 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 241

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 142 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 198
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 82
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 142
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 143 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYR 199
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 244

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGVEEFK-NEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLR 81
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 142 KYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 137
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 138 KYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 194
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 38  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 97
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 157
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 158 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 259

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 16  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 75
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 135
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 136 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 237

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 117/251 (46%), Gaps = 30/251 (11%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ 404
           AT  +    ++G G +G VY+      G  +A+K +   +G+         EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 405 ---HRNLVRLLG-CCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456
              H N+VRL+  C T R +R     L++E++ ++ L  ++ D      L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
              RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +     +   D VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL---- 572
           T  Y +PE  +   ++   D++S G +  E+    R +  +  +   + LG  + L    
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDLIGLP 230
Query: 573 ----WTEDRSL 579
               W  D SL
Sbjct: 231 PEDDWPRDVSL 241

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 16  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 75
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 135
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 136 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 237

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSKRCQ----- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +     
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQ 404
           D F +K KLG G FG V+   L E    G E  +K ++K   Q  +E+ + E+ ++  L 
Sbjct: 22  DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLP-NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           H N++++           ++ E     + LE+ +    R K L      ++++ +   L 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTYG 519
           Y H      ++H+DLK  N+L   D +P    KI DFG+A  F  D+   N     GT  
Sbjct: 139 YFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTAL 191
Query: 520 YMSPE-YAIDGLFSVKSDVFSFGVLVLEIVCG 550
           YM+PE +  D  F  K D++S GV++  ++ G
Sbjct: 192 YMAPEVFKRDVTF--KCDIWSAGVVMYFLLTG 221

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI  FG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLS-KSSGQGVEEFK-NEVLLIAK 402
           A + D +    KLGEG +G VY+ + T   E +A+KR+  +   +GV      EV L+ +
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC--QIIEGIAR 460
           LQHRN++ L           LI+EY  N  L++++      K  D S R     +  +  
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-----DKNPDVSMRVIKSFLYQLIN 143
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLL---DNDMNP--KISDFGMARAFGVDQTEANTDRVV 515
           G+ + H  SR R +HRDLK  N+LL   D    P  KI DFG+ARAFG+   +   + + 
Sbjct: 144 GVNFCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199
Query: 516 GTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIV 548
            T  Y  PE  +    +S   D++S   +  E++
Sbjct: 200 -TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 113/253 (44%), Gaps = 26/253 (10%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVE--EFKNEVL 398
           I    ++F     LG+G FG V+     +  Q  A+K L K        VE    +  VL
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
            +A  +H  L  +      ++    + EYL    L   ++ +      D S+       I
Sbjct: 72  SLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 127
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
             GL +LH      I++RDLK  N+LLD D + KI+DFGM +   +   +A T+   GT 
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNXFCGTP 182
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL------ 572
            Y++PE  +   ++   D +SFGVL+ E++ G+     +H      L  H+ R+      
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELF-HSIRMDNPFYP 238
Query: 573 -WTEDRSLELIDK 584
            W E  + +L+ K
Sbjct: 239 RWLEKEAKDLLVK 251

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ + A L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI D G+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKL 403
           A   +    ++GEG +G V+  R +   G+ +A+KR+   +G+         EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 404 Q---HRNLVRLLGCCTL-RDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
           +   H N+VRL   CT+ R +R     L++E++ ++ L  ++  V        + +  + 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
           + + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +       +   VV
Sbjct: 128 Q-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VV 180
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            T  Y +PE  +   ++   D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++  
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLA 79
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 139
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 140 KYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 241

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSS--GQGVE-EFKNEVLLIAKL 403
             D+F     LG+G FG VY     + + I A+K L KS    +GVE + + E+ + + L
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++R+      R    L+ E+ P   L +   ++ +    D  +    +E +A  L 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYK---ELQKHGRFDEQRSATFMEELADALH 129
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H+    ++IHRD+K  N+L+      KI+DFG    + V         + GT  Y+ P
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 182
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E         K D++  GVL  E + G
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG    
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 418 RDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
               + ++ EY+   SL  ++    R+  L      +    +   + YL  ++    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT--YGYMSPEYAIDGLFSVK 534
           DL A NVL+  D   K+SDFG+ +       EA++ +  G     + +PE   +  FS K
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAAFSTK 185
Query: 535 SDVFSFGVLVLEI 547
           SDV+SFG+L+ EI
Sbjct: 186 SDVWSFGILLWEI 198

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSS--GQGVE-EFKNEVLLIAKL 403
             D+F     LG+G FG VY     + + I A+K L KS    +GVE + + E+ + + L
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H N++R+      R    L+ E+ P   L +   ++ +    D  +    +E +A  L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYK---ELQKHGRFDEQRSATFMEELADALH 128
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           Y H+    ++IHRD+K  N+L+      KI+DFG    + V         + GT  Y+ P
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 181
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E         K D++  GVL  E + G
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQHRNLVRLLG 413
           LG GGFG V+   M   G+  A K+L+K   +  + ++  ++   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-IARGLLYLHQDSRLR 472
               + +  L+   +    +   I++V          R       I  GL +LHQ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           II+RDLK  NVLLD+D N +ISD G+A      QT+  T    GT G+M+PE  +   + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 533 VKSDVFSFGVLVLEIVCGK---RNRG 555
              D F+ GV + E++  +   R RG
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQHRNLVRLLG 413
           LG GGFG V+   M   G+  A K+L+K   +  + ++  ++   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-IARGLLYLHQDSRLR 472
               + +  L+   +    +   I++V          R       I  GL +LHQ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           II+RDLK  NVLLD+D N +ISD G+A      QT+  T    GT G+M+PE  +   + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 533 VKSDVFSFGVLVLEIVCGK---RNRG 555
              D F+ GV + E++  +   R RG
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 356 NKLGEGGFGPVYRGM--LTEGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQHRNLVR 410
           + LG G FG V  G   LT G ++AVK L++   + ++   + + E+  +   +H ++++
Sbjct: 22  DTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L    +   +  ++ EY+    L  +I    R   LD  +  ++ + I  G+ Y H   R
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH---R 134
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
             ++HRDLK  NVLLD  MN KI+DFG++      +    +    G+  Y +PE     L
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRL 191
Query: 531 FS-VKSDVFSFGVLVLEIVCG 550
           ++  + D++S GV++  ++CG
Sbjct: 192 YAGPEVDIWSSGVILYALLCG 212

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A++++S    Q   +    E+ ++ +
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLR 81
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 142 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 27/282 (9%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRL--SKSSGQGVEEFKNEVLL 399
           N    + + +    K+GEG FG       TE G++  +K +  S+ S +  EE + EV +
Sbjct: 17  NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV 76
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
           +A ++H N+V+            ++ +Y     L + I       F    +  QI++   
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF----QEDQILDWFV 132
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           +  L L      +I+HRD+K+ N+ L  D   ++ DFG+AR   ++ T       +GT  
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPY 190
Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           Y+SPE   +  ++ KSD+++ G ++ E+   K     + A    NL+            L
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHA---FEAGSMKNLV------------L 235
Query: 580 ELIDKSLDG-SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
           ++I  S    S   S  LR +   L   ++ P DRP+++S++
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVSQLF--KRNPRDRPSVNSIL 275

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++  
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLA 79
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + +T+ L     C  +  I RGL
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 139
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 140 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 196
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 241

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 16/213 (7%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI--AVKRLSKSSGQGVEEFKNEVLLI 400
           +T  D    ++ +N +G G +G V +  + +G  I  A K++ K   + V+ FK E+ ++
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
             L H N++RL        +  L+ E      L +    V   +    S   +I++ +  
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE---RVVHKRVFRESDAARIMKDVLS 117
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLL--DNDMNP-KISDFGMARAFGVDQTEANTDRVVGT 517
            + Y H   +L + HRDLK  N L   D+  +P K+ DFG+A  F   +        VGT
Sbjct: 118 AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGT 171
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             Y+SP+  ++GL+  + D +S GV++  ++CG
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQHRNLVRLLG 413
           LG GGFG V+   M   G+  A K+L+K   +  + ++  ++   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-IARGLLYLHQDSRLR 472
               + +  L+   +    +   I++V          R       I  GL +LHQ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           II+RDLK  NVLLD+D N +ISD G+A      QT+  T    GT G+M+PE  +   + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 533 VKSDVFSFGVLVLEIVCGK---RNRG 555
              D F+ GV + E++  +   R RG
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI D G+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQHRNLVRLLG 413
           LG GGFG V+   M   G+  A K+L+K   +  + ++  ++   ++AK+  R +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-IARGLLYLHQDSRLR 472
               + +  L+   +    +   I++V          R       I  GL +LHQ +   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--- 309
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           II+RDLK  NVLLD+D N +ISD G+A      QT+  T    GT G+M+PE  +   + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYD 367
Query: 533 VKSDVFSFGVLVLEIVCGK---RNRG 555
              D F+ GV + E++  +   R RG
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 116/251 (46%), Gaps = 30/251 (11%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ 404
           AT  +    ++G G +G VY+      G  +A+K +   +G+         EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 405 ---HRNLVRLLG-CCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456
              H N+VRL+  C T R +R     L++E++ ++ L  ++ D      L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
              RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +      A    VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVV 173
Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL---- 572
           T  Y +PE  +   ++   D++S G +  E+    R +  +  +   + LG  + L    
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDLIGLP 230
Query: 573 ----WTEDRSL 579
               W  D SL
Sbjct: 231 PEDDWPRDVSL 241

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKL 403
           A   +    ++GEG +G V+  R +   G+ +A+KR+   +G+         EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 404 Q---HRNLVRLLGCCTL-RDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
           +   H N+VRL   CT+ R +R     L++E++ ++ L  ++  V        + +  + 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
           + + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +       +   VV
Sbjct: 128 Q-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VV 180
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            T  Y +PE  +   ++   D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ--- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI D G+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 348 ATDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKL 403
           A   +    ++GEG +G V+  R +   G+ +A+KR+   +G+         EV ++  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 404 Q---HRNLVRLLGCCTL-RDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
           +   H N+VRL   CT+ R +R     L++E++ ++ L  ++  V        + +  + 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
           + + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +       +   VV
Sbjct: 128 Q-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VV 180
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            T  Y +PE  +   ++   D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE---EFKNEV 397
             T +  +D +     LG GG   V+    L + +++AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 398 LLIAKLQHRNLVRLLGCCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC- 452
              A L H  +V +               ++ EY+   +L     D+  T+     KR  
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR----DIVHTEGPMTPKRAI 119
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG-----VDQT 507
           ++I    + L + HQ+    IIHRD+K +N+L+      K+ DFG+ARA       V QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            A    V+GT  Y+SPE A       +SDV+S G ++ E++ G+
Sbjct: 177 AA----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D  +    LG G FG V              + +AVK L + +        + E K   +
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 84
Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIY------------------EYLPNKSLEQFIFDV 440
           LI    H N+V LLG CT     +++                   E++P K+ E    D 
Sbjct: 85  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF 144
Query: 441 TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
              + L     C   + +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR
Sbjct: 145 LTLEHL----ICYSFQ-VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
               D              +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHRNLVRLLGC 414
           +G G +G   +    ++G+ +  K L   S    E+    +EV L+ +L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 415 CTLRDERML--IYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQ--DS 469
              R    L  + EY     L   I   T+ + +LD     +++  +   L   H+  D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
              ++HRDLK +NV LD   N K+ DFG+AR    D + A T   VGT  YMSPE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM 191
Query: 530 LFSVKSDVFSFGVLVLEI 547
            ++ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D  +    LG G FG V              + +AVK L + +        + E K   +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 399 LIAKLQHRNLVRLLGCCTLRD-ERMLIYE---------YLPNKSLEQFIFDVTRTKFLDW 448
           LI    H N+V LLG CT      M+I E         YL +K  E   +      FL  
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTL 143
Query: 449 SKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE 508
                    +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR    D   
Sbjct: 144 EHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                      +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 201 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 38  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 97
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   YL    +   ++ + +T+ L     C  +  I RGL
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 157
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 158 KYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 259

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 31/208 (14%)
Query: 358 LGEGGFGPVYRG-MLTEGQ---EIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G+G FG VY G  + + Q   + A+K LS+ +  Q VE F  E LL+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 413 GCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           G   L  E +  ++  Y+ +  L QFI    R   +           +ARG+ YL +   
Sbjct: 89  GI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYLAEQ-- 143
Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMAR------AFGVDQTEANTDRVVGTYGYMSPE 524
            + +HRDL A N +LD     K++DFG+AR       + V Q       V  T       
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT------- 195
Query: 525 YAIDGL----FSVKSDVFSFGVLVLEIV 548
            A++ L    F+ KSDV+SFGVL+ E++
Sbjct: 196 -ALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 12/200 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLG 413
           K+GEG +G V++    E  EI A+KR+      +GV      E+ L+ +L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                 +  L++E+  ++ L+++ FD      LD       +  + +GL + H  +   +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFS 532
           +HRDLK  N+L++ +   K++DFG+ARAFG+     + +  V T  Y  P+      L+S
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE--VVTLWYRPPDVLFGAKLYS 180
Query: 533 VKSDVFSFGVLVLEIVCGKR 552
              D++S G +  E+    R
Sbjct: 181 TSIDMWSAGCIFAELANAAR 200

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 16/229 (6%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQ 404
           D    ++    +GEG +G V           +A+K++S    Q   +    E+ ++ + +
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFR 99
Query: 405 HRNLV---RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
           H N++    +L   TL   R +   Y+    +E  ++ + +++ L     C  +  I RG
Sbjct: 100 HENVIGIRDILRASTLEAMRDV---YIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRG 156
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGY 520
           L Y+H  +   ++HRDLK SN+L++   + KI DFG+AR    +          V T  Y
Sbjct: 157 LKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 521 MSPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
            +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 259

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG    
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 418 RDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
               + ++ EY+   SL  ++    R+  L      +    +   + YL  ++    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT--YGYMSPEYAIDGLFSVK 534
           DL A NVL+  D   K+SDFG+ +       EA++ +  G     + +PE   +  FS K
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 535 SDVFSFGVLVLEI 547
           SDV+SFG+L+ EI
Sbjct: 367 SDVWSFGILLWEI 379

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG    
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 418 RDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
               + ++ EY+   SL  ++    R+  L      +    +   + YL  ++    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT--YGYMSPEYAIDGLFSVK 534
           DL A NVL+  D   K+SDFG+ +       EA++ +  G     + +PE   +  FS K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 535 SDVFSFGVLVLEI 547
           SDV+SFG+L+ EI
Sbjct: 195 SDVWSFGILLWEI 207

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE---EFKNEV 397
             T +  +D +     LG GG   V+    L + +++AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 398 LLIAKLQHRNLVRLLGCCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC- 452
              A L H  +V +               ++ EY+   +L     D+  T+     KR  
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR----DIVHTEGPMTPKRAI 119
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG-----VDQT 507
           ++I    + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            A    V+GT  Y+SPE A       +SDV+S G ++ E++ G+
Sbjct: 177 AA----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 17/193 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG    
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 418 RDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
               + ++ EY+   SL  ++    R+  L      +    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 477 DLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT--YGYMSPEYAIDGLFSVK 534
           DL A NVL+  D   K+SDFG+ +       EA++ +  G     + +PE   +  FS K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 535 SDVFSFGVLVLEI 547
           SDV+SFG+L+ EI
Sbjct: 180 SDVWSFGILLWEI 192

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 10/228 (4%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQ-EIAVKRLSKSSGQGV-EEFKNEVLLIAK 402
           + D    ++  + +GEG +G V        +  +A+K++S    Q   +    E+ ++ +
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +           +   Y+    +E  ++ + + + L     C  +  I RGL
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGL 141
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y 
Sbjct: 142 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
           +PE  ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE---EFKNEV 397
             T +  +D +     LG GG   V+    L + +++AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 398 LLIAKLQHRNLVRLLGCCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC- 452
              A L H  +V +               ++ EY+   +L     D+  T+     KR  
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR----DIVHTEGPMTPKRAI 119
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG-----VDQT 507
           ++I    + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            A    V+GT  Y+SPE A       +SDV+S G ++ E++ G+
Sbjct: 177 AA----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLI 400
           TI +  + +   + +G G +G V     T+ G  +AVK+LS+     +   +   E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSKRCQ----- 453
             ++H N++ LL   T            P +SLE+F  ++ VT     D +   +     
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKSQKLT 123
Query: 454 ------IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+ R      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HT 175
Query: 508 EANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           +      V T  Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D       LG G FG V              + +AVK L + +        + E K   +
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---I 85
Query: 399 LIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFL-----DWSKRC 452
           LI    H N+V LLG CT      M+I E+    +L  ++    R +F+     D  K  
Sbjct: 86  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKPEDLYKDF 144
Query: 453 QIIEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
             +E        +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR    D
Sbjct: 145 LTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                         +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D  +    LG G FG V              + +AVK L + +        + E K   +
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 399 LIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFL---DWSKRCQI 454
           LI    H N+V LLG CT      M+I E+    +L  ++    R +F+   D  K    
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKDLYKDFLT 142
Query: 455 IEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
           +E        +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR    D  
Sbjct: 143 LEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 199
Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                       +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 13  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 72  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 124
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 185 EPVDVWSCGIVLTAMLAGE 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 14/224 (6%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT 416
           LG G FG V++   T  G ++A K +     +  EE KNE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHR 476
            +++ +L+ EY+    L   I D +    L        ++ I  G+ ++HQ   + I+H 
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ---MYILHL 211
Query: 477 DLKASNVLLDN--DMNPKISDFGMARAFGV-DQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           DLK  N+L  N      KI DFG+AR +   ++ + N     GT  +++PE       S 
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTPEFLAPEVVNYDFVSF 267
Query: 534 KSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAWRLWTED 576
            +D++S GV+   ++ G     G   A+  +N+L   W L  E+
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 187 EPVDVWSCGIVLTAMLAGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE---EFKNEV 397
             T +  +D +     LG GG   V+    L   +++AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 398 LLIAKLQHRNLVRLLGCCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC- 452
              A L H  +V +               ++ EY+   +L     D+  T+     KR  
Sbjct: 64  QNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLR----DIVHTEGPMTPKRAI 119
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG-----VDQT 507
           ++I    + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            A    V+GT  Y+SPE A       +SDV+S G ++ E++ G+
Sbjct: 177 AA----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D       LG G FG V              + +AVK L + +        + E K   +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 399 LIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFL-------DWSK 450
           LI    H N+V LLG CT      M+I E+    +L  ++    R +F+       D  K
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKVAPEDLYK 142
Query: 451 RCQIIEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
               +E        +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR   
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            D              +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVRLL 412
           +G G +G V   Y   L   Q++AVK+LS+     +   +   E+ L+  L+H N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 413 GCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ---------IIEGIA 459
              T            P  S+E F  ++ VT     D +   +CQ         ++  + 
Sbjct: 86  DVFT------------PATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           RGL Y+H      IIHRDLK SNV ++ D   +I DFG+AR     Q +      V T  
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRW 185
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE  ++ + ++   D++S G ++ E++ GK
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 104/241 (43%), Gaps = 33/241 (13%)
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSS 386
           E+ E   +D +      D       LG G FG V              + +AVK L + +
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 387 GQG-----VEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDV 440
                   + E K   +LI    H N+V LLG CT      M+I E+    +L  ++   
Sbjct: 61  THSEHRALMSELK---ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS- 116
Query: 441 TRTKFL-------DWSKRCQIIEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLD 486
            R +F+       D  K    +E        +A+G+ +L   +  + IHRDL A N+LL 
Sbjct: 117 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLS 173
Query: 487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLE 546
                KI DFG+AR    D              +M+PE   D +++++SDV+SFGVL+ E
Sbjct: 174 EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 233
Query: 547 I 547
           I
Sbjct: 234 I 234

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVRLL 412
           +G G +G V   Y   L   Q++AVK+LS+     +   +   E+ L+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 413 GCCTLRDERMLIYEYLPNKSLEQF--IFDVTRTKFLDWSK--RCQ---------IIEGIA 459
              T            P  S+E F  ++ VT     D +   +CQ         ++  + 
Sbjct: 94  DVFT------------PATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           RGL Y+H      IIHRDLK SNV ++ D   +I DFG+AR     Q +      V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRW 193
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE  ++ + ++   D++S G ++ E++ GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYR----GMLTE--GQEIAVKRLSKSSG-QGVEEFKNEVLLIAK 402
           +  S+   LG G FG V      G++       +AVK L  S+     E   +E+ +++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG---- 457
           L  H N+V LLG CT+    ++I EY     L  F+    R  F+       I+E     
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELA 164
Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
                       +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKND 221
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                         +M+PE   + +++ +SDV+S+G+ + E+
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 10/198 (5%)
Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHRNLVRLLGC 414
           +G G +G   +    ++G+ +  K L   S    E+    +EV L+ +L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 415 CTLRDERML--IYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQ--DS 469
              R    L  + EY     L   I   T+ + +LD     +++  +   L   H+  D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
              ++HRDLK +NV LD   N K+ DFG+AR    D + A     VGT  YMSPE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRM 191
Query: 530 LFSVKSDVFSFGVLVLEI 547
            ++ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 104/241 (43%), Gaps = 33/241 (13%)
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSS 386
           E+ E   +D +      D       LG G FG V              + +AVK L + +
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 387 GQG-----VEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDV 440
                   + E K   +LI    H N+V LLG CT      M+I E+    +L  ++   
Sbjct: 61  THSEHRALMSELK---ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRS- 116
Query: 441 TRTKFL-------DWSKRCQIIEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLD 486
            R +F+       D  K    +E        +A+G+ +L   +  + IHRDL A N+LL 
Sbjct: 117 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLS 173
Query: 487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLE 546
                KI DFG+AR    D              +M+PE   D +++++SDV+SFGVL+ E
Sbjct: 174 EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 233
Query: 547 I 547
           I
Sbjct: 234 I 234

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYR----GMLTE--GQEIAVKRLSKSSG-QGVEEFKNEVLLIAK 402
           +  S+   LG G FG V      G++       +AVK L  S+     E   +E+ +++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG---- 457
           L  H N+V LLG CT+    ++I EY     L  F+    R  F+       I+E     
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELA 157
Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
                       +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 214
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                         +M+PE   + +++ +SDV+S+G+ + E+
Sbjct: 215 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 256

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYR----GMLTE--GQEIAVKRLSKSSG-QGVEEFKNEVLLIAK 402
           +  S+   LG G FG V      G++       +AVK L  S+     E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG---- 457
           L  H N+V LLG CT+    ++I EY     L  F+    R  F+       I+E     
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELA 141
Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
                       +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                         +M+PE   + +++ +SDV+S+G+ + E+
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 116/251 (46%), Gaps = 30/251 (11%)
Query: 348 ATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQ 404
           AT  +    ++G G +G VY+      G  +A+K +   +G+         EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 405 ---HRNLVRLLG-CCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456
              H N+VRL+  C T R +R     L++E++ ++ L  ++ D      L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
              RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +     +     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL---- 572
           T  Y +PE  +   ++   D++S G +  E+    R +  +  +   + LG  + L    
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDLIGLP 230
Query: 573 ----WTEDRSL 579
               W  D SL
Sbjct: 231 PEDDWPRDVSL 241

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D       LG G FG V              + +AVK L + +        + E K   +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 399 LIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFL-------DWSK 450
           LI    H N+V LLG CT      M+I E+    +L  ++    R +F+       D  K
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKVAPEDLYK 142
Query: 451 RCQIIEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
               +E        +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR   
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            D              +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 10/198 (5%)
Query: 358 LGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHRNLVRLLGC 414
           +G G +G   +    ++G+ +  K L   S    E+    +EV L+ +L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 415 CTLRDERML--IYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQ--DS 469
              R    L  + EY     L   I   T+ + +LD     +++  +   L   H+  D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
              ++HRDLK +NV LD   N K+ DFG+AR    D+  A     VGT  YMSPE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK--EFVGTPYYMSPEQMNRM 191
Query: 530 LFSVKSDVFSFGVLVLEI 547
            ++ KSD++S G L+ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYR----GMLTE--GQEIAVKRLSKSSG-QGVEEFKNEVLLIAK 402
           +  S+   LG G FG V      G++       +AVK L  S+     E   +E+ +++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG---- 457
           L  H N+V LLG CT+    ++I EY     L  F+    R  F+       I+E     
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELA 164
Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
                       +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 221
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                         +M+PE   + +++ +SDV+S+G+ + E+
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE---EFKNEV 397
             T +  +D +     LG GG   V+    L   +++AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 398 LLIAKLQHRNLVRLLGCCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC- 452
              A L H  +V +               ++ EY+   +L     D+  T+     KR  
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR----DIVHTEGPMTPKRAI 119
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG-----VDQT 507
           ++I    + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            A    V+GT  Y+SPE A       +SDV+S G ++ E++ G+
Sbjct: 177 AA----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 12/200 (6%)
Query: 357 KLGEGGFGPVYRGMLTEGQEI-AVKRLS-KSSGQGVEEFK-NEVLLIAKLQHRNLVRLLG 413
           K+GEG +G V++    E  EI A+KR+      +GV      E+ L+ +L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                 +  L++E+  ++ L+++ FD      LD       +  + +GL + H  +   +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFS 532
           +HRDLK  N+L++ +   K+++FG+ARAFG+     + + V  T  Y  P+      L+S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 180
Query: 533 VKSDVFSFGVLVLEIVCGKR 552
              D++S G +  E+    R
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYR----GMLTE--GQEIAVKRLSKSSG-QGVEEFKNEVLLIAK 402
           +  S+   LG G FG V      G++       +AVK L  S+     E   +E+ +++ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG---- 457
           L  H N+V LLG CT+    ++I EY     L  F+    R  F+       I+E     
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELA 159
Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
                       +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D
Sbjct: 160 LDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 216
Query: 506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
                         +M+PE   + +++ +SDV+S+G+ + E+
Sbjct: 217 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 258

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 23/193 (11%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRL---SKSSGQGVEEFKNEVLLIAK 402
           D    +    K+G+G FG V++    + GQ++A+K++   ++  G  +   + E+ ++  
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQL 73
Query: 403 LQHRNLVRLLGCCTLRDERM--------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
           L+H N+V L+  C  +            L++++  +  L   + +V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--V 130
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV---DQTEANT 511
           ++ +  GL Y+H++   +I+HRD+KA+NVL+  D   K++DFG+ARAF +    Q     
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 512 DRVVGTYGYMSPE 524
           +RVV T  Y  PE
Sbjct: 188 NRVV-TLWYRPPE 199

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 351 NFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQH 405
           ++   + LG G FG V  G   LT G ++AVK L++   + ++   + K E+  +   +H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            ++++L    +   +  ++ EY+    L  +I    R + ++  +   + + I   + Y 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYC 127
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H   R  ++HRDLK  NVLLD  MN KI+DFG++      +   ++    G+  Y +PE 
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEV 181
Query: 526 AIDGLFS-VKSDVFSFGVLVLEIVCG 550
               L++  + D++S GV++  ++CG
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D       LG G FG V              + +AVK L + +        + E K   +
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 85
Query: 399 LIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG 457
           LI    H N+V LLG CT      M+I E+    +L  ++    R +F+ + +  + +  
Sbjct: 86  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKEAPEDLYK 144
Query: 458 --------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
                         +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR   
Sbjct: 145 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 201
Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            D              +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 202 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D       LG G FG V              + +AVK L + +        + E K   +
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 83
Query: 399 LIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFL-------DWSK 450
           LI    H N+V LLG CT      M+I E+    +L  ++    R +F+       D  K
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKVAPEDLYK 142
Query: 451 RCQIIEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
               +E        +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR   
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            D              +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 23/193 (11%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRL---SKSSGQGVEEFKNEVLLIAK 402
           D    +    K+G+G FG V++    + GQ++A+K++   ++  G  +   + E+ ++  
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQL 73
Query: 403 LQHRNLVRLLGCCTLRDERM--------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
           L+H N+V L+  C  +            L++++  +  L   + +V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--V 130
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV---DQTEANT 511
           ++ +  GL Y+H++   +I+HRD+KA+NVL+  D   K++DFG+ARAF +    Q     
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 512 DRVVGTYGYMSPE 524
           +RVV T  Y  PE
Sbjct: 188 NRVV-TLWYRPPE 199

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+          +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+ ++   K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 23/193 (11%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRL---SKSSGQGVEEFKNEVLLIAK 402
           D    +    K+G+G FG V++    + GQ++A+K++   ++  G  +   + E+ ++  
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQL 72
Query: 403 LQHRNLVRLLGCCTLRDERM--------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
           L+H N+V L+  C  +            L++++  +  L   + +V     L   KR  +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--V 129
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV---DQTEANT 511
           ++ +  GL Y+H++   +I+HRD+KA+NVL+  D   K++DFG+ARAF +    Q     
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 512 DRVVGTYGYMSPE 524
           +RVV T  Y  PE
Sbjct: 187 NRVV-TLWYRPPE 198

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 104/241 (43%), Gaps = 33/241 (13%)
Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSS 386
           E+ E   +D +      D       LG G FG V              + +AVK L + +
Sbjct: 1   EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA 60
Query: 387 GQG-----VEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDV 440
                   + E K   +LI    H N+V LLG CT      M+I E+    +L  ++   
Sbjct: 61  THSEHRALMSELK---ILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RS 116
Query: 441 TRTKFL-------DWSKRCQIIEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLD 486
            R +F+       D  K    +E        +A+G+ +L   +  + IHRDL A N+LL 
Sbjct: 117 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLS 173
Query: 487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLE 546
                KI DFG+AR    D              +M+PE   D +++++SDV+SFGVL+ E
Sbjct: 174 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 233
Query: 547 I 547
           I
Sbjct: 234 I 234

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE---EFKNEV 397
             T +  +D +     LG GG   V+    L   +++AVK L     +       F+ E 
Sbjct: 21  MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 80
Query: 398 LLIAKLQHRNLVRLLGCCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC- 452
              A L H  +V +               ++ EY+   +L     D+  T+     KR  
Sbjct: 81  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR----DIVHTEGPMTPKRAI 136
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG-----VDQT 507
           ++I    + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       V QT
Sbjct: 137 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            A    V+GT  Y+SPE A       +SDV+S G ++ E++ G+
Sbjct: 194 AA----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           LG GGFG V+      +    A+KR+   + +   E+   EV  +AKL+H  +VR     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDW-SKRCQIIE-----------GIARGLL 463
             ++    +    P   L   +    +    DW + RC I E            IA  + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE----------ANTDR 513
           +LH      ++HRDLK SN+    D   K+ DFG+  A   D+ E          A    
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
            VGT  YMSPE      +S K D+FS G+++ E++
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 358 LGEGGFGPVYRGM--LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           LGEG  G V   +  +TE + +AVK +  K +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAAGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQIIEGIARGLLYLHQDSRLRI 473
               + + L  EY     L    FD       +      +    +  G++YLH    + I
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
            HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE      F  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 534 KS-DVFSFGVLVLEIVCGK 551
           +  DV+S G+++  ++ G+
Sbjct: 186 EPVDVWSCGIVLTAMLAGE 204

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 21/169 (12%)
Query: 385 SSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ-----FIFD 439
           S     ++FKNE+ +I  +++   +   G  T  DE  +IYEY+ N S+ +     F+ D
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 440 VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA 499
              T F+       II+ +     Y+H +    I HRD+K SN+L+D +   K+SDFG  
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFG-- 197
Query: 500 RAFGVDQTEANTDRVV----GTYGYMSPEYAID--GLFSVKSDVFSFGV 542
                 ++E   D+ +    GTY +M PE+  +       K D++S G+
Sbjct: 198 ------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D       LG G FG V              + +AVK L + +        + E K   +
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 74
Query: 399 LIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFL-------DWSK 450
           LI    H N+V LLG CT      M+I E+    +L  ++    R +F+       D  K
Sbjct: 75  LIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYK 133
Query: 451 RCQIIEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
               +E        +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR   
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            D              +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 191 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 23/193 (11%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRL---SKSSGQGVEEFKNEVLLIAK 402
           D    +    K+G+G FG V++    + GQ++A+K++   ++  G  +   + E+ ++  
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQL 73
Query: 403 LQHRNLVRLLGCCTLRDERM--------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
           L+H N+V L+  C  +            L++++  +  L   + +V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--V 130
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV---DQTEANT 511
           ++ +  GL Y+H++   +I+HRD+KA+NVL+  D   K++DFG+ARAF +    Q     
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 512 DRVVGTYGYMSPE 524
           +RVV T  Y  PE
Sbjct: 188 NRVV-TLWYRPPE 199

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 351 NFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQGVE---EFKNEVLLIAKLQH 405
           ++   + LG G FG V  G   LT G ++AVK L++   + ++   + K E+  +   +H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            ++++L    +   +  ++ EY+    L  +I    R + ++  +   + + I   + Y 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYC 127
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H   R  ++HRDLK  NVLLD  MN KI+DFG++      +    +    G+  Y +PE 
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEV 181
Query: 526 AIDGLFS-VKSDVFSFGVLVLEIVCG 550
               L++  + D++S GV++  ++CG
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+          +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+ ++   K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+    +     +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 75  GVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+ ++   K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+    +     +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 80  GVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+ ++   K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+    +     +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 83  GVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+ ++   K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+    +     +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 81  GVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+ ++   K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+    +     +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+ ++   K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P KSLE+F  DV     L  +  CQ+I+              +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQ-DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   T    +  V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTRYYR 192
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+VC K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 350 DNFSWKNKLGEGGFGPVYRG------MLTEGQEIAVKRLSKSSGQG-----VEEFKNEVL 398
           D       LG G FG V              + +AVK L + +        + E K   +
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---I 120
Query: 399 LIAKLQHRNLVRLLGCCTLRD-ERMLIYEYLPNKSLEQFIFDVTRTKFL-------DWSK 450
           LI    H N+V LLG CT      M+I E+    +L  ++    R +F+       D  K
Sbjct: 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKVAPEDLYK 179
Query: 451 RCQIIEG-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
               +E        +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR   
Sbjct: 180 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 236
Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
            D              +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 237 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+    +     +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+ ++   K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 109/277 (39%), Gaps = 38/277 (13%)
Query: 356 NKLGEGGFGPVYRGMLTEGQ----EIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 408
            KLG+G FG V RG           +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +RL G       +M + E  P  SL   +        L    R  +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEYA 526
              R IHRDL A N+LL      KI DFG+ RA     D       R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 196
Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
               FS  SD + FGV + E+    +                 W      + L  IDK  
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHKIDKE- 240
Query: 587 DGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSV 619
                L     C Q    V + C   +PEDRP   ++
Sbjct: 241 --GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 94/326 (28%), Positives = 127/326 (38%), Gaps = 50/326 (15%)
Query: 357 KLGEGGFGPVYRGMLT----EGQEIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNLV 409
           KLG+G FG V RG       +   +AVK L     S  + +++F  EV  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           RL G       +M + E  P  SL   +        L    R  +   +A G+ YL    
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEYAI 527
             R IHRDL A N+LL      KI DFG+ RA     D       R V  + + +PE   
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLK 191
Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD 587
              FS  SD + FGV + E+    +                 W      + L  IDK   
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHKIDKE-- 234
Query: 588 GSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNL 643
               L     C Q    V + C   +PEDRP   ++       R      QP     R L
Sbjct: 235 -GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL-------RDFLLEAQPTDM--RAL 284
Query: 644 PESESSSSKRKLPLSNEITISLIEGR 669
            + E      KL +     I++IEGR
Sbjct: 285 QDFEEPD---KLHIQMNDVITVIEGR 307

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 405
           TD +     +G+G F  V R + L  G E A K ++  K S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+VRL    +      L+++ +    L +   D+   ++   +     I+ I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIQQILEAVLHC 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           HQ   + ++HRDLK  N+LL +       K++DFG+A     DQ         GT GY+S
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           PE      +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 39/221 (17%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH----------- 405
           LG+G FG V +     + +  A+K++ + + + +    +EV+L+A L H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 406 --RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD--WSKRCQIIEGIARG 461
             RN V+ +     +    +  EY  N++L   I      +  D  W    QI+E ++  
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS-- 130
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA----RAFGVDQTEA-------- 509
             Y+H      IIHRDLK  N+ +D   N KI DFG+A    R+  + + ++        
Sbjct: 131 --YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 510 NTDRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIV 548
           N    +GT  Y++ E  +DG   ++ K D++S G++  E++
Sbjct: 186 NLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 349 TDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEE---FKNEVLLIAKL 403
           +D +    KLG G +G V   +  LT G E A+K + KSS           +EV ++ +L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARG 461
            H N+++L      +    L+ E      L    FD  + R KF +      I++ +  G
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAV-IMKQVLSG 133
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
             YLH+ +   I+HRDLK  N+LL++   D   KI DFG++  F V          +GT 
Sbjct: 134 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTA 187
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y++PE  +   +  K DV+S GV++  ++CG
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 110/277 (39%), Gaps = 38/277 (13%)
Query: 356 NKLGEGGFGPVYRGMLT----EGQEIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 408
            KLG+G FG V RG       +   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +RL G       +M + E  P  SL   +        L    R  +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEYA 526
              R IHRDL A N+LL      KI DFG+ RA     D       R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 186
Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
               FS  SD + FGV + E+    +                 W      + L  IDK  
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHKIDKE- 230
Query: 587 DGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSV 619
                L     C Q    V + C   +PEDRP   ++
Sbjct: 231 --GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 109/277 (39%), Gaps = 38/277 (13%)
Query: 356 NKLGEGGFGPVYRGMLTEGQ----EIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 408
            KLG+G FG V RG           +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +RL G       +M + E  P  SL   +        L    R  +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEYA 526
              R IHRDL A N+LL      KI DFG+ RA     D       R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 196
Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
               FS  SD + FGV + E+    +                 W      + L  IDK  
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHKIDKE- 240
Query: 587 DGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSV 619
                L     C Q    V + C   +PEDRP   ++
Sbjct: 241 --GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 110/277 (39%), Gaps = 38/277 (13%)
Query: 356 NKLGEGGFGPVYRGMLT----EGQEIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 408
            KLG+G FG V RG       +   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +RL G       +M + E  P  SL   +        L    R  +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEYA 526
              R IHRDL A N+LL      KI DFG+ RA     D       R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
               FS  SD + FGV + E+    +                 W      + L  IDK  
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHKIDKE- 230
Query: 587 DGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSV 619
                L     C Q    V + C   +PEDRP   ++
Sbjct: 231 --GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 349 TDNFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEE---FKNEVLLIAKL 403
           +D +    KLG G +G V   +  LT G E A+K + KSS           +EV ++ +L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARG 461
            H N+++L      +    L+ E      L    FD  + R KF +      I++ +  G
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAV-IMKQVLSG 116
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
             YLH+ +   I+HRDLK  N+LL++   D   KI DFG++  F V          +GT 
Sbjct: 117 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTA 170
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y++PE  +   +  K DV+S GV++  ++CG
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 84
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P KSLE+F  DV     L  +  CQ+I+              +  G
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQ-DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 143
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 144 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 197
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+VC K
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN-----EVLLIAKLQHRNLVRL 411
           LGEG F  VY+       Q +A+K++        ++  N     E+ L+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           L     +    L+++++    LE  I D   +  L  S     +    +GL YLHQ    
Sbjct: 78  LDAFGHKSNISLVFDFM-ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-L 530
            I+HRDLK +N+LLD +   K++DFG+A++FG     A   +VV T  Y +PE      +
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVV-TRWYRAPELLFGARM 189
Query: 531 FSVKSDVFSFGVLVLEIV 548
           + V  D+++ G ++ E++
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P KSLE+F       + +D +  CQ+I+              +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   T    +  V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTRYYR 192
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+VC K
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 26  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P KSLE+F  DV     L  +  CQ+I+              +  G
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQ-DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 132
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 186
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+VC K
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 41/213 (19%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHRNLVRLL 412
           +G G +G V   Y   L   Q++AVK+LS+     +   +   E+ L+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 413 GCCTLRDERMLIYEYLPNKSLEQF-------------IFDVTRTKFLDWSKRCQIIEGIA 459
              T            P  S+E F             + ++ +++ L       ++  + 
Sbjct: 94  DVFT------------PATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL 141
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           RGL Y+H      IIHRDLK SNV ++ D   +I DFG+AR     Q +      V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRW 193
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE  ++ + ++   D++S G ++ E++ GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 110/277 (39%), Gaps = 38/277 (13%)
Query: 356 NKLGEGGFGPVYRGMLT----EGQEIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 408
            KLG+G FG V RG       +   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +RL G       +M + E  P  SL   +        L    R  +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEYA 526
              R IHRDL A N+LL      KI DFG+ RA     D       R V  + + +PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
               FS  SD + FGV + E+    +                 W      + L  IDK  
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHKIDKE- 234
Query: 587 DGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSV 619
                L     C Q    V + C   +PEDRP   ++
Sbjct: 235 --GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 110/277 (39%), Gaps = 38/277 (13%)
Query: 356 NKLGEGGFGPVYRGMLT----EGQEIAVKRLSK---SSGQGVEEFKNEVLLIAKLQHRNL 408
            KLG+G FG V RG       +   +AVK L     S  + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +RL G       +M + E  P  SL   +        L    R  +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSPEYA 526
              R IHRDL A N+LL      KI DFG+ RA     D       R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
               FS  SD + FGV + E+    +                 W      + L  IDK  
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHKIDKE- 230
Query: 587 DGSYSLSEALRCIQ----VGLLCVQQRPEDRPNMSSV 619
                L     C Q    V + C   +PEDRP   ++
Sbjct: 231 --GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   Y     + +E+ A K + KS        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K +   +    +    +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L++DM+ KI DFG+A     D     T  + GT  Y++PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSF 221
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + D++S G ++  ++ GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 413 GCCTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIAR 460
              T            P KSLE+F        + D   ++     LD  +   ++  +  
Sbjct: 90  NVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-Y 191
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +PE  +   +    D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G +G V   +    G+++A+K+LS+   S    +    E+LL+  +QH N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 415 CTLRDERMLIYE-YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
            T        Y+ YL    ++  +  +   KF +  K   ++  + +GL Y+H      +
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE-EKIQYLVYQMLKGLKYIHSAG---V 147
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL-FS 532
           +HRDLK  N+ ++ D   KI DFG+AR       +A     V T  Y +PE  +  + ++
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHYN 202
Query: 533 VKSDVFSFGVLVLEIVCGK 551
              D++S G ++ E++ GK
Sbjct: 203 QTVDIWSVGCIMAEMLTGK 221

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   +     + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L+ D+  KI DFG+A     D     T  + GT  Y++PE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 413 GCCTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIAR 460
              T            P KSLE+F        + D   ++     LD  +   ++  +  
Sbjct: 90  NVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-Y 191
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +PE  +   +    D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
            +LG+G F  V R + +  GQE A K ++  K S +  ++ + E  +   L+H N+VRL 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
              +      LI++ +    L +   D+   ++   +     I+ I   +L+ HQ   + 
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFE---DIVAREYYSEADASHCIQQILEAVLHCHQ---MG 141
Query: 473 IIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
           ++HRDLK  N+LL + +     K++DFG+A    V+  +       GT GY+SPE     
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 530 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
            +    D+++ GV++  ++ G     F+  D H
Sbjct: 200 PYGKPVDLWACGVILYILLVG--YPPFWDEDQH 230

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   +     + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L+ D+  KI DFG+A     D     T  + GT  Y++PE       S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + DV+S G ++  ++ GK
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   +     + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L+ D+  KI DFG+A     D     T  + GT  Y++PE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+    +     +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+ ++   K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 22/235 (9%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQ----EIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ 404
            F+    LG+G FG V    L +      ++AVK L     +   +EEF  E   + +  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 405 HRNLVRLLGCCTLRDER-------MLIYEYLPNKSLEQFIFD--VTRTKF-LDWSKRCQI 454
           H ++ +L+G  +LR          M+I  ++ +  L  F+    +    F L      + 
Sbjct: 84  HPHVAKLVGV-SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
           +  IA G+ YL   S    IHRDL A N +L  DM   ++DFG++R              
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 515 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN--RGFYHADHHHNLLG 567
                +++ E   D L++V SDV++FGV + EI+   +    G  +A+ ++ L+G
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 351 NFSWKNKLGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
            F +   LG G F  V+  +  LT G+  A+K + KS        +NE+ ++ K++H N+
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ-IIEGIARGLLYLHQ 467
           V L           L+ + +    L    FD    + +   K    +I+ +   + YLH+
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 468 DSRLRIIHRDLKASNVL-LDNDMNPKISDFGMARAFGVDQTEAN--TDRVVGTYGYMSPE 524
           +    I+HRDLK  N+L L  + N KI    M   FG+ + E N       GT GY++PE
Sbjct: 125 NG---IVHRDLKPENLLYLTPEENSKI----MITDFGLSKMEQNGIMSTACGTPGYVAPE 177
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCG 550
                 +S   D +S GV+   ++CG
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+          +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+      K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH----------- 405
           LG+G FG V +     + +  A+K++ + + + +    +EV+L+A L H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 406 --RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD--WSKRCQIIEGIARG 461
             RN V+ +     +    +  EY  N +L   I      +  D  W    QI+E ++  
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS-- 130
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA----RAFGVDQTEA-------- 509
             Y+H      IIHRDLK  N+ +D   N KI DFG+A    R+  + + ++        
Sbjct: 131 --YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 510 NTDRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIV 548
           N    +GT  Y++ E  +DG   ++ K D++S G++  E++
Sbjct: 186 NLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 33/254 (12%)
Query: 348 ATDNFSWKNKLGEGGFGPVYR------GMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIA 401
           AT  +    ++G G +G VY+      G     + + V       G        EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 402 KLQ---HRNLVRLLG-CCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
           +L+   H N+VRL+  C T R +R     L++E++ ++ L  ++ D      L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           ++    RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +     +     
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL- 572
           VV T  Y +PE  +   ++   D++S G +  E+    R +  +  +   + LG  + L 
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDLI 235
Query: 573 -------WTEDRSL 579
                  W  D SL
Sbjct: 236 GLPPEDDWPRDVSL 249

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G +G V   +    G+++A+K+LS+   S    +    E+LL+  +QH N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWS--KRCQIIEGIARGLLYLHQDSRLR 472
            T        Y++       Q   D+ +   +++S  K   ++  + +GL Y+H      
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQT--DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG--- 164
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL-F 531
           ++HRDLK  N+ ++ D   KI DFG+AR       +A     V T  Y +PE  +  + +
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHY 219
Query: 532 SVKSDVFSFGVLVLEIVCGK 551
           +   D++S G ++ E++ GK
Sbjct: 220 NQTVDIWSVGCIMAEMLTGK 239

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 91/167 (54%), Gaps = 14/167 (8%)
Query: 390 VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-IFDVTRTKFLDW 448
           +E+   E+ ++ KL H N+V+L+      +E  L   Y+  + + Q  + +V   K L  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSE 136
Query: 449 SKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQT 507
            +     + + +G+ YLH     +IIHRD+K SN+L+  D + KI+DFG++  F G D  
Sbjct: 137 DQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 508 EANTDRVVGTYGYMSPEYAIDG--LFSVKS-DVFSFGVLVLEIVCGK 551
            +NT   VGT  +M+PE   +   +FS K+ DV++ GV +   V G+
Sbjct: 194 LSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
           +D F  +++LG G    VYR      Q+  A+K L K+  + +   + E+ ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPN 109
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGLLYLH 466
           +++L        E  L+ E +    L    FD +    +         ++ I   + YLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLH 165
Query: 467 QDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           ++    I+HRDLK  N+L      D   KI+DFG+++   + + +     V GT GY +P
Sbjct: 166 ENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGYCAP 219
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E      +  + D++S G++   ++CG
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   Y     + +E+ A K + KS        E+   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K +   +    +    +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 147
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L++DM+ KI DFG+A     D  E   D + GT  Y++PE       S 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKD-LCGTPNYIAPEVLCKKGHSF 205
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + D++S G ++  ++ GK
Sbjct: 206 EVDIWSLGCILYTLLVGK 223

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 350 DNFSWKNKLGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
           + F     LG+GGFG V        G +   +++  KR+ K  G+ +    NE  ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKV 241
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
             R +V L      +D   L+   +    L+  I+ + +  F +        E I  GL 
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLE 300
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
            LH   R RI++RDLK  N+LLD+  + +ISD G+A      QT       VGT GYM+P
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAP 354
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E   +  ++   D ++ G L+ E++ G+
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQE----IAVKRLSKSSGQGV-EEFKNEVLLIAKLQHRNLVRLL 412
           +GEG FG V++G+    +     +A+K     +   V E+F  E L + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T  +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
            +HRD+ A NVL+      K+ DFG++R +  D T     +      +M+PE      F+
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 533 VKSDVFSFGVLVLEIV 548
             SDV+ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 35/224 (15%)
Query: 345 IADAT----DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLL 399
           +AD+T      +     +G G  G V     T  G  +AVK+LS+        F+N+   
Sbjct: 15  VADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH- 66
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE--- 456
            AK  +R LV LL C   ++   L+  + P K+LE+F  DV     L  +  CQ+I    
Sbjct: 67  -AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIHMEL 123
Query: 457 ----------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
                      +  G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR    + 
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 180
Query: 507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
               T  VV  Y Y +PE  +   ++   D++S G ++ E+V G
Sbjct: 181 M--MTPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 350 DNFSWKNKLGEGGFGPV------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL 403
           + F     LG+GGFG V        G +   +++  KR+ K  G+ +    NE  ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKV 241
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
             R +V L      +D   L+   +    L+  I+ + +  F +        E I  GL 
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLE 300
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
            LH   R RI++RDLK  N+LLD+  + +ISD G+A      QT       VGT GYM+P
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAP 354
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E   +  ++   D ++ G L+ E++ G+
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   Y     + +E+ A K + KS        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K +   +    +    +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L++DM+ KI DFG+A     D  E   D + GT  Y++PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKD-LCGTPNYIAPEVLCKKGHSF 221
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + D++S G ++  ++ GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIA--VKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           T+ +    +LG+G F  V R + +  GQE A  +    K S +  ++ + E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+VRL    +      LI++ +    L +   D+   ++   +     I+ I   +L+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFE---DIVAREYYSEADASHCIQQILEAVLHC 126
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           HQ   + ++HR+LK  N+LL + +     K++DFG+A    V+  +       GT GY+S
Sbjct: 127 HQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLS 181
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           PE      +    D+++ GV++  ++ G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   Y     + +E+ A K + KS        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K +   +    +    +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L++DM+ KI DFG+A     D        + GT  Y++PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX--LCGTPNYIAPEVLCKKGHSF 221
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + D++S G ++  ++ GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   +     + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L+ D+  KI DFG+A     D        + GT  Y++PE       S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + DV+S G ++  ++ GK
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 347 DATDNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVKRLSK----SSGQGV--EEFKNEVLL 399
           D  D++    +LG G F  V +      G+E A K + K    SS +GV  EE + EV +
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
           + +++H N++ L      + + +LI E +    L  F+      + L   +  Q ++ I 
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQIL 125
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLL--DNDMNPKIS--DFGMARAFGVDQTEANTDRVV 515
            G+ YLH     RI H DLK  N++L   N  NP+I   DFG+A          N   + 
Sbjct: 126 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IF 179
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           GT  +++PE        +++D++S GV+   ++ G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   +     + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L+ D+  KI DFG+A     D        + GT  Y++PE       S 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 218
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + DV+S G ++  ++ GK
Sbjct: 219 EVDVWSIGCIMYTLLVGK 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 16/220 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 405
           TD +    +LG+G F  V R M +  GQE A K ++  K S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+VRL    +      L+++ +    L +   D+   ++   +     I+ I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIQQILESVNHC 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           H +    I+HRDLK  N+LL +       K++DFG+A     DQ         GT GY+S
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
           PE      +    D+++ GV++  ++ G     F+  D H
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG--YPPFWDEDQH 212

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 16/220 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 405
           TD +    +LG+G F  V R M +  GQE A K ++  K S +  ++ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+VRL    +      L+++ +    L +   D+   ++   +     I+ I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIQQILESVNHC 119
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           H +    I+HRDLK  N+LL +       K++DFG+A     DQ         GT GY+S
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
           PE      +    D+++ GV++  ++ G     F+  D H
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG--YPPFWDEDQH 212

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 351 NFSWKNKLGEGGFGPV----------YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
           +F     LG G FG V          Y  M    +EI V RL +     VE   +E L++
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQ-----VEHTNDERLML 60
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT--KFLDWSKRCQIIEGI 458
           + + H  ++R+ G      +  +I +Y+    L    F + R   +F +   +    E +
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAE-V 115
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L YLH      II+RDLK  N+LLD + + KI+DFG A+          T  + GT 
Sbjct: 116 CLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTP 167
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y++PE      ++   D +SFG+L+ E++ G
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 29/204 (14%)
Query: 357 KLGEGGFGPVYRGMLTEGQ------EIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
           ++G G F  VY+G+ TE        E+  ++L+KS  Q    FK E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 411 LLGC--CTLRDER--MLIYEYLPNKSLEQFI--FDVTRTKFL-DWSKRCQIIEGIARGLL 463
                  T++ ++  +L+ E   + +L+ ++  F V + K L  W ++      I +GL 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQ 143
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           +LH  +   IIHRDLK  N+ +       KI D G+A        +A    V+GT  + +
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFXA 198
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLE 546
           PE   +  +    DV++FG   LE
Sbjct: 199 PE-XYEEKYDESVDVYAFGXCXLE 221

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHRNLVRLLGC 414
           +GEG +G V +    + G+ +A+K+  +S    + +     E+ L+ +L+H NLV LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 415 CTLRDERMLIYEYLPNKSLEQF-IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
           C  +    L++E++ +  L+   +F       LD+    + +  I  G+ + H  +   I
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---I 145
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-DGLFS 532
           IHRD+K  N+L+      K+ DFG AR       E   D  V T  Y +PE  + D  + 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDE-VATRWYRAPELLVGDVKYG 203
Query: 533 VKSDVFSFGVLVLEIVCGK 551
              DV++ G LV E+  G+
Sbjct: 204 KAVDVWAIGCLVTEMFMGE 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 35/209 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P KSLE+F  DV     L  +  CQ+I+              +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQ-DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPEVVTRY-YR 192
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +PE  +   +    D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   +     + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L+ D+  KI DFG+A     D        + GT  Y++PE       S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194
Query: 534 KSDVFSFGVLVLEIVCGK 551
           + DV+S G ++  ++ GK
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 37/210 (17%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 413 GCCTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIAR 460
              T            P KSLE+F        + D   ++     LD  +   ++  +  
Sbjct: 90  NVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-Y 191
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +PE  +   +    D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 78  IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ----THGKWPVKWYAPECI 186
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 187 NYYKFSSKSDVWSFGVLMWE 206

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 33/208 (15%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIARGL 462
              ++   L+  + P KSLE+F        + D   ++     LD  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y +
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 193
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           PE  +   +    D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPK----ISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   PK    I DFG+A          N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 182 AFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 94  IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 202
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 203 NYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 94  IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 147
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 148 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 202
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 203 NYYKFSSKSDVWSFGVLMWE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 92  IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 145
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 146 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 200
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 201 NYYKFSSKSDVWSFGVLMWE 220

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 345 IADAT----DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLL 399
           +AD+T      +     +G G  G V     T  G  +AVK+LS+        F+N+   
Sbjct: 13  VADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH- 64
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE--- 456
            AK  +R LV LL C   ++   L+  + P K+LE+F  DV     L  +  CQ+I    
Sbjct: 65  -AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIHMEL 121
Query: 457 ----------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
                      +  G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR    + 
Sbjct: 122 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF 178
Query: 507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
               T  VV  Y Y +PE  +   +    D++S G ++ E+V G
Sbjct: 179 M--MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 35/209 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P KSLE+F  DV     L  +  CQ+I+              +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQ-DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 192
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +PE  +   +    D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 35/209 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 80
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P KSLE+F  DV     L  +  CQ+I+              +  G
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQ-DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 193
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +PE  +   +    D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 74  IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 127
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 182
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 183 NYYKFSSKSDVWSFGVLMWE 202

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 78  IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 131
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 186
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 187 NYYKFSSKSDVWSFGVLMWE 206

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 17/218 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKL 403
           + F +   LG+G FG V   ++ E   G+  A+K L K      +E  +   E  ++   
Sbjct: 148 NEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H  L  L       D    + EY     L    F ++R +     +       I   L 
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH  S   +++RDLK  N++LD D + KI+DFG+ +    D     T    GT  Y++P
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 318
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
           E   D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 354

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 17/218 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKL 403
           + F +   LG+G FG V   ++ E   G+  A+K L K      +E  +   E  ++   
Sbjct: 151 NEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H  L  L       D    + EY     L    F ++R +     +       I   L 
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 265
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH  S   +++RDLK  N++LD D + KI+DFG+ +    D     T    GT  Y++P
Sbjct: 266 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 321
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
           E   D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 322 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 357

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 72  IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 125
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 126 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 180
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 181 NYYKFSSKSDVWSFGVLMWE 200

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 358 LGEGGFGPVYR-----GMLTEGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNL 408
           LG+GG+G V++     G  T G+  A+K L K+    + +     K E  ++ +++H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANT-GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V L+       +  LI EYL    L      + R         C  +  I+  L +LHQ 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               II+RDLK  N++L++  + K++DFG+ +    D T  +T    GT  YM+PE  + 
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMR 195
Query: 529 GLFSVKSDVFSFGVLVLEIVCG 550
              +   D +S G L+ +++ G
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTG 217

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 413 GCCTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIAR 460
              T            P K+LE+F        + D    +     LD  +   ++  +  
Sbjct: 90  NVFT------------PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLX 137
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-Y 191
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            +PE  +   +    D++S G ++ E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 192
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 193 NYYKFSSKSDVWSFGVLMWE 212

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 437 IGICEA-ESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 490
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 491 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 545
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 546 NYYKFSSKSDVWSFGVLMWE 565

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 35/209 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P KSLE+F  DV     L  +  CQ+I+              +  G
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQ-DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 192
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +PE  +   +    D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 357 KLGEGGFGPVYRG---MLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G   M    + +AVK L   +      +E   E  ++ +L +  +VR+
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL + +  
Sbjct: 436 IGICEA-ESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEESN-- 489
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYA 526
             +HRDL A NVLL      KISDFG+++A   D+          T+G     + +PE  
Sbjct: 490 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 544
Query: 527 IDGLFSVKSDVFSFGVLVLE 546
               FS KSDV+SFGVL+ E
Sbjct: 545 NYYKFSSKSDVWSFGVLMWE 564

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 33/208 (15%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIARGL 462
              ++   L+  + P KSLE+F        + D   ++     LD  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y +
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 193
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           PE  +   +    D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 39/212 (18%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIA 459
              T            P K+LE+F  DV     L  +  CQ+I+              + 
Sbjct: 90  NVFT------------PQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
            G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y 
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY- 190
Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           Y +PE  +   +    D++S G ++ E+V  K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +S   ++G GG   V++ +  + Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 115
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---WSKRCQIIEGIARG----- 461
                    D+ + +Y+Y   +  +Q+I+ V     +D   W K+ + I+   R      
Sbjct: 116 ---------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 462 -LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    D  VGT  Y
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 222
Query: 521 MSPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 551
           M PE AI  + S +             DV+S G ++  +  GK
Sbjct: 223 MPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 37/210 (17%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 413 GCCTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIAR 460
              T            P KSLE+F        + D   ++     LD  +   ++  +  
Sbjct: 90  NVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGT--SFMMTPYVVTRY-Y 191
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +PE  +   +    D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKL 403
           + F +   LG+G FG V   ++ E   G+  A+K L K      +E  +   E  ++   
Sbjct: 8   NEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H  L  L       D    + EY     L    F ++R +     +       I   L 
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH  S   +++RDLK  N++LD D + KI+DFG+ +  G+ +  A      GT  Y++P
Sbjct: 123 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPEYLAP 178
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
           E   D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 214

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKL 403
           + F +   LG+G FG V   ++ E   G+  A+K L K      +E  +   E  ++   
Sbjct: 10  NEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H  L  L       D    + EY     L    F ++R +     +       I   L 
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 124
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH  S   +++RDLK  N++LD D + KI+DFG+ +  G+ +  A      GT  Y++P
Sbjct: 125 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPEYLAP 180
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
           E   D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 216

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 16/220 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLS--KSSGQGVEEFKNEVLLIAKLQH 405
           TD++    +LG+G F  V R +  T  QE A K ++  K S +  ++ + E  +   L+H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+VRL    +      L+++ +    L +   D+   ++   +     I  I   + ++
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIHQILESVNHI 146
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           HQ     I+HRDLK  N+LL +       K++DFG+A    V   +       GT GY+S
Sbjct: 147 HQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLS 201
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
           PE      +    D+++ GV++  ++ G     F+  D H
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILLVG--YPPFWDEDQH 239

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKN---EVLLIAKL 403
           + F +   LG+G FG V   ++ E   G+  A+K L K      +E  +   E  ++   
Sbjct: 9   NEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +H  L  L       D    + EY     L    F ++R +     +       I   L 
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 123
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YLH  S   +++RDLK  N++LD D + KI+DFG+ +  G+ +  A      GT  Y++P
Sbjct: 124 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPEYLAP 179
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
           E   D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 215

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +S   ++G GG   V++ +  + Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 71
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---WSKRCQIIEGIARG----- 461
                    D+ + +Y+Y   +  +Q+I+ V     +D   W K+ + I+   R      
Sbjct: 72  ---------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 119
Query: 462 -LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    D  VGT  Y
Sbjct: 120 MLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 178
Query: 521 MSPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 551
           M PE AI  + S +             DV+S G ++  +  GK
Sbjct: 179 MPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 126
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 180
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 126
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 180
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIARGL 462
              ++   L+  + P K+LE+F        + D    +     LD  +   ++  +  G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y +
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 193
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE  +   +    D++S G ++ E+V  K
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 35/207 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 117
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 176
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 177 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 230
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           +PE  +   +    D++S G ++ E+V
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQGVE---EFKNEVLLIAKLQHRN 407
           +  +  LGEG FG V      + Q+ +A+K +S+   +  +     + E+  +  L+H +
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           +++L    T   + +++ EY      E F + V + +  +   R +  + I   + Y H 
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGG---ELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH- 125
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV-VGTYGYMSPEYA 526
             R +I+HRDLK  N+LLD+++N KI+DFG++       T+ N  +   G+  Y +PE  
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPEVI 179
Query: 527 IDGLFS-VKSDVFSFGVLVLEIVCGK 551
              L++  + DV+S G+++  ++ G+
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +S   ++G GG   V++ +  + Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 68
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---WSKRCQIIEGIARG----- 461
                    D+ + +Y+Y   +  +Q+I+ V     +D   W K+ + I+   R      
Sbjct: 69  ---------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 116
Query: 462 -LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    D  VGT  Y
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 521 MSPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 551
           M PE AI  + S +             DV+S G ++  +  GK
Sbjct: 176 MPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 33/209 (15%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 72
Query: 415 CTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIARGL 462
              ++   L+  + P K+LE+F        + D    +     LD  +   ++  +  G+
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 132
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y +
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRA 186
Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE  +   +    D++S G ++ E+V  K
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +S   ++G GG   V++ +  + Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 67
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---WSKRCQIIEGIARG----- 461
                    D+ + +Y+Y   +  +Q+I+ V     +D   W K+ + I+   R      
Sbjct: 68  ---------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 115
Query: 462 -LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    D  VGT  Y
Sbjct: 116 MLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 174
Query: 521 MSPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 551
           M PE AI  + S +             DV+S G ++  +  GK
Sbjct: 175 MPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 16/217 (7%)
Query: 350 DNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQ 404
           ++F +   LG+G FG V   R   T G+  A+K L K      +E  + V    ++   +
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  L  L       D    + EY     L    F ++R +     +       I   L Y
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEY 123
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      +++RD+K  N++LD D + KI+DFG+ +    D     T    GT  Y++PE
Sbjct: 124 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 178
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
              D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 213

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +S   ++G GG   V++ +  + Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 115
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---WSKRCQIIEGIARG----- 461
                    D+ + +Y+Y   +  +Q+I+ V     +D   W K+ + I+   R      
Sbjct: 116 ---------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 462 -LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    D  VGT  Y
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 222
Query: 521 MSPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 551
           M PE AI  + S +             DV+S G ++  +  GK
Sbjct: 223 MPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKL 403
           D +     +G+G F  V R +  E GQ+ AVK     + + S G   E+ K E  +   L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGIARGL 462
           +H ++V LL   +      +++E++    L   I       F+   +     +  I   L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 463 LYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
            Y H ++   IIHRD+K  NVLL   +N    K+ DFG+A   G     A     VGT  
Sbjct: 144 RYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPH 198
Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +M+PE      +    DV+  GV++  ++ G
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +S   ++G GG   V++ +  + Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 87
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---WSKRCQIIEGIARG----- 461
                    D+ + +Y+Y   +  +Q+I+ V     +D   W K+ + I+   R      
Sbjct: 88  ---------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 135
Query: 462 -LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    D  VGT  Y
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194
Query: 521 MSPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 551
           M PE AI  + S +             DV+S G ++  +  GK
Sbjct: 195 MPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 347 DATDNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLL 399
           +  D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
           + ++QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVV 515
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           GT  +++PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 35/209 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 81
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P KSLE+F  DV     L  +  CQ+I+              +  G
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQ-DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 140
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   T       V T  Y 
Sbjct: 141 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPFVVTRYYR 194
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +PE  +   +    D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 16/217 (7%)
Query: 350 DNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQ 404
           ++F +   LG+G FG V   R   T G+  A+K L K      +E  + V    ++   +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  L  L       D    + EY     L    F ++R +     +       I   L Y
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      +++RD+K  N++LD D + KI+DFG+ +    D     T    GT  Y++PE
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
              D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 351 NFSWKNKLGEGGFGPVY--RGML--TEGQEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQ 404
           +F     LG+G FG V+  R +     G   A+K L K++ +  +    K E  ++A + 
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN 88
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIA 459
           H  +V+L        +  LI ++L    L     ++ +F     KF         +  +A
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF--------YLAELA 140
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
            GL +LH    L II+RDLK  N+LLD + + K++DFG+++   +D  E       GT  
Sbjct: 141 LGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDH-EKKAYSFCGTVE 195
Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           YM+PE       S  +D +S+GVL+ E++ G
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 117
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 176
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 177 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 230
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+V  K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 350 DNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQ 404
           ++F +   LG+G FG V   R   T G+  A+K L K      +E  + V    ++   +
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  L  L       D    + EY     L    F ++R +     +       I   L Y
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEY 125
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      +++RD+K  N++LD D + KI+DFG+ +  G+    A      GT  Y++PE
Sbjct: 126 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYLAPE 180
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
              D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 215

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 350 DNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQ 404
           ++F +   LG+G FG V   R   T G+  A+K L K      +E  + V    ++   +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  L  L       D    + EY     L    F ++R +     +       I   L Y
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      +++RD+K  N++LD D + KI+DFG+ +  G+    A      GT  Y++PE
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYLAPE 175
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
              D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 80
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 193
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+V  K
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 16/217 (7%)
Query: 350 DNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQ 404
           ++F +   LG+G FG V   R   T G+  A+K L K      +E  + V    ++   +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  L  L       D    + EY     L    F ++R +     +       I   L Y
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      +++RD+K  N++LD D + KI+DFG+ +    D     T    GT  Y++PE
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 175
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
              D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 192
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+V  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 347 DATDNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLL 399
           +  D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
           + ++QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVV 515
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           GT  +++PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVKRLSK----SSGQGV--EEFKNEVLLIAK 402
           D++    +LG G F  V +      G+E A K + K    SS +GV  EE + EV ++ +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           ++H N++ L      + + +LI E +    L  F+      + L   +  Q ++ I  G+
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 121
Query: 463 LYLHQDSRLRIIHRDLKASNVLL--DNDMNPKIS--DFGMARAFGVDQTEANTDRVVGTY 518
            YLH     RI H DLK  N++L   N  NP+I   DFG+A          N   + GT 
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTP 175
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 78
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 137
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 138 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 191
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+V  K
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 132
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 186
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+V  K
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 79
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 192
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+V  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 80
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 193
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+V  K
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 73
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 132
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 186
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+V  K
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 358 LGEGGFGPVYR-----GMLTEGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNL 408
           LG+GG+G V++     G  T G+  A+K L K+    + +     K E  ++ +++H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANT-GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V L+       +  LI EYL    L      + R         C  +  I+  L +LHQ 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
               II+RDLK  N++L++  + K++DFG+ +    D T   T    GT  YM+PE  + 
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPEILMR 195
Query: 529 GLFSVKSDVFSFGVLVLEIVCG 550
              +   D +S G L+ +++ G
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTG 217

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G  G V   Y  +L   + +A+K+LS+        F+N+    AK  +R LV L+ C
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKC 72
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE-------------GIARG 461
              ++   L+  + P K+LE+F  DV     L  +  CQ+I+              +  G
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQ-DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           + +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y 
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY-YR 185
Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE  +   +    D++S G ++ E+V  K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 347 DATDNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLL 399
           +  D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
           + ++QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVV 515
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           GT  +++PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 350 DNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQ 404
           ++F +   LG+G FG V   R   T G+  A+K L K      +E  + V    ++   +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  L  L       D    + EY     L    F ++R +     +       I   L Y
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      +++RD+K  N++LD D + KI+DFG+ +  G+    A      GT  Y++PE
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYLAPE 175
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
              D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVY--RGMLTEGQE-IAVKRLSKSSGQGVEEFKN 395
           MF  +     ++ +    KLG G +G V   R  +T  +  I + R +  S     +   
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
           EV ++  L H N+++L      +    L+ E    K  E F   + R KF +      II
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY--KGGELFDEIIHRMKFNEVDAAV-II 142
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTD 512
           + +  G+ YLH+ +   I+HRDLK  N+LL++   D   KI DFG++  F   + +    
Sbjct: 143 KQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMK 196
Query: 513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             +GT  Y++PE  +   +  K DV+S GV++  ++ G
Sbjct: 197 ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 350 DNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVL---LIAKLQ 404
           ++F +   LG+G FG V   R   T G+  A+K L K      +E  + V    ++   +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  L  L       D    + EY     L    F ++R +     +       I   L Y
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      +++RD+K  N++LD D + KI+DFG+ +  G+    A      GT  Y++PE
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYLAPE 175
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
              D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI----AVKRLSKSS----GQGVEEFKNEVLLIA 401
           +NF     LG G +G V+      G +     A+K L K++     +  E  + E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 402 KL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
            + Q   LV L        +  LI +Y+    L  F     R +F +   +  + E I  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGE-IVL 170
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L +LH   +L II+RD+K  N+LLD++ +  ++DFG+++ F  D+TE   D   GT  Y
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 521 MSPEYAI--DGLFSVKSDVFSFGVLVLEIVCG 550
           M+P+     D       D +S GVL+ E++ G
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH----------- 405
           LG+G FG V +     + +  A+K++ + + + +    +EV L+A L H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 406 --RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD--WSKRCQIIEGIARG 461
             RN V+       +    +  EY  N++L   I      +  D  W    QI+E ++  
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS-- 130
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA----RAFGVDQTEA-------- 509
             Y+H      IIHR+LK  N+ +D   N KI DFG+A    R+  + + ++        
Sbjct: 131 --YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 510 NTDRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIV 548
           N    +GT  Y++ E  +DG   ++ K D +S G++  E +
Sbjct: 186 NLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVKRLSK----SSGQGV--EEFKNEVLLIAK 402
           D++    +LG G F  V +      G+E A K + K    SS +GV  EE + EV ++ +
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           ++H N++ L      + + +LI E +    L  F+      + L   +  Q ++ I  G+
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGV 142
Query: 463 LYLHQDSRLRIIHRDLKASNVLL--DNDMNPKIS--DFGMARAFGVDQTEANTDRVVGTY 518
            YLH     RI H DLK  N++L   N  NP+I   DFG+A          N   + GT 
Sbjct: 143 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTP 196
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 37/211 (17%)
Query: 358 LGEGGFGPV---YRGMLTEGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           +G G  G V   Y  +L   + +A+K+LS+   +    +    E++L+  + H+N++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 413 GCCTLRDERMLIYEYLPNKSLEQF--------IFDVTRTKF----LDWSKRCQIIEGIAR 460
              T            P K+LE+F        + D    +     LD  +   ++  +  
Sbjct: 90  NVFT------------PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLC 137
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR  G   +   T  VV  Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-Y 191
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            +PE  +   +    D++S G ++ E+V  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 358 LGEGGFGPVYRGMLT----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LGEG FG VY G+ T    E   +AVK   K  +    E+F +E +++  L H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRL 471
           G     +   +I E  P   L  ++    R K  L           I + + YL     +
Sbjct: 76  GIIE-EEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES---I 128
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTEANTDRVVGTYGYMSPEYAIDGL 530
             +HRD+   N+L+ +    K+ DFG++R     D  +A+  R+     +MSPE      
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRR 186
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFY 557
           F+  SDV+ F V + EI+   +   F+
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQHR 406
           +F++   LG+G FG V        +E+ A+K L K        VE    E  ++A L   
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 407 N-LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             L +L  C    D    + EY+    L   I  V + K     +       I+ GL +L
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFK---EPQAVFYAAEISIGLFFL 136
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H+     II+RDLK  NV+LD++ + KI+DFGM +   +D     T    GT  Y++PE 
Sbjct: 137 HKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGTPDYIAPEI 191
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +    D +++GVL+ E++ G+
Sbjct: 192 IAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-----GMLTEGQEIAVKRLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +       L    +   KR +KSS +GV  E+ + EV ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGV 127
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 358 LGEGGFGPVYRGMLT----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LGEG FG VY G+ T    E   +AVK   K  +    E+F +E +++  L H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRL 471
           G     +   +I E  P   L  ++    R K  L           I + + YL     +
Sbjct: 92  GIIE-EEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES---I 144
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTEANTDRVVGTYGYMSPEYAIDGL 530
             +HRD+   N+L+ +    K+ DFG++R     D  +A+  R+     +MSPE      
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRR 202
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFY 557
           F+  SDV+ F V + EI+   +   F+
Sbjct: 203 FTTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 21/165 (12%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +ARG+ +L   S  + IHRDL A N+LL  +   KI DFG+AR    +            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADHHHNLLGHAWRLWTE 575
             +M+PE   D ++S KSDV+S+GVL+ EI    G    G    +   + L    R+   
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAP 324
Query: 576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
           +             YS  E     Q+ L C  + P++RP  + +V
Sbjct: 325 E-------------YSTPE---IYQIMLDCWHRDPKERPRFAELV 353

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 358 LGEGGFGPVYRGMLT----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LGEG FG VY G+ T    E   +AVK   K  +    E+F +E +++  L H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSRL 471
           G     +   +I E  P   L  ++    R K  L           I + + YL     +
Sbjct: 80  GIIE-EEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTEANTDRVVGTYGYMSPEYAIDGL 530
             +HRD+   N+L+ +    K+ DFG++R     D  +A+  R+     +MSPE      
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRR 190
Query: 531 FSVKSDVFSFGVLVLEIVCGKRNRGFY 557
           F+  SDV+ F V + EI+   +   F+
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 30/234 (12%)
Query: 326 IDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLS 383
           +DR      M+LP      I   +D +     +G G FG V R M  +   + +AVK + 
Sbjct: 1   MDRPAVAGPMDLP------IMHDSDRYELVKDIGAGNFG-VARLMRDKQANELVAVKYIE 53
Query: 384 KSSGQGVEE-FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR 442
           +  G+ ++E  K E++    L+H N+VR            ++ EY     L + I +  R
Sbjct: 54  R--GEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 111
Query: 443 TKFLDWSKRC---QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFG 497
             F +   R    Q+I G++    Y H    +++ HRDLK  N LLD    P  KI+DFG
Sbjct: 112 --FSEDEARFFFQQLISGVS----YAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFG 162
Query: 498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 550
            ++A       +     VGT  Y++PE  +   +  K +DV+S GV +  ++ G
Sbjct: 163 YSKA---SVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 26/229 (11%)
Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNE 396
           LP+    TIA          ++G+G +G V+ G    G+++AVK    ++ +     + E
Sbjct: 27  LPLLVQRTIAKQIQMV---KQIGKGRYGEVWMGKW-RGEKVAVKVFF-TTEEASWFRETE 81
Query: 397 VLLIAKLQHRNLVRLLGC----CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC 452
           +     ++H N++  +           +  LI +Y  N SL    +D  ++  LD     
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSML 137
Query: 453 QIIEGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
           ++      GL +LH +      +  I HRDLK+ N+L+  +    I+D G+A  F  D  
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 508 EANT--DRVVGTYGYMSPEYAIDGL------FSVKSDVFSFGVLVLEIV 548
           E +   +  VGT  YM PE   + L        + +D++SFG+++ E+ 
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR 406
           D++    +LG G FG V+R  +TE   G   A K +        E  + E+  ++ L+H 
Sbjct: 157 DHYDIHEELGTGAFGVVHR--VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
            LV L       +E ++IYE++    L + + D       D  +  + +  + +GL ++H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMH 272
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           +++    +H DLK  N++     +   K+ DFG+       Q+   T    GT  + +PE
Sbjct: 273 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPE 326
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCG 550
            A        +D++S GVL   ++ G
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR 406
           D++    +LG G FG V+R  +TE   G   A K +        E  + E+  ++ L+H 
Sbjct: 51  DHYDIHEELGTGAFGVVHR--VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 108
Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
            LV L       +E ++IYE++    L + + D       D  +  + +  + +GL ++H
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMH 166
Query: 467 QDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           +++    +H DLK  N++     +   K+ DFG+       Q+   T    GT  + +PE
Sbjct: 167 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPE 220
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCG 550
            A        +D++S GVL   ++ G
Sbjct: 221 VAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 29/210 (13%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G+G +G V+RG L  G+ +AVK  S    Q      E  N VLL    +H N++  +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILGFIAS 70
Query: 415 -CTLRD---ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-- 468
             T R+   +  LI  Y  + SL    +D  + + L+     ++    A GL +LH +  
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 469 ---SRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGVDQTEANTDRVVGTYGYMSP 523
               +  I HRD K+ NVL+ +++   I+D G+A   + G D  +   +  VGT  YM+P
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 524 EYA-----IDGLFSVK-SDVFSFGVLVLEI 547
           E        D   S K +D+++FG+++ EI
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V++        +  ++L     +     +N+++   ++ H    
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNS 66
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    R       K   +   + +GL YL
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 123
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++    +D+     +  VGT  YMSPE 
Sbjct: 124 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM---ANEFVGTRSYMSPER 177
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNR 554
                +SV+SD++S G+ ++E+  G+  R
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEMAVGRYPR 206

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G+G +G V+RG   +G+ +AVK  S    +      E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 415 -CTLRD---ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH---- 466
             T R    +  LI  Y    SL    +D  +   LD     +I+  IA GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 467 -QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGVDQTEANTDRVVGTYGYMSP 523
               +  I HRDLK+ N+L+  +    I+D G+A   +   +Q +   +  VGT  YM+P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 524 EY-----AIDGLFSVKS-DVFSFGVLVLEI 547
           E       +D   S K  D+++FG+++ E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 345 IADATDNFSWKNKLGEGGFGP--VYRGMLTEGQEIAVKRLSKSSGQGVEE-FKNEVLLIA 401
           I   +D + +   +G G FG   + R  LT+ + +AVK + +  G  ++E  + E++   
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIER--GAAIDENVQREIINHR 71
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
            L+H N+VR            +I EY     L + I +  R  F +   R    + +  G
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARF-FFQQLLSG 128
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYG 519
           + Y H    ++I HRDLK  N LLD    P  KI DFG +++  +     +T   VGT  
Sbjct: 129 VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPA 182
Query: 520 YMSPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 550
           Y++PE  +   +  K +DV+S GV +  ++ G
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +S   ++G GG   V++ +  + Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 115
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---WSKRCQIIEGIARG----- 461
                    D+ + +Y+Y   +  +Q+I+ V     +D   W K+ + I+   R      
Sbjct: 116 ---------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 462 -LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    D  VG   Y
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 521 MSPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 551
           M PE AI  + S +             DV+S G ++  +  GK
Sbjct: 223 MPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G+G +G V+RG   +G+ +AVK  S    +      E  N V+L    +H N++  +  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 415 -CTLRDERM---LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH---- 466
             T R       LI  Y    SL    +D  +   LD     +I+  IA GL +LH    
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 467 -QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGVDQTEANTDRVVGTYGYMSP 523
               +  I HRDLK+ N+L+  +    I+D G+A   +   +Q +   +  VGT  YM+P
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 524 EY-----AIDGLFSVKS-DVFSFGVLVLEI 547
           E       +D   S K  D+++FG+++ E+
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V++        +  ++L     +     +N+++   ++ H    
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNS 125
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    R       K   +   + +GL YL
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 182
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YMSPE 
Sbjct: 183 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 236
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +SV+SD++S G+ ++E+  G+
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G+G +G V+RG   +G+ +AVK  S    +      E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 415 -CTLRD---ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH---- 466
             T R    +  LI  Y    SL    +D  +   LD     +I+  IA GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 467 -QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGVDQTEANTDRVVGTYGYMSP 523
               +  I HRDLK+ N+L+  +    I+D G+A   +   +Q +   +  VGT  YM+P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 524 EY-----AIDGLFSVKS-DVFSFGVLVLEI 547
           E       +D   S K  D+++FG+++ E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V++        +  ++L     +     +N+++   ++ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNS 63
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    R       K   +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +SV+SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V++        +  ++L     +     +N+++   ++ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNS 63
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    R       K   +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +SV+SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEG----QEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQ 404
            F     LG+G FG V+      G    Q  A+K L K++ +  +    K E  ++ ++ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  +V+L        +  LI ++L    L  F        F +   +  + E +A  L +
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAE-LALALDH 141
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH    L II+RDLK  N+LLD + + K++DFG+++   +D  E       GT  YM+PE
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPE 196
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCG 550
                  +  +D +SFGVL+ E++ G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +S   ++G GG   V++ +  + Q  A+K   L ++  Q ++ ++NE+  + KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-- 87
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD---WSKRCQIIEGIARG----- 461
                    D+ + +Y+Y   +  +Q+I+ V     +D   W K+ + I+   R      
Sbjct: 88  ---------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 135
Query: 462 -LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D      D  VGT  Y
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNY 194
Query: 521 MSPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 551
           M PE AI  + S +             DV+S G ++  +  GK
Sbjct: 195 MPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V++        +  ++L     +     +N+++   ++ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNS 63
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    R       K   +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +SV+SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V +        I  ++L     +     +N+++   ++ H    
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNS 73
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q + +  R       K   +   + RGL YL
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VSIAVLRGLAYL 130
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YM+PE 
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMAPER 184
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +SV+SD++S G+ ++E+  G+
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V++        +  ++L     +     +N+++   ++ H    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNS 90
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    R       K   +   + +GL YL
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 147
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YMSPE 
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 201
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +SV+SD++S G+ ++E+  G+
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V++        +  ++L     +     +N+++   ++ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNS 63
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    R       K   +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +SV+SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V++        +  ++L     +     +N+++   ++ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNS 63
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    R       K   +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 120
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YMSPE 
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +SV+SD++S G+ ++E+  G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEG----QEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQ 404
            F     LG+G FG V+      G    Q  A+K L K++ +  +    K E  ++ ++ 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  +V+L        +  LI ++L    L  F        F +   +  + E +A  L +
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAE-LALALDH 142
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH    L II+RDLK  N+LLD + + K++DFG+++   +D  E       GT  YM+PE
Sbjct: 143 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPE 197
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCG 550
                  +  +D +SFGVL+ E++ G
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTEG----QEIAVKRLSKSSGQGVEEF--KNEVLLIAKLQ 404
            F     LG+G FG V+      G    Q  A+K L K++ +  +    K E  ++ ++ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIA 459
           H  +V+L        +  LI ++L    L     ++ +F     KF         +  +A
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELA 136
Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
             L +LH    L II+RDLK  N+LLD + + K++DFG+++   +D  E       GT  
Sbjct: 137 LALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVE 191
Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           YM+PE       +  +D +SFGVL+ E++ G
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 349 TDNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
            D+     +LG G +G V +   +  GQ +AVKR+  +      + +  +L+   +  R 
Sbjct: 50  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRT 106
Query: 408 L-----VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARG 461
           +     V   G    R+  + I   L + SL++F   V  + + +      +I   I + 
Sbjct: 107 VDCPFTVTFYGAL-FREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 165
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L +LH  S+L +IHRD+K SNVL++     K+ DFG++  + VD      D   G   YM
Sbjct: 166 LEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDSVAKTID--AGCKPYM 220
Query: 522 SPEYAIDGL----FSVKSDVFSFGVLVLEI 547
           +PE     L    +SVKSD++S G+ ++E+
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 349 TDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
            D+     +LG G +G V +   +  GQ +AVKR+  +      + +  +L+   +  R 
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---QEQKRLLMDLDISMRT 62
Query: 408 L-----VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARG 461
           +     V   G    R+  + I   L + SL++F   V  + + +      +I   I + 
Sbjct: 63  VDCPFTVTFYGAL-FREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L +LH  S+L +IHRD+K SNVL++     K+ DFG++  + VD    + D   G   YM
Sbjct: 122 LEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAKDID--AGCKPYM 176
Query: 522 SPEYAIDGL----FSVKSDVFSFGVLVLEI 547
           +PE     L    +SVKSD++S G+ ++E+
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--- 406
           D+F   ++LG G  G V++        +  ++L     +     +N+++   ++ H    
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNS 82
Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    R       K   +   + +GL YL
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 139
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
            +  + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YMSPE 
Sbjct: 140 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 193
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +SV+SD++S G+ ++E+  G+
Sbjct: 194 LQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 117 YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 167
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 168 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY- 221
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 110
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 111 YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 161
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 162 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY- 215
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 117 YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 167
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 168 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY- 221
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 118
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 119 YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 169
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+   + + E N   +   Y 
Sbjct: 170 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY- 223
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 286

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 547
             +M+PE   D +++++SDV+SFGVL+ EI
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 293

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 120
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 121 YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 171
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+   + + E N   +   Y 
Sbjct: 172 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY- 225
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 161
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 162 YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 212
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+   + + E N   +   Y 
Sbjct: 213 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY- 266
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 91  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 141
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 142 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY- 195
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 95  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 145
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 146 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY- 199
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 95  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 145
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 146 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY- 199
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLSKSSGQGVEE-FKNEVLLIA 401
           I   +D +     +G G FG V R M  +   + +AVK + +  G+ ++E  K E++   
Sbjct: 13  IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHR 69
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
            L+H N+VR            ++ EY     L + I +  R  F +   R    + +  G
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF-FFQQLISG 126
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYG 519
           + Y H    +++ HRDLK  N LLD    P  KI DFG +++  +     +T   VGT  
Sbjct: 127 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPA 180
Query: 520 YMSPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 550
           Y++PE  +   +  K +DV+S GV +  ++ G
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 87
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 88  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 138
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 139 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY- 192
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 102 YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 152
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 153 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY- 206
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL--- 403
           +F++   LG+G FG V   ML+E     +  AVK L K     +++   E  ++ K    
Sbjct: 342 DFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLA 396
Query: 404 ---QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
              +   L +L  C    D    + EY+    L   I  V R K             IA 
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAVFYAAEIAI 453
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GL +L       II+RDLK  NV+LD++ + KI+DFGM +    D     T    GT  Y
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDY 508
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           ++PE      +    D ++FGVL+ E++ G+
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 96  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 146
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 147 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY- 200
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 34/271 (12%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVRLLG 413
           +G G FG V        Q++ A+K LSK       +   F  E  ++A      +V+L  
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 141
Query: 414 CCTLRDERML--IYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
            C  +D++ L  + EY+P   L   +  +DV       W+K        A  +L L    
Sbjct: 142 -CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEVVLALDAIH 191
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT-EANTDRVVGTYGYMSPEY--- 525
            + +IHRD+K  N+LLD   + K++DFG      +D+T   + D  VGT  Y+SPE    
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 526 -AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH----HHNLLGHAWRL-WTEDRSL 579
              DG +  + D +S GV + E++ G      ++AD     +  ++ H   L + ED  +
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTP---FYADSLVGTYSKIMDHKNSLCFPEDAEI 306
Query: 580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRP 610
               K+L  ++     +R  + G+  ++Q P
Sbjct: 307 SKHAKNLICAFLTDREVRLGRNGVEEIKQHP 337

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 87  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 137
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+   + + E N   +   Y 
Sbjct: 138 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSXICSRY- 191
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 83  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 133
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY- 187
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 83  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 133
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY- 187
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 84  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 134
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 135 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY- 188
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 39/225 (17%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +G G +G V   +    G ++A+K+L +   S    +    E+ L+  ++H N++ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL--DWSK----------RCQ-IIEGIARG 461
            T            P+++L+ F        F+  D  K          R Q ++  + +G
Sbjct: 93  FT------------PDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L Y+H      IIHRDLK  N+ ++ D   KI DFG+AR     Q ++     V T  Y 
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYR 192
Query: 522 SPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 565
           +PE  ++ + ++   D++S G ++ E++ GK    F  +DH   L
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTL--FKGSDHLDQL 235

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 126/281 (44%), Gaps = 53/281 (18%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ----HR 406
           LG+GGFG V+ G  LT+  ++A+K + ++   G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 407 NLVRLLGCCTLRDERMLIYEY-LPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARGL 462
            ++RLL     ++  ML+ E  LP + L  +I +  +    +   RC   Q++  I    
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQ--- 153
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMN-PKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
              H  SR  ++HRD+K  N+L+D      K+ DFG + A   D+   + D   GT  Y 
Sbjct: 154 ---HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFD---GTRVYS 205
Query: 522 SPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
            PE+     + ++ + V+S G+L+ ++VCG                         +R  E
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPF---------------------ERDQE 244
Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL 621
           +++  L     +S    C  +   C+  +P  RP++  ++L
Sbjct: 245 ILEAELHFPAHVSP--DCCALIRRCLAPKPSSRPSLEEILL 283

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +        FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 83  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 133
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+   + + E N   +   Y 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY- 187
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL--- 403
           +F++   LG+G FG V   ML+E     +  AVK L K     +++   E  ++ K    
Sbjct: 21  DFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLA 75
Query: 404 ---QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
              +   L +L  C    D    + EY+    L   I  V R K             IA 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAVFYAAEIAI 132
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GL +L       II+RDLK  NV+LD++ + KI+DFGM +    D     T    GT  Y
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDY 187
Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           ++PE      +    D ++FGVL+ E++ G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 83  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 133
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY- 187
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +        FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 83  YSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 133
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+   + + E N   +   Y 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY- 187
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRLLGCC 415
           +G G FG VY+  L + G+ +A+K++ +      + FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 416 TLRDERM------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
               E+       L+ +Y+P     + ++ V R     +S+  Q +  I          R
Sbjct: 83  YSSGEKKDVVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 133
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY- 187
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 39/213 (18%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRL---- 411
           +G G FG VY+  L + G+ +A+K++ +        FKN E+ ++ KL H N+VRL    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIVRLRYFF 82
Query: 412 LGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA---------R 460
                 +DE  L  + +Y+P       ++ V R     +S+  Q +  I          R
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPAT-----VYRVAR----HYSRAKQTLPVIYVKLYMYQLFR 133
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYG 519
            L Y+H      I HRD+K  N+LLD D    K+ DFG A+   + + E N   +   Y 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSXICSRY- 187
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
           Y +PE       ++   DV+S G ++ E++ G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 326 IDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLS 383
           +DR      M+LP      I   +D +     +G G FG V R M  +   + +AVK + 
Sbjct: 1   MDRPAVSGPMDLP------IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIE 53
Query: 384 KSSGQGVEE-FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR 442
           +  G+ ++E  K E++    L+H N+VR            ++ EY     L + I +  R
Sbjct: 54  R--GEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 111
Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMAR 500
             F +   R    + +  G+ Y H    +++ HRDLK  N LLD    P  KI  FG ++
Sbjct: 112 --FSEDEARF-FFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK 165
Query: 501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 550
           +  +     +T   VGT  Y++PE  +   +  K +DV+S GV +  ++ G
Sbjct: 166 SSVLHSQPKDT---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W + A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 23  WESPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHYAMKILDKQKVVKLKQIE 79
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHAR 137
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 138 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 188
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 22/230 (9%)
Query: 326 IDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLS 383
           +DR      M+LP      I   +D +     +G G FG V R M  +   + +AVK + 
Sbjct: 1   MDRPAVSGPMDLP------IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIE 53
Query: 384 KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT 443
           +   +     K E++    L+H N+VR            ++ EY     L + I +  R 
Sbjct: 54  RGE-KIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR- 111
Query: 444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARA 501
            F +   R    + +  G+ Y H    +++ HRDLK  N LLD    P  KI DFG +++
Sbjct: 112 -FSEDEARF-FFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 166
Query: 502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 550
             +     +T   VGT  Y++PE  +   +  K +DV+S GV +  ++ G
Sbjct: 167 SVLHSQPKST---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEE--FKNEVLLIAKLQHRNLVRLLG 413
           K+GEG +G V++    + GQ +A+K+  +S    V +     E+ ++ +L+H NLV LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 414 CCTLRDERMLIYEYLPNKSLEQF-IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
               +    L++EY  +  L +   +     + L  S   Q ++ +     + H+ +   
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN----FCHKHN--- 122
Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-DGLF 531
            IHRD+K  N+L+      K+ DFG AR   +       D  V T  Y SPE  + D  +
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 532 SVKSDVFSFGVLVLEIVCG 550
               DV++ G +  E++ G
Sbjct: 181 GPPVDVWAIGCVFAELLSG 199

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 28/230 (12%)
Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN- 395
           LP+    TIA        +  +G+G FG V+RG    G+E+AVK  S  S +    F+  
Sbjct: 19  LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREA 72
Query: 396 EVLLIAKLQHRNLVRLLGCCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
           E+     L+H N++  +      +    +  L+ +Y  + SL    FD      +     
Sbjct: 73  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGM 128
Query: 452 CQIIEGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGV 504
            ++    A GL +LH +      +  I HRDLK+ N+L+  +    I+D G+A       
Sbjct: 129 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 188
Query: 505 DQTEANTDRVVGTYGYMSPEYAIDGL----FSV--KSDVFSFGVLVLEIV 548
           D  +   +  VGT  YM+PE   D +    F    ++D+++ G++  EI 
Sbjct: 189 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 326 IDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE--GQEIAVKRLS 383
           +DR      M+LP      I   +D +     +G G FG V R M  +   + +AVK + 
Sbjct: 1   MDRPAVSGPMDLP------IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIE 53
Query: 384 KSSGQGVEE-FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR 442
           +  G+ ++E  K E++    L+H N+VR            ++ EY     L + I +  R
Sbjct: 54  R--GEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 111
Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMAR 500
             F +   R    + +  G+ Y H    +++ HRDLK  N LLD    P  KI  FG ++
Sbjct: 112 --FSEDEARF-FFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK 165
Query: 501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 550
           +  +     +T   VGT  Y++PE  +   +  K +DV+S GV +  ++ G
Sbjct: 166 SSVLHSQPKST---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 20/148 (13%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 300 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 352
Query: 518 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED 576
           +GYM+PE    G+ +   +D FS G ++ +++     RG      H     H     T  
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-----RGHSPFRQHKTKDKHEIDRMTLT 407
Query: 577 RSLELIDKSLDGSYSLSEALRCIQVGLL 604
            ++EL D       S S  LR +  GLL
Sbjct: 408 MAVELPD-------SFSPELRSLLEGLL 428

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 20/148 (13%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 518 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED 576
           +GYM+PE    G+ +   +D FS G ++ +++     RG      H     H     T  
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-----RGHSPFRQHKTKDKHEIDRMTLT 408
Query: 577 RSLELIDKSLDGSYSLSEALRCIQVGLL 604
            ++EL D       S S  LR +  GLL
Sbjct: 409 MAVELPD-------SFSPELRSLLEGLL 429

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 28/230 (12%)
Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN- 395
           LP+    TIA        +  +G+G FG V+RG    G+E+AVK  S  S +    F+  
Sbjct: 32  LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREA 85
Query: 396 EVLLIAKLQHRNLVRLLGCCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
           E+     L+H N++  +      +    +  L+ +Y  + SL    FD      +     
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGM 141
Query: 452 CQIIEGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGV 504
            ++    A GL +LH +      +  I HRDLK+ N+L+  +    I+D G+A       
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 505 DQTEANTDRVVGTYGYMSPEYAIDGL----FSV--KSDVFSFGVLVLEIV 548
           D  +   +  VGT  YM+PE   D +    F    ++D+++ G++  EI 
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 20/148 (13%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 518 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED 576
           +GYM+PE    G+ +   +D FS G ++ +++     RG      H     H     T  
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-----RGHSPFRQHKTKDKHEIDRMTLT 408
Query: 577 RSLELIDKSLDGSYSLSEALRCIQVGLL 604
            ++EL D       S S  LR +  GLL
Sbjct: 409 MAVELPD-------SFSPELRSLLEGLL 429

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 20/148 (13%)
Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 518 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED 576
           +GYM+PE    G+ +   +D FS G ++ +++     RG      H     H     T  
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-----RGHSPFRQHKTKDKHEIDRMTLT 408
Query: 577 RSLELIDKSLDGSYSLSEALRCIQVGLL 604
            ++EL D       S S  LR +  GLL
Sbjct: 409 MAVELPD-------SFSPELRSLLEGLL 429

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     +G G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTIGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     K++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 348 ATDNFSWK---------NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEV 397
           +TD+FS +         + LGEG    V   + L   QE AVK + K  G        EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 398 LLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456
            ++ + Q HRN++ L+      D   L++E +   S+   I        L+ S    +++
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQ 118
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDMNP-KISDFGMARAFGV--DQTEANT 511
            +A  L +LH      I HRDLK  N+L +  N ++P KI DFG+     +  D +  +T
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 512 DRVV---GTYGYMSPEYA-----IDGLFSVKSDVFSFGVLVLEIVCG 550
             ++   G+  YM+PE          ++  + D++S GV++  ++ G
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
           TD +  K  +G G +    R +      E AVK + KS     EE +   +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           ++ L     + D+   +Y         + +  + R KF    +   ++  I + + YLH 
Sbjct: 78  IITLKD---VYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 468 DSRLRIIHRDLKASNVL-LDNDMNP---KISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
                ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  +++P
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP--CYTANFVAP 189
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E      +    D++S GVL+   + G
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 20/235 (8%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAK 402
           + + + +F  K+ LGEG +G V         EI   +  +   + +   +   E+ ++  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +               Y+  + ++  +  V  T+ L        I    R +
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD---------- 512
             LH  +   +IHRDLK SN+L++++ + K+ DFG+AR   +D++ A+            
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT 180
Query: 513 RVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
             V T  Y +PE  +    +S   DV+S G ++ E+    R   F   D+ H LL
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL--RRPIFPGRDYRHQLL 233

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     +G G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTIGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     K++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
           TD +  K  +G G +    R +      E AVK + KS     EE +   +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           ++ L     + D+   +Y         + +  + R KF    +   ++  I + + YLH 
Sbjct: 78  IITL---KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 468 DSRLRIIHRDLKASNVL-LDNDMNP---KISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
                ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  +++P
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--CYTANFVAP 189
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E      +    D++S GVL+  ++ G
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEEFK 394
           W   A  T   D F     LG G FG   R ML +    G   A+K L K     ++E +
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKEIE 86
Query: 395 ---NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     K++DFG+A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHFAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W + A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 20/235 (8%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAK 402
           + + + +F  K+ LGEG +G V         EI   +  +   + +   +   E+ ++  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +               Y+  + ++  +  V  T+ L        I    R +
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD---------- 512
             LH  +   +IHRDLK SN+L++++ + K+ DFG+AR   +D++ A+            
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMV 180
Query: 513 RVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
             V T  Y +PE  +    +S   DV+S G ++ E+    R   F   D+ H LL
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL--RRPIFPGRDYRHQLL 233

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W + A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 51  WESPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHYAMKILDKQKVVKLKQIE 107
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 108 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 165
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 166 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 216
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W + A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHFAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHFAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 20/235 (8%)
Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN--EVLLIAK 402
           + + + +F  K+ LGEG +G V         EI   +  +   + +   +   E+ ++  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            +H N++ +               Y+  + ++  +  V  T+ L        I    R +
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD---------- 512
             LH  +   +IHRDLK SN+L++++ + K+ DFG+AR   +D++ A+            
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMT 180
Query: 513 RVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
             V T  Y +PE  +    +S   DV+S G ++ E+    R   F   D+ H LL
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL--RRPIFPGRDYRHQLL 233

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W + A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 23  WESPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHYAMKILDKQKVVKLKQIE 79
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 137
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 138 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 188
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W + A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     +G G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTIGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     K++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     K++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W + A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     K++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 31/234 (13%)
Query: 340 FDWNTIADATDNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSGQGVEEFKNEV 397
           F  + +     ++ +  KLGEGGF  V    G L +G   A+KR+     Q  EE + E 
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREA 77
Query: 398 LLIAKLQHRNLVRLLGCCT----LRDERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRC 452
            +     H N++RL+  C      + E  L+  +    +L   I  +  +  FL   +  
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG-MARAF----GVDQT 507
            ++ GI RGL  +H        HRDLK +N+LL ++  P + D G M +A     G  Q 
Sbjct: 138 WLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 508 EANTDRVVG--TYGYMSPEYAIDGLFSVKS--------DVFSFGVLVLEIVCGK 551
               D      T  Y +PE     LFSV+S        DV+S G ++  ++ G+
Sbjct: 195 LTLQDWAAQRCTISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN- 395
           P+FD N   +  D+F     +G+G FG V      + +++ A+K ++K       E +N 
Sbjct: 4   PVFDENEDVNF-DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62
Query: 396 --EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
             E+ ++  L+H  LV L       ++  ++ + L    L   +       F + + +  
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLF 120
Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           I E +   L YL      RIIHRD+K  N+LLD   +  I+DF +A A    +T+  T  
Sbjct: 121 ICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA-AMLPRETQITT-- 173
Query: 514 VVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVCGKR 552
           + GT  YM+PE         +S   D +S GV   E++ G+R
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVK----RLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +    + G E A K    R S++S +GV  EE + EV ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           + H N++ L      R + +LI E +    L  F+    + + L   +    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH     +I H DLK  N++L +   P    K+ DFG+A      +       + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTP 182
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVK----RLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +    + G E A K    R S++S +GV  EE + EV ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           + H N++ L      R + +LI E +    L  F+    + + L   +    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH     +I H DLK  N++L +   P    K+ DFG+A     D  E     + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN--IFGTP 182
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E + P + L  FI           ++R  + E +AR   +   
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFI-----------TERGALQEELARSFFWQVL 124
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 180
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 181 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVK----RLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +    + G E A K    R S++S +GV  EE + EV ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           + H N++ L      R + +LI E +    L  F+    + + L   +    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH     +I H DLK  N++L +   P    K+ DFG+A      +       + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTP 182
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRLLG 413
           +  +G+G FG V+RG    G+E+AVK  S  S +    F+  E+     L+H N++  + 
Sbjct: 9   QESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 414 CCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
                +    +  L+ +Y  + SL    FD      +      ++    A GL +LH + 
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 121
Query: 469 ----SRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGVDQTEANTDRVVGTYGYMS 522
                +  I HRDLK+ N+L+  +    I+D G+A       D  +   +  VGT  YM+
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 523 PEYAIDGL----FSV--KSDVFSFGVLVLEIV 548
           PE   D +    F    ++D+++ G++  EI 
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 16  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 72
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+P   +   +  + R  F +   R
Sbjct: 73  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 130
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 131 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 181
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 182 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVK----RLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +    + G E A K    R S++S +GV  EE + EV ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           + H N++ L      R + +LI E +    L  F+    + + L   +    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH     +I H DLK  N++L +   P    K+ DFG+A     D  E     + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN--IFGTP 182
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVK----RLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +    + G E A K    R S++S +GV  EE + EV ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           + H N++ L      R + +LI E +    L  F+    + + L   +    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH     +I H DLK  N++L +   P    K+ DFG+A     D  E     + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN--IFGTP 182
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLI-AKLQHRNLVRLLGC 414
           +LG G FG V+R    + G + AVK++       +E F+ E L+  A L    +V L G 
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLYGA 153
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
                   +  E L   SL Q    V     L   +    +     GL YLH  SR RI+
Sbjct: 154 VREGPWVNIFMELLEGGSLGQL---VKEQGCLPEDRALYYLGQALEGLEYLH--SR-RIL 207
Query: 475 HRDLKASNVLLDND-MNPKISDFGMARAF---GVDQTEANTDRVVGTYGYMSPEYAIDGL 530
           H D+KA NVLL +D  +  + DFG A      G+ ++    D + GT  +M+PE  +   
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 531 FSVKSDVFSFGVLVLEIVCG 550
              K DV+S   ++L ++ G
Sbjct: 268 CDAKVDVWSSCCMMLHMLNG 287

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRLLG 413
           +  +G+G FG V+RG    G+E+AVK  S  S +    F+  E+     L+H N++  + 
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 414 CCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
                +    +  L+ +Y  + SL    FD      +      ++    A GL +LH + 
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 469 ----SRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGVDQTEANTDRVVGTYGYMS 522
                +  I HRDLK+ N+L+  +    I+D G+A       D  +   +  VGT  YM+
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 523 PEYAIDGL----FSV--KSDVFSFGVLVLEIV 548
           PE   D +    F    ++D+++ G++  EI 
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     K++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRLLG 413
           +  +G+G FG V+RG    G+E+AVK  S  S +    F+  E+     L+H N++  + 
Sbjct: 11  QESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 414 CCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
                +    +  L+ +Y  + SL    FD      +      ++    A GL +LH + 
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 123
Query: 469 ----SRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGVDQTEANTDRVVGTYGYMS 522
                +  I HRDLK+ N+L+  +    I+D G+A       D  +   +  VGT  YM+
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 523 PEYAIDGL----FSV--KSDVFSFGVLVLEIV 548
           PE   D +    F    ++D+++ G++  EI 
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHRNLVRLLG 413
           +  +G+G FG V+RG    G+E+AVK  S  S +    F+  E+     L+H N++  + 
Sbjct: 14  QESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 414 CCTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD- 468
                +    +  L+ +Y  + SL    FD      +      ++    A GL +LH + 
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 126
Query: 469 ----SRLRIIHRDLKASNVLLDNDMNPKISDFGMA--RAFGVDQTEANTDRVVGTYGYMS 522
                +  I HRDLK+ N+L+  +    I+D G+A       D  +   +  VGT  YM+
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 523 PEYAIDGL----FSV--KSDVFSFGVLVLEIV 548
           PE   D +    F    ++D+++ G++  EI 
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 350 DNFSWKNKLGEGGFGPVYR-GMLTEGQEIAVK----RLSKSSGQGV--EEFKNEVLLIAK 402
           D +    +LG G F  V +    + G E A K    R S++S +GV  EE + EV ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           + H N++ L      R + +LI E +    L  F+    + + L   +    I+ I  G+
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH     +I H DLK  N++L +   P    K+ DFG+A     D  E     + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKN--IFGTP 182
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +++PE        +++D++S GV+   ++ G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKL 403
           D +     +G+G F  V R +  E GQ+ AVK     + + S G   E+ K E  +   L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGIARGL 462
           +H ++V LL   +      +++E++    L   I       F+   +     +  I   L
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 463 LYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
            Y H ++   IIHRD+K   VLL   +N    K+  FG+A   G     A     VGT  
Sbjct: 146 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPH 200
Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +M+PE      +    DV+  GV++  ++ G
Sbjct: 201 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQGVEEFK 394
           W   A  T   D F     LG G FG   R ML +    G   A+K L K     ++E +
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKEIE 86
Query: 395 ---NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     +++DFG+A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVK-----RLSKSSGQGVEEFKNEVLLIAKL 403
           D +     +G+G F  V R +  E GQ+ AVK     + + S G   E+ K E  +   L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFL-DWSKRCQIIEGIARGL 462
           +H ++V LL   +      +++E++    L   I       F+   +     +  I   L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 463 LYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
            Y H ++   IIHRD+K   VLL   +N    K+  FG+A   G     A     VGT  
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPH 198
Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +M+PE      +    DV+  GV++  ++ G
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNE 396
           P   W+  A+   +     ++G G +G V + +    GQ +AVKR+  +     E+ + +
Sbjct: 13  PEQHWDFTAEDLKDL---GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQ 66
Query: 397 VLLIAKLQHRN-----LVRLLGCCTLRDERMLIYEYLPNKSLEQF-------IFDVTRTK 444
           +L+   +  R+     +V+  G    R+    I   L + S ++F       + DV   +
Sbjct: 67  LLMDLDVVMRSSDCPYIVQFYGAL-FREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 445 FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
            L      +I     + L +L ++  L+IIHRD+K SN+LLD   N K+ DFG++    V
Sbjct: 126 ILG-----KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-V 177
Query: 505 DQTEANTDRVVGTYGYMSPE----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           D      D   G   YM+PE     A    + V+SDV+S G+ + E+  G+
Sbjct: 178 DSIAKTRD--AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSG--QGVEEFKNEV 397
           ++   D  D +     +G G +G V   R  LT GQ++A+K++  +       +    E+
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 398 LLIAKLQHRNLVRL---LGCCTLRDERMLIYEYLP--NKSLEQFIFDVTRTKFLDWSKRC 452
            ++   +H N++ +   L       E   +Y  L      L Q I     ++ L      
Sbjct: 106 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS---SQPLTLEHVR 162
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-- 510
             +  + RGL Y+H     ++IHRDLK SN+L++ +   KI DFGMAR       E    
Sbjct: 163 YFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF 219
Query: 511 TDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 565
               V T  Y +PE  +    ++   D++S G +  E++   R + F   ++ H L
Sbjct: 220 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA--RRQLFPGKNYVHQL 273

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W + A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WESPAQNTAHLDQFERIRTLGTGSFG---RVMLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  +   +    LV+L           ++ EY P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     K++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 13/106 (12%)
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE---- 508
            I   IA  + +LH      ++HRDLK SN+    D   K+ DFG+  A   D+ E    
Sbjct: 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 509 ------ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                 A     VGT  YMSPE      +S K D+FS G+++ E++
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 358 LGEGGFGPVYRGMLTE-----GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LGEG +G V   + +E       +I  K+  +    G    K E+ L+ +L+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 413 GCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKR---CQIIEGIARGLLYLHQ 467
                 +++   ++ EY     +++ +  V   +F         CQ+I+G    L YLH 
Sbjct: 73  DVLYNEEKQKMYMVMEYC-VCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG----LEYLHS 127
Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA- 526
                I+H+D+K  N+LL      KIS  G+A A      +       G+  +  PE A 
Sbjct: 128 QG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 527 -IDGLFSVKSDVFSFGVLVLEIVCG 550
            +D     K D++S GV +  I  G
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 349 TDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
            D+     +LG G +G V +   +  GQ  AVKR+  +      + +  +L    +  R 
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS---QEQKRLLXDLDISXRT 89
Query: 408 L-----VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARG 461
           +     V   G    R+  + I   L + SL++F   V  + + +      +I   I + 
Sbjct: 90  VDCPFTVTFYGAL-FREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 148
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L +LH  S+L +IHRD+K SNVL++     K  DFG++  + VD    + D   G   Y 
Sbjct: 149 LEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS-GYLVDDVAKDID--AGCKPYX 203
Query: 522 SPEYAIDGL----FSVKSDVFSFGVLVLEI 547
           +PE     L    +SVKSD++S G+  +E+
Sbjct: 204 APERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    L +L           ++ EY P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     K++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 28/226 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-QEIAVKRLSKSSG-----QGVEEFK----NEVLL 399
           +N+  K  LG G    V R +     +E AVK +  + G     + V+E +     EV +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 400 IAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
           + K+  H N+++L           L+++ +    L  ++   T    L   +  +I+  +
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 120
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              +  LH   +L I+HRDLK  N+LLD+DMN K++DFG +    +D  E     V GT 
Sbjct: 121 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGE-KLREVCGTP 174
Query: 519 GYMSPEYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYH 558
            Y++PE     +      +  + D++S GV++  ++ G  +  F+H
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--SPPFWH 218

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-QEIAVKRLSKSSG-----QGVEEFK----NEVLL 399
           +N+  K  LG G    V R +     +E AVK +  + G     + V+E +     EV +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 400 IAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
           + K+  H N+++L           L+++ +    L  ++   T    L   +  +I+  +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 133
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              +  LH   +L I+HRDLK  N+LLD+DMN K++DFG   +  +D  E     V GT 
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGE-KLREVCGTP 187
Query: 519 GYMSPEYAIDGL------FSVKSDVFSFGVLVLEIVCG 550
            Y++PE     +      +  + D++S GV++  ++ G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE----GQ----EIAVKRLSKSSGQGVEEFKNEVLLIA 401
           ++  +   LG+G F  +++G+  E    GQ    E+ +K L K+     E F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
           KL H++LV   G C   DE +L+ E++   SL+ ++        + W  + ++ + +A  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAA 125
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD--FGMARAFGVDQTEANTDRVVGTYG 519
           + +L +++   +IH ++ A N+LL  + + K  +  F      G+  T    D +     
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 520 YMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 550
           ++ PE   +    ++ +D +SFG  + EI  G
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVRLLGC 414
           +LG G FG V+R    + G + AVK++       +E F+  E++  A L    +V L G 
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGA 132
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
                   +  E L   SL Q I    +   L   +    +     GL YLH     RI+
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RIL 186
Query: 475 HRDLKASNVLLDNDMN-PKISDFGMARAF---GVDQTEANTDRVVGTYGYMSPEYAIDGL 530
           H D+KA NVLL +D +   + DFG A      G+ ++    D + GT  +M+PE  +   
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 531 FSVKSDVFSFGVLVLEIVCG 550
              K D++S   ++L ++ G
Sbjct: 247 CDAKVDIWSSCCMMLHMLNG 266

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI--AVKRLSKSSGQGVEEFKNEV--- 397
           N  A  +D F +   +G+G FG V      + +E+  AVK L K +    +E K+ +   
Sbjct: 32  NPHAKPSD-FHFLKVIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSER 89
Query: 398 -LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQII 455
            +L+  ++H  LV L       D+   + +Y+    L    + + R + FL+   R    
Sbjct: 90  NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAA 146
Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN--TDR 513
           E IA  L YLH    L I++RDLK  N+LLD+  +  ++DFG+ +    +  E N  T  
Sbjct: 147 E-IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNSTTST 198
Query: 514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             GT  Y++PE      +    D +  G ++ E++ G
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLI-AKLQHRNLVRLLGC 414
           +LG G FG V+R    + G + AVK++       +E F+ E L+  A L    +V L G 
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLYGA 134
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
                   +  E L   SL Q    V     L   +    +     GL YLH  SR RI+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQL---VKEQGCLPEDRALYYLGQALEGLEYLH--SR-RIL 188
Query: 475 HRDLKASNVLLDND-MNPKISDFGMARAF---GVDQTEANTDRVVGTYGYMSPEYAIDGL 530
           H D+KA NVLL +D  +  + DFG A      G+ +     D + GT  +M+PE  +   
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 531 FSVKSDVFSFGVLVLEIVCG 550
              K DV+S   ++L ++ G
Sbjct: 249 CDAKVDVWSSCCMMLHMLNG 268

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 110/239 (46%), Gaps = 29/239 (12%)
Query: 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK-------RLSKSSG 387
           ELP  DW    +    +  K+ +G G    V R +    G E AVK       RLS    
Sbjct: 82  ELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139
Query: 388 QGVEEF-KNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF 445
           + V E  + E  ++ ++  H +++ L+          L+++ +    L  ++   T    
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVA 196
Query: 446 LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
           L   +   I+  +   + +LH ++   I+HRDLK  N+LLD++M  ++SDFG +      
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL--- 250
Query: 506 QTEANTDRVVGTYGYMSPEY---AIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYH 558
           +       + GT GY++PE    ++D     +  + D+++ GV++  ++ G  +  F+H
Sbjct: 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPPFWH 307

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 139
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 195
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY P   +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG-QEIAVKRLSKSSG-----QGVEEFK----NEVLL 399
           +N+  K  LG G    V R +     +E AVK +  + G     + V+E +     EV +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 400 IAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
           + K+  H N+++L           L+++ +    L  ++   T    L   +  +I+  +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 133
Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              +  LH   +L I+HRDLK  N+LLD+DMN K++DFG   +  +D  E     V GT 
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGE-KLRSVCGTP 187
Query: 519 GYMSPEYAIDGL------FSVKSDVFSFGVLVLEIVCG 550
            Y++PE     +      +  + D++S GV++  ++ G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 140
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 196
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 140
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 196
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 140
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 196
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 197 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    L +L           ++ EY P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     K++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 76  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 124
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 180
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 181 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 120
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 121 EAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 176
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 125
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 181
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 139
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 195
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 153
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG + A   D    + D   GT  Y 
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRVYS 209
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 153
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 209
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 30/227 (13%)
Query: 348 ATDNFSWK---------NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEV 397
           +TD+FS +         + LGEG    V   + L   QE AVK + K  G        EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 398 LLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456
            ++ + Q HRN++ L+      D   L++E +   S+   I        L+ S    +++
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQ 118
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDMNP-KISDFGMARAFGV--DQTEANT 511
            +A  L +LH      I HRDLK  N+L +  N ++P KI DF +     +  D +  +T
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 512 DRVV---GTYGYMSPEYA-----IDGLFSVKSDVFSFGVLVLEIVCG 550
             ++   G+  YM+PE          ++  + D++S GV++  ++ G
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 120
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 176
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 152
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 208
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 125
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 181
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 120
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 176
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 159
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 215
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    L +L           ++ EY P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     K++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 75  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 123
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 124 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 179
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 180 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 167
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 223
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 125
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 181
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 153
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG + A   D    + D   GT  Y 
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRVYS 209
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 152
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG + A   D    + D   GT  Y 
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFD---GTRVYS 208
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 152
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 208
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 153
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 209
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 51  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 107
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 108 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHAR 165
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 166 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 216
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 357 KLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVRLLGCC 415
           K+G G +G VY+    +G++     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 416 TLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY-----LHQD 468
               +R   L+++Y  +      I    R    +  K  Q+  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWH--IIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 469 SRLRIIHRDLKASNVLLDNDMNP-----KISDFGMARAFGVD-QTEANTDRVVGTYGYMS 522
               ++HRDLK +N+L+  +  P     KI+D G AR F    +  A+ D VV T+ Y +
Sbjct: 145 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 523 PEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 551
           PE  +      K+ D+++ G +  E++  +
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 152
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 208
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
           +D +  K  +G G +    R +      E AVK + KS     EE +   +L+   QH N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPN 82
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           ++ L           L+ E +    L   +  + R KF    +   ++  I + + YLH 
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 468 DSRLRIIHRDLKASNVL-LDNDMNP---KISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
                ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  +++P
Sbjct: 140 QG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTANFVAP 194
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E      +    D++S G+L+  ++ G
Sbjct: 195 EVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 167
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 223
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 124 IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 172
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 173 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 228
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 229 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 342 WNTIADATDNFSWKNKLGEGGFGPV--YRGMLTEGQEIAVKRLSKSSG--QGVEEFKNEV 397
           ++   D  D +     +G G +G V   R  LT GQ++A+K++  +       +    E+
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 398 LLIAKLQHRNLVRL---LGCCTLRDERMLIYEYLP--NKSLEQFIFDVTRTKFLDWSKRC 452
            ++   +H N++ +   L       E   +Y  L      L Q I     ++ L      
Sbjct: 105 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS---SQPLTLEHVR 161
Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-- 510
             +  + RGL Y+H     ++IHRDLK SN+L++ +   KI DFGMAR       E    
Sbjct: 162 YFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF 218
Query: 511 TDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 565
               V T  Y +PE  +    ++   D++S G +  E++   R + F   ++ H L
Sbjct: 219 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA--RRQLFPGKNYVHQL 272

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FAEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
           +D +  K  +G G +    R +      E AVK + KS     EE +   +L+   QH N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPN 82
Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           ++ L           L+ E +    L   +  + R KF    +   ++  I + + YLH 
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 468 DSRLRIIHRDLKASNVL-LDNDMNP---KISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
                ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  +++P
Sbjct: 140 QG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTANFVAP 194
Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E      +    D++S G+L+  ++ G
Sbjct: 195 EVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQ--HRNL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 409 VRLLGCCTLRDERMLIYEYL-PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY--- 464
           +RLL      D  +LI E   P + L  FI           ++R  + E +AR   +   
Sbjct: 99  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 147
Query: 465 --LHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + D   GT  Y 
Sbjct: 148 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 203
Query: 522 SPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 550
            PE+     +  +S  V+S G+L+ ++VCG
Sbjct: 204 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 25  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 81
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 82  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHAR 139
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 140 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 190
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 191 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+++D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  I   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE----GQ----EIAVKRLSKSSGQGVEEFKNEVLLI 400
            ++  +   LG+G F  +++G+  E    GQ    E+ +K L K+     E F     ++
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
           +KL H++LV   G C   DE +L+ E++   SL+ ++        + W  + ++ + +A 
Sbjct: 67  SKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAW 124
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD--FGMARAFGVDQTEANTDRVVGTY 518
            + +L +++   +IH ++ A N+LL  + + K  +  F      G+  T    D +    
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 519 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 550
            ++ PE   +    ++ +D +SFG  + EI  G
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLVRLLGC 414
           ++G G FG V+R    + G + AVK++       +E F+  E++  A L    +V L G 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
                   +  E L   SL Q I    +   L   +    +     GL YLH     RI+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RIL 172
Query: 475 HRDLKASNVLLDNDMN-PKISDFGMARAF---GVDQTEANTDRVVGTYGYMSPEYAIDGL 530
           H D+KA NVLL +D +   + DFG A      G+ ++    D + GT  +M+PE  +   
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 531 FSVKSDVFSFGVLVLEIVCG 550
              K D++S   ++L ++ G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNG 252

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 60/310 (19%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCC 415
           L EGGF  VY    +  G+E A+KRL  +  +       EV  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 416 TLRDER-------MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           ++  E         L+   L    L +F+  +     L      +I     R + ++H+ 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMA---------------RAFGVDQTEANTDR 513
            +  IIHRDLK  N+LL N    K+ DFG A               RA   ++   NT  
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT-- 212
Query: 514 VVGTYGYMSPEYAIDGLFS-----VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 568
              T  Y +PE  I  L+S      K D+++ G  +L ++C ++         H    G 
Sbjct: 213 ---TPMYRTPE--IIDLYSNFPIGEKQDIWALGC-ILYLLCFRQ---------HPFEDGA 257
Query: 569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML---SG 625
             R+     S+   D      +SL  A+         +Q  PE+R +++ VV  L   + 
Sbjct: 258 KLRIVNGKYSIPPHDTQYTVFHSLIRAM---------LQVNPEERLSIAEVVHQLQEIAA 308
Query: 626 ERSLPQPKQP 635
            R++  PK P
Sbjct: 309 ARNV-NPKSP 317

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 31  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 87
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 145
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 146 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  LV L  C         + EY+    L   +F + R + L           I+  L Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH+     II+RDLK  NVLLD++ + K++D+GM +  G+   +  T    GT  Y++PE
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSTFCGTPNYIAPE 223
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                 +    D ++ GVL+ E++ G+
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFK-NEVLLIAKLQHRNLV 409
            + + ++G G FG V+R    + G + AVK++       +E F+  E++  A L    +V
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 129
Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
            L G         +  E L   SL Q I    +   L   +    +     GL YLH   
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR- 185
Query: 470 RLRIIHRDLKASNVLLDNDMN-PKISDFGMARAF---GVDQTEANTDRVVGTYGYMSPEY 525
             RI+H D+KA NVLL +D +   + DFG A      G+ ++    D + GT  +M+PE 
Sbjct: 186 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCG 550
            +      K D++S   ++L ++ G
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 51  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 107
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 108 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 165
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 166 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGAT 216
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 217 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 38/212 (17%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCC- 415
           +G G FG V++  L E  E+A+K++ +      + FKN  L I ++ +H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 416 ---TLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE---------GIARG 461
                +DE    L+ EY+P     + ++  +R     ++K  Q +           + R 
Sbjct: 103 SNGDKKDEVFLNLVLEYVP-----ETVYRASR----HYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYGY 520
           L Y+H    + I HRD+K  N+LLD      K+ DFG A+       E N   +   Y Y
Sbjct: 154 LAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSXICSRY-Y 207
Query: 521 MSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
            +PE       ++   D++S G ++ E++ G+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  LV L  C         + EY+    L   +F + R + L           I+  L Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH+     II+RDLK  NVLLD++ + K++D+GM +  G+   +  T    GT  Y++PE
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 191
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                 +    D ++ GVL+ E++ G+
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 12/101 (11%)
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            I + L YL +  +  +IHRD+K SN+LLD     K+ DFG++     D+ +   DR  G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAG 186
Query: 517 TYGYMSPEYAIDGL------FSVKSDVFSFGVLVLEIVCGK 551
              YM+PE  ID        + +++DV+S G+ ++E+  G+
Sbjct: 187 CAAYMAPE-RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 17  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 73
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 74  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 131
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 132 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRT 182
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 183 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  LV L  C         + EY+    L   +F + R + L           I+  L Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH+     II+RDLK  NVLLD++ + K++D+GM +  G+   +  T    GT  Y++PE
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 176
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                 +    D ++ GVL+ E++ G+
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 351 NFSWKNKLGEGGFGP-VYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +F  K+ LG G  G  VYRGM  + +++AVKR+        +  +   LL    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVI 81
Query: 410 RLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWS-KRCQIIEGIARGLLYLHQ 467
           R    CT +D +   I   L   +L+++   V +  F     +   +++    GL +LH 
Sbjct: 82  RYF--CTEKDRQFQYIAIELCAATLQEY---VEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 468 DSRLRIIHRDLKASNVLLD-----NDMNPKISDFGMARAFGVDQTE-ANTDRVVGTYGYM 521
              L I+HRDLK  N+L+        +   ISDFG+ +   V +   +    V GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 522 SPEYAIDGLF---SVKSDVFSFGVLVLEIV 548
           +PE   +      +   D+FS G +   ++
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVI 223

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  LV L  C         + EY+    L   +F + R + L           I+  L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH+     II+RDLK  NVLLD++ + K++D+GM +  G+   +  T    GT  Y++PE
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 180
Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                 +    D ++ GVL+ E++ G+
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W   A  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFG---RVMLVKHMETGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCC 415
           LGEG +  V   + L  G+E AVK + K +G        EV  + + Q ++N++ L+   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
                  L++E L   S+   +  + + K  +  +  +++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 476 RDLKASNVLLDN--DMNP-KISDFGMARAFGVDQ-----TEANTDRVVGTYGYMSPEYA- 526
           RDLK  N+L ++   ++P KI DF +     ++      T        G+  YM+PE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 527 ----IDGLFSVKSDVFSFGVLVLEIVCG 550
                   +  + D++S GV++  ++ G
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 358 LGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL 417
           LG G FG V+R + T  ++  + +  K  G      K E+ ++   +HRN++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--CQIIEGIARGLLYLHQDSRLRIIH 475
            +E ++I+E++        IF+   T   + ++R     +  +   L +LH  +   I H
Sbjct: 73  MEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 476 RDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTY-GYMSPEYAIDGLFS 532
            D++  N++     +   KI +FG AR         +  R++ T   Y +PE     + S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 533 VKSDVFSFGVLVLEIVCG 550
             +D++S G LV  ++ G
Sbjct: 182 TATDMWSLGTLVYVLLSG 199

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++PE  +   ++   D ++ GVL+ ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 25/232 (10%)
Query: 328 RGNRKENMELPMFDWNTIADA-TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS 385
           RG   E ++ P +D +        +F   ++LG G +G V++    E G+  AVKR S S
Sbjct: 34  RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMS 92
Query: 386 SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER------MLIYEYLPNKSLEQF--I 437
             +G    K+    +A++     V    CC   ++       + +   L   SL+Q    
Sbjct: 93  PFRGP---KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEA 149
Query: 438 FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497
           +  +  +   W      +      L +LH      ++H D+K +N+ L      K+ DFG
Sbjct: 150 WGASLPEAQVWG----YLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG 202
Query: 498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC 549
           +    G   T    +   G   YM+PE  + G +   +DVFS G+ +LE+ C
Sbjct: 203 LLVELG---TAGAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLTILEVAC 250

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           D +    +LG G FG V+R +    G+    K ++          KNE+ ++ +L H  L
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLY 464
           + L      + E +LI E+L    L   I    + ++  + +++ ++         GL +
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA------CEGLKH 164
Query: 465 LHQDSRLRIIHRDLKASNVLLDNDM--NPKISDFGMARAFGVDQTEANTDRVV----GTY 518
           +H+ S   I+H D+K  N++ +     + KI DFG+A       T+ N D +V     T 
Sbjct: 165 MHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA-------TKLNPDEIVKVTTATA 214
Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            + +PE          +D+++ GVL   ++ G
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 116/242 (47%), Gaps = 25/242 (10%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RN 407
           D++    KLG G +  V+  + +T  +++ VK L       +   K E+ ++  L+   N
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKI---KREIKILENLRGGPN 93
Query: 408 LVRLLGCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
           ++ L         R   L++E++ N   +Q    +T     D+  R  + E I + L Y 
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIRFYMYE-ILKALDYC 147
Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           H    + I+HRD+K  NV++D++    ++ D+G+A  +   Q E N  RV   Y +  PE
Sbjct: 148 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVASRY-FKGPE 201
Query: 525 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA-DHHHNLLGHAWRLWTEDRSLELI 582
             +D  ++    D++S G ++  ++   R   F+H  D++  L+  A  L TED   + I
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIF--RKEPFFHGHDNYDQLVRIAKVLGTED-LYDYI 258
Query: 583 DK 584
           DK
Sbjct: 259 DK 260

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT  Y++P   +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE--EFKNEVLLIAKLQHR 406
           DN+  K+ +G G +G VY        + +A+K++++     ++      E+ ++ +L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 407 NLVRLLGCCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++RL         L+ + + I   + +  L++         FL       I+  +  G 
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLF---KTPIFLTEQHVKTILYNLLLGE 144
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
            ++H+     IIHRDLK +N LL+ D + KI DFG+AR    D+
Sbjct: 145 KFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 357 KLGEGGFGPVYRGML-TEGQEIAVKRLSKSS-GQGVE-EFKNE--VLLIAKLQHRNLVRL 411
           +LG G F  V + +  + GQE A K L K   GQ    E  +E  VL +AK   R ++ L
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR-VINL 94
Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR---CQIIEGIARGLLYLHQD 468
                   E +LI EY         IF +   +  +        ++I+ I  G+ YLHQ+
Sbjct: 95  HEVYENTSEIILILEYAAGGE----IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 469 SRLRIIHRDLKASNVLLDNDM---NPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           +   I+H DLK  N+LL +     + KI DFGM+R  G          ++GT  Y++PE 
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEI 204
Query: 526 AIDGLFSVKSDVFSFGVL 543
                 +  +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGII 222

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 342 WNTIADAT---DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG---QGVE 391
           W T +  T   D F     LG G FG   R ML +    G   A+K L K      + +E
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 392 EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
              NE  ++  +    LV+L           ++ EY+    +   +  + R  F +   R
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
               + I     YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 195
Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             + GT   ++PE  +   ++   D ++ GVL+ E+  G
Sbjct: 196 WXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC- 415
           LG GG G V+  +  +  + +A+K++  +  Q V+    E+ +I +L H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 416 ----TLRDERMLIYE----YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
                L D+   + E    Y+  + +E  + +V     L        +  + RGL Y+H 
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS 138
Query: 468 DSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVDQT-EANTDRVVGTYGYMSPEY 525
            +   ++HRDLK +N+ ++  D+  KI DFG+AR      + + +    + T  Y SP  
Sbjct: 139 AN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195
Query: 526 AID-GLFSVKSDVFSFGVLVLEIVCGK 551
            +    ++   D+++ G +  E++ GK
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 19/221 (8%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRL--SKSSGQGVEEFKN---------EVLLI 400
           ++ +  +  G +G V  G+ +EG  +A+KR+  + S G+ V    +         E+ L+
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
               H N++ L       +E  +   YL  + +   +  V   + +  S +  I   +  
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ-HIQYFMYH 142
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            LL LH      ++HRDL   N+LL ++ +  I DF +AR    D  +AN    V    Y
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE---DTADANKTHYVTHRWY 199
Query: 521 MSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK---RNRGFY 557
            +PE  +    F+   D++S G ++ E+   K   R   FY
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 19/221 (8%)
Query: 352 FSWKNKLGEGGFGPVYRGMLTEGQEIAVKRL--SKSSGQGVEEFKN---------EVLLI 400
           ++ +  +  G +G V  G+ +EG  +A+KR+  + S G+ V    +         E+ L+
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
               H N++ L       +E  +   YL  + +   +  V   + +  S +  I   +  
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ-HIQYFMYH 142
Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            LL LH      ++HRDL   N+LL ++ +  I DF +AR    D  +AN    V    Y
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE---DTADANKTHYVTHRWY 199
Query: 521 MSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK---RNRGFY 557
            +PE  +    F+   D++S G ++ E+   K   R   FY
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 54/261 (20%)
Query: 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS-----SGQGVEEF 393
           F   ++ +    +  K  +G+G +G V   +  + + I A+K ++K+     + + VE  
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 394 KNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE-----YLPNKSLEQFI--------FDV 440
           K EV L+ KL H N+ RL           L+ E     +L +K L  FI         DV
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK-LNVFIDDSTGKCAMDV 134
Query: 441 TRTKF---------------------LDWSKRCQIIEGIAR----GLLYLHQDSRLRIIH 475
            +T+                      LD+ +R ++I  I R     L YLH      I H
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICH 191
Query: 476 RDLKASNVLLDND--MNPKISDFGMARAF-GVDQTE-ANTDRVVGTYGYMSPEY--AIDG 529
           RD+K  N L   +     K+ DFG+++ F  ++  E        GT  +++PE     + 
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 530 LFSVKSDVFSFGVLVLEIVCG 550
            +  K D +S GVL+  ++ G
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMG 272

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLI----AKLQ 404
           D F  +   G+G FG V  G   + G  +A+K++ +        F+N  L I    A L 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLH 77
Query: 405 HRNLVRL------LGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQI-IE 456
           H N+V+L      LG    RD  + ++ EY+P+ +L +   +  R +        ++ + 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVDQTEANTDRVV 515
            + R +  LH  S + + HRD+K  NVL++  D   K+ DFG A+      +E N   + 
Sbjct: 137 QLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--PSEPNVAYIC 193
Query: 516 GTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVCGK 551
             Y Y +PE    +  ++   D++S G +  E++ G+
Sbjct: 194 SRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/259 (22%), Positives = 108/259 (41%), Gaps = 41/259 (15%)
Query: 334 NMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVE- 391
           +M  P  DW       D +  ++ +G G +G V       E + +A+K++ +     ++ 
Sbjct: 41  SMPRPHSDWQI----PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC 96
Query: 392 -EFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWS 449
                E+ ++ +L H ++V++L     +D       Y+  +  +     + RT  +L   
Sbjct: 97  KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL 156
Query: 450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA 509
               ++  +  G+ Y+H      I+HRDLK +N L++ D + K+ DFG+AR   VD  E 
Sbjct: 157 HIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART--VDYPEN 211
Query: 510 NTDRV---------------------------VGTYGYMSPEYA-IDGLFSVKSDVFSFG 541
              ++                           V T  Y +PE   +   ++   DV+S G
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
Query: 542 VLVLEIVCGKRNRGFYHAD 560
            +  E++   +    YHAD
Sbjct: 272 CIFAELLNMIKENVAYHAD 290

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-IAVKRLSKSSGQGVE--EFKNEVLLIAKLQHR 406
           DN+  K+ +G G +G VY       ++ +A+K++++     ++      E+ ++ +L+  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 407 NLVRLLGCCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++RL         L+ + + I   + +  L++         FL       I+  +  G 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF---KTPIFLTEEHIKTILYNLLLGE 142
Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
            ++H+     IIHRDLK +N LL+ D + K+ DFG+AR    ++
Sbjct: 143 NFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVRLLG 413
           +G G FG V        +++ A+K LSK       +   F  E  ++A      +V+L  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 140
Query: 414 CCTLRDERML--IYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
               +D+R L  + EY+P   L   +  +DV       W++        A  +L L    
Sbjct: 141 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIH 190
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY---- 525
            +  IHRD+K  N+LLD   + K++DFG        +     D  VGT  Y+SPE     
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCG 550
             DG +  + D +S GV + E++ G
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVRLLG 413
           +G G FG V        +++ A+K LSK       +   F  E  ++A      +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 414 CCTLRDERML--IYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
               +D+R L  + EY+P   L   +  +DV       W++        A  +L L    
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYT-----AEVVLALDAIH 185
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY---- 525
            +  IHRD+K  N+LLD   + K++DFG        +     D  VGT  Y+SPE     
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCG 550
             DG +  + D +S GV + E++ G
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 358 LGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEE---FKNEVLLIAKLQHRNLVRLLG 413
           +G G FG V        +++ A+K LSK       +   F  E  ++A      +V+L  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 140
Query: 414 CCTLRDERML--IYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
               +D+R L  + EY+P   L   +  +DV       W++        A  +L L    
Sbjct: 141 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYT-----AEVVLALDAIH 190
Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY---- 525
            +  IHRD+K  N+LLD   + K++DFG        +     D  VGT  Y+SPE     
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCG 550
             DG +  + D +S GV + E++ G
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 37/227 (16%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKL-Q 404
           T  F    K+G G FG V++ +   +G   A+KR  K     V+E     EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLL 463
           H ++VR        D  ++  EY    SL   I +  R   +   ++   ++  + RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP-------------------KISDFGMARAFGV 504
           Y+H    + ++H D+K SN+ +     P                   KI D G       
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 505 DQTEANTDRVVGTYGYMSPEYAIDGLFSV-KSDVFSFGVLVLEIVCG 550
            Q E    R      +++ E   +    + K+D+F+   L L +VC 
Sbjct: 187 PQVEEGDSR------FLANEVLQENYTHLPKADIFA---LALTVVCA 224

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 37/227 (16%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKL-Q 404
           T  F    K+G G FG V++ +   +G   A+KR  K     V+E     EV   A L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLL 463
           H ++VR        D  ++  EY    SL   I +  R   +   ++   ++  + RGL 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP-------------------KISDFGMARAFGV 504
           Y+H    + ++H D+K SN+ +     P                   KI D G       
Sbjct: 128 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 184
Query: 505 DQTEANTDRVVGTYGYMSPEYAIDGLFSV-KSDVFSFGVLVLEIVCG 550
            Q E    R      +++ E   +    + K+D+F+   L L +VC 
Sbjct: 185 PQVEEGDSR------FLANEVLQENYTHLPKADIFA---LALTVVCA 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 16/199 (8%)
Query: 358 LGEGGFGPVYRGMLTEG-QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCC 415
           LGEG F    + +  +  Q  AVK +SK      ++   E+  +   + H N+V+L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
             +    L+ E L    L + I    + K    ++   I+  +   + ++H    + ++H
Sbjct: 76  HDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHMHD---VGVVH 129
Query: 476 RDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           RDLK  N+L    ++++  KI DFG AR    D     T     T  Y +PE      + 
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP--CFTLHYAAPELLNQNGYD 187
Query: 533 VKSDVFSFGVLVLEIVCGK 551
              D++S GV++  ++ G+
Sbjct: 188 ESCDLWSLGVILYTMLSGQ 206

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 37/227 (16%)
Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFK--NEVLLIAKL-Q 404
           T  F    K+G G FG V++ +   +G   A+KR  K     V+E     EV   A L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLL 463
           H ++VR        D  ++  EY    SL   I +  R   +   ++   ++  + RGL 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP-------------------KISDFGMARAFGV 504
           Y+H    + ++H D+K SN+ +     P                   KI D G       
Sbjct: 128 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 184
Query: 505 DQTEANTDRVVGTYGYMSPEYAIDGLFSV-KSDVFSFGVLVLEIVCG 550
            Q E    R      +++ E   +    + K+D+F+   L L +VC 
Sbjct: 185 PQVEEGDSR------FLANEVLQENYTHLPKADIFA---LALTVVCA 222

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--------SGQGVEEFKNEV 397
           + +  +S  + LG G FG V+  +  E  +E+ VK + K             + +   E+
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 398 LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG 457
            ++++++H N++++L     +    L+ E      L+ F F + R   LD      I   
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEK-HGSGLDLFAF-IDRHPRLDEPLASYIFRQ 138
Query: 458 IARGLLYLHQDSRLR-IIHRDLKASNVLLDNDMNPKISDFGMA 499
           +   + YL    RL+ IIHRD+K  N+++  D   K+ DFG A
Sbjct: 139 LVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 105/265 (39%), Gaps = 43/265 (16%)
Query: 308 KKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNK-LGEGGFGPV 366
           +KK+R +G+  G        +G +     +P F+      +  N     K LG G  G V
Sbjct: 2   EKKKRKRGSRGGK-------KGRKSRIANIPNFE-----QSLKNLVVSEKILGYGSSGTV 49
Query: 367 YRGMLTEGQEIAVKR-LSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY 425
                 +G+ +AVKR L       + E K   LL     H N++R   C    D  + I 
Sbjct: 50  VFQGSFQGRPVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRYY-CSETTDRFLYIA 105
Query: 426 EYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKAS 481
             L N +L+  +          K         ++  IA G+ +LH    L+IIHRDLK  
Sbjct: 106 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQ 162
Query: 482 NVLLDN-------------DMNPKISDFGMARAFGVDQT--EANTDRVVGTYGYMSPEYA 526
           N+L+               ++   ISDFG+ +     Q     N +   GT G+ +PE  
Sbjct: 163 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELL 222
Query: 527 IDGL---FSVKSDVFSFGVLVLEIV 548
            +      +   D+FS G +   I+
Sbjct: 223 EESTKRRLTRSIDIFSMGCVFYYIL 247
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	669
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-148
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-143
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-124
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-93
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-74
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-59
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-58
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-50
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-46
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-45
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-45
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-43
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-43
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-42
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-42
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-42
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-41
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-41
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-41
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-41
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-40
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-40
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-40
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-40
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-40
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-39
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-39
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-39
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-39
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-38
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-38
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-38
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-26
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-24
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  430 bits (1109), Expect = e-148
 Identities = 102/313 (32%), Positives = 164/313 (52%), Gaps = 19/313 (6%)

Query: 327 DRGNRKENMELPMFDWNTIADATDNFS------WKNKLGEGGFGPVYRGMLTEGQEIAVK 380
           ++     +     F +  + + T+NF         NK+GEGGFG VY+G +     +AVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 381 RLSK----SSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF 436
           +L+     ++ +  ++F  E+ ++AK QH NLV LLG  +  D+  L+Y Y+PN SL   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 437 IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF 496
           +  +  T  L W  RC+I +G A G+ +LH++     IHRD+K++N+LLD     KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177

Query: 497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 556
           G+ARA         T R+VGT  YM+PE  + G  + KSD++SFGV++LEI+ G      
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 557 YHADHHHNLLGHAWRLWTEDRSLE-LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN 615
           +       LL     +  E++++E  IDK +      +       V   C+ ++   RP+
Sbjct: 237 HREP--QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPD 293

Query: 616 MSSVVLMLSGERS 628
           +  V  +L    +
Sbjct: 294 IKKVQQLLQEMTA 306

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  420 bits (1082), Expect = e-143
 Identities = 124/291 (42%), Positives = 168/291 (57%), Gaps = 5/291 (1%)

Query: 340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVE-EFKNEVL 398
           F    +  A+DNFS KN LG GGFG VY+G L +G  +AVKRL +   QG E +F+ EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEG 457
           +I+   HRNL+RL G C    ER+L+Y Y+ N S+   + +   ++  LDW KR +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
            ARGL YLH     +IIHRD+KA+N+LLD +    + DFG+A+      T   T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN--RGFYHADHHHNLLGHAWRLWTE 575
            G+++PEY   G  S K+DVF +GV++LE++ G+R         D    LL     L  E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 626
            +   L+D  L G+Y   E  + IQV LLC Q  P +RP MS VV ML G+
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  371 bits (954), Expect = e-124
 Identities = 104/290 (35%), Positives = 165/290 (56%), Gaps = 6/290 (2%)

Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
           + +AT+NF  K  +G G FG VY+G+L +G ++A+KR +  S QG+EEF+ E+  ++  +
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLL 463
           H +LV L+G C  R+E +LIY+Y+ N +L++ ++     T  + W +R +I  G ARGL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF-GVDQTEANTDRVVGTYGYMS 522
           YLH  +   IIHRD+K+ N+LLD +  PKI+DFG+++    +DQT  +T  V GT GY+ 
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGTLGYID 209

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
           PEY I G  + KSDV+SFGV++ E++C +            NL   A       +  +++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269

Query: 583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP 632
           D +L          +     + C+    EDRP+M  V+  L     L + 
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  291 bits (746), Expect = 1e-93
 Identities = 64/299 (21%), Positives = 123/299 (41%), Gaps = 28/299 (9%)

Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
            +           G FG V++  L   + +AVK       Q   + + EV  +  ++H N
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHEN 79

Query: 408 LVRLLGCCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
           +++ +G       +  +  LI  +    SL  F+    +   + W++ C I E +ARGL 
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLA 135

Query: 464 YLHQD-------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
           YLH+D        +  I HRD+K+ NVLL N++   I+DFG+A  F   ++  +T   VG
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195

Query: 517 TYGYMSPEYAIDGL-----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 571
           T  YM+PE     +       ++ D+++ G+++ E+            ++         +
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255

Query: 572 LWTEDRSLELIDK-----SLDGSYSLSEALRCI-QVGLLCVQQRPEDRPNMSSVVLMLS 624
             + +   E++        L   +     +  + +    C     E R +   V   ++
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  242 bits (619), Expect = 1e-74
 Identities = 72/339 (21%), Positives = 129/339 (38%), Gaps = 51/339 (15%)

Query: 335 MELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFK 394
           ME    + +      DN      +G G +G VY+G L + + +AVK  S ++ Q    F 
Sbjct: 1   MEAAASEPSL---DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFI 53

Query: 395 NE--VLLIAKLQHRNLVRLLGCCT-----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
           NE  +  +  ++H N+ R +          R E +L+ EY PN SL +++         D
Sbjct: 54  NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSD 109

Query: 448 WSKRCQIIEGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
           W   C++   + RGL YLH +       +  I HRDL + NVL+ ND    ISDFG++  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169

Query: 502 F------GVDQTEANTDRVVGTYGYMSPEYAIDGLFSV--------KSDVFSFGVLVLEI 547
                     + +      VGT  YM+PE  ++G  ++        + D+++ G++  EI
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 548 VCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK--------SLDGSYSLSEALRCI 599
                +     +   + +      +       ++               ++  +      
Sbjct: 229 FMRCTDLFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 600 QVGLL--CVQQRPEDRPNMSSVVLMLSG-ERSLPQPKQP 635
               +  C  Q  E R         ++       + K  
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  208 bits (531), Expect = 4e-62
 Identities = 77/282 (27%), Positives = 135/282 (47%), Gaps = 23/282 (8%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           K K+G G FG V+R     G ++AVK L +     + V EF  EV ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T      ++ EYL   SL + +      + LD  +R  +   +A+G+ YLH      
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           I+HR+LK+ N+L+D     K+ DFG++R      T  ++    GT  +M+PE   D   +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 533 VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSL 592
            KSDV+SFGV++ E+   ++    +    + N       +  + + LE+         ++
Sbjct: 218 EKSDVYSFGVILWELATLQQ---PW---GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271

Query: 593 SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG--ERSLPQP 632
            E          C    P  RP+ ++++ +L    + ++P P
Sbjct: 272 IEG---------CWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  198 bits (506), Expect = 6e-59
 Identities = 79/284 (27%), Positives = 123/284 (43%), Gaps = 42/284 (14%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQHRNLVR 410
           +  +G GGFG VYR     G E+AVK           Q +E  + E  L A L+H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L G C       L+ E+     L + +      K +           IARG+ YLH ++ 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 471 LRIIHRDLKASNVLLDNDMNP--------KISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
           + IIHRDLK+SN+L+   +          KI+DFG+AR     +T   +    G Y +M+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMS--AAGAYAWMA 182

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK---RNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           PE     +FS  SDV+S+GVL+ E++ G+   R                A+ +     +L
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV---------AYGVAMNKLAL 233

Query: 580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
            +     +    L E          C    P  RP+ ++++  L
Sbjct: 234 PIPSTCPEPFAKLMED---------CWNPDPHSRPSFTNILDQL 268

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  199 bits (508), Expect = 7e-59
 Identities = 71/321 (22%), Positives = 124/321 (38%), Gaps = 35/321 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
                +  +G G FG V +      +++A+K++   S    + F  E+  ++++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           +L G C   +   L+ EY    SL   +       +   +         ++G+ YLH   
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 470 RLRIIHRDLKASNVLLDNDMN-PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
              +IHRDLK  N+LL       KI DFG A       T        G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPEVFEG 177

Query: 529 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG 588
             +S K DVFS+G+++ E++  ++    +  +         W +    R   LI      
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAFRIMWAVHNGTR-PPLIK----- 227

Query: 589 SYSLSEALRC-IQVGLLCVQQRPEDRPNMSSVVLML-SGERSLPQPKQPGFFTERNLPES 646
             +L + +   +     C  + P  RP+M  +V ++    R  P   +P       L   
Sbjct: 228 --NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP-------LQYP 275

Query: 647 ESSSSKRKLPLSNEITISLIE 667
              S         E  +   E
Sbjct: 276 CQHSLPPGEDGRVEPYVDFAE 296

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  198 bits (505), Expect = 2e-58
 Identities = 72/303 (23%), Positives = 115/303 (37%), Gaps = 45/303 (14%)

Query: 355 KNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
              LG+G FG   +      G+ + +K L +   +    F  EV ++  L+H N+++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                     I EY+   +L   I          WS+R    + IA G+ YLH    + I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR------------VVGTYGYM 521
           IHRDL + N L+  + N  ++DFG+AR    ++T+    R            VVG   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           +PE      +  K DVFSFG+++ EI+                    A   +        
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------ADPDYLP--RTMD 231

Query: 582 IDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLML-----SGERSLPQP 632
              ++ G         C      + + C    PE RP+   +   L          LP  
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

Query: 633 KQP 635
            Q 
Sbjct: 292 PQL 294

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  195 bits (498), Expect = 1e-57
 Identities = 64/289 (22%), Positives = 138/289 (47%), Gaps = 38/289 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG-------VEEFKNEVLLIA 401
           +   ++ ++G+GGFG V++G L +    +A+K L     +G        +EF+ EV +++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
            L H N+V+L G     +   ++ E++P   L   + D  +   + WS + +++  IA G
Sbjct: 79  NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDN-----DMNPKISDFGMARAFGVDQTEANTDRVVG 516
           + Y+       I+HRDL++ N+ L +      +  K++DFG+++     Q+  +   ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188

Query: 517 TYGYMSPE--YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT 574
            + +M+PE   A +  ++ K+D +SF +++  I+ G+     +  ++ +  +     +  
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-DEYSYGKIKFINMIRE 244

Query: 575 EDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
           E     + +       ++ E          C    P+ RP+ S +V  L
Sbjct: 245 EGLRPTIPEDCPPRLRNVIEL---------CWSGDPKKRPHFSYIVKEL 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  191 bits (488), Expect = 4e-56
 Identities = 67/274 (24%), Positives = 128/274 (46%), Gaps = 24/274 (8%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
             ++G G FG VY+G      ++AVK L+ +  + Q ++ FKNEV ++ K +H N++  +
Sbjct: 29  GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G  T   +  ++ ++    SL   +         +  K   I    ARG+ YLH      
Sbjct: 87  GYST-APQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KS 140

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE---YAIDG 529
           IIHRDLK++N+ L  D   KI DFG+A            +++ G+  +M+PE        
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 530 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS 589
            +S +SDV++FG+++ E++ G+     Y   + +N       +     S +L     +  
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP---Y--SNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255

Query: 590 YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
             +   +        C++++ ++RP+   ++  +
Sbjct: 256 KRMKRLMA------ECLKKKRDERPSFPRILAEI 283

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  189 bits (483), Expect = 1e-55
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
             KL E   G +++G   +G +I VK L     S +   +F  E   +    H N++ +L
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 413 GCCT--LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           G C         LI  ++P  SL   + + T    +D S+  +    +ARG+ +LH    
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEP 132

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG- 529
           L I    L + +V++D DM  +IS   +  +F        +   +    +++PE A+   
Sbjct: 133 L-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQKK 183

Query: 530 ---LFSVKSDVFSFGVLVLEIVCGK 551
                   +D++SF VL+ E+V  +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTRE 208

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  184 bits (468), Expect = 6e-53
 Identities = 75/303 (24%), Positives = 121/303 (39%), Gaps = 44/303 (14%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
              +G+G FG VY G      E+A++ +     +   ++ FK EV+   + +H N+V  +
Sbjct: 38  GELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
           G C       +I      ++L   + D      LD +K  QI + I +G+ YLH      
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR---VVGTYGYMSPE----- 524
           I+H+DLK+ NV  DN     I+DFG+    GV Q     D+     G   +++PE     
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 525 ----YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
                     FS  SDVF+ G +  E+   +     +            W++ T  +   
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---F---KTQPAEAIIWQMGTGMK-PN 262

Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ----PKQPG 636
           L    +    S         + L C     E+RP  + ++ ML     LP+       PG
Sbjct: 263 LSQIGMGKEIS--------DILLFCWAFEQEERPTFTKLMDML---EKLPKRNRRLSHPG 311

Query: 637 FFT 639
            F 
Sbjct: 312 HFW 314

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  181 bits (461), Expect = 8e-52
 Identities = 72/321 (22%), Positives = 128/321 (39%), Gaps = 53/321 (16%)

Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNE 396
           LP+    TIA          ++G+G +G V+ G    G+++AVK            +  E
Sbjct: 27  LPLLVQRTIAK---QIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRE 79

Query: 397 --VLLIAKLQHRNLVRLLGCCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK 450
             +     ++H N++  +           +  LI +Y  N SL  ++    ++  LD   
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKS 135

Query: 451 RCQIIEGIARGLLYLHQDSRLR-----IIHRDLKASNVLLDNDMNPKISDFGMARAF--G 503
             ++      GL +LH +         I HRDLK+ N+L+  +    I+D G+A  F   
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195

Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEIVCGKRNRGF 556
            ++ +   +  VGT  YM PE  +D   +         +D++SFG+++ E+     + G 
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254

Query: 557 Y--HADHHHNLLGHAWRLWTEDRSLELIDK---------SLDGSYSLSEALRCIQVGLL- 604
              +   +H+L+         D S E + +         S    +S  E LR +   L+ 
Sbjct: 255 VEEYQLPYHDLVP-------SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM-GKLMT 306

Query: 605 -CVQQRPEDRPNMSSVVLMLS 624
            C    P  R     V   L+
Sbjct: 307 ECWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  176 bits (448), Expect = 2e-50
 Identities = 64/296 (21%), Positives = 118/296 (39%), Gaps = 38/296 (12%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNE--VLLIAKLQHRNLVRLLG 413
             +G+G +G V+RG   +G+ +AVK  S    +  + +  E  +     L+H N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 414 CCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
                     +  LI  Y    SL  ++    +   LD     +I+  IA GL +LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 470 RLR-----IIHRDLKASNVLLDNDMNPKISDFGMAR--AFGVDQTEANTDRVVGTYGYMS 522
                   I HRDLK+ N+L+  +    I+D G+A   +   +Q +   +  VGT  YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 523 PE------YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG--------FYHADHHHNLLGH 568
           PE               + D+++FG+++ E+     + G        FY    +      
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245

Query: 569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
             ++   D+    I        +L+   + ++    C  Q P  R     +   L+
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (448), Expect = 6e-50
 Identities = 65/316 (20%), Positives = 120/316 (37%), Gaps = 43/316 (13%)

Query: 337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNE 396
           LP+    TIA        +  +G+G FG V+RG    G+E+AVK  S    +    +  E
Sbjct: 32  LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFRE 84

Query: 397 --VLLIAKLQHRNLVRLLGCCT----LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK 450
             +     L+H N++  +           +  L+ +Y  + SL  ++        +    
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEG 140

Query: 451 RCQIIEGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--G 503
             ++    A GL +LH +      +  I HRDLK+ N+L+  +    I+D G+A      
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200

Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEIVCGKRNRG- 555
            D  +   +  VGT  YM+PE  +D   ++       ++D+++ G++  EI       G 
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259

Query: 556 -------FYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQ 608
                  +Y        +    ++  E +    I        +L    + ++    C   
Sbjct: 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYA 316

Query: 609 RPEDRPNMSSVVLMLS 624
               R     +   LS
Sbjct: 317 NGAARLTALRIKKTLS 332

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  165 bits (419), Expect = 6e-46
 Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 37/295 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
            +  +  +LG+G FG V            G+ +AVK+L  S+ + + +F+ E+ ++  LQ
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 405 HRNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGI 458
           H N+V+  G C     R   LI EYLP  SL  ++      +   K L ++        I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 154

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
            +G+ YL      R IHRDL   N+L++N+   KI DFG+ +    D+        V   
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEP 207

Query: 519 G-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 573
           G     + +PE   +  FSV SDV+SFGV++ E+           A+    +        
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267

Query: 574 TEDRSLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLMLS 624
                +EL+      +  L     C      +   C       RP+   + L + 
Sbjct: 268 IVFHLIELLKN----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  163 bits (415), Expect = 1e-45
 Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 37/295 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
            +  +  +LG+G FG V            G+ +AVK+L  S+ + + +F+ E+ ++  LQ
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 405 HRNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGI 458
           H N+V+  G C     R   LI EYLP  SL  ++      +   K L ++        I
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 123

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
            +G+ YL      R IHRDL   N+L++N+   KI DFG+ +    D+        V   
Sbjct: 124 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEP 176

Query: 519 G-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 573
           G     + +PE   +  FSV SDV+SFGV++ E+           A+    +        
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236

Query: 574 TEDRSLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLMLS 624
                +EL+      +  L     C      +   C       RP+   + L + 
Sbjct: 237 IVFHLIELLKN----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  163 bits (415), Expect = 2e-45
 Identities = 78/336 (23%), Positives = 136/336 (40%), Gaps = 66/336 (19%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
            +  + ++LG+G FG V            G  +AVK+L  S      +F+ E+ ++  L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 405 HRNLVRLLGCCTLRDER--MLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGI 458
              +V+  G       +   L+ EYLP+  L  F+      +  ++ L +S        I
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
            +G+ YL      R +HRDL A N+L++++ + KI+DFG+A+   +D+       VV   
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREP 189

Query: 519 G-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRL 572
           G     + +PE   D +FS +SDV+SFGV++ E+     ++                   
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------------------- 230

Query: 573 WTEDRSLELIDKSLDGSYSLSEALRCIQVG-----------------LLCVQQRPEDRPN 615
            +       +        +LS  L  ++ G                  LC    P+DRP+
Sbjct: 231 CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS 290

Query: 616 MSSVVLMLSGERSLPQPKQPGFFTERNLPESESSSS 651
            S++   L    S  +  +   FT     +  S S 
Sbjct: 291 FSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSF 326

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  162 bits (412), Expect = 4e-45
 Identities = 80/299 (26%), Positives = 123/299 (41%), Gaps = 35/299 (11%)

Query: 355 KNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 408
              LGEG FG V            G+ +AVK L   +G Q    +K E+ ++  L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 409 VRLLGCCTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           ++  GCC         L+ EY+P  SL  ++        +  ++     + I  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YM 521
                  IHRDL A NVLLDND   KI DFG+A+A             V   G     + 
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
           +PE   +  F   SDV+SFGV + E++     ++          L+G A    T  R  E
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ--SPPTKFLELIGIAQGQMTVLRLTE 262

Query: 581 LIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQP 635
           L+++       L    +C      +   C +     RP   +++ +L       Q + P
Sbjct: 263 LLER----GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  160 bits (406), Expect = 1e-43
 Identities = 69/295 (23%), Positives = 109/295 (36%), Gaps = 44/295 (14%)

Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRN 407
           ++     ++G G FG V+ G L  +   +AVK            +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           +VRL+G CT +    ++ E +       F+   T    L      Q++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
                 IHRDL A N L+      KISDFGM+R        A+         + +PE   
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 528 DGLFSVKSDVFSFGVLVLEIV-------CGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
            G +S +SDV+SFG+L+ E             N+                         +
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------------------------Q 323

Query: 581 LIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 631
             +    G   L     C     ++   C    P  RP+ S++   L   R   +
Sbjct: 324 TREFVEKG-GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  157 bits (399), Expect = 4e-43
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 30/214 (14%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-----IAVKRLSKSSGQGV-EEFKNEVLLIAKL 403
             F     LG G FG VY+G+     E     +A+K L +++     +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIA 459
            + ++ RLLG C       LI + +P   L  ++ +    +     L+W         IA
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           +G+ YL      R++HRDL A NVL+    + KI+DFG+A+  G ++ E + +      G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179

Query: 520 -----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                +M+ E  +  +++ +SDV+S+GV V E++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  155 bits (394), Expect = 8e-43
 Identities = 71/292 (24%), Positives = 125/292 (42%), Gaps = 41/292 (14%)

Query: 355 KNKLGEGGFGPVYRGMLT-----EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNL 408
              LGEG FG V            G+++AVK L  +S G  + + K E+ ++  L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 409 VRLLGCCTLRDER--MLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGL 462
           V+  G CT        LI E+LP+ SL++++      +   + L ++        I +G+
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------QICKGM 139

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG--- 519
            YL      + +HRDL A NVL++++   KI DFG+ +A   D+        V       
Sbjct: 140 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSP 192

Query: 520 --YMSPEYAIDGLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLWTED 576
             + +PE  +   F + SDV+SFGV + E++     +           ++G      T  
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS--PMALFLKMIGPTHGQMTVT 250

Query: 577 RSLELIDKSLDGSYSLSEALRC----IQVGLLCVQQRPEDRPNMSSVVLMLS 624
           R +  + +       L     C     Q+   C + +P +R +  +++    
Sbjct: 251 RLVNTLKE----GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  155 bits (393), Expect = 3e-42
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 31/217 (14%)

Query: 355 KNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           K +LGEG FG V+           +   +AVK L ++S    ++F+ E  L+  LQH+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQF------------IFDVTRTKFLDWSKRCQIIE 456
           VR  G CT     ++++EY+ +  L +F              +      L   +   +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D    +  R VG
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VG 217

Query: 517 TYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                   +M PE  +   F+ +SDV+SFGV++ EI 
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  152 bits (387), Expect = 3e-42
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
              ++  ++G G FG V+ G      ++A+K + +      E+F  E  ++ KL H  LV
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYL 465
           +L G C  +    L+ E++ +  L  ++            L           +  G+ YL
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL------DVCEGMAYL 120

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMS 522
                  +IHRDL A N L+  +   K+SDFGM R    DQ  ++T    GT     + S
Sbjct: 121 ---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWAS 173

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIV 548
           PE      +S KSDV+SFGVL+ E+ 
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVF 199

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  153 bits (389), Expect = 4e-42
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 32/218 (14%)

Query: 355 KNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           K +LGEG FG V+           +   +AVK L   +    ++F+ E  L+  LQH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQF-------------IFDVTRTKFLDWSKRCQII 455
           V+  G C   D  ++++EY+ +  L +F                      L  S+   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
             IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +  R V
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-V 191

Query: 516 GTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           G +      +M PE  +   F+ +SDV+SFGV++ EI 
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  151 bits (384), Expect = 9e-42
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +  +   +LG G FG V  G      ++AVK + K      +EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           +  G C+      ++ EY+ N  L  ++   +  K L+ S+  ++   +  G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYA 526
             + IHRDL A N L+D D+  K+SDFGM R    DQ  ++     GT     + +PE  
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVF 177

Query: 527 IDGLFSVKSDVFSFGVLVLEIV 548
               +S KSDV++FG+L+ E+ 
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVF 199

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  154 bits (391), Expect = 1e-41
 Identities = 68/292 (23%), Positives = 118/292 (40%), Gaps = 31/292 (10%)

Query: 274 ERTKRRKKKKVVIIIICALLATGVILIGGFMYMRKKKRRDQGNT-VGSSELDYIDRGNRK 332
              +RR      I++         I     +     K+    N     +   +ID     
Sbjct: 13  HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72

Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEG----QEIAVKRLSK-SSG 387
             +   +        +     +   +G G FG VY G L +        AVK L++ +  
Sbjct: 73  PELVQAVQHVVIGPSSL-IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 131

Query: 388 QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-RMLIYEYLPNKSLEQFI----FDVTR 442
             V +F  E +++    H N++ LLG C   +   +++  Y+ +  L  FI     + T 
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191

Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
              + +         +A+G+ +L   +  + +HRDL A N +LD     K++DFG+AR  
Sbjct: 192 KDLIGFGL------QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-- 240

Query: 503 GVDQTEANTDRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
             D  +   D V    G      +M+ E      F+ KSDV+SFGVL+ E++
Sbjct: 241 --DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  153 bits (388), Expect = 1e-41
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 355 KNKLGEGGFGPVYRGMLT---EGQEI--AVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNL 408
              LG G FG V++G+     E  +I   +K +   SG Q  +   + +L I  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLY 464
           VRLLG C       L+ +YLP  SL   +      +     L+W         IA+G+ Y
Sbjct: 78  VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYY 130

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG----- 519
           L       ++HR+L A NVLL +    +++DFG+A     D  +                
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIK 182

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           +M+ E    G ++ +SDV+S+GV V E++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELM 211

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  151 bits (383), Expect = 2e-41
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 13/202 (6%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
            + ++  +LG G FG V  G      ++A+K + K      +EF  E  ++  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           +L G CT +    +I EY+ N  L  ++            +  ++ + +   + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYA 526
             + +HRDL A N L+++    K+SDFG++R    D+  ++     G+     +  PE  
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVL 193

Query: 527 IDGLFSVKSDVFSFGVLVLEIV 548
           +   FS KSD+++FGVL+ EI 
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIY 215

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  151 bits (383), Expect = 2e-41
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 33/219 (15%)

Query: 355 KNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRN 407
             +LGE  FG VY+G L       + Q +A+K L   + G   EEF++E +L A+LQH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQF-------------IFDVTRTKFLDWSKRCQI 454
           +V LLG  T      +I+ Y  +  L +F               D T    L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
           +  IA G+ YL   S   ++H+DL   NVL+ + +N KISD G+ R    +   A+  ++
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186

Query: 515 VGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                     +M+PE  + G FS+ SD++S+GV++ E+ 
Sbjct: 187 -LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  152 bits (386), Expect = 2e-41
 Identities = 86/321 (26%), Positives = 138/321 (42%), Gaps = 47/321 (14%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAK 402
           +  +   +LG+G FG VY G+            +A+K +++ +S +   EF NE  ++ +
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-------IFDVTRTKFLDWSKRCQII 455
               ++VRLLG  +     ++I E +    L+ +       + +         SK  Q+ 
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
             IA G+ YL   +  + +HRDL A N ++  D   KI DFGM R    D  E +  R  
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-K 196

Query: 516 GTYGY-----MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 568
           G  G      MSPE   DG+F+  SDV+SFGV++ EI           Y    +  +L  
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA----TLAEQPYQGLSNEQVL-- 250

Query: 569 AWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 628
             R   E   L+  D   D  + L           +C Q  P+ RP+   ++  +  E  
Sbjct: 251 --RFVMEGGLLDKPDNCPDMLFELM---------RMCWQYNPKMRPSFLEIISSIKEEME 299

Query: 629 LPQPKQPGFFTERN-LPESES 648
               +   +++E N LPE E 
Sbjct: 300 PGFREVSFYYSEENKLPEPEE 320

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  151 bits (384), Expect = 2e-41
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 29/209 (13%)

Query: 356 NKLGEGGFGPVYRGMLTEG----QEIAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVR 410
             +G G FG VY G L +        AVK L++ +    V +F  E +++    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 411 LLGCCTLRDE-RMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLYL 465
           LLG C   +   +++  Y+ +  L  FI     + T    + +         +A+G+ YL
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL------QVAKGMKYL 144

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------ 519
              +  + +HRDL A N +LD     K++DFG+AR    D  +     V    G      
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVK 197

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           +M+ E      F+ KSDV+SFGVL+ E++
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELM 226

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  150 bits (381), Expect = 5e-41
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 13/203 (6%)

Query: 350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
            + + K+KLG G +G VY G+       +AVK L K     VEEF  E  ++ +++H NL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V+LLG CT      +I E++   +L  ++ +    + +       +   I+  + YL   
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL--- 127

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEY 525
            +   IHRDL A N L+  +   K++DFG++R    D   A+     G      + +PE 
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPES 183

Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                FS+KSDV++FGVL+ EI 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIA 206

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  151 bits (383), Expect = 5e-41
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 30/214 (14%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-----IAVKRL-SKSSGQGVEEFKNEVLLIAKL 403
             F     LG G FG VY+G+     E     +A+K L   +S +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIA 459
            + ++ RLLG C       LI + +P   L  ++ +    +     L+W         IA
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           +G+ YL      R++HRDL A NVL+    + KI+DFG+A+  G ++ E + +      G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179

Query: 520 -----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                +M+ E  +  +++ +SDV+S+GV V E++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  154 bits (392), Expect = 5e-41
 Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 13/196 (6%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            KLG G FG V+     +  ++AVK + K     VE F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           T ++   +I E++   SL  F+            K       IA G+ ++    +   IH
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYAIDGLFS 532
           RDL+A+N+L+   +  KI+DFG+AR    ++  A      G      + +PE    G F+
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFT 363

Query: 533 VKSDVFSFGVLVLEIV 548
           +KSDV+SFG+L++EIV
Sbjct: 364 IKSDVWSFGILLMEIV 379

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  149 bits (379), Expect = 7e-41
 Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 13/202 (6%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +      +LG G FG V+ G      ++AVK L K      + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           RL    T ++   +I EY+ N SL  F+        L  +K   +   IA G+ ++    
Sbjct: 72  RLYAVVT-QEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFI---E 126

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYA 526
               IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A      G      + +PE  
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAI 182

Query: 527 IDGLFSVKSDVFSFGVLVLEIV 548
             G F++KSDV+SFG+L+ EIV
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIV 204

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  150 bits (380), Expect = 7e-41
 Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 35/231 (15%)

Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQE----IAVKRLSK-SSG 387
           +++ +P  +                +G+G FG VY G   +  +     A+K LS+ +  
Sbjct: 12  KDVLIP-HERVVTHS-------DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63

Query: 388 QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER-MLIYEYLPNKSLEQFI----FDVTR 442
           Q VE F  E LL+  L H N++ L+G     +    ++  Y+ +  L QFI     + T 
Sbjct: 64  QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123

Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
              + +         +ARG+ YL   +  + +HRDL A N +LD     K++DFG+AR  
Sbjct: 124 KDLISFGL------QVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR-- 172

Query: 503 GVDQTEANTDRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
            +   E  + +    +      + + E      F+ KSDV+SFGVL+ E++
Sbjct: 173 DILDREYYSVQ-QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  148 bits (377), Expect = 1e-40
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 25/206 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
                   +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77

Query: 410 RLLGCCTLRDER-MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +LLG          ++ EY+   SL  ++    R   L      +    +   + YL   
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------YMS 522
                +HRDL A NVL+  D   K+SDFG+ +    + +                  + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTA 182

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIV 548
           PE   +  FS KSDV+SFG+L+ EI 
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIY 208

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  151 bits (382), Expect = 1e-40
 Identities = 73/332 (21%), Positives = 136/332 (40%), Gaps = 39/332 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHR 406
           + +    K+GEG FG         +G++  +K   +S+ S +  EE + EV ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+            ++ +Y     L + I    +       +       I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVH 142

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
                +I+HRD+K+ N+ L  D   ++ DFG+AR        A     +GT  Y+SPE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
            +  ++ KSD+++ G ++ E+   K    F                        L+ K +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK--HAFEAGSM-----------------KNLVLKII 238

Query: 587 DGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSV----VLMLSGERSLPQPKQPGF 637
            GS+       S  LR +   L   ++ P DRP+++S+     +    E+ L        
Sbjct: 239 SGSFPPVSLHYSYDLRSLVSQLF--KRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEE 296

Query: 638 FTERNLPESESSSSKRKLPLSNEITISLIEGR 669
           F  +   +  S     K P S + +IS++  +
Sbjct: 297 FCLKTFSKFGSQPIPAKRPASGQNSISVMPAQ 328

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  154 bits (390), Expect = 2e-40
 Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 7/194 (3%)

Query: 356 NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +KLG G +G VY G+       +AVK L K     VEEF  E  ++ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
           CT      +I E++   +L  ++ +    + +       +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVK 534
           HR+L A N L+  +   K++DFG++R    D   A+         + +PE      FS+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399

Query: 535 SDVFSFGVLVLEIV 548
           SDV++FGVL+ EI 
Sbjct: 400 SDVWAFGVLLWEIA 413

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  149 bits (378), Expect = 2e-40
 Identities = 71/312 (22%), Positives = 126/312 (40%), Gaps = 46/312 (14%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRL---SKSSGQGVEEFKNEVLLIAKLQH 405
            NF  + K+G G F  VYR   L +G  +A+K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGLLY 464
            N+++        +E  ++ E      L + I    +  + +      +    +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           +H     R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT  YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL-ELID 583
              +  ++ KSD++S G L+ E+   +                  +    +  +L  L  
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ----------------SPFY--GDKMNLYSLCK 248

Query: 584 KSLDGSYS------LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGF 637
           K     Y        SE LR  Q+  +C+   PE RP+++ V             K+   
Sbjct: 249 KIEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYV---------YDVAKRMHA 297

Query: 638 FTERNLPESESS 649
            T  +L      
Sbjct: 298 CTASSLEHHHHH 309

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  149 bits (379), Expect = 2e-40
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 38/228 (16%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRL-SKSSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V              E   +AVK L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-- 457
             + +H+N++ LLG CT      +I EY    +L +++    R   +++S     +    
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQ 153

Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
                       +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    D
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----D 206

Query: 506 QTEANTDRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
               +  +   T G     +M+PE   D +++ +SDV+SFGVL+ EI 
Sbjct: 207 INNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  149 bits (378), Expect = 3e-40
 Identities = 69/218 (31%), Positives = 98/218 (44%), Gaps = 27/218 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAK 402
            N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGI 458
             H+N+VR +G       R ++ E +    L+ F+       ++   L       +   I
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVV 515
           A G  YL        IHRD+ A N LL         KI DFGMAR    D   A+  R  
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-K 201

Query: 516 GTYGY-----MSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           G         M PE  ++G+F+ K+D +SFGVL+ EI 
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  147 bits (374), Expect = 3e-40
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 21/204 (10%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQE---IAVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVR 410
             +LG G FG V +G+    ++   +A+K L + +     EE   E  ++ +L +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L+G C   +  ML+ E      L +F+  V + + +  S   +++  ++ G+ YL     
Sbjct: 75  LIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------YMSPE 524
              +HRDL A NVLL N    KISDFG+++A G D +                  + +PE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA-----RSAGKWPLKWYAPE 183

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIV 548
                 FS +SDV+S+GV + E +
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEAL 207

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  147 bits (374), Expect = 4e-40
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 23/203 (11%)

Query: 357 KLGEGGFGPVYRGML-TEGQEI--AVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
           +LG G FG V +G    +      AVK L    +     +E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
           +G C   +  ML+ E      L ++   + + + +      +++  ++ G+ YL      
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKY---LQQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------YMSPEY 525
             +HRDL A NVLL      KISDFG+++A   D+                   + +PE 
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191

Query: 526 AIDGLFSVKSDVFSFGVLVLEIV 548
                FS KSDV+SFGVL+ E  
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAF 214

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  152 bits (385), Expect = 4e-40
 Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 7/193 (3%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           +  +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +H
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKS 535
           RDL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362

Query: 536 DVFSFGVLVLEIV 548
           DV+SFG+L+ E+ 
Sbjct: 363 DVWSFGILLTELT 375

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  148 bits (377), Expect = 4e-40
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 21/205 (10%)

Query: 355 KNKLGEGGFGPVYRGMLT----EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +  +G G  G V  G L         +A+K L +  + +   +F +E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           RL G  T     M++ EY+ N SL+ F+   T        +   ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------YMSP 523
            L  +HRDL A NVL+D+++  K+SDFG++R       E + D    T G      + +P
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-----EDDPDAAYTTTGGKIPIRWTAP 223

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIV 548
           E      FS  SDV+SFGV++ E++
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVL 248

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  148 bits (377), Expect = 4e-40
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 43/237 (18%)

Query: 336 ELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQE---IAVKRL-SKSSGQGVE 391
             P+ DWN I        +++ +GEG FG V +  + +       A+KR+   +S     
Sbjct: 18  IYPVLDWNDI-------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 70

Query: 392 EFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-------------I 437
           +F  E+ ++ KL  H N++ LLG C  R    L  EY P+ +L  F              
Sbjct: 71  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130

Query: 438 FDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497
              +    L   +       +ARG+ YL   S+ + IHRDL A N+L+  +   KI+DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 187

Query: 498 MARAFGVDQTEANTDRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           ++R           +  V          +M+ E     +++  SDV+S+GVL+ EIV
Sbjct: 188 LSR---------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  147 bits (373), Expect = 4e-40
 Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 49/287 (17%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
            +F     +G GGFG V++     +G+   +KR+  ++    E+ + EV  +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 409 VRLLGC-------------CTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRC 452
           V   GC              + R +   ++   E+    +LEQ+I +  R + LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
           ++ E I +G+ Y+H     ++I+RDLK SN+ L +    KI DFG+  +   D  +    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTR- 180

Query: 513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 572
              GT  YMSPE      +  + D+++ G+++ E++          A             
Sbjct: 181 -SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFF------ 228

Query: 573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
                  +L D  +   +   +  + +   LL  +  PEDRPN S +
Sbjct: 229 ------TDLRDGIISDIF--DKKEKTLLQKLLSKK--PEDRPNTSEI 265

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  147 bits (373), Expect = 6e-40
 Identities = 61/206 (29%), Positives = 86/206 (41%), Gaps = 26/206 (12%)

Query: 357 KLGEGGFGPVYRGMLT--EGQEI--AVKRL---SKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           KLG+G FG V RG      G+ +  AVK L     S  + +++F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLYL 465
           RL G         ++ E  P  SL   +              ++        +A G+ YL
Sbjct: 85  RLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGYL 137

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMS 522
                 R IHRDL A N+LL      KI DFG+ RA   +               + + +
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCA 192

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIV 548
           PE      FS  SD + FGV + E+ 
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMF 218

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  153 bits (387), Expect = 7e-40
 Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 7/193 (3%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
            KLG+G FG V+ G       +A+K L K      E F  E  ++ KL+H  LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIH 475
           +  +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+    R+  +H
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 476 RDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKS 535
           RDL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G F++KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445

Query: 536 DVFSFGVLVLEIV 548
           DV+SFG+L+ E+ 
Sbjct: 446 DVWSFGILLTELT 458

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  151 bits (383), Expect = 7e-40
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 25/201 (12%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
              +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG 
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 415 CTLRDER-MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                    ++ EY+   SL  ++    R   L      +    +   + YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNF 310

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------YMSPEYAI 527
           +HRDL A NVL+  D   K+SDFG+ +           +             + +PE   
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 359

Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
           +  FS KSDV+SFG+L+ EI 
Sbjct: 360 EKKFSTKSDVWSFGILLWEIY 380

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  149 bits (378), Expect = 7e-40
 Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 27/218 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSK-SSGQGVEEFKNEVLLIAK 402
            N +    LG G FG VY G ++         ++AVK L +  S Q   +F  E L+I+K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGI 458
             H+N+VR +G       R ++ E +    L+ F+       ++   L       +   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVV 515
           A G  YL        IHRD+ A N LL         KI DFGMAR    D   A   R  
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-K 242

Query: 516 GTYGY-----MSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           G         M PE  ++G+F+ K+D +SFGVL+ EI 
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  148 bits (376), Expect = 9e-40
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 41/232 (17%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N  +   +GEG FG V++              +AVK L  ++S     +F+ E  L+A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF---------------------IFDVT 441
             + N+V+LLG C +     L++EY+    L +F                          
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 442 RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
               L  +++  I   +A G+ YL   S  + +HRDL   N L+  +M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR- 222

Query: 502 FGVDQTEANTDRVVGTYGY-----MSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
              +   A+  +            M PE      ++ +SDV+++GV++ EI 
Sbjct: 223 ---NIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  147 bits (373), Expect = 1e-39
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)

Query: 355 KNKLGEGGFGPVYRGMLT----EGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNL 408
              LGEG FG V  G L        ++AVK +    SS + +EEF +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 409 VRLLGCCTLRD-----ERMLIYEYLPNKSLEQFI---FDVTRTKFLDWSKRCQIIEGIAR 460
           +RLLG C         + M+I  ++    L  ++      T  K +      + +  IA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG- 519
           G+ YL   S    +HRDL A N +L +DM   ++DFG+++         +  R  G    
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQ-GRIAK 210

Query: 520 ----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
               +++ E   D +++ KSDV++FGV + EI 
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  147 bits (373), Expect = 1e-39
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 41/232 (17%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
            N      LGEG FG V +              +AVK L   +S   + +  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-------IFDVTRTKFLDWSKRCQII 455
           + H ++++L G C+     +LI EY    SL  F             +     S      
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 456 EG--------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
           +               I++G+ YL   + ++++HRDL A N+L+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198

Query: 502 FGVDQTEANTDRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
              D  E ++     + G     +M+ E   D +++ +SDV+SFGVL+ EIV
Sbjct: 199 ---DVYEEDSYVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  148 bits (375), Expect = 2e-39
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 38/228 (16%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRL-SKSSGQGVEEFKNEVLLI 400
           D  +    LGEG FG V              E   +AVK L   ++ + + +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG-- 457
             + +H+N++ LLG CT      +I EY    +L +++    R   +++S     +    
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQ 199

Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
                       +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    D
Sbjct: 200 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----D 252

Query: 506 QTEANTDRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
               +  +   T G     +M+PE   D +++ +SDV+SFGVL+ EI 
Sbjct: 253 INNIDYYKK-TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  146 bits (370), Expect = 2e-39
 Identities = 65/334 (19%), Positives = 116/334 (34%), Gaps = 68/334 (20%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRN 407
            +F     LG GGFG V+      +    A+KR+         E+   EV  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 408 LVRLLGC---------CTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
           +VR                   ++ +Y   +    ++L+ ++      +  + S    I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV- 514
             IA  + +LH      ++HRDLK SN+    D   K+ DFG+  A   D+ E       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 515 ---------VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 565
                    VGT  YMSPE      +S K D+FS G+++ E+                  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL------------------ 223

Query: 566 LGHAWRLWTEDRSLELIDKSLDGSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
               +   T+   +  +    +  +             +   +L     P +RP   +++
Sbjct: 224 ---LYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPS--PMERPEAINII 278

Query: 621 LMLSGERSLPQPKQPGFFTERNLPESESSSSKRK 654
                       +    F + + P       + +
Sbjct: 279 ------------ENA-VFEDLDFPGKTVLRQRSR 299

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  146 bits (371), Expect = 3e-39
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 30/210 (14%)

Query: 355 KNKLGEGGFGPVYRGML---TEGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNL 408
           +  +G G FG VY+GML   +  +E+  A+K L    + +   +F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLY 464
           +RL G  +     M+I EY+ N +L++F+     + +  + +   +      GIA G+ Y
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR------GIAAGMKY 162

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG----- 519
           L   + +  +HRDL A N+L+++++  K+SDFG++R    D     T     T G     
Sbjct: 163 L---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPI 214

Query: 520 -YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
            + +PE      F+  SDV+SFG+++ E++
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVM 244

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  146 bits (370), Expect = 3e-39
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 28/214 (13%)

Query: 355 KNKLGEGGFGPVYRGMLT----EGQEIAVKRLSK--SSGQGVEEFKNEVLLIAKLQHRNL 408
              LG+G FG V    L        ++AVK L     +   +EEF  E   + +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 409 VRLLGCCTLRDER------MLIYEYLPNKSLEQFIFD---VTRTKFLDWSKRCQIIEGIA 459
            +L+G       +      M+I  ++ +  L  F+           L      + +  IA
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
            G+ YL   S    IHRDL A N +L  DM   ++DFG++R         +  R  G   
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQ-GCAS 199

Query: 520 -----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                +++ E   D L++V SDV++FGV + EI+
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  145 bits (369), Expect = 4e-39
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 37/227 (16%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           D       LG G FG V              + +AVK L   ++        +E+ ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 403 L-QHRNLVRLLGCCTLRDE-RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG--- 457
           +  H N+V LLG CT      M+I E+    +L  ++    R +F+ +    + +     
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKVAPEDLYKDFL 145

Query: 458 -----------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
                      +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR    D 
Sbjct: 146 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DI 198

Query: 507 TEANTDRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
            +                +M+PE   D +++++SDV+SFGVL+ EI 
Sbjct: 199 YKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  144 bits (366), Expect = 4e-39
 Identities = 63/266 (23%), Positives = 113/266 (42%), Gaps = 31/266 (11%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           ++G G F  VY+G+      E+A    +  K +    + FK E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 414 CC--TLRDERML--IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
               T++ ++ +  + E + + +L+ ++    R K +           I +GL +LH  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 470 RLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
              IIHRDLK  N+ +     + KI D G+A       + A    V+GT  +M+PE   +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA--VIGTPEFMAPEM-YE 203

Query: 529 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG 588
             +    DV++FG+ +LE+   +      +           +R  T        DK    
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASFDKVAI- 256

Query: 589 SYSLSEALRCIQVGLLCVQQRPEDRP 614
                E    I+    C++Q  ++R 
Sbjct: 257 ----PEVKEIIE---GCIRQNKDERY 275

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  144 bits (366), Expect = 5e-39
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 32/209 (15%)

Query: 355 KNKLGEGGFGPVYRGMLT--EGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLV 409
              LGEG FG VY G+ T  +G++I  AVK   K  +    E+F +E +++  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLYL 465
           +L+G     +   +I E  P   L  ++      +     + +S        I + + YL
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICKAMAYL 129

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG------ 519
                +  +HRD+   N+L+ +    K+ DFG++R    +     +              
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-------VTRLPIK 179

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           +MSPE      F+  SDV+ F V + EI+
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEIL 208

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  144 bits (365), Expect = 5e-39
 Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 36/283 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           +++     +G G +G   +    ++G+ +  K L     +    +   +EV L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 407 NLVRLLGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLL 463
           N+VR       R    L  + EY     L   I   T+ + +LD     +++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 464 YLHQ--DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             H+  D    ++HRDLK +NV LD   N K+ DFG+AR    D + A T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           SPE      ++ KSD++S G L+ E+        F                       EL
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTAFSQK-----------------EL 224

Query: 582 IDKSLDGSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             K  +G +       S+ L  I   +L ++     RP++  +
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLK--DYHRPSVEEI 265

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  147 bits (372), Expect = 5e-39
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE----IAVKRLSK-SSGQGVEEFKNEVLLIAKLQ 404
            N S    +G G FG V  G L    +    +A+K L    + +   +F  E  ++ +  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H N++RL G  T     M++ EY+ N SL+ F+            +   ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG----- 519
           L   S +  +HRDL A N+L+++++  K+SDFG+ R       E + +    T G     
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL-----EDDPEAAYTTRGGKIPI 214

Query: 520 -YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
            + SPE      F+  SDV+S+G+++ E++
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  144 bits (366), Expect = 6e-39
 Identities = 63/300 (21%), Positives = 113/300 (37%), Gaps = 52/300 (17%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
             +F     LG+G FG V +     + +  A+K++  +  + +    +EV+L+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 408 LVRLLGC----------CTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRCQI 454
           +VR               T   ++  ++   EY  N +L   I   +        +  ++
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR- 513
              I   L Y+H      IIHRDLK  N+ +D   N KI DFG+A+           D  
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 514 -----------VVGTYGYMSPE-YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
                       +GT  Y++ E     G ++ K D++S G++  E++       F     
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFSTGME 233

Query: 562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             N+L          + L  +       +     +  + I   L+     P  RP   ++
Sbjct: 234 RVNIL----------KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH--DPNKRPGARTL 281

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (364), Expect = 8e-39
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 30/206 (14%)

Query: 357 KLGEGGFGPVYRGMLT--EGQEI--AVKRLSK-SSGQGVEEFKNEVLLIAKLQHRNLVRL 411
            +GEG FG V++G+    E   +  A+K     +S    E+F  E L + +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           +G  T  +   +I E      L  F+    + +     + ++        ++  L YL  
Sbjct: 82  IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY------QLSTALAYL-- 132

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMS 522
               R +HRD+ A NVL+ ++   K+ DFG++R         ++     + G     +M+
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMA 185

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIV 548
           PE      F+  SDV+ FGV + EI+
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEIL 211

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  143 bits (364), Expect = 9e-39
 Identities = 47/226 (20%), Positives = 93/226 (41%), Gaps = 48/226 (21%)

Query: 350 DNFSWKNKLGEGGFGPVYRGML--------TEGQEIAVKRLSKSSGQGVEEFKNEVLLIA 401
           ++  +   LG+G F  +++G+             E+ +K L K+     E F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEG 457
           KL H++LV   G C   DE +L+ E++   SL+ ++      +     L+ +K       
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK------Q 121

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP--------KISDFGMARAFGVDQTEA 509
           +A  + +L       +IH ++ A N+LL  + +         K+SD G++          
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------- 170

Query: 510 NTDRVVGTYGY------MSPEYAIDG-LFSVKSDVFSFGVLVLEIV 548
               V+           + PE   +    ++ +D +SFG  + EI 
Sbjct: 171 ----VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  145 bits (369), Expect = 1e-38
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 38/223 (17%)

Query: 355 KNKLGEGGFGPVYRGMLT--------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAKL-Q 404
              LGEG FG V                 ++AVK L S ++ + + +  +E+ ++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG------- 457
           H+N++ LLG CT      +I EY    +L +++    R   L++S               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 458 -------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN 510
                  +ARG+ YL   +  + IHRDL A NVL+  D   KI+DFG+AR   +   +  
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYY 247

Query: 511 TDRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                 T G     +M+PE   D +++ +SDV+SFGVL+ EI 
Sbjct: 248 K---KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  144 bits (366), Expect = 1e-38
 Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 32/223 (14%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRL-SKSSGQGVEEFKNEVLLIAK 402
           +N  +   LG G FG V               ++AVK L S +     E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----------IFDVTRTKFLDWSK 450
           L QH N+V LLG CT     ++I EY     L  F                         
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 451 RCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN 510
                  +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR         +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMND 217

Query: 511 TDRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           ++ +V         +M+PE   D +++V+SDV+S+G+L+ EI 
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  143 bits (364), Expect = 2e-38
 Identities = 60/236 (25%), Positives = 95/236 (40%), Gaps = 54/236 (22%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAK 402
           +  S+   LG G FG V                +AVK L  S      E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEG---- 457
           L  H N+V LLG CT+    ++I EY     L  F+    R  F+       I+E     
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR-KRDSFICSKTSPAIMEDDELA 141

Query: 458 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
                       +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR     
Sbjct: 142 LDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR----- 193

Query: 506 QTEANTDRVVGTYGY-------------MSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
                    +                  M+PE   + +++ +SDV+S+G+ + E+ 
Sbjct: 194 --------DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  143 bits (363), Expect = 2e-38
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 23/211 (10%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNL--VRL 411
            ++G GG   V++ +  + Q  A+K ++      Q ++ ++NE+  + KLQ  +   +RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                      ++ E   N  L  ++    + K +D  +R    + +   +  +HQ    
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 146

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE------- 524
            I+H DLK +N L+ +    K+ DFG+A     D T    D  VGT  YM PE       
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 525 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                      S KSDV+S G ++  +  GK
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  149 bits (377), Expect = 4e-38
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 15/201 (7%)

Query: 355 KNKLGEGGFGPVYRGML-TEGQEI--AVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
             +LG G FG V +G+     ++I  A+K L   +     EE   E  ++ +L +  +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           L+G C   +  ML+ E      L +F+  V + + +  S   +++  ++ G+ YL     
Sbjct: 401 LIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT---YGYMSPEYAI 527
              +HR+L A NVLL N    KISDFG+++A G D +               + +PE   
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECIN 512

Query: 528 DGLFSVKSDVFSFGVLVLEIV 548
              FS +SDV+S+GV + E +
Sbjct: 513 FRKFSSRSDVWSYGVTMWEAL 533

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  142 bits (361), Expect = 9e-38
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 23/211 (10%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNL--VRL 411
            ++G GG   V++ +  + Q  A+K ++      Q ++ ++NE+  + KLQ  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                      ++ E   N  L  ++    + K +D  +R    + +   +  +HQ    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE------- 524
            I+H DLK +N L+ +    K+ DFG+A     D T    D  VGT  YM PE       
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 525 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                      S KSDV+S G ++  +  GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  142 bits (360), Expect = 1e-37
 Identities = 68/280 (24%), Positives = 111/280 (39%), Gaps = 57/280 (20%)

Query: 307 RKKKRRDQGNTVGSSELDYIDRGNRKENMELPM-----FDWNTIADATDNFSWKNKLGEG 361
           R + +       GSS+ +Y          E        F    +        +   LG G
Sbjct: 8   RYESQLQMVQVTGSSDNEYFYVDF----REYEYDLKWEFPRENL-------EFGKVLGSG 56

Query: 362 GFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLG 413
            FG V               ++AVK L +       E   +E+ ++ +L  H N+V LLG
Sbjct: 57  AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116

Query: 414 CCTLRDERMLIYEYLPNKSLEQF------IFDVTRTKFLDWSKRCQIIEG---------- 457
            CTL     LI+EY     L  +       F     ++ +  +  +  +           
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176

Query: 458 ----IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
               +A+G+ +L        +HRDL A NVL+ +    KI DFG+AR    D    +   
Sbjct: 177 FAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDSNYV 229

Query: 514 VVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
           V          +M+PE   +G++++KSDV+S+G+L+ EI 
Sbjct: 230 V-RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  140 bits (354), Expect = 2e-37
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 352 FSWKNK--LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
               ++  LG+G +G VY G  L+    IA+K + +   +  +    E+ L   L+H+N+
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR----GLLY 464
           V+ LG  +      +  E +P  SL   +    R+K+       Q I    +    GL Y
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKY 137

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           LH +   +I+HRD+K  NVL++      KISDFG ++          T    GT  YM+P
Sbjct: 138 LHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAP 192

Query: 524 EYAIDGL---FSVKSDVFSFGVLVLEIVCGKR 552
           E  ID     +   +D++S G  ++E+  GK 
Sbjct: 193 E-IIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  142 bits (359), Expect = 3e-37
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 23/211 (10%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNL--VRL 411
            ++G GG   V++ +  + Q  A+K ++      Q ++ ++NE+  + KLQ  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 412 LGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                      ++ E   N  L  ++    + K +D  +R    + +   +  +HQ    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 174

Query: 472 RIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE------- 524
            I+H DLK +N L+ +    K+ DFG+A     D T    D  VG   YM PE       
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 525 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                      S KSDV+S G ++  +  GK
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  146 bits (369), Expect = 6e-37
 Identities = 62/255 (24%), Positives = 109/255 (42%), Gaps = 24/255 (9%)

Query: 304 MYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGF 363
           +   +K+         S   DY +  + ++   +P      I    +       +GEG F
Sbjct: 346 LANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR--ERIELGRCIGEGQF 403

Query: 364 GPVYRGMLT--EGQEI--AVKRL-SKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR 418
           G V++G+    E   +  A+K   + +S    E+F  E L + +  H ++V+L+G  T  
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462

Query: 419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDL 478
           +   +I E      L  F+    R   LD +        ++  L YL      R +HRD+
Sbjct: 463 NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDI 517

Query: 479 KASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG-----YMSPEYAIDGLFSV 533
            A NVL+ ++   K+ DFG++R         ++     + G     +M+PE      F+ 
Sbjct: 518 AARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPESINFRRFTS 571

Query: 534 KSDVFSFGVLVLEIV 548
            SDV+ FGV + EI+
Sbjct: 572 ASDVWMFGVCMWEIL 586

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  136 bits (345), Expect = 7e-36
 Identities = 68/302 (22%), Positives = 113/302 (37%), Gaps = 48/302 (15%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           KLGEGGF  V     L +G   A+KR+     Q  EE + E  +     H N++RL+  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 416 TLRDERM----LIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLLYLHQDSR 470
                      L+  +    +L   I  +     FL   +   ++ GI RGL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV-------GTYGYMSP 523
               HRDLK +N+LL ++  P + D G      +    +     +        T  Y +P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 524 EYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           E         +   ++DV+S G ++  ++ G+               G          S+
Sbjct: 213 E-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDMVFQKGD---------SV 256

Query: 580 ELIDKSLDGSYSL------SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 633
            L    +    S+      S AL  +   ++ V   P  RP++  ++  L   +  P P 
Sbjct: 257 ALA---VQNQLSIPQSPRHSSALWQLLNSMMTVD--PHQRPHIPLLLSQLEALQP-PAPG 310

Query: 634 QP 635
           Q 
Sbjct: 311 QH 312

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  136 bits (343), Expect = 2e-35
 Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 23/230 (10%)

Query: 333 ENMELPMFDWNTIADATDNFSW---KNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQ 388
           E + L         +  +   W   + ++G G FG V+R      G + AVK++      
Sbjct: 38  EGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----- 92

Query: 389 GVEEFK-NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
            +E F+  E++  A L    +V L G         +  E L   SL Q I    +   L 
Sbjct: 93  -LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP 148

Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMAR---AFG 503
             +    +     GL YLH     RI+H D+KA NVLL +D +   + DFG A      G
Sbjct: 149 EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205

Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKR 552
           + ++    D + GT  +M+PE  + G     K D++S   ++L ++ G  
Sbjct: 206 LGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  133 bits (336), Expect = 1e-34
 Identities = 63/272 (23%), Positives = 103/272 (37%), Gaps = 38/272 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QH 405
            +F   ++LG G +G V++     +G+  AVKR        +       EV    K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 406 RNLVRLLGCCTLRDERMLIY-EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
              VRL          + +  E     SL+Q          L  ++    +      L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAH 172

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      ++H D+K +N+ L      K+ DFG+    G            G   YM+PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGDPRYMAPE 226

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
             + G +   +DVFS G+ +LE+ C             H   G  W+        +L   
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME--------LPHG--GEGWQ--------QLRQG 267

Query: 585 SLDGSYS--LSEALRCIQVGLLCVQQRPEDRP 614
            L   ++  LS  LR   V ++ ++  P+ R 
Sbjct: 268 YLPPEFTAGLSSELR--SVLVMMLEPDPKLRA 297

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  128 bits (325), Expect = 2e-33
 Identities = 59/209 (28%), Positives = 111/209 (53%), Gaps = 10/209 (4%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  M    GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++ N+V  L    + DE  ++ EYL   SL     DV     +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH +   ++IHRD+K+ N+LL  D + K++DFG       +Q++ +T  +VGT  +M+
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE      +  K D++S G++ +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (322), Expect = 1e-32
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 10/209 (4%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
              D         K+GEG  G V        G+++AVK +     Q  E   NEV+++  
Sbjct: 39  DQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 98

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            QH N+V +     + +E  ++ E+L   +L     D+     L+  +   + E + + L
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQAL 154

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            YLH      +IHRD+K+ ++LL  D   K+SDFG       D  +  +  +VGT  +M+
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMA 209

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE     L++ + D++S G++V+E+V G+
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  127 bits (321), Expect = 1e-32
 Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 22/218 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRN 407
             +   + LG+G    V+RG     G   A+K  +  S  + V+    E  ++ KL H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 408 LVRLLGCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
           +V+L         R   LI E+ P  SL   + + +    L  S+   ++  +  G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 466 HQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
            +     I+HR++K  N++     D     K++DFG AR    D  +  +  + GT  Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182

Query: 522 SPE--------YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            P+              +    D++S GV       G 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  127 bits (321), Expect = 2e-32
 Identities = 69/332 (20%), Positives = 124/332 (37%), Gaps = 67/332 (20%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGC 414
            L EGGF  VY    +  G+E A+KRL  +  +       EV  + KL  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 415 CTLRDERM-------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
            ++  E         L+   L    L +F+  +     L      +I     R + ++H+
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR----------VVGT 517
             +  IIHRDLK  N+LL N    K+ DFG A         + + +             T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 518 YGYMSPEYAIDGLFSV--------KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
             Y +PE     +  +        K D+++ G ++  +   +                H 
Sbjct: 214 PMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ----------------HP 252

Query: 570 WRLWTEDRSLELIDKSLDGSYSL------SEALRCIQVGLLCVQQRPEDRPNMSSV---V 620
           +    ED +   I   ++G YS+            +   +L V   PE+R +++ V   +
Sbjct: 253 F----EDGAKLRI---VNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIAEVVHQL 303

Query: 621 LMLSGERSLPQPKQPGFFTERNLPESESSSSK 652
             ++  R++          E+N     ++ S+
Sbjct: 304 QEIAAARNVNPKSPITELLEQNGGYGSATLSR 335

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (317), Expect = 3e-32
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 11/200 (5%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           KLG GG   VY         ++A+K +    +   + ++ F+ EV   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                 D   L+ EY+   +L ++I        L           I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           I+HRD+K  N+L+D++   KI DFG+A+A   + +   T+ V+GT  Y SPE A      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 533 VKSDVFSFGVLVLEIVCGKR 552
             +D++S G+++ E++ G+ 
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  127 bits (321), Expect = 4e-32
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 24/219 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHR 406
             +   + LG+G    V+RG    T G   A+K  +  S  + V+    E  ++ KL H+
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKT-GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67

Query: 407 NLVRLLGCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           N+V+L         R   LI E+ P  SL   + + +    L  S+   ++  +  G+ +
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 465 LHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           L +     I+HR++K  N++     D     K++DFG AR    D  +  +  + GT  Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEY 181

Query: 521 MSPE--------YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           + P+              +    D++S GV       G 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  126 bits (318), Expect = 5e-32
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 12/198 (6%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   +     +  +  A K + KS        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R    +   R   +  I  G  YLH+    R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHR---NRV 162

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L+ D+  KI DFG+A     D        + GT  Y++PE       S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220

Query: 534 KSDVFSFGVLVLEIVCGK 551
           + DV+S G ++  ++ GK
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  128 bits (323), Expect = 5e-32
 Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 21/232 (9%)

Query: 331 RKENMELPMFDWNTIADATDNFSW--KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ 388
              ++E    D  T        S+  K+ LG G  G +    + + +++AVKR+      
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-- 60

Query: 389 GVEEFKNEV-LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
                  EV LL    +H N++R       R  + +  E     +L++++    +     
Sbjct: 61  -FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHL 116

Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----DMNPKISDFGMARAF 502
             +   +++    GL +LH    L I+HRDLK  N+L+        +   ISDFG+ +  
Sbjct: 117 GLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173

Query: 503 GVDQTE-ANTDRVVGTYGYMSPEY---AIDGLFSVKSDVFSFGVLVLEIVCG 550
            V +   +    V GT G+++PE          +   D+FS G +   ++  
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  124 bits (313), Expect = 8e-32
 Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 38/230 (16%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKR--LSKSSGQGVEEFKNEVLLIAKL-Q 404
           T  F    K+G G FG V++ +   +G   A+KR     +     +    EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 405 HRNLVRLLGCCTLRDERMLIY-EYLPNKSLEQFIFDVTRT-KFLDWSKRCQIIEGIARGL 462
           H ++VR        D+ MLI  EY    SL   I +  R   +   ++   ++  + RGL
Sbjct: 70  HSHVVRYFSAW-AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP-------------------KISDFGMARAFG 503
            Y+H      ++H D+K SN+ +     P                   KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFS--VKSDVFSFGVLVLEIVCGK 551
             Q E       G   +++ E  +   ++   K+D+F+  + V+     +
Sbjct: 186 SPQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  124 bits (314), Expect = 8e-32
 Identities = 76/279 (27%), Positives = 136/279 (48%), Gaps = 37/279 (13%)

Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLI 400
           N  AD  + F+   K+G+G FG V++G+     + +A+K +  + +   +E+ + E+ ++
Sbjct: 15  NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
           ++     + +  G      +  +I EYL   S      D+     LD ++   I+  I +
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILK 130

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GL YLH +   + IHRD+KA+NVLL      K++DFG+A      Q + NT   VGT  +
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFW 185

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
           M+PE      +  K+D++S G+  +E+  G+      H++ H              + L 
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPP----HSELHPM------------KVLF 229

Query: 581 LIDKS----LDGSYSLSEALR-CIQVGLLCVQQRPEDRP 614
           LI K+    L+G+Y  S+ L+  ++    C+ + P  RP
Sbjct: 230 LIPKNNPPTLEGNY--SKPLKEFVE---ACLNKEPSFRP 263

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  124 bits (313), Expect = 9e-32
 Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 12/198 (6%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRLLG 413
           LG+GGF   +     +  +  A K + KS        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                D   ++ E    +SL +      R    +   R   +  I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLH---RNRV 136

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           IHRDLK  N+ L+ D+  KI DFG+A     D        + GT  Y++PE       S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194

Query: 534 KSDVFSFGVLVLEIVCGK 551
           + DV+S G ++  ++ GK
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (308), Expect = 3e-31
 Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEE-FKNEVLLIAKLQHRNLVRLLG 413
           LG+G F  VYR      G E+A+K + K +    G+ +  +NEV +  +L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRI 473
                +   L+ E   N  + +++    R K    ++    +  I  G+LYLH      I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLH---SHGI 133

Query: 474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSV 533
           +HRDL  SN+LL  +MN KI+DFG+A    +   +  T  + GT  Y+SPE A      +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGL 191

Query: 534 KSDVFSFGVLVLEIVCGK 551
           +SDV+S G +   ++ G+
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  125 bits (314), Expect = 4e-31
 Identities = 44/303 (14%), Positives = 86/303 (28%), Gaps = 66/303 (21%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH-------- 405
           LG+              G+   V     +       +++ K EVL +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 406 --------RNLVRLLGCCTLRD-----ERMLIYEY-----LPNKSLEQFIF----DVTRT 443
                    +LV+      +         M +            +L+ F        +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
           K L    R Q+   + R L  LH      ++H  L+  +++LD      ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 504 VDQTEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 558
                +   R        +            L +   D ++ G+ +  I C         
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA-------- 313

Query: 559 ADHHHNLLGHAWRL-WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMS 617
                        L  T+D +L   +       ++ + +R +  G L  +   EDR    
Sbjct: 314 ------------DLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPL 359

Query: 618 SVV 620
             +
Sbjct: 360 QAM 362

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  127 bits (321), Expect = 6e-31
 Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 19/216 (8%)

Query: 349 TDNFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQH 405
              +  K +LG GGFG V R     T G+++A+K+  +       E +  E+ ++ KL H
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDT-GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71

Query: 406 RNLVRLL------GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
            N+V               D  +L  EY     L +++        L       ++  I+
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAFGVDQTEANTDRVVG 516
             L YLH+    RIIHRDLK  N++L      +  KI D G A+              VG
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVG 185

Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
           T  Y++PE      ++V  D +SFG L  E + G R
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  121 bits (307), Expect = 8e-31
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVK--RLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL 412
            LG GG   V+    L + +++AVK  R   +        F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 413 --GCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
             G        +  ++ EY+   +L   +        +   +  ++I    + L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG-VDQTEANTDRVVGTYGYMSPEYAI 527
            +  IIHRD+K +N+++      K+ DFG+ARA      +   T  V+GT  Y+SPE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKR 552
                 +SDV+S G ++ E++ G+ 
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (317), Expect = 2e-30
 Identities = 41/204 (20%), Positives = 81/204 (39%), Gaps = 24/204 (11%)

Query: 357 KLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLVRLL- 412
            +  GG G +Y        G+ + +K L  S           E   +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 413 -GCCTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
               T R    + Y   EY+  +SL++          L  ++    +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
             + +++ DLK  N++L  +   K+ D G      ++        + GT G+ +PE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSFGY----LYGTPGFQAPEIV-R 250

Query: 529 GLFSVKSDVFSFGVLVLEIVCGKR 552
              +V +D+++ G  +  +     
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLP 274

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  119 bits (301), Expect = 4e-30
 Identities = 53/212 (25%), Positives = 105/212 (49%), Gaps = 13/212 (6%)

Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
            D  + +    +LG+G FG VY+    E G   A K +   S + +E++  E+ ++A   
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD 74

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  +V+LLG      +  ++ E+ P  +++  +  +   + L   +   +   +   L +
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNF 132

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH     RIIHRDLKA NVL+  + + +++DFG++        + ++   +GT  +M+PE
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPE 187

Query: 525 -----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                   D  +  K+D++S G+ ++E+   +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  119 bits (299), Expect = 8e-30
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 10/210 (4%)

Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIA 401
           +      + F    KLGEG +G VY+ +  E GQ +A+K++       ++E   E+ ++ 
Sbjct: 22  SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQ 79

Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
           +    ++V+  G      +  ++ EY    S+   I    R K L   +   I++   +G
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKG 137

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L YLH     R IHRD+KA N+LL+ + + K++DFG+A        + NT  V+GT  +M
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWM 192

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE   +  ++  +D++S G+  +E+  GK
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (300), Expect = 1e-29
 Identities = 32/298 (10%), Positives = 64/298 (21%), Gaps = 51/298 (17%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           L  G    V+     E  ++ A+K  +     S   +E         A+L   +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 414 CCTL--------------------------RDERMLIYEYLP---NKSLEQFIFDVTRTK 444
              L                              +L+                F      
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 445 FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
                    +   + R    L       ++H      N+ +  D    + D       G 
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG- 245

Query: 505 DQTEANTDRVVGTYGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
                          Y   E+  A    F+   + +  G+ +  + C      F      
Sbjct: 246 ----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299

Query: 563 HNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
                 +W+     R       +      L + ++ +    L        R      +
Sbjct: 300 IK---GSWKR-PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLLPLEAM 351

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (297), Expect = 2e-29
 Identities = 46/205 (22%), Positives = 80/205 (39%), Gaps = 21/205 (10%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQHRNLVRL- 411
            +G GG G VY        + +A+K +S++           + E     +LQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 412 -LGCCTLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
             G      +  L Y     +    L   +    R   L   +   I+  I   L   H 
Sbjct: 101 DFG----EIDGQL-YVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA 152

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
                  HRD+K  N+L+  D    + DFG+A A   D+        VGT  YM+PE   
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFS 208

Query: 528 DGLFSVKSDVFSFGVLVLEIVCGKR 552
           +   + ++D+++   ++ E + G  
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSP 233

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  119 bits (299), Expect = 3e-29
 Identities = 49/311 (15%), Positives = 93/311 (29%), Gaps = 81/311 (26%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ--------- 404
           LG+            E G+   V     +       +++ K EVL +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 405 ----------------HRNLVRLLGCCTLRDERMLIY---EYLPNKSLEQF---IFDVTR 442
                            + ++R+      RD  +L           +L+ F   +   + 
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 443 T-KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
           T K L    R Q+   + R L  LH      ++H  L+  +++LD      ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 502 FGVDQTEANTDRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIVCG 550
            G             + G+  PE                L +   D ++ G+++  I C 
Sbjct: 256 DGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 551 KRNRGFYHADHHHNLLGHAWRL-WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQR 609
                                L  T+D +L   +       ++ + +R +  G L     
Sbjct: 310 --------------------DLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--P 347

Query: 610 PEDRPNMSSVV 620
            EDR      +
Sbjct: 348 KEDRLLPLQAM 358

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  120 bits (304), Expect = 3e-29
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 24/224 (10%)

Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS--SGQGVEEFKN 395
           MF  +     ++ +    KLG G +G V          E A+K + K+  S     +   
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85

Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR-- 451
           EV ++  L H N+++L      +    L+ E      L    FD  + R KF   ++   
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKF---NEVDA 138

Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTE 508
             II+ +  G+ YLH+     I+HRDLK  N+LL++   D   KI DFG++  F   +  
Sbjct: 139 AVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK- 194

Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
                 +GT  Y++PE  +   +  K DV+S GV++  ++ G  
Sbjct: 195 --MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (291), Expect = 5e-29
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 14/206 (6%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F     LG+G FG VY     +    +A+K L K+         + + EV + + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N++RL G         LI EY P  ++ + +     +KF +       I  +A  L Y 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSYC 125

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R+IHRD+K  N+LL +    KI+DFG    + V    +    + GT  Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 178

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGK 551
               +   K D++S GVL  E + GK
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  117 bits (295), Expect = 6e-29
 Identities = 39/257 (15%), Positives = 73/257 (28%), Gaps = 23/257 (8%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGM------LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           +      + LGEG F  VY             Q+  +K    ++          +  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI--FDVTRTKFLDWSKRCQIIEGIAR 460
                 ++       ++  +L+ E     +L   I  +  T  K +           +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-----------KISDFGMARAFGVDQTEA 509
            +  +H      IIH D+K  N +L N                + D G +    +     
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 569
                  T G+   E   +  ++ + D F     V  ++ G   +   +        G  
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK-VKNEGGECKPEGLF 299

Query: 570 WRLWTEDRSLELIDKSL 586
            RL   D   E     L
Sbjct: 300 RRLPHLDMWNEFFHVML 316

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  117 bits (295), Expect = 6e-29
 Identities = 55/228 (24%), Positives = 104/228 (45%), Gaps = 11/228 (4%)

Query: 326 IDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSK 384
           +D   RK                 D+F   ++LG G  G V++      G  +A K +  
Sbjct: 9   LDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 68

Query: 385 SSGQGV-EEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT 443
                +  +   E+ ++ +     +V   G      E  +  E++   SL+Q +    + 
Sbjct: 69  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKA 125

Query: 444 KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
             +      ++   + +GL YL    + +I+HRD+K SN+L+++    K+ DFG++    
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--Q 181

Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +  + AN+   VGT  YMSPE      +SV+SD++S G+ ++E+  G+
Sbjct: 182 LIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  119 bits (299), Expect = 7e-29
 Identities = 53/228 (23%), Positives = 86/228 (37%), Gaps = 34/228 (14%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNL 408
           +    +  LG G  G V      +G+ +AVKR+        +    E+ LL     H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFI----FDVTRTKFLDWSKRCQIIEGIARGLLY 464
           +R     T      +  E   N +L+  +          K         ++  IA G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 465 LHQDSRLRIIHRDLKASNVLLDN-------------DMNPKISDFGMARAFGVDQT--EA 509
           LH    L+IIHRDLK  N+L+               ++   ISDFG+ +     Q+    
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 510 NTDRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEIVCG 550
           N +   GT G+ +PE   +              D+FS G +   I+  
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  119 bits (300), Expect = 9e-29
 Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 25/223 (11%)

Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS---SGQGVEEFK 394
           MF  ++ A  +D +  +  LG+G FG V        GQE AVK +SK         E   
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74

Query: 395 NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR- 451
            EV L+ +L H N+++L      +    L+ E      L    FD  ++R +F   S+  
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRF---SEVD 127

Query: 452 -CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQT 507
             +II  +  G+ Y+H+    +I+HRDLK  N+LL++   D N +I DFG++  F   + 
Sbjct: 128 AARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184

Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
                  +GT  Y++PE  + G +  K DV+S GV++  ++ G
Sbjct: 185 ---MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  114 bits (289), Expect = 2e-28
 Identities = 55/186 (29%), Positives = 98/186 (52%), Gaps = 28/186 (15%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN--------EVLLIA 401
           + +    K+GEG +G VY+   ++G+ +A+KR+       ++            E+ L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGI 458
           +L H N+V L+          L++E++  K L++ + D  +T   D   +    Q++ G+
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLYQLLRGV 132

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           A    + HQ    RI+HRDLK  N+L+++D   K++DFG+ARAFG+    + T  VV T 
Sbjct: 133 A----HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TL 183

Query: 519 GYMSPE 524
            Y +P+
Sbjct: 184 WYRAPD 189

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  118 bits (297), Expect = 2e-28
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 24/228 (10%)

Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS--SGQG 389
            +      +        + ++    LG+G FG V +       QE AVK ++K+    + 
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 390 VEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLD 447
                 EV L+ KL H N+++L           ++ E      L    FD  + R +F  
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF-- 118

Query: 448 WSKR--CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAF 502
            S+    +II+ +  G+ Y+H+     I+HRDLK  N+LL++   D + KI DFG++  F
Sbjct: 119 -SEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             +         +GT  Y++PE  + G +  K DV+S GV++  ++ G
Sbjct: 175 QQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  115 bits (289), Expect = 4e-28
 Identities = 69/248 (27%), Positives = 109/248 (43%), Gaps = 20/248 (8%)

Query: 312 RDQGNTVGSSELDYIDRGNRKENMELP-MFDWNTIADATDNFSWKNKLGEGGFGPVYRGM 370
               N      +D +  G R  +++ P + +     D    FS   ++G G FG VY   
Sbjct: 15  PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74

Query: 371 -LTEGQEIAVKRLS---KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE 426
            +   + +A+K++S   K S +  ++   EV  + KL+H N ++  GC        L+ E
Sbjct: 75  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134

Query: 427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD 486
           Y    S    +      K L   +   +  G  +GL YLH      +IHRD+KA N+LL 
Sbjct: 135 YCLG-SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLS 188

Query: 487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE---YAIDGLFSVKSDVFSFGVL 543
                K+ DFG A         AN+   VGT  +M+PE      +G +  K DV+S G+ 
Sbjct: 189 EPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242

Query: 544 VLEIVCGK 551
            +E+   K
Sbjct: 243 CIELAERK 250

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (287), Expect = 5e-28
 Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 20/235 (8%)

Query: 330 NRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQ 388
           +      L   D + + D    F     +G G +G VY+G   + GQ  A+K +   +G 
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62

Query: 389 GVEEFKNEVLLIAKL-QHRNLVRLLGC------CTLRDERMLIYEYLPNKSLEQFIFDVT 441
             EE K E+ ++ K   HRN+    G         + D+  L+ E+    S+   +   T
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNT 121

Query: 442 RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
           +   L       I   I RGL +LHQ    ++IHRD+K  NVLL  +   K+ DFG++  
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 502 FGVDQTEANTDRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                   NT   +GT  +M+PE        D  +  KSD++S G+  +E+  G 
Sbjct: 179 LDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  112 bits (283), Expect = 1e-27
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 22/184 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN--------EVLLI 400
           +NF    K+GEG +G VY+      G+ +A+K++       ++            E+ L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
            +L H N+V+LL      ++  L++E+L  + L++F+ D +    +        +  + +
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQ 114

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           GL + H     R++HRDLK  N+L++ +   K++DFG+ARAFGV      T  VV T  Y
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWY 169

Query: 521 MSPE 524
            +PE
Sbjct: 170 RAPE 173

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  112 bits (282), Expect = 1e-27
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 20/219 (9%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-----EV 397
           ++    D+     +LG G +G V +      GQ +AVKR+  +     +E K      ++
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDI 58

Query: 398 LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIE 456
            +   +     V   G      +  +  E + + SL++F   V  + + +      +I  
Sbjct: 59  SM-RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            I + L +LH  S+L +IHRD+K SNVL++     K+ DFG++    VD    + D   G
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AG 171

Query: 517 TYGYMSPE----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
              YM+PE          +SVKSD++S G+ ++E+   +
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  112 bits (282), Expect = 1e-27
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 24/222 (10%)

Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS--SGQGVEEFKN 395
             +        + ++    LG+G FG V +       QE AVK ++K+    +       
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70

Query: 396 EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR-- 451
           EV L+ KL H N+++L           ++ E      L    FD  + R +F   S+   
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF---SEHDA 123

Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTE 508
            +II+ +  G+ Y+H+     I+HRDLK  N+LL   + D + KI DFG++  F  +   
Sbjct: 124 ARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179

Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
                 +GT  Y++PE  + G +  K DV+S GV++  ++ G
Sbjct: 180 --MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  113 bits (285), Expect = 1e-27
 Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 37/229 (16%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS-----------------SGQGVEE 392
           +++     L +G F  +        +  A+K+  KS                      ++
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 393 FKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLD 447
           FKNE+ +I  +++   +   G  T  DE  +IYEY+ N S+       F+ D   T F+ 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 II+ +     Y+H  +   I HRD+K SN+L+D +   K+SDFG +        
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGES----EYMV 203

Query: 508 EANTDRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +       GTY +M PE      + +G    K D++S G+ +  +    
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  111 bits (281), Expect = 1e-27
 Identities = 52/186 (27%), Positives = 95/186 (51%), Gaps = 28/186 (15%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN--------EVLLIA 401
           + +    K+GEG +G VY+     G+  A+K++       +E+           E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGI 458
           +L+H N+V+L      +   +L++E+L  + L++ + DV        + +    Q++ GI
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL-DVCEGGLESVTAKSFLLQLLNGI 113

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           A    Y H     R++HRDLK  N+L++ +   KI+DFG+ARAFG+      T  +V T 
Sbjct: 114 A----YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TL 164

Query: 519 GYMSPE 524
            Y +P+
Sbjct: 165 WYRAPD 170

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  113 bits (284), Expect = 3e-27
 Identities = 40/231 (17%), Positives = 81/231 (35%), Gaps = 16/231 (6%)

Query: 333 ENMELPMFDWNTIADATDNFSWKNKLGEG--GFGPVYRGM-LTEGQEIAVKR--LSKSSG 387
               L     ++       +     +G+G      V        G+ + V+R  L   S 
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67

Query: 388 QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD 447
           + V   + E+ +     H N+V         +E  ++  ++   S +  +        ++
Sbjct: 68  EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN 126

Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                 I++G+ + L Y+H       +HR +KAS++L+  D    +S      +      
Sbjct: 127 ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183

Query: 508 EANT-----DRVVGTYGYMSPE--YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                       V    ++SPE        +  KSD++S G+   E+  G 
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  109 bits (276), Expect = 5e-27
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 22/213 (10%)

Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ 404
            D    ++ +N +G G +G V   +        A K++ K   + V+ FK E+ ++  L 
Sbjct: 5   GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIAR 460
           H N++RL        +  L+ E      L    F+  V +  F    +    +I++ +  
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVF---RESDAARIMKDVLS 117

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
            + Y H+   L + HRDLK  N L      D   K+ DFG+A  F   +        VGT
Sbjct: 118 AVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGT 171

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
             Y+SP+  ++GL+  + D +S GV++  ++CG
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  110 bits (277), Expect = 6e-27
 Identities = 45/187 (24%), Positives = 90/187 (48%), Gaps = 29/187 (15%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--------EVLLI 400
             +    K+GEG +G V++    E  + +A+KR+       +++           E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEG 457
            +L+H+N+VRL        +  L++E+   + L+++  D           +    Q+++G
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF-DSCNGDLDPEIVKSFLFQLLKG 113

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +     + H      ++HRDLK  N+L++ +   K+++FG+ARAFG+      +  VV T
Sbjct: 114 LG----FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-T 164

Query: 518 YGYMSPE 524
             Y  P+
Sbjct: 165 LWYRPPD 171

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  110 bits (277), Expect = 1e-26
 Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 26/187 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--------EVLLI 400
             +   + LGEG F  VY+       Q +A+K++         E K+        E+ L+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEG 457
            +L H N++ LL     +    L+++++    LE  I             +      ++G
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVII-KDNSLVLTPSHIKAYMLMTLQG 124

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +     YLHQ     I+HRDLK +N+LLD +   K++DFG+A++FG     A T +VV T
Sbjct: 125 LE----YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-T 175

Query: 518 YGYMSPE 524
             Y +PE
Sbjct: 176 RWYRAPE 182

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  109 bits (274), Expect = 2e-26
 Identities = 54/225 (24%), Positives = 101/225 (44%), Gaps = 38/225 (16%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLS-KSSGQGVEEFKNEVLLIAKLQHRN 407
           D++  +  +G G    V       + +++A+KR++ +     ++E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIE--GIA------ 459
           +V       ++DE  L+ + L   S+     D+ +        +  +++   IA      
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 460 -RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA-----RAFGVDQTEANTDR 513
             GL YLH++     IHRD+KA N+LL  D + +I+DFG++                T  
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-- 185

Query: 514 VVGTYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            VGT  +M+PE       Y        K+D++SFG+  +E+  G 
Sbjct: 186 FVGTPCWMAPEVMEQVRGY------DFKADIWSFGITAIELATGA 224

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (273), Expect = 2e-26
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 13/211 (6%)

Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKL 403
               D F +K KLG G FG V+       G E  +K ++K   Q  +E+ + E+ ++  L
Sbjct: 18  GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-EQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            H N++++           ++ E      L E+ +    R K L      ++++ +   L
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
            Y H      ++H+DLK  N+L  +       KI DFG+A  F  D+   N     GT  
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTAL 191

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           YM+PE       + K D++S GV++  ++ G
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  109 bits (275), Expect = 2e-26
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 25/190 (13%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-----EVLLI 400
            ++  F    KLG G +  VY+G+    G  +A+K +   S +G           E+ L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPN---KSLEQFIFDVTRTKFLDWSKRC---QI 454
            +L+H N+VRL       ++  L++E++ N   K ++      T         +    Q+
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRV 514
           ++G+A    + H++   +I+HRDLK  N+L++     K+ DFG+ARAFG+      +  V
Sbjct: 118 LQGLA----FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEV 169

Query: 515 VGTYGYMSPE 524
           V T  Y +P+
Sbjct: 170 V-TLWYRAPD 178

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 2e-26
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           D+F     LG+G FG VY     +    +A+K L KS         + + E+ + + L+H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 406 RNLVRLLGCCTLRDERM--LIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGL 462
            N++R+       D +   L+ E+ P   L    +  + +    D  +    +E +A  L
Sbjct: 74  PNILRMYN--YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADAL 127

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            Y H     ++IHRD+K  N+L+      KI+DFG +           T  + GT  Y+ 
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT--MCGTLDYLP 180

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE         K D++  GVL  E + G 
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (281), Expect = 3e-26
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 35/235 (14%)

Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRG-MLTEGQEIAVKRLSKS------------ 385
           M+         +++    KLG G +G V          E A+K + KS            
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84

Query: 386 -SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTR 442
              +  EE  NE+ L+  L H N+++L      +    L+ E+     L    F+  + R
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINR 140

Query: 443 TKFLDWSKR--CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFG 497
            KF    +     I++ I  G+ YLH+     I+HRD+K  N+LL+N    +N KI DFG
Sbjct: 141 HKF---DECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFG 194

Query: 498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
           ++  F  D         +GT  Y++PE  +   ++ K DV+S GV++  ++CG  
Sbjct: 195 LSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  109 bits (273), Expect = 3e-26
 Identities = 49/247 (19%), Positives = 91/247 (36%), Gaps = 31/247 (12%)

Query: 383 SKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTR 442
             SS   ++    ++  +     +N V  L   + +    +  +    ++L+ ++     
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157

Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
            +  +      I   IA  + +LH      ++HRDLK SN+    D   K+ DFG+  A 
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214

Query: 503 GVDQTEANTD----------RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
             D+ E                VGT  YMSPE      +S K D+FS G+++ E+     
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL----- 269

Query: 553 NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPED 612
               Y        +    R+ T+ R+L+               ++        +   P +
Sbjct: 270 ---LYSFSTQMERV----RIITDVRNLKFPLLFTQKYPQEHMMVQ------DMLSPSPTE 316

Query: 613 RPNMSSV 619
           RP  + +
Sbjct: 317 RPEATDI 323

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  108 bits (273), Expect = 4e-26
 Identities = 52/184 (28%), Positives = 89/184 (48%), Gaps = 24/184 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-----EVLLIAKL 403
           + +   +KLGEG +  VY+G        +A+K +     +G           EV L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIAR 460
           +H N+V L           L++EYL +K L+Q++ D         + +    Q++ G+A 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLA- 114

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
              Y H+    +++HRDLK  N+L++     K++DFG+ARA  +  T+   + VV T  Y
Sbjct: 115 ---YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWY 166

Query: 521 MSPE 524
             P+
Sbjct: 167 RPPD 170

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  108 bits (272), Expect = 4e-26
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 21/214 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVL-----LIAKL 403
           ++     ++G G +G V + +    GQ +AVKR+  +     E+ + ++L     ++   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDV--TRTKFLDWSKRCQIIEGIARG 461
               +V+  G      +  +  E + + S ++F   V       +      +I     + 
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           L +L     L+IIHRD+K SN+LLD   N K+ DFG++    +  + A T R  G   YM
Sbjct: 138 LNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKT-RDAGCRPYM 192

Query: 522 SPE----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +PE     A    + V+SDV+S G+ + E+  G+
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  107 bits (270), Expect = 7e-26
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 32/212 (15%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LGEG +G V   + +E     AVK L K        G    K E+ L+ +L+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 413 GCCTLRDERM--LIYEYLPNKSLEQFIFD-VTRTKFLDWSKR---CQIIEGIARGLLYLH 466
                 +++   ++ EY      E  + D V   +F         CQ+I+G+     YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE-- 524
                 I+H+D+K  N+LL      KIS  G+A A      +       G+  +  PE  
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 525 -----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                +   G    K D++S GV +  I  G 
Sbjct: 184 NGLDTF--SGF---KVDIWSAGVTLYNITTGL 210

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  107 bits (269), Expect = 1e-25
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 21/183 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQ 404
           + +     +GEG +G V +    + G+ +A+K+  +S     +  K     E+ L+ +L+
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLR 82

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARG 461
           H NLV LL  C  +    L++E++ + ++   + ++          +    QII GI   
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQIINGIG-- 138

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             + H      IIHRD+K  N+L+      K+ DFG AR       E   D V  T  Y 
Sbjct: 139 --FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYR 191

Query: 522 SPE 524
           +PE
Sbjct: 192 APE 194

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (270), Expect = 2e-25
 Identities = 49/212 (23%), Positives = 85/212 (40%), Gaps = 19/212 (8%)

Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
               D +    +LG G FG V+R    E   G+    K ++          KNE+ ++ +
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRC--VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 104

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIAR 460
           L H  L+ L      + E +LI E+L    L    FD        +  ++    +     
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACE 160

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTY 518
           GL ++H+     I+H D+K  N++ +       KI DFG+A     D+          T 
Sbjct: 161 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATA 214

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            + +PE          +D+++ GVL   ++ G
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  109 bits (274), Expect = 3e-25
 Identities = 53/250 (21%), Positives = 98/250 (39%), Gaps = 19/250 (7%)

Query: 308 KKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVY 367
             ++       G+   +Y +          P           D++    +LG G FG V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174

Query: 368 RGMLTE---GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI 424
           R   TE   G   A K +        E  + E+  ++ L+H  LV L       +E ++I
Sbjct: 175 RV--TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232

Query: 425 YEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN 482
           YE++    L    F+        +   +  + +  + +GL ++H+      +H DLK  N
Sbjct: 233 YEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPEN 285

Query: 483 VLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSF 540
           ++     +   K+ DFG+      D  ++      GT  + +PE A        +D++S 
Sbjct: 286 IMFTTKRSNELKLIDFGLTAHL--DPKQSVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSV 342

Query: 541 GVLVLEIVCG 550
           GVL   ++ G
Sbjct: 343 GVLSYILLSG 352

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  105 bits (265), Expect = 3e-25
 Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 17/181 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--EVLLIAKLQHR 406
           + +    K+GEG +G V++    + GQ +A+K+  +S    V +     E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARGLL 463
           NLV LL     +    L++EY  + ++   + D  +    +   +    Q ++ +     
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVN---- 116

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           + H+      IHRD+K  N+L+      K+ DFG AR      ++   D V  T  Y SP
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSP 171

Query: 524 E 524
           E
Sbjct: 172 E 172

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  105 bits (263), Expect = 6e-25
 Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 22/213 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVL-----LIAKL 403
           ++     ++G G  G V++    + G  IAVK++ +S     +E    +L     ++   
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSH 81

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
               +V+  G      +  +  E +     E+    +          +  +   I + L 
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALY 138

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
           YL    +  +IHRD+K SN+LLD     K+ DFG++    VD    +     G   YM+P
Sbjct: 139 YLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS-GRLVDDKAKDRS--AGCAAYMAP 193

Query: 524 E-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           E           + +++DV+S G+ ++E+  G+
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (264), Expect = 7e-25
 Identities = 55/209 (26%), Positives = 84/209 (40%), Gaps = 23/209 (11%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVK-----RLSKSSGQGVEEFKNEVLLIAK 402
            D +     +G+G F  V R +    GQ+ AVK     + + S G   E+ K E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDW---SKRCQIIEG 457
           L+H ++V LL   +      +++E++    L        V R         +     +  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQ 138

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRV 514
           I   L Y H      IIHRD+K   VLL   +N    K+  FG+A   G     A     
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--R 193

Query: 515 VGTYGYMSPEYAIDGLFSVKSDVFSFGVL 543
           VGT  +M+PE      +    DV+  GV+
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (262), Expect = 8e-25
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +    F +   LG G F  V+       G+  A+K + KS        +NE+ ++ K++H
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARG 461
            N+V L           L+ + +    L    FD  + R  +   +++    +I+ +   
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVY---TEKDASLVIQQVLSA 118

Query: 462 LLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           + YLH+     I+HRDLK  N+L    + +    I+DFG+++               GT 
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTP 171

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           GY++PE      +S   D +S GV+   ++CG
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  104 bits (262), Expect = 1e-24
 Identities = 77/284 (27%), Positives = 120/284 (42%), Gaps = 66/284 (23%)

Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           +G+G F  V     +LT G+E+A+K + K+  +   +++   EV ++  L H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 414 CCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLYLH 466
                    LI EY     +  ++           R+KF       QI+  +     Y H
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF------RQIVSAVQ----YCH 131

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE-- 524
              + RI+HRDLKA N+LLD DMN KI+DFG +  F V       D   G   Y +PE  
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELF 185

Query: 525 ----YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL- 579
               Y  DG    + DV+S GV++  +V G                     L  + ++L 
Sbjct: 186 QGKKY--DGP---EVDVWSLGVILYTLVSG--------------------SLPFDGQNLK 220

Query: 580 ELIDKSLDGSYS----LSEALRCIQVGLLCVQQRPEDRPNMSSV 619
           EL ++ L G Y     +S     +    L +   P  R  +  +
Sbjct: 221 ELRERVLRGKYRIPFYMSTDCENLLKRFLVL--NPIKRGTLEQI 262

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (263), Expect = 1e-24
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 15/198 (7%)

Query: 351 NFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
             S    LG G FG V++   T  G ++A K +     +  EE KNE+ ++ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           +L      +++ +L+ EY+    L    FD  +  +  L        ++ I  G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 468 DSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
              + I+H DLK  N+L  N      KI DFG+AR +   +         GT  +++PE 
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEV 259

Query: 526 AIDGLFSVKSDVFSFGVL 543
                 S  +D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVI 277

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (263), Expect = 1e-24
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 23/215 (10%)

Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFK 394
             F  N     +DN+  K +LG+G F  V R +    G E A K ++    S +  ++ +
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76

Query: 395 NEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR- 451
            E  +  KLQH N+VRL           L+++ +    L    F+  V R  +   S+  
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEAD 129

Query: 452 -CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQT 507
               I+ I   + Y H      I+HR+LK  N+LL         K++DFG+A     + +
Sbjct: 130 ASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDS 184

Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 542
           EA      GT GY+SPE      +S   D+++ GV
Sbjct: 185 EAWHG-FAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  103 bits (258), Expect = 1e-24
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQH 405
           +DN+  K +LG+G F  V R +    G E A K ++    S +  ++ + E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARG 461
            N+VRL           L+++ +    L    F+  V R  +   S+      I+ I   
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEADASHCIQQILES 117

Query: 462 LLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           + Y H      I+HR+LK  N+LL         K++DFG+A     D    +     GT 
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHG--FAGTP 171

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGV 542
           GY+SPE      +S   D+++ GV
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGV 195

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  102 bits (257), Expect = 2e-24
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 31/207 (14%)

Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V      +T  + +AVK +         E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 415 CTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR---CQIIEGIARGLLYLHQDS 469
               + + L  EY     L    FD         +   +    Q++ G+     YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE----- 524
            + I HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 525 -YAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +          DV+S G+++  ++ G
Sbjct: 183 EF--HAE---PVDVWSCGIVLTAMLAG 204

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (261), Expect = 2e-24
 Identities = 53/271 (19%), Positives = 90/271 (33%), Gaps = 52/271 (19%)

Query: 330 NRKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVK-----RLS 383
           +     E   F   ++ +    +  K  +G+G +G V   +  +     A+K     ++ 
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65

Query: 384 KSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRT 443
           + + + VE  K EV L+ KL H N+ RL           L+ E      L   +      
Sbjct: 66  QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 444 KFLDWSKRC-------------------------------------QIIEGIARGLLYLH 466
                +                                         I+  I   L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 467 QDSRLRIIHRDLKASNVLL--DNDMNPKISDFGMARAFGVDQTEANTDR--VVGTYGYMS 522
                 I HRD+K  N L   +     K+ DFG+++ F               GT  +++
Sbjct: 186 N---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 523 PE--YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE     +  +  K D +S GVL+  ++ G 
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  104 bits (261), Expect = 2e-24
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 43/200 (21%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSSGQGVEEFKN--------EVLLI 400
             +    K+G+G FG V++    +  +  A+K++       +E  K         E+ ++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70

Query: 401 AKLQHRNLVRLLGCCTLRDERM--------LIYEYLPN--KSLEQFIFDVTRTKFLDWSK 450
             L+H N+V L+  C  +            L++++  +    L          KF     
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTLSEI 126

Query: 451 RC---QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
           +     ++ G+     Y+H++   +I+HRD+KA+NVL+  D   K++DFG+ARAF + + 
Sbjct: 127 KRVMQMLLNGLY----YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 508 EAN---TDRVVGTYGYMSPE 524
                 T+RVV T  Y  PE
Sbjct: 180 SQPNRYTNRVV-TLWYRPPE 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  104 bits (262), Expect = 2e-24
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 46/233 (19%)

Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKN-EVLL 399
           D  T       ++    +G G FG V++  L E  E+A+K++ +      + FKN E+ +
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQI 85

Query: 400 IAKLQHRNLVRLLGC----CTLRDER--MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
           +  ++H N+V L          +DE    L+ EY+P +++ +            ++K  Q
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRAS--------RHYAKLKQ 136

Query: 454 IIEG---------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFG 503
            +           + R L Y+H    + I HRD+K  N+LLD      K+ DFG A+   
Sbjct: 137 TMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL- 192

Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLF-----SVKSDVFSFGVLVLEIVCGK 551
               E N   +   Y Y +PE     +F     +   D++S G ++ E++ G+
Sbjct: 193 -IAGEPNVSYICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (258), Expect = 3e-24
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 22/191 (11%)

Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLS-KSSGQGVEEFKN----EVLLIA 401
           AT  +    ++G G +G VY+      G  +A+K +   + G G          EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 402 KLQ---HRNLVRLLGCCTLRDER-----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
           +L+   H N+VRL+  C            L++E++ ++ L  ++ D      L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124

Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
           ++    RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +        T  
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179

Query: 514 VVGTYGYMSPE 524
           VV T  Y +PE
Sbjct: 180 VV-TLWYRAPE 189

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  103 bits (258), Expect = 4e-24
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 39/194 (20%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN--------EVLLI 400
           D +    KLGEG +G VY+ + T   + +A+KR+       +E  +         EV L+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-----FDVTRTKFLDWSKRCQII 455
            +LQHRN++ L           LI+EY     L++++       +   K   +    Q+I
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLY----QLI 142

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-----KISDFGMARAFGVDQTEAN 510
            G+     + H     R +HRDLK  N+LL           KI DFG+ARAFG+      
Sbjct: 143 NGVN----FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQF 194

Query: 511 TDRVVGTYGYMSPE 524
           T  ++ T  Y  PE
Sbjct: 195 THEII-TLWYRPPE 207

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (257), Expect = 4e-24
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 31/207 (14%)

Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQGVEE-FKNEVLLIAKLQHRNLVRLLGC 414
           LGEG +G V      +T  + +AVK +         E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 415 CTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRC---QIIEGIARGLLYLHQDS 469
               + + L  EY     L    FD         +   +    Q++ G+     YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE----- 524
            + I HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 525 -YAIDGLFSVKSDVFSFGVLVLEIVCG 550
            +          DV+S G+++  ++ G
Sbjct: 183 EF--HAE---PVDVWSCGIVLTAMLAG 204

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (257), Expect = 4e-24
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 32/193 (16%)

Query: 350 DNFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQGVEEFKN--------EVLL 399
             +    ++GEG +G V++   +   G+ +A+KR+       V+  +         EV +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64

Query: 400 IAKLQ---HRNLVRLLGCCTLRDER-----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKR 451
           +  L+   H N+VRL   CT+          L++E++ ++ L  ++ D      +     
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122

Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
             ++  + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +        T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177

Query: 512 DRVVGTYGYMSPE 524
             VV T  Y +PE
Sbjct: 178 SVVV-TLWYRAPE 189

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  102 bits (256), Expect = 5e-24
 Identities = 57/259 (22%), Positives = 99/259 (38%), Gaps = 33/259 (12%)

Query: 355 KNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLL 412
           ++ LGEG    V   + L   QE AVK + K  G        EV ++ + Q HRN++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARGLLYLHQD 468
                 D   L++E +   S+          R  F   ++     +++ +A  L +LH  
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHF---NELEASVVVQDVASALDFLHN- 129

Query: 469 SRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDR-----VVGTYGY 520
               I HRDLK  N+L    +     KI DF +     ++   +           G+  Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 521 MSPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE 575
           M+PE          ++  + D++S GV++  ++ G     F       +  G        
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP--FV--GRCGSDCGWDRGEACP 243

Query: 576 DRSLELIDKSLDGSYSLSE 594
                L +   +G Y   +
Sbjct: 244 ACQNMLFESIQEGKYEFPD 262

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (253), Expect = 8e-24
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 34/231 (14%)

Query: 341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGV--------- 390
             ++     +N+  K  LG G    V R +     +E AVK +  + G            
Sbjct: 8   GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67

Query: 391 EEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLD 447
           E    EV ++ K+  H N+++L           L+++ +    L    FD    +     
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTL-- 121

Query: 448 WSKR--CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
            S++   +I+  +   +  LH+   L I+HRDLK  N+LLD+DMN K++DFG +      
Sbjct: 122 -SEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177

Query: 506 QTEANTDRVVGTYGYMSPE------YAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +       V GT  Y++PE            +  + D++S GV++  ++ G
Sbjct: 178 EK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  101 bits (255), Expect = 8e-24
 Identities = 42/202 (20%), Positives = 82/202 (40%), Gaps = 16/202 (7%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  + +     LG G FG V+R +  +  +    K +    G      K E+ ++   +H
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARH 60

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLL 463
           RN++ L       +E ++I+E++    +    F+   T    L+  +    +  +   L 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYGYM 521
           +LH      I H D++  N++     +   KI +FG AR       +     +     Y 
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRL-LFTAPEYY 170

Query: 522 SPEYAIDGLFSVKSDVFSFGVL 543
           +PE     + S  +D++S G L
Sbjct: 171 APEVHQHDVVSTATDMWSLGTL 192

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (256), Expect = 1e-23
 Identities = 49/191 (25%), Positives = 89/191 (46%), Gaps = 36/191 (18%)

Query: 357 KLGEGGFGPVYRGM---LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLG 413
           K+G G +G VY+       + ++ A+K++ + +G  +   + E+ L+ +L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85

Query: 414 CCTLRDER--MLIYEYL-------------PNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
                 +R   L+++Y                 + +         K L +    QI++GI
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY----QILDGI 141

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGV-DQTEANTDR 513
                YLH +    ++HRDLK +N+L+  +       KI+D G AR F    +  A+ D 
Sbjct: 142 H----YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 514 VVGTYGYMSPE 524
           VV T+ Y +PE
Sbjct: 195 VVVTFWYRAPE 205

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (258), Expect = 2e-23
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 22/209 (10%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS--SGQGVEEFKNEVLLI 400
           T    T+ +    +LG+G F  V R + +  GQE A   ++    S +  ++ + E  + 
Sbjct: 5   TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64

Query: 401 AKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIE 456
             L+H N+VRL    +      LI++ +    L    F+  V R  +   S+      I+
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYY---SEADASHCIQ 117

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDR 513
            I   +L+ HQ   + ++HR+LK  N+LL         K++DFG+A     +Q       
Sbjct: 118 QILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172

Query: 514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGV 542
             GT GY+SPE      +    D+++ GV
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGV 201

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =   99 bits (250), Expect = 2e-23
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 32/215 (14%)

Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKS------SGQGVEEFKNE 396
           +   D++    +LG G F  V +    +   G+E A K + K        G   EE + E
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKC--RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 58

Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--C 452
           V ++ +++H N++ L      + + +LI E +    L    FD    +      ++    
Sbjct: 59  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESL---TEDEAT 111

Query: 453 QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTE 508
           Q ++ I  G+ YLH     RI H DLK  N++L +   P    K+ DFG+A         
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 543
            N   + GT  +++PE        +++D++S GV+
Sbjct: 169 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  101 bits (254), Expect = 2e-23
 Identities = 49/234 (20%), Positives = 95/234 (40%), Gaps = 37/234 (15%)

Query: 331 RKENMELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSG 387
           +    E  + DW    +    +  K+ +G G    V R        G E AVK +  ++ 
Sbjct: 75  QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC--VHRATGHEFAVKIMEVTAE 132

Query: 388 QG--------VEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF 438
           +          E  + E  ++ ++  H +++ L+          L+++ +    L    F
Sbjct: 133 RLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----F 188

Query: 439 D--VTRTKFLDWSKR--CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS 494
           D    +      S++    I+  +   + +LH      I+HRDLK  N+LLD++M  ++S
Sbjct: 189 DYLTEKVAL---SEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLS 242

Query: 495 DFGMARAFGVDQTEANTDRVVGTYGYMSPE------YAIDGLFSVKSDVFSFGV 542
           DFG +      +       + GT GY++PE            +  + D+++ GV
Sbjct: 243 DFGFSCHLEPGEK-LRE--LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  101 bits (253), Expect = 2e-23
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)

Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSS------GQGVEEFKNE 396
               D +    +LG G F  V +    E   G E A K + K        G   EE + E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65

Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQII 455
           V ++ ++ H N++ L      R + +LI E +    L    FD + + + L   +    I
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFI 121

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANT 511
           + I  G+ YLH     +I H DLK  N++L +   P    K+ DFG+A     +      
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK 176

Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 543
           + + GT  +++PE        +++D++S GV+
Sbjct: 177 N-IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  100 bits (250), Expect = 3e-23
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)

Query: 346 ADATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKS------SGQGVEEFKNE 396
               D +    +LG G F  V +    E   G E A K + K        G   EE + E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65

Query: 397 VLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQII 455
           V ++ ++ H N++ L      R + +LI E +    L    FD + + + L   +    I
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFI 121

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANT 511
           + I  G+ YLH     +I H DLK  N++L +   P    K+ DFG+A     +      
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFK 176

Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 543
           + + GT  +++PE        +++D++S GV+
Sbjct: 177 N-IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  101 bits (254), Expect = 4e-23
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 51/235 (21%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLL 399
                    +++    +G G FG VY+  L + G+ +A+K++ +      + FKN E+ +
Sbjct: 46  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQI 100

Query: 400 IAKLQHRNLVRLLGCCTLRDERM------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
           + KL H N+VRL        E+       L+ +Y+P +++ +     +R K        Q
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAK--------Q 151

Query: 454 IIEG---------IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFG 503
            +           + R L Y+H      I HRD+K  N+LLD D    K+ DFG A+   
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL- 207

Query: 504 VDQTEANTDRVVGTYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
             + E N   +   Y Y +PE       Y      +   DV+S G ++ E++ G+
Sbjct: 208 -VRGEPNVSYICSRY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.0 bits (247), Expect = 7e-23
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 46/218 (21%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EVLLIAKLQHR--NL 408
           LG GGFG VY G+ +++   +A+K + K       E  N      EV+L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 409 VRLLGCCTLRDERMLIYEY-LPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIAR 460
           +RLL      D  +LI E   P + L  FI        ++ R+ F       Q++E +  
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF------WQVLEAVR- 163

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
              + H      ++HRD+K  N+L+D N    K+ DFG          +       GT  
Sbjct: 164 ---HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 213

Query: 520 YMSPE------YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           Y  PE      Y   G     + V+S G+L+ ++VCG 
Sbjct: 214 YSPPEWIRYHRY--HGR---SAAVWSLGILLYDMVCGD 246

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 98.8 bits (247), Expect = 7e-23
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 24/213 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSS---GQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V            A+K L K        V     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 406 RNLVRLLGCCTLRDERML--IYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
              V+L    T +D+  L     Y  N  L     +   FD T T+F       +I+  +
Sbjct: 90  PFFVKLY--FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY----TAEIVSAL 143

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
                YLH      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT 
Sbjct: 144 E----YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            Y+SPE   +      SD+++ G ++ ++V G 
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (254), Expect = 8e-23
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 26/215 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           D F     LG GGFG V+   +    ++ A K+L+K      +G +    E  ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 406 RNLVRLLGCCTLRDERMLIYEY---------LPNKSLEQFIFDVTRTKFLDWSKRCQIIE 456
           R +V L      + +  L+            + N   +   F   R  F          +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY-------TAQ 297

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            I  GL +LHQ     II+RDLK  NVLLD+D N +ISD G+A      QT+       G
Sbjct: 298 -IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAG 351

Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           T G+M+PE  +   +    D F+ GV + E++  +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 47/227 (20%), Positives = 89/227 (39%), Gaps = 42/227 (18%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKS--------SGQGVEEFKNEVLLIAKLQHRNL 408
           LG G FG V+  +   + +E+ VK + K             + +   E+ ++++++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARGLLYL 465
           +++L     +    L+ E   +  L+ F F     +  +        Q++  +     YL
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----YL 146

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE- 524
                  IIHRD+K  N+++  D   K+ DFG A      +         GT  Y +PE 
Sbjct: 147 R---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEV 200

Query: 525 -----YAIDGLFSVKSDVFSFGVLVLEIVCG--------KRNRGFYH 558
                Y   G    + +++S GV +  +V          +      H
Sbjct: 201 LMGNPY--RGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIH 242

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 26/211 (12%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKS------SGQGVEEFKNEV 397
           +  D +    +LG G F  V +    E   G + A K + K        G   E+ + EV
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 398 LLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIE 456
            ++ ++QH N++ L      + + +LI E +    L    FD +   + L   +  + ++
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLK 121

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTD 512
            I  G+ YLH    L+I H DLK  N++L +   P    KI DFG+A     D      +
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176

Query: 513 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 543
            + GT  +++PE        +++D++S GV+
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 55/233 (23%)

Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLSKS--------------------------SGQG 389
           +G+G +G V             A+K LSK                               
Sbjct: 21  IGKGSYGVVKLAYNEND-NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 390 VEEFKNEVLLIAKLQHRNLVRL---LGCCTLRDERMLIYEYLPNKSLEQFIFD-VTRTKF 445
           +E+   E+ ++ KL H N+V+L   L      D   +++E +    +     +  T    
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPV----MEVPTLKPL 134

Query: 446 LDWSKRC---QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
            +   R     +I+GI     YLH     +IIHRD+K SN+L+  D + KI+DFG++  F
Sbjct: 135 SEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSV----KSDVFSFGVLVLEIVCGK 551
                  +    VGT  +M+PE ++     +      DV++ GV +   V G+
Sbjct: 188 KGSDALLSN--TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 40/215 (18%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKN------EV----LLIAKLQHR 406
           LG+GGFG V+ G  LT+  ++A+K + ++   G     +      EV     + A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF---------DVTRTKFLDWSKRCQIIEG 457
            ++RLL     ++  ML+ E  P  + + F +           +R  F       Q++  
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFF------GQVVAA 151

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDRVVG 516
           I     + H      ++HRD+K  N+L+D      K+ DFG   A   D+         G
Sbjct: 152 IQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDE---PYTDFDG 200

Query: 517 TYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVCG 550
           T  Y  PE+     +  + + V+S G+L+ ++VCG
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 29/219 (13%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--------SGQGVEEFKNEVLL 399
            D +     LG G  G V      +  +++A++ +SK                 + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 400 IAKLQHRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEG 457
           + KL H  ++++        E   ++ E +    L    FD V   K L  +        
Sbjct: 194 LKKLNHPCIIKIKNFFD--AEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ 247

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRV 514
           +   + YLH+     IIHRDLK  NVLL   + D   KI+DFG ++  G + +   T  +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT--L 301

Query: 515 VGTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIVCG 550
            GT  Y++PE         ++   D +S GV++   + G
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
             +D F  +++LG G    VYR       +  A+K L K+     +  + E+ ++ +L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSH 107

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARG 461
            N+++L        E  L+ E +    L    FD  V +  +   S+R     ++ I   
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYY---SERDAADAVKQILEA 160

Query: 462 LLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           + YLH+     I+HRDLK  N+L      D   KI+DFG+++             V GT 
Sbjct: 161 VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTP 214

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGV 542
           GY +PE      +  + D++S G+
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGI 238

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 98.7 bits (246), Expect = 9e-22
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 25/213 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           + F     LG+GGFG V    +    ++ A K+L K      +G     NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSL-------EQFIFDVTRTKFLDWSKRCQIIEGI 458
           R +V L      +D   L+   +    L        Q  F   R  F            I
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------AAEI 295

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
             GL  LH   R RI++RDLK  N+LLD+  + +ISD G+A      QT       VGT 
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTV 349

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           GYM+PE   +  ++   D ++ G L+ E++ G+
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.8 bits (239), Expect = 9e-22
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 37/223 (16%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEE--------FKNEVLL 399
            D +     LG G  G V      +  +++A+K +SK                 + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 400 IAKLQHRNLVRLLGCCTLRDERM-LIYEYLPNKSLEQFIFD--VTRTKFL-DWSKRC--Q 453
           + KL H  ++++        E   ++ E +    L    FD  V   +      K    Q
Sbjct: 69  LKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ 122

Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEAN 510
           ++  +     YLH      IIHRDLK  NVLL   + D   KI+DFG ++  G + +   
Sbjct: 123 MLLAVQ----YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMR 174

Query: 511 TDRVVGTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIVCG 550
           T  + GT  Y++PE         ++   D +S GV++   + G
Sbjct: 175 T--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 36/217 (16%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN 407
           TD +  K  +G G +    R +      E AVK + KS     EE     +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIEGIARGLL 463
           ++ L           ++ E +    L     D  + +  F   S+R    ++  I + + 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF---SEREASAVLFTITKTVE 130

Query: 464 YLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
           YLH      ++HRDLK SN+L      N  + +I DFG A+    +     T     T  
Sbjct: 131 YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTAN 185

Query: 520 YMSPE------YAIDGLFSVKSDVFSFGVLVLEIVCG 550
           +++PE      Y          D++S GVL+  ++ G
Sbjct: 186 FVAPEVLERQGY------DAACDIWSLGVLLYTMLTG 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.8 bits (246), Expect = 1e-21
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 32/217 (14%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VL-LIAK 402
           ++FS    +G GGFG VY     +  ++ A+K L K      QG     NE  +L L++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEG 457
                +V +       D+   I + +    L     +  +F     +F            
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--------AAE 300

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I  GL ++H      +++RDLK +N+LLD   + +ISD G+A  F   +  A     VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGT 353

Query: 518 YGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVCGK 551
           +GYM+PE    G+    S   D FS G ++ +++ G 
Sbjct: 354 HGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 40/212 (18%)

Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LG G FG V  G   LT G ++AVK L++    S   V + K E+  +   +H ++++L 
Sbjct: 19  LGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLYL 465
              +   +  ++ EY+    L  +I           R  F       QI+  +     Y 
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF------QQILSAVD----YC 127

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE- 524
           H   R  ++HRDLK  NVLLD  MN KI+DFG++     D     T    G+  Y +PE 
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRT--SCGSPNYAAPEV 181

Query: 525 -----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                Y   G    + D++S GV++  ++CG 
Sbjct: 182 ISGRLY--AGP---EVDIWSCGVILYALLCGT 208

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 24/217 (11%)

Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIA 401
           +      D       LGEG F    + +     Q  AVK +SK         + E+  + 
Sbjct: 4   SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALK 60

Query: 402 KLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--VTRTKFLDWSKR--CQIIE 456
             + H N+V+L      +    L+ E L    L    F+    +  F   S+     I+ 
Sbjct: 61  LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHF---SETEASYIMR 113

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDR 513
            +   + ++H    + ++HRDLK  N+L    ++++  KI DFG AR    D     T  
Sbjct: 114 KLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-- 168

Query: 514 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
              T  Y +PE      +    D++S GV++  ++ G
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 33/208 (15%)

Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LGEG FG V       T  Q++A+K +S+            + E+  +  L+H ++++L 
Sbjct: 17  LGEGSFGKVKLATHYKT-QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC---QIIEGIARGLLYLHQDS 469
              T   + +++ EY      E F + V + +  +   R    QII  I     Y H   
Sbjct: 76  DVITTPTDIVMVIEYA---GGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH--- 125

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE----- 524
           R +I+HRDLK  N+LLD+++N KI+DFG++     D     T    G+  Y +PE     
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKT--SCGSPNYAAPEVINGK 182

Query: 525 -YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            Y   G    + DV+S G+++  ++ G+
Sbjct: 183 LY--AGP---EVDVWSCGIVLYVMLVGR 205

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 39/225 (17%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKR-LSKSSGQGVEEFKN----EVLLIAK 402
            D F  +   G+G FG V  G     G  +A+K+ +          F+N     +  +A 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75

Query: 403 LQHRNLVRLLGCCTLRDER-------MLIYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQI 454
           L H N+V+L        ER        ++ EY+P  +L +   +  R +           
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 455 IEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP-KISDFGMARAFGVDQTEANTDR 513
           +  + R +  LH  S + + HRD+K  NVL++      K+ DFG A+      +E N   
Sbjct: 135 LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAY 191

Query: 514 VVGTYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +   Y Y +PE       Y      +   D++S G +  E++ G+
Sbjct: 192 ICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 93.7 bits (233), Expect = 2e-20
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 40/212 (18%)

Query: 358 LGEGGFGPVYRG--MLTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLL 412
           LG G FG V  G   LT G ++AVK L++    S   V + + E+  +   +H ++++L 
Sbjct: 24  LGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLYL 465
              +   +  ++ EY+    L  +I          +R  F       QI+ G+     Y 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF------QQILSGVD----YC 132

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE- 524
           H   R  ++HRDLK  NVLLD  MN KI+DFG++      +    T    G+  Y +PE 
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRT--SCGSPNYAAPEV 186

Query: 525 -----YAIDGLFSVKSDVFSFGVLVLEIVCGK 551
                Y   G    + D++S GV++  ++CG 
Sbjct: 187 ISGRLY--AGP---EVDIWSSGVILYALLCGT 213

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 51/204 (25%), Positives = 82/204 (40%), Gaps = 30/204 (14%)

Query: 355 KNKLGEGGFGPVYRGMLTE---GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR-NL 408
             +LG G F  V +        GQE A K L K         E  +E+ ++   +    +
Sbjct: 34  SKELGRGKFAVVRQC--ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR------CQIIEGIARGL 462
           + L        E +LI EY     +               S+        QI+EG+    
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVIRLIKQILEGVY--- 145

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
            YLHQ     I+H DLK  N+LL +     + KI DFGM+R           + ++GT  
Sbjct: 146 -YLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELRE-IMGTPE 198

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVL 543
           Y++PE       +  +D+++ G++
Sbjct: 199 YLAPEILNYDPITTATDMWNIGII 222

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 40/210 (19%)

Query: 358 LGEGGFGPVY--RGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           +G G FG     R  LT  + +AVK + + +    E  + E++    L+H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLT-KELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVI 85

Query: 416 TLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
                  +I EY     L + I        D  R  F       Q++ G++    Y H  
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ------QLLSGVS----YCH-- 133

Query: 469 SRLRIIHRDLKASNVLLDND--MNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE-- 524
             ++I HRDLK  N LLD       KI DFG +++  +      +   VGT  Y++PE  
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS--TVGTPAYIAPEVL 189

Query: 525 ----YAIDGLFSVKSDVFSFGVLVLEIVCG 550
               Y  DG     +DV+S GV +  ++ G
Sbjct: 190 LRQEY--DGK---IADVWSCGVTLYVMLVG 214

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 50/207 (24%), Positives = 83/207 (40%), Gaps = 26/207 (12%)

Query: 355 KNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNLVRLL 412
           K  LG G  G V        GQ+ A+K L  S      + + EV          ++V +L
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCIL 88

Query: 413 GCC-TLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKR--CQIIEGIARGLLYLH 466
                +   +  +    E +    L   I +     F   ++R   +I+  I   + +LH
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF---TEREAAEIMRDIGTAIQFLH 145

Query: 467 QDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
                 I HRD+K  N+L    + D   K++DFG A+     Q    T     T  Y++P
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQT--PCYTPYYVAP 198

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E      +    D++S GV++  ++CG
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 55/233 (23%), Positives = 104/233 (44%), Gaps = 27/233 (11%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLI 400
                   D++    KLG G +  V+  + +T  +++ VK L     +   + K E+ ++
Sbjct: 28  HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKIL 84

Query: 401 AKLQ-HRNLVRLLGCCTLRDERM----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
             L+   N++ L     ++D       L++E++ N   +Q           D+  R  + 
Sbjct: 85  ENLRGGPNIITLA--DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMY 137

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFGVDQTEANTDRV 514
           E I + L Y H  S   I+HRD+K  NV++D++    ++ D+G+A  F     E    RV
Sbjct: 138 E-ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQE-YNVRV 191

Query: 515 VGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
              Y +  PE  +D      S D++S G ++  ++  K    F+H   +++ L
Sbjct: 192 ASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK--EPFFHGHDNYDQL 241

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 85.0 bits (210), Expect = 6e-18
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 3/91 (3%)

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           +A+G+ +L   +  + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 548
             +M+PE   D +++++SDV+SFGVL+ EI 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 34/160 (21%), Positives = 58/160 (36%), Gaps = 19/160 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 402
           D       LG G FG V              + +AVK L + +         +E+ ++  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 403 L-QHRNLVRLLGCCTLRDER-MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
           +  H N+V LLG CT      M+I E+    +L  ++           SKR + +    +
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR 500
           G  +      +  I  DLK     + +  +   S F   +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 85.2 bits (211), Expect = 7e-18
 Identities = 48/251 (19%), Positives = 92/251 (36%), Gaps = 65/251 (25%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-EVLLIAKLQHR 406
           +  +S    LG G FG V      E G+  A+K++ +        +KN E+ ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60

Query: 407 NLVRLLGC-----------CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLD-------- 447
           N+++L+                 D+   +       +       V  ++           
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 448 ----------WSKRCQIIEG---------IARGLLYLHQDSRLRIIHRDLKASNVLLD-N 487
                     + +  + I           + R + ++H    L I HRD+K  N+L++  
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177

Query: 488 DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE-------YAIDGLFSVKSDVFSF 540
           D   K+ DFG A+      +E +   +   + Y +PE       Y      +   D++S 
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEY------TPSIDLWSI 228

Query: 541 GVLVLEIVCGK 551
           G +  E++ GK
Sbjct: 229 GCVFGELILGK 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.1 bits (211), Expect = 8e-18
 Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 33/220 (15%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           D+F     +G G F  V    + +  ++ A+K ++K        V  F+ E  ++     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 406 RNLVRLLGCCTLRDERML--IYEYLPNKSL------EQFIFDVTRTKFLDWSKRCQIIEG 457
           R + +L      +DE  L  + EY     L                +F        + E 
Sbjct: 121 RWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-------LAE- 170

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           I   +  +H+   L  +HRD+K  N+LLD   + +++DFG       D T   +   VGT
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGT 226

Query: 518 YGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIVCG 550
             Y+SPE           G +  + D ++ GV   E+  G
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 85.2 bits (211), Expect = 9e-18
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 25/207 (12%)

Query: 355 KNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNLVRLL 412
              LG G  G V +       ++ A+K L         + + EV L     Q  ++VR++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 121

Query: 413 GCC-TLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKR--CQIIEGIARGLLYLH 466
                L   R  +    E L    L   I D     F   ++R   +I++ I   + YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSIGEAIQYLH 178

Query: 467 QDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSP 523
               + I HRD+K  N+L      +   K++DFG A+      +   T     T  Y++P
Sbjct: 179 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTT--PCYTPYYVAP 232

Query: 524 EYAIDGLFSVKSDVFSFGVLVLEIVCG 550
           E      +    D++S GV++  ++CG
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCG 259

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 85.2 bits (211), Expect = 1e-17
 Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 46/282 (16%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F     +G G FG V    L    ++ A+K L+K           F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSL------EQFIFDVTRTKFLDWSKRCQIIEGIA 459
           + +  L       +   L+ +Y     L       +        +F        + E + 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-------LAE-MV 185

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
             +  +HQ   L  +HRD+K  N+L+D + + +++DFG       D T   +   VGT  
Sbjct: 186 IAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPD 241

Query: 520 YMSPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH---HNLLGHAWR 571
           Y+SPE         G +  + D +S GV + E++ G+    FY          ++ H  R
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--FYAESLVETYGKIMNHKER 299

Query: 572 LWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDR 613
                       +       +SE  + +   L+C     E R
Sbjct: 300 F-----------QFPTQVTDVSENAKDLIRRLIC---SREHR 327

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 30/217 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           D+F     +G+G FG V      + +++ A+K ++K        V     E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIAR 460
             LV L       ++  ++ + L    L     +   F     K         I E +  
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-------ICE-LVM 126

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L YL      RIIHRD+K  N+LLD   +  I+DF +A      +T+  T  + GT  Y
Sbjct: 127 ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPY 180

Query: 521 MSPE--YAIDGL---FSVKSDVFSFGVLVLEIVCGKR 552
           M+PE   +  G    F+V  D +S GV   E++ G+R
Sbjct: 181 MAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.1 bits (203), Expect = 7e-17
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 28/215 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           +++     +G G FG V        +++ A+K LSK           F  E  ++A    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 406 RNLVRLLGCCTLRDERML--IYEYLPN----KSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
             +V+L      +D+R L  + EY+P       +  +       +F          E + 
Sbjct: 129 PWVVQLF--YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-------TAE-VV 178

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
             L  +H    +  IHRD+K  N+LLD   + K++DFG       +      D  VGT  
Sbjct: 179 LALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPD 234

Query: 520 YMSPE----YAIDGLFSVKSDVFSFGVLVLEIVCG 550
           Y+SPE       DG +  + D +S GV + E++ G
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 23/221 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           + F +   LG+G FG V            A+K L K    +   V     E  ++   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIAR 460
             L  L       D    + EY     L      + +F   R +F            I  
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--------GAEIVS 259

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L YLH  S   +++RDLK  N++LD D + KI+DFG+ +    D     T    GT  Y
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
           ++PE   D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 354

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 24/200 (12%), Positives = 62/200 (31%), Gaps = 41/200 (20%)

Query: 357 KLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLL 412
             G       ++ + T   +++A+  +          ++E  +  L ++++    + R+L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 413 GCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                R   +++ E++   SL+    +V  T         + ++ +A      H   R  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQ----EVADTS-PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 473 IIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS 532
           +       S V +  D        G                V+     M          +
Sbjct: 150 VALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDA-------N 180

Query: 533 VKSDVFSFGVLVLEIVCGKR 552
            + D+   G  +  ++  + 
Sbjct: 181 PQDDIRGIGASLYALLVNRW 200

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 51/233 (21%), Positives = 89/233 (38%), Gaps = 38/233 (16%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEE--FKN---- 395
              +      ++ +  +  G +G V  G+ +EG  +A+KR+  +   G       +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 396 -----EVLLIAKLQHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRTKF 445
                E+ L+    H N++ L       +E       L+ E +    L Q I      + 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI----HDQR 128

Query: 446 LDWSK-RCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG 503
           +  S    Q  +  I  GL  LH+     ++HRDL   N+LL ++ +  I DF +AR   
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--E 183

Query: 504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 551
                  T  V     Y +PE     +   K      D++S G ++ E+   K
Sbjct: 184 DTADANKTHYVT-HRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 51/234 (21%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
            ++       +     +G G  G V         + +A+K+LS+        F+N     
Sbjct: 17  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAK 69

Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFD------- 439
               E++L+  + H+N++ LL              + P KSLE+F     + +       
Sbjct: 70  RAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLC 117

Query: 440 -VTRTKFLDWSKRCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG 497
            V + +     +R   ++  +  G+ +LH      IIHRDLK SN+++ +D   KI DFG
Sbjct: 118 QVIQMELDH--ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172

Query: 498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           +AR      +   T  VV T  Y +PE  +   +    D++S G ++ E++ G 
Sbjct: 173 LAR--TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 31/223 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           D F     LG G FG V      E     A+K L K      + +E   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 406 RNLVRLLGCCTLRDERML--IYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
             LV+L      +D   L  + EY+    +         F     +F       QI+   
Sbjct: 101 PFLVKLEFSF--KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY----AAQIVLTF 154

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
                YLH    L +I+RDLK  N+L+D     +++DFG A+     + +  T  + GT 
Sbjct: 155 E----YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTP 202

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
             ++PE  +   ++   D ++ GVL+ E+  G     F+    
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQP 243

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 40/237 (16%), Positives = 92/237 (38%), Gaps = 32/237 (13%)

Query: 307 RKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFD-WNTIADATDNFSWKNKLGEGGFGP 365
            ++      +TV  S+ +   R     +         ++     D +  ++ +G G +G 
Sbjct: 9   AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68

Query: 366 VYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---------EVLLIAKLQHRNLVRLLGCC 415
           V         + +A+K++ +        F++         E+ ++ +L H ++V++L   
Sbjct: 69  VCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121

Query: 416 TLRDERM-----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ-IIEGIARGLLYLHQDS 469
             +D        ++ E       ++     T     +     + ++  +  G+ Y+H  S
Sbjct: 122 IPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTE--LHIKTLLYNLLVGVKYVH--S 174

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
              I+HRDLK +N L++ D + K+ DFG+AR     +   +   +      M+    
Sbjct: 175 A-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 55/228 (24%), Positives = 104/228 (45%), Gaps = 40/228 (17%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
             T  +    +     +G G +G V   +    G+++A+K+LS+        F++     
Sbjct: 16  NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAK 68

Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERM------LIYEYLPNKSLEQFIFDVTRTKF 445
               E+LL+  +QH N++ LL   T            L+  ++    L++ +      KF
Sbjct: 69  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKF 123

Query: 446 LDWSKRCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV 504
            +  ++ Q ++  + +GL Y+H      ++HRDLK  N+ ++ D   KI DFG+AR    
Sbjct: 124 SE--EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178

Query: 505 DQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 551
           + T       V T  Y +PE  +    ++   D++S G ++ E++ GK
Sbjct: 179 EMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 41/229 (17%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
            ++       +     +G G  G V         + +A+K+LS+        F+N     
Sbjct: 54  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAK 106

Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERM------LIYEYLP---NKSLEQFIFDVTR 442
               E++L+  + H+N++ LL   T +          L+ E +     + ++  +     
Sbjct: 107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166

Query: 443 TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
           +  L      Q++     G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR  
Sbjct: 167 SYLL-----YQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 212

Query: 503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
               +   T  VV T  Y +PE  +   +    D++S G ++ E+V  K
Sbjct: 213 TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 34/199 (17%)

Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN------ 395
             + D    ++  + +GEG +G V           +A+K++S         F++      
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQR 71

Query: 396 ---EVLLIAKLQHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRTKFLD 447
              E+ ++ + +H N++ +                ++ + +    L + +    +T+ L 
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLS 126

Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
               C  +  I RGL Y+H  S   ++HRDLK SN+LL+   + KI DFG+AR    D  
Sbjct: 127 NDHICYFLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183

Query: 508 EAN--TDRVVGTYGYMSPE 524
                T+ V  T  Y +PE
Sbjct: 184 HTGFLTEYVA-TRWYRAPE 201

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 22/211 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LG+G FG V            A+K L K    +   V     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIAR 460
             L  L       D    + EY     L      + +F   R +F          E I  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-------GAE-IVS 116

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L YLH      +++RD+K  N++LD D + KI+DFG+ +    D     T    GT  Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           ++PE   D  +    D +  GV++ E++CG+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.3 bits (186), Expect = 8e-15
 Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
           DNF +   LG+G FG V    + E  ++ AVK L K        VE    E  +L +A+ 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR- 81

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
            H  L +L  C    D    + E++    L     +   FD  R +F          E I
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY-------AAE-I 133

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              L++LH      II+RDLK  NVLLD++ + K++DFGM +    +     T    GT 
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTP 188

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            Y++PE   + L+    D ++ GVL+ E++CG 
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.4 bits (186), Expect = 8e-15
 Identities = 52/238 (21%), Positives = 99/238 (41%), Gaps = 59/238 (24%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
             T  +    +     +G G +G V   +    G ++A+K+L +        F++     
Sbjct: 17  TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAK 69

Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFD------- 439
               E+ L+  ++H N++ LL              + P+++L+ F     +         
Sbjct: 70  RAYRELRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLG 117

Query: 440 -VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498
            + + + L   +   ++  + +GL Y+H      IIHRDLK  N+ ++ D   KI DFG+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174

Query: 499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 551
           AR    + T       V T  Y +PE     + +        D++S G ++ E++ GK
Sbjct: 175 ARQADSEMTGY-----VVTRWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 25/213 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
            +F     +G G +  V    L +   I A+K + K      + ++  + E  V   A  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-S 67

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
            H  LV L  C         + EY+    L      Q        +F          E I
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY-------SAE-I 119

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           +  L YLH+     II+RDLK  NVLLD++ + K++D+GM +         +T    GT 
Sbjct: 120 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTP 174

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            Y++PE      +    D ++ GVL+ E++ G+
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.6 bits (188), Expect = 1e-14
 Identities = 63/213 (29%), Positives = 91/213 (42%), Gaps = 25/213 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
            +F++   LG+G FG V         E+ AVK L K        VE    E  VL +   
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-G 399

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
           +   L +L  C    D    + EY+    L     +   F      F          E I
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-------AAE-I 451

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           A GL +L       II+RDLK  NV+LD++ + KI+DFGM +    D     T    GT 
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTP 506

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            Y++PE      +    D ++FGVL+ E++ G+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 63/213 (29%), Positives = 91/213 (42%), Gaps = 25/213 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
            +F++   LG+G FG V         E+ AVK L K        VE    E  VL +   
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 78

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
           +   L +L  C    D    + EY+    L     +   F      F          E I
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-------AAE-I 130

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           A GL +L       II+RDLK  NV+LD++ + KI+DFGM +    D     T    GT 
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTP 185

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            Y++PE      +    D ++FGVL+ E++ G+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 33/214 (15%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKSS----GQGVEEFKNEVLLIAKLQ 404
            +F     LG G FG V+           A+K L K       Q VE   +E L+++ + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIA 459
           H  ++R+ G      +  +I +Y+    L     +   F     KF          E + 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-------AAE-VC 116

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
             L YLH      II+RDLK  N+LLD + + KI+DFG A+          T  + GT  
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT--LCGTPD 168

Query: 520 YMSPEYAIDGL---FSVKSDVFSFGVLVLEIVCG 550
           Y++PE  +       S+  D +SFG+L+ E++ G
Sbjct: 169 YIAPE-VVSTKPYNKSI--DWWSFGILIYEMLAG 199

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 25/213 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
            +F     +G G +  V    L +   I A++ + K      + ++  + E  V   A  
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-S 110

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
            H  LV L  C         + EY+    L      Q        +F          E I
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY-------SAE-I 162

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           +  L YLH+     II+RDLK  NVLLD++ + K++D+GM +         +T    GT 
Sbjct: 163 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTP 217

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            Y++PE      +    D ++ GVL+ E++ G+
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 25/212 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
           ++F     LG+G FG V+     +  +  A+K L K        VE    E  VL +A  
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-W 75

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
           +H  L  +      ++    + EYL    L         FD++R  F          E I
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY-------AAE-I 127

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
             GL +LH      I++RDLK  N+LLD D + KI+DFGM +   +   + NT    GT 
Sbjct: 128 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTP 182

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG 550
            Y++PE  +   ++   D +SFGVL+ E++ G
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 51/234 (21%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
             TI +  + +   + +G G +G V     T+ G  +AVK+LS+        F++     
Sbjct: 21  NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAK 73

Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFD------- 439
               E+ L+  ++H N++ LL              + P +SLE+F     +         
Sbjct: 74  RTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLN 121

Query: 440 -VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM 498
            + + + L       +I  I RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178

Query: 499 ARAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 551
           AR    + T       V T  Y +PE  ++   ++   D++S G ++ E++ G+
Sbjct: 179 ARHTADEMTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 30/216 (13%)

Query: 350 DNFSWKNKLGEGGFGPVY----RGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL 403
             F     LG+G FG V+           Q  A+K L K++   +     K E  ++ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
            H  +V+L        +  LI ++L    L     ++ +F     KF        + E +
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY-------LAE-L 135

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           A  L +LH    L II+RDLK  N+LLD + + K++DFG+++     + +A +    GT 
Sbjct: 136 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 190

Query: 519 GYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVCGK 551
            YM+PE  ++      S   D +SFGVL+ E++ G 
Sbjct: 191 EYMAPE-VVNRRGHTQSA--DWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 26/215 (12%)

Query: 350 DNFSWKNKLGEGGFGPVY---RGMLTEGQEI-AVKRLSKSS----GQGVEEFKNEVLLIA 401
           + F     LG+GG+G V+   +       +I A+K L K+      +     K E  ++ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIE 456
           +++H  +V L+       +  LI EYL    L      + IF      F        + E
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-------LAE 129

Query: 457 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVG 516
            I+  L +LHQ     II+RDLK  N++L++  + K++DFG+ +    D T  +T    G
Sbjct: 130 -ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCG 183

Query: 517 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           T  YM+PE  +    +   D +S G L+ +++ G 
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 50/241 (20%), Positives = 93/241 (38%), Gaps = 52/241 (21%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN----- 395
                D    +     LG GG G V+  +  +  + +A+K++            +     
Sbjct: 3   NIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVK 53

Query: 396 ----EVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQF-----IFD------- 439
               E+ +I +L H N+V++         +          SL +      + +       
Sbjct: 54  HALREIKIIRRLDHDNIVKVFEILGPSGSQ----LTDDVGSLTELNSVYIVQEYMETDLA 109

Query: 440 -VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFG 497
            V     L        +  + RGL Y+H  +   ++HRDLK +N+ ++  D+  KI DFG
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG 166

Query: 498 MARAFGVDQTEAN--TDRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIVCG 550
           +AR      +     ++ +V T  Y SP      L S  +     D+++ G +  E++ G
Sbjct: 167 LARIMDPHYSHKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTG 221

Query: 551 K 551
           K
Sbjct: 222 K 222

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEI-AVKRLSKS---SGQGVEEFKNE--VLLIAKL 403
            +F +   +G+G FG V        +   AVK L K      +  +   +E  VLL   +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-V 96

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGI 458
           +H  LV L       D+   + +Y+    L      +  F   R +F          E I
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-------AAE-I 148

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           A  L YLH    L I++RDLK  N+LLD+  +  ++DFG+ +      +  +T    GT 
Sbjct: 149 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTP 203

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            Y++PE      +    D +  G ++ E++ G 
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 40/207 (19%), Positives = 81/207 (39%), Gaps = 31/207 (14%)

Query: 339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN-- 395
            F         DN+  K+ +G G +G VY        + +A+K++++        F++  
Sbjct: 15  YFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLI 67

Query: 396 -------EVLLIAKLQHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRT 443
                  E+ ++ +L+   ++RL       D        ++ E      L++     T  
Sbjct: 68  DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPI 124

Query: 444 KFLDWSKRCQ-IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF 502
              +  +  + I+  +  G  ++H      IIHRDLK +N LL+ D + K+ DFG+AR  
Sbjct: 125 FLTE--EHIKTILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 503 GVDQTEANTDRVVGTYGYMSPEYAIDG 529
             ++     + +            +  
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKK 206

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 42/173 (24%), Positives = 65/173 (37%), Gaps = 22/173 (12%)

Query: 338 PMFDWNTIADATDNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNE 396
                   A   D       LG G  G V +       ++ A+K L         + + E
Sbjct: 6   SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60

Query: 397 V-LLIAKLQHRNLVRLLGCC-TLRDERMLIY---EYLPNKSLEQFIFDVTRTKFLDWSKR 451
           V L     Q  ++VR++     L   R  +    E L    L   I D     F   ++R
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TER 117

Query: 452 --CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMA 499
              +I++ I   + YLH    + I HRD+K  N+L      +   K++DFG A
Sbjct: 118 EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.7 bits (172), Expect = 3e-13
 Identities = 37/200 (18%), Positives = 65/200 (32%), Gaps = 46/200 (23%)

Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRL--------SKSSGQGVEEFKNEVLL 399
            T+      K+GEG FG V++ +      +A+K +        + S  +  EE   E+++
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 400 IAKLQ---------HRNLVRLLG--CCTLRDERMLIYEY------------LPNKSLEQF 436
             +L              + L    C       +L+  +             P+   +  
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 437 IFDVT------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL 484
           +F V             RTK    +    I+  +   L        LR  HRDL   NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 485 LDNDMNPKISDFGMARAFGV 504
           L      K+      ++  +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTI 214

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 43/275 (15%)

Query: 304 MYMRKKKRRDQGNTVGSSELDYIDRGNRKENMELPMFDWNTIADAT-------DNFSWKN 356
           M        ++G + G +     D G+  E +     +  T            +NF    
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60

Query: 357 KLGEGGFGPVY---RGMLTEGQEI-AVKRLSKSS----GQGVEEFKNE--VLLIAKLQHR 406
            LG G +G V+   +    +  ++ A+K L K++     +  E  + E  VL   + Q  
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSP 119

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSL-----EQFIFDVTRTKFLDWSKRCQIIEGIARG 461
            LV L        +  LI +Y+    L     ++  F     +         + E I   
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-------VGE-IVLA 171

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-ANTDRVVGTYGY 520
           L +LH+   L II+RD+K  N+LLD++ +  ++DFG+++ F  D+TE A      GT  Y
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEY 226

Query: 521 MSPEYAIDGL----FSVKSDVFSFGVLVLEIVCGK 551
           M+P+    G      +V  D +S GVL+ E++ G 
Sbjct: 227 MAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 34/192 (17%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---------EVL 398
           + +F  K+ LGEG +G V        G+ +A+K++          F           E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 399 LIAKLQHRNLVRLLGCCTLRDERM-----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
           ++   +H N++ +                +I E +    L + I     T+ L       
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY 116

Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR 513
            I    R +  LH  +   +IHRDLK SN+L++++ + K+ DFG+AR   +D++ A+   
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSE 171

Query: 514 VVGTYGYMSPEY 525
             G    M  E+
Sbjct: 172 PTGQQSGMV-EF 182

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 48/198 (24%), Positives = 93/198 (46%), Gaps = 34/198 (17%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKN---------EVL 398
              +    KLG+G +G V++ +    G+ +AVK++  +       F+N         E++
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 399 LIAKLQ-HRNLVRLLGCCTLRDERM----LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQ 453
           ++ +L  H N+V LL    LR +      L+++Y+    L   I    R   L+     Q
Sbjct: 61  ILTELSGHENIVNLLNV--LRADNDRDVYLVFDYME-TDLHAVI----RANILE-PVHKQ 112

Query: 454 -IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD 512
            ++  + + + YLH  S   ++HRD+K SN+LL+ + + K++DFG++R+F   +   N  
Sbjct: 113 YVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 513 RVVGTYGYMSPEYAIDGL 530
            +       + +     L
Sbjct: 170 PLSINENTENFDDDQPIL 187

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 54/241 (22%), Positives = 95/241 (39%), Gaps = 51/241 (21%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ----------- 404
           KLG G F  V+    +     +A+K + +      E  ++E+ L+ ++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 405 HRNLVRLLGCCTLRDERM----LIYEYLPNKSLEQFI-------FDVTRTKFLDWSKRCQ 453
             ++++LL     +        +++E L  ++L   I         +   K        Q
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK--------Q 135

Query: 454 IIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP------KISDFGMARAFGVDQT 507
           I + +  GL Y+H   R  IIH D+K  NVL++   +P      KI+D G A        
Sbjct: 136 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYD 189

Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-----RNRGFYHADHH 562
           E  T+ +  T  Y SPE  +   +   +D++S   L+ E++ G           Y  D  
Sbjct: 190 EHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248

Query: 563 H 563
           H
Sbjct: 249 H 249

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 40/205 (19%), Positives = 76/205 (37%), Gaps = 48/205 (23%)

Query: 354 WK--NKLGEGGFGPVYRGMLTEGQEI------AVKRLSKSSGQGVEEFK-----NEVLLI 400
           WK    +G+GGFG +Y   +   + +       VK     +G    E K      +   I
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 401 AKLQHRNLVRLLGCCTLR----------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK 450
            K      ++ LG                 R +I +      L++ I++    +F   S+
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRF---SR 151

Query: 451 RC------QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI--SDFGMARAF 502
           +       +I++ +     Y+H+      +H D+KASN+LL+     ++   D+G+A  +
Sbjct: 152 KTVLQLSLRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

Query: 503 GVDQT-----EANTDRVVGTYGYMS 522
             +               GT  + S
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTS 229

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 32/205 (15%), Positives = 68/205 (33%), Gaps = 48/205 (23%)

Query: 354 WK--NKLGEGGFGPVYRGM---------LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           WK  +       G +Y              + Q+ ++K L    G+   E          
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKP 102

Query: 403 LQHRNLVRLLGCCTL------------RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSK 450
           LQ     +L     L               R L+   L  +SL+  +    +      S+
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL---SE 158

Query: 451 RC------QIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI--SDFGMARAF 502
           R       ++++ +     +LH++     +H ++ A N+ +D +   ++  + +G A  +
Sbjct: 159 RSVLQVACRLLDALE----FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

Query: 503 -----GVDQTEANTDRVVGTYGYMS 522
                 V   E +     G   ++S
Sbjct: 212 CPSGKHVAYVEGSRSPHEGDLEFIS 236

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 38/215 (17%)

Query: 356 NKLGEGGFGPVYRGM-LTEGQEIAVK---RLSKSSGQGVEEFKNEVLLIAKLQHR----- 406
           + +G+G FG V +     E + +A+K          Q     + EV L+  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115

Query: 407 -NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC--QIIEGIARGLL 463
             +V L      R+   L++E L + +L   +     T F   S     +  + +   LL
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL---RNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTY--- 518
           +L     L IIH DLK  N+LL N      KI DFG +             + +  Y   
Sbjct: 172 FLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---------CQLGQRIYQYIQS 221

Query: 519 -GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
             Y SPE  + G+ + +  D++S G +++E+  G+
Sbjct: 222 RFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 40/178 (22%), Positives = 70/178 (39%), Gaps = 22/178 (12%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV-RLLGC 414
           K+G G FG +Y G  +   +E+A+K  +  +         E  +   LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71

Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR--CQIIEGIARGLLYLHQDSRLR 472
               D  +L+ + L   SLE  +F+    K    S +    + + +   + ++H  S   
Sbjct: 72  GVEGDYNVLVMDLL-GPSLED-LFNFCSRKL---SLKTVLMLADQMINRVEFVHSKS--- 123

Query: 473 IIHRDLKASNVLLDNDMNPK---ISDFGMARAFGVDQTEA-----NTDRVVGTYGYMS 522
            +HRD+K  N L+          I DFG+A+ +    T           + GT  Y S
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 42/176 (23%), Positives = 71/176 (40%), Gaps = 18/176 (10%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLGC 414
           K+G G FG +Y G  +  G+E+A+K     +         E  +   +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73

Query: 415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII 474
               D  +++ E L   SLE  +F+    KF        + + +   + Y+H  +    I
Sbjct: 74  GAEGDYNVMVMELL-GPSLED-LFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN---FI 127

Query: 475 HRDLKASNVLLDNDMNPK---ISDFGMARAFGVDQTEA-----NTDRVVGTYGYMS 522
           HRD+K  N L+          I DFG+A+ +   +T           + GT  Y S
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 40/183 (21%), Positives = 68/183 (37%), Gaps = 30/183 (16%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           K+G G FG +  G  L   + +A+K     S       +             + ++    
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFG 74

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC------QIIEGIARGLLYLHQDS 469
                  ++ E L   SLE  +FD+    F   S +       Q+I  +     Y+H  +
Sbjct: 75  PCGKYNAMVLELL-GPSLED-LFDLCDRTF---SLKTVLMIAIQLISRME----YVHSKN 125

Query: 470 RLRIIHRDLKASNVLLDNDMNPK-----ISDFGMARAFGVDQTEA-----NTDRVVGTYG 519
              +I+RD+K  N L+    N       I DF +A+ +   +T+          + GT  
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182

Query: 520 YMS 522
           YMS
Sbjct: 183 YMS 185

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 44/228 (19%), Positives = 81/228 (35%), Gaps = 48/228 (21%)

Query: 330 NRKENMELPM-FDWNTIADATDNFSWK--NKLGEGGFGPVYRGM-LTEGQEIA---VKRL 382
             +      M F    + D  +   W    K+G GGFG +Y      + ++ A   VK  
Sbjct: 14  GTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE 73

Query: 383 SKSSGQGVEEFK-----NEVLLIAKLQHRNLVRLLGCCTLR----------DERMLIYEY 427
            + +G    E K      +   I K   R  +  LG                 R ++ E 
Sbjct: 74  YQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER 133

Query: 428 LPNKSLEQFIFDVTRTKFLDWSKRC------QIIEGIARGLLYLHQDSRLRIIHRDLKAS 481
           L    L++ I       F    K        ++++ +     Y+H++     +H D+KA+
Sbjct: 134 L-GIDLQK-ISGQNG-TF---KKSTVLQLGIRMLDVLE----YIHENE---YVHGDIKAA 180

Query: 482 NVLLDNDMNPKI--SDFGMARAFGVDQT-----EANTDRVVGTYGYMS 522
           N+LL      ++  +D+G++  +  +       E       GT  + S
Sbjct: 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 32/209 (15%)

Query: 358 LGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR------NLVR 410
           +G+G FG V +       Q +A+K + ++  +   +   E+ ++  L+ +      N++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF--LDWSKRCQIIEGIARGLLYLHQD 468
           +L   T R+   + +E L + +L + I    + KF         +    I + L  LH  
Sbjct: 164 MLENFTFRNHICMTFELL-SMNLYELI---KKNKFQGFSLPLVRKFAHSILQCLDALH-- 217

Query: 469 SRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTY----GYMS 522
            + RIIH DLK  N+LL        K+ DFG +             + V TY     Y +
Sbjct: 218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---------CYEHQRVYTYIQSRFYRA 267

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           PE  +   + +  D++S G ++ E++ G 
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 38/183 (20%), Positives = 73/183 (39%), Gaps = 30/183 (16%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           ++GEG FG ++ G  L   Q++A+K   + S       +     +       +  +    
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGIPNVYYFG 75

Query: 416 TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC------QIIEGIARGLLYLHQDS 469
                 +L+ + L   SLE  + D+   KF   S +       Q++  +      +H+ S
Sbjct: 76  QEGLHNVLVIDLLG-PSLED-LLDLCGRKF---SVKTVAMAAKQMLARVQ----SIHEKS 126

Query: 470 RLRIIHRDLKASNVLLDNDMNPK-----ISDFGMARAFGVDQTEANTD-----RVVGTYG 519
              +++RD+K  N L+    +       + DFGM + +    T+ +        + GT  
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 520 YMS 522
           YMS
Sbjct: 184 YMS 186

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 8e-08
 Identities = 81/613 (13%), Positives = 164/613 (26%), Gaps = 218/613 (35%)

Query: 15  MSSWKSAD-DPA--QDNYIYEVDP-RGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPN 70
           MS  K+    P+     YI + D      Q VF K + +  R  P+  L      +L+P 
Sbjct: 95  MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ-VFAKYN-VS-RLQPYLKLR-QALLELRPA 150

Query: 71  P---VY----------TFEYVSNE-------NEVFY-RFNLIKS--SVLTMM-----VIN 102
               +             +   +         ++F+       S  +VL M+      I+
Sbjct: 151 KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210

Query: 103 P---------QGEPQRLTWMEQ----TQKWAPFVPFSGLILDQCDNYALCGAYAICNMNS 149
           P              R+  ++       K  P+     L+L   +         + N   
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-ENCLLVLL--N---------VQNA-- 256

Query: 150 NSARCECLEGFVPKSPSEWDLLDTSDGCI-------RRTQLDCEH-GDGFLKRESVKLPD 201
                +    F         LL T    +         T +  +H        E      
Sbjct: 257 -----KAWNAFNLSCKI---LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV----- 303

Query: 202 TSFSRVDKNISILACKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKVLSEGGQDL 261
                          K L  K                     +    +D +      QDL
Sbjct: 304 ---------------KSLLLK---------------------Y----LDCRP-----QDL 318

Query: 262 YIRMATSELDNFERTKRRKKKKV---VIIIICALLATGVILIGGFMYMRKKKRRDQGNTV 318
                            R+        + II   +  G+     + ++   K       +
Sbjct: 319 ----------------PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK---LTTII 359

Query: 319 GSSELDYIDRGNRKEN-MELPMFDWNT-IADATDNFSWKNKLGEGGFGPVYRGMLTEGQE 376
            SS L+ ++    ++    L +F  +  I     +  W +             ++     
Sbjct: 360 ESS-LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD-------------VIKSDVM 405

Query: 377 IAVKRLSKSS---GQGVE----------EFKNEVLLIAKLQHRNLV---RLLGC-----C 415
           + V +L K S    Q  E          E K ++     L HR++V    +         
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDL 464

Query: 416 TLRDERMLIYEYLPN--KSLEQF-IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLR 472
                    Y ++ +  K++E      + R  FLD                        R
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-----------------------FR 501

Query: 473 IIHRDLKASNVLLD--NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL 530
            + + ++  +   +    +   +      + +  D  +   +R+V       P+   + +
Sbjct: 502 FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN-DPKYERLVNAILDFLPKIEENLI 560

Query: 531 FSVKSDVFSFGVL 543
            S  +D+    ++
Sbjct: 561 CSKYTDLLRIALM 573

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 4e-04
 Identities = 54/404 (13%), Positives = 107/404 (26%), Gaps = 149/404 (36%)

Query: 316 NTVGSSELDYI-DRGNRKENMELPMFDW------NTIADATD-----NFSW-KNKLGEGG 362
           + +   E+D+I    +        +F          +    +     N+ +  + +    
Sbjct: 44  SILSKEEIDHIIMSKDAVSGTLR-LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102

Query: 363 FGPV--------YRGML-TEGQEIA---VKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR 410
             P          R  L  + Q  A   V RL         + +  +L   +L+    V 
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP-----YLKLRQALL---ELRPAKNVL 154

Query: 411 L---LGC-------CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDW--SKRCQIIEGI 458
           +   LG              +  +   +  K     IF         W   K C   E +
Sbjct: 155 IDGVLGSGKTWVALDVCLSYK--VQCKMDFK-----IF---------WLNLKNCNSPETV 198

Query: 459 ARGL--LYLHQDS---------------------RLR--IIHRDLKASNVLLDNDMNPKI 493
              L  L    D                       LR  +  +  +   ++L N  N K 
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA 258

Query: 494 SDFGMARAFGVD-QT------EANTDRVVG-TYGYMSPEYAIDGLFSVKS-DVFSFGVLV 544
                  AF +  +       +  TD +   T  ++S ++    L   +   +       
Sbjct: 259 -----WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL---KY 310

Query: 545 LEI------------------VCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
           L+                   +  +  R         N     W+    D+   +I+ SL
Sbjct: 311 LDCRPQDLPREVLTTNPRRLSIIAESIRD--GLATWDN-----WKHVNCDKLTTIIESSL 363

Query: 587 DGSYSLSEALRCIQVGLLCVQQR-------PEDRPNMSSVVLML 623
           +    L  A           ++        P    ++ +++L L
Sbjct: 364 N---VLEPAE---------YRKMFDRLSVFPPS-AHIPTILLSL 394

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 67/359 (18%), Positives = 112/359 (31%), Gaps = 119/359 (33%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ--------HRN 407
           KLG G F  V+    +   + +A+K + KS+    E   +E+ L+  ++           
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 408 LVRLLGC-----------CTLRDERMLIYEYLPNKSLEQFIFDVTRTKF-LDWSKRCQII 455
           +V+LL             C       +++E L    L ++I         L   K  +II
Sbjct: 103 VVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKSNYQGLPLPCVK--KII 152

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLL------------------------------ 485
           + + +GL YLH  ++ RIIH D+K  N+LL                              
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 486 -------------------DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
                                 +  KI+D G A       TE      + T  Y S E  
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVL 265

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKR------NRGFYHADHH----HNLLG----HAWRL 572
           I   ++  +D++S   +  E+  G           +   + H      LLG         
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325

Query: 573 WTE-----DRSLELIDKSLDGSYSLSEALR------------CIQVGLLCVQQRPEDRP 614
                    +  +L   +    + L E L                  L  ++  PE R 
Sbjct: 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 53/233 (22%), Positives = 86/233 (36%), Gaps = 60/233 (25%)

Query: 357 KLGEGGFGPVYRG--MLTEGQEIAVK------RLSKSSGQGVEEFKNEVLLIAKLQHR-- 406
            LGEG FG V         G+ +AVK      R  +++       ++E+ ++  L     
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVLEHLNTTDP 73

Query: 407 ----NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
                 V++L          +++E L   S   FI       FL +      I  +A  +
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFI---KENGFLPFR--LDHIRKMAYQI 127

Query: 463 L----YLHQDSRLRIIHRDLKASNVLLDNDMNP-------------------KISDFGMA 499
                +LH     ++ H DLK  N+L                          K+ DFG A
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
             +  D+  +    +V T  Y +PE  I  L +S   DV+S G +++E   G 
Sbjct: 185 -TY-DDEHHST---LVSTRHYRAPE-VILALGWSQPCDVWSIGCILIEYYLGF 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 56/227 (24%), Positives = 87/227 (38%), Gaps = 44/227 (19%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVK---RLSKSSGQGVEEFKNEVLLIAKLQHR-----N 407
           K+G+G FG V     +   +  AVK    + K +       K E  ++ K+Q+      N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRC--QIIEGIARGLLYL 465
           +V+  G     D   LI+E L   SL + I   TR  +  +           I + L YL
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPL-GPSLYEII---TRNNYNGFHIEDIKLYCIEILKALNYL 153

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR------------ 513
               ++ + H DLK  N+LLD+    K          G       T              
Sbjct: 154 R---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210

Query: 514 --------VVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
                   ++ T  Y +PE  I  L + V SD++SFG ++ E+  G 
Sbjct: 211 FKSDYHGSIINTRQYRAPE-VILNLGWDVSSDMWSFGCVLAELYTGS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 48/231 (20%), Positives = 86/231 (37%), Gaps = 56/231 (24%)

Query: 357 KLGEGGFGPVYRGM--LTEGQEIAVKRLSKSSGQGVEEFKN----EVLLIAKLQHR---- 406
            LGEG FG V   +       ++A+K +     + V +++     E+ ++ K++ +    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 407 --NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL- 463
               V +           + +E L  K+  +F+       F  +      +  +A  L  
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFL---KENNFQPYP--LPHVRHMAYQLCH 134

Query: 464 ---YLHQDSRLRIIHRDLKASNVLLDNDMNP-------------------KISDFGMARA 501
              +LH     ++ H DLK  N+L  N                       +++DFG A  
Sbjct: 135 ALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189

Query: 502 FGVDQTEANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
                 E +T  +V T  Y  PE  I  L ++   DV+S G ++ E   G 
Sbjct: 190 --TFDHEHHT-TIVATRHYRPPE-VILELGWAQPCDVWSIGCILFEYYRGF 236

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	669
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.03
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.94
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.85
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.59
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.54
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.37
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.27
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.25
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.02
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.88
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.85
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.82
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.7
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.43
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.32
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.31
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.29
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.29
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.21
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.11
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	97.05
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.88
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.82
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.6
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.5
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	95.57
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	95.37
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	95.31
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.27
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.97
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	92.33
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	90.98
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	85.35
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.02
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	84.88
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	84.12
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	83.44
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	83.21
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	83.03
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.38
1edm_B	39	Factor IX; epidermal growth factor, EGF, calcium-	80.62
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	80.23

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.3e-53  Score=442.31  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=207.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|.+.++||+|+||.||+|++.      +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46777899999999999999864      478899999987776777899999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          424 IYEYLPNKSLEQFIFDVT------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      ||||+++|+|.+++....            ....++|.+++.|+.|||+||+|||+.+   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999997532            2346999999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~  570 (669)
                      ||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||......   .++..  
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~--  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDC--  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHH--
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHH--
Confidence            9999999987654444444445679999999999999999999999999999999999 89996532211   11111  


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                                 +........+...+..+.+|+.+||+.||++||||+||++.|+.+..
T Consensus       273 -----------i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          273 -----------ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             -----------HHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----------HHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence                       11111112233445678899999999999999999999999988644

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-52  Score=434.91  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=212.0

Q ss_pred             CCCccCeeeecCccceEEEEeC------CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++.+.++||+|+||+||+|.+.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999963      46889999997543 3456789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc
Q 005933          424 IYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN  490 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~  490 (669)
                      ||||+++|+|.++|.....             ...++|.++++|+.|||+||+|||+.+   |+||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            9999999999999964321             245899999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHh
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA  569 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~  569 (669)
                      +||+|||+++.+.............||+.|||||++.++.++.++|||||||+||||+| |+.||.....   ..+..  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~--  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVE--  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHH--
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHH--
Confidence            99999999987654444444555789999999999999999999999999999999998 8888653321   11111  


Q ss_pred             hhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                                 .+......+.+...+..+.+|+.+||+.||++||||+||++.|+..
T Consensus       259 -----------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 -----------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                       1111111123344566788999999999999999999999999764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.6e-53  Score=436.12  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=213.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46778899999999999999864      378899999987766777899999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          424 IYEYLPNKSLEQFIFDVT----------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                      ||||+++|+|.++|....          ....++|.+++.++.|||+||+|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          3456999999999999999999999998   999999999999999999999


Q ss_pred             eecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhh
Q 005933          494 SDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       494 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      +|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||......   .+....   
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i---  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECI---  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH---
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence            99999987654443333444678999999999999999999999999999999998 89996533211   111111   


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                                ........+...+..+.+|+.+||+.||++||||+||++.|+..
T Consensus       244 ----------~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          244 ----------TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             ----------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                      11111122334456788999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-51  Score=425.20  Aligned_cols=259  Identities=24%  Similarity=0.409  Sum_probs=202.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .+++.+.++||+|+||+||+|+++  ..||||+++..  .....+.|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            357888999999999999999976  46999998643  33456789999999999999999999999865 56899999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++|+|.++|..  ....+++.+++.|+.|||+||+|||+.+   |+||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999954  3356999999999999999999999998   9999999999999999999999999998765444


Q ss_pred             cCcCcccccccCCccCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          507 TEANTDRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      .........||+.|||||++.+   ..|+.++|||||||+||||+||+.||.......  .+........        ..
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~~~~~~~~--------~~  256 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIFMVGRGY--------AS  256 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHTTC--------CC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCC--------CC
Confidence            4444455789999999999964   468999999999999999999999975322111  1111110000        01


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +.+ ...+...+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus       257 p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          257 PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111 112233456788999999999999999999999999765

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.3e-50  Score=417.57  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=208.4

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      +.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..+|||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56899999999999999999976 59999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++|+|.+++.+    ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+....  
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  224 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  224 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence            99999999854    34899999999999999999999999   9999999999999999999999999998764332  


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.....   ...+.....         .....+  
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~---------~~~~~~--  290 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRD---------NLPPRL--  290 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHH---------SSCCCC--
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHc---------CCCCCC--
Confidence            223457899999999999999999999999999999999999999753221   111111100         000001  


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111223457889999999999999999999976

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-50  Score=421.12  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=201.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.+.  .....+.|.+|+.+|++|+|||||++++++.+++..+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999965 5999999999754  23346789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++|+|.++|.. .+...+++.+++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999954 33455799999999999999999999999   9999999999999999999999999998753221


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                        ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.....   ..++...            +....
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i------------~~~~~  242 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLKI------------ISGSF  242 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHH------------HHTCC
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHH------------HcCCC
Confidence              122346799999999999999999999999999999999999999754221   1111111            00000


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1122233457889999999999999999999985

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.1e-50  Score=414.26  Aligned_cols=248  Identities=24%  Similarity=0.322  Sum_probs=209.2

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||+||+++.. +|+.||||++.+.   .....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999965 5899999999753   3445678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++.+   .+.+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999954   346999999999999999999999999   999999999999999999999999999987655


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .........+||+.|||||++.+..|+.++||||+||+||||++|+.||.....   ..+.....            ...
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~------------~~~  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKII------------KLE  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH------------HTC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH------------cCC
Confidence            444555567899999999999999999999999999999999999999753221   11111110            000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV  620 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  620 (669)
                      .  .++...+..+.+|+.+||+.||++|||++|++
T Consensus       251 ~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 Y--DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             C--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             C--CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            0  12222345678999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.4e-50  Score=420.78  Aligned_cols=269  Identities=27%  Similarity=0.378  Sum_probs=216.2

Q ss_pred             ccHHHHHHHhcCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccCc-cchHHHHHHHHHHHHhCC-CceeEE
Q 005933          340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQH-RNLVRL  411 (669)
Q Consensus       340 ~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l  411 (669)
                      ++..+.+...++|++.++||+|+||.||+|.+..      ++.||||++..... ...+.|.+|+.+|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3444444456789999999999999999999642      36799999976543 345789999999999965 899999


Q ss_pred             EEEEecC-CcceEEEeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecc
Q 005933          412 LGCCTLR-DERMLIYEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD  477 (669)
Q Consensus       412 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D  477 (669)
                      +|+|.+. +..+||||||++|+|.++|....             ....+++.+++.++.|||+||+|||+++   |+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999765 56899999999999999996532             1345899999999999999999999998   99999


Q ss_pred             CCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005933          478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGF  556 (669)
Q Consensus       478 ikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~  556 (669)
                      |||+||||++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999997755444444455678999999999999999999999999999999998 8999754


Q ss_pred             CCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          557 YHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .....  .+.             ..+........+...+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus       291 ~~~~~--~~~-------------~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          291 VKIDE--EFC-------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CCCSH--HHH-------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHH--HHH-------------HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            32211  111             11111111122333456788999999999999999999999998764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.3e-50  Score=416.86  Aligned_cols=251  Identities=25%  Similarity=0.261  Sum_probs=202.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      +.|.+.++||+|+||.||+|+.. +|+.||||+++....     +.+|+.+++.++|||||++++++.+++..+|||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            46788899999999999999975 489999999965322     247999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeecCCCcccCCCcc
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGVDQT  507 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla~~~~~~~~  507 (669)
                      ++|+|.++|.+   .+.+++.++..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+|+.+.....
T Consensus       133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999954   346999999999999999999999998   99999999999999988 699999999997654322


Q ss_pred             C---cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          508 E---ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       508 ~---~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .   ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +......   .....     
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~---~~~~~-----  275 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIAS---EPPPI-----  275 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHHH---SCCGG-----
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHc---CCCCc-----
Confidence            1   12234679999999999999999999999999999999999999976433221   1111110   00000     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                         ...+...+..+.+++.+||+.||++|||+.|+++.|..
T Consensus       276 ---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          276 ---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             ---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence               01122334678899999999999999999999987754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-49  Score=412.19  Aligned_cols=270  Identities=21%  Similarity=0.256  Sum_probs=199.0

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCC----cceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----ERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~  425 (669)
                      ++|.+.++||+|+||+||+|+++ |+.||||+++.... ....+..|+..+.+++|||||+++|++.+++    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            45778899999999999999985 89999999964322 2223345666677889999999999998764    468999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      ||+++|+|.++|..    ..++|..+++++.|+++||+|||++     ..++|+||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999954    3489999999999999999999987     12359999999999999999999999999998


Q ss_pred             ccCCCccC--cCcccccccCCccCchhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          501 AFGVDQTE--ANTDRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       501 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      ........  .......||+.|||||++.+.      .++.++|||||||+||||+||.+|+.......... .......
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~~  235 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSD  235 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCSS
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhccccc
Confidence            76443322  223346799999999999764      36789999999999999999988765332211100 0000000


Q ss_pred             cccccc-hhhcccccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          573 WTEDRS-LELIDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       573 ~~~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ...... ..+....+.+..     +.+.+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            000000 011112222222     224556788999999999999999999999999764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=418.76  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=208.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            357999999999999999999975 5999999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|.+++..    ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+.... 
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            999999999853    34899999999999999999999999   9999999999999999999999999998764332 


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.....   ...+....         ......+.
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~---------~~~~~~~~  368 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIR---------DNLPPRLK  368 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH---------HSCCCCCS
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHH---------cCCCCCCc
Confidence             223457899999999999999999999999999999999999999753221   11111110         00011111


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        .....+..+.+|+.+||+.||++|||+.|+++
T Consensus       369 --~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              11123456889999999999999999999976

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.9e-48  Score=395.45  Aligned_cols=245  Identities=23%  Similarity=0.370  Sum_probs=190.2

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||+||++... +|+.||||++.+..   ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999965 59999999997542   334678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+ +|+|.+++.+   .+.+++.++..++.||+.||+|||+++   |+||||||+||||++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6899999854   346999999999999999999999999   999999999999999999999999999865332


Q ss_pred             ccCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .   ......||+.|||||++.+..+ +.++||||+||+||||++|+.||.....   ..+.....            ..
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~------------~~  227 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNIS------------NG  227 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH------------HT
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH------------cC
Confidence            2   2334689999999999998876 5799999999999999999999753211   11111110            00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  ..++...+..+.+|+.+||+.||++|||++|+++
T Consensus       228 ~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          228 V--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0  0112223456789999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-48  Score=398.57  Aligned_cols=246  Identities=24%  Similarity=0.386  Sum_probs=194.8

Q ss_pred             CccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEec----CCcceEEE
Q 005933          353 SWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERMLIY  425 (669)
Q Consensus       353 ~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~  425 (669)
                      .+.++||+|+||+||+|... +++.||||++...  .....+.|.+|+.++++|+|||||++++++..    ....+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999975 4889999999654  33446789999999999999999999999865    34578999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~~~~  504 (669)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||+|||+++ .+|+||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999954   356899999999999999999999976 35999999999999984 79999999999986432


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                          ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.....  ...+.    ..........    
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~----~~i~~~~~~~----  249 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIY----RRVTSGVKPA----  249 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHH----HHHTTTCCCG----
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHH----HHHHcCCCCC----
Confidence                22334689999999998864 699999999999999999999999753211  11111    1111000000    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                          ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus       250 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                011112346789999999999999999999985

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.1e-48  Score=402.72  Aligned_cols=247  Identities=23%  Similarity=0.273  Sum_probs=195.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC----CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|++.+.||+|+||+||+++..    .++.||||++++..  .....++.+|+.+|++++|||||++++++.+++..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999852    37889999997542  2334578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++.+   .+.+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999954   345999999999999999999999999   9999999999999999999999999998653


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ...  ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.....   ..+....            ..
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i------------~~  240 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMI------------LK  240 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH------------HH
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHH------------Hc
Confidence            222  223346899999999999999999999999999999999999999753221   1111111            00


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNM-----SSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  621 (669)
                      ...  .++...+..+.+|+.+||+.||++|||+     +|+++
T Consensus       241 ~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          241 AKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            011  1222234578899999999999999984     66664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.6e-47  Score=391.85  Aligned_cols=248  Identities=24%  Similarity=0.357  Sum_probs=189.2

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCc-------
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-------  420 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------  420 (669)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.+|++|+|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46889999999999999999965 589999999975443 345789999999999999999999999876543       


Q ss_pred             -----ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEee
Q 005933          421 -----RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD  495 (669)
Q Consensus       421 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  495 (669)
                           .++||||+++|+|.+++.........++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 6899999999999999976544455677889999999999999999998   99999999999999999999999


Q ss_pred             cCCCcccCCCccCc----------CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccch
Q 005933          496 FGMARAFGVDQTEA----------NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL  565 (669)
Q Consensus       496 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~  565 (669)
                      ||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||+||||++   |+..  ..   ..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~--~~---~~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST--QM---ER  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS--HH---HH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC--cc---HH
Confidence            99998775432211          1233579999999999999999999999999999999996   4321  00   00


Q ss_pred             hhHhhhhcccccchhhcccccCCCCCH---HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          566 LGHAWRLWTEDRSLELIDKSLDGSYSL---SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .             ..+........+.   .....+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~-------------~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 V-------------RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H-------------HHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-------------HHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0             0000011112221   22345678999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.9e-45  Score=380.91  Aligned_cols=283  Identities=35%  Similarity=0.601  Sum_probs=241.4

Q ss_pred             HHHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       343 ~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      .++...+++|.+.+.||+|+||.||+|...+++.||||++........+.+.+|+.+++.++||||+++++++...+..+
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            34455778999999999999999999998889999999987776667789999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          423 LIYEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      +||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+   |+||||||+||+|+.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence            99999999999999965332 235899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ..............||..|+|||++.+..++.++||||||+++|||++|+.|+....+........+.............
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI  268 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence            54333333334456899999999999999999999999999999999999998766555555555554444444555556


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      +++.+........+..+.+++.+||+.||++|||+.||++.|+....
T Consensus       269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            66666666777888899999999999999999999999999987543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=385.67  Aligned_cols=263  Identities=20%  Similarity=0.307  Sum_probs=201.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEec------CC
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTL------RD  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~  419 (669)
                      .++|++.++||+|+||.||+|+.. +|+.||||++.+...  ...+.+.+|+.+|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999975 599999999975432  345678899999999999999999998754      35


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..+|||||++ |+|.+++.   +.+.+++.++..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            6899999996 67999984   4457999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCc--cCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          500 RAFGVDQ--TEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       500 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      +.+....  ........+||+.|+|||++.+. .++.++||||+||++|||++|++||.......   .+..........
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p  282 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTP  282 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCC
Confidence            8764332  22334457899999999998876 56999999999999999999999976433211   111111110000


Q ss_pred             -----------cchhhccccc-CCCCCHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 -----------RSLELIDKSL-DGSYSLS-----EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 -----------~~~~~~~~~~-~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                 .....+.... ....+..     ....+.+|+.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                       0000000000 0111111     1346789999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-43  Score=372.77  Aligned_cols=291  Identities=42%  Similarity=0.681  Sum_probs=244.1

Q ss_pred             CCCccHHHHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEE
Q 005933          337 LPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCC  415 (669)
Q Consensus       337 ~~~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~  415 (669)
                      +..++..++....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            456888999999999999999999999999999988899999999975432 2344789999999999999999999999


Q ss_pred             ecCCcceEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEe
Q 005933          416 TLRDERMLIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS  494 (669)
Q Consensus       416 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  494 (669)
                      ...+..++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+....+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997543 33459999999999999999999999922229999999999999999999999


Q ss_pred             ecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCCccchhhHhhhh
Q 005933          495 DFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH--ADHHHNLLGHAWRL  572 (669)
Q Consensus       495 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~--~~~~~~~~~~~~~~  572 (669)
                      |||++........ .......||..|+|||++.+..++.++||||||+++|||++|+.|+....  .........+....
T Consensus       177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            9999987643322 22333568999999999999999999999999999999999999975322  22233444455555


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ........+.+..+........+..+.+++.+||+.||++|||+.||++.|++...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            55666667777777777888888999999999999999999999999999987544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.2e-44  Score=377.44  Aligned_cols=201  Identities=24%  Similarity=0.371  Sum_probs=172.1

Q ss_pred             HHHHHhcCCCccCeeeecCccceEEEEeC----CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecC
Q 005933          344 TIADATDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR  418 (669)
Q Consensus       344 ~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  418 (669)
                      .+....++|++.++||+|+||+||+|+.+    .++.||||++....  ...++.+|+.+|..+ +||||+++++++.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            33445688999999999999999999853    47889999986543  346788999999998 699999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-cceEEeecC
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFG  497 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~Dfg  497 (669)
                      +..+|||||+++|+|.+++.      .+++.++..++.||+.||+|||+++   |+||||||+||||+.+ +.+||+|||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            99999999999999999982      3899999999999999999999999   9999999999999876 799999999


Q ss_pred             CCcccCCCccC--------------------------cCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhC
Q 005933          498 MARAFGVDQTE--------------------------ANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCG  550 (669)
Q Consensus       498 la~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG  550 (669)
                      +|+........                          ......+||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            99865432110                          112235799999999999876 589999999999999999999


Q ss_pred             CCCCC
Q 005933          551 KRNRG  555 (669)
Q Consensus       551 ~~p~~  555 (669)
                      +.||.
T Consensus       244 ~~Pf~  248 (361)
T 4f9c_A          244 RYPFY  248 (361)
T ss_dssp             CSSSS
T ss_pred             CCCCC
Confidence            99974

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.2e-43  Score=395.07  Aligned_cols=252  Identities=22%  Similarity=0.324  Sum_probs=207.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|++.+.||+|+||.||+++.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+....+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999975 5999999999776666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC--cceEEeecCCCcccCCC
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND--MNPKISDFGMARAFGVD  505 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~--~~~kl~Dfgla~~~~~~  505 (669)
                      +++|+|.++|.+  +...+++.++..++.||+.||.|||+++   |+||||||+||||+.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999843  3456999999999999999999999999   9999999999999854  89999999999986433


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .   .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......   ..+......          +..
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~~----------~~~  374 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSC----------DWN  374 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTT----------CCC
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHhC----------CCC
Confidence            2   223467999999999999999999999999999999999999997532211   111111000          000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +........+..+.+|+.+||+.||++|||+.|+++
T Consensus       375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000112356789999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.2e-41  Score=354.07  Aligned_cols=285  Identities=34%  Similarity=0.556  Sum_probs=231.3

Q ss_pred             CCCCCccHHHHHHHhcCCCcc------CeeeecCccceEEEEeCCCcEEEEEEecccC----ccchHHHHHHHHHHHHhC
Q 005933          335 MELPMFDWNTIADATDNFSWK------NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQ  404 (669)
Q Consensus       335 ~~~~~~~~~~l~~~~~~~~~~------~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~  404 (669)
                      ...+.|++.++..++++|...      ++||+|+||.||+|.. +++.||||++....    ....+.+.+|+.+++.++
T Consensus        10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            345678999999999998877      8999999999999997 48899999986532    334678999999999999


Q ss_pred             CCceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEE
Q 005933          405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL  484 (669)
Q Consensus       405 h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIl  484 (669)
                      ||||+++++++...+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+   ++||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            99999999999999999999999999999999976555567999999999999999999999998   999999999999


Q ss_pred             EcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 005933          485 LDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN  564 (669)
Q Consensus       485 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~  564 (669)
                      ++.++.+||+|||++................|+..|+|||.+.+ .++.++||||||+++|+|++|..|+..........
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            99999999999999987654333333444678999999998865 58899999999999999999999976543322111


Q ss_pred             hhhHhhhh-cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          565 LLGHAWRL-WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       565 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                        ...... .......+.++..+ ...+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       245 --~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          245 --DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             --HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             --HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence              111111 11112233333333 2345667788999999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6e-43  Score=390.58  Aligned_cols=249  Identities=24%  Similarity=0.286  Sum_probs=199.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHH---HHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNE---VLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E---~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|++.+.||+|+||.||+++.. +|+.||||++.+.   .......+.+|   +.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            468999999999999999999976 4999999999653   12233344444   5566667899999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      +|||||++||+|.++|.+   .+.+++..+..++.||+.||.|||+++   |+||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999954   345999999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      +...    .....+||+.|||||++.. ..|+.++|||||||+||||++|++||..........+...            
T Consensus       342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~------------  405 (689)
T 3v5w_A          342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------  405 (689)
T ss_dssp             CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH------------
T ss_pred             cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------
Confidence            6432    2334689999999999975 5799999999999999999999999754322211111100            


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      ....  ...++...+..+.+|+.+||+.||++|++     ++||++
T Consensus       406 i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          406 TLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             hcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            0000  11122233456889999999999999998     677764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-41  Score=364.10  Aligned_cols=259  Identities=27%  Similarity=0.405  Sum_probs=211.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC--------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecC
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR  418 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  418 (669)
                      .++|.+.+.||+|+||.||+|...        ++..||||++.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467889999999999999999852        35679999997543 33467899999999999 899999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999975432             245899999999999999999999998   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  564 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~  564 (669)
                      +.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |+.|+......   .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence            9999999999999987654433333444567889999999999999999999999999999999 88886542211   1


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +..             .+........+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       314 ~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          314 LFK-------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             HHH-------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH-------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111             1111111122333456788999999999999999999999999865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.6e-42  Score=358.76  Aligned_cols=262  Identities=27%  Similarity=0.421  Sum_probs=204.3

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..++|++.++||+|+||.||+|.. .++.||||++....  ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356889999999999999999987 48899999987543  234568999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999965433345899999999999999999999976 34999999999999999999999999999764322


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .  .......||..|+|||++.+..++.++||||||+++|||++|+.|+.......   .....            ....
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~------------~~~~  255 (309)
T 3p86_A          193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAV------------GFKC  255 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHH------------HHSC
T ss_pred             c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH------------HhcC
Confidence            1  12234578999999999999999999999999999999999999975332111   00000            0001


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      .....+...+..+.+|+.+||+.||++|||+.++++.|+....
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1112223344578899999999999999999999999987643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9e-42  Score=355.77  Aligned_cols=259  Identities=26%  Similarity=0.418  Sum_probs=211.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|.+.++||+|+||+||++... +++.||+|++........+.|.+|+.+++.++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357888999999999999999975 4899999999776667788999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++...  ...+++.+++.++.||++||+|||+.+   |+||||||+||||+.++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999653  345899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             Cc------------CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc
Q 005933          508 EA------------NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       508 ~~------------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+............         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------  234 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------  234 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---------
Confidence            11            111457899999999999999999999999999999999999886643332211100         


Q ss_pred             ccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                       ......+...    +...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       235 -~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          235 -NVRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             -CHHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -hhhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             0011111111    112234578999999999999999999999999876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.9e-42  Score=358.35  Aligned_cols=269  Identities=23%  Similarity=0.341  Sum_probs=208.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc----ceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE----RMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~lV  424 (669)
                      .++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.....    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999986 7999999996533 334556779999999999999999999987554    5999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCceeccCCCCCEEEcCCcceEEe
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD----------SRLRIIHRDLKASNVLLDNDMNPKIS  494 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------~~~~iiH~Dikp~NIll~~~~~~kl~  494 (669)
                      |||+++|+|.+++..    ..+++..++.++.||+.||+|||+.          +   |+||||||+||||+.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999954    3489999999999999999999998          7   9999999999999999999999


Q ss_pred             ecCCCcccCCCccCcCcccccccCCccCchhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh
Q 005933          495 DFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  569 (669)
Q Consensus       495 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~  569 (669)
                      |||+++.+.............||+.|+|||++.+.     .++.++|||||||++|||++|+.|+...............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999877554444444456799999999999873     4567899999999999999999997654332221111110


Q ss_pred             hhhcccccchhh-cccccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          570 WRLWTEDRSLEL-IDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       570 ~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..........+. .........     ....+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            000000011111 111111111     123456789999999999999999999999999865

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4e-41  Score=348.83  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|++.++||+|+||+||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999996 45899999999776666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999954    24899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.......   ..   ......        ....
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~---~~~~~~--------~~~~  235 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---AL---YLIATN--------GTPE  235 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHHHHH--------CSCC
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhC--------CCCC
Confidence              2334678999999999999999999999999999999999999965322110   00   000000        0001


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1112233456889999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=356.92  Aligned_cols=261  Identities=26%  Similarity=0.411  Sum_probs=209.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC----CCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|.+.+.||+|+||.||+|.+.    .+..||||++... .....+.|.+|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357888999999999999999974    3556999999754 33446789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999953  3345999999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          504 VDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       504 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ..... .......+|..|+|||++.+..++.++||||||+++|||++ |..|+......   ...             ..
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~-------------~~  266 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVI-------------SS  266 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH-------------HH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHH-------------HH
Confidence            43221 12223445778999999999999999999999999999999 99886432211   111             11


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP  630 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  630 (669)
                      +........+...+..+.+|+.+||+.||++||++.+|++.|+.....+
T Consensus       267 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            1111111223344567889999999999999999999999998865433

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-40  Score=349.77  Aligned_cols=262  Identities=24%  Similarity=0.333  Sum_probs=213.9

Q ss_pred             CCccHHHHHHHhcC----------CCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCC
Q 005933          338 PMFDWNTIADATDN----------FSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR  406 (669)
Q Consensus       338 ~~~~~~~l~~~~~~----------~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  406 (669)
                      +.++++++..+++.          |...++||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45788888777754          667789999999999999976 6999999999876667778899999999999999


Q ss_pred             ceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc
Q 005933          407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD  486 (669)
Q Consensus       407 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~  486 (669)
                      ||+++++++...+..++||||+++++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            999999999999999999999999999999842    35899999999999999999999998   99999999999999


Q ss_pred             CCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchh
Q 005933          487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL  566 (669)
Q Consensus       487 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~  566 (669)
                      .++.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+......   ...
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH
T ss_pred             CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence            999999999999987643221  223467899999999999999999999999999999999999996532211   111


Q ss_pred             hHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          567 GHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ...    .     ....+.+  ......+..+.+++.+||+.||++|||+.++++.
T Consensus       251 ~~~----~-----~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 KRL----R-----DSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHH----H-----HSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHH----h-----cCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000    0     0000001  0111234568899999999999999999999873

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=362.90  Aligned_cols=272  Identities=27%  Similarity=0.400  Sum_probs=217.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC--------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecC
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR  418 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  418 (669)
                      .++|.+.++||+|+||.||+|...        .+..||||++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468889999999999999999952        24679999997543 33457899999999999 899999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+.+   |+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999975432             245899999999999999999999998   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  564 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~  564 (669)
                      +.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |..|+......   .
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence            9999999999999987654443334444567889999999999999999999999999999999 88886532211   1


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCccc
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFT  639 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~p~~p~~~~  639 (669)
                      +             .+.+........+...+..+.+|+.+||+.||++||++.||++.|+.+.+.......+.+.
T Consensus       302 ~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~  363 (382)
T 3tt0_A          302 L-------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYH  363 (382)
T ss_dssp             H-------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-----
T ss_pred             H-------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCC
Confidence            1             1111111111222334467889999999999999999999999999886655545555544

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.3e-42  Score=354.25  Aligned_cols=273  Identities=26%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             hcCCCccCeeeecCccceEEEEe-----CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecC--Ccc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~  421 (669)
                      .++|++.++||+|+||.||++.+     .+++.||||++........+.+.+|+.+++.++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46788999999999999999984     35889999999876666678899999999999999999999998654  558


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999643  335899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+...................+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6433221 222234567789999999999999999999999999999999988543211000000000000000001111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .+........+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111112223334456788999999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-41  Score=360.10  Aligned_cols=270  Identities=27%  Similarity=0.382  Sum_probs=214.9

Q ss_pred             CccHHHHHHHhcCCCccCeeeecCccceEEEEe------CCCcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeE
Q 005933          339 MFDWNTIADATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVR  410 (669)
Q Consensus       339 ~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~  410 (669)
                      .+.........++|.+.++||+|+||.||+|.+      .+++.||||++..... ...+.+.+|+.++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            345555566678999999999999999999984      2368899999976433 3456799999999999 7999999


Q ss_pred             EEEEEecCCc-ceEEEeecCCCCHHHHhhccCC-----------------------------------------------
Q 005933          411 LLGCCTLRDE-RMLIYEYLPNKSLEQFIFDVTR-----------------------------------------------  442 (669)
Q Consensus       411 l~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------  442 (669)
                      +++++.+.+. .++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987655 8999999999999999975432                                               


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          443 ----------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       443 ----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                                      ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++..+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            222899999999999999999999998   9999999999999999999999999998764443


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .........+|..|+|||++.+..++.++||||||+++|||++ |..|+........  ..             ..+...
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~-------------~~~~~~  312 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC-------------RRLKEG  312 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HH-------------HHHHHT
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HH-------------HHHHcC
Confidence            3333445678899999999999999999999999999999998 9998654322110  00             011111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .....+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11112223345688999999999999999999999999754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-41  Score=365.30  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=208.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|.+.+.||+|+||.||+|... +++.||||++..... ...+.|.+|+.+++.++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888999999999999999986 689999999875432 344678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999642  335899999999999999999999998   9999999999999999999999999998654332


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .........++..|+|||++....++.++||||||+++|||++ |..|+.......   .             .+.+...
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~-------------~~~~~~~  331 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---T-------------REFVEKG  331 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---H-------------HHHHHTT
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H-------------HHHHHcC
Confidence            2222222345778999999999999999999999999999998 888865322110   0             1111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .....+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            11122233456788999999999999999999999999764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8e-41  Score=350.84  Aligned_cols=254  Identities=24%  Similarity=0.330  Sum_probs=204.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999976 68999999986443 2335678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++.   ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999983   3455999999999999999999999998   9999999999999999999999999998764443


Q ss_pred             cCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .........||+.|+|||++.+..+ +.++||||||+++|||++|+.|+........  .. ..   +.        ...
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~-~~---~~--------~~~  225 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY-SD---WK--------EKK  225 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HH-HH---HH--------TTC
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HH-HH---Hh--------ccc
Confidence            3333445689999999999988775 7799999999999999999999764332211  00 00   00        000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0001112234567899999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.4e-41  Score=353.28  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=205.3

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999997 46999999999754  2334677899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999999543   45899999999999999999999998   999999999999999999999999999865432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .   ......||+.|+|||++.+..+. .++|||||||++|||++|+.|+......   .+...            +...
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~------------i~~~  229 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRER------------VLRG  229 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH------------HHHC
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHH------------HHhC
Confidence            2   23446799999999999988765 8999999999999999999997532211   11100            0000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .  ...+...+..+.+|+.+||+.||++|||++|+++-
T Consensus       230 ~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          230 K--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             C--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0  11222334578899999999999999999999863

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6e-41  Score=342.08  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=209.0

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|++.+.||+|+||.||++...+++.||||++.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            5788899999999999999999889999999996543 345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++..  ....+++..++.++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++........ .
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  162 (269)
T 4hcu_A           89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  162 (269)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence            9999999954  3346899999999999999999999998   99999999999999999999999999986543221 1


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+......   .....             +......
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~-------------~~~~~~~  226 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED-------------ISTGFRL  226 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH-------------HHTTCCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH-------------HhcCccC
Confidence            2233456778999999999999999999999999999999 88886532211   11100             0111111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            12222345688999999999999999999999999764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4e-41  Score=360.10  Aligned_cols=257  Identities=27%  Similarity=0.446  Sum_probs=197.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC----CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|.+.+.||+|+||.||+|+..    ++..||||++.... ....+.|.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999965    47789999997543 3446789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999954  3346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccCc-CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          504 VDQTEA-NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       504 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ...... ......++..|+|||++.+..++.++||||||+++|||++ |+.|+......   ..             ...
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~-------------~~~  262 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DV-------------IKA  262 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HH-------------HHH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH-------------HHH
Confidence            332211 1222345778999999999999999999999999999998 99886432211   11             111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +........+...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus       263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            111111122334456788999999999999999999999999865

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.6e-41  Score=340.27  Aligned_cols=257  Identities=27%  Similarity=0.402  Sum_probs=210.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|++.+.||+|+||.||++...++..||||++.... ...+++.+|+.++.+++||||+++++++......++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            46788999999999999999999988899999996543 34578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999999643  335899999999999999999999998   999999999999999999999999999875433221


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......   ....             +.....
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~-------------~~~~~~  223 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVLK-------------VSQGHR  223 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH-------------HHTTCC
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HHHH-------------HHcCCC
Confidence             1223456778999999999899999999999999999999 998865332111   0000             000001


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ...+...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            11122224568899999999999999999999999988654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.3e-41  Score=353.52  Aligned_cols=256  Identities=25%  Similarity=0.437  Sum_probs=201.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCc----EEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      .++|++.+.||+|+||.||+|... +++    +||+|.+... .....++|.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            357888999999999999999964 344    4688887543 3345678999999999999999999999998754 78


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +|+||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999999653  345899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .............+|..|+|||++.+..++.++||||||+++|||++ |+.|+.......                ....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~  231 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI  231 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----------------HHHH
Confidence            55444434444567889999999999999999999999999999999 999865432211                1111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +........+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111222333456788999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-41  Score=353.77  Aligned_cols=263  Identities=25%  Similarity=0.412  Sum_probs=212.4

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD  419 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  419 (669)
                      ...++|.+.+.||+|+||.||+|...      +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34678999999999999999999975      34889999997543 334678999999999999999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTR---------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDL  478 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Di  478 (669)
                      ..++||||+++|+|.+++.....                     ...+++.+++.++.||++||.|||+++   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999999975322                     256899999999999999999999998   999999


Q ss_pred             CCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005933          479 KASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFY  557 (669)
Q Consensus       479 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~  557 (669)
                      ||+||||+.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987644333233334567889999999999999999999999999999999 88886432


Q ss_pred             CCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          558 HADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ...   .....    ....         .....+...+..+.+++.+||+.||++||++.+|++.|+....
T Consensus       281 ~~~---~~~~~----~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          281 AHE---EVIYY----VRDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             CHH---HHHHH----HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ChH---HHHHH----HhCC---------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            111   11100    0000         0011222334578899999999999999999999999988644

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-40  Score=347.25  Aligned_cols=259  Identities=26%  Similarity=0.413  Sum_probs=211.8

Q ss_pred             hcCCCccCeeeecCccceEEEEe------CCCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|.+.+.||+|+||.||++..      .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            56888999999999999999986      235889999997543 34467899999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCC
Q 005933          422 MLIYEYLPNKSLEQFIFDVTR---------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA  480 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp  480 (669)
                      ++||||+++++|.+++.....                     ...+++..++.++.||+.||.|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                     234899999999999999999999998   99999999


Q ss_pred             CCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005933          481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHA  559 (669)
Q Consensus       481 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~  559 (669)
                      +|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654433333344567888999999999999999999999999999999 9888653322


Q ss_pred             CCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          560 DHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..   +.             ..+........+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       259 ~~---~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          259 ER---LF-------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GG---HH-------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH---HH-------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11   11             11111111122233456788999999999999999999999999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=351.51  Aligned_cols=263  Identities=27%  Similarity=0.433  Sum_probs=210.2

Q ss_pred             HhcCCCccCeeeecCccceEEEEe------CCCcEEEEEEeccc-CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD  419 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  419 (669)
                      ..++|.+.+.||+|+||.||+|..      .++..||||++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            357899999999999999999996      23668999999754 334567899999999999 8999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRT--------------------KFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK  479 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dik  479 (669)
                      ..++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999653321                    34899999999999999999999998   9999999


Q ss_pred             CCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 005933          480 ASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYH  558 (669)
Q Consensus       480 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~  558 (669)
                      |+||||+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987644333333334567889999999999999999999999999999998 988865432


Q ss_pred             CCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ....  .             ...+........+...+..+.+|+.+||+.||.+||++.+|++.|+....
T Consensus       280 ~~~~--~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          280 VDAN--F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CSHH--H-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cHHH--H-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            2110  0             01111111112223335678899999999999999999999999987543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=358.97  Aligned_cols=259  Identities=29%  Similarity=0.435  Sum_probs=208.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC------CCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|.+.+.||+|+||.||+|.+.      +++.||||++... .......+.+|+.+++.++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357888999999999999999953      3678999999654 334456789999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc---ceEEe
Q 005933          422 MLIYEYLPNKSLEQFIFDVT----RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKIS  494 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~  494 (669)
                      ++||||+++|+|.+++....    ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997543    2245899999999999999999999998   99999999999999555   59999


Q ss_pred             ecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhc
Q 005933          495 DFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       495 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      |||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..|+......   .+.       
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~-------  296 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL-------  296 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH-------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH-------
Confidence            9999986533333333344567899999999999999999999999999999998 88886532211   111       


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                            +.+........+...+..+.+|+.+||+.||++||++.+|++.|+..
T Consensus       297 ------~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          297 ------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             ------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                  11111111112223345688999999999999999999999999765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=341.44  Aligned_cols=273  Identities=21%  Similarity=0.266  Sum_probs=213.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC--cceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--ERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3578899999999999999999765 8999999997543 344678899999999999999999999998765  67999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE----cCCcceEEeecCCCc
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMAR  500 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~Dfgla~  500 (669)
                      |||+++++|.+++........+++..++.++.||+.||+|||+.+   |+||||||+||||    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976555555999999999999999999999998   9999999999999    788899999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-cchhhHhhh
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAI--------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH-HNLLGHAWR  571 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~-~~~~~~~~~  571 (669)
                      ......   ......+|..|+|||++.        +..++.++|||||||++|||++|+.||........ .........
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            764332   223356899999999986        57889999999999999999999999754332221 111111111


Q ss_pred             hcccccchhh-------c----ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          572 LWTEDRSLEL-------I----DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       572 ~~~~~~~~~~-------~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      .........+       +    ...............+.+++.+||+.||++|||++|+++-.+...
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            1100000000       0    001112344566778899999999999999999999999887543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-40  Score=348.85  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=200.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE------  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------  420 (669)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467889999999999999999986 69999999997543 3456789999999999999999999999866542      


Q ss_pred             ---------------------------------------------------ceEEEeecCCCCHHHHhhccCCCCCCCHH
Q 005933          421 ---------------------------------------------------RMLIYEYLPNKSLEQFIFDVTRTKFLDWS  449 (669)
Q Consensus       421 ---------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~  449 (669)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               78999999999999999766555667888


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC----------cCcccccccCC
Q 005933          450 KRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE----------ANTDRVVGTYG  519 (669)
Q Consensus       450 ~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~  519 (669)
                      .++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++.........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999998   999999999999999999999999999876543211          12234578999


Q ss_pred             ccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCC---HHHHH
Q 005933          520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS---LSEAL  596 (669)
Q Consensus       520 y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  596 (669)
                      |+|||++.+..++.++||||||+++|||++|..|..        ..             ............+   .....
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~-------------~~~~~~~~~~~~~~~~~~~~~  300 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ER-------------VRIITDVRNLKFPLLFTQKYP  300 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HH-------------HHHHHHHHTTCCCHHHHHHCH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HH-------------HHHHHHhhccCCCcccccCCh
Confidence            999999999999999999999999999999866511        00             0011111111122   12335


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          597 RCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       597 ~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .+.+++.+||+.||++||++.|+++
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhh
Confidence            6789999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.5e-40  Score=349.27  Aligned_cols=248  Identities=22%  Similarity=0.302  Sum_probs=204.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc------chHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ------GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      ..+.|.+.+.||+|+||.||++... +|+.||||++.+....      ..+.+.+|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3468999999999999999999976 4899999999764321      35789999999999999999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc----ceEEeec
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDF  496 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~Df  496 (669)
                      .++||||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999994   3456999999999999999999999998   99999999999998877    7999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      |++..+....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ......       
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~i-------  230 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANI-------  230 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH-------
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-------
Confidence            9998764322   233467999999999999999999999999999999999999996532111   111000       


Q ss_pred             cchhhcccccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 RSLELIDKSLDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                           ...  ...++.    ..+..+.+++.+||+.||++|||+.|+++
T Consensus       231 -----~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          231 -----TAV--SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -----HTT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----Hhc--CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 000  001111    12346789999999999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-40  Score=368.53  Aligned_cols=257  Identities=27%  Similarity=0.425  Sum_probs=212.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|.+.++||+|+||.||+|.+.. +..||||++... ....++|.+|+.++++++||||+++++++...+..+|||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4578889999999999999999875 889999999654 34578899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|.+++... ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus       298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            9999999999653 3345899999999999999999999998   99999999999999999999999999987643221


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                       .......++..|+|||++....++.++||||||++||||++ |..|+......   .+             .+.+....
T Consensus       374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~-------------~~~~~~~~  436 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QV-------------YELLEKDY  436 (495)
T ss_dssp             -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GH-------------HHHHHTTC
T ss_pred             -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HH-------------HHHHHcCC
Confidence             12223456788999999999999999999999999999999 88886533211   11             11111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ....+...+..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus       437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            22223344567889999999999999999999999998763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.7e-40  Score=342.07  Aligned_cols=263  Identities=24%  Similarity=0.331  Sum_probs=206.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++.+.||+|+||.||++... +++.||||++....   ....+.+.+|+.++..++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999965 58999999986533   23457889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999999543   45899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+......      .......... .... ..
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~-~~~~-~~  234 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDS-VPNV-TT  234 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSC-CCCH-HH
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhcc-CCCc-ch
Confidence            221 2233457899999999999999999999999999999999999997532211      0011111000 0000 00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhcCCCCCC
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGERSLP  630 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  630 (669)
                          ......+..+.+++.+||+.||++|| +++++.+.|+....-.
T Consensus       235 ----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          235 ----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             ----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             ----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence                01112345688999999999999999 9999999998765433

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.1e-41  Score=366.96  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=210.3

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..++|.+.++||+|+||.||+|.++++..||||++... ....+.|.+|+.+++.++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            45678899999999999999999988999999999654 345789999999999999999999999986 6678999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|.+++... ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus       264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            9999999999542 1235789999999999999999999998   99999999999999999999999999987643221


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                       .......++..|+|||++....++.++||||||++||||++ |+.|+......   .....             +....
T Consensus       340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~-------------i~~~~  402 (454)
T 1qcf_A          340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA-------------LERGY  402 (454)
T ss_dssp             -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH-------------HHHTC
T ss_pred             -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH-------------HHcCC
Confidence             11223446788999999999999999999999999999999 99886532211   11111             11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ....+...+..+.+|+.+||+.||++|||+.+|++.|+....
T Consensus       403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            112223345678899999999999999999999999988643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.2e-40  Score=345.34  Aligned_cols=260  Identities=26%  Similarity=0.421  Sum_probs=211.7

Q ss_pred             hcCCCccCeeeecCccceEEEEe------CCCcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  420 (669)
                      .++|.+.+.||+|+||.||+|..      .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46788999999999999999985      2478899999975433 3457899999999999 89999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTR---------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                      .++||||+++|+|.+++.....               ...+++..++.++.||+.||.|||+.+   |+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999975432               224899999999999999999999998   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  564 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~  564 (669)
                      +.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+........  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence            9999999999999987654443333334567889999999999999999999999999999999 8888654322110  


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                       .            ...+........+...+..+.+++.+||+.||.+|||+.|+++.|+..
T Consensus       257 -~------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 -F------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             -H------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -H------------HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence             0            011111111112223346788999999999999999999999999764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=343.59  Aligned_cols=266  Identities=23%  Similarity=0.397  Sum_probs=204.2

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|++.+.||+|+||.||++... ++.||||++..  ....+.|.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            57888899999999999999986 78999999854  334678999999999999999999999886  45899999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc-eEEeecCCCcccCCCccC
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-PKISDFGMARAFGVDQTE  508 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~-~kl~Dfgla~~~~~~~~~  508 (669)
                      +++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+||||+.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976544456889999999999999999999943334999999999999998886 799999999764322   


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                        .....|+..|+|||++.+..++.++||||||+++|||++|+.|+.......    ....+....          ....
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~----------~~~~  223 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN----------GTRP  223 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT----------TCCC
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc----------CCCC
Confidence              223468999999999999999999999999999999999999975332211    000000000          0011


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC-CCCCCCCCCCccc
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE-RSLPQPKQPGFFT  639 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~-~~~~~p~~p~~~~  639 (669)
                      ......+..+.+++.+||+.||++|||+.++++.|+.. ..++.+..|..+.
T Consensus       224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  275 (307)
T 2eva_A          224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP  275 (307)
T ss_dssp             CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCCE
T ss_pred             CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccccc
Confidence            11122345678999999999999999999999999875 3444545555443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-40  Score=348.89  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=204.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++.+.||+|+||.||++... +|+.||||++.+.   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357889999999999999999976 5899999999754   344567889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999999854   345899999999999999999999998   99999999999999999999999999986422


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.|+......   .+...            +...
T Consensus       158 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~------------i~~~  220 (337)
T 1o6l_A          158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFEL------------ILME  220 (337)
T ss_dssp             T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH------------HHHC
T ss_pred             C--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHH------------HHcC
Confidence            2  12234467999999999999999999999999999999999999996432111   11100            0000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      .  ..++...+..+.+|+.+||+.||++||     +++|+++
T Consensus       221 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          221 E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            0  112223345788999999999999999     8999975

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2e-40  Score=363.99  Aligned_cols=258  Identities=26%  Similarity=0.442  Sum_probs=205.0

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..++|.+.++||+|+||.||+|.++.+..||||++.... ...+.|.+|+.++++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            346788899999999999999999888899999996543 346789999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|.+++... ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999999532 2245899999999999999999999998   99999999999999999999999999987643221


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                       .......++..|+|||++....++.++||||||++||||++ |+.|+......   ....             .+....
T Consensus       336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~-------------~i~~~~  398 (452)
T 1fmk_A          336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD-------------QVERGY  398 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH-------------HHHTTC
T ss_pred             -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH-------------HHHcCC
Confidence             11223456788999999999999999999999999999999 88886532211   1111             111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ....+...+..+.+|+.+||+.||++|||+.+|++.|+....
T Consensus       399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            112233445678899999999999999999999999988643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3e-40  Score=337.05  Aligned_cols=253  Identities=30%  Similarity=0.461  Sum_probs=197.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC----ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++.+.||+|+||.||+|... ++.||||++....    ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357888999999999999999986 8999999986542    23457899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC--------CcceEEeec
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------DMNPKISDF  496 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~--------~~~~kl~Df  496 (669)
                      |||+++++|.+++.    ...+++..++.++.||+.||.|||+.+..+++||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999983    346899999999999999999999988656899999999999986        778999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      |++.......    .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......      ...      
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~------  224 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAY------  224 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHH------
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH------
Confidence            9998653322    223568999999999999999999999999999999999999965322110      000      


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                         ...........+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          225 ---GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ---HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence               0111111112233345678899999999999999999999999975

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-40  Score=340.70  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=206.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|.+.+.||+|+||.||++...++..||||++.... ...+++.+|+.++..++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            46788999999999999999999988899999996543 34578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            999999999542  345899999999999999999999998   99999999999999999999999999986543221 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      .......++..|+|||++.+..++.++||||||+++|||++ |+.|+.......   .             .+.+.....
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~-------------~~~~~~~~~  239 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---T-------------AEHIAQGLR  239 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H-------------HHHHHTTCC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---H-------------HHHHhcccC
Confidence            12223456788999999999999999999999999999998 998865322111   0             011111111


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ...+...+..+.+++.+||+.+|++|||+.++++.|...
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            112222345788999999999999999999999998753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.1e-40  Score=347.46  Aligned_cols=260  Identities=23%  Similarity=0.377  Sum_probs=193.9

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCCC----cEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTEG----QEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      ..++|.+.+.||+|+||.||+|.....    ..||||++...  .....+.+.+|+.+++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            356899999999999999999997643    27999998754  344567899999999999999999999999887665


Q ss_pred             ------eEEEeecCCCCHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceE
Q 005933          422 ------MLIYEYLPNKSLEQFIFDVT---RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK  492 (669)
Q Consensus       422 ------~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  492 (669)
                            ++||||+++|+|.+++....   ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986432   2225899999999999999999999998   99999999999999999999


Q ss_pred             EeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhh
Q 005933          493 ISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWR  571 (669)
Q Consensus       493 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~  571 (669)
                      |+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......   .....   
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~---  251 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNY---  251 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH---
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHH---
Confidence            999999987644433333334556788999999999999999999999999999999 88886532221   11110   


Q ss_pred             hcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          572 LWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                                +........+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       252 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          252 ----------LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             ----------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                      000011122233446788999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.9e-40  Score=341.85  Aligned_cols=265  Identities=23%  Similarity=0.315  Sum_probs=201.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.++||+|+||+||++...+++.||||++....  ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46899999999999999999999889999999996543  2335678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 78887753  3345899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh----
Q 005933          507 TEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL----  581 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  581 (669)
                      .  ......+|..|+|||++.+ ..++.++|||||||++|||++|+.|+...........+...............    
T Consensus       174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            2  2233578999999999976 56899999999999999999999998654433221111110000000000000    


Q ss_pred             --ccccc--CCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 --IDKSL--DGSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 --~~~~~--~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        .....  ....+.     .....+.+|+.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              00000  001111     12346789999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-40  Score=344.24  Aligned_cols=247  Identities=19%  Similarity=0.297  Sum_probs=203.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|.+.+.||+|+||.||++... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999976 4889999998643 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC--CcceEEeecCCCcccCCC
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--DMNPKISDFGMARAFGVD  505 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~Dfgla~~~~~~  505 (669)
                      +++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||++..+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999943  2345899999999999999999999998   999999999999997  789999999999876432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .   ......+|+.|+|||++.+..++.++||||||+++|+|++|..|+......   ......            ....
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i------------~~~~  219 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENI------------MNAE  219 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH------------HHTC
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHH------------HcCC
Confidence            2   223457899999999999988999999999999999999999996532211   111100            0000


Q ss_pred             cCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  ..+.    ..+..+.+++.+||+.||++|||+.|+++
T Consensus       220 ~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          220 Y--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             C--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0  1111    12356889999999999999999999997

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8e-40  Score=358.93  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=205.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCC-cceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD-ERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~E~  427 (669)
                      .++|.+.++||+|+||.||+|.+. ++.||||+++...  ..+.|.+|+.++++++||||+++++++.... ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467888999999999999999986 7899999996543  5678999999999999999999999987765 68999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|.+++... ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....  
T Consensus       269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999653 2334799999999999999999999998   999999999999999999999999999854321  


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                         .....++..|+|||++.+..++.++||||||++||||++ |+.|+.......   ....             +....
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~-------------i~~~~  403 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-------------VEKGY  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH-------------HHTTC
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------HHcCC
Confidence               112356789999999999999999999999999999998 998865432211   1111             11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ....+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1122334456788999999999999999999999999764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=341.55  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=203.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc------cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|.+.+.||+|+||.||++... +++.||||++.....      ...+.+.+|+.+++.++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457889999999999999999976 489999999875432      2467899999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc----ceEEeecC
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFG  497 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~Dfg  497 (669)
                      ++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999994   3456899999999999999999999998   99999999999999887    89999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..|+......   ........      
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~------  231 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSA------  231 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHH------
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHh------
Confidence            998764322   223457899999999999999999999999999999999999996432111   11110000      


Q ss_pred             chhhcccccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLELIDKSLDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                              .....+.    ..+..+.+++.+||+.||++|||+.|+++
T Consensus       232 --------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          232 --------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             --------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                    0001111    12346789999999999999999999987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.3e-39  Score=340.72  Aligned_cols=260  Identities=18%  Similarity=0.173  Sum_probs=207.6

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++....  ..+.+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999996 468999999986543  235689999999999 99999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc-----eEEeecCCCcc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-----PKISDFGMARA  501 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~Dfgla~~  501 (669)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999999653  346999999999999999999999998   999999999999999887     99999999987


Q ss_pred             cCCCccCc-----CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          502 FGVDQTEA-----NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       502 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      +.......     ......||..|+|||++.+..++.++||||||+++|||++|+.|+..................... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-  238 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-  238 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-
Confidence            64332211     123567999999999999999999999999999999999999997654333221111111000000 


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                          .....+..    ..+ .+.+++..||+.||.+||++.+|++.|+..
T Consensus       239 ----~~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          239 ----TPIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             ----SCHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ----CCHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence                00000000    112 788999999999999999999999988643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.2e-41  Score=350.29  Aligned_cols=264  Identities=26%  Similarity=0.402  Sum_probs=211.9

Q ss_pred             HHHhcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecC
Q 005933          346 ADATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR  418 (669)
Q Consensus       346 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  418 (669)
                      ....++|.+.+.||+|+||.||+|...      .++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            345678999999999999999999864      368899999975432 3456789999999999999999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVT-------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      +..++||||+++|+|.+++....       ....+++..++.++.||+.||.|||+.+   |+||||||+||+|+.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence            99999999999999999986422       1245799999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~  570 (669)
                      ||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+......   .....  
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~--  252 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLRF--  252 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHHH--
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHHH--
Confidence            9999999986543332222333456889999999999999999999999999999999 77775432111   11100  


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                        ....         .....+...+..+.+++.+||+.||.+||++.|+++.|+....
T Consensus       253 --~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          253 --VMEG---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             --HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             --HHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence              0000         0011222334568899999999999999999999999988644

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.1e-39  Score=338.03  Aligned_cols=260  Identities=23%  Similarity=0.329  Sum_probs=198.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHH--hCCCceeEEEEEEecC----Ccce
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVRLLGCCTLR----DERM  422 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~~~  422 (669)
                      .++|.+.+.||+|+||.||+|.. +++.||||++...   ....+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999998 5899999998643   34566777777777  7899999999987553    4578


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceeccCCCCCEEEcCCcceEEe
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNDMNPKIS  494 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dikp~NIll~~~~~~kl~  494 (669)
                      +||||+++|+|.+++.    ...+++..++.++.||+.||+|||        +.+   |+||||||+||||+.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    345999999999999999999999        766   9999999999999999999999


Q ss_pred             ecCCCcccCCCccC--cCcccccccCCccCchhhccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCC
Q 005933          495 DFGMARAFGVDQTE--ANTDRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIVCG----------KRNRGF  556 (669)
Q Consensus       495 Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwS~G~~l~elltG----------~~p~~~  556 (669)
                      |||+++........  .......||+.|+|||++.+.      .++.++||||||+++|||++|          +.|+..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999865433221  122335789999999999877      455799999999999999999          555432


Q ss_pred             CCCCCccchhhHhhhhcccccchhhccccc-CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          557 YHADHHHNLLGHAWRLWTEDRSLELIDKSL-DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      .......  ............    ..+.+ ....+...+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       236 ~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          236 VVPNDPS--FEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TSCSSCC--HHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCcc--hhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            2211110  111111000000    00000 001123456789999999999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.3e-40  Score=345.16  Aligned_cols=261  Identities=27%  Similarity=0.404  Sum_probs=210.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC--------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecC
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR  418 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  418 (669)
                      .++|.+.+.||+|+||.||+|...        +++.||||++.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468999999999999999999863        46789999997543 33467899999999999 899999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+||||
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999965332             234899999999999999999999998   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  564 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~  564 (669)
                      +.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+......   .
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---H
Confidence            9999999999999987654433333344567889999999999999999999999999999999 88886532211   1


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      +..             .+........+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       268 ~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          268 LFK-------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             HHH-------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH-------------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            111             011111111222334578899999999999999999999999987633

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-40  Score=348.48  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=203.6

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcE----EEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQE----IAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|.+.+.||+|+||.||+|.... ++.    ||+|.+.... ......+.+|+.+++.++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            578889999999999999999643 443    8888875432 344567889999999999999999999986 567899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999999954  2346899999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.|+........   .             +.+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~-------------~~~  230 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---P-------------DLL  230 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---H-------------HHH
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---H-------------HHH
Confidence            5544444455678889999999999999999999999999999999 9999764322111   1             111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ........+...+..+.+++.+||+.||++||++.++++.|+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          231 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111111112222345678999999999999999999999997754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.3e-40  Score=348.11  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=203.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ..++|.+.+.||+|+||.||++... +++.||||++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3568999999999999999999975 48999999996542  23456789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc---ceEEeecCCCcc
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKISDFGMARA  501 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~Dfgla~~  501 (669)
                      |||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999984   3456899999999999999999999998   99999999999998654   599999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|..|+.....   ..+.....           
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~-----------  243 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIK-----------  243 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH-----------
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH-----------
Confidence            64322   22346789999999999999999999999999999999999999643211   11111100           


Q ss_pred             cccccCCCC--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSY--SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ........  ....+..+.+|+.+||+.||++||++.++++
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          244 -AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             -HTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -hCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             00000000  0122456889999999999999999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.9e-40  Score=350.71  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=199.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|++.++||+|+||.||+++... ++.||||++.+..   ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4678999999999999999999764 8899999997642   33456788999999887 89999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999998543   45899999999999999999999998   9999999999999999999999999998532


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc--chhhHhhhhcccccchhh
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH--NLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  581 (669)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ........        .+
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~--------~i  274 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VI  274 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH--------HH
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH--------HH
Confidence            21  22334468999999999999999999999999999999999999998643221110  00000000        01


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNM  616 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  616 (669)
                      ....  ..++...+..+.+|+.+||+.||++||++
T Consensus       275 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          275 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             hccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            1111  12223344578899999999999999995

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=350.62  Aligned_cols=248  Identities=27%  Similarity=0.404  Sum_probs=199.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|++.+.||+|+||.||+++.. +++.||||++.+.   .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999976 4899999999754   234567788999999998 69999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|..++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999999543   45899999999999999999999998   9999999999999999999999999997532


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...            +..
T Consensus       176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~------------i~~  238 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFEA------------ILN  238 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH------------HHH
T ss_pred             cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHHH------------HHc
Confidence            21  22233467999999999999989999999999999999999999997532211   11111            111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNM------SSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  621 (669)
                      ...  .++......+.+++.+||+.||++||++      .|+++
T Consensus       239 ~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          239 DEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            111  1222234567899999999999999998      77764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.9e-39  Score=331.57  Aligned_cols=261  Identities=16%  Similarity=0.187  Sum_probs=209.4

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++....  ..+.+.+|+.++..+ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999996 568999999986433  345688999999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc-----eEEeecCCCcc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-----PKISDFGMARA  501 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~Dfgla~~  501 (669)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.     +||+|||++..
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999643  345899999999999999999999998   999999999999987776     99999999987


Q ss_pred             cCCCccC-----cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          502 FGVDQTE-----ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       502 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      .......     .......||..|+|||++.+..++.++||||||+++|||++|+.|+......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543221     12344678999999999999999999999999999999999999976543332222211111110000


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ...+.     ..    ..+..+.+++.+||+.||++||++.+|++.|+..
T Consensus       241 ~~~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          241 PLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             CHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cHHHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            00000     01    1235788999999999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-39  Score=335.49  Aligned_cols=262  Identities=22%  Similarity=0.307  Sum_probs=199.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.++||+|+||+||+|... +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999975 48999999997543  2335788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++ +|.+.+..  ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 55555533  2355999999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cCcCcccccccCCccCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc------h
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS------L  579 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~  579 (669)
                        .......+|..|+|||++.+.. ++.++||||||+++|||++|..|+-.  .......+....+.......      .
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC--CCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence              2233457899999999998765 89999999999999999998887421  11111111111111110000      0


Q ss_pred             hhcccc---------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          580 ELIDKS---------LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       580 ~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...+..         ............+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000000         000111223457789999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=355.33  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=202.4

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ..++|++.++||+|+||.||++... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4578999999999999999999964 58999999986543  23456789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc---CCcceEEeecCCCcc
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARA  501 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~Dfgla~~  501 (669)
                      |||+++|+|.+.+..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999854   345899999999999999999999998   99999999999998   467899999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|.+|+.....   ..+......    ..    
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~----~~----  229 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIKA----GA----  229 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH----TC----
T ss_pred             ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHh----CC----
Confidence            64322  222346799999999999999999999999999999999999999643211   111111000    00    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          230 Y--DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             C--CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C--CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0  0000001122456889999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.3e-40  Score=332.54  Aligned_cols=254  Identities=27%  Similarity=0.419  Sum_probs=208.1

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|.+.+.||+|+||.||++...+++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            5788899999999999999999888999999996543 345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++........ .
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  160 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  160 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence            99999999643  345899999999999999999999998   99999999999999999999999999986533211 1


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+......   .....             +......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~-------------i~~~~~~  224 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED-------------ISTGFRL  224 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH-------------HHTTCCC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHH-------------HhcCCcC
Confidence            2223456788999999999999999999999999999999 88886532211   11100             0000111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11222345688999999999999999999999999764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.7e-39  Score=333.01  Aligned_cols=255  Identities=25%  Similarity=0.498  Sum_probs=202.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc-------chHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ-------GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      .++|++.+.||+|+||.||+|... +++.||||++......       ..+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367889999999999999999975 5899999998654322       1268899999999999999999999986554 


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc-----eEEee
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN-----PKISD  495 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~D  495 (669)
                       ++||||+++++|.+++..  +...+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999998854  3456999999999999999999999986 34999999999999988776     99999


Q ss_pred             cCCCcccCCCccCcCcccccccCCccCchhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAI--DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       496 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      ||+++....     ......++..|+|||++.  ...++.++||||||+++|||++|+.|+......... ...      
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~------  240 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FIN------  240 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHH------
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHH------
Confidence            999975322     223457899999999984  456889999999999999999999997543322110 000      


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                            ...........+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus       241 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 ------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                  01111112223334456788999999999999999999999999753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.6e-40  Score=345.99  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=197.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCC--CceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++.+.||+|+||.||++...+++.||||++....  ....+.+.+|+.++..++|  +||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45789999999999999999999889999999986542  3345789999999999986  9999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      || +.+++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899999954   345899999999999999999999998   99999999999997 57899999999987654


Q ss_pred             CccCcCcccccccCCccCchhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.|+.....     ....     
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~-----  229 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISK-----  229 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHH-----
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHH-----
Confidence            443333445679999999999865           6789999999999999999999999653211     0111     


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                          ....++.......+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          230 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                111222222222232334568899999999999999999999863

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2e-39  Score=344.25  Aligned_cols=250  Identities=23%  Similarity=0.311  Sum_probs=202.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc-----CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      .++|++.+.||+|+||.||++... +++.||||++...     .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457999999999999999999975 5899999998542     1234678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc---eEEeecCC
Q 005933          423 LIYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGM  498 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~Dfgl  498 (669)
                      +||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988875432 3345899999999999999999999998   999999999999987655   99999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      +.......  .......||+.|+|||++.+..++.++|||||||++|||++|+.|+....    ..+...          
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~----------  243 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEG----------  243 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHH----------
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHH----------
Confidence            98764322  22334579999999999999999999999999999999999999965321    011100          


Q ss_pred             hhhcccccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 LELIDKSLDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 ~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        +.....  ..+.    ..+..+.+|+.+||+.||++|||+.|+++
T Consensus       244 --i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          244 --IIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             --HHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              000000  0111    12356789999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.6e-40  Score=345.70  Aligned_cols=261  Identities=26%  Similarity=0.409  Sum_probs=209.7

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeEEEEEEecCC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD  419 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  419 (669)
                      ..++|.+.+.||+|+||.||+|....      ...||||++..... ...+.+.+|+.++..+ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45789999999999999999999643      24799999975432 3467899999999999 8999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVT-----------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND  488 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~  488 (669)
                      ..++||||+++|+|.+++....           ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            9999999999999999986432           1345899999999999999999999998   9999999999999999


Q ss_pred             cceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhh
Q 005933          489 MNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLG  567 (669)
Q Consensus       489 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~  567 (669)
                      +.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+........   . 
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~-  276 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK---F-  276 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---H-
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---H-
Confidence            9999999999987644333333334567889999999999999999999999999999998 8888653221110   0 


Q ss_pred             HhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          568 HAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                                 ...+........+...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       277 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          277 -----------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -----------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence                       011111111112222345788999999999999999999999999754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=337.87  Aligned_cols=249  Identities=25%  Similarity=0.342  Sum_probs=194.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--------------------------cchHHHHHHHHHHH
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--------------------------QGVEEFKNEVLLIA  401 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  401 (669)
                      .++|.+.+.||+|+||.||+|... +++.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            368999999999999999999965 589999999865421                          12467899999999


Q ss_pred             HhCCCceeEEEEEEec--CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 005933          402 KLQHRNLVRLLGCCTL--RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK  479 (669)
Q Consensus       402 ~l~h~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dik  479 (669)
                      .++||||+++++++.+  ....++||||+++++|.+++    ....+++..+..++.||+.||+|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56789999999999998865    3356999999999999999999999998   9999999


Q ss_pred             CCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCC
Q 005933          480 ASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGF  556 (669)
Q Consensus       480 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwS~G~~l~elltG~~p~~~  556 (669)
                      |+|||++.++.+||+|||++.......  .......||+.|+|||++.+..   ++.++||||||+++|||++|+.|+..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999998764322  1223457899999999998765   47889999999999999999999653


Q ss_pred             CCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          557 YHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...   ......            +.............+..+.+++.+||+.||++||++.|+++
T Consensus       243 ~~~---~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERI---MCLHSK------------IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSH---HHHHHH------------HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccH---HHHHHH------------HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            211   000000            00000110111123456889999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-39  Score=333.78  Aligned_cols=255  Identities=30%  Similarity=0.471  Sum_probs=206.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|.+.+.||+|+||.||+|...+++.||||++.... ...+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            46788999999999999999999888899999996543 35678999999999999999999999986 45689999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++++|.+++... ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            999999998432 1125899999999999999999999998   99999999999999999999999999987643322 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      .......++..|+|||++.+..++.++||||||+++|||++ |+.|+......   .....             +.....
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~-------------~~~~~~  228 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQN-------------LERGYR  228 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH-------------HHTTCC
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHH-------------HhcccC
Confidence            12223456788999999998999999999999999999999 88886532211   11111             000011


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            112223345788999999999999999999999999865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.1e-40  Score=341.14  Aligned_cols=269  Identities=27%  Similarity=0.385  Sum_probs=213.4

Q ss_pred             ccHHHHHHHhcCCCccCeeeecCccceEEEEe------CCCcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeEE
Q 005933          340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRL  411 (669)
Q Consensus       340 ~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l  411 (669)
                      +.........++|.+.+.||+|+||.||+|..      .+++.||||++..... ...+.+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34444555678999999999999999999984      3468899999976433 3456799999999999 79999999


Q ss_pred             EEEEecCCc-ceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecc
Q 005933          412 LGCCTLRDE-RMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRD  477 (669)
Q Consensus       412 ~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D  477 (669)
                      ++++...+. .++||||+++++|.+++.....             ...+++..++.++.||++||.|||+.+   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            999877654 8999999999999999965332             223889999999999999999999998   99999


Q ss_pred             CCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005933          478 LKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGF  556 (669)
Q Consensus       478 ikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~  556 (669)
                      |||+||+|+.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..|+..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654433333344567889999999999999999999999999999998 9888654


Q ss_pred             CCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          557 YHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .....  ....    .         +........+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       254 ~~~~~--~~~~----~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDE--EFCR----R---------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSH--HHHH----H---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhH--HHHH----H---------hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            32211  0000    0         000011111222345688999999999999999999999999764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.8e-40  Score=344.81  Aligned_cols=271  Identities=24%  Similarity=0.329  Sum_probs=199.5

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc---
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER---  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~---  421 (669)
                      .++|++.+.||+|+||.||++.. .+++.||||++.....   .....+.+|+.++..++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999996 4689999999976432   3346789999999999999999999998776654   


Q ss_pred             -eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          422 -MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       422 -~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                       ++||||+++++|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             9999999999999999543   45899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          501 AFGVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       501 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      .+...... .......||..|+|||++.+..++.++||||||+++|||++|+.|+......      .............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC
Confidence            76433221 2233456899999999999999999999999999999999999996532211      0111110000000


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH-HHhcCCCCCCCCCCCCcc
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV-LMLSGERSLPQPKQPGFF  638 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~~~~~~~p~~p~~~  638 (669)
                      .   ...    ....+..+.+++.+||+.||++||++.+++ ..|........|..|...
T Consensus       239 ~---~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~  291 (311)
T 3ork_A          239 P---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVL  291 (311)
T ss_dssp             H---HHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCC
T ss_pred             c---ccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCccc
Confidence            0   000    011235688999999999999999666554 455444333333334333

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-39  Score=336.03  Aligned_cols=257  Identities=28%  Similarity=0.429  Sum_probs=211.6

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ..++|.+.+.||+|+||.||+|.... +..||||++... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            35678899999999999999999765 889999999643 3456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999999653 3456899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      . .......++..|+|||++.+..++.++||||||+++|+|++ |..|+.......                ..+.+...
T Consensus       166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----------------~~~~~~~~  228 (288)
T 3kfa_A          166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKD  228 (288)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HHHHHHTT
T ss_pred             c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHhcc
Confidence            2 22233456788999999999999999999999999999999 888865432211                11111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            11222233446788999999999999999999999998754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=339.62  Aligned_cols=245  Identities=24%  Similarity=0.311  Sum_probs=203.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++.+.||+|+||.||+++.. +|+.||||++.+..   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357889999999999999999975 58999999997542   24567788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999954   345899999999999999999999998   99999999999999999999999999986532


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                           ......||+.|+|||++.+..++.++|||||||++|||++|+.|+......   ....            .++..
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~------------~i~~~  218 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYE------------KILNA  218 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH------------HHHHC
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH------------HHHhC
Confidence                 223457899999999999999999999999999999999999996532111   1110            01111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      .+  .++......+.+++.+||+.||++||     +++++++
T Consensus       219 ~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          219 EL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            11  12222345688999999999999999     8999884

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.8e-39  Score=334.77  Aligned_cols=261  Identities=22%  Similarity=0.352  Sum_probs=199.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|.+.++||+|+||.||+|...+++.||||++....  ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5788999999999999999999889999999986543  23457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++ +|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            985 89988854  2345899999999999999999999998   9999999999999999999999999998654321 


Q ss_pred             CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc------ch-
Q 005933          508 EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR------SL-  579 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~-  579 (669)
                       .......+|..|+|||++.+. .++.++||||||+++|||++|+.|+......   ..+....+......      .. 
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence             122335689999999999764 5899999999999999999999997543211   11111111100000      00 


Q ss_pred             -hhcccccC--C-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          580 -ELIDKSLD--G-----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       580 -~~~~~~~~--~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ...+....  .     ......+..+.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             00000000  0     001123456789999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.7e-40  Score=347.39  Aligned_cols=274  Identities=27%  Similarity=0.399  Sum_probs=212.6

Q ss_pred             hcCCCccCeeeecCccceEEEEe-----CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEe--cCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT--LRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~  421 (669)
                      .++|.+.+.||+|+||.||++++     .+++.||||++........+.+.+|+.+++.++||||+++++++.  .....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35788999999999999999984     358899999998776666788999999999999999999999886  44568


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            8999999999999999643  235899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ....... .......++..|+|||++.+..++.++||||||+++|+|++|+.|+.....+... ...............+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLE  255 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHH
Confidence            6433221 2233356788899999999999999999999999999999999885422111000 0000000000011111


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      .+........+...+..+.+|+.+||+.||++|||+.++++.|+....
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            222222223344455678999999999999999999999999987744

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=346.17  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=204.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||++.... ++.||||++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            3578999999999999999999764 889999998653   234567889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++..+..
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999953   456999999999999999999999998   99999999999999999999999999987543


Q ss_pred             CccCcCcccccccCCccCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .   .......||+.|+|||++..   ..++.++|||||||++|||++|+.|+................           
T Consensus       168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-----------  233 (384)
T 4fr4_A          168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-----------  233 (384)
T ss_dssp             T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-----------
T ss_pred             C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-----------
Confidence            2   22344679999999999974   458999999999999999999999976433322211111100           


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-MSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  621 (669)
                       .  .....+...+..+.+|+.+||+.||++||+ +++|+.
T Consensus       234 -~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          234 -T--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -H--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -h--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             0  011122233467889999999999999998 777764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-39  Score=343.67  Aligned_cols=244  Identities=22%  Similarity=0.330  Sum_probs=201.8

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++.+.   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999996 45899999998653   223456889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+ +|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 78898888543   45899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CccCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..   ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.|+........                   ..
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------------~~  218 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------------FK  218 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------------BC
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------------HH
Confidence            22   2334578999999999988776 7899999999999999999999753222111                   11


Q ss_pred             cccC--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLD--GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....  ...+...+..+.+|+.+||+.||.+|||++|+++
T Consensus       219 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          219 KVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1111  1122223456789999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.3e-40  Score=338.56  Aligned_cols=251  Identities=22%  Similarity=0.414  Sum_probs=203.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-C-------cEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-G-------QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      .++|.+.+.||+|+||.||+|.... +       ..||+|++........+.+.+|+.+++.++||||+++++++..++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3578889999999999999999653 3       5799999977766777899999999999999999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc--------eE
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--------PK  492 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~--------~k  492 (669)
                      .++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999642  334899999999999999999999999   999999999999998887        99


Q ss_pred             EeecCCCcccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCCccchhhHhh
Q 005933          493 ISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAW  570 (669)
Q Consensus       493 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p-~~~~~~~~~~~~~~~~~  570 (669)
                      |+|||++......      ....++..|+|||++.+ ..++.++||||||+++|||++|..| +.....   .....   
T Consensus       162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~---  229 (289)
T 4fvq_A          162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---QRKLQ---  229 (289)
T ss_dssp             ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH---
T ss_pred             eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---HHHHH---
Confidence            9999998754221      22457889999999987 6799999999999999999996554 221110   00000   


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                       ..         ..  ....+...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus       230 -~~---------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          230 -FY---------ED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             -HH---------HT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             -Hh---------hc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             00         00  001111123457799999999999999999999999988755

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-40  Score=345.12  Aligned_cols=258  Identities=25%  Similarity=0.430  Sum_probs=200.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcE----EEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQE----IAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      .++|++.++||+|+||.||+|... +++.    ||+|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            357899999999999999999964 3443    577777543 3446788999999999999999999999998754 78


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +|+||+.+|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999999653  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .............++..|+|||++.+..++.++||||||+++|||++ |..|+.......                ....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~~~  231 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI  231 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHH
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHH
Confidence            54443333344566889999999999999999999999999999999 999865432211                1111


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      +........+...+..+.+++.+||+.||++||++.|+++.|+....
T Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11111122233345578899999999999999999999999987654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.7e-39  Score=335.11  Aligned_cols=260  Identities=25%  Similarity=0.444  Sum_probs=194.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.++||+|+||.||+|...  ..||||++....  ....+.|.+|+.+++.++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467999999999999999999875  469999986543  33457899999999999999999999965 5567899999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999853  3456899999999999999999999998   9999999999999999999999999998654433


Q ss_pred             cCcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          507 TEANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      .........++..|+|||++.   +..++.++||||||+++|||++|+.|+......  ..+......    ...    .
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~----~~~----~  244 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGR----GSL----S  244 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHH----TSC----C
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcc----ccc----C
Confidence            333344567899999999986   567899999999999999999999997532211  111111100    000    0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ..+ .......+..+.+|+.+||+.+|++||++.++++.|+...
T Consensus       245 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          245 PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            000 0112233467889999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=339.78  Aligned_cols=244  Identities=23%  Similarity=0.301  Sum_probs=192.2

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.++||+|+||+||+|... +++.||||++.....  .....+..|+..+..+ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999976 699999999865432  2334556666666666 8999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+ +++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++......
T Consensus       137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 67999988653  345999999999999999999999998   999999999999999999999999999875432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .   ......||+.|+|||++.+ .++.++||||||+++|||++|..++....          .+..        +....
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~--------~~~~~  268 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQ--------LRQGY  268 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHH--------HTTTC
T ss_pred             C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHH--------HhccC
Confidence            2   2234568999999998875 78999999999999999999976532110          0000        10000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            000001112357889999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-39  Score=334.17  Aligned_cols=255  Identities=23%  Similarity=0.338  Sum_probs=194.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC----CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|++.+.||+|+||.||+|....    +..||||++.... ....+.+.+|+.+++.++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678899999999999999999743    4579999986543 334678999999999999999999999984 567899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999642  345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .... .......+++.|+|||++.+..++.++||||||+++|||++ |..|+......   ......             
T Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i-------------  230 (281)
T 1mp8_A          168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI-------------  230 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH-------------
T ss_pred             cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH-------------
Confidence            3221 11223456788999999999999999999999999999997 88886533221   111110             


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ........+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00001112233456788999999999999999999999999754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.9e-40  Score=339.07  Aligned_cols=266  Identities=26%  Similarity=0.393  Sum_probs=206.1

Q ss_pred             cCCCccCeeeecCccceEEEEe-----CCCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecC--Ccc
Q 005933          350 DNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DER  421 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~  421 (669)
                      +.|++.++||+|+||.||++++     .+++.||||++... .....+.+.+|+.+++.++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588889999999999999983     35899999999754 334567899999999999999999999999877  568


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            9999999999999999543  245899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh----cccc
Q 005933          502 FGVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL----WTED  576 (669)
Q Consensus       502 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~  576 (669)
                      ....... .......+|..|+|||++.+..++.++||||||+++|||++|..|+.....     ........    ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCGGGHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCcccccCHH
Confidence            6543321 223345678889999999999999999999999999999999887331100     00000000    0000


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      .....+........+...+..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            1111111111222333445678899999999999999999999999975

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.7e-40  Score=345.54  Aligned_cols=248  Identities=26%  Similarity=0.381  Sum_probs=203.3

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcce
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  422 (669)
                      ..++|.+.+.||+|+||.||+++.+ +++.||||++.+..   ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999976 48999999997542   34567788999999987 8999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999543   45899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|+.|+......   .+....            .
T Consensus       169 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i------------~  231 (345)
T 1xjd_A          169 MLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSI------------R  231 (345)
T ss_dssp             CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH------------H
T ss_pred             ccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH------------H
Confidence            222  12234467999999999999999999999999999999999999996532211   111110            0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMS-SVV  620 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  620 (669)
                      ..  ...++...+..+.+++.+||+.||++||++. +++
T Consensus       232 ~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          232 MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             hC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            00  0112222345688999999999999999997 665

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=365.33  Aligned_cols=257  Identities=26%  Similarity=0.444  Sum_probs=208.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|.+.++||+|+||.||+|.+..+..||||++.... ...+.|.+|+.+|++++||||+++++++.+ +..+|||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            46788899999999999999999888899999996543 346789999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++|+|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....... 
T Consensus       344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  418 (535)
T 2h8h_A          344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  418 (535)
T ss_dssp             TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-
T ss_pred             cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-
Confidence            999999999532 2245899999999999999999999998   99999999999999999999999999987543211 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                      .......++..|+|||++....++.++||||||++||||++ |+.|+......   ....             .+.....
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~-------------~i~~~~~  482 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD-------------QVERGYR  482 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHH-------------HHHTTCC
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-------------HHHcCCC
Confidence            11223456788999999999999999999999999999999 88886532211   1111             1111111


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ...+...+..+.+|+.+||+.||++|||+.+|+++|+....
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            12223345678899999999999999999999999988643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-39  Score=347.07  Aligned_cols=253  Identities=22%  Similarity=0.277  Sum_probs=206.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+.++..++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999976 5899999999766555567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC--CcceEEeecCCCcccCCC
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--DMNPKISDFGMARAFGVD  505 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~Dfgla~~~~~~  505 (669)
                      +++|+|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.  ++.+||+|||++......
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999999843  3345899999999999999999999998   999999999999974  578999999999876432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .   ......+|..|+|||++.+..++.++|||||||++|||++|..|+.....   ...+......          ...
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~----------~~~  268 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRC----------DWE  268 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHC----------CCC
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhC----------CCC
Confidence            2   22335789999999999999999999999999999999999999653221   1111111000          000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .........+..+.+++.+||+.||++|||+.|+++-
T Consensus       269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1111111234568899999999999999999999973

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-39  Score=331.28  Aligned_cols=254  Identities=21%  Similarity=0.341  Sum_probs=204.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC--CcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+|+.. ++.||||++....  ....+.|.+|+.++++++||||+++++++...  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            357888999999999999999986 8999999997543  33456899999999999999999999999887  778999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++... ....+++..++.++.||++||.|||+.+ .+++||||||+||+++.++.++|+|||++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            9999999999999642 2335899999999999999999999875 349999999999999999999999998875432 


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSV---KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                            .....+|+.|+|||++.+..++.   ++||||||+++|||++|+.|+.......   ..            ...
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~------------~~~  223 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IG------------MKV  223 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---HH------------HHH
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---HH------------HHH
Confidence                  12346789999999998765444   8999999999999999999965322110   00            011


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      .........+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1111112223334567889999999999999999999999997653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-39  Score=347.32  Aligned_cols=211  Identities=27%  Similarity=0.332  Sum_probs=183.0

Q ss_pred             CCCCCccHHHHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhC-----CCce
Q 005933          335 MELPMFDWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----HRNL  408 (669)
Q Consensus       335 ~~~~~~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni  408 (669)
                      .+...+++.+.....++|.+.++||+|+||.||++... +++.||||++.. .....+.+..|+.++..++     ||||
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            34455666666677889999999999999999999974 589999999854 2344567788999999997     9999


Q ss_pred             eEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-
Q 005933          409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-  487 (669)
Q Consensus       409 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-  487 (669)
                      +++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+||||+. 
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP  173 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence            99999999999999999999 99999999653 3345899999999999999999999998   999999999999975 


Q ss_pred             ------------------------CcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHH
Q 005933          488 ------------------------DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL  543 (669)
Q Consensus       488 ------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~  543 (669)
                                              ++.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    789999999999864322     224578999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCC
Q 005933          544 VLEIVCGKRNRGF  556 (669)
Q Consensus       544 l~elltG~~p~~~  556 (669)
                      +|||++|+.|+..
T Consensus       249 l~ell~g~~pf~~  261 (360)
T 3llt_A          249 LAELYTGSLLFRT  261 (360)
T ss_dssp             HHHHHHSSCSCCC
T ss_pred             HHHHHHCCCCCCC
Confidence            9999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.1e-39  Score=344.03  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=193.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|.+.++||+|+||.||++... +++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999976 58999999996543 3346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc--eEEeecCCCcccCCC
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--PKISDFGMARAFGVD  505 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~--~kl~Dfgla~~~~~~  505 (669)
                      +++|+|.+++...   +.+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999998542   35899999999999999999999998   999999999999987765  999999999753221


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~-sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                         .......||+.|+|||++.+..+..+ +|||||||++|+|++|+.|+........  ......         .+...
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~---------~~~~~  237 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQ---------RILSV  237 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHH---------HHHTT
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHH---------HHhcC
Confidence               22234578999999999988887665 8999999999999999999764332211  111100         01111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            1111111123456789999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-39  Score=337.46  Aligned_cols=260  Identities=23%  Similarity=0.372  Sum_probs=189.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999965 48999999997543 3345788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          427 YLPNKSLEQFIFDVT---RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |++ ++|.+++....   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999886432   2245899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc---c---
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE---D---  576 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~---  576 (669)
                      ...  .......+|..|+|||++.+. .++.++|||||||++|||++|+.|+........   +.........   .   
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhh
Confidence            322  122345789999999999764 689999999999999999999999764332211   1111110000   0   


Q ss_pred             ------------------cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 ------------------RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 ------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                        ...+.+....    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                              0000000000    0112346889999999999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-39  Score=349.04  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=198.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC--ccchHHHHHHHHHHHHhC--CCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||++...+++.||||++....  ....+.+.+|+.++..++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            35699999999999999999998889999999986542  345678999999999996  59999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      || +.+++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 6788999999642   36899999999999999999999998   99999999999995 58999999999987654


Q ss_pred             CccCcCcccccccCCccCchhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      ...........||+.|+|||++.+           ..++.++|||||||+||||++|+.|+......     ...     
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~-----  276 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK-----  276 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHH-----
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHH-----
Confidence            433333445679999999999875           46899999999999999999999997532110     000     


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                          ...+++.......+...+..+.+|+.+||+.||++||++.|+++.
T Consensus       277 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          277 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                111222222212222224568899999999999999999999863

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.4e-39  Score=330.49  Aligned_cols=247  Identities=21%  Similarity=0.328  Sum_probs=203.9

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ..++|.+.+.||+|+||.||+|.... +..||+|++........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            35679999999999999999999765 77999999987766778899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE---cCCcceEEeecCCCcccC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFG  503 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~Dfgla~~~~  503 (669)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++||||||+||++   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999998854   245899999999999999999999998   9999999999999   788999999999998754


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ...   ......+|+.|+|||++.+. ++.++||||||+++|||++|+.|+......   .....            +..
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~------------~~~  221 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVMLK------------IRE  221 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH------------HHH
T ss_pred             Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHHH------------HHh
Confidence            322   22345789999999988654 899999999999999999999996532211   00000            000


Q ss_pred             cccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..  ...+.    ..+..+.+++.+||+.||++||++.++++
T Consensus       222 ~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          222 GT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CC--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00  01111    12357889999999999999999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.3e-39  Score=340.37  Aligned_cols=248  Identities=23%  Similarity=0.320  Sum_probs=193.7

Q ss_pred             hcCCCccCeeeecCccceEEEEe----CCCcEEEEEEecccC----ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML----TEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      .++|++.+.||+|+||.||++..    .+++.||||++.+..    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46789999999999999999997    468999999997542    2345678899999999999999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999954   345899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ......  .......||+.|+|||++.+..++.++||||||+++|||++|+.|+......   .....            
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~------------  232 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDK------------  232 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH------------
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHH------------
Confidence            543221  2233457899999999999999999999999999999999999997532211   11111            


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      +.....  ..+...+..+.+++.+||+.||++||     ++.++++
T Consensus       233 i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          233 ILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            111111  12222345788999999999999999     7778875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-39  Score=343.07  Aligned_cols=260  Identities=21%  Similarity=0.256  Sum_probs=202.0

Q ss_pred             HHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc-----CccchHHHHHHHHHHHHhCCCceeEEEEEEec
Q 005933          344 TIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-----SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL  417 (669)
Q Consensus       344 ~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~  417 (669)
                      .+....++|.+.+.||+|+||.||+|... +++.||||++...     .....+.+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            45566789999999999999999999975 4889999998643     34556789999999999999999999999999


Q ss_pred             CCcceEEEeecCCCCHHHHhhccC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 005933          418 RDERMLIYEYLPNKSLEQFIFDVT-------------------------------------RTKFLDWSKRCQIIEGIAR  460 (669)
Q Consensus       418 ~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~  460 (669)
                      .+..++||||+++|+|.+++....                                     ....+++..+..++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999984210                                     0122467788899999999


Q ss_pred             HHHHHHhCCCCCceeccCCCCCEEEcCCc--ceEEeecCCCcccCCCccC--cCcccccccCCccCchhhcc--CCCCch
Q 005933          461 GLLYLHQDSRLRIIHRDLKASNVLLDNDM--NPKISDFGMARAFGVDQTE--ANTDRVVGTYGYMSPEYAID--GLFSVK  534 (669)
Q Consensus       461 ~L~yLH~~~~~~iiH~Dikp~NIll~~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~~  534 (669)
                      ||+|||+.+   |+||||||+||||+.++  .+||+|||++..+......  .......+|+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999998   99999999999998776  8999999999865332221  12334678999999999975  678999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCC--CCHHHHHHHHHHHHHhccCCCCC
Q 005933          535 SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS--YSLSEALRCIQVGLLCVQQRPED  612 (669)
Q Consensus       535 sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~  612 (669)
                      +||||||+++|||++|+.|+.......   ...            .+........  .....+..+.+|+.+||+.||++
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~---~~~------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  321 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDAD---TIS------------QVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE  321 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH------------HHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHH---HHH------------HHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence            999999999999999999965322111   110            1111111000  00112457889999999999999


Q ss_pred             CCCHHHHHH
Q 005933          613 RPNMSSVVL  621 (669)
Q Consensus       613 RPs~~evl~  621 (669)
                      ||++.++++
T Consensus       322 Rps~~~~l~  330 (345)
T 3hko_A          322 RFDAMRALQ  330 (345)
T ss_dssp             SCCHHHHHH
T ss_pred             CCCHHHHhc
Confidence            999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.2e-39  Score=338.44  Aligned_cols=263  Identities=21%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             hcCCCcc-CeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWK-NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .+.|.+. +.||+|+||.||++... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 78999999999999964 5899999999877666778899999999995 7999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc---eEEeecCCCccc
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAF  502 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~Dfgla~~~  502 (669)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.   +||+|||++...
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999999643   45899999999999999999999998   999999999999998776   999999998865


Q ss_pred             CCCcc-----CcCcccccccCCccCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          503 GVDQT-----EANTDRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       503 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      .....     ........||..|+|||++.+     ..++.++||||||+++|||++|+.|+................  
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--  242 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC--  242 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC--
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc--
Confidence            32211     111223568999999999975     468899999999999999999999976543221100000000  


Q ss_pred             cccccchhhcccccCC--CCCHH----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 WTEDRSLELIDKSLDG--SYSLS----EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~--~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ......+.......  ..+..    .+..+.+|+.+||+.||++|||+.|+++
T Consensus       243 --~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          243 --PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             --HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              00000000000001  11111    2356889999999999999999999997

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.2e-39  Score=341.58  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=202.4

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|.+.+.||+|+||.||+++.. +++.||||++.+..   ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57889999999999999999976 48999999997643   23456788999999988 899999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999999543   45899999999999999999999998   99999999999999999999999999985322


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc--chhhHhhhhcccccchhhc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH--NLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  582 (669)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.........  .........        +.
T Consensus       163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------i~  232 (345)
T 3a8x_A          163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------IL  232 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH--------HH
T ss_pred             C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH--------HH
Confidence            1  12234468999999999999999999999999999999999999997542221110  000000000        01


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNM------SSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  621 (669)
                      ...  ..++...+..+.+|+.+||+.||++||++      .|+++
T Consensus       233 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          233 EKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             HCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            111  11222334578899999999999999995      56653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.6e-39  Score=342.88  Aligned_cols=245  Identities=20%  Similarity=0.241  Sum_probs=204.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+++.. +|+.||||++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            357889999999999999999976 5899999999653   234567889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999999643   34899999999999999999999998   99999999999999999999999999987532


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .     .....||+.|+|||++.+..++.++|||||||++|||++|+.|+......   .....            +...
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~------------i~~~  253 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEK------------IVSG  253 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH------------HHHC
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHHH------------HHcC
Confidence            2     23457899999999999999999999999999999999999996532211   11100            0111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      .+  .++...+..+.+++.+||+.||++||+     +++|++
T Consensus       254 ~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          254 KV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            11  122233457889999999999999998     888875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-39  Score=331.93  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=205.9

Q ss_pred             cCCCccC-eeeecCccceEEEEeC---CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKN-KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|.+.+ .||+|+||.||+|...   ++..||||++.... ....+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555666 9999999999999854   57889999997643 34567899999999999999999999999 55678999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999953  3456899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          505 DQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       505 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+......   ...             ..+
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~-------------~~i  226 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM-------------AFI  226 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH-------------HHH
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHH-------------HHH
Confidence            3221 12223456889999999998899999999999999999998 99986533221   111             011


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ........+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          227 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111122334456788999999999999999999999999765

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=341.96  Aligned_cols=251  Identities=22%  Similarity=0.327  Sum_probs=188.5

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ..++|.+.+.||+|+||.||+|.... ++.||||++....  ..+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            35689999999999999999999864 8899999997543  34678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEeecCCCcccC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFG  503 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~Dfgla~~~~  503 (669)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999984   3456899999999999999999999998   999999999999975   8899999999998653


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..   .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......  ......    ....      
T Consensus       203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i----~~~~------  267 (349)
T 2w4o_A          203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRI----LNCE------  267 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHH----HTTC------
T ss_pred             cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHH----HhCC------
Confidence            22   12234578999999999999999999999999999999999999964322110  011000    0000      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00001111223457889999999999999999999987

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.6e-39  Score=345.78  Aligned_cols=268  Identities=18%  Similarity=0.236  Sum_probs=203.7

Q ss_pred             hcCCCccCeeeec--CccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEG--GFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G--~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|++.++||+|  +||.||++... +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  99999999976 59999999997543  3345778899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999999653 2345899999999999999999999998   9999999999999999999999999886542


Q ss_pred             CCc-----cCcCcccccccCCccCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc-
Q 005933          504 VDQ-----TEANTDRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE-  575 (669)
Q Consensus       504 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-  575 (669)
                      ...     .........||..|+|||++.+  ..++.++|||||||++|||++|+.|+........  +.......... 
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~  257 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCL  257 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC--------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcc
Confidence            211     1112223478899999999987  5799999999999999999999999764322211  00000000000 


Q ss_pred             ---------------------ccchhhccc---c------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          576 ---------------------DRSLELIDK---S------LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       576 ---------------------~~~~~~~~~---~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                                           ....+.+..   .      .........+..+.+|+.+||+.||++|||+.|+++-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                 000000000   0      0000111223468899999999999999999999853

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.7e-39  Score=342.89  Aligned_cols=248  Identities=27%  Similarity=0.360  Sum_probs=203.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|.+.+.||+|+||.||+++... ++.||||++.+.   .....+.+..|..++..+ +||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4689999999999999999999865 789999999754   234567788999999988 79999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999543   35899999999999999999999998   9999999999999999999999999998642


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.|+......   .+...            +..
T Consensus       173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~------------i~~  235 (353)
T 2i0e_A          173 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS------------IME  235 (353)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH------------HHH
T ss_pred             cC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHH------------HHh
Confidence            21  12234467999999999999999999999999999999999999996532211   11111            111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      ..+  .++...+..+.+|+.+||+.||++||+     ++++++
T Consensus       236 ~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          236 HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            111  122233467889999999999999995     577764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.2e-39  Score=336.92  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=197.0

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC----CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      ...++|.+.+.||+|+||.||+|...    .++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34578999999999999999999864    24589999986542  3345789999999999999999999999987654


Q ss_pred             -----ceEEEeecCCCCHHHHhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceE
Q 005933          421 -----RMLIYEYLPNKSLEQFIFDV---TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPK  492 (669)
Q Consensus       421 -----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~k  492 (669)
                           .++||||+++++|.+++...   .....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence                 49999999999999998532   23456999999999999999999999998   99999999999999999999


Q ss_pred             EeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhh
Q 005933          493 ISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWR  571 (669)
Q Consensus       493 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~  571 (669)
                      |+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+......   ......  
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~--  262 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYL--  262 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH--
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHH--
Confidence            999999987644333233334567889999999999999999999999999999999 87776533221   111110  


Q ss_pred             hcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          572 LWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                                 ........+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       263 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          263 -----------LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             -----------HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                       00001112223345788999999999999999999999999764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.9e-39  Score=344.77  Aligned_cols=266  Identities=18%  Similarity=0.191  Sum_probs=203.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC------CcEEEEEEecccCccc-----------hHHHHHHHHHHHHhCCCceeEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQG-----------VEEFKNEVLLIAKLQHRNLVRL  411 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l  411 (669)
                      .++|.+.++||+|+||.||+|.+..      ++.||||++.......           ...+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999999764      4789999986543211           1223445556677789999999


Q ss_pred             EEEEecC----CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-
Q 005933          412 LGCCTLR----DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-  486 (669)
Q Consensus       412 ~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-  486 (669)
                      ++++...    ...+|||||+ +++|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+||||+ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9998775    3479999999 9999999964  3356999999999999999999999998   99999999999999 


Q ss_pred             -CCcceEEeecCCCcccCCCccCc-----CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005933          487 -NDMNPKISDFGMARAFGVDQTEA-----NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD  560 (669)
Q Consensus       487 -~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~  560 (669)
                       .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.|+......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999998764332211     113355999999999999999999999999999999999999997642222


Q ss_pred             CccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          561 HHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .  ....... ........++++..+..   ...+..+.+++..||+.+|++||++.+|++.|+..
T Consensus       268 ~--~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          268 P--KYVRDSK-IRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             H--HHHHHHH-HHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             H--HHHHHHH-HHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            1  1111111 11112233333333321   12235678999999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=342.65  Aligned_cols=269  Identities=26%  Similarity=0.393  Sum_probs=209.0

Q ss_pred             hcCCCccCeeeecCccceEEEEe-----CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCC--cc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-----TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--ER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~  421 (669)
                      .++|.+.+.||+|+||.||++..     .+++.||||++........+.+.+|+.+++.++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35788899999999999999984     358999999998766667788999999999999999999999987654  68


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||+|+.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999653  345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhh----hcccc
Q 005933          502 FGVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR----LWTED  576 (669)
Q Consensus       502 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~~  576 (669)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......    .......    .....
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHH
Confidence            6443221 1122345677899999999989999999999999999999998874421100    0000000    00000


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ...+.+........+...+..+.+++.+||+.||++||++.+|++.|+.+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            01111111111122333456788999999999999999999999999764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.1e-40  Score=343.94  Aligned_cols=267  Identities=28%  Similarity=0.382  Sum_probs=207.1

Q ss_pred             CCccCeeeecCccceEEEEeC-----CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecC--CcceE
Q 005933          352 FSWKNKLGEGGFGPVYRGMLT-----EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR--DERML  423 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  423 (669)
                      |.+.++||+|+||.||++.+.     +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998743     588999999976532 3467799999999999999999999999874  56789


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999954    23899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ..... .......++..|+|||++.+..++.++||||||+++|||++|..|+....... .................+.+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHH
Confidence            43221 22334567888999999999999999999999999999999998854211100 00000000001111122222


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ........+...+..+.+|+.+||+.||++|||+.++++.|+..
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            22222333444556789999999999999999999999999865

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-39  Score=353.22  Aligned_cols=262  Identities=18%  Similarity=0.221  Sum_probs=207.4

Q ss_pred             HHHHHHHhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEec
Q 005933          342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL  417 (669)
Q Consensus       342 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~  417 (669)
                      ..++....++|++.++||+|+||.||+++... ++.||||++.+.   .......+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34445567899999999999999999999765 789999999653   22334568999999999999999999999999


Q ss_pred             CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       418 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      .+..+|||||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence            9999999999999999999954  2355999999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      +++....... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||......   .........
T Consensus       221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~  296 (437)
T 4aw2_A          221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNH  296 (437)
T ss_dssp             TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTH
T ss_pred             hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhc
Confidence            9986543222 1223367999999999997     557899999999999999999999997532211   111111000


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPED--RPNMSSVVL  621 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  621 (669)
                         ..  ..   .. .......+..+.+|+.+||+.+|++  ||+++|+++
T Consensus       297 ---~~--~~---~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          297 ---KE--RF---QF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ---HH--HC---CC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ---cc--cc---cC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence               00  00   00 0011113456789999999988888  999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-39  Score=334.97  Aligned_cols=264  Identities=20%  Similarity=0.301  Sum_probs=198.1

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|.+.++||+|+||.||++.... ++.||||++.....  ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            578999999999999999999764 89999999865433  235678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999998843   345899999999999999999999998   9999999999999999999999999998754322


Q ss_pred             cCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh--------hhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW--------RLWTEDR  577 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  577 (669)
                      .  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.|+...........+....        ..+....
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            1  2234578999999999976 578999999999999999999999976433221111111000        0000000


Q ss_pred             chhhcc-cccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLELID-KSLDGSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...... +......+     ...+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000 00000001     112346789999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.4e-39  Score=327.98  Aligned_cols=253  Identities=24%  Similarity=0.328  Sum_probs=204.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467899999999999999999976 58999999986443 3446789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999984   3456899999999999999999999998   9999999999999999999999999998754333


Q ss_pred             cCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .........++..|+|||++.+..+ +.++||||||+++|||++|+.|+........  .. .   .+...        .
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~-~---~~~~~--------~  225 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY-S---DWKEK--------K  225 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HH-H---HHHTT--------C
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HH-H---Hhhhc--------c
Confidence            3333445678999999999987765 7899999999999999999999764332111  00 0   00000        0


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .........+..+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            000011123456789999999999999999999976

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.3e-39  Score=331.40  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=203.8

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEec---------
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL---------  417 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------  417 (669)
                      ...+|++.+.||+|+||.||++... +++.||||++....    +.+.+|+.+++.++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467899999999999999999986 69999999986543    467889999999999999999998854         


Q ss_pred             -------CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc
Q 005933          418 -------RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN  490 (669)
Q Consensus       418 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~  490 (669)
                             ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   34578999999999999999643 2346899999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      +||+|||++.......   ......++..|+|||++.+..++.++||||||+++|||++|..|+...         ....
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHH
Confidence            9999999998764332   223356899999999999999999999999999999999998773100         0000


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ  631 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~  631 (669)
                              ..+....+    +...+..+.+++.+||+.||++||++.|+++.|+.....+.
T Consensus       229 --------~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          229 --------TDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             --------HHHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             --------HHhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence                    01111111    12223457899999999999999999999999987655443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=331.36  Aligned_cols=263  Identities=25%  Similarity=0.360  Sum_probs=198.7

Q ss_pred             HhcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccC-----ccchHHHHHHHHHHHHhC---CCceeEEEEEEecC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS-----GQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLR  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~  418 (669)
                      ..++|++.++||+|+||+||+|.. .+++.||||++....     ......+.+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999996 458999999986432     222456778888887775   99999999999876


Q ss_pred             C-----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEE
Q 005933          419 D-----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKI  493 (669)
Q Consensus       419 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl  493 (669)
                      .     ..++||||+. ++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999997 5999998643 2334899999999999999999999999   999999999999999999999


Q ss_pred             eecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          494 SDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       494 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      +|||++......   .......+|+.|+|||++.+..++.++|||||||++|||++|+.|+.......   .........
T Consensus       162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~  235 (308)
T 3g33_A          162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLI  235 (308)
T ss_dssp             CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHH
T ss_pred             eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence            999999865322   22334678999999999999999999999999999999999999975432211   111111110


Q ss_pred             cc---ccch---hhcccccC--CCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          574 TE---DRSL---ELIDKSLD--GSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       574 ~~---~~~~---~~~~~~~~--~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..   ....   .+......  ...+.     .....+.+|+.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00   0000   00000000  00111     12356789999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=337.55  Aligned_cols=263  Identities=23%  Similarity=0.319  Sum_probs=206.5

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEec----CCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~l  423 (669)
                      .++|.+.+.||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999997 4689999999977666677889999999999999999999999863    346789


Q ss_pred             EEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          424 IYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      ||||+++|+|.+++... .....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998653 23456999999999999999999999998   999999999999999999999999998764


Q ss_pred             CCCccCc-------CcccccccCCccCchhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          503 GVDQTEA-------NTDRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       503 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      .......       ......++..|+|||++.+..   ++.++||||||+++|||++|+.|+........          
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------  254 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD----------  254 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS----------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc----------
Confidence            3211110       011245689999999987654   78999999999999999999998642111100          


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                          .....+............+..+.+++.+||+.||.+||++.++++.|+....
T Consensus       255 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          255 ----SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ----CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ----hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                0000111111111122334578899999999999999999999999988754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-38  Score=333.99  Aligned_cols=247  Identities=22%  Similarity=0.299  Sum_probs=203.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc------cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|.+.+.||+|+||.||++... +++.||||++.....      ...+.+.+|+.++..++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            457899999999999999999976 589999999975432      1367899999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc----ceEEeecC
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFG  497 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~Dfg  497 (669)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999953   356899999999999999999999998   99999999999999887    79999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ++.......   ......+++.|+|||++.+..++.++||||||+++|+|++|..|+......   .......       
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~-------  231 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT-------  231 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH-------
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH-------
Confidence            998764322   223456899999999999999999999999999999999999996432211   1110000       


Q ss_pred             chhhcccccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLELIDKSLDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                           ..  ....+.    ..+..+.+++.+||+.||++|||+.|+++
T Consensus       232 -----~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          232 -----SV--SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -----TT--CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -----hc--ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00  001111    12346789999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-39  Score=331.08  Aligned_cols=255  Identities=26%  Similarity=0.341  Sum_probs=202.9

Q ss_pred             CCCccCeeeecCccceEEEEeCC----CcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc-eEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER-MLI  424 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV  424 (669)
                      .|.+.++||+|+||.||+|...+    +..||+|++..... ...+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45566899999999999998543    23799999975433 3467899999999999999999999999877665 999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+.+++|.+++..  ....+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999954  3456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             Cc--cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCCccchhhHhhhhcccccchhh
Q 005933          505 DQ--TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       505 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ..  .........++..|+|||.+.+..++.++||||||+++|+|++|..| +.....   ....             ..
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~-------------~~  240 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLT-------------HF  240 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHH-------------HH
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHH-------------HH
Confidence            32  12223345678899999999999999999999999999999996655 221111   1111             11


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +........+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       241 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111111112223345788999999999999999999999999875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-39  Score=350.64  Aligned_cols=257  Identities=20%  Similarity=0.216  Sum_probs=205.5

Q ss_pred             HHHHHhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCC
Q 005933          344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD  419 (669)
Q Consensus       344 ~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  419 (669)
                      ++....++|.+.+.||+|+||.||+++... ++.||||++.+.   .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            344456889999999999999999999764 889999999653   2234566889999999999999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence            99999999999999999854    24899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      +....... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||......   ......   ...
T Consensus       216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i---~~~  288 (410)
T 3v8s_A          216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKI---MNH  288 (410)
T ss_dssp             EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH---HTH
T ss_pred             EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHH---Hhc
Confidence            87643221 1233467999999999998765    789999999999999999999997532211   111110   000


Q ss_pred             ccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 005933          576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPED--RPNMSSVVL  621 (669)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  621 (669)
                      .       ..+........+..+.+|+.+||+.+|++  ||+++||++
T Consensus       289 ~-------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          289 K-------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             H-------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             c-------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            0       00000111123456789999999999998  999999996

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-39  Score=338.19  Aligned_cols=256  Identities=27%  Similarity=0.450  Sum_probs=199.7

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-----CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|.+.+.||+|+||.||+|....     +..||||++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999999653     2459999997543 2345678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++....
T Consensus       124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999964  2346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          504 VDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       504 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ..... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+......   .+.             ..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~-------------~~  262 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVM-------------KA  262 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH-------------HH
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHH-------------HH
Confidence            33221 11222345778999999999999999999999999999999 99886432111   111             01


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      +........+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       263 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111112223456788999999999999999999999999765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.8e-39  Score=344.98  Aligned_cols=272  Identities=21%  Similarity=0.261  Sum_probs=211.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC--cceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD--ERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.+++.++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3578899999999999999999765 8999999997543 344678889999999999999999999998765  67999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE----cCCcceEEeecCCCc
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKISDFGMAR  500 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl~Dfgla~  500 (669)
                      |||+++|+|.+++........+++..++.++.||+.||+|||+.+   |+||||||+||||    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976544455999999999999999999999998   9999999999999    788889999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-cchhhHhhh
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAID--------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH-HNLLGHAWR  571 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~-~~~~~~~~~  571 (669)
                      ......   ......||..|+|||++.+        ..++.++|||||||++|||++|+.||........ .........
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            764322   2233578999999999865        5678899999999999999999999764332221 111111111


Q ss_pred             hcccccchhh---------c--ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          572 LWTEDRSLEL---------I--DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       572 ~~~~~~~~~~---------~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..........         .  ...............+.+++.+||+.||++||++.++++.|+.+
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            1000000000         0  00111233456677889999999999999999999999887654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.2e-39  Score=328.86  Aligned_cols=255  Identities=25%  Similarity=0.360  Sum_probs=202.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC----CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|.+.+.||+|+||.||+|....    +..||||++.... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678899999999999999998643    3469999987653 3456789999999999999999999999864 45789


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999643  345899999999999999999999998   9999999999999999999999999998754


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+.......   ....             +
T Consensus       165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~-------------~  227 (281)
T 3cc6_A          165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV-------------L  227 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH-------------H
T ss_pred             cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH-------------H
Confidence            3221 11223456788999999999999999999999999999998 999865332211   1111             0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ........+...+..+.+++.+||+.||++||++.|+++.|+..
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          228 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            00011111222345688999999999999999999999999764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.7e-39  Score=351.76  Aligned_cols=247  Identities=25%  Similarity=0.412  Sum_probs=204.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            357889999999999999999976 69999999996532   23456899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++.   +.+.+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999994   3456999999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.|+......   .+...            +..
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~------------i~~  230 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKK------------ICD  230 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHH------------HHT
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHH------------Hhc
Confidence            22   2234578999999999988775 68999999999999999999997532211   11111            111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...  ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          231 GIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             TCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            111  111122356789999999999999999999996

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-39  Score=336.97  Aligned_cols=262  Identities=23%  Similarity=0.322  Sum_probs=199.3

Q ss_pred             HHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHh--CCCceeEEEEEEecC----C
Q 005933          346 ADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL--QHRNLVRLLGCCTLR----D  419 (669)
Q Consensus       346 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~----~  419 (669)
                      ....++|.+.++||+|+||.||+|... ++.||||++...   ....+..|.+++..+  +||||+++++++...    .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            345578999999999999999999986 899999998543   234455566666554  899999999999887    6


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCceeccCCCCCEEEcCCcce
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD--------SRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      ..++||||+++|+|.+++..    ..+++..++.++.||+.||.|||+.        +   |+||||||+||||+.++.+
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCE
T ss_pred             ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCE
Confidence            78999999999999999954    2489999999999999999999998        6   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCc--CcccccccCCccCchhhccCCCCch------hhHHHHHHHHHHHHhCCCCC---------
Q 005933          492 KISDFGMARAFGVDQTEA--NTDRVVGTYGYMSPEYAIDGLFSVK------SDVFSFGVLVLEIVCGKRNR---------  554 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~------sDVwS~G~~l~elltG~~p~---------  554 (669)
                      ||+|||++..+.......  ......||..|+|||++.+.....+      +|||||||++|||++|..|+         
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999997664332221  1224578999999999987766654      99999999999999995443         


Q ss_pred             -CCCCCCCccchhhHhhhhcccccchhhcccccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          555 -GFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       555 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                       .........  .......        ..........+     ...+..+.+|+.+||+.||++|||+.+|++.|+....
T Consensus       262 ~~~~~~~~~~--~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          262 YHDLVPSDPS--YEDMREI--------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             TTTTSCSSCC--HHHHHHH--------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhhhcCCCCc--hhhhHHH--------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence             221111100  0000000        01111112222     2556789999999999999999999999999987543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.2e-39  Score=330.34  Aligned_cols=246  Identities=22%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  423 (669)
                      ..++|.+.+.||+|+||.||++... +++.||||++...  ......++.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3567999999999999999999976 6999999999754  233466788999999999 99999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC--------------
Q 005933          424 IYEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND--------------  488 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~--------------  488 (669)
                      ||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999965322 255899999999999999999999998   9999999999999844              


Q ss_pred             -----cceEEeecCCCcccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005933          489 -----MNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH  562 (669)
Q Consensus       489 -----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~  562 (669)
                           ..+||+|||++.......      ...++..|+|||++.+. .++.++||||||+++|||++|.+++...     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----  234 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----  234 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence                 479999999998754322      23589999999999876 6678999999999999999998763211     


Q ss_pred             cchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          563 HNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ...    ..        +... .....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       235 -~~~----~~--------~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          235 -DQW----HE--------IRQG-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -HHH----HH--------HHTT-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -hHH----HH--------HHcC-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             000    00        0000 011122223457889999999999999999999975

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=342.63  Aligned_cols=257  Identities=23%  Similarity=0.274  Sum_probs=191.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEec--------C
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTL--------R  418 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--------~  418 (669)
                      ..+|.+.++||+|+||.||++... +++.||||++........+.+.+|+.++.++. ||||+++++++..        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457899999999999999999965 58999999997666666778999999999996 9999999999843        3


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                      ...++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            34789999996 799999876555667999999999999999999999875 2499999999999999999999999999


Q ss_pred             CcccCCCccCc----------CcccccccCCccCchhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccch
Q 005933          499 ARAFGVDQTEA----------NTDRVVGTYGYMSPEYA---IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL  565 (669)
Q Consensus       499 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~  565 (669)
                      +..........          ......+++.|+|||++   .+..++.++||||||+++|||++|+.|+......     
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----  259 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----  259 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence            98764332211          11134589999999998   5667899999999999999999999996432111     


Q ss_pred             hhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          566 LGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                                    ..+...............+.+|+.+||+.||++||++.|+++.|+..
T Consensus       260 --------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          260 --------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                          11111111111112223477899999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=336.33  Aligned_cols=267  Identities=20%  Similarity=0.224  Sum_probs=199.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC----CCcEEEEEEecccCcc-----------chHHHHHHHHHHHHhCCCceeEEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSSGQ-----------GVEEFKNEVLLIAKLQHRNLVRLLG  413 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g  413 (669)
                      .++|.+.+.||+|+||.||+|...    .+..||||++......           ....+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999975    5788999998754321           2234667888899999999999999


Q ss_pred             EEec----CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc
Q 005933          414 CCTL----RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM  489 (669)
Q Consensus       414 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~  489 (669)
                      ++..    ....++||||+ +++|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9987    67789999999 99999998543   36899999999999999999999998   99999999999999887


Q ss_pred             --ceEEeecCCCcccCCCccC-----cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005933          490 --NPKISDFGMARAFGVDQTE-----ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH  562 (669)
Q Consensus       490 --~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~  562 (669)
                        .+||+|||+++.+......     .......+|..|+|||++.+..++.++||||||+++|||++|+.|+........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876433211     111345789999999999999999999999999999999999999753211111


Q ss_pred             cchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          563 HNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                        ........... .....+.....   ....+..+.+++.+||+.||++||++.+|++.|+....
T Consensus       269 --~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 --AVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             --HHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             --HHHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence              11111111100 01111110000   01233578899999999999999999999999987644

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.8e-39  Score=337.62  Aligned_cols=244  Identities=23%  Similarity=0.302  Sum_probs=178.9

Q ss_pred             cCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEeecCCCC
Q 005933          355 KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKS  432 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gs  432 (669)
                      .+.||+|+||.||++... +++.||||++.+.   ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999976 4899999998643   4567889999999997 9999999999999999999999999999


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc---ceEEeecCCCcccCCCccCc
Q 005933          433 LEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       433 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~  509 (669)
                      |.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++   .+||+|||+++......  .
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence            9999954   356899999999999999999999998   99999999999998765   89999999998653322  2


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS  589 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (669)
                      ......+|..|+|||++.+..++.++||||||+++|||++|+.|+..........            ...+++.....+.
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------------~~~~~~~~i~~~~  232 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT------------SAVEIMKKIKKGD  232 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC------------CHHHHHHHHTTTC
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc------------cHHHHHHHHHcCC
Confidence            2234568999999999999999999999999999999999999976433211110            0111111111111


Q ss_pred             C--CH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          590 Y--SL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       590 ~--~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  +.    ..+..+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1  11    12457889999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-39  Score=334.68  Aligned_cols=255  Identities=26%  Similarity=0.405  Sum_probs=202.4

Q ss_pred             hcCCCccC-eeeecCccceEEEEeC---CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          349 TDNFSWKN-KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       349 ~~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      .++|.+.+ .||+|+||.||+|...   .++.||||++....  ....+++.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 9999999999999642   36889999997543  23367899999999999999999999999 567789


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999964   345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          503 GVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       503 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ...... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+......   ...             .
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~-------------~  231 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT-------------A  231 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH-------------H
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH-------------H
Confidence            433221 11222345788999999998899999999999999999999 99886532211   110             1


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .+........+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          232 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111111122333456788999999999999999999999999754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-39  Score=363.80  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=200.6

Q ss_pred             CCCccC-eeeecCccceEEEEeC---CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          351 NFSWKN-KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       351 ~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++.+.+ +||+|+||.||+|.+.   ++..||||+++... ....++|.+|+.+++.++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            333444 7999999999999864   46679999997643 3457889999999999999999999999976 5689999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999953  3456999999999999999999999998   999999999999999999999999999876433


Q ss_pred             ccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          506 QTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       506 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ... .......++..|+|||++.+..++.++|||||||+||||++ |+.|+......   .+.             +.+.
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~-------------~~i~  553 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM-------------AFIE  553 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHH-------------HHHH
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHH-------------HHHH
Confidence            221 11122345689999999999999999999999999999998 99996543221   111             1111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .......+...+..+.+|+.+||+.+|++||++.+|++.|+..
T Consensus       554 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          554 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1111122334456788999999999999999999999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=344.64  Aligned_cols=246  Identities=24%  Similarity=0.302  Sum_probs=194.9

Q ss_pred             cCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          355 KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      .+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..+|||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            568999999999999965 5899999999776556678899999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE--cCCcceEEeecCCCcccCCCccCcCc
Q 005933          434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNDMNPKISDFGMARAFGVDQTEANT  511 (669)
Q Consensus       434 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~  511 (669)
                      .+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||  +.++.+||+|||+++.+....   ..
T Consensus       174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~  245 (373)
T 2x4f_A          174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL  245 (373)
T ss_dssp             HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred             HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence            998854  2345899999999999999999999998   9999999999999  567899999999998764332   22


Q ss_pred             ccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCC
Q 005933          512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYS  591 (669)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (669)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.|+......   ..+......   .       ..+.....
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~---~-------~~~~~~~~  312 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLNNILAC---R-------WDLEDEEF  312 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHT---C-------CCSCSGGG
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhc---c-------CCCChhhh
Confidence            3356899999999999999999999999999999999999997533211   111110000   0       00000000


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          592 LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       592 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...+..+.+|+.+||+.||++||++.|+++
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            112356889999999999999999999987

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-39  Score=356.18  Aligned_cols=248  Identities=23%  Similarity=0.303  Sum_probs=193.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++.++||+|+||.||++... +++.||||++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            367899999999999999999965 5899999999753   334556788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |||+++|+|..++..   ...+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999854   3458999999999999999999998 77   9999999999999999999999999998643


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..  ........||+.|+|||++.+..++.++|||||||+||||++|+.|+......   .+....            ..
T Consensus       301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i------------~~  363 (446)
T 4ejn_A          301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI------------LM  363 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH------------HH
T ss_pred             CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHH------------Hh
Confidence            22  22233467999999999999999999999999999999999999996532211   111000            00


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                      ..  ..++...+..+.+|+.+||+.||++||     +++|+++
T Consensus       364 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          364 EE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            00  112223345788999999999999999     9999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.7e-39  Score=338.72  Aligned_cols=259  Identities=29%  Similarity=0.431  Sum_probs=203.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeC------CCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|.+.+.||+|+||.||+|...      +++.||||++... ......++.+|+.+++.++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            468999999999999999999842      4778999999654 334566899999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEe
Q 005933          422 MLIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKIS  494 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~  494 (669)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432    245899999999999999999999998   999999999999994   4469999


Q ss_pred             ecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhc
Q 005933          495 DFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       495 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      |||++................++..|+|||++.+..++.++||||||+++|||++ |..|+......   ....      
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~------  256 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE------  256 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH------
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHH------
Confidence            9999876543333333334567889999999999999999999999999999998 88886532211   1110      


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                             .+........+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus       257 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          257 -------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                   0110011112223345788999999999999999999999999765

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.2e-38  Score=324.53  Aligned_cols=262  Identities=19%  Similarity=0.258  Sum_probs=202.4

Q ss_pred             HhcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEE-ecCCcceEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC-TLRDERMLIY  425 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~  425 (669)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++....  ....+..|+.++..++|++++..++.+ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 568999999875433  234688999999999988777666555 6677789999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE---cCCcceEEeecCCCccc
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAF  502 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~Dfgla~~~  502 (669)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999998642  345899999999999999999999998   9999999999999   78899999999999876


Q ss_pred             CCCccC-----cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          503 GVDQTE-----ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       503 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ......     .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            543321     122346789999999999999999999999999999999999999875443333222221111100000


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..     .+..    ..+..+.+++.+||+.||++||++.+|++.|+..
T Consensus       239 ~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          239 IE-----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HH-----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hh-----hhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            00     0001    1135788999999999999999999999999865

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.8e-39  Score=328.18  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=202.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999975 48999999986542  334577889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc---eEEeecCCCccc
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFGMARAF  502 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~Dfgla~~~  502 (669)
                      ||+++++|.+.+...   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999999988543   45899999999999999999999998   999999999999986655   999999999765


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ....   ......+++.|+|||++.+..++.++||||||+++|+|++|+.|+......   .........    .    .
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~----~----~  224 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAG----A----Y  224 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT----C----C
T ss_pred             ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHhc----c----c
Confidence            4322   223457899999999999999999999999999999999999996432111   111100000    0    0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  .........+..+.+++.+||+.||++|||+.|+++
T Consensus       225 ~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          225 D--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             C--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c--CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0  000001122456889999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.2e-39  Score=328.25  Aligned_cols=249  Identities=28%  Similarity=0.441  Sum_probs=183.9

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46789999999999999999997 468999999986432   23457899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++..  ....+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999953  3356899999999999999999999998   99999999999999999999999999987543


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........               .....
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~  227 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLA  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhc
Confidence            221  1223568999999999999899999999999999999999999975432211100               00000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  ...+...+..+.+++.+||+.||++||++.++++
T Consensus       228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            0  0112223456789999999999999999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.9e-39  Score=329.15  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=200.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++.+.||+|+||.||++.... ++.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4678999999999999999999764 7799999986432   23456789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+||+|+.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999998543   45899999999999999999999998   99999999999999999999999998865322


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .    ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+......   ......            .. 
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~------------~~-  221 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRI------------SR-  221 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH------------HH-
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHHHH------------Hh-
Confidence            2    223357899999999999999999999999999999999999996532211   000000            00 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                       .....+...+..+.+|+.+||+.||++||++.|+++-
T Consensus       222 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 -VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0111222234567899999999999999999999963

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.2e-39  Score=331.24  Aligned_cols=257  Identities=26%  Similarity=0.361  Sum_probs=200.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC----CcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEe-cCCcce
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCT-LRDERM  422 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~  422 (669)
                      ..+|.+.++||+|+||.||+|...+    ...||||.+..... ...+.+.+|+.++++++||||+++++++. ..+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568888999999999999999643    23589999875433 34678999999999999999999999864 456789


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999954  3455899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccC--cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCccchhhHhhhhcccccch
Q 005933          503 GVDQTE--ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-RNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       503 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ......  .......+|..|+|||.+.+..++.++||||||+++|||++|. +|+......   .......         
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~~---------  246 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL---------  246 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHHH---------
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHh---------
Confidence            433221  1223356778999999999999999999999999999999954 443322111   1111100         


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                          .......+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       247 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          247 ----QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                0001111222345688999999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.9e-38  Score=322.91  Aligned_cols=261  Identities=20%  Similarity=0.263  Sum_probs=205.2

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEE-ecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC-TLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~E  426 (669)
                      .++|.+.+.||+|+||.||+|+. .+++.||||++....  ..+++.+|+.++..++|++++..+..+ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            56899999999999999999996 569999999986543  335789999999999988766655554 66677899999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE---cCCcceEEeecCCCcccC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFG  503 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~Dfgla~~~~  503 (669)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+||||   +.++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999999542  345899999999999999999999998   9999999999999   488899999999998765


Q ss_pred             CCccCc-----CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          504 VDQTEA-----NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       504 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      ......     ......++..|+|||++.+..++.++||||||+++|||++|+.|+........................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            433211     123467899999999999999999999999999999999999998754433222222211111000000


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       579 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                           ..+.    ...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus       240 -----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          240 -----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -----HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -----HHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence                 0001    11235688999999999999999999999999865

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=326.81  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=200.3

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      +|.....||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4445569999999999999964 588999999987666667889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecCCCcccCCCccC
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      +++|.+++........+++..+..++.||+.||.|||+.+   ++|+||||+||+++. ++.+||+|||++.......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            9999999976544556789999999999999999999998   999999999999997 8999999999998753321  


Q ss_pred             cCcccccccCCccCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      .......++..|+|||++.+..  ++.++||||||+++|||++|+.|+.......  .   ....         ......
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~---------~~~~~~  243 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--A---AMFK---------VGMFKV  243 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--H---HHHH---------HHHHCC
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--H---HHHh---------hccccc
Confidence            1223457899999999997654  8899999999999999999999864221110  0   0000         000011


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....+...+..+.+++.+||+.||++||++.++++
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11223334467889999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=347.82  Aligned_cols=261  Identities=20%  Similarity=0.225  Sum_probs=205.3

Q ss_pred             HHHHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEec
Q 005933          342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL  417 (669)
Q Consensus       342 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~  417 (669)
                      +.++....++|++.+.||+|+||.||+++.+ +++.||||++.+..   ....+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455789999999999999999999975 59999999996532   2345568999999999999999999999999


Q ss_pred             CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       418 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      .+..+|||||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            99999999999999999999643  235899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAI-------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      +++....... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||......   .......
T Consensus       208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~  283 (412)
T 2vd5_A          208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIV  283 (412)
T ss_dssp             TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH
T ss_pred             hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence            9987643222 1223467999999999997       357899999999999999999999997532211   1111100


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHH
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDR---PNMSSVVL  621 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~  621 (669)
                      ..   .  ....    ........+..+.+|+.+||+ +|++|   |+++|+++
T Consensus       284 ~~---~--~~~~----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          284 HY---K--EHLS----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             TH---H--HHCC----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             hc---c--cCcC----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            00   0  0000    000111234578899999999 99998   68999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.9e-39  Score=338.67  Aligned_cols=247  Identities=28%  Similarity=0.392  Sum_probs=198.8

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .+.|.+.+.||+|+||.||+|.. .+++.||||++.....   ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34588889999999999999996 4689999999975432   2346789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+. |+|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 6888877532  345899999999999999999999998   99999999999999999999999999976532


Q ss_pred             CccCcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .      ....||+.|+|||++.   +..++.++|||||||++|||++|+.|+......      ..........     
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~-----  269 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-----  269 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-----
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-----
Confidence            2      2357899999999985   567899999999999999999999996432111      1111110000     


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                       .+.   ......+..+.+++.+||+.||++|||+.++++.
T Consensus       270 -~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          270 -SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -CCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             000   1111224567899999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.8e-39  Score=336.65  Aligned_cols=243  Identities=21%  Similarity=0.314  Sum_probs=202.0

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--------cchHHHHHHHHHHHHhCCCceeEEEEEEecC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  418 (669)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....        ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999964 589999999975421        2345788899999999999999999999999


Q ss_pred             CcceEEEeecCCC-CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          419 DERMLIYEYLPNK-SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       419 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      +..++||||+.+| +|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 99999843   345899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      ++.......   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.....                 
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------  235 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------  235 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence            998764322   2233578999999999998877 8899999999999999999999642110                 


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                          .......  .+...+..+.+|+.+||+.||++|||+.++++-
T Consensus       236 ----~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ----TVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----GTTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----HHhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                1111111  111124568899999999999999999999984

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-39  Score=343.33  Aligned_cols=255  Identities=26%  Similarity=0.375  Sum_probs=192.4

Q ss_pred             CCCccCeeeecCccceEEEEeCC----CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEec-CCcceEE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL-RDERMLI  424 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV  424 (669)
                      .|.+.+.||+|+||.||+|.+.+    +..||||.+.... ....++|.+|+.++++++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46677899999999999999642    2468999986543 3456789999999999999999999998754 4578999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999953  3345889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CccC--cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          505 DQTE--ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       505 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ....  .......++..|+|||++.+..++.++||||||+++|||++ |.+|+......   ........          
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~~----------  311 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQ----------  311 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHHT----------
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHHc----------
Confidence            2211  11223456788999999999999999999999999999999 56665432221   11111000          


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                         ......+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       312 ---~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          312 ---GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               000111222345688999999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=340.00  Aligned_cols=252  Identities=15%  Similarity=0.143  Sum_probs=203.8

Q ss_pred             HhcCCCccCeeeecCccceEEEE------eCCCcEEEEEEecccCccchHHHHHHHHHHHHhC---CCceeEEEEEEecC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGM------LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLR  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~  418 (669)
                      ..++|.+.++||+|+||.||+|+      ..+++.||||++...   ...++..|+.++..++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35679999999999999999994      445899999998643   3567888888888886   99999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---------
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVT--RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---------  487 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---------  487 (669)
                      +..+|||||+++|+|.+++....  ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999996432  3456999999999999999999999998   999999999999998         


Q ss_pred             --CcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccch
Q 005933          488 --DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL  565 (669)
Q Consensus       488 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~  565 (669)
                        ++.+||+|||+++.+.............||..|+|||++.+..++.++|||||||++|||++|+.|+.......    
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence              89999999999976543333334445679999999999999999999999999999999999999854221110    


Q ss_pred             hhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHhcCC
Q 005933          566 LGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDR-PNMSSVVLMLSGE  626 (669)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~  626 (669)
                                    ..+...+.. .  .....+.+++..|++.+|.+| |+++++.+.|+..
T Consensus       293 --------------~~~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 --------------CKPEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             --------------EEECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             --------------eeechhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                          001111111 1  124456688999999999999 5788888777653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.7e-38  Score=328.29  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=205.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .+.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++..++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            457889999999999999999965 58999999997543 3456889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++.    ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999984    245899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      .  ......++..|+|||++.+..++.++||||||+++|+|++|+.|+......   .....             +....
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~-------------~~~~~  235 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL-------------IPKNN  235 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH-------------HHHSC
T ss_pred             c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH-------------hhcCC
Confidence            1  223457899999999999999999999999999999999999986532211   00000             00000


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ....+...+..+.+++.+||+.||++|||+.++++.
T Consensus       236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111122234568899999999999999999999863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.9e-39  Score=333.88  Aligned_cols=262  Identities=22%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+|... +++.||||++...   .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            457999999999999999999964 6899999999753   233457789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          425 YEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   ++|+||||+||+|+.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999986432 3456899999999999999999999998   9999999999999999999999999988654


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ...  .......++..|+|||++.+..++.++||||||+++|+|++|+.|+......    ........ ...       
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~-------  253 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EQC-------  253 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHH-HTT-------
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHh-hcc-------
Confidence            322  1223356899999999999999999999999999999999999986432111    11111000 000       


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                       ..........+..+.+++.+||+.||++||++.+|++.|+.+.+
T Consensus       254 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          254 -DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             -CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence             00000112234568899999999999999999999999988754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-38  Score=327.51  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=197.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|.+.++||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            467899999999999999999975 48999999987653 3456889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE---cCCcceEEeecCCCccc
Q 005933          427 YLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAF  502 (669)
Q Consensus       427 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~Dfgla~~~  502 (669)
                      |+++++|.+++... .....+++..++.++.||+.||+|||+.+   |+||||||+||++   +.++.+||+|||++..+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999998643 23456899999999999999999999998   9999999999999   45678999999999865


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ....   ......++..|+|||++. ..++.++||||||+++|||++|+.|+......   .......  ..        
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~~~--~~--------  240 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQKAT--YK--------  240 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH--HC--------
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhhhc--cC--------
Confidence            4322   223457899999999885 57899999999999999999999996532211   1100000  00        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..... ......+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 EPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             Ccccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000 000112356789999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-38  Score=335.26  Aligned_cols=248  Identities=24%  Similarity=0.315  Sum_probs=204.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||++...+ ++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4678899999999999999999765 7899999986542   23467789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999998542   45899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ..  .......++..|+|||++.+..++.++||||||+++|||++|+.|+......   .....            +...
T Consensus       194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~------------~~~~  256 (335)
T 2owb_A          194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLR------------IKKN  256 (335)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH------------HHHT
T ss_pred             Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHHHH------------HhcC
Confidence            22  2233457899999999999999999999999999999999999996532211   00000            0000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  ...+......+.+|+.+||+.||++||++.|+++
T Consensus       257 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          257 E--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  0112223356789999999999999999999996

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-38  Score=334.72  Aligned_cols=255  Identities=28%  Similarity=0.467  Sum_probs=202.0

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcE--EEEEEeccc-CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQE--IAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|.+.+.||+|+||.||++... ++..  ||||++... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            47889999999999999999965 4554  499998653 334567899999999999 899999999999999999999


Q ss_pred             EeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          425 YEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996532             2346899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~  570 (669)
                      ||+|||+++....   ........++..|+|||++.+..++.++||||||+++|||++ |+.|+......   ...    
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~----  251 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY----  251 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHH----
Confidence            9999999874321   112223456789999999999899999999999999999998 99886532211   000    


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                               +.+........+...+..+.+|+.+||+.||++||++.++++.|+..
T Consensus       252 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          252 ---------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             ---------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                     01111111122223346788999999999999999999999998765

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.4e-39  Score=328.25  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=197.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecC-CcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-DERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~  427 (669)
                      .++|.+.+.||+|+||.||++... ++.||||++...  ...+.+.+|+.+++.++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467889999999999999999985 899999998643  3567899999999999999999999997654 478999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++++|.+++... ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999999542 1223789999999999999999999998   999999999999999999999999998764322  


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                         .....++..|+|||++.+..++.++||||||+++|||++ |+.|+......   ....             .+....
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~-------------~~~~~~  231 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP-------------RVEKGY  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH-------------HHTTTC
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-------------HHhcCC
Confidence               122356789999999999999999999999999999998 99886533211   1110             011111


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            1122233456788999999999999999999999999764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.5e-38  Score=336.02  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=199.6

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..++|++.+.||+|+||.||++..+ +++.||||++.+...    .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567999999999999999999976 489999999975433    345788888888 7999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC----cceEEeecCCCcc
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND----MNPKISDFGMARA  501 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~----~~~kl~Dfgla~~  501 (669)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+.++    +.+||+|||++..
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999853   356899999999999999999999998   9999999999998543    3599999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .....  .......+|+.|+|||++.+..++.++|||||||++|||++|..|+..........+.....    ...    
T Consensus       170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~----  239 (342)
T 2qr7_A          170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGK----  239 (342)
T ss_dssp             CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCC----
T ss_pred             CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCC----
Confidence            54322  22334578999999999988889999999999999999999999976432222111111110    000    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ..+........+..+.+|+.+||+.||++||++.++++
T Consensus       240 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          240 --FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              00111111223456789999999999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5e-39  Score=343.22  Aligned_cols=245  Identities=21%  Similarity=0.275  Sum_probs=190.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHH-HHHhCCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLL-IAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|++.+.||+|+||.||+++.+. ++.||||++.+..   ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4679999999999999999999764 8899999997643   2334566677776 467899999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999954   345889999999999999999999998   9999999999999999999999999998632


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|..|+......   ....            .++.
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~------------~i~~  253 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD------------NILN  253 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHHH------------HHHH
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHH------------HHHh
Confidence            21  22334568999999999999999999999999999999999999996532111   1110            0111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS  618 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  618 (669)
                      ..+  .++...+..+.+|+.+||+.||.+||++.+
T Consensus       254 ~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          254 KPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             SCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            111  112223456789999999999999999853

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-38  Score=342.14  Aligned_cols=265  Identities=22%  Similarity=0.381  Sum_probs=192.2

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhC-CCceeEEEEEEecCC--c
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRD--E  420 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~  420 (669)
                      ...++|.+.+.||+|+||.||+|... +++.||||++...  .......+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34678999999999999999999965 5899999998653  2334567889999999997 999999999997554  6


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++||||++ ++|..++..    ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            799999997 689998854    35899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCc-------------------cCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005933          501 AFGVDQ-------------------TEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD  560 (669)
Q Consensus       501 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~  560 (669)
                      .+....                   .........||+.|+|||++.+ ..++.++|||||||++|||++|++||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            653211                   1112234679999999999987 67999999999999999999999997643321


Q ss_pred             CccchhhHhhhhcccccchhh-----------c----------ccccCCCC------------CHHHHHHHHHHHHHhcc
Q 005933          561 HHHNLLGHAWRLWTEDRSLEL-----------I----------DKSLDGSY------------SLSEALRCIQVGLLCVQ  607 (669)
Q Consensus       561 ~~~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~~------------~~~~~~~l~~li~~cl~  607 (669)
                      .   .+..............+           +          .......+            .......+.+|+.+||+
T Consensus       238 ~---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 N---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             H---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             H---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            1   11111111110000000           0          00000000            00123467899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 005933          608 QRPEDRPNMSSVVLM  622 (669)
Q Consensus       608 ~dP~~RPs~~evl~~  622 (669)
                      .||++|||++|+++-
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.5e-38  Score=323.06  Aligned_cols=247  Identities=22%  Similarity=0.327  Sum_probs=199.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc------cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|.+.+.||+|+||.||++... +++.||||++.....      ...+.+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357889999999999999999976 589999999865421      2467899999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc----ceEEeecC
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFG  497 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~Dfg  497 (669)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999954   345899999999999999999999998   99999999999999877    89999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ++.......   ......++..|+|||++.+..++.++||||||+++|+|++|+.|+......   .......       
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-------  224 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLTNIS-------  224 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH-------
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHHHhH-------
Confidence            998754322   223356899999999999999999999999999999999999986532211   1110000       


Q ss_pred             chhhcccccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLELIDKSLDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                           .  .....+.    ..+..+.+++.+||+.||++||++.++++
T Consensus       225 -----~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          225 -----A--VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -----T--TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----h--cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                 0  0001111    12346789999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.8e-38  Score=334.38  Aligned_cols=267  Identities=21%  Similarity=0.346  Sum_probs=200.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC-------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-------  418 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------  418 (669)
                      .++|.+.++||+|+||.||+|... +++.||||++....  ......+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            367999999999999999999974 68999999986543  23356788999999999999999999999773       


Q ss_pred             -CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          419 -DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       419 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                       +..++||||+++ +|.+.+..  ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             467999999985 77777743  3345899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCcc--CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc
Q 005933          498 MARAFGVDQT--EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT  574 (669)
Q Consensus       498 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~  574 (669)
                      +++.+.....  ........+|+.|+|||++.+. .++.++|||||||++|||++|+.|+...........+........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987643222  2223446789999999999764 589999999999999999999999764332211111111100000


Q ss_pred             cc-----cchhhc---ccccCCCCCHHH-------HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          575 ED-----RSLELI---DKSLDGSYSLSE-------ALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       575 ~~-----~~~~~~---~~~~~~~~~~~~-------~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..     ...+..   ............       ...+.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00     000000   000011111111       235789999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.9e-38  Score=346.34  Aligned_cols=258  Identities=24%  Similarity=0.271  Sum_probs=193.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCC------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------  419 (669)
                      .++|++.++||+|+||.||++... +++.||||++...  .....+++.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999965 4899999999754  3344678899999999999999999999996653      


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..+|||||++++ |.+.+.     ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            469999999765 666552     23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc---
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED---  576 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---  576 (669)
                      +.....   .......||+.|+|||++.+..++.++|||||||+||||++|+.||.......   .+..........   
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPE  285 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence            875432   22344678999999999999999999999999999999999999976432211   111111100000   


Q ss_pred             ----------------------cchhhcccccCCCCC---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 ----------------------RSLELIDKSLDGSYS---LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 ----------------------~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                            .........+.....   ......+.+|+.+||+.||++|||++|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                  000000000000000   112457899999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=336.83  Aligned_cols=261  Identities=23%  Similarity=0.352  Sum_probs=194.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc-chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ-GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|.+.++||+|+||.||+|... +++.||||++...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999976 5899999998654322 223556799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      ++ |+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            97 5898888543  345899999999999999999999998   9999999999999999999999999997643222 


Q ss_pred             CcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc---ccchhhcc
Q 005933          508 EANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE---DRSLELID  583 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  583 (669)
                       .......+|..|+|||++.+ ..++.++||||||+++|||++|+.|+........   .....+....   ........
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhc
Confidence             22233567999999999876 5689999999999999999999999764332211   1111111100   00000000


Q ss_pred             ---------cccCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 ---------KSLDGS----YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ---------~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                               +.....    ........+.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                     000000    00112346789999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.4e-38  Score=333.96  Aligned_cols=255  Identities=21%  Similarity=0.369  Sum_probs=205.1

Q ss_pred             cHHHHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--------cchHHHHHHHHHHHHh-CCCceeE
Q 005933          341 DWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKL-QHRNLVR  410 (669)
Q Consensus       341 ~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~  410 (669)
                      .+.......++|.+.+.||+|+||.||+|... +|+.||||++.....        ...+.+.+|+.++.++ +||||++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            34444556678999999999999999999986 699999999865432        1245688999999999 7999999


Q ss_pred             EEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc
Q 005933          411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN  490 (669)
Q Consensus       411 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~  490 (669)
                      +++++......++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+|+||||+||||+.++.
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            99999999999999999999999999954   245899999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN  564 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~  564 (669)
                      +||+|||++..+....   ......||+.|+|||++.+      ..++.++||||||+++|||++|+.|+......   .
T Consensus       239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~  312 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---L  312 (365)
T ss_dssp             EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H
T ss_pred             EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---H
Confidence            9999999998764322   2234678999999999863      35889999999999999999999996432110   0


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .....            .....  ....    ..+..+.+++.+||+.||++||++.++++
T Consensus       313 ~~~~i------------~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 MLRMI------------MEGQY--QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHH------------HHTCC--CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHH------------HhCCC--CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            10000            00000  0111    11346889999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-38  Score=362.96  Aligned_cols=247  Identities=27%  Similarity=0.418  Sum_probs=196.7

Q ss_pred             CeeeecCccceEEEEeC---CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      ++||+|+||.||+|.+.   .++.||||++....  ....++|.+|+.++.+++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999753   36789999997543  234678999999999999999999999996 4568899999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC-c
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-A  509 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  509 (669)
                      |+|.+++..   ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999953   345899999999999999999999998   999999999999999999999999999876443221 2


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......+|..|+|||++.+..++.++|||||||+||||++ |+.|+......   .             ..+.+......
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~-------------~~~~i~~~~~~  591 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E-------------VTAMLEKGERM  591 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H-------------HHHHHHTTCCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H-------------HHHHHHcCCCC
Confidence            2223456788999999999999999999999999999998 99996532221   1             11111111112


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ..+...+..+.+|+.+||+.||++||++.+|++.|+.
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            2233445678899999999999999999999999975

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.2e-38  Score=331.17  Aligned_cols=262  Identities=21%  Similarity=0.286  Sum_probs=204.4

Q ss_pred             HHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHH--hCCCceeEEEEEEecCC--
Q 005933          344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAK--LQHRNLVRLLGCCTLRD--  419 (669)
Q Consensus       344 ~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~--  419 (669)
                      ......++|.+.+.||+|+||.||+|+.. ++.||||++...   ....+..|++++..  ++||||+++++++....  
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            33445678999999999999999999985 899999998543   34678889999988  78999999999998876  


Q ss_pred             --cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceeccCCCCCEEEcCCc
Q 005933          420 --ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNDM  489 (669)
Q Consensus       420 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dikp~NIll~~~~  489 (669)
                        ..++||||+++|+|.+++..    ..+++..++.++.||+.||.|||        +.+   |+||||||+||||+.++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred             cceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence              78999999999999999954    24899999999999999999999        666   99999999999999999


Q ss_pred             ceEEeecCCCcccCCCccC--cCcccccccCCccCchhhccC------CCCchhhHHHHHHHHHHHHhCC----------
Q 005933          490 NPKISDFGMARAFGVDQTE--ANTDRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIVCGK----------  551 (669)
Q Consensus       490 ~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwS~G~~l~elltG~----------  551 (669)
                      .+||+|||++.........  .......+|..|+|||++.+.      .++.++||||||+++|||++|.          
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            9999999999876433221  123345789999999999776      2347899999999999999994          


Q ss_pred             CCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          552 RNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       552 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .|+........  ........        +.........     ....+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       265 ~p~~~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          265 LPYYDLVPSDP--SVEEMRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CTTTTTSCSSC--CHHHHHHH--------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCccccCcCcc--cHHHHHHH--------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            44332111110  00010010        1111111111     235567889999999999999999999999999865

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.9e-38  Score=351.04  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=206.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||++... +|+.||||++.+.   .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467889999999999999999975 5999999999653   234567789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++..+..
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999996432 334899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...........+.   .         .+..
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~---~---------~i~~  403 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---R---------LVKE  403 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH---H---------HHHH
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH---H---------Hhhc
Confidence            22   2233579999999999999999999999999999999999999976433221111110   0         0000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                       ....++...+..+.+|+.+||+.||.+||     ++.||++
T Consensus       404 -~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          404 -VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             01112223346788999999999999999     7888875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-38  Score=327.57  Aligned_cols=248  Identities=24%  Similarity=0.320  Sum_probs=204.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||++.... ++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            4678899999999999999999764 8899999986542   23457789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++...   ..+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999988542   45899999999999999999999998   99999999999999999999999999987543


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ..  .......++..|+|||++.+..++.++||||||+++|+|++|+.|+.......   ...   .         +...
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~---------~~~~  230 (294)
T 2rku_A          168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYL---R---------IKKN  230 (294)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---H---------HHTT
T ss_pred             Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H---------Hhhc
Confidence            22  22234578999999999999999999999999999999999999965322110   000   0         0000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .  ...+......+.+++.+||+.||++||++.|+++
T Consensus       231 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          231 E--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             c--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            0  0112223356789999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=323.99  Aligned_cols=252  Identities=22%  Similarity=0.265  Sum_probs=199.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC----ccchHHHHHHHHHHHHhCCCceeEEEEEEe--cCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKLQHRNLVRLLGCCT--LRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~  421 (669)
                      .++|.+.+.||+|+||.||++... +++.||||++....    ....+.+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 58899999996532    345678999999999999999999999984  45578


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||++++ |.+++... ....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999877 77777543 3456899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ..............++..|+|||++.+..  ++.++||||||+++|||++|+.|+......   ....    ...     
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~i~-----  226 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFE----NIG-----  226 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHH-----
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHH----HHh-----
Confidence            65433333334567899999999997654  478999999999999999999996532111   1100    000     


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                         ...  ...+...+..+.+++.+||+.||++||++.|+++.
T Consensus       227 ---~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          227 ---KGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ---HCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---cCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               000  01122234567899999999999999999999963

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.3e-39  Score=329.28  Aligned_cols=259  Identities=24%  Similarity=0.315  Sum_probs=203.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEec--CCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l  423 (669)
                      .++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468899999999999999999976 58999999997542  3346789999999999999999999998754  567899


Q ss_pred             EEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          424 IYEYLPNKSLEQFIFDVT-RTKFLDWSKRCQIIEGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      ||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+  ..+++|+||||+||+++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999996532 3345899999999999999999999976  2349999999999999999999999999987


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      .......  ......++..|+|||++.+..++.++||||||+++|+|++|+.|+......   .+...    ...     
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----i~~-----  230 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGK----IRE-----  230 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHH-----
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHH----Hhh-----
Confidence            6533211  122356899999999999999999999999999999999999986543211   11100    000     


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                          ......+...+..+.+++.+||+.||++||++.||++.+..
T Consensus       231 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          231 ----GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                00111222334678899999999999999999999987744

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-38  Score=333.48  Aligned_cols=266  Identities=24%  Similarity=0.305  Sum_probs=197.5

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-----cchHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-----QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      ...++|.+.+.||+|+||.||++... +|+.||||++.....     ...+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999975 489999999864322     123578899999999999999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++||||+++ +|..++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 88888843  3356889999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc-
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS-  578 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  578 (669)
                      .+....  .......+|+.|+|||++.+. .++.++|||||||++|||++|.+|+......   ..+............ 
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEE  235 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChh
Confidence            764322  223345789999999999764 5899999999999999999999886543211   111111111000000 


Q ss_pred             -----hhhccccc---CCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 005933          579 -----LELIDKSL---DGSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVLML  623 (669)
Q Consensus       579 -----~~~~~~~~---~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  623 (669)
                           ..+.+...   ....+.     ..+..+.+|+.+||+.||++|||+.|+++.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence                 00000000   011111     1235788999999999999999999999753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.5e-39  Score=336.19  Aligned_cols=265  Identities=23%  Similarity=0.356  Sum_probs=199.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .++|++.+.||+|+||.||++.... ++.||||++.....  ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3578999999999999999999765 89999999865433  23466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++..+...
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999988742   345899999999999999999999998   999999999999999999999999999865432


Q ss_pred             ccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhH--------hhhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH--------AWRLWTED  576 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~  576 (669)
                      .  .......++..|+|||++.+. .++.++||||||+++|||++|+.|+...........+..        ....+...
T Consensus       178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  222345789999999999876 789999999999999999999999764332111000000        00000000


Q ss_pred             c-chhhcccccCCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 R-SLELIDKSLDGSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 ~-~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      . ......+.+....+.     ..+..+.+|+.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0 000001111111111     12457889999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-38  Score=339.83  Aligned_cols=263  Identities=23%  Similarity=0.317  Sum_probs=203.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999976 58999999997653 3345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      |+++++|.+++...   ..+++..+..++.||+.||.|||+. +   |+||||||+||||+.++.+||+|||++..... 
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            99999999999543   3589999999999999999999985 7   99999999999999999999999999975422 


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhH-----------------
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH-----------------  568 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~-----------------  568 (669)
                         .......++..|+|||++.+..++.++||||||+++|||++|+.|+..............                 
T Consensus       185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence               122335789999999999999999999999999999999999999764322111000000                 


Q ss_pred             ------hhhhcccccchhhcccccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          569 ------AWRLWTEDRSLELIDKSLDG----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       569 ------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                            ...........+.++.....    ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                  00000000011111111111    011122456889999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-38  Score=335.48  Aligned_cols=263  Identities=23%  Similarity=0.309  Sum_probs=192.3

Q ss_pred             HHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ...++|.+.++||+|+||+||++... +++.||||++.....  ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34578999999999999999999965 589999999965432  235678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-----CCcceEEeecCC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-----NDMNPKISDFGM  498 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-----~~~~~kl~Dfgl  498 (669)
                      ||||++ |+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+     .++.+||+|||+
T Consensus       111 v~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999998 499999854   335899999999999999999999998   99999999999994     455699999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      +..+....  .......+|..|+|||++.+. .++.++|||||||++|||++|+.|+.......   .+...........
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~  258 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPD  258 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCC
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCc
Confidence            98764322  122335679999999999875 58999999999999999999999975432211   1111111000000


Q ss_pred             ---chhh-----cccccC--CCCCHH------HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 ---SLEL-----IDKSLD--GSYSLS------EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ---~~~~-----~~~~~~--~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         ....     ......  ......      ....+.+|+.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence               0000     000000  000111      2356789999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-37  Score=327.12  Aligned_cols=256  Identities=19%  Similarity=0.302  Sum_probs=199.6

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEec--CCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTL--RDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV  424 (669)
                      .++|++.++||+|+||.||+|.. .+++.||||++..   ...+.+.+|+.++..++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999986 4589999999863   33578999999999997 9999999999987  5678999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeecCCCcccC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFG  503 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla~~~~  503 (669)
                      |||+++++|.+++.      .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999983      2889999999999999999999998   99999999999999776 89999999998754


Q ss_pred             CCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ...   ......++..|+|||++.+ ..++.++|||||||++|||++|+.|+......  ...+.............+.+
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHH
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHH
Confidence            332   2234578999999999987 67999999999999999999999996432211  11111111111111111100


Q ss_pred             c-----------------------cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 D-----------------------KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +                       ...........+..+.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0                       00111111123567889999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=335.66  Aligned_cols=267  Identities=26%  Similarity=0.362  Sum_probs=193.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHH--HHHhCCCceeEEEEEEec-----CCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLL--IAKLQHRNLVRLLGCCTL-----RDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~-----~~~~  421 (669)
                      .++|.+.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46889999999999999999987 58999999986432   3444445444  445899999999986532     2246


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCceeccCCCCCEEEcCCcceE
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD---------SRLRIIHRDLKASNVLLDNDMNPK  492 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------~~~~iiH~Dikp~NIll~~~~~~k  492 (669)
                      ++||||+++|+|.+++...    ..++..++.++.||++||+|||+.         +   |+||||||+||||+.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            8999999999999999542    358999999999999999999998         7   99999999999999999999


Q ss_pred             EeecCCCcccCCCcc------CcCcccccccCCccCchhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005933          493 ISDFGMARAFGVDQT------EANTDRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA  559 (669)
Q Consensus       493 l~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwS~G~~l~elltG~~p~~~~~~  559 (669)
                      |+|||++..+.....      ........||..|+|||++.+       ..++.++|||||||++|||++|..|+-....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987643221      112224568999999999987       4567799999999999999999776432221


Q ss_pred             -CCccchhhHhhhhc-ccccchhhc-ccccCCC------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          560 -DHHHNLLGHAWRLW-TEDRSLELI-DKSLDGS------YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       560 -~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                       .............. ........+ .......      .....+..+.+|+.+||+.||++|||+.|+++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence             11111111000000 000000000 0011111      1223556799999999999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.3e-38  Score=328.98  Aligned_cols=259  Identities=21%  Similarity=0.333  Sum_probs=205.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|.+.+.||+|+||.||++... +|+.||||++........+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467899999999999999999975 5899999999766555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE---cCCcceEEeecCCCcccCC
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~Dfgla~~~~~  504 (669)
                      +++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++|+||||+||++   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999998543   45899999999999999999999998   9999999999999   7889999999999875432


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .    ......++..|+|||++.+..++.++||||||+++|||++|+.|+......   .+.......    .      .
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~----~------~  224 (304)
T 2jam_A          162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEG----Y------Y  224 (304)
T ss_dssp             B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHC----C------C
T ss_pred             C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcC----C------C
Confidence            1    223356899999999999999999999999999999999999996532211   111110000    0      0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HhcCCCCCC
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGERSLP  630 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~  630 (669)
                      ..........+..+.+++.+||+.||++||++.++++  .+.+...+.
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (304)
T 2jam_A          225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH  272 (304)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSCC
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCccc
Confidence            0011111223457889999999999999999999996  455544433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.7e-38  Score=343.85  Aligned_cols=197  Identities=23%  Similarity=0.419  Sum_probs=155.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC-----Cc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~  420 (669)
                      .++|.+.+.||+|+||.||+|... +++.||||++....  ....+++.+|+.+|+.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999965 58999999996542  23457889999999999999999999999543     56


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++||||+ +++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 578999884   3356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCccC-------------------------cCcccccccCCccCchhh-ccCCCCchhhHHHHHHHHHHHHhCCC
Q 005933          501 AFGVDQTE-------------------------ANTDRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIVCGKR  552 (669)
Q Consensus       501 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~sDVwS~G~~l~elltG~~  552 (669)
                      ........                         ......+||+.|+|||++ ....++.++|||||||+||||++|..
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            76432211                         122345789999999986 45679999999999999999999543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-38  Score=329.57  Aligned_cols=262  Identities=18%  Similarity=0.233  Sum_probs=198.6

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ..++|.+.+.||+|+||.||++... +++.||||++.....   ...+.+.+|+.++..++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999975 588999999975432   234788999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999999643   45899999999999999999999998   9999999999999999999999999997654


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      .... .......++..|+|||++.+..++.++||||||+++|||++|+.|+......    ...   ...... ..   .
T Consensus       186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~---~~~~~~-~~---~  253 (309)
T 2h34_A          186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMG---AHINQA-IP---R  253 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHH---HHHHSC-CC---C
T ss_pred             cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHH---HHhccC-CC---C
Confidence            3221 1223456899999999999999999999999999999999999996532211    000   000000 00   0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhcCCCCCC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGERSLP  630 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~  630 (669)
                      .   .......+..+.+++.+||+.||++|| +++++++.|+......
T Consensus       254 ~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 P---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             G---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             c---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            0   011112234678999999999999999 9999999998764433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.5e-38  Score=324.22  Aligned_cols=246  Identities=24%  Similarity=0.324  Sum_probs=203.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||++... +++.||||++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            357889999999999999999976 4789999998643   233457899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999999643   35899999999999999999999998   99999999999999999999999999876432


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .    ......++..|+|||++.+..++.++||||||+++|+|++|+.|+......   ....            .+...
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~------------~~~~~  227 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---ETHR------------RIVNV  227 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH------------HHHTT
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---HHHH------------HHhcc
Confidence            2    123457899999999999999999999999999999999999996532211   0000            00000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ....+...+..+.+++.+||+.||++||++.++++
T Consensus       228 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 --DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence              01122223456789999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-37  Score=346.55  Aligned_cols=255  Identities=27%  Similarity=0.378  Sum_probs=206.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+++.. +|+.||||++.+..   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888999999999999999975 59999999996532   34467889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          425 YEYLPNKSLEQFIFDVTR-TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      |||+++|+|..++..... ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999865432 446999999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+  . .        .+..
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~-~--------~i~~  407 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--K-Q--------RVLE  407 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--H-H--------HHHH
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--H-H--------HHhh
Confidence            3321  223358999999999999999999999999999999999999997643221111000  0 0        0111


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNM-----SSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  621 (669)
                      ..  ..++...+..+.+|+.+||+.||++||++     .++++
T Consensus       408 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          408 QA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             cc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            11  11223334678899999999999999975     66663

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-37  Score=335.51  Aligned_cols=252  Identities=20%  Similarity=0.247  Sum_probs=190.6

Q ss_pred             hcCCCcc-CeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEec----CCcc
Q 005933          349 TDNFSWK-NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL----RDER  421 (669)
Q Consensus       349 ~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~  421 (669)
                      .++|.+. +.||+|+||.||++... +++.||||++..     ...+.+|+.++.++ +||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3466665 68999999999999976 489999999853     24677899887554 89999999998865    5668


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEeecCC
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGM  498 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~Dfgl  498 (669)
                      +|||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999999642 2345899999999999999999999998   999999999999997   78999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc-hhhHhhhhccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN-LLGHAWRLWTEDR  577 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~  577 (669)
                      ++.....   .......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ...... .   . 
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~-~---~-  282 (400)
T 1nxk_A          211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-M---G-  282 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH-H---T-
T ss_pred             ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH-c---C-
Confidence            9865322   12234678999999999999999999999999999999999999976433322110 100000 0   0 


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                           ............+..+.+|+.+||+.||++|||+.|+++-
T Consensus       283 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 -----QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -----CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 0000000011234568899999999999999999999973

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-38  Score=336.63  Aligned_cols=255  Identities=23%  Similarity=0.326  Sum_probs=203.4

Q ss_pred             hcCCCccCeeeecCccceEEEEe----CCCcEEEEEEecccC----ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCC
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML----TEGQEIAVKRLSKSS----GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRD  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  419 (669)
                      .++|.+.+.||+|+||.||++..    .+++.||||++....    ....+.+.+|+.++..+ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35789999999999999999997    368999999986532    23456788899999999 6999999999999999


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999999643   35899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      +.+..... .......||+.|+|||++.+.  .++.++|||||||+||||++|+.|+...........+  ....     
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~-----  278 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRI-----  278 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHH-----
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHH-----
Confidence            86543222 222345789999999999863  5789999999999999999999997643322111111  0000     


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLML  623 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  623 (669)
                          ..  .....+...+..+.+|+.+||+.||++||     ++.|+++..
T Consensus       279 ----~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          279 ----LK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ----HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ----hc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                00  01122233345678999999999999999     999998754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=335.30  Aligned_cols=262  Identities=15%  Similarity=0.156  Sum_probs=203.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC---------CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeE---------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE---------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVR---------  410 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  410 (669)
                      .++|.+.+.||+|+||.||+|....         ++.||||++...     +.+.+|+.++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999764         789999998643     46889999999999999987         


Q ss_pred             ------EEEEEec-CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCE
Q 005933          411 ------LLGCCTL-RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNV  483 (669)
Q Consensus       411 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NI  483 (669)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777766 67789999999 99999999643 2356999999999999999999999998   99999999999


Q ss_pred             EEcCCc--ceEEeecCCCcccCCCccC-----cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005933          484 LLDNDM--NPKISDFGMARAFGVDQTE-----ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF  556 (669)
Q Consensus       484 ll~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~  556 (669)
                      |++.++  .+||+|||+++.+......     .......+|+.|+|||++.+..++.++||||||++||||++|+.|+..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999876433221     112335789999999999999999999999999999999999999764


Q ss_pred             CCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          557 YHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .....  ..+......+. .....+.....   .....+..+.+|+.+||+.||++||++.+|++.|+..
T Consensus       271 ~~~~~--~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          271 CLPNT--EDIMKQKQKFV-DKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GTTCH--HHHHHHHHHHH-HSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CCcCH--HHHHHHHHhcc-CChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            33211  11111111000 00011111000   0011246688999999999999999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.3e-38  Score=341.25  Aligned_cols=248  Identities=20%  Similarity=0.311  Sum_probs=190.4

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccC--------ccchHHHHHHHHHHHHhCCCceeEEEEEEecC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  418 (669)
                      ..++|.+.+.||+|+||.||+|.... ++.||||++....        ......+.+|+.++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            46789999999999999999999754 8999999986532        122346889999999999999999999975 4


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc---ceEEee
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---NPKISD  495 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~---~~kl~D  495 (669)
                      +..++||||+++|+|.+++.   ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++   .+||+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            55799999999999999884   3456999999999999999999999998   99999999999997544   599999


Q ss_pred             cCCCcccCCCccCcCcccccccCCccCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       496 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      ||+++.....   .......||+.|+|||++.+   ..++.++|||||||++|||++|+.|+........  +....   
T Consensus       286 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i---  357 (419)
T 3i6u_A          286 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI---  357 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH---
T ss_pred             cccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH---
Confidence            9999876432   22334678999999999864   5788999999999999999999999754322111  11100   


Q ss_pred             cccccchhhcccccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 WTEDRSLELIDKSLDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                .... .....    ..+..+.+++.+||+.||++||++.|+++
T Consensus       358 ----------~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 ----------TSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ----------HTTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----------hcCC-CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                      0000 00111    12356889999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.2e-38  Score=330.72  Aligned_cols=264  Identities=21%  Similarity=0.298  Sum_probs=206.2

Q ss_pred             CccHHHHHHHhcCCCcc-CeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhC-CCceeEEEE
Q 005933          339 MFDWNTIADATDNFSWK-NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQ-HRNLVRLLG  413 (669)
Q Consensus       339 ~~~~~~l~~~~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g  413 (669)
                      ...+.......+.|.+. +.||+|+||.||++... +++.||||++....  ......+.+|+.++..+. ||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34444555666778877 88999999999999976 48999999987542  334678999999999995 699999999


Q ss_pred             EEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---Ccc
Q 005933          414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMN  490 (669)
Q Consensus       414 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~  490 (669)
                      ++...+..++||||+++|+|.+++.. .....+++..++.++.||+.||+|||+.+   |+||||||+||||+.   ++.
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence            99999999999999999999999843 23356899999999999999999999998   999999999999998   789


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      +||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|||++|+.|+......   .......
T Consensus       173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~  246 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNIS  246 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred             EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHH
Confidence            9999999998764322   223357899999999999999999999999999999999999996532211   1100000


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ..          ............+..+.+++.+||+.||++|||++++++-
T Consensus       247 ~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          247 QV----------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HT----------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             hc----------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00          0001111112234568899999999999999999999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.2e-38  Score=341.66  Aligned_cols=199  Identities=25%  Similarity=0.419  Sum_probs=167.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC-----Cc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~  420 (669)
                      .++|.+.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999975 48899999997542  23457889999999999999999999999776     56


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++||||++ ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 599999843   356899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCccC--------------------cCcccccccCCccCchhh-ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005933          501 AFGVDQTE--------------------ANTDRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIVCGKRNR  554 (669)
Q Consensus       501 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~sDVwS~G~~l~elltG~~p~  554 (669)
                      ........                    .......+|+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            76433211                    123456889999999986 4567999999999999999999866554

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.1e-38  Score=326.81  Aligned_cols=259  Identities=27%  Similarity=0.382  Sum_probs=196.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC--CCc--EEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT--EGQ--EIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|++.+.||+|+||.||+|++.  +++  .||||++...   .....+.+.+|+.+++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357899999999999999999853  233  6899998654   2345678999999999999999999999998754 8


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++|+||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999999643  345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          502 FGVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       502 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ....... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+......   .....           
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~-----------  236 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHK-----------  236 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH-----------
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHH-----------
Confidence            6433221 12233456788999999999899999999999999999999 99886532211   11110           


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                       +.........+...+..+.+++.+||+.||++||++.++++.|+....
T Consensus       237 -~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          237 -IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -HHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence             000001111222344678899999999999999999999999987543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-38  Score=330.22  Aligned_cols=264  Identities=25%  Similarity=0.403  Sum_probs=186.5

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..++|.+.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++..++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3578999999999999999999964 58999999986442 344677899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          426 EYLPNKSLEQFIFDV-----TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       426 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      ||+++++|.+++...     .....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999998642     23456899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCcc---CcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          501 AFGVDQT---EANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       501 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      .......   ........++..|+|||++.+ ..++.++||||||+++|||++|+.|+.......   ........    
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~----  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQN----  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTS----
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhcc----
Confidence            6543211   112234578999999999876 568999999999999999999999976432211   11111000    


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..................+..+.+++.+||+.||.+||++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000000000001111122356789999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.7e-38  Score=336.88  Aligned_cols=268  Identities=21%  Similarity=0.277  Sum_probs=198.8

Q ss_pred             HHHHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCcc-----------chHHHHHHHHHHHHhCCCceeE
Q 005933          342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ-----------GVEEFKNEVLLIAKLQHRNLVR  410 (669)
Q Consensus       342 ~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~  410 (669)
                      ..++....++|.+.+.||+|+||.||+|...+++.||||++......           ..+.+.+|+.+++.++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45677788999999999999999999999888999999998653221           1378999999999999999999


Q ss_pred             EEEEEecC-----CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          411 LLGCCTLR-----DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       411 l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                      +++++...     ...++||||++ |+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||||
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            99998543     35799999998 688888753  3456899999999999999999999998   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN  564 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~  564 (669)
                      +.++.+||+|||++......   .......++..|+|||++.+ ..++.++||||||+++|+|++|+.|+.......   
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---  241 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---  241 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---
T ss_pred             cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---
Confidence            99999999999999754322   22234578899999999987 679999999999999999999999976432211   


Q ss_pred             hhhHhhhhcccc-----------cchhhcccccCCC--CC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          565 LLGHAWRLWTED-----------RSLELIDKSLDGS--YS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       565 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~--~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ............           ...+.+.......  ..     ......+.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            111111111100           0111111111100  00     112346889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.1e-38  Score=327.48  Aligned_cols=253  Identities=23%  Similarity=0.385  Sum_probs=198.5

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ..++|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++..++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            35689999999999999999999864 89999999987766778899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++...  ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++...... 
T Consensus        97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-  170 (302)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999998643  344899999999999999999999998   999999999999999999999999987542111 


Q ss_pred             cCcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          507 TEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                       ........++..|+|||++.     +..++.++||||||+++|+|++|+.|+......   ...   ...... ...  
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~~-~~~--  240 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVL---LKIAKS-DPP--  240 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHHS-CCC--
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHH---HHHhcc-CCc--
Confidence             11122356899999999983     667899999999999999999999986533211   000   000000 000  


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                           ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       241 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 -----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 00112223456889999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.4e-39  Score=345.99  Aligned_cols=242  Identities=17%  Similarity=0.176  Sum_probs=189.3

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEeccc---CccchHHHHHHHH---HHHHhCCCceeEEE-------EE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKS---SGQGVEEFKNEVL---LIAKLQHRNLVRLL-------GC  414 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------g~  414 (669)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 45999999999743   3345678999995   55555899999998       66


Q ss_pred             EecCC-----------------cceEEEeecCCCCHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 005933          415 CTLRD-----------------ERMLIYEYLPNKSLEQFIFDVTR----TKFLDWSKRCQIIEGIARGLLYLHQDSRLRI  473 (669)
Q Consensus       415 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  473 (669)
                      +...+                 ..++||||+ +|+|.+++.....    ...+++..++.++.||+.||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            65543                 278999999 6899999964321    223556889999999999999999998   9


Q ss_pred             eeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccC-----------CCCchhhHHHHHH
Q 005933          474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-----------LFSVKSDVFSFGV  542 (669)
Q Consensus       474 iH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~sDVwS~G~  542 (669)
                      +||||||+||||+.++.+||+|||+++....     ......| ..|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986322     2223466 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          543 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       543 ~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +||||++|+.|+.........                   .......  ...+..+.+|+.+||+.||++||++.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~~-------------------~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGS-------------------EWIFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCS-------------------GGGGSSC--CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccch-------------------hhhhhhc--cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999996533221110                   0000100  112356789999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.3e-38  Score=322.02  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=195.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+|... +++.||||++...   .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367899999999999999999976 6899999998653   234567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999999543   35899999999999999999999998   99999999999999999999999999987543


Q ss_pred             CccCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      ..   ......++..|+|||.+.+..+ +.++||||||+++|+|++|+.|+......   .....    ...        
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~----~~~--------  225 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKK----IRG--------  225 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHH--------
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHH----hhc--------
Confidence            22   1233568899999999988765 68999999999999999999986532111   11100    000        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ..  ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus       226 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          226 GV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             Cc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00  01122224567899999999999999999999973

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=330.99  Aligned_cols=260  Identities=27%  Similarity=0.412  Sum_probs=198.8

Q ss_pred             ccHHHHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEec
Q 005933          340 FDWNTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL  417 (669)
Q Consensus       340 ~~~~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~  417 (669)
                      +++.++....++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            344445556789999999999999999999974 5899999998644 33457899999999999 79999999999977


Q ss_pred             ------CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          418 ------RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       418 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                            .+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+||||+.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                  45789999999999999999653 2356899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL  566 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~  566 (669)
                      ||+|||++.......  .......++..|+|||++.     +..++.++||||||+++|+|++|+.|+......   ...
T Consensus       169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~  243 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RAL  243 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH
T ss_pred             EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH
Confidence            999999998653221  1223357899999999997     567899999999999999999999986432211   000


Q ss_pred             hHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          567 GHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         ..... ..     .+.   ......+..+.+++.+||+.||++||++.++++
T Consensus       244 ---~~~~~-~~-----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 ---FLIPR-NP-----APR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ---HHHHH-SC-----CCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHhhc-Cc-----ccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               00000 00     000   011122456889999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.8e-38  Score=359.20  Aligned_cols=249  Identities=27%  Similarity=0.354  Sum_probs=204.7

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcce
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  422 (669)
                      ..++|++.+.||+|+||.||++... +++.||||++.+.   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3468999999999999999999976 4889999999753   334567888999999988 7999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      |||||+++|+|..++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999999643   45899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ....  .......||+.|+|||++.+..++.++|||||||+||||++|+.||......   .+..            .++
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~------------~i~  555 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ------------SIM  555 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH------------HHH
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHH------------HHH
Confidence            2222  2234568999999999999999999999999999999999999997532211   1111            111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNM-----SSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  621 (669)
                      ...  ..++...+..+.+|+.+||+.||++||++     +||++
T Consensus       556 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          556 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            111  12233345678899999999999999998     77764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.2e-37  Score=337.81  Aligned_cols=261  Identities=20%  Similarity=0.250  Sum_probs=205.4

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCC-CceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|.+.++||+|+||.||+|.. .+++.||||++.....  ..++..|+.++..++| +++..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999996 4589999998765432  3468899999999986 566667777788888999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE---cCCcceEEeecCCCcccC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARAFG  503 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~Dfgla~~~~  503 (669)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999999643  345899999999999999999999998   9999999999999   688999999999998765


Q ss_pred             CCccCc-----CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          504 VDQTEA-----NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       504 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      ......     ......||..|+|||++.+..++.++|||||||+||||++|+.|+...........+............
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            433211     122567999999999999999999999999999999999999997654433222222111111100011


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       579 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..+.     .    ..+..+.+|+..||+.+|++||++.+|+++|+..
T Consensus       238 ~~l~-----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          238 EALC-----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHH-----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHh-----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1110     1    1135788999999999999999999999988754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-38  Score=334.12  Aligned_cols=257  Identities=21%  Similarity=0.308  Sum_probs=194.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------  419 (669)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+++.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999975 59999999986532  234567899999999999999999999997763      


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++||||+ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899999854    35899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc---
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE---  575 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---  575 (669)
                      +.....     .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.|+......   ..+.........   
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPA  247 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCH
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence            875322     234578999999999987 68999999999999999999999997643221   111111110000   


Q ss_pred             --------ccchhhccccc---CC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          576 --------DRSLELIDKSL---DG---SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       576 --------~~~~~~~~~~~---~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                              ......+....   ..   .........+.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                    00000000000   00   011122456889999999999999999999997

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.6e-38  Score=326.51  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=198.0

Q ss_pred             HHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC--ccchHHHHHHHHHHHHhC--CCceeEEEEEEecCCc
Q 005933          345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLRDE  420 (669)
Q Consensus       345 l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~  420 (669)
                      +....++|.+.+.||+|+||.||++...+++.||||++....  ....+.+.+|+.++.+++  |+||+++++++...+.
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            334467899999999999999999999889999999986542  345678999999999997  5999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++||| +.+++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||+++ +.+||+|||++.
T Consensus       103 ~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~  174 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN  174 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred             EEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence            999999 668899999954   346899999999999999999999998   999999999999975 899999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  569 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~  569 (669)
                      ...............++..|+|||++.+           ..++.++||||||+++|||++|+.|+......     ... 
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~-  248 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK-  248 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHH-
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHH-
Confidence            7654333333344578999999999875           47889999999999999999999996532111     000 


Q ss_pred             hhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          570 WRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                              ....++.......+...+..+.+++.+||+.||++||++.|+++
T Consensus       249 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          249 --------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             --------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                    11111221111222223457889999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.4e-38  Score=337.40  Aligned_cols=253  Identities=11%  Similarity=0.090  Sum_probs=182.0

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHh--CCCceeEEE-------EEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKL--QHRNLVRLL-------GCCT  416 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~  416 (669)
                      .+|.+.+.||+|+||.||+|... +++.||||++.....   ...+.+.+|+.++..|  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888899999999999999965 689999999976543   3456778886666666  599988865       4443


Q ss_pred             cC-----------------CcceEEEeecCCCCHHHHhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCc
Q 005933          417 LR-----------------DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKR------CQIIEGIARGLLYLHQDSRLRI  473 (669)
Q Consensus       417 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~i  473 (669)
                      ..                 ...+|||||++ |+|.+++....  ..+.+..+      +.++.||++||+|||+++   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            33                 23799999999 89999996532  23455555      788899999999999998   9


Q ss_pred             eeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhcc--CCCCchhhHHHHHHHHHHHHhCC
Q 005933          474 IHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVCGK  551 (669)
Q Consensus       474 iH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~G~~l~elltG~  551 (669)
                      +||||||+||||+.++.+||+|||+++......     ....+++.|+|||++.+  ..++.++|||||||+||||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999998653211     13456799999999987  67999999999999999999999


Q ss_pred             CCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          552 RNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       552 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .|+..........        +.....................+..+.+|+.+||+.||++|||+.++++
T Consensus       291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9976543221110        0000000000111111111133467889999999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-37  Score=333.79  Aligned_cols=262  Identities=22%  Similarity=0.245  Sum_probs=201.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhC--------CCceeEEEEEEe---
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ--------HRNLVRLLGCCT---  416 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~---  416 (669)
                      .++|.+.++||+|+||.||++... +++.||||++... ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            468999999999999999999964 5889999999643 344678899999999996        788999999987   


Q ss_pred             -cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCc-----
Q 005933          417 -LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDM-----  489 (669)
Q Consensus       417 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~-----  489 (669)
                       .....++||||+ +++|.+.+... ....+++..+..++.||+.||.|||++ +   |+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             556789999999 55666666432 334589999999999999999999998 7   99999999999999776     


Q ss_pred             --------------------------------------------ceEEeecCCCcccCCCccCcCcccccccCCccCchh
Q 005933          490 --------------------------------------------NPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY  525 (669)
Q Consensus       490 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~  525 (669)
                                                                  .+||+|||++......     .....+|..|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999875422     233578999999999


Q ss_pred             hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchh---hHhhhhcccccc---------hhhccc------c--
Q 005933          526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL---GHAWRLWTEDRS---------LELIDK------S--  585 (669)
Q Consensus       526 ~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~------~--  585 (669)
                      +.+..++.++|||||||+||||++|+.|+............   ............         .+....      .  
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999998754433221111   111110000000         000000      0  


Q ss_pred             -----------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 -----------LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                 -....+......+.+|+.+||+.||++|||+.|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                       001234556678899999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.5e-37  Score=330.76  Aligned_cols=268  Identities=21%  Similarity=0.260  Sum_probs=191.3

Q ss_pred             HHHHHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc-
Q 005933          343 NTIADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-  420 (669)
Q Consensus       343 ~~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-  420 (669)
                      .......++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345566789999999999999999999975 5899999998553 3344567888999999999999999999976444 


Q ss_pred             ------ceEEEeecCCCCHHHHhh-ccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceeccCCCCCEEEcC-Ccc
Q 005933          421 ------RMLIYEYLPNKSLEQFIF-DVTRTKFLDWSKRCQIIEGIARGLLYLH--QDSRLRIIHRDLKASNVLLDN-DMN  490 (669)
Q Consensus       421 ------~~lV~E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiH~Dikp~NIll~~-~~~  490 (669)
                            .++||||++++ |...+. .......+++..+..++.||+.||.|||  +.+   |+||||||+||||+. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence                  78999999874 444332 2345567899999999999999999999  777   999999999999996 899


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  569 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~  569 (669)
                      +||+|||++.......   ......+|..|+|||++.+. .++.++|||||||++|||++|+.|+.......   .+...
T Consensus       171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~  244 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEI  244 (360)
T ss_dssp             EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred             EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHH
Confidence            9999999998764322   22335689999999998765 48999999999999999999999976432211   11111


Q ss_pred             hhhccccc------------chhhccc------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          570 WRLWTEDR------------SLELIDK------SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       570 ~~~~~~~~------------~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .+......            .......      ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11100000            0000000      0001112224567899999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.3e-37  Score=344.94  Aligned_cols=252  Identities=24%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ..++|.+.++||+|+||+||++... +++.||||++.+.  .......+.+|+.++++++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999975 5899999998643  234567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc---CCcceEEeecCCCcc
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARA  501 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~Dfgla~~  501 (669)
                      |||+++|+|.+.+...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+   .++.+||+|||++..
T Consensus       100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999988543   45899999999999999999999998   99999999999995   456799999999986


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      +....   ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.....   ...+......    ..   
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~----~~---  239 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETG----KY---  239 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT----CC---
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC----CC---
Confidence            54322   2234578999999999875 599999999999999999999999653221   1111110000    00   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                         ..........+..+.+++.+||+.||++|||+.++++.
T Consensus       240 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          240 ---AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ---CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ---CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               00000001224568899999999999999999999973

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-37  Score=346.13  Aligned_cols=251  Identities=24%  Similarity=0.324  Sum_probs=197.0

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ..++|.+.++||+|+||+||++... ++..||||++.+..  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3457999999999999999999976 58899999997543  34467899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC---cceEEeecCCCcc
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDFGMARA  501 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~Dfgla~~  501 (669)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+..   +.+||+|||++..
T Consensus       115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999988543   45899999999999999999999998   9999999999999764   4599999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      +....   ......||+.|+|||++. ..++.++|||||||++|+|++|..|+......   .+.......    ..   
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~----~~---  254 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKVEKG----KY---  254 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT----CC---
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC----CC---
Confidence            64322   233457999999999886 56999999999999999999999997543221   111111000    00   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus       255 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          255 ---TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ---CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence               0000000112356789999999999999999999984

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.1e-38  Score=332.16  Aligned_cols=262  Identities=22%  Similarity=0.317  Sum_probs=202.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCcc---c--------------hHHHHHHHHHHHHhCCCceeEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQ---G--------------VEEFKNEVLLIAKLQHRNLVRL  411 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~---~--------------~~~~~~E~~~l~~l~h~niv~l  411 (669)
                      .++|.+.+.||+|+||.||++.. +++.||||++......   .              .+.+.+|+.++..++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8999999998653211   1              1889999999999999999999


Q ss_pred             EEEEecCCcceEEEeecCCCCHHHH------hhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEE
Q 005933          412 LGCCTLRDERMLIYEYLPNKSLEQF------IFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVL  484 (669)
Q Consensus       412 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIl  484 (669)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||+ .+   ++|+||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      422 225679999999999999999999999 88   999999999999


Q ss_pred             EcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 005933          485 LDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSV-KSDVFSFGVLVLEIVCGKRNRGFYHADHH  562 (669)
Q Consensus       485 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-~sDVwS~G~~l~elltG~~p~~~~~~~~~  562 (669)
                      ++.++.+||+|||++......    ......++..|+|||++.+. .++. ++||||||+++|||++|+.|+......  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence            999999999999999875332    23345789999999999887 6666 999999999999999999997643321  


Q ss_pred             cchhhHhhhh-cccc-cchhhcccccC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          563 HNLLGHAWRL-WTED-RSLELIDKSLD---GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       563 ~~~~~~~~~~-~~~~-~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .......... .... ...........   .......+..+.+|+.+||+.||.+||++.|+++
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111111000 0000 00000000000   0000223457889999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-37  Score=344.30  Aligned_cols=247  Identities=26%  Similarity=0.381  Sum_probs=199.0

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc-------------cchHHHHHHHHHHHHhCCCceeEEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG-------------QGVEEFKNEVLLIAKLQHRNLVRLLG  413 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~g  413 (669)
                      ..++|.+.++||+|+||+||++.... ++.||||++.....             ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            46789999999999999999999764 88999999865321             34578999999999999999999999


Q ss_pred             EEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc---c
Q 005933          414 CCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM---N  490 (669)
Q Consensus       414 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~---~  490 (669)
                      ++.+....++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999998543   45899999999999999999999998   99999999999998775   6


Q ss_pred             eEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          491 PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       491 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      +||+|||++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|..|+......   .++....
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~  260 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKKVE  260 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence            9999999998764322   233457999999999986 56999999999999999999999997532211   1111110


Q ss_pred             hhcccccchhhcccccCCCCCHH----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLS----EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                  ....  ..+..    .+..+.+|+.+||+.||.+|||+.|+++
T Consensus       261 ------------~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          261 ------------KGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ------------HCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------------cCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                        0000  11111    2356889999999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-37  Score=321.63  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=195.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEec----CCcce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~  422 (669)
                      ..|.+.+.||+|+||.||+|... ++..||+|++...  .....+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34777889999999999999975 4889999998654  33456789999999999999999999998865    34579


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-CCcceEEeecCCCcc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARA  501 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~Dfgla~~  501 (669)
                      +||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+ .+++|+||||+||||+ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999999542   45899999999999999999999875 2499999999999998 789999999999975


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ....    ......++..|+|||++. +.++.++||||||+++|+|++|+.|+......  .....    ......... 
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~----~~~~~~~~~-  249 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR----RVTSGVKPA-  249 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH----HHTTTCCCG-
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHH----HHhccCCcc-
Confidence            4322    223356899999999876 46899999999999999999999996532211  11110    000000000 


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                             ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   011112346889999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-37  Score=321.25  Aligned_cols=250  Identities=22%  Similarity=0.301  Sum_probs=201.8

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---------ccchHHHHHHHHHHHHhC-CCceeEEEEEEe
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---------GQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCT  416 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~  416 (669)
                      ..++|.+.+.||+|+||.||++... +++.||||++....         ....+.+.+|+.++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999976 58999999986543         123467889999999996 999999999999


Q ss_pred             cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeec
Q 005933          417 LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF  496 (669)
Q Consensus       417 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  496 (669)
                      .....++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999954   245899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAI------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      |++.......   ......++..|+|||++.      ...++.++||||||+++|||++|+.|+......   .....  
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~--  240 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLRM--  240 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH--
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHHH--
Confidence            9998764322   223456899999999985      456889999999999999999999986432111   00000  


Q ss_pred             hhcccccchhhcccccC--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          571 RLWTEDRSLELIDKSLD--GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                +......  .......+..+.+++.+||+.||++||++.|+++
T Consensus       241 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 ----------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             ----------HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----------HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                      0000000  0111223457889999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.3e-38  Score=336.63  Aligned_cols=260  Identities=19%  Similarity=0.259  Sum_probs=195.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc------ce
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE------RM  422 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~  422 (669)
                      ..+|.+.+.||+|+||.||+|....+..||+|++.....    ...+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357889999999999999999998777899998864332    22369999999999999999999965443      78


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-CCcceEEeecCCCcc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARA  501 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~Dfgla~~  501 (669)
                      +||||++++.+............+++..+..++.||++||+|||+.+   |+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987655544433334556999999999999999999999998   99999999999999 799999999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      +....   ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.......   .+....+.........
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence            63322   22335789999999999765 58999999999999999999999976433211   1111111111000000


Q ss_pred             -------hcccccC--CC------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 -------LIDKSLD--GS------YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 -------~~~~~~~--~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                             .......  ..      +....+..+.+|+.+||+.||++|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                   0000000  00      11123457889999999999999999999996

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=323.89  Aligned_cols=262  Identities=21%  Similarity=0.321  Sum_probs=194.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEe-----------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCT-----------  416 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----------  416 (669)
                      .++|.+.+.||+|+||.||+|.... ++.||||++........+.+.+|+.+++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4688999999999999999999765 8999999997766666788999999999999999999999874           


Q ss_pred             ---cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-CCcceE
Q 005933          417 ---LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPK  492 (669)
Q Consensus       417 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-~~~~~k  492 (669)
                         +....++||||++ |+|.+++.    ...+++..+..++.||+.||+|||+.+   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3456789999998 69999983    245899999999999999999999998   99999999999997 567999


Q ss_pred             EeecCCCcccCCCcc-CcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh
Q 005933          493 ISDFGMARAFGVDQT-EANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       493 l~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~  570 (669)
                      |+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......   ......
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~  238 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL  238 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            999999987643221 122334567899999998875 678999999999999999999999976433211   111110


Q ss_pred             hhcc---cccchh-------hcccccC-CCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          571 RLWT---EDRSLE-------LIDKSLD-GSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       571 ~~~~---~~~~~~-------~~~~~~~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....   .....+       .+..... ...+.     ..+..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0000   000000       0000000 11111     12457889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.6e-37  Score=324.34  Aligned_cols=262  Identities=20%  Similarity=0.262  Sum_probs=202.3

Q ss_pred             hcCCCccCeeeecCccceEEEEe--CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCc------eeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML--TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN------LVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~  420 (669)
                      .++|.+.+.||+|+||.||++..  .+++.||||++... ....+.+.+|+.++..++|+|      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999996  35889999998643 344577899999999997665      9999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-------------
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------------  487 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-------------  487 (669)
                      .++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88999998653 3345899999999999999999999998   999999999999987             


Q ss_pred             ------CcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005933          488 ------DMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH  561 (669)
Q Consensus       488 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~  561 (669)
                            ++.+||+|||++.....     ......+|..|+|||++.+..++.++||||||+++|||++|..|+.......
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  66899999999986432     2234578999999999999999999999999999999999999976543221


Q ss_pred             ccchhhHhhhhccc-----ccch---------------------hhccccc-CCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 005933          562 HHNLLGHAWRLWTE-----DRSL---------------------ELIDKSL-DGSYSLSEALRCIQVGLLCVQQRPEDRP  614 (669)
Q Consensus       562 ~~~~~~~~~~~~~~-----~~~~---------------------~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RP  614 (669)
                      ....+.........     ....                     ....... ........+..+.+|+.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            11111000000000     0000                     0000000 0112334567889999999999999999


Q ss_pred             CHHHHHH
Q 005933          615 NMSSVVL  621 (669)
Q Consensus       615 s~~evl~  621 (669)
                      |+.|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999974

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.3e-38  Score=346.92  Aligned_cols=248  Identities=26%  Similarity=0.338  Sum_probs=202.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||++... +++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999976 58999999986542   34567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE---cCCcceEEeecCCCcc
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNDMNPKISDFGMARA  501 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll---~~~~~~kl~Dfgla~~  501 (669)
                      |||+.+|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||   +.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999998853   345899999999999999999999998   9999999999999   5678999999999986


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      +....   ......||+.|+|||++.+ .++.++|||||||++|+|++|.+|+......   .......           
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~-----------  240 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVE-----------  240 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-----------
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH-----------
Confidence            54322   2233578999999999866 6999999999999999999999997532211   1111110           


Q ss_pred             cccccCCCC--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSY--SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ........  ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       241 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          241 -KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence             00000000  0123456889999999999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.7e-37  Score=320.49  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=199.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ..++|++.+.||+|+||.||+|.... |+.||||++...  ...+.+.+|+.++..++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            45689999999999999999999764 899999998654  345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999853  2345899999999999999999999998   9999999999999999999999999998754322


Q ss_pred             cCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      .  ......++..|+|||++.+..++.++||||||+++|+|++|+.|+......      ........ .     .....
T Consensus       180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~-----~~~~~  245 (314)
T 3com_A          180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPT-N-----PPPTF  245 (314)
T ss_dssp             S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-S-----CCCCC
T ss_pred             c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhc-C-----CCccc
Confidence            1  223457899999999999999999999999999999999999986532211      00000000 0     00000


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ..+...+..+.+++.+||+.||.+||++.++++
T Consensus       246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              111222457889999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.3e-37  Score=329.70  Aligned_cols=258  Identities=22%  Similarity=0.249  Sum_probs=191.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------  419 (669)
                      .++|.+.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999965 58999999997532  234567889999999999999999999997665      


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++||||+++ +|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 7888773     23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc----
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE----  575 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----  575 (669)
                      +.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.|+.......   ...........    
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPE  248 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHH
T ss_pred             cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence            865322   12234578999999999999999999999999999999999999976432211   11000000000    


Q ss_pred             ---------------------ccchhhcccccCCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          576 ---------------------DRSLELIDKSLDGSY---SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       576 ---------------------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                           ...............   .......+.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                                 000000000010000   1122567899999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-37  Score=339.06  Aligned_cols=198  Identities=22%  Similarity=0.309  Sum_probs=171.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHh------CCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL------QHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~  421 (669)
                      ..+|++.++||+|+||.||+|.... ++.||||++... ....+.+.+|+.++..+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            4679999999999999999998654 899999999643 33456788899999888      467999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc--eEEeecCCC
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN--PKISDFGMA  499 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~--~kl~Dfgla  499 (669)
                      ++||||+. ++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6899988653 3344899999999999999999999998   999999999999999887  999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY  557 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~  557 (669)
                      .....     ......+|+.|+|||++.+..++.++|||||||+||||++|.+|+...
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            76432     222357899999999999999999999999999999999999987643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.1e-38  Score=328.49  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=199.4

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCCCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..++|.+.+.||+|+||.||+|....  .||||++...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35688999999999999999999863  5999998653  2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++++|.+++..  ....+++..++.++.||+.||+|||+.+   ++||||||+|||++ ++.+||+|||++......
T Consensus       109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999954  2345899999999999999999999998   99999999999998 679999999998765322


Q ss_pred             c---cCcCcccccccCCccCchhhcc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhc
Q 005933          506 Q---TEANTDRVVGTYGYMSPEYAID---------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  573 (669)
Q Consensus       506 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~  573 (669)
                      .   .........++..|+|||++..         ..++.++||||||+++|||++|+.|+......   ...   ... 
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~---~~~-  255 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII---WQM-  255 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH---HHH-
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHh-
Confidence            1   1222334568999999999874         45789999999999999999999996532211   111   000 


Q ss_pred             ccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          574 TEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ...     ..+..   .....+..+.+++.+||+.||++||++.+++++|+....
T Consensus       256 ~~~-----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          256 GTG-----MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             HTT-----CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             ccC-----CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            000     00000   011123457899999999999999999999999998744

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-37  Score=333.22  Aligned_cols=261  Identities=20%  Similarity=0.284  Sum_probs=195.0

Q ss_pred             HHhcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecC-------
Q 005933          347 DATDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-------  418 (669)
Q Consensus       347 ~~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------  418 (669)
                      ...++|.+.+.||+|+||.||+|.. .+|+.||||++.....    ...+|+.+++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4567899999999999999999996 4589999999865432    234799999999999999999998543       


Q ss_pred             -------------------------------CcceEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005933          419 -------------------------------DERMLIYEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLH  466 (669)
Q Consensus       419 -------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH  466 (669)
                                                     ...++||||++ ++|.+.+... .....+++..+..++.||++||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           23789999998 5888777542 34456999999999999999999999


Q ss_pred             hCCCCCceeccCCCCCEEEc-CCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHH
Q 005933          467 QDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLV  544 (669)
Q Consensus       467 ~~~~~~iiH~Dikp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l  544 (669)
                      +.+   |+||||||+||||+ .++.+||+|||+++.+....   ......+|+.|+|||++.+. .++.++|||||||++
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            998   99999999999998 68899999999998754322   22345779999999998875 489999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc----------cccCC-----CCCHHHHHHHHHHHHHhccCC
Q 005933          545 LEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID----------KSLDG-----SYSLSEALRCIQVGLLCVQQR  609 (669)
Q Consensus       545 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~-----~~~~~~~~~l~~li~~cl~~d  609 (669)
                      |||++|+.|+.......   .+....+.........+..          +....     ..+...+..+.+|+.+||+.|
T Consensus       233 ~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          233 GELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            99999999976432211   1111111111110000000          00000     011223456889999999999


Q ss_pred             CCCCCCHHHHHH
Q 005933          610 PEDRPNMSSVVL  621 (669)
Q Consensus       610 P~~RPs~~evl~  621 (669)
                      |++|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999984

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.6e-38  Score=322.43  Aligned_cols=252  Identities=22%  Similarity=0.316  Sum_probs=186.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .++|++.+.||+|+||.||++... +++.||||++.....  ...+.+..+...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467899999999999999999974 689999999965422  22334445555678889999999999999999999999


Q ss_pred             eecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          426 EYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       426 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||++ |+|.+++... .....+++..++.++.||+.||.|||+. +   ++||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 5888877542 2445699999999999999999999997 8   9999999999999999999999999998654


Q ss_pred             CCccCcCcccccccCCccCchhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYA----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ...   ......+++.|+|||++    .+..++.++||||||+++|||++|+.|+......     .....         
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~---------  224 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLK---------  224 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHH---------
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHH---------
Confidence            322   22234689999999996    4567899999999999999999999997532211     00000         


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..+............+..+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            011111111111223456889999999999999999999976

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.6e-37  Score=322.26  Aligned_cols=263  Identities=23%  Similarity=0.354  Sum_probs=200.4

Q ss_pred             HhcCCCccCeeeecCccceEEEEe--CCCcEEEEEEecccC--ccchHHHHHHHHHHHHh---CCCceeEEEEEEe----
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGML--TEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL---QHRNLVRLLGCCT----  416 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~----  416 (669)
                      ..++|.+.+.||+|+||.||++..  .+++.||||++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  358899999986432  22345677888888777   8999999999987    


Q ss_pred             -cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEee
Q 005933          417 -LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD  495 (669)
Q Consensus       417 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  495 (669)
                       .....++||||++ |+|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999998 69999986533 345899999999999999999999998   99999999999999999999999


Q ss_pred             cCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc
Q 005933          496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       496 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      ||++.......   ......++..|+|||++.+..++.++||||||+++|||++|+.|+......   ..+.........
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~  237 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL  237 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCC
Confidence            99998654221   223457899999999999999999999999999999999999997543221   111111110000


Q ss_pred             ---ccchh---hcccccC-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          576 ---DRSLE---LIDKSLD-------GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       576 ---~~~~~---~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         .....   .......       .......+..+.+|+.+||+.||++||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               00000   0000000       0011123456789999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-37  Score=336.86  Aligned_cols=258  Identities=21%  Similarity=0.278  Sum_probs=191.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCC------cce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------ERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~  422 (669)
                      .+|.+.+.||+|+||.||+|+.. +++.||||++....    ..+.+|+.+++.++||||+++++++....      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888899999999999999986 48999999986532    22347999999999999999999985422      257


Q ss_pred             EEEeecCCCCHHHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-cceEEeecCCCc
Q 005933          423 LIYEYLPNKSLEQFIFD-VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMAR  500 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-~~~kl~Dfgla~  500 (669)
                      +||||+++ +|.+++.. ......+++..+..++.||++||+|||+.+   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 56665543 223456999999999999999999999998   9999999999999965 678999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      .+....   ......+|+.|+|||++.+. .++.++|||||||+||||++|+.||......   ..+....+........
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHH
Confidence            754322   22335789999999999765 7999999999999999999999997643221   1111111111110000


Q ss_pred             ---hh-------cccccCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          580 ---EL-------IDKSLDG-----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       580 ---~~-------~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         +.       ..+.+..     .++...+..+.+|+.+||+.||++||++.|+++
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence               00       0000000     011122457889999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.8e-37  Score=318.85  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=192.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEec----------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----------  417 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------  417 (669)
                      .++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467899999999999999999975 6899999999543 3446788999999999999999999998865          


Q ss_pred             ---CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEe
Q 005933          418 ---RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS  494 (669)
Q Consensus       418 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  494 (669)
                         ....++||||+++++|.+++..  ....+++..++.++.||+.||+|||+.+   ++|+||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               3457899999999999999964  2345788999999999999999999998   9999999999999999999999


Q ss_pred             ecCCCcccCCCcc------------CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005933          495 DFGMARAFGVDQT------------EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH  561 (669)
Q Consensus       495 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~  561 (669)
                      |||++........            ........++..|+|||++.+. .++.++||||||+++|||++   |+..  ...
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~~~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--GME  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--HHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--chh
Confidence            9999987543211            1122345689999999999865 78999999999999999998   3211  000


Q ss_pred             ccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .......    ..      ..........+...+..+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~----~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 RVNILKK----LR------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHH----HH------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHh----cc------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            0000000    00      00111112233344566889999999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.3e-37  Score=323.13  Aligned_cols=252  Identities=21%  Similarity=0.294  Sum_probs=194.5

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--------ccchHHHHHHHHHHHHhCCCceeEEEEEEecC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  418 (669)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|+.+++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999975 48899999986432        12345688999999999999999999998765


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc---eEEee
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISD  495 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~D  495 (669)
                      . .++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 899999999999999984   3456899999999999999999999998   999999999999987664   99999


Q ss_pred             cCCCcccCCCccCcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       496 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      ||++.......   ......++..|+|||++.   ...++.++||||||+++|+|++|..|+.......  .+.......
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~  235 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSG  235 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHHT
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHhC
Confidence            99998753221   122356899999999974   4678999999999999999999999975432221  111110000


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ......+.         ....+..+.+++.+||+.||++||++.++++
T Consensus       236 -~~~~~~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 -KYNFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -CCCCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -ccccCchh---------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             00000000         0012356789999999999999999999984

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.7e-37  Score=331.08  Aligned_cols=262  Identities=19%  Similarity=0.321  Sum_probs=200.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecC-----Ccc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~  421 (669)
                      .++|++.+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++..++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999965 588999999975432 3457889999999999999999999999665     357


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 589998853    34899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccC-cCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc-
Q 005933          502 FGVDQTE-ANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS-  578 (669)
Q Consensus       502 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  578 (669)
                      ....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+........   +............ 
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQE  254 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHH
Confidence            6433222 12344678999999998765 4589999999999999999999999764332221   1111111110000 


Q ss_pred             ----------hhhccccc-CCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 ----------LELIDKSL-DGSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 ----------~~~~~~~~-~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                                ........ ....+.     .....+.+|+.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                      00000000 011111     12356889999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.5e-37  Score=329.83  Aligned_cols=257  Identities=23%  Similarity=0.328  Sum_probs=183.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC------C
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------D  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~  419 (669)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999964 58999999996542  23456888999999999999999999998654      5


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++|+|++ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999999 7899988843    45899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc---
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE---  575 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---  575 (669)
                      +.....     .....+|..|+|||++.+ ..++.++|||||||++|||++|+.|+......   ..+....+....   
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGA  251 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCH
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence            864321     234578999999999987 67899999999999999999999997643321   111111111100   


Q ss_pred             --------ccchhhcccccC-CCCCHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          576 --------DRSLELIDKSLD-GSYSLS-----EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       576 --------~~~~~~~~~~~~-~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                              ......+..... ...+..     ....+.+|+.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                    000111111000 111111     1346789999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.2e-37  Score=350.83  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=202.1

Q ss_pred             HhcCCCccCeeeecCccceEEEEeCC----CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      ..++|.+.+.||+|+||.||+|.+..    +..||||++.... ....+.|.+|+.+++.++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            35678899999999999999999743    5679999986543 334578999999999999999999999985 46689


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            999999999999999642  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ..... .......+++.|+|||++.+..++.++||||||+++|||++ |..|+......   ......            
T Consensus       542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i------------  605 (656)
T 2j0j_A          542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI------------  605 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH------------
T ss_pred             CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH------------
Confidence            43322 11223456789999999999999999999999999999997 88886532211   111110            


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                       ........+...+..+.+|+.+||+.||++||++.+|++.|+..
T Consensus       606 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          606 -ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             00011112233446788999999999999999999999999754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=332.65  Aligned_cols=266  Identities=22%  Similarity=0.340  Sum_probs=182.0

Q ss_pred             cCCCc-cCeeeecCccceEEEEeC---CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEec--CCcceE
Q 005933          350 DNFSW-KNKLGEGGFGPVYRGMLT---EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERML  423 (669)
Q Consensus       350 ~~~~~-~~~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l  423 (669)
                      +.|.+ .++||+|+||.||+|...   +++.||||++....  ....+.+|+.+++.++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 468999999999999965   47899999986432  34578899999999999999999999954  667899


Q ss_pred             EEeecCCCCHHHHhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE----cCCcceEE
Q 005933          424 IYEYLPNKSLEQFIFDV------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNDMNPKI  493 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll----~~~~~~kl  493 (669)
                      ||||++ ++|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+||||    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999997 4787776421      12235899999999999999999999999   9999999999999    67889999


Q ss_pred             eecCCCcccCCCcc-CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc------cch
Q 005933          494 SDFGMARAFGVDQT-EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH------HNL  565 (669)
Q Consensus       494 ~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~------~~~  565 (669)
                      +|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+..      ...
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987643322 1223446789999999999874 589999999999999999999999864332110      011


Q ss_pred             hhHhhhhcccccc---h---------hh---cccccCCCCCH---------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          566 LGHAWRLWTEDRS---L---------EL---IDKSLDGSYSL---------SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       566 ~~~~~~~~~~~~~---~---------~~---~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      +............   .         .+   ...........         .....+.+|+.+||+.||++|||++|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111110000000   0         00   00000000000         11346789999999999999999999997

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.6e-37  Score=324.82  Aligned_cols=262  Identities=22%  Similarity=0.297  Sum_probs=198.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecC-----Ccc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~  421 (669)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999976 58999999996433 23456788999999999999999999998664     668


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++||||+. ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 689998854    35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccCc--------CcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          502 FGVDQTEA--------NTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       502 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      ........        ......||..|+|||++.+ ..++.++||||||+++|||++|+.|+.......   .+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~  238 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI  238 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence            64322111        1223578999999998765 679999999999999999999999976432111   11111000


Q ss_pred             cccc------------cchhhcccccC-CCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 WTED------------RSLELIDKSLD-GSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ~~~~------------~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....            ...+.+..... ....     ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000            00001100000 0001     122356789999999999999999999987

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6.8e-37  Score=315.21  Aligned_cols=249  Identities=24%  Similarity=0.333  Sum_probs=200.2

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ..++|.+.+.||+|+||.||++... +++.||||++....  ....+.+.+|+.++++++||||+++++++......++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4568999999999999999999976 58999999986542  34567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC---cceEEeecCCCcc
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND---MNPKISDFGMARA  501 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~---~~~kl~Dfgla~~  501 (669)
                      +||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   ++|+||||+||+++.+   +.+||+|||++..
T Consensus       100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999999988543   35899999999999999999999998   9999999999999764   4699999999886


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      .....   ......++..|+|||++.+ .++.++||||||+++|+|++|..|+......   ......    .       
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~----~-------  235 (287)
T 2wei_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRV----E-------  235 (287)
T ss_dssp             BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----H-------
T ss_pred             ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHH----H-------
Confidence            53322   2223468899999998865 4899999999999999999999986532211   111100    0       


Q ss_pred             cccccCCCCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ........+  ...+..+.+++.+||+.||++|||+.++++
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          236 -TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -HCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -cCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence             000000000  112356889999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.8e-36  Score=322.36  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=199.0

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHhC-----------CCceeEEEEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----------HRNLVRLLGCCT  416 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~  416 (669)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++.+++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35799999999999999999996 45899999998642 334567889999999886           899999999987


Q ss_pred             cCC----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEc-----
Q 005933          417 LRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLD-----  486 (669)
Q Consensus       417 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~-----  486 (669)
                      ..+    ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +   |+||||||+||||+     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    689999999 899999996533 34589999999999999999999998 8   99999999999994     


Q ss_pred             -CCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccch
Q 005933          487 -NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL  565 (669)
Q Consensus       487 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~  565 (669)
                       ..+.+||+|||++......     .....+|..|+|||++.+..++.++||||||+++|||++|+.|+...........
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4458999999999875322     2335789999999999999999999999999999999999999865432211110


Q ss_pred             ---hhHhhhhccc------------------ccc------------hhhcccccCCCCCHHHHHHHHHHHHHhccCCCCC
Q 005933          566 ---LGHAWRLWTE------------------DRS------------LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPED  612 (669)
Q Consensus       566 ---~~~~~~~~~~------------------~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  612 (669)
                         +.........                  ...            .+.+..  ....+...+..+.+|+.+||+.||++
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccc
Confidence               1110000000                  000            000000  11234566778999999999999999


Q ss_pred             CCCHHHHHH
Q 005933          613 RPNMSSVVL  621 (669)
Q Consensus       613 RPs~~evl~  621 (669)
                      |||+.|+++
T Consensus       325 Rpt~~ell~  333 (373)
T 1q8y_A          325 RADAGGLVN  333 (373)
T ss_dssp             CBCHHHHHT
T ss_pred             cCCHHHHhh
Confidence            999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-36  Score=324.32  Aligned_cols=201  Identities=24%  Similarity=0.356  Sum_probs=170.5

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhC-CC-----ceeEEEEEEecCCc
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HR-----NLVRLLGCCTLRDE  420 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~  420 (669)
                      ..++|.+.+.||+|+||.||+|... +++.||||++... .....++..|+.++..++ |+     +++++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999975 5889999999643 334567888999998885 44     49999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc--CCcceEEeecCC
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDMNPKISDFGM  498 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~--~~~~~kl~Dfgl  498 (669)
                      .++||||++ ++|.+++... ....+++..+..++.||+.||.|||.+. .+|+||||||+||||+  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 5999998653 2345899999999999999999999531 2399999999999995  578899999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY  557 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~  557 (669)
                      ++.....     .....+|+.|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9875322     23457899999999999999999999999999999999999997643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-36  Score=323.99  Aligned_cols=257  Identities=21%  Similarity=0.314  Sum_probs=195.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc----
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER----  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----  421 (669)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999965 58999999997543  23357889999999999999999999999887765    


Q ss_pred             --eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          422 --MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       422 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                        ++||||+. ++|.+++.     ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 68888772     23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc----
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT----  574 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~----  574 (669)
                      +.....     .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.|+......   ..+........    
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~  263 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGT  263 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCH
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCcH
Confidence            865322     233578999999999987 68999999999999999999999997543211   11111111000    


Q ss_pred             -------cccchhhcccccCC-CCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          575 -------EDRSLELIDKSLDG-SYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       575 -------~~~~~~~~~~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                             .............. ...     ...+..+.+|+.+||+.||++|||+.|+++-
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                   00000011100000 011     1124578899999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=322.51  Aligned_cols=256  Identities=21%  Similarity=0.318  Sum_probs=195.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc-----
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-----  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----  420 (669)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367889999999999999999975 58999999996543  2335678999999999999999999999987654     


Q ss_pred             -ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          421 -RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       421 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                       .++||||++ ++|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 68888762     23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc----
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT----  574 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~----  574 (669)
                      ......     .....++..|+|||++.+ ..++.++||||||+++|||++|+.|+......   ..+....+...    
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGT  245 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence            864322     223578999999999987 67899999999999999999999997643221   11111111000    


Q ss_pred             -------cccchhhccc---ccCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          575 -------EDRSLELIDK---SLDG---SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       575 -------~~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                             .......+..   ....   ......+..+.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   0000000000   0000   111233567889999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-36  Score=319.52  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=178.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc-cchHHHHHHHH-HHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-QGVEEFKNEVL-LIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .++|.+.+.||+|+||.||++... +++.||||++..... ....++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367888999999999999999975 589999999975432 33445666666 677789999999999999999999999


Q ss_pred             eecCCCCHHHHhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          426 EYLPNKSLEQFIFD--VTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       426 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+||||+.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 88887753  12345689999999999999999999998 8   999999999999999999999999999875


Q ss_pred             CCCccCcCcccccccCCccCchhh----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYA----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      ....   ......++..|+|||++    .+..++.++||||||+++|||++|+.|+........     .... ..... 
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~-  246 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ-VVKGD-  246 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSC-
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH-HhcCC-
Confidence            3322   12234689999999998    456789999999999999999999999753221100     0000 00000 


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                          ...+........+..+.+|+.+||+.||++||++.++++
T Consensus       247 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          247 ----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                001111111223457889999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.6e-36  Score=318.95  Aligned_cols=259  Identities=19%  Similarity=0.267  Sum_probs=198.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-C-cEEEEEEecccCccchHHHHHHHHHHHHhCCCc------eeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-G-QEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN------LVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~  420 (669)
                      .++|.+.+.||+|+||.||++.... + +.||||++... ....+.+.+|+.+++.++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            4689999999999999999999753 4 78999999643 344577889999999998766      9999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE---------------
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL---------------  485 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll---------------  485 (669)
                      .++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||||               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 66777776442 3345899999999999999999999998   9999999999999               


Q ss_pred             ----cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005933          486 ----DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH  561 (669)
Q Consensus       486 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~  561 (669)
                          +.++.+||+|||++......     .....+|..|+|||++.+..++.++||||||+++|||++|+.|+.......
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                66789999999999864322     233578999999999999999999999999999999999999976433211


Q ss_pred             ccchhhHhhhhccccc--------chh---------------------hccc-ccCCCCCHHHHHHHHHHHHHhccCCCC
Q 005933          562 HHNLLGHAWRLWTEDR--------SLE---------------------LIDK-SLDGSYSLSEALRCIQVGLLCVQQRPE  611 (669)
Q Consensus       562 ~~~~~~~~~~~~~~~~--------~~~---------------------~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~  611 (669)
                      .   +...........        ...                     .... .............+.+|+.+||+.||+
T Consensus       247 ~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          247 H---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             H---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             H---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            1   111100000000        000                     0000 000011234456788999999999999


Q ss_pred             CCCCHHHHHH
Q 005933          612 DRPNMSSVVL  621 (669)
Q Consensus       612 ~RPs~~evl~  621 (669)
                      +|||+.|+++
T Consensus       324 ~Rpt~~e~l~  333 (355)
T 2eu9_A          324 QRITLAEALL  333 (355)
T ss_dssp             TSCCHHHHTT
T ss_pred             hCcCHHHHhc
Confidence            9999999974

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.1e-36  Score=328.88  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=186.1

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      +.|.+.+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345556889999999998776667999999998643   345678999999987 8999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC-------------cce
Q 005933          429 PNKSLEQFIFDVTRTK----FLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND-------------MNP  491 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~-------------~~~  491 (669)
                      + |+|.+++.......    ..++..++.++.||+.||+|||+.+   |+||||||+||||+.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999996432211    1233456789999999999999998   9999999999999764             489


Q ss_pred             EEeecCCCcccCCCccCc--CcccccccCCccCchhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005933          492 KISDFGMARAFGVDQTEA--NTDRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH  561 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~  561 (669)
                      ||+|||++..+.......  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.|+.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999998765432211  2234679999999999976       578999999999999999999 888865321110


Q ss_pred             ccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ..+.   .....        ............+..+.+|+.+||+.||++|||+.+|++
T Consensus       248 -~~i~---~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 -SNII---RGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -HHHH---HTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHh---cCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             0000   00000        000111123345678899999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.7e-36  Score=318.14  Aligned_cols=252  Identities=21%  Similarity=0.256  Sum_probs=172.5

Q ss_pred             HhcCCCccC-eeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHH-HHHHHhCCCceeEEEEEEec----CCc
Q 005933          348 ATDNFSWKN-KLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEV-LLIAKLQHRNLVRLLGCCTL----RDE  420 (669)
Q Consensus       348 ~~~~~~~~~-~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~g~~~~----~~~  420 (669)
                      ..++|.+.+ .||+|+||.||++... +++.||||++...     .....|+ ..+..++||||+++++++..    ...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            356888855 6999999999999976 5899999998542     1223333 34566789999999999876    445


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEeecC
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFG  497 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~Dfg  497 (669)
                      .++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.   ++.+||+|||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence            79999999999999999643 2346999999999999999999999998   999999999999986   4559999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ++......    ......+|+.|+|||++.+..++.++||||||+++|+|++|+.|+............   ....    
T Consensus       177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~----  245 (336)
T 3fhr_A          177 FAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRI----  245 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhh----
Confidence            99865322    223356799999999998889999999999999999999999997543222110000   0000    


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ...............+..+.+|+.+||+.||++|||+.|+++
T Consensus       246 --~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          246 --RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              000000000111123457889999999999999999999997

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=316.92  Aligned_cols=244  Identities=24%  Similarity=0.428  Sum_probs=191.4

Q ss_pred             HHHhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc------cchHHHHHHHHHHHHh----CCCceeEEEEE
Q 005933          346 ADATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKL----QHRNLVRLLGC  414 (669)
Q Consensus       346 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~g~  414 (669)
                      ....++|.+.+.||+|+||.||+|... +++.||||++.....      .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            345678999999999999999999964 588999999965432      2234567899999999    89999999999


Q ss_pred             EecCCcceEEEee-cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-CCcceE
Q 005933          415 CTLRDERMLIYEY-LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPK  492 (669)
Q Consensus       415 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-~~~~~k  492 (669)
                      +...+..++|+|+ +.+++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 789999999964   235899999999999999999999998   99999999999999 889999


Q ss_pred             EeecCCCcccCCCccCcCcccccccCCccCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhh
Q 005933          493 ISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR  571 (669)
Q Consensus       493 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~  571 (669)
                      |+|||++.......    .....++..|+|||++.+..+. .++||||||+++|||++|+.|+....             
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------  243 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------  243 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------
Confidence            99999998764322    2345689999999999877764 58999999999999999999864210             


Q ss_pred             hcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          572 LWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                              +......  ..+...+..+.+++.+||+.||++||++.|+++.
T Consensus       244 --------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 --------EILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --------HHHHTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------HHhhhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0000111  1122234567899999999999999999999973

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.9e-36  Score=317.14  Aligned_cols=242  Identities=25%  Similarity=0.392  Sum_probs=198.6

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc------chHHHHHHHHHHHHhC--CCceeEEEEEEecC
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ------GVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLR  418 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~  418 (669)
                      ..++|.+.+.||+|+||.||+|... +++.||||++......      ..+.+.+|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            4578999999999999999999964 5899999999654321      2356788999999996  59999999999999


Q ss_pred             CcceEEEeecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-CCcceEEeec
Q 005933          419 DERMLIYEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDF  496 (669)
Q Consensus       419 ~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~Df  496 (669)
                      +..++|+|++.+ ++|.+++..   ...+++..++.++.||+.||+|||+.+   |+||||||+||||+ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999986 899999854   345899999999999999999999998   99999999999999 7899999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE  575 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  575 (669)
                      |++......    ......+|..|+|||++.+..+ +.++||||||+++|||++|+.|+.....                
T Consensus       195 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------------  254 (320)
T 3a99_A          195 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------  254 (320)
T ss_dssp             TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------
T ss_pred             ccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------------
Confidence            999876432    2233568999999999987766 6889999999999999999998642110                


Q ss_pred             ccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                           ......  ..+...+..+.+|+.+||+.||++||++.++++.
T Consensus       255 -----~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          255 -----IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -----HHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----hhcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000000  0111223567899999999999999999999873

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.1e-36  Score=338.02  Aligned_cols=259  Identities=25%  Similarity=0.326  Sum_probs=197.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEec------CCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL------RDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~  420 (669)
                      .++|.+.++||+|+||.||+|... +|+.||||++... .....+.+.+|+.++..++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999975 5899999998654 33446789999999999999999999998765      667


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcc---eEEeecC
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMN---PKISDFG  497 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~---~kl~Dfg  497 (669)
                      .++||||+++|+|.+++........+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555557899999999999999999999998   999999999999997665   9999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ++.......   ......++..|+|||++.+..++.++||||||+++|||++|..|+......     ..+.........
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence            998764332   223467899999999999999999999999999999999999997532110     000000000000


Q ss_pred             chhhcc----------ccc--CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 005933          578 SLELID----------KSL--DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS  618 (669)
Q Consensus       578 ~~~~~~----------~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  618 (669)
                      ......          ..+  ........+..+.+++.+||+.||++|||+.+
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            000000          000  11233445678899999999999999999966

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=324.01  Aligned_cols=250  Identities=23%  Similarity=0.301  Sum_probs=185.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..+|.+.+.||+|+||+|+.....+++.||||++....   ...+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            34688889999999999766555679999999986532   23467899999999 799999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-----CcceEEeecCCCccc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----DMNPKISDFGMARAF  502 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~Dfgla~~~  502 (669)
                      +. |+|.+++....  ..+.+..++.++.||+.||.|||+.+   |+||||||+||||+.     ...+||+|||+++.+
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 59999986432  23444566789999999999999998   999999999999953     336889999999876


Q ss_pred             CCCcc-CcCcccccccCCccCchhhc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          503 GVDQT-EANTDRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       503 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ..... ........||+.|+|||++.   ...++.++|||||||++|||++ |..|++......    .   ...... .
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~---~~~~~~-~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----A---NILLGA-C  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----H---HHHTTC-C
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----H---HHHhcc-C
Confidence            43321 12233467999999999997   4567889999999999999999 888864221110    0   000000 0


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...      ...........+.+|+.+||+.||++|||+.+|++
T Consensus       246 ~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLD------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCT------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Ccc------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            000      00112234556789999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.6e-36  Score=310.94  Aligned_cols=251  Identities=21%  Similarity=0.344  Sum_probs=178.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc--chHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ--GVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      .++|.+.+.||+|+||.||++... +++.||||++......  ..+.+..+..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457888999999999999999976 5899999999754322  2234445556778889999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      ||+ ++.+..+...  ....+++..+..++.||+.||.|||+. +   ++|+||||+||+++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 5556555532  234589999999999999999999985 7   99999999999999999999999999976533


Q ss_pred             CccCcCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ..   ......++..|+|||++.     ...++.++||||||+++|||++|+.|+......  .......   ... .  
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~---~~~-~--  246 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKV---LQE-E--  246 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH---HHS-C--
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHH---hcc-C--
Confidence            22   223356899999999994     457889999999999999999999986532111  1111110   000 0  


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         ...+  ......+..+.+++.+||+.||.+||++.++++
T Consensus       247 ---~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 ---PPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ---CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               0000  001123456889999999999999999999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-35  Score=338.03  Aligned_cols=238  Identities=20%  Similarity=0.303  Sum_probs=190.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeC--CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCc-----
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT--EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE-----  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----  420 (669)
                      .++|.+.+.||+|+||.||++...  +++.||||++.... ......+.+|+.++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999975  58999999986543 3445678999999999999999999999988766     


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .+|||||+++++|.+++..     .+++.+++.++.||+.||.|||+++   |+||||||+||||+.+ .+||+|||++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            6999999999999987732     5899999999999999999999998   9999999999999985 99999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      .....      ....||+.|+|||++.+.. +.++|||||||+||+|++|.+|+.......                   
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------  283 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------  283 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence            75432      3457899999999987654 899999999999999999987743211000                   


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHhcC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-MSSVVLMLSG  625 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~  625 (669)
                          .............+.+|+.+||+.||++||+ ++++...|.+
T Consensus       284 ----~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 ----LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ----CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                0000011122356789999999999999995 5556555543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-34  Score=298.75  Aligned_cols=232  Identities=10%  Similarity=0.062  Sum_probs=182.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|.+.+.||+|+||.||+|.... ++.||||++.....   ...+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            3679999999999999999999765 89999999975432   2347899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++..    + ....++.+++.||+.||.|||+++   |+||||||+||||+.++.+||++++       
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999999832    2 355678899999999999999998   9999999999999999999998543       


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                                     |++       .++.++||||||+++|||++|+.||..............  ..........    
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~----  226 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER--DTAGQPIEPA----  226 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB--CTTSCBCCHH----
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH--HhccCCCChh----
Confidence                           233       368899999999999999999999764333211100000  0000000000    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ..    ....+..+.+|+.+||+.||++| |+.|+++.|+....
T Consensus       227 ~~----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          227 DI----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             HH----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             hc----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            00    11123568899999999999999 99999999987644

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.9e-34  Score=293.47  Aligned_cols=225  Identities=21%  Similarity=0.290  Sum_probs=177.6

Q ss_pred             hcCCCcc-CeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHH-HHhCCCceeEEEEEEec----CCcc
Q 005933          349 TDNFSWK-NKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLI-AKLQHRNLVRLLGCCTL----RDER  421 (669)
Q Consensus       349 ~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~  421 (669)
                      .++|.+. +.||+|+||.||++... +++.||||++..     ...+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567776 77999999999999974 589999999853     35678899988 55589999999999876    6678


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEeecCC
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGM  498 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~Dfgl  498 (669)
                      ++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999999653 3346899999999999999999999998   999999999999998   78999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      +....                        +..++.++||||||+++|||++|+.|+..........              
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--------------  208 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--------------  208 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--------------
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--------------
Confidence            86532                        2446789999999999999999999975332211000              


Q ss_pred             hhhcccccCC--CCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 LELIDKSLDG--SYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 ~~~~~~~~~~--~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       .........  ..+.    ..+..+.+++.+||+.||++|||+.|+++
T Consensus       209 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 -GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             -CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             000000001  1111    12457889999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-34  Score=313.78  Aligned_cols=240  Identities=17%  Similarity=0.180  Sum_probs=177.7

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC---ccchHHHHHHHHHHHHhCC-Cc---------ee------
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQH-RN---------LV------  409 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~n---------iv------  409 (669)
                      .+|...+.||+|+||.||+|... +|+.||||++....   ....+.|.+|+.++..++| +|         ++      
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45667789999999999999954 59999999987432   2346889999999999977 21         11      


Q ss_pred             E------EEEEEec-----CCcceEEEeecCCCCHHHHhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 005933          410 R------LLGCCTL-----RDERMLIYEYLPNKSLEQFIFD----VTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRII  474 (669)
Q Consensus       410 ~------l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii  474 (669)
                      .      ++.++..     ....+++|+++ +++|.+++..    ......+++..++.++.||++||+|||+.+   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            1      1111111     12346666655 6899998842    223455888999999999999999999998   99


Q ss_pred             eccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhh----------ccCCCCchhhHHHHHHHH
Q 005933          475 HRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA----------IDGLFSVKSDVFSFGVLV  544 (669)
Q Consensus       475 H~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~~sDVwS~G~~l  544 (669)
                      ||||||+||||+.++.+||+|||+++.....     .....| ..|+|||++          ....++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998864322     333567 999999999          555688999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 005933          545 LEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV  620 (669)
Q Consensus       545 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  620 (669)
                      |||++|+.|+........                   ....+....  ..+..+.+|+.+||+.||++||++.+++
T Consensus       308 ~elltg~~Pf~~~~~~~~-------------------~~~~~~~~~--~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-------------------SEWIFRSCK--NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-------------------SGGGGSSCC--CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhh-------------------HHHHHhhcc--cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999754322111                   111111111  1135688999999999999999976664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.1e-34  Score=303.69  Aligned_cols=237  Identities=15%  Similarity=0.158  Sum_probs=182.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccC--------ccchHHHHHHHHHHHHhC---------CCceeEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSS--------GQGVEEFKNEVLLIAKLQ---------HRNLVRL  411 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  411 (669)
                      .++|.+.++||+|+||.||+|+. +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45788899999999999999998 58999999997542        233478999999999986         7888877


Q ss_pred             EEEEe------------------------------cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 005933          412 LGCCT------------------------------LRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG  461 (669)
Q Consensus       412 ~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  461 (669)
                      .+.+.                              ..+..+|||||+++|++.+.+.+    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            77643                              26788999999999977666622    458999999999999999


Q ss_pred             HHHHH-hCCCCCceeccCCCCCEEEcCCc--------------------ceEEeecCCCcccCCCccCcCcccccccCCc
Q 005933          462 LLYLH-QDSRLRIIHRDLKASNVLLDNDM--------------------NPKISDFGMARAFGVDQTEANTDRVVGTYGY  520 (669)
Q Consensus       462 L~yLH-~~~~~~iiH~Dikp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y  520 (669)
                      |+||| +.+   |+||||||+||||+.++                    .+||+|||+++.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 888   99999999999999887                    8999999999875421       34789999


Q ss_pred             cCchhhccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc-cCCC----CCHHH
Q 005933          521 MSPEYAIDGLFSVKSDVFSFGVL-VLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS-LDGS----YSLSE  594 (669)
Q Consensus       521 ~aPE~~~~~~~t~~sDVwS~G~~-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~  594 (669)
                      +|||++.+.. +.++|||||+++ .+++++|..|+..           ..|   .......+.... ....    .....
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLW---LHYLTDKMLKQMTFKTKCNTPAMKQI  308 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHH---HHHHHHHHHHTCCCSSCCCSHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhh---hhHHHHhhhhhhccCcccchhhhhhc
Confidence            9999998766 899999998777 7888888887421           000   000001111100 0011    11235


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHH
Q 005933          595 ALRCIQVGLLCVQQRPEDRPNMSSVV  620 (669)
Q Consensus       595 ~~~l~~li~~cl~~dP~~RPs~~evl  620 (669)
                      +..+.+|+.+||+.|     |++|++
T Consensus       309 s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          309 KRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             CHHHHHHHHHHhccC-----CHHHHH
Confidence            668899999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.4e-28  Score=276.04  Aligned_cols=185  Identities=18%  Similarity=0.155  Sum_probs=130.6

Q ss_pred             CeeeecCccceEEEE-eCCCcEEEEEEecccC----------ccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceE
Q 005933          356 NKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSS----------GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  423 (669)
                      ..++.|+.|.+..++ .--|+.+|||++.+..          ....++|.+|+++|+++ .|+||+++++++.+++..+|
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            345666666665544 2238899999996542          22346799999999999 79999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||++|++|.++|..   .+.++..   +|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+...
T Consensus       320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            9999999999999953   3456654   58899999999999999   9999999999999999999999999998764


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR  552 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~  552 (669)
                      ....  .....+||+.|+|||++.+ .+..++|+||+|+++++|.++..
T Consensus       391 ~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          391 QDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             CCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            3322  2334679999999999865 46778999999999999877643

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=2.7e-25  Score=247.99  Aligned_cols=184  Identities=18%  Similarity=0.183  Sum_probs=144.7

Q ss_pred             CccCeeeecCccceEEEEeCCCcEEEEEEecccCc--------cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG--------QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       353 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ...+.||+|+||.||++... ++.+++|+......        ...+++.+|+.++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            44579999999999999654 78899998643211        1235689999999999999999666666678888999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++++|.+++..           +..++.||++||.|||+++   |+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999943           5689999999999999998   999999999999999  999999999998644


Q ss_pred             CccCc-----CcccccccCCccCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCC
Q 005933          505 DQTEA-----NTDRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRN  553 (669)
Q Consensus       505 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwS~G~~l~elltG~~p  553 (669)
                      .....     ......||+.|+|||++..  ..|+...|+|+..+-..+.+.++.+
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence            32211     1234679999999999987  5688889999999998888877655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=1.8e-22  Score=206.64  Aligned_cols=151  Identities=18%  Similarity=0.151  Sum_probs=121.2

Q ss_pred             HHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCc------------------cchHHHHHHHHHHHHhCC
Q 005933          344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG------------------QGVEEFKNEVLLIAKLQH  405 (669)
Q Consensus       344 ~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h  405 (669)
                      .+......|.+.+.||+|+||.||+|...+|+.||||+++....                  .....+.+|+.+++.++|
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            34445566778899999999999999997799999999864321                  134578999999999994


Q ss_pred             CceeEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       406 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                         +++.+++. .+..++||||+++++|.+ +..         .....++.||+.||.|||+.+   |+||||||+||||
T Consensus       164 ---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl  226 (282)
T 1zar_A          164 ---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV  226 (282)
T ss_dssp             ---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             ---CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence               45555443 356799999999999988 411         224579999999999999998   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI  527 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  527 (669)
                      + ++.+||+|||+++.               +..+.|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            9 99999999999864               34578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=1.5e-18  Score=175.24  Aligned_cols=136  Identities=15%  Similarity=0.179  Sum_probs=107.4

Q ss_pred             CCccCeeeecCccceEEEEe-CCCcE--EEEEEecccCcc------------------------chHHHHHHHHHHHHhC
Q 005933          352 FSWKNKLGEGGFGPVYRGML-TEGQE--IAVKRLSKSSGQ------------------------GVEEFKNEVLLIAKLQ  404 (669)
Q Consensus       352 ~~~~~~lg~G~fg~Vy~g~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  404 (669)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+.++..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999998 67889  999987543111                        1136889999999998


Q ss_pred             CCce--eEEEEEEecCCcceEEEeecCC-C----CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceec
Q 005933          405 HRNL--VRLLGCCTLRDERMLIYEYLPN-K----SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH-QDSRLRIIHR  476 (669)
Q Consensus       405 h~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~  476 (669)
                      |+++  +.+++.    ...+|||||+.+ |    +|.++...      .++..+..++.||+.||.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8753  444443    367899999942 4    67766532      224467789999999999999 888   9999


Q ss_pred             cCCCCCEEEcCCcceEEeecCCCccc
Q 005933          477 DLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       477 Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      ||||.|||++.  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=1.8e-16  Score=166.55  Aligned_cols=137  Identities=14%  Similarity=0.195  Sum_probs=101.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCc--------------cchH--------HHHHHHHHHHHhCCC
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG--------------QGVE--------EFKNEVLLIAKLQHR  406 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~  406 (669)
                      ..-|++.++||+|++|.||+|...+|+.||||+++....              ....        ....|+..|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            345899999999999999999998999999998753210              0011        123466666666544


Q ss_pred             ce--eEEEEEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEE
Q 005933          407 NL--VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVL  484 (669)
Q Consensus       407 ni--v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIl  484 (669)
                      ++  ...++.    ...+|||||+++++|..+..         ......++.||+.+|.+||+.+   ||||||||.|||
T Consensus       174 gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL  237 (397)
T 4gyi_A          174 GFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNIL  237 (397)
T ss_dssp             TCSCCCEEEE----ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             CCCCCeeeec----cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence            43  222322    23479999999998876541         1123568899999999999998   999999999999


Q ss_pred             EcCCc----------ceEEeecCCCcc
Q 005933          485 LDNDM----------NPKISDFGMARA  501 (669)
Q Consensus       485 l~~~~----------~~kl~Dfgla~~  501 (669)
                      |++++          .+.|+||+-+..
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EeCCCCcccccccccceEEEEeCCccc
Confidence            98877          389999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=5.3e-12  Score=127.19  Aligned_cols=148  Identities=14%  Similarity=0.094  Sum_probs=117.5

Q ss_pred             HHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceE
Q 005933          345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       345 l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l  423 (669)
                      +......|.+...++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. +..+.++++++...+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3445567888888898999999999865 6899999986533233457899999999995 6788899999988888999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS----------------------------------  469 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------  469 (669)
                      ||||++|.+|.+.+.        +......++.+++++|+.||+..                                  
T Consensus        88 v~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999999987641        11223478899999999999821                                  


Q ss_pred             ----------------------CCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          470 ----------------------RLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       470 ----------------------~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                                            +..++|+|++|.||+++++..+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                  13489999999999998876678999997753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=4e-11  Score=120.26  Aligned_cols=138  Identities=17%  Similarity=0.195  Sum_probs=103.2

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCc--eeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN--LVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~E~  427 (669)
                      ..+.+....+.|..+.||+....+|+.++||+....   ....+..|+.+++.+.+.+  +.+++++...++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            344443333455669999998877889999997543   3356889999999996544  55688888888888999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS--------------------------------------  469 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------  469 (669)
                      ++|.+|.  ...      .+   ...++.++++.|..||+..                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9998884  211      11   2367788888888888753                                      


Q ss_pred             -----------------CCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          470 -----------------RLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       470 -----------------~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                                       +..++|+|++|.||+++++..+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             12399999999999998877778999998753

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.03  E-value=2.9e-10  Score=114.52  Aligned_cols=108  Identities=11%  Similarity=0.010  Sum_probs=76.9

Q ss_pred             CccccccccCCeeEEEeecCCCCCCCCccEEEEccCCCCeEEEEeC-CEEEEeecCCCCcceeccccCCCCCceeEEeee
Q 005933            1 MKLGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKG-SKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVS   79 (669)
Q Consensus         1 mklg~~~~tg~~~~L~Sw~s~~DPs~G~~s~~~d~~g~~~~~~~~~-~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~   79 (669)
                      ||||+++++|.+  |   +|.+||++|.|+++++++|  +++++++ +.+||++|.|++....  -.+..  ..++.+.+
T Consensus       143 ~~~~~~l~~g~~--L---~S~~dps~G~fsl~l~~dG--nlvLy~~~~~~yW~Sgt~~~~~~~--l~l~~--dGnLvl~d  211 (276)
T 3m7h_A          143 AIDSLLLAPGSE--L---VQGVVYGAGASKLVFQGDG--NLVAYGPNGAATWNAGTQGKGAVR--AVFQG--DGNLVVYG  211 (276)
T ss_dssp             CTTCEEECSSEE--E---CTTCEEEETTEEEEECTTS--CEEEECTTSSEEEECCCTTTTCCE--EEECT--TSCEEEEC
T ss_pred             cccccccccCcc--c---ccCCCCCCceEEEeecCCc--eEEEEeCCCeEEEECCCCCCccEE--EEEcC--CCeEEEEe
Confidence            899999999976  5   6789999999999999998  4567764 6899999999764311  11222  22333333


Q ss_pred             cC-CeeEEEEEeecCCeeeeEEEccCCCeEEEEeecCCCceeeeec
Q 005933           80 NE-NEVFYRFNLIKSSVLTMMVINPQGEPQRLTWMEQTQKWAPFVP  124 (669)
Q Consensus        80 ~~-~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~w~~~~~~w~~~~~  124 (669)
                      +. ..+.++++.  .....|++|+.||++++|.|   ...|..++.
T Consensus       212 ~~~~~vWsS~t~--~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~  252 (276)
T 3m7h_A          212 AGNAVLWHSHTG--GHASAVLRLQANGSIAILDE---KPVWARFGF  252 (276)
T ss_dssp             TTSCEEEECSCT--TCTTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred             CCCcEEEEecCC--CCCCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence            33 344444433  23358999999999999999   357988883

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.94  E-value=2.7e-09  Score=112.54  Aligned_cols=142  Identities=15%  Similarity=0.244  Sum_probs=107.8

Q ss_pred             ccCeeeecCccceEEEEeCCCcEEEEEEec--ccC-ccchHHHHHHHHHHHHhC--CCceeEEEEEEecC---CcceEEE
Q 005933          354 WKNKLGEGGFGPVYRGMLTEGQEIAVKRLS--KSS-GQGVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLR---DERMLIY  425 (669)
Q Consensus       354 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lV~  425 (669)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.|.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3578999999999999876 4688888875  221 123457889999999997  45688899988776   3479999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS------------------------------------  469 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  469 (669)
                      ||++|..+.+..     ...++...+..++.++++.|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998874321     123678888999999999999999831                                    


Q ss_pred             -------------------CCCceeccCCCCCEEEcCCcc--eEEeecCCCcc
Q 005933          470 -------------------RLRIIHRDLKASNVLLDNDMN--PKISDFGMARA  501 (669)
Q Consensus       470 -------------------~~~iiH~Dikp~NIll~~~~~--~kl~Dfgla~~  501 (669)
                                         +..++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               245999999999999997653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=3.1e-09  Score=109.41  Aligned_cols=186  Identities=19%  Similarity=0.223  Sum_probs=123.4

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCc--eeEEEEEEecCC---cceEEEeec
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRN--LVRLLGCCTLRD---ERMLIYEYL  428 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~E~~  428 (669)
                      .+.++.|....||+..    ..++||+....  .....+.+|+.+++.+. +..  +.+++......+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3678999999999853    56889986432  34567899999999883 332  445555544333   347899999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS---------------------------------------  469 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------  469 (669)
                      +|.+|.....     ..++..++..++.++++.|+.||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998875432     23677788888999999999998621                                       


Q ss_pred             ----------------CCCceeccCCCCCEEEcC--CcceEEeecCCCcccCCCccCcCccc------------ccccCC
Q 005933          470 ----------------RLRIIHRDLKASNVLLDN--DMNPKISDFGMARAFGVDQTEANTDR------------VVGTYG  519 (669)
Q Consensus       470 ----------------~~~iiH~Dikp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~------------~~gt~~  519 (669)
                                      +..++|+|++|.||++++  ...+.|+||+.+..-.....-.....            .....+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            134799999999999998  56789999999865322110000000            000011


Q ss_pred             ccC-chhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 005933          520 YMS-PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN  553 (669)
Q Consensus       520 y~a-PE~~~~~~~t~~sDVwS~G~~l~elltG~~p  553 (669)
                      ... |+....  .....+.|+++.+++.+.+|..+
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence            112 222211  11236899999999999999765

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.85  E-value=3.1e-09  Score=104.94  Aligned_cols=100  Identities=11%  Similarity=0.043  Sum_probs=76.3

Q ss_pred             cccc-ccCC-----eeEEEeecCCCCCCCCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEe
Q 005933            4 GVNL-VTGL-----KRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEY   77 (669)
Q Consensus         4 g~~~-~tg~-----~~~L~Sw~s~~DPs~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~   77 (669)
                      |.|. .+|+     +++|+|   .+||++|.|+++++++|  ++++++++.+||++|+|++. +.+.|+|.....+ +.|
T Consensus       124 g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly  196 (236)
T 1dlp_A          124 GNSILYSTQGNDNHPQTLHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVL  196 (236)
T ss_dssp             CCEECCCC--CCCCCCEECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEE
T ss_pred             cceEEecCCcCCCccceEEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEE
Confidence            5565 6777     678885   78999999999999998  78999998999999999764 7777887644421 223


Q ss_pred             eecCCeeEEEEEeecCCeeeeEEEccCCCeEEEE
Q 005933           78 VSNENEVFYRFNLIKSSVLTMMVINPQGEPQRLT  111 (669)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~  111 (669)
                      ..+.++++++|+.... ...|++|+.+|++++|.
T Consensus       197 ~~~~~~vw~s~~~~~~-~~~rl~Ld~dG~l~ly~  229 (236)
T 1dlp_A          197 TNQNIAVWTSGNSRSA-GRYVFVLQPDRNLAIYG  229 (236)
T ss_dssp             ETTTEEEEECCCCCSS-SCCEEEECSSSCEEEEC
T ss_pred             eCCCcEEEEeCCCCCC-CCEEEEEcCCCcEEEeC
Confidence            3455677777765544 46899999999999984

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=2e-06  Score=86.45  Aligned_cols=136  Identities=19%  Similarity=0.192  Sum_probs=100.5

Q ss_pred             CeeeecCcc-ceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEeecCCCC
Q 005933          356 NKLGEGGFG-PVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKS  432 (669)
Q Consensus       356 ~~lg~G~fg-~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gs  432 (669)
                      +.+..|..+ .||+.... ++..++||+-...   ....+..|...|+.+. +--+.++++++.+++..++|||++++.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            455666666 58987765 4678999986432   3457888999999884 4457788999999999999999999998


Q ss_pred             HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 005933          433 LEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS-------------------------------------------  469 (669)
Q Consensus       433 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------------  469 (669)
                      +.+.....       ......++.+++..|+.||...                                           
T Consensus       107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            87765321       1223456667777777777531                                           


Q ss_pred             ------------CCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          470 ------------RLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       470 ------------~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                                  +..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        11379999999999999888788999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.37  E-value=2.3e-06  Score=87.92  Aligned_cols=135  Identities=20%  Similarity=0.177  Sum_probs=97.1

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCC---ceeEEEEEEe-cCCcceEEEeecCCC
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR---NLVRLLGCCT-LRDERMLIYEYLPNK  431 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~E~~~~g  431 (669)
                      +.++.|....||+.    +..++||+...  ......+..|+.+|..|.+.   .+.+++.+.. ..+..++|||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            56888888899987    57788998532  23456889999999999752   3566777764 445678999999999


Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS------------------------------------------  469 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------------  469 (669)
                      +|......     .++......++.++++.|+.||+..                                          
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88763211     1345556666666666666666532                                          


Q ss_pred             ---------------CCCceeccCCCCCEEEcC---Ccc-eEEeecCCCcc
Q 005933          470 ---------------RLRIIHRDLKASNVLLDN---DMN-PKISDFGMARA  501 (669)
Q Consensus       470 ---------------~~~iiH~Dikp~NIll~~---~~~-~kl~Dfgla~~  501 (669)
                                     +..++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           224699999999999997   455 58999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.27  E-value=1.7e-06  Score=90.80  Aligned_cols=80  Identities=8%  Similarity=-0.006  Sum_probs=57.4

Q ss_pred             Cee-eecCccceEEEEeC-------CCcEEEEEEecccC---ccchHHHHHHHHHHHHhC-C--CceeEEEEEEecC---
Q 005933          356 NKL-GEGGFGPVYRGMLT-------EGQEIAVKRLSKSS---GQGVEEFKNEVLLIAKLQ-H--RNLVRLLGCCTLR---  418 (669)
Q Consensus       356 ~~l-g~G~fg~Vy~g~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~---  418 (669)
                      +.| +.|....+|+....       +++.+++|+.....   ......+..|+.+++.|. +  ..+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78888999988764       26789999864322   112356788999999885 3  3577888887665   


Q ss_pred             CcceEEEeecCCCCHHH
Q 005933          419 DERMLIYEYLPNKSLEQ  435 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~  435 (669)
                      +..++|||+++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            34689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.02  E-value=2.1e-05  Score=83.69  Aligned_cols=75  Identities=11%  Similarity=0.144  Sum_probs=51.6

Q ss_pred             cCeeeecCccceEEEEeC-CCcEEEEEEecccCc-------cchHHHHHHHHHHHHhCC--C-ceeEEEEEEecCCcceE
Q 005933          355 KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-------QGVEEFKNEVLLIAKLQH--R-NLVRLLGCCTLRDERML  423 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~~~l  423 (669)
                      .+.||.|.++.||++... +++.++||.......       ...+++..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999864 468899998643211       234567889999988842  3 34456544  3456789


Q ss_pred             EEeecCCC
Q 005933          424 IYEYLPNK  431 (669)
Q Consensus       424 V~E~~~~g  431 (669)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.88  E-value=2.5e-05  Score=81.12  Aligned_cols=141  Identities=16%  Similarity=0.217  Sum_probs=81.7

Q ss_pred             CeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCC--CceeEEEE------EEecCCcceEEEee
Q 005933          356 NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVRLLG------CCTLRDERMLIYEY  427 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g------~~~~~~~~~lV~E~  427 (669)
                      +.|+.|..+.||+....+| .+++|+....    ..++..|+.++..|..  -.+.+++.      +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677889999987654 5899988642    2445556666666642  12334443      11235667899999


Q ss_pred             cCCCCHH--------------HHhhccCC----C-------CCCCHHHH-------------------------------
Q 005933          428 LPNKSLE--------------QFIFDVTR----T-------KFLDWSKR-------------------------------  451 (669)
Q Consensus       428 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~-------------------------------  451 (669)
                      ++|..+.              ..++....    .       ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9987542              01111100    0       01233221                               


Q ss_pred             HHHHHHHHHHHHHHHh----------CCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          452 CQIIEGIARGLLYLHQ----------DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       452 ~~i~~~ia~~L~yLH~----------~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ..+...+..++.+|++          ..+..++|+|+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111224446667763          1234599999999999998888999999997753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.85  E-value=7.9e-05  Score=75.49  Aligned_cols=80  Identities=20%  Similarity=0.229  Sum_probs=60.6

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCC---CceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH---RNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ..+.-.+.+|.|..+.||+.++.+|+.|+||+...........|..|+..|+.|..   -.+.+++++.    ..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            34555678999999999999999999999998765544455678899999999842   2345555542    4589999


Q ss_pred             ecCCCCH
Q 005933          427 YLPNKSL  433 (669)
Q Consensus       427 ~~~~gsL  433 (669)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.82  E-value=9e-05  Score=75.89  Aligned_cols=138  Identities=21%  Similarity=0.190  Sum_probs=93.8

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhC---CCceeEEEEEEecCCcceEEEeecCCC
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ---HRNLVRLLGCCTLRDERMLIYEYLPNK  431 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~E~~~~g  431 (669)
                      .+.|+.|....+|+.... +..++||+....   ....+..|+..|+.|.   ...+++++++....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            467899999999998864 678899987532   3567889999999884   367888999888888899999999998


Q ss_pred             CHHH-----------HhhccCC-CC------------------CCCHHHHH---HHH----------------HHHHHH-
Q 005933          432 SLEQ-----------FIFDVTR-TK------------------FLDWSKRC---QII----------------EGIARG-  461 (669)
Q Consensus       432 sL~~-----------~l~~~~~-~~------------------~l~~~~~~---~i~----------------~~ia~~-  461 (669)
                      .+..           -|+.... ..                  .-+|....   ++.                ..++.. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           1222211 00                  12454321   111                111212 


Q ss_pred             HHHHHh-CCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          462 LLYLHQ-DSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       462 L~yLH~-~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      ...|.. ..++.++|+|+.+.||+++.++ +.|+|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            223432 2346799999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.70  E-value=0.00017  Score=77.40  Aligned_cols=80  Identities=10%  Similarity=0.015  Sum_probs=48.1

Q ss_pred             CCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccC---CCCchhhHHHHHHHHHH
Q 005933          470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLE  546 (669)
Q Consensus       470 ~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwS~G~~l~e  546 (669)
                      ...++|+|++|.|||++.++ +.|+||+.+..-..... .......-...|++|+.....   .-....++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            34599999999999998876 99999998865211100 000000011345666554311   12234566688888888


Q ss_pred             HHhCC
Q 005933          547 IVCGK  551 (669)
Q Consensus       547 lltG~  551 (669)
                      .+.+.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.43  E-value=0.00037  Score=71.54  Aligned_cols=159  Identities=16%  Similarity=0.143  Sum_probs=90.2

Q ss_pred             ccHHHHHHHhcCCCcc-----CeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCc--eeEEE
Q 005933          340 FDWNTIADATDNFSWK-----NKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN--LVRLL  412 (669)
Q Consensus       340 ~~~~~l~~~~~~~~~~-----~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  412 (669)
                      ++.+++......|.+.     +.|+.|....+|+....+| .+++|+....  ...+.+..|+.++..|....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4555666666667653     3466688889999987655 6889987642  12345667888888774222  23333


Q ss_pred             EE------EecCCcceEEEeecCCCCHHH--------------HhhccCC----C--CC---CCHHHHHH----------
Q 005933          413 GC------CTLRDERMLIYEYLPNKSLEQ--------------FIFDVTR----T--KF---LDWSKRCQ----------  453 (669)
Q Consensus       413 g~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~----~--~~---l~~~~~~~----------  453 (669)
                      ..      ....+..++|++|++|..+..              -++....    .  ..   ..|...+.          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      122355689999999865421              0111110    0  00   11322111          


Q ss_pred             --HHHHHHHHHHHHHhC----CCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          454 --IIEGIARGLLYLHQD----SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       454 --i~~~ia~~L~yLH~~----~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                        +...+...+..+++.    .+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011244455555532    234589999999999999876678999997753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.32  E-value=0.00031  Score=75.45  Aligned_cols=72  Identities=18%  Similarity=0.313  Sum_probs=51.1

Q ss_pred             CeeeecCccceEEEEeCC--------CcEEEEEEecccCccchHHHHHHHHHHHHhCCCce-eEEEEEEecCCcceEEEe
Q 005933          356 NKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E  426 (669)
                      +.|+.|....+|+....+        ++.+++|+....  ...+.+..|..++..|...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            678888899999998753        578999987432  122566689999998853333 567776542    38999


Q ss_pred             ecCCCCH
Q 005933          427 YLPNKSL  433 (669)
Q Consensus       427 ~~~~gsL  433 (669)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9987444

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.31  E-value=0.001  Score=67.68  Aligned_cols=138  Identities=13%  Similarity=0.128  Sum_probs=77.3

Q ss_pred             cCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCce-eEEEEEEecCCcceEEEeec-CCCC
Q 005933          355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYL-PNKS  432 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~-~~gs  432 (669)
                      .+.|+.|....+|+.     +.+++|+....... .....+|+.+++.+...++ .+++++.  .+.-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            578999999999998     66889987543222 1233568888887753333 4555543  44567899999 6655


Q ss_pred             HHHH------------------hhccCCC--CCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCCCC
Q 005933          433 LEQF------------------IFDVTRT--KFLD-WSKRCQIIE--------------GIARGL----LYLHQ-DSRLR  472 (669)
Q Consensus       433 L~~~------------------l~~~~~~--~~l~-~~~~~~i~~--------------~ia~~L----~yLH~-~~~~~  472 (669)
                      |...                  ++.....  ...+ +..+..+..              .+...+    ..|.. ..+..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4321                  1111000  0011 111111110              011111    11111 22345


Q ss_pred             ceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          473 IIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       473 iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5667789999998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.29  E-value=0.00099  Score=70.02  Aligned_cols=141  Identities=20%  Similarity=0.246  Sum_probs=84.9

Q ss_pred             CeeeecCccceEEEEeC--------CCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcceEEEe
Q 005933          356 NKLGEGGFGPVYRGMLT--------EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      +.|..|-...+|+....        +++.+++|+... .......+.+|..+++.|. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            57888888999998875        257899998633 2234566778999998885 3223567776654    39999


Q ss_pred             ecCCCCHHHH-----------------hhccC--CCCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 005933          427 YLPNKSLEQF-----------------IFDVT--RTKFLD--WSKRCQIIEGIAR-------------------GLLY--  464 (669)
Q Consensus       427 ~~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~L~y--  464 (669)
                      |++|.+|..-                 |+...  -.+...  +.++.++..++..                   .+..  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665311                 11110  011122  3455555443321                   1222  


Q ss_pred             --HHhC-CCCCceeccCCCCCEEEcCC----cceEEeecCCCcc
Q 005933          465 --LHQD-SRLRIIHRDLKASNVLLDND----MNPKISDFGMARA  501 (669)
Q Consensus       465 --LH~~-~~~~iiH~Dikp~NIll~~~----~~~kl~Dfgla~~  501 (669)
                        |... .+..++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              3222 23468999999999999876    7899999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.29  E-value=0.0014  Score=70.85  Aligned_cols=73  Identities=11%  Similarity=0.100  Sum_probs=49.5

Q ss_pred             CeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCce-eEEEEEEecCCcceEEEeecCCCCH
Q 005933          356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      +.|+.|-...+|+....+ +..+++|+......... ....|..++..|...++ .++++.+.  +  .+||||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            678889899999999875 57899998744322222 22689999999965444 46777763  2  369999997554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.21  E-value=0.0023  Score=66.03  Aligned_cols=141  Identities=16%  Similarity=0.127  Sum_probs=74.5

Q ss_pred             CeeeecCccc-eEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCC--CceeEEEEEEecCCcceEEEeecCCCC
Q 005933          356 NKLGEGGFGP-VYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRDERMLIYEYLPNKS  432 (669)
Q Consensus       356 ~~lg~G~fg~-Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~~~~gs  432 (669)
                      +.|+.|.... +|+....++..+++|......   ...+..|+.++..+..  -.+.+++.+....  -++|||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            4566665544 667765446778887653321   1344567777777742  2355677664332  378999998776


Q ss_pred             HHHHhhc---------------------cCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 005933          433 LEQFIFD---------------------VTR--TKFLDWSKRC-------Q-------------IIEGIARGLLYLH---  466 (669)
Q Consensus       433 L~~~l~~---------------------~~~--~~~l~~~~~~-------~-------------i~~~ia~~L~yLH---  466 (669)
                      +.+++..                     ...  ....+.....       .             ....+...+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6544321                     000  0111111100       0             0011112222221   


Q ss_pred             hCCCCCceeccCCCCCEEEcCC----cceEEeecCCCcc
Q 005933          467 QDSRLRIIHRDLKASNVLLDND----MNPKISDFGMARA  501 (669)
Q Consensus       467 ~~~~~~iiH~Dikp~NIll~~~----~~~kl~Dfgla~~  501 (669)
                      ...+..++|+|+.+.||+++.+    ..+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1223469999999999999875    6899999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.11  E-value=0.0046  Score=63.42  Aligned_cols=158  Identities=15%  Similarity=0.165  Sum_probs=89.6

Q ss_pred             ccHHHHHHHhcCCCc-----cCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCC--ceeEEE
Q 005933          340 FDWNTIADATDNFSW-----KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHR--NLVRLL  412 (669)
Q Consensus       340 ~~~~~l~~~~~~~~~-----~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~  412 (669)
                      .+.+.+....+.|.+     ...|+ |....||+....+|+.+++|+.... ......+..|+.++..+...  .+++++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~   88 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPV   88 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeeccee
Confidence            444555554444433     23466 8888999988777888999998532 12356777888888888522  234444


Q ss_pred             EE-----EecCCcceEEEeecCCCCHH-----HH---------hhcc-C-----CCCCCCHHHH----HHH---------
Q 005933          413 GC-----CTLRDERMLIYEYLPNKSLE-----QF---------IFDV-T-----RTKFLDWSKR----CQI---------  454 (669)
Q Consensus       413 g~-----~~~~~~~~lV~E~~~~gsL~-----~~---------l~~~-~-----~~~~l~~~~~----~~i---------  454 (669)
                      ..     ....+..++|||+++|..+.     .+         ++.. .     .....++...    ..+         
T Consensus        89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  168 (328)
T 1zyl_A           89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS  168 (328)
T ss_dssp             CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred             ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence            43     11234457899999885432     11         1110 0     0111222211    001         


Q ss_pred             ------HHHHHHHHHHHHh----CCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          455 ------IEGIARGLLYLHQ----DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       455 ------~~~ia~~L~yLH~----~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                            ...+...+..+..    ..+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                  1111122223322    1234589999999999999 4 899999988754

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=97.05  E-value=0.00061  Score=58.26  Aligned_cols=41  Identities=15%  Similarity=0.237  Sum_probs=36.4

Q ss_pred             EeecCCCCCCCCccEEEEccCCCCeEEEEe-CCEEEEeecCCCC
Q 005933           16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRK-GSKIKFRAGPWNG   58 (669)
Q Consensus        16 ~Sw~s~~DPs~G~~s~~~d~~g~~~~~~~~-~~~~y~~sg~w~g   58 (669)
                      +-|.|..||++|.|++.++++|.  ++++. ++.+||+|++|+|
T Consensus        70 ~~W~S~~~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           70 AIWASNTNRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             EEEECCCCCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred             EEEECCccCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence            45999999999999999999997  67776 5789999999987

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.88  E-value=0.0019  Score=67.78  Aligned_cols=73  Identities=15%  Similarity=0.133  Sum_probs=45.7

Q ss_pred             CeeeecCccceEEEEeCC---------CcEEEEEEecccCccchHHHHHHHHHHHHhCCCc-eeEEEEEEecCCcceEEE
Q 005933          356 NKLGEGGFGPVYRGMLTE---------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~  425 (669)
                      +.|+.|....+|+....+         ++.+++|+...... .......|..++..+...+ ..++++..    .-++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            567888888999988754         26888888754322 1223467888888885333 34666554    247899


Q ss_pred             eecCCCCH
Q 005933          426 EYLPNKSL  433 (669)
Q Consensus       426 E~~~~gsL  433 (669)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998644

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.82  E-value=0.0043  Score=58.87  Aligned_cols=101  Identities=11%  Similarity=0.032  Sum_probs=66.1

Q ss_pred             CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCcCc
Q 005933          432 SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT  511 (669)
Q Consensus       432 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  511 (669)
                      ||.++|..  ...++++.+++.++.|.+.+|.-+-... .+ ..+=+.|..|+|..+|.+.+.+ ..+.           
T Consensus        34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            78888853  4567999999999999999988762211 01 1233457899999999988764 1110           


Q ss_pred             ccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 005933          512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR  552 (669)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~  552 (669)
                         .....+.|||... ...+.+.=|||||++||.-+--..
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence               1233466888653 455788999999999999876443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.50  E-value=0.0076  Score=62.32  Aligned_cols=64  Identities=9%  Similarity=0.121  Sum_probs=42.4

Q ss_pred             ccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCC---CceeEEEEE------EecCCcceEEEeecCCCCH
Q 005933          363 FGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH---RNLVRLLGC------CTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       363 fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~------~~~~~~~~lV~E~~~~gsL  433 (669)
                      ...||+....+| .+++|+......      ..|+.++..|..   |++++++..      ....+..++||||++|..+
T Consensus        36 ~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           36 NAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             SCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             ccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            678999987777 899998754331      356666666632   224455432      2234567899999998765

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=95.57  E-value=0.013  Score=50.14  Aligned_cols=40  Identities=20%  Similarity=0.232  Sum_probs=34.3

Q ss_pred             EeecCCCCCCCCccEEEEccCCCCeEEEEeCCEEEEeecCCCCc
Q 005933           16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGL   59 (669)
Q Consensus        16 ~Sw~s~~DPs~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~   59 (669)
                      +-|.|.+.|++|.|++.++++|.  ++++++  +||+||+|...
T Consensus        72 ~vW~S~~~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~  111 (115)
T 2dpf_A           72 DVWGSACWGDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR  111 (115)
T ss_dssp             EEEECCCCCSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred             EEEEcCCCCCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence            34999999999999999999996  678865  89999999653

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=95.37  E-value=0.016  Score=49.86  Aligned_cols=36  Identities=14%  Similarity=0.301  Sum_probs=30.9

Q ss_pred             EeecCCCCCCCCccEEEEccCCCCeEEEEeCCEEEEeecC
Q 005933           16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGP   55 (669)
Q Consensus        16 ~Sw~s~~DPs~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~   55 (669)
                      +-|.|..||++|.|++.++++|.  ++++.  .+||+||+
T Consensus        82 ~lW~S~~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~  117 (119)
T 1b2p_A           82 TVWQSPVAGKAGHYVLVLQPDRN--VVIYG--DALWATQT  117 (119)
T ss_dssp             EEEECSCCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred             EEEcCCCCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence            35999999999999999999987  67777  38999986

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=95.31  E-value=0.018  Score=48.82  Aligned_cols=37  Identities=14%  Similarity=0.342  Sum_probs=31.8

Q ss_pred             EeecCCCCCCCCccEEEEccCCCCeEEEEeCCEEEEeecCC
Q 005933           16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPW   56 (669)
Q Consensus        16 ~Sw~s~~DPs~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w   56 (669)
                      +-|.|..+|++|.|++.++++|.  ++++++  +||+||++
T Consensus        72 ~~W~S~t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~  108 (110)
T 3a0c_A           72 VIWQTKTNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG  108 (110)
T ss_dssp             EEEECCCCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred             EEEecCCCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence            34999999999999999999986  677775  89999886

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.27  E-value=0.082  Score=56.18  Aligned_cols=140  Identities=15%  Similarity=0.166  Sum_probs=85.0

Q ss_pred             CeeeecCccceEEEEeCC--------CcEEEEEEecccCccchHHHHHHHHHHHHhCCCc-eeEEEEEEecCCcceEEEe
Q 005933          356 NKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRN-LVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E  426 (669)
                      +.|..|-...+|+....+        ++.+++|+....... .-...+|..+++.+...+ ..++++.+.    -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            567778888999998763        578999986443222 223467888888885322 345665432    378999


Q ss_pred             ecCCCCHHH-------H----------hhc--c-----C---CCCCCCHHHHHHHHHHH-------------------HH
Q 005933          427 YLPNKSLEQ-------F----------IFD--V-----T---RTKFLDWSKRCQIIEGI-------------------AR  460 (669)
Q Consensus       427 ~~~~gsL~~-------~----------l~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a~  460 (669)
                      |++|.+|..       .          |+.  .     .   ...+.-|.++.++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            999876421       0          110  1     0   11111244444433222                   12


Q ss_pred             HHHHHH---------------------hCCCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          461 GLLYLH---------------------QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       461 ~L~yLH---------------------~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      .+..|.                     ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            223332                     112345899999999999 8888999999998754

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.97  E-value=0.11  Score=54.92  Aligned_cols=30  Identities=23%  Similarity=0.363  Sum_probs=25.1

Q ss_pred             CceeccCCCCCEEE------cCCcceEEeecCCCcc
Q 005933          472 RIIHRDLKASNVLL------DNDMNPKISDFGMARA  501 (669)
Q Consensus       472 ~iiH~Dikp~NIll------~~~~~~kl~Dfgla~~  501 (669)
                      .++|+|+.+.|||+      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36899999999999      4466799999998754

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=92.33  E-value=1.1  Score=37.13  Aligned_cols=80  Identities=11%  Similarity=0.118  Sum_probs=45.8

Q ss_pred             CccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccCCC
Q 005933           27 DNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQGE  106 (669)
Q Consensus        27 G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G~  106 (669)
                      |.|+|.|..+|.  +++|.+..++|.++.-+...-...-.+....  ++-..+.....-++........-.+++|..||+
T Consensus        19 g~y~l~~q~DgN--Lvly~~~~~vW~ant~~~~~~~~~L~l~~dG--nLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGN   94 (105)
T 4h3o_A           19 EPYHFIMQDDCN--LVLYDHSTSTWASNTEIGGKSGCSAVLQSDG--NFVVYDSSGRSLWASHSTRGSGNYILILQDDGN   94 (105)
T ss_dssp             TTEEEEECTTSC--EEEEETTEEEEECCCCCTTCCSCEEEECTTS--CEEEECTTCCEEEECCCCCCSSCEEEEECTTSC
T ss_pred             CCEEEEECCCCe--EEEEECCEEEEEecCCCCCCccEEEEEeCCc--cEEEECCCcEEEEEecCCCCCCCEEEEEeCCCe
Confidence            889999998886  5889999999987654321110001122211  121122222333333333333446789999999


Q ss_pred             eEEE
Q 005933          107 PQRL  110 (669)
Q Consensus       107 l~~~  110 (669)
                      +..|
T Consensus        95 lVly   98 (105)
T 4h3o_A           95 VIIY   98 (105)
T ss_dssp             EEEE
T ss_pred             EEEE
Confidence            9988

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=90.98  E-value=0.9  Score=37.96  Aligned_cols=81  Identities=10%  Similarity=-0.004  Sum_probs=46.1

Q ss_pred             CCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccCC
Q 005933           26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG  105 (669)
Q Consensus        26 ~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G  105 (669)
                      .|.|.|.|..+|.  +++++...++|.++.-+.. -...-.+....  ++-..+..................+++|+.||
T Consensus        18 ~g~~~L~~q~dGn--Lvly~~~~~vW~snt~~~~-~~~~l~l~~dG--NLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddG   92 (109)
T 3dzw_A           18 NGRYVFIMQEDCN--LVLYDVDKPIWATNTGGLD-RRCHLSMQSDG--NLVVYSPRNNPIWASNTGGENGNYVCVLQKDR   92 (109)
T ss_dssp             ETTEEEEECTTSC--EEEEETTEEEEECCCTTSS-SSCEEEECTTS--CEEEECTTSCEEEECCCCCSSSCEEEEECTTS
T ss_pred             CCCEEEEEcCCCc--EEEEeCCEEEEECCcccCC-CCEEEEEeCCC--CEEEECCCCCEEEECCCCCCCCCEEEEEeCCC
Confidence            6999999998885  5778888999988764310 00001122111  12222222223232222223344689999999


Q ss_pred             CeEEEE
Q 005933          106 EPQRLT  111 (669)
Q Consensus       106 ~l~~~~  111 (669)
                      ++..|.
T Consensus        93 Nlvly~   98 (109)
T 3dzw_A           93 NVVIYG   98 (109)
T ss_dssp             CEEEEE
T ss_pred             EEEEEC
Confidence            999985

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=85.35  E-value=7.8  Score=32.70  Aligned_cols=97  Identities=11%  Similarity=-0.006  Sum_probs=51.3

Q ss_pred             cccccccCCeeEEEeecCCCCCCCCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeeecCC
Q 005933            3 LGVNLVTGLKRFMSSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNEN   82 (669)
Q Consensus         3 lg~~~~tg~~~~L~Sw~s~~DPs~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~   82 (669)
                      .|..+..|.  .|++ +|    ..|.|.|.+..+|.  ++++++..+.|.++.-.. .-...-.+.....+.. +..+..
T Consensus        13 ~g~~L~~g~--~l~~-~S----~~g~~~L~~~~dgn--lvly~~~~~vW~sn~~~~-~~~~~l~l~~dGNLVl-~d~~~~   81 (119)
T 1b2p_A           13 HPQILHATE--SLEI-LF----GTHVYRFIMQTDCN--LVLYDNNNPIWATNTGGL-GNGCRAVLQPDGVLVV-ITNENV   81 (119)
T ss_dssp             CCCEEETTC--EEEE-EE----TTEEEEEEECTTSC--EEEEETTEEEEECCCTTS-CSSCEEEECTTSCEEE-ECTTCC
T ss_pred             CCCEEcCCC--EEEE-eC----CCCCEEEEEecCCC--EEEEECCEEEEeCCCccC-CCceEEEEccCCEEEE-EeCCCc
Confidence            355566665  4661 11    46899999998875  467887889998765421 1001112222111111 111222


Q ss_pred             eeEEEEEeecCCeeeeEEEccCCCeEEEE
Q 005933           83 EVFYRFNLIKSSVLTMMVINPQGEPQRLT  111 (669)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~l~~~G~l~~~~  111 (669)
                      .+.-+++-.. .....+.|+.+|++.+|.
T Consensus        82 ~lW~S~~~~~-~g~~~l~l~~~Gnlvl~~  109 (119)
T 1b2p_A           82 TVWQSPVAGK-AGHYVLVLQPDRNVVIYG  109 (119)
T ss_dssp             EEEECSCCCC-SSCEEEEECTTSCEEEEE
T ss_pred             EEEcCCCCCC-CCCEEEEEECCCcEEEEC
Confidence            3333333221 223578899999987763

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.02  E-value=1.8  Score=40.92  Aligned_cols=115  Identities=15%  Similarity=0.131  Sum_probs=77.8

Q ss_pred             CCCceeEEEEEEecCCcceEEEeecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCC
Q 005933          404 QHRNLVRLLGCCTLRDERMLIYEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASN  482 (669)
Q Consensus       404 ~h~niv~l~g~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~N  482 (669)
                      .||+++.. .+-.+.+...+.|+.-+. -++.. +      ..++...+++++.+|+....+++.     -+|--|+|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            58888866 455556666666665432 23322 2      237889999999999988866554     4788999999


Q ss_pred             EEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005933          483 VLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG  555 (669)
Q Consensus       483 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~  555 (669)
                      |+++.++.+++.-.|+-..                   ++|.     ..+...=.-.+=+++..+++++..|+
T Consensus       110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999986665332                   2222     12233334567788888999877643

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=84.88  E-value=1.7  Score=36.30  Aligned_cols=79  Identities=9%  Similarity=0.091  Sum_probs=42.0

Q ss_pred             CCCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccC
Q 005933           25 AQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQ  104 (669)
Q Consensus        25 s~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  104 (669)
                      +.|.|.|.|..+|.  ++++++   ||.++..+... ...-.+....  ++-..+..................+++|+.|
T Consensus        19 ~~g~~~L~~q~dGN--Lvl~~~---~Wssnt~~~~~-~~~l~l~~dG--nLvl~d~~~~~vWss~t~~~~~~~~~~L~~d   90 (109)
T 3r0e_A           19 KNGDFDLVMQDDCN--LVLYNG---NWQSNTANNGR-DCKLTLTDYG--ELVIKNGDGSTVWKSGAQSVKGNYAAVVHPD   90 (109)
T ss_dssp             EETTEEEEECTTSC--EEEETT---TEECCCTTSCS-SCEEEECTTS--CEEEECTTSCEEEECCCCCSSSCCEEEEETT
T ss_pred             ECCCEEEEEecCCe--EEEEeC---eEEcCCCCCCC-cEEEEEcCCC--eEEEEeCCCCEEEcCCCcCCCcCEEEEEcCC
Confidence            46999999998885  466664   78876543100 0000111111  1111222222223222222234568999999


Q ss_pred             CCeEEEE
Q 005933          105 GEPQRLT  111 (669)
Q Consensus       105 G~l~~~~  111 (669)
                      |+++.|.
T Consensus        91 GNlvly~   97 (109)
T 3r0e_A           91 GRLVVFG   97 (109)
T ss_dssp             TEEEEEC
T ss_pred             CeEEEEe
Confidence            9999984

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=84.12  E-value=5.5  Score=33.38  Aligned_cols=79  Identities=10%  Similarity=0.012  Sum_probs=43.6

Q ss_pred             CCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeee-cCCeeEEEEEeecCCeeeeEEEccC
Q 005933           26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVS-NENEVFYRFNLIKSSVLTMMVINPQ  104 (669)
Q Consensus        26 ~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~  104 (669)
                      .|.|.|.+..+|.  ++++++..++|.++..+... ...-.+.....  +-..+ +...+.-+++.. .....+++|+.+
T Consensus        19 ~g~~~L~~~~dgn--lvly~~~~~vW~sn~~~~~~-~~~l~l~~~Gn--Lvl~d~~~~~vW~S~~~~-~~g~~~l~l~~d   92 (115)
T 2dpf_A           19 AGAYTLTIQNKCN--LVKYQNGRQIWASNTDRRGS-GCRLTLLSDGN--LVIYDHNNNDVWGSACWG-DNGKYALVLQKD   92 (115)
T ss_dssp             ETTEEEEECTTSC--EEEEETTEEEEECSCTTSCS-SCEEEECTTSC--EEEECTTCCEEEECCCCC-SSSCCEEEECTT
T ss_pred             CCCEEEEEcCCCc--EEEEeCCEEEEeCCCCCCCC-ceEEEECCCCc--EEEECCCceEEEEcCCCC-CCCCEEEEEeCC
Confidence            5899999988775  46677888999987653210 00111221111  11111 222232233321 223467999999


Q ss_pred             CCeEEE
Q 005933          105 GEPQRL  110 (669)
Q Consensus       105 G~l~~~  110 (669)
                      |++.+|
T Consensus        93 Gnlvl~   98 (115)
T 2dpf_A           93 GRFVIY   98 (115)
T ss_dssp             SCEEEE
T ss_pred             CeEEEE
Confidence            998886

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=83.44  E-value=2.6  Score=35.15  Aligned_cols=80  Identities=8%  Similarity=-0.007  Sum_probs=42.7

Q ss_pred             CCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccCC
Q 005933           26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG  105 (669)
Q Consensus        26 ~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G  105 (669)
                      +|.|.|.+..+|.  ++++++ .+||.++.-+.. ....-.+....  ++-..+....+...........-.+++|+.||
T Consensus        23 sg~~~L~~q~dGn--Lvl~~~-~~vW~snt~~~~-~~~~l~l~~dG--NLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dG   96 (110)
T 3r0e_B           23 AKNHQLVMQGDCN--LVLYGG-KYGWQSNTHGNG-EHCFLRLNHKG--ELIIKDDDFKTIWSSRSSSKQGEYVLILQDDG   96 (110)
T ss_dssp             CSSCEEEECTTSC--EEEECS-SSCEECCCTTSS-SSCEEEECTTS--CEEEECTTCCEEEECCCCCSSSCCEEEECTTS
T ss_pred             eCCEEEEEcCCCe--EEEECC-eEEEECCCcCCC-cCEEEEEeCCC--cEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCc
Confidence            3779999998885  566766 589987654310 00000122111  12222222223222222112223689999999


Q ss_pred             CeEEEE
Q 005933          106 EPQRLT  111 (669)
Q Consensus       106 ~l~~~~  111 (669)
                      +++.|.
T Consensus        97 Nlvly~  102 (110)
T 3r0e_B           97 FGVIYG  102 (110)
T ss_dssp             CEEEEC
T ss_pred             cEEEec
Confidence            999985

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=83.21  E-value=3.7  Score=34.38  Aligned_cols=81  Identities=11%  Similarity=0.130  Sum_probs=44.0

Q ss_pred             CCccEEEEccCCCCeEEEEeC--CEEEEeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEcc
Q 005933           26 QDNYIYEVDPRGVPQAVFRKG--SKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINP  103 (669)
Q Consensus        26 ~G~~s~~~d~~g~~~~~~~~~--~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  103 (669)
                      .|.|.|.|..+|.  ++++..  ..+||.++.-+.. ....-.+....  ++-..+................-.+++|+.
T Consensus        23 ~g~~~L~~q~dGN--LvL~~~~~~~~vWssnt~~~~-~~~~l~l~~dG--NLVl~d~~~~~iW~S~t~~~~~~~~~~L~~   97 (113)
T 3mez_B           23 TRDYSLVMRDDCN--LVLTKGSKTNIVWESGTSGRG-QHCFMRLGHSG--ELDITDDRLNTVFVSNTVGQEGDYVLILQI   97 (113)
T ss_dssp             ETTEEEEECTTSC--EEEEETTTTEEEEECCCTTSC-SSCEEEECTTS--CEEEECTTSCEEEECSCCCSSSCCEEEECT
T ss_pred             cCCEEEEEcCCCE--EEEEECCCCEEEEECCcccCC-cCEEEEEeCCC--cEEEECCCCCEEEECCCcCCCCCEEEEEcC
Confidence            4899999998885  577775  5899988764210 00000122111  121122222222222221122236899999


Q ss_pred             CCCeEEEE
Q 005933          104 QGEPQRLT  111 (669)
Q Consensus       104 ~G~l~~~~  111 (669)
                      ||+++.|.
T Consensus        98 dGnlvly~  105 (113)
T 3mez_B           98 NGQAVVYG  105 (113)
T ss_dssp             TSCEEEEC
T ss_pred             CceEEEec
Confidence            99999984

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=83.03  E-value=0.14  Score=35.00  Aligned_cols=21  Identities=29%  Similarity=0.392  Sum_probs=10.0

Q ss_pred             HHHHHHHHhhheeeeeecccc
Q 005933          292 LLATGVILIGGFMYMRKKKRR  312 (669)
Q Consensus       292 ~~~~~~~~~~~~~~~r~~k~~  312 (669)
                      ++++++++++.++|+|+|+.+
T Consensus        21 v~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           21 LLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHHHHHHHhhhhHhh
Confidence            444444444445555554443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.38  E-value=3  Score=39.53  Aligned_cols=113  Identities=10%  Similarity=0.095  Sum_probs=75.2

Q ss_pred             CCCceeEEEEEEecCCcceEEEeecCCC-CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCceeccCCCC
Q 005933          404 QHRNLVRLLGCCTLRDERMLIYEYLPNK-SLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL-YLHQDSRLRIIHRDLKAS  481 (669)
Q Consensus       404 ~h~niv~l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~iiH~Dikp~  481 (669)
                      .||++  -...-.+.+...+.|+.-+++ ++.. +      ..++...+++++.+|+.... +++.     -+|--|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            58888  334446667777777765333 3333 2      22678899999999887766 5543     688899999


Q ss_pred             CEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005933          482 NVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR  554 (669)
Q Consensus       482 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~  554 (669)
                      ||++|.++.++|.-.|+-..                   ++|.-     .+..-=.-++=+++..++.++..|
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             eEEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999999987665332                   23321     122222446778888888887653

>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A

Probab=80.62  E-value=0.6  Score=30.78  Aligned_cols=32  Identities=34%  Similarity=0.529  Sum_probs=24.3

Q ss_pred             ccCCCCCCCCCCCccccCCCCCCcccccCCCcc
Q 005933          130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVP  162 (669)
Q Consensus       130 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~  162 (669)
                      .|+|. ...|...|.|.....+-.|.|++||..
T Consensus         3 ~d~C~-~~pC~ngg~C~~~~~~~~C~C~~G~~G   34 (39)
T 1edm_B            3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEG   34 (39)
T ss_dssp             CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred             cccCC-CCCCCCCCEeEcCCCceEeECCCCCcC
Confidence            36786 467988899976544568999999974

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=80.23  E-value=0.46  Score=32.32  Aligned_cols=21  Identities=19%  Similarity=0.297  Sum_probs=9.9

Q ss_pred             HHHHHHHHhhheeeeeecccc
Q 005933          292 LLATGVILIGGFMYMRKKKRR  312 (669)
Q Consensus       292 ~~~~~~~~~~~~~~~r~~k~~  312 (669)
                      ++++++++++.++|+|+|+.+
T Consensus        20 v~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           20 LFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHhhhhhhh
Confidence            344444444445555554443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	669
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-73
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-65
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-55
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-24

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (599), Expect = 5e-73
 Identities = 65/286 (22%), Positives = 137/286 (47%), Gaps = 21/286 (7%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
              +   ++G G FG VY+G       + +  ++  + Q ++ FKNEV ++ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
             +G  T   +  ++ ++    SL   +         +  K   I    A+G+ YLH  S
Sbjct: 68  LFMGYST-APQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA--- 526
              IIHRDLK++N+ L  D+  KI DFG+A            +++ G+  +M+PE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
               +S +SDV++FG+++ E++ G+    + + ++   ++    R +      ++     
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRS--- 236

Query: 587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG-ERSLPQ 631
               +  +A++  ++   C++++ ++RP    ++  +    RSLP+
Sbjct: 237 ----NCPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 1e-66
 Identities = 79/274 (28%), Positives = 132/274 (48%), Gaps = 22/274 (8%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           +      +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           RL    T ++   +I EY+ N SL  F+   +  K L  +K   +   IA G+ ++ + +
Sbjct: 72  RLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
               IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          + +PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 530 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS 589
            F++KSDV+SFG+L+ EIV   R                 +   T    ++ +++     
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR---------------IPYPGMTNPEVIQNLERGYRMV 230

Query: 590 YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
              +      Q+  LC ++RPEDRP    +  +L
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 3e-65
 Identities = 71/288 (24%), Positives = 130/288 (45%), Gaps = 23/288 (7%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
           ++   + KLG+G FG V+ G       +A+K L   +    E F  E  ++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           +L    +  +   ++ EY+   SL  F+      K+L   +   +   IA G+ Y+ +  
Sbjct: 76  QLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
            +  +HRDL+A+N+L+  ++  K++DFG+AR    ++  A          + +PE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189

Query: 530 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS 589
            F++KSDV+SFG+L+ E+    R                 +        L+ +++     
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR---------------VPYPGMVNREVLDQVERGYRMP 234

Query: 590 YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK-QPG 636
                      +   C ++ PE+RP    +   L    +  +P+ QPG
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 9e-65
 Identities = 68/275 (24%), Positives = 118/275 (42%), Gaps = 22/275 (8%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
              ++  ++G G FG V+ G      ++A+K + + +    E+F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           +L G C  +    L++E++ +  L  ++    +           +   +  G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
              +IHRDL A N L+  +   K+SDFGM R    DQ   ++        + SPE     
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 530 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS 589
            +S KSDV+SFGVL+ E+    +                 +   +    +E I       
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK---------------IPYENRSNSEVVEDISTGFRLY 222

Query: 590 YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
                +    Q+   C ++RPEDRP  S ++  L+
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 2e-64
 Identities = 60/292 (20%), Positives = 115/292 (39%), Gaps = 28/292 (9%)

Query: 355 KNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGC 414
           +  +G+G FG V+RG    G+E+AVK  S    +     + E+     L+H N++  +  
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65

Query: 415 CTLRD----ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-- 468
               +    +  L+ +Y  + SL  ++        +      ++    A GL +LH +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 469 ---SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF--GVDQTEANTDRVVGTYGYMSP 523
               +  I HRDLK+ N+L+  +    I+D G+A       D  +   +  VGT  YM+P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 524 EYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH----NLLGHAWRLW 573
           E   D +         ++D+++ G++  EI       G +               +    
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 574 TEDRSLELIDKSLDGSYSLSEALRCI-QVGLLCVQQRPEDRPNMSSVVLMLS 624
            +    + +  ++   +   EALR + ++   C       R     +   LS
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 5e-63
 Identities = 62/274 (22%), Positives = 120/274 (43%), Gaps = 22/274 (8%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
            + ++  +LG G FG V  G      ++A+K + + S    +EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
           +L G CT +    +I EY+ N  L  ++ +          +  ++ + +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDG 529
             + +HRDL A N L+++    K+SDFG++R + +D    ++        +  PE  +  
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 530 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS 589
            FS KSD+++FGVL+ EI    +                 +  +T   + E I + L   
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221

Query: 590 YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
                + +   +   C  ++ ++RP    ++  +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (528), Expect = 2e-62
 Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 22/275 (8%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
            + + K+KLG G +G VY G+  +    +AVK L + + + VEEF  E  ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V+LLG CT      +I E++   +L  ++ +  R + +       +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE-- 132

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
            +   IHRDL A N L+  +   K++DFG++R    D   A+         + +PE    
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190

Query: 529 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG 588
             FS+KSDV++FGVL+ EI     +   Y       +              EL++K    
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQV-------------YELLEKDYRM 235

Query: 589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
                   +  ++   C Q  P DRP+ + +    
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (527), Expect = 3e-62
 Identities = 67/301 (22%), Positives = 124/301 (41%), Gaps = 37/301 (12%)

Query: 340 FDWNTIADATDNFSWK---------NKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS- 385
           F +    +A   F+ +           +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 386 SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF 445
           + +   +F +E  ++ +  H N++ L G  T     M+I E++ N SL+ F+        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124

Query: 446 LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD 505
               +   ++ GIA G+ YL     +  +HRDL A N+L+++++  K+SDFG++R    D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 506 QTEANTDRVVG---TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 562
            ++      +G      + +PE      F+  SDV+S+G+++ E++              
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 563 HNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 622
                  +   T    +  I++       +       Q+ L C Q+    RP    +V  
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 623 L 623
           L
Sbjct: 287 L 287

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-61
 Identities = 50/207 (24%), Positives = 98/207 (47%), Gaps = 11/207 (5%)

Query: 348 ATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQH 405
             D+F   ++LG G  G V++      G  +A K +       +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             +V   G      E  +  E++   SL+Q +    +   +      ++   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
               + +I+HRD+K SN+L+++    K+ DFG++        ++  +  VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKR 552
                +SV+SD++S G+ ++E+  G+ 
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (515), Expect = 2e-60
 Identities = 68/302 (22%), Positives = 124/302 (41%), Gaps = 46/302 (15%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSK-SSGQGVEEFKNEVLLIAK 402
           +N  +   +GEG FG V++              +AVK L + +S     +F+ E  L+A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKF----------------- 445
             + N+V+LLG C +     L++EY+    L +F+  ++                     
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 446 ----LDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
               L  +++  I   +A G+ YL +    + +HRDL   N L+  +M  KI+DFG++R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
                             +M PE      ++ +SDV+++GV++ EI         Y+   
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA 247

Query: 562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL 621
           H  ++        +   L   +         +  L    +  LC  + P DRP+  S+  
Sbjct: 248 HEEVI----YYVRDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 622 ML 623
           +L
Sbjct: 295 IL 296

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 4e-60
 Identities = 66/275 (24%), Positives = 110/275 (40%), Gaps = 28/275 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLV 409
                   +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 410 RLLGCCTLRDERM-LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +LLG        + ++ EY+   SL  ++    R   L      +    +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
                +HRDL A NVL+  D   K+SDFG+ +     +  +  D       + +PE   +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174

Query: 529 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG 588
             FS KSDV+SFG+L+ EI    R    Y      +++        +   ++  D     
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVV----PRVEKGYKMDAPDG---- 224

Query: 589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
                 A+   +V   C       RP+   +   L
Sbjct: 225 ---CPPAVY--EVMKNCWHLDAAMRPSFLQLREQL 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 4e-60
 Identities = 67/282 (23%), Positives = 121/282 (42%), Gaps = 27/282 (9%)

Query: 348 ATDNFSWKN-KLGEGGFGPVYRGML---TEGQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 402
             DN    + +LG G FG V +G+     +  ++A+K L + + +   EE   E  ++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           L +  +VRL+G C   +  ML+ E      L +F+    + + +  S   +++  ++ G+
Sbjct: 66  LDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEAN-TDRVVGTYGYM 521
            YL +      +HRDL A NVLL N    KISDFG+++A G D +             + 
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           +PE      FS +SDV+S+GV + E +   +                 ++       +  
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAF 224

Query: 582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
           I++                +   C   + EDRP+  +V   +
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-59
 Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 28/274 (10%)

Query: 356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSSGQG--VEEFKNEVLLIAKLQHRNLVR 410
            +LG G FG V +G        + +AVK L   +      +E   E  ++ +L +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 411 LLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR 470
           ++G C   +  ML+ E      L +++    + + +      +++  ++ G+ YL +   
Sbjct: 73  MIGICE-AESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES-- 126

Query: 471 LRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT-DRVVGTYGYMSPEYAIDG 529
              +HRDL A NVLL      KISDFG+++A   D+              + +PE     
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 530 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS 589
            FS KSDV+SFGVL+ E     +                 +R         +++K     
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMG 230

Query: 590 YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
                      +  LC     E+RP  ++V L L
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 4e-59
 Identities = 73/320 (22%), Positives = 134/320 (41%), Gaps = 44/320 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEG---QEIAVKRLSK-SSGQGVEEFKNEVLLIAKL-Q 404
           ++  +++ +GEG FG V +  + +     + A+KR+ + +S     +F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFI-------------FDVTRTKFLDWSKR 451
           H N++ LLG C  R    L  EY P+ +L  F+                +    L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 452 CQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT 511
                 +ARG+ YL Q    + IHRDL A N+L+  +   KI+DFG++R     +     
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183

Query: 512 DRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 571
                   +M+ E     +++  SDV+S+GVL+ EIV                     + 
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---------------YC 228

Query: 572 LWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 631
             T     E + +       L+       +   C +++P +RP+ + +++ L   R L +
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL--NRMLEE 286

Query: 632 PKQPGFFTERNLPESESSSS 651
            K    +    L E  + + 
Sbjct: 287 RKT---YVNTTLYEKFTYAG 303

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 6e-59
 Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 23/273 (8%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRN 407
           +++     LGEG +G V   +     + +AVK +         E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           +V+  G     + + L  EY     L   I        +      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
              + I HRD+K  N+LLD   N KISDFG+A  F  +  E   +++ GT  Y++PE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 528 DGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
              F +   DV+S G+++  ++ G+            +     +  W E ++     K +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232

Query: 587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
           D     S  L  +      + + P  R  +  +
Sbjct: 233 D-----SAPLALLH---KILVENPSARITIPDI 257

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 6e-59
 Identities = 67/288 (23%), Positives = 124/288 (43%), Gaps = 27/288 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQE-----IAVKRLSKSSGQG-VEEFKNEVLLIAKL 403
              + +  +G G FG VY+GML          +A+K L     +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 404 QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLL 463
            H N++RL G  +     M+I EY+ N +L++F+ +  +       +   ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 464 YLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTD-RVVGTYGYMS 522
           YL     +  +HRDL A N+L+++++  K+SDFG++R    D     T         + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
           PE      F+  SDV+SFG+++ E++                     +   +    ++ I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAI 226

Query: 583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 630
           +        +       Q+ + C QQ    RP  + +V +L      P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 7e-59
 Identities = 72/329 (21%), Positives = 136/329 (41%), Gaps = 28/329 (8%)

Query: 345 IADATDNFSWKNKLGEGGFGPVYRGMLTEGQE-----IAVKRLSKS-SGQGVEEFKNEVL 398
           I   T+ F     LG G FG VY+G+     E     +A+K L ++ S +  +E  +E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 399 LIAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
           ++A + + ++ RLLG C       LI + +P   L  ++ +      +           I
Sbjct: 64  VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 120

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
           A+G+ YL      R++HRDL A NVL+    + KI+DFG+A+  G ++ E + +      
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS 578
            +M+ E  +  +++ +SDV+S+GV V E++                     +        
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEI 222

Query: 579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF 638
             +++K           +    + + C     + RP    +++  S     PQ       
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

Query: 639 TERNLPESESSSSKRKLPLSNEITISLIE 667
            ER    S + S+  +  +  E    +++
Sbjct: 283 DERMHLPSPTDSNFYRALMDEEDMDDVVD 311

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 8e-59
 Identities = 66/302 (21%), Positives = 112/302 (37%), Gaps = 40/302 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 402
           +  S+   LG G FG V                +AVK L  S+     E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD---------------VTRTKFL 446
           L  H N+V LLG CT+    ++I EY     L  F+                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
           D          +A+G+ +L        IHRDL A N+LL +    KI DFG+AR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
                        +M+PE   + +++ +SDV+S+G+ + E+     +           + 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVD 254

Query: 567 GHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 626
              +++  E   +   + +               +   C    P  RP    +V ++  +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPA---------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

Query: 627 RS 628
            S
Sbjct: 306 IS 307

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-58
 Identities = 60/279 (21%), Positives = 122/279 (43%), Gaps = 27/279 (9%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH 405
           +  D +    +LG+G FG VY+    E     A K +   S + +E++  E+ ++A   H
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N+V+LL      +   ++ E+    +++  + +    + L  S+   + +     L YL
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     +IIHRDLKA N+L   D + K++DFG++          ++   +GT  +M+PE 
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181

Query: 526 AI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
            +     D  +  K+DV+S G+ ++E+   +     +H  +   +L    ++   +    
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL---LKIAKSEPPTL 235

Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
                       S     ++    C+++  + R   S +
Sbjct: 236 AQPSRWS-----SNFKDFLK---KCLEKNVDARWTTSQL 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 3e-58
 Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 28/278 (10%)

Query: 355 KNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSSGQG-VEEFKNEVLLIAKLQHRNLV 409
              +G G FG VY G L +        AVK L++ +  G V +F  E +++    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 410 RLLGCCTLRDER-MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
            LLG C   +   +++  Y+ +  L  FI +   T              +A+G+      
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGM---KFL 146

Query: 469 SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR--VVGTYGYMSPEYA 526
           +  + +HRDL A N +LD     K++DFG+AR     + ++  ++        +M+ E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
               F+ KSDV+SFGVL+ E++        Y   +  ++  +      + R L   +   
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLL----QGRRLLQPEYCP 260

Query: 587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
           D            +V L C   + E RP+ S +V  +S
Sbjct: 261 D---------PLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 4e-58
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 36/284 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHR 406
           +++     +G G +G   +      G+ +  K L   S      +   +EV L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 407 NLVRLLGCCTLRDERML--IYEYLPNKSLEQFIFDVTRTK-FLDWSKRCQIIEGIARGLL 463
           N+VR       R    L  + EY     L   I   T+ + +LD     +++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 464 YLHQ--DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
             H+  D    ++HRDLK +NV LD   N K+ DFG+AR    D + A     VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           SPE      ++ KSD++S G L+ E+                         +T     EL
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALM-------------------PPFTAFSQKEL 222

Query: 582 IDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
             K  +G +       S+ L   ++    +  +   RP++  ++
Sbjct: 223 AGKIREGKFRRIPYRYSDELN--EIITRMLNLKDYHRPSVEEIL 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 8e-58
 Identities = 76/303 (25%), Positives = 131/303 (43%), Gaps = 33/303 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKS-SGQGVEEFKNEVLLIAK 402
           +  +   +LG+G FG VY G+            +A+K ++++ S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF-------DVTRTKFLDWSKRCQII 455
               ++VRLLG  +     ++I E +    L+ ++        +         SK  Q+ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVV 515
             IA G+ YL+ +   + +HRDL A N ++  D   KI DFGM R            + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 516 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTE 575
               +MSPE   DG+F+  SDV+SFGV++ EI         Y    +  +L    R   E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVL----RFVME 250

Query: 576 DRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQP 635
              L+  D   D            ++  +C Q  P+ RP+   ++  +  E   P  ++ 
Sbjct: 251 GGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME-PGFREV 300

Query: 636 GFF 638
            F+
Sbjct: 301 SFY 303

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (496), Expect = 1e-57
 Identities = 81/322 (25%), Positives = 126/322 (39%), Gaps = 47/322 (14%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAK 402
           D    FS   ++G G FG VY        + +A+K++S S  Q     ++   EV  + K
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           L+H N ++  GC        L+ EY    + +         K L   +   +  G  +GL
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGL 128

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            YLH      +IHRD+KA N+LL      K+ DFG A         A  +  VGT  +M+
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMA 179

Query: 523 PEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           PE  +   +G +  K DV+S G+  +E+   K         +  + L H  +   E  +L
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIAQ--NESPAL 234

Query: 580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFT 639
           +        S   SE  R       C+Q+ P+DRP    ++            K   F  
Sbjct: 235 Q--------SGHWSEYFR--NFVDSCLQKIPQDRPTSEVLL------------KHR-FVL 271

Query: 640 ERNLPESESSSSKRKLPLSNEI 661
               P       +R      E+
Sbjct: 272 RERPPTVIMDLIQRTKDAVREL 293

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 5e-57
 Identities = 68/305 (22%), Positives = 110/305 (36%), Gaps = 45/305 (14%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQG-VEEFKNEVLLIAK 402
           +N  +   LG G FG V               ++AVK L + +     E   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 403 L-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFD--------------------VT 441
           L  H N+V LLG CTL     LI+EY     L  ++                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 442 RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARA 501
               L +         +A+G+ +L        +HRDL A NVL+ +    KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 561
              D              +M+PE   +G++++KSDV+S+G+L+ EI        +     
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272

Query: 562 HHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL 621
             N               +LI                  +   C       RP+  ++  
Sbjct: 273 DANF-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 622 MLSGE 626
            L  +
Sbjct: 320 FLGCQ 324

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-56
 Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 31/274 (11%)

Query: 355 KNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRL 411
             ++G G F  VY+G+ TE   E+A   L     +    + FK E  ++  LQH N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 412 LGCC----TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
                     +   +L+ E + + +L+ ++    R K +           I +GL +LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 468 DSRLRIIHRDLKASNVLL-DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
            +   IIHRDLK  N+ +     + KI D G+A        +     V+GT  +M+PE  
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEM- 184

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
            +  +    DV++FG+ +LE+   +    +    +   +    +R  T        DK  
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQI----YRRVTSGVKPASFDKVA 238

Query: 587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV 620
                  E    I+    C++Q  ++R ++  ++
Sbjct: 239 I-----PEVKEIIE---GCIRQNKDERYSIKDLL 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 7e-56
 Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 24/277 (8%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAK 402
           ++ D    ++   K+G+G  G VY  M    GQE+A+++++       E   NE+L++ +
Sbjct: 14  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
            ++ N+V  L    + DE  ++ EYL   SL   + +      +D  +   +     + L
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQAL 129

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            +LH     ++IHRD+K+ N+LL  D + K++DFG       +Q++ +T  +VGT  +M+
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 184

Query: 523 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI 582
           PE      +  K D++S G++ +E++ G+     Y  ++    L       T +      
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRALYLIATNGTPE------ 235

Query: 583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
              L     LS   R      L      E R +   +
Sbjct: 236 ---LQNPEKLSAIFRDFLNRCL--DMDVEKRGSAKEL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-55
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 28/282 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSK---SSGQGVEEFKNEVLLIAK 402
            +     KLG+G FG V RG       +   +AVK L     S  + +++F  EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           L HRNL+RL G         ++ E  P  SL   +               +    +A G+
Sbjct: 68  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-ANTDRVVGTYGYM 521
            YL      R IHRDL A N+LL      KI DFG+ RA   +       +     + + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           +PE      FS  SD + FGV + E+    +    +   +   +L    ++  E   L  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL---HKIDKEGERLPR 236

Query: 582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
            +          + +    V + C   +PEDRP   ++   L
Sbjct: 237 PED-------CPQDIY--NVMVQCWAHKPEDRPTFVALRDFL 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 2e-55
 Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 35/277 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F     LG+G FG VY     +    +A+K L K+         + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
            N++RL G         LI EY P  ++ + +  +++    D  +    I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H     R+IHRD+K  N+LL +    KI+DFG +      +       + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
               +   K D++S GVL  E + GK                     +  +   E   + 
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK-------------------PPFEANTYQETYKRI 216

Query: 586 LDGSYSLSEAL--RCIQVGLLCVQQRPEDRPNMSSVV 620
               ++  + +      +    ++  P  RP +  V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 5e-52
 Identities = 74/297 (24%), Positives = 108/297 (36%), Gaps = 39/297 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKSSGQG-VEEFKNEV-LLIA 401
           D       LG G FG V              + +AVK L + +         +E+ +LI 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 402 KLQHRNLVRLLGCCTLRDER-MLIYEYLPNKSLEQFIF-------------DVTRTKFLD 447
              H N+V LLG CT      M+I E+    +L  ++              +     FL 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 448 WSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT 507
                     +A+G+ +L      + IHRDL A N+LL      KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 567
                       +M+PE   D +++++SDV+SFGVL+ EI                 +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244

Query: 568 HAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
              R   E   +   D +              Q  L C    P  RP  S +V  L 
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 3e-51
 Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 27/280 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKSSGQGV-EEFKNEVLLIAKLQ 404
           +       +GEG FG V++G+          +A+K     +   V E+F  E L + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H ++V+L+G  T  +   +I E      L  F+    R   LD +        ++  L Y
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 123

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           L      R +HRD+ A NVL+ ++   K+ DFG++R    D T     +      +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
                 F+  SDV+ FGV + EI+        +    +++++            L +   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVI----GRIENGERLPMPP- 232

Query: 585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
                 +    L    +   C    P  RP  + +   LS
Sbjct: 233 ------NCPPTLY--SLMTKCWAYDPSRRPRFTELKAQLS 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-50
 Identities = 63/274 (22%), Positives = 103/274 (37%), Gaps = 31/274 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LGEG F  V     L   +E A+K L K        V     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
              V+L       ++      Y  N  L ++I    +    D +        I   L YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H      IIHRDLK  N+LL+ DM+ +I+DFG A+    +  +A  +  VGT  Y+SPE 
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
             +      SD+++ G ++ ++V G                      +       +  K 
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKI 222

Query: 586 LDGSYSLSEAL--RCIQVGLLCVQQRPEDRPNMS 617
           +   Y   E    +   +    +      R    
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCE 256

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 3e-50
 Identities = 72/298 (24%), Positives = 116/298 (38%), Gaps = 41/298 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE--------GQEIAVKRLSK-SSGQGVEEFKNEVLLI 400
           D       LGEG FG V                 ++AVK L   ++ + + +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 401 AKL-QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIF-------------DVTRTKFL 446
             + +H+N++ LLG CT      +I EY    +L +++                   + L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 447 DWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ 506
                      +ARG+ YL      + IHRDL A NVL+  D   KI+DFG+AR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 507 TEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
               T        +M+PE   D +++ +SDV+SFGVL+ EI     +   Y       L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL- 246

Query: 567 GHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
              ++L  E   ++      +             +   C    P  RP    +V  L 
Sbjct: 247 ---FKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  175 bits (444), Expect = 1e-49
 Identities = 55/320 (17%), Positives = 109/320 (34%), Gaps = 49/320 (15%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           D++    +LG G FG V+R      G   A K +        E  + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           V L       +E ++IYE++    L + + D      +   +  + +  + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141

Query: 469 SRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
                +H DLK  N++     +   K+ DFG+       Q+        GT  + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
                   +D++S GVL   ++ G                      +  +   E +    
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL-------------------SPFGGENDDETLRNVK 238

Query: 587 DGSYSLSEALR------CIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTE 640
              +++ ++                +   P  R  +                 +  + T 
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA-------------LEHPWLTP 285

Query: 641 RNLPESESSSSKRKLPLSNE 660
            N P  +S     +     +
Sbjct: 286 GNAPGRDSQIPSSRYTKIRD 305

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  171 bits (435), Expect = 1e-48
 Identities = 58/318 (18%), Positives = 108/318 (33%), Gaps = 38/318 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           D +    +LG G FG V+R +    G+    K ++          KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           + L      + E +LI E+L    L   I        +  ++    +     GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 469 SRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
               I+H D+K  N++ +       KI DFG+A     D+          T  + +PE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
                   +D+++ GVL   ++ G                      +  +  LE +    
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL-------------------SPFAGEDDLETLQNVK 241

Query: 587 DGSYSLSEALR------CIQVGLLCVQQRPEDRPNMSSVVLM--LSGERSLPQPKQPGFF 638
              +   E                 +Q+ P  R  +   +    L G+ S    + P   
Sbjct: 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 301

Query: 639 TERNLPESESSSSKRKLP 656
             +   + +   +    P
Sbjct: 302 YNKIRQKIKEKYADWPAP 319

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-46
 Identities = 66/297 (22%), Positives = 123/297 (41%), Gaps = 27/297 (9%)

Query: 344 TIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG-VEEFKNEVLLIA 401
            + D    ++  + +GEG +G V           +A+K++S    Q   +    E+ ++ 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 402 KLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARG 461
           + +H N++ +           +   YL    +   ++ + +T+ L     C  +  I RG
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 462 LLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANT-DRVVGTYGY 520
           L Y+H      ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 521 MSPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAWRLWTEDRS 578
            +PE  ++     KS D++S G ++ E++  +    G ++ D  +++LG       ED +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 579 LELIDKSLDGSYSL----------------SEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +  K+ +   SL                S+AL  +      +   P  R  +   
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (416), Expect = 2e-46
 Identities = 60/324 (18%), Positives = 115/324 (35%), Gaps = 40/324 (12%)

Query: 342 WNTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEE-FKNEVLL 399
           W    D  D + +++ LG G F  V         + +A+K ++K + +G E   +NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIA 459
           + K++H N+V L           LI + +    L   I       F       ++I  + 
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117

Query: 460 RGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYG 519
             + YLH    +    +        LD D    ISDFG+++               GT G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPG 174

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           Y++PE      +S   D +S GV+   ++CG                      + ++   
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY-------------------PPFYDENDA 215

Query: 580 ELIDKSLDGSYSLSEALR------CIQVGLLCVQQRPEDRPNMSSVVLM--LSGERSLPQ 631
           +L ++ L   Y                     +++ PE R      +    ++G+ +L +
Sbjct: 216 KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 632 PKQPGFFTERNLPESESSSSKRKL 655
                        + + + +K K 
Sbjct: 276 NIHQSV-----SEQIKKNFAKSKW 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (405), Expect = 4e-45
 Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 28/282 (9%)

Query: 349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG---VEEFKNEVLLIAKLQ 404
           +D +     LG GG   V+        +++AVK L     +       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 405 HRNLVRLLGCCTLRDER----MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
           H  +V +               ++ EY+   +L   +        +   +  ++I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-ANTDRVVGTYG 519
            L + H   +  IIHRD+K +N+++      K+ DFG+ARA          T  V+GT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 520 YMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL 579
           Y+SPE A       +SDV+S G ++ E++ G+     +  D   ++    ++   ED   
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVA---YQHVREDPIP 233

Query: 580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL 621
                       LS  L    V L  + + PE+R   ++ + 
Sbjct: 234 PSARHE-----GLSADLD--AVVLKALAKNPENRYQTAAEMR 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-44
 Identities = 52/279 (18%), Positives = 104/279 (37%), Gaps = 37/279 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           + +     LG G FG V+R + T   +    K + K  G      K E+ ++   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           + L       +E ++I+E++    + + I   T    L+  +    +  +   L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 469 SRLRIIHRDLKASNVLLDNDMNP--KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
               I H D++  N++     +   KI +FG AR         N   +     Y +PE  
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
              + S  +D++S G LV  ++ G                      +  + + ++I+  +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI-------------------NPFLAETNQQIIENIM 216

Query: 587 DGSYSLSEALR------CIQVGLLCVQQRPEDRPNMSSV 619
           +  Y+  E          +      + +  + R   S  
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 4e-44
 Identities = 67/279 (24%), Positives = 106/279 (37%), Gaps = 34/279 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---QGVEEFKNEV-LLIAKLQ 404
           ++F     LG+G FG V+     +  Q  A+K L K        VE    E  +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 405 HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLY 464
           H  L  +      ++    + EYL    L   I         D S+       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 465 LHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           LH      I++RDLK  N+LLD D + KI+DFGM +   +   + NT    GT  Y++PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 525 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK 584
             +   ++   D +SFGVL+ E++ G+                     +      EL   
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ-------------------SPFHGQDEEELFHS 214

Query: 585 SLDGSYSLSEAL--RCIQVGLLCVQQRPEDRPNMSSVVL 621
               +      L      + +    + PE R  +   + 
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (402), Expect = 8e-44
 Identities = 64/275 (23%), Positives = 107/275 (38%), Gaps = 32/275 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQ- 404
           ++FS    +G GGFG VY     + G+  A+K L K      QG     NE ++++ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 405 --HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
                +V +       D+   I + +    L   +    +      +        I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMS 522
            ++H      +++RDLK +N+LLD   + +ISD G+A  F   +        VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 523 PEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL 581
           PE    G+ +   +D FS G ++ +++ G      +      +         T    L  
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHS---PFRQHKTKDKHEIDRMTLTMAVEL-- 228

Query: 582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNM 616
                    S S  LR +  GLL        R   
Sbjct: 229 -------PDSFSPELRSLLEGLLQRD--VNRRLGC 254

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (391), Expect = 3e-43
 Identities = 62/287 (21%), Positives = 112/287 (39%), Gaps = 39/287 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSG---------QGVEEFKNEVLL 399
           +N+  K  LG G    V R +     +E AVK +  + G         +  E    EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 400 IAKLQ-HRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
           + K+  H N+++L           L+++ +    L  ++   T    L   +  +I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
              +  LH   +L I+HRDLK  N+LLD+DMN K++DFG +      +       V GT 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173

Query: 519 GYMSPEYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 572
            Y++PE     +      +  + D++S GV++  ++ G      +       +L      
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSG 230

Query: 573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
             +  S E  D S             +      +  +P+ R      
Sbjct: 231 NYQFGSPEWDDYS-------DTVKDLVS---RFLVVQPQKRYTAEEA 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (394), Expect = 4e-43
 Identities = 56/271 (20%), Positives = 101/271 (37%), Gaps = 36/271 (13%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
            +F     LG G FG V+       G+  A+K L K      + VE   +E L+++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             ++R+ G      +  +I +Y+    L   +    R            +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
                  II+RDLK  N+LLD + + KI+DFG A+             + GT  Y++PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
                ++   D +SFG+L+ E++ G                      + +  +++  +K 
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMKTYEKI 213

Query: 586 LDGSYSLSEAL--RCIQVGLLCVQQRPEDRP 614
           L+               +    + +    R 
Sbjct: 214 LNAELRFPPFFNEDVKDLLSRLITRDLSQRL 244

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 4e-43
 Identities = 49/283 (17%), Positives = 90/283 (31%), Gaps = 25/283 (8%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
           + +    K+G G FG +Y G     G+E+A+K     +     +   E  +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +  +  C    +  ++   L   SLE        ++         + + +   + Y+H  
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH-- 120

Query: 469 SRLRIIHRDLKASNVL---LDNDMNPKISDFGMARAFGVDQTEAN-----TDRVVGTYGY 520
                IHRD+K  N L           I DFG+A+ +   +T  +        + GT  Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLE 580
            S    +    S + D+ S G +++    G        A                     
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 623
           L                       C   R +D+P+ S +  + 
Sbjct: 240 LCKG-------YPSEFA--TYLNFCRSLRFDDKPDYSYLRQLF 273

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 7e-42
 Identities = 64/295 (21%), Positives = 117/295 (39%), Gaps = 32/295 (10%)

Query: 348 ATDNFSWKNKLGEGGFGPVYRG--MLTEGQEIAVKRLSKSSGQG--VEEFKNEVLLIAKL 403
           A   +    ++GEG +G V++   +   G+ +A+KR+   +G+         EV ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 404 ---QHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQ---FIFDVTRTKFLDWSKRCQIIEG 457
              +H N+VRL   CT+          L  + ++Q      D      +       ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 458 IARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGT 517
           + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +           VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178

Query: 518 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL----- 572
             Y +PE  +   ++   D++S G +  E+   K     +      + LG    +     
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235

Query: 573 ---WTEDRSLELIDKSLDGSYSLSEALRCIQVGLL-----CVQQRPEDRPNMSSV 619
              W  D +L         +  + + +  I          C+   P  R +  S 
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (375), Expect = 6e-41
 Identities = 61/288 (21%), Positives = 115/288 (39%), Gaps = 29/288 (10%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGVEEFKNEVLLIAKLQHRN 407
           + +    K+GEG +G VY+     G+  A+K  RL K           E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           +V+L      +   +L++E+L     +           L+       +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 468 DSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAI 527
               R++HRDLK  N+L++ +   KI+DFG+ARAFG+   +      + T  Y +P+  +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 528 -DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
               +S   D++S G +  E+V G      +      + L   +R+     S    + + 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 587 DGSYS----------LSEALRCIQVGLL-----CVQQRPEDRPNMSSV 619
              Y               L+ +    +      ++  P  R      
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 7e-41
 Identities = 64/315 (20%), Positives = 116/315 (36%), Gaps = 45/315 (14%)

Query: 356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEE-----FKNEVLLIAKLQHRNLV 409
           + LGEG F  VY+       Q +A+K++        ++        E+ L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 410 RLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS 469
            LL     +    L+++++              +  L  S     +    +GL YLHQ  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 470 RLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID- 528
              I+HRDLK +N+LLD +   K++DFG+A++FG           V T  Y +PE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGA 175

Query: 529 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG 588
            ++ V  D+++ G ++ E++       F   D   + L   +         +  D     
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 589 SYSLSEALRCIQVGLL--------------CVQQRPEDRPNMSSVVLMLSGERSLPQPKQ 634
            Y   ++   I +  +                   P  R   +  +            K 
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL------------KM 280

Query: 635 PGFFTERNLPESESS 649
             +F+ R  P     
Sbjct: 281 K-YFSNRPGPTPGCQ 294

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 4e-39
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 14/221 (6%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
           +NF    K+GEG +G VY+      G+ +A+K++     +         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+V+LL      ++  L++E+L     +    D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE-Y 525
                R++HRDLK  N+L++ +   K++DFG+ARAFGV          V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 566
                +S   D++S G +  E+V  +     +  D   + L
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQL 212

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (362), Expect = 5e-39
 Identities = 42/286 (14%), Positives = 96/286 (33%), Gaps = 27/286 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
            ++    ++GEG FG ++ G  L   Q++A+K   + S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 409 VRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD 468
           +  +          ++   L   SLE  +      +           + +   +  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 469 SRLRIIHRDLKASNVLLDNDMNP-----KISDFGMARAFGVDQTEANTDR-----VVGTY 518
               +++RD+K  N L+    +       + DFGM + +    T+ +        + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS 578
            YMS    +    S + D+ + G + +  + G      +             R+  + +S
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL---PWQGLKAATNKQKYERIGEKKQS 234

Query: 579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 624
             L +          + +              +  P+   +  + S
Sbjct: 235 TPLRELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLFS 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 7e-39
 Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 33/281 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSS------GQGVEEFKNEVLLIAK 402
           D +    +LG G F  V +      G + A K + K        G   E+ + EV ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 403 LQHRNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           +QH N++ L      + + +LI E +    L  F+      + L   +  + ++ I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGV 126

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDNDMNP----KISDFGMARAFGVDQTEANTDRVVGTY 518
            YLH    L+I H DLK  N++L +   P    KI DFG+A              + GT 
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 519 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS 578
            +++PE        +++D++S GV+   ++ G      +  D     L +   +  E   
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSAVNYEFED 237

Query: 579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
               + S       + A   I+     + + P+ R  +   
Sbjct: 238 EYFSNTS-------ALAKDFIR---RLLVKDPKKRMTIQDS 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 1e-38
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 17/211 (8%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL 408
            +++    +G G FG VY+  L + G+ +A+K++ +           E+ ++ KL H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75

Query: 409 VRLLGCCTLRDERM------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGL 462
           VRL        E+       L+ +Y+P              + L        +  + R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 463 LYLHQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
            Y+H      I HRD+K  N+LLD D    K+ DFG A+     + E N   +   Y   
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRA 190

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 552
                    ++   DV+S G ++ E++ G+ 
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-37
 Identities = 63/313 (20%), Positives = 122/313 (38%), Gaps = 31/313 (9%)

Query: 358 LGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCC 415
           LG G  G V +       ++ A+K L         + + EV L  +  Q  ++VR++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74

Query: 416 ----TLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRL 471
                 R   +++ E L    L   I D    +     +  +I++ I   + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 472 RIIHRDLKASNVLLDNDMNP---KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAID 528
            I HRD+K  N+L  +       K++DFG A+      +         T  Y++PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 529 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG 588
             +    D++S GV++  ++CG      ++++H   +      + T  R  +    + + 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAIS---PGMKTRIRMGQYEFPNPEW 241

Query: 589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNLPESES 648
           S    E    I+     ++  P  R  ++  +      +S   P+ P   T R L E + 
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP-LHTSRVLKEDKE 297

Query: 649 SSSKRKLPLSNEI 661
                K  +++ +
Sbjct: 298 RWEDVKEEMTSAL 310

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-37
 Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 33/273 (12%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           ++F +   LG+G FG V        G+  A+K L K    +   V     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             L  L       D    + EY     L   +   +R +     +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H      +++RD+K  N++LD D + KI+DFG+ +    D          GT  Y++PE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
             D  +    D +  GV++ E++CG+    FY+ DH                   L +  
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE-----------------RLFELI 217

Query: 586 LDGSYSLSEAL--RCIQVGLLCVQQRPEDRPNM 616
           L         L      +    +++ P+ R   
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 6e-37
 Identities = 58/302 (19%), Positives = 120/302 (39%), Gaps = 35/302 (11%)

Query: 347 DATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQG--VEEFKNEVLLIAKL 403
           D    +    K+G+G FG V++    + GQ++A+K++   + +         E+ ++  L
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 404 QHRNLVRLLGCCTLRDERM--------LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQII 455
           +H N+V L+  C  +            L++++  +         + +      S+  +++
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVM 123

Query: 456 EGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR-- 513
           + +  GL Y+H++   +I+HRD+KA+NVL+  D   K++DFG+ARAF + +         
Sbjct: 124 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 514 VVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKR----NRGFYHADHHHNLLG- 567
            V T  Y  PE  + +  +    D++  G ++ E+         N   +       L G 
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 568 ---HAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLL-------CVQQRPEDRPNMS 617
                W         E ++        + + L+               +   P  R +  
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 618 SV 619
             
Sbjct: 301 DA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-36
 Identities = 62/274 (22%), Positives = 101/274 (36%), Gaps = 43/274 (15%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEE------FKNEVLLIAKLQ--HRN 407
            LG GGFG VY G+ +++   +A+K + K       E         EV+L+ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 408 LVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ 467
           ++RLL      D  +LI E             +T    L           +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARSFFWQVLEAVRHCHN 128

Query: 468 DSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY- 525
                ++HRD+K  N+L+D N    K+ DFG          +       GT  Y  PE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
                    + V+S G+L+ ++VCG     F H +                   E+I   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDE-------------------EIIRGQ 220

Query: 586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSV 619
           +     +S   +   +   C+  RP DRP    +
Sbjct: 221 VFFRQRVSSECQ--HLIRWCLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-36
 Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 27/288 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
             +    K+GEG +G V++    E  + +A+KR+               E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 407 NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLH 466
           N+VRL        +  L++E+      + F         LD       +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 467 QDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYA 526
                 ++HRDLK  N+L++ +   K+++FG+ARAFG+      +  VV  +        
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174

Query: 527 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL 586
              L+S   D++S G +  E+    R    +  +   + L   +RL       +    + 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 587 DGSYSLSEALRCIQVGLL---------------CVQQRPEDRPNMSSV 619
              Y            +                 ++  P  R +    
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (337), Expect = 4e-35
 Identities = 60/270 (22%), Positives = 96/270 (35%), Gaps = 32/270 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQH 405
           D F     LG G FG V      E G   A+K L K      + +E   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
             LV+L           ++ EY+    +   +    R               I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEY 525
           H    L +I+RDLK  N+L+D     +++DFG A+     + +  T  + GT   ++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209

Query: 526 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS 585
            +   ++   D ++ GVL+ E+  G      + AD    +            S       
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSGKVRFPS------- 259

Query: 586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPN 615
                  S  L+ +   LL V      R  
Sbjct: 260 -----HFSSDLKDLLRNLLQVD--LTKRFG 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-33
 Identities = 66/329 (20%), Positives = 125/329 (37%), Gaps = 40/329 (12%)

Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLL 399
            T  +    +     +G G +G V   +    G ++A+K+L +   S    +    E+ L
Sbjct: 11  KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70

Query: 400 IAKLQHRNLVRLLGCCTLRDERMLIYE-YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
           +  ++H N++ LL   T  +      + YL    +   +  + + + L   +   ++  +
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
            +GL Y+H      IIHRDLK  N+ ++ D   KI DFG+AR    + T       V T 
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YVVTR 182

Query: 519 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAWRLWTED 576
            Y +PE  ++ + ++   D++S G ++ E++ GK   +G  H D    ++        E 
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242

Query: 577 RSLELIDKSLDGSYSLSEALRCIQVGLL-------------CVQQRPEDRPNMSSVVLML 623
                 D++ +    L E  +     +L              +    E R          
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG------ 296

Query: 624 SGERSLPQPKQPGFFTERNLPESESSSSK 652
                  +     +F   +  E E    K
Sbjct: 297 -------EALAHPYFESLHDTEDEPQVQK 318

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (316), Expect = 2e-32
 Identities = 51/241 (21%), Positives = 108/241 (44%), Gaps = 23/241 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRN 407
           D++    KLG G +  V+  + +T  +++ VK L        ++ K E+ ++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 408 LVRLLGCCTLRDERM--LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
           ++ L         R   L++E++ N   +Q        + L        +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 466 HQDSRLRIIHRDLKASNVLLDND-MNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPE 524
           H    + I+HRD+K  NV++D++    ++ D+G+A  +   Q     +  V +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199

Query: 525 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID 583
             +D  ++    D++S G ++  ++  K    F+H   +++ L    ++   +   + ID
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 584 K 584
           K
Sbjct: 258 K 258

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-31
 Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 31/276 (11%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS----GQGVEEFKNEVLLIA 401
           +NF     LG G +G V+          G+  A+K L K++     +  E  + E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 402 KLQHR-NLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
            ++    LV L        +  LI +Y+    L   +    R       +    +  I  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
            L +LH   +L II+RD+K  N+LLD++ +  ++DFG+++ F  D+TE       GT  Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 521 MSPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS 578
           M+P+    G        D +S GVL+ E++ G      +  D   N      R   +   
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEP 253

Query: 579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP 614
               + S       + A   IQ     + + P+ R 
Sbjct: 254 PYPQEMS-------ALAKDLIQ---RLLMKDPKKRL 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 5e-30
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 350 DNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHR 406
             +     +G G  G V         + +A+K+LS+   +    +    E++L+  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 407 NLVRLLGCCTLRD------ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIAR 460
           N++ LL   T +       +  L+ E +     +           LD  +   ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 130

Query: 461 GLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGY 520
           G+ +LH      IIHRDLK SN+++ +D   KI DFG+AR  G           V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184

Query: 521 MSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
            +PE  +   +    D++S G ++ E+V  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 7e-30
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 13/214 (6%)

Query: 343 NTIADATDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS--SGQGVEEFKNEVLL 399
            TI +  + +   + +G G +G V     T+ G  +AVK+LS+   S    +    E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 400 IAKLQHRNLVRLLGCCTLRDERMLI-YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGI 458
           +  ++H N++ LL   T           YL    +   + ++ + + L       +I  I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 459 ARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTY 518
            RGL Y+H      IIHRDLK SN+ ++ D   KI DFG+AR    + T         T 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TR 182

Query: 519 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 551
            Y +PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (277), Expect = 4e-27
 Identities = 45/210 (21%), Positives = 84/210 (40%), Gaps = 18/210 (8%)

Query: 357 KLGEGGFGPVYRGM-LTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCC 415
           KLG G F  V+    +     +A+K +        E  ++E+ L+ ++   +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 416 TLRDERMLIY--EYLPNKSLEQFIFDVTRTKFLDWSKR-----------CQIIEGIARGL 462
                ++L +     PN      +F+V     L   K+            QI + +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 463 LYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYM 521
            Y+H+  R  IIH D+K  NVL++  D    +    +A        + +    + T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 522 SPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 551
           SPE  +   +   +D++S   L+ E++ G 
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 98.7 bits (245), Expect = 2e-24
 Identities = 39/202 (19%), Positives = 71/202 (35%), Gaps = 27/202 (13%)

Query: 356 NKLGEGGFGPVYRGMLTEGQEIAVK--RLSKSSGQGV--------EEFKNEVLLIAKLQH 405
             +GEG    V+     +  E  VK  ++  +S + V          F    +  A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 406 RNLVRLLGCCTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYL 465
           R L +L G    +      Y +  N  L + I      +    +   ++++ I   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 466 HQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEANTDR-VVGTYGYMSPE 524
           +      I+H DL   NVL+  +    I DF  +   G +      +R V     Y S  
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175

Query: 525 YAIDGLFSVKSDVFSFGVLVLE 546
           Y        + D+ S    +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	669
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.59
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.84
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.78
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	96.21
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.17
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	94.82
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	94.74
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	94.64
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	94.62
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	92.87
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	90.76
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	90.43
d1xkba1	39	Factor X, N-terminal module {Human (Homo sapiens)	89.31
d1lmja1	44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	86.52
d1edmb_	39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	86.35
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	86.09
d2vj3a2	39	Neurogenic locus notch homolog protein 1, Notch1 {	85.91
d1i0ua2	41	Low density lipoprotein (LDL) receptor, different	84.69
d2vj3a3	35	Neurogenic locus notch homolog protein 1, Notch1 {	81.77
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	80.66
d1uzka1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	80.24

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-50  Score=403.62  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=200.2

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|++.++||+|+||+||+|.+.+++.||||+++.. ....++|.+|+.++++++|||||+++|++..++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            578889999999999999999988999999999653 3456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +|+|.+++..  ....+++..++.++.|||+||.|||+.+   |+||||||+||||++++.+||+|||+++....... .
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            9999999854  3456899999999999999999999998   99999999999999999999999999987643322 2


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......||..|+|||++.+..++.++|||||||++|||+|+.. |+....   ...+...             +......
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~-------------i~~~~~~  221 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVED-------------ISTGFRL  221 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHH-------------HHHTCCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHH-------------HHhcCCC
Confidence            2234578999999999999999999999999999999999644 432211   1111111             1111111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..+...+..+.+|+.+||+.||++||||+||++.|+.+
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            22233356788999999999999999999999999764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=400.86  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=202.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|.+.++||+|+||+||+|+++  ..||||+++..  .....+.|.+|+.++++++|||||+++|++.+ +..+||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467899999999999999999875  46999998654  34567889999999999999999999998754 56899999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+++|+|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999954  3345999999999999999999999998   9999999999999999999999999998765544


Q ss_pred             cCcCcccccccCCccCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          507 TEANTDRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      .........||+.|+|||++.+   ..++.++|||||||+||||+||+.||.......  .+.....+.......     
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p~~-----  231 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDL-----  231 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCCCG-----
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCCcc-----
Confidence            4444455789999999999964   358999999999999999999999975322111  111111111100000     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                          ...+...+..+.+|+.+||+.||++||||+||++.|+.+
T Consensus       232 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         232 ----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             ----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                011223345788999999999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=401.35  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=203.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57899999999999999999975 58999999997543 33456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|.+++.   +...+++.++..++.||++||+|||+.+   |+||||||+||||++++.+||+|||+|+.+.....
T Consensus        85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999984   3456999999999999999999999998   99999999999999999999999999998754444


Q ss_pred             CcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                      ........||+.|+|||++.+..+ +.++|||||||+||||++|+.|+........  .....            .....
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~~------------~~~~~  224 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDW------------KEKKT  224 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHHH------------HTTCT
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHHH------------hcCCC
Confidence            444555789999999999988876 5789999999999999999999754322111  00000            00000


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ........+..+.+|+.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00111122356779999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-49  Score=407.19  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=211.8

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC-CcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE-GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|++.++||+|+||+||+|++.. ++.||||+++.. ....++|.+|+.++++++|||||+++|++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            4678889999999999999999764 889999998654 34567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +++|+|.+++... ....+++..++.++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus        95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999999653 3456999999999999999999999998   99999999999999999999999999987643322


Q ss_pred             CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          508 EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                       .......++..|+|||++.+..++.++|||||||++|||++|..|+....  ....             ..+.+.....
T Consensus       171 -~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~-------------~~~~i~~~~~  234 (287)
T d1opja_         171 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQ-------------VYELLEKDYR  234 (287)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHH-------------HHHHHHTTCC
T ss_pred             -eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHH-------------HHHHHhcCCC
Confidence             22233567899999999999999999999999999999999776632111  1111             1111222222


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ...+...+..+.+|+.+||+.||++||||+||++.|+..
T Consensus       235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            233334456789999999999999999999999999765

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=402.02  Aligned_cols=255  Identities=29%  Similarity=0.455  Sum_probs=206.1

Q ss_pred             hcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++|++.++||+|+||+||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            3578889999999999999999998899999999653 3456789999999999999999999998854 5679999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++|+|.+++... ....+++..+++++.||++||.|||+.+   |+||||||+||||++++.+||+|||+++.+..... 
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            999999987432 2235899999999999999999999998   99999999999999999999999999998653322 


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      .......+|+.|+|||++.+..++.++|||||||+||||+||..|+....  ....+...             +......
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~-------------i~~~~~~  229 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQN-------------LERGYRM  229 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHH-------------HHTTCCC
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHH-------------HHhcCCC
Confidence            22334578999999999999999999999999999999999765532111  11111111             1111111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ..+...+..+.+|+.+||+.||++||||++|+++|+.
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            2222334578899999999999999999999999874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5e-49  Score=405.04  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=197.9

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-C---cEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-G---QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|++.++||+|+||+||+|.+.. +   ..||||++... .....++|.+|+.+|++++|||||+++|++..++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456677899999999999999753 3   35899988654 334567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++..  ..+.+++.+++.++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998853  3456999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CccCcC---cccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          505 DQTEAN---TDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       505 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ......   .....+|+.|+|||++.+..++.++|||||||+||||+| |+.|+......   .+.             .
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~-------------~  244 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVI-------------N  244 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH-------------H
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHH-------------H
Confidence            332221   223457899999999999999999999999999999998 88886532211   111             1


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .+........+...+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus       245 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         245 AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1111111223334556788999999999999999999999999764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=392.38  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=211.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|++.++||+|+||+||+|++++++.||||++++. ....++|++|+.++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            588999999999999999999988899999999754 3456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +|+|..++..  ....+++..+.+++.||++||+|||+.+   |+||||||+||||++++.+||+|||+++.+..... .
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence            9999999753  3455899999999999999999999998   99999999999999999999999999987644322 2


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......+|..|+|||++.+..++.++|||||||++|||+| |+.|+......   .+...             +......
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~-------------i~~~~~~  220 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEH-------------IAQGLRL  220 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHH-------------HHTTCCC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHH-------------HHhCCCC
Confidence            3334678999999999999999999999999999999998 78886543221   11111             1111111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ..+...+..+.+|+.+||+.||++|||++++++.|..
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            2223334678899999999999999999999999854

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=395.88  Aligned_cols=249  Identities=24%  Similarity=0.377  Sum_probs=207.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      ++|++.++||+|+||+||+|... +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999964 59999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++|+|.+++.+    ..+++.++..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+....  
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            99999998853    35899999999999999999999998   9999999999999999999999999998764332  


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..+...   ...        .....
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~---~~~--------~~~~~  236 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLI---ATN--------GTPEL  236 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH---HHH--------CSCCC
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---HHHHHH---HhC--------CCCCC
Confidence            2234467999999999999999999999999999999999999997532211   111110   000        00001


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            112223467889999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=393.68  Aligned_cols=245  Identities=25%  Similarity=0.354  Sum_probs=205.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999975 5899999998643   2345678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||++......
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999954   345899999999999999999999998   999999999999999999999999999865322


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                          ......||+.|+|||++.+..++.++|||||||+||||++|+.||......   .......            .. 
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~------------~~-  219 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRIS------------RV-  219 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH------------TT-
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHHHHH------------cC-
Confidence                233467999999999999999999999999999999999999997532211   1111100            00 


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       ....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       220 -~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence             01122223457889999999999999999999985

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=403.95  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=207.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC------CcEEEEEEeccc-CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE------GQEIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  420 (669)
                      .++|++.++||+|+||+||+|++..      ...||||++... .......|.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3678899999999999999999643      236999998654 344567899999999998 89999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCC
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTR--------------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKA  480 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp  480 (669)
                      .++||||+++|+|.++|.....                    ...+++..++.++.||++||+|||+.+   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999965321                    245899999999999999999999998   99999999


Q ss_pred             CCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005933          481 SNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHA  559 (669)
Q Consensus       481 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~  559 (669)
                      +|||++.++.+||+|||+|+...............+|+.|+|||++.+..++.++|||||||+||||++ |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654443333345678999999999999999999999999999999998 8988653322


Q ss_pred             CCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 005933          560 DHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS  624 (669)
Q Consensus       560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  624 (669)
                      ..  .+             .+++........+...+..+.+|+.+||+.||++||||+||++.|.
T Consensus       273 ~~--~~-------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA--NF-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH--HH-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH--HH-------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            11  11             1111111122233334567889999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=395.01  Aligned_cols=257  Identities=26%  Similarity=0.440  Sum_probs=203.8

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLP  429 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  429 (669)
                      ++|++.+.||+|+||.||+|++++++.||||++... ....+.|.+|+.++++++|||||+++|++. .+..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            578999999999999999999998889999999643 445678999999999999999999999985 456899999999


Q ss_pred             CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccCc
Q 005933          430 NKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTEA  509 (669)
Q Consensus       430 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  509 (669)
                      +|+|..++... ....++|.+++.++.||+.||+|||+.+   |+||||||+||||+.++++||+|||+++.+..... .
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            99999998543 2345899999999999999999999998   99999999999999999999999999987643322 2


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDGS  589 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (669)
                      ......+|+.|+|||++.++.++.++|||||||+||||++|..|+.....  ....+..             +.......
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~-------------i~~~~~~~  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQ-------------VERGYRMP  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHH-------------HHTTCCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHH-------------HHhcCCCC
Confidence            22335789999999999999999999999999999999997666332111  1111111             11111122


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          590 YSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       590 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      .+...+..+.+|+.+||+.||++||+|++|+.+|+..-.
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            333445678899999999999999999999999987543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=397.01  Aligned_cols=259  Identities=26%  Similarity=0.438  Sum_probs=202.3

Q ss_pred             cCCCccCeeeecCccceEEEEeCCC-----cEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEG-----QEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      +.|++.+.||+|+||+||+|.++..     ..||||++.... .....+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4677889999999999999997642     479999996543 3345679999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+.+++|.+++..  ....+++.+++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999998854  3356999999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ..... .......||..|+|||++.+..++.++|||||||+||||++|..|+.....  ...+             .+.+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~-------------~~~i  226 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEV-------------MKAI  226 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH-------------HHHH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHH-------------HHHH
Confidence            43222 223345689999999999999999999999999999999997665332111  1111             1111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                      ........+...+..+.+|+.+||+.||++||||.||+++|+.+..
T Consensus       227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            2222223344455678999999999999999999999999987543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=397.11  Aligned_cols=248  Identities=24%  Similarity=0.321  Sum_probs=202.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.+.||+|+||+||+|... +|+.||||++.+.   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 5899999998653   2345678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|.+++..   .+.+++..+..++.||+.||+|||+.+   |+||||||+||||++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999999854   345899999999999999999999999   999999999999999999999999999987654


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      ..........||+.|+|||++.+..++.++|||||||+||||++|+.||.....   ..+....            ....
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i------------~~~~  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI------------IKLE  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH------------HTTC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHHHH------------HcCC
Confidence            444444557899999999999999999999999999999999999999753221   1111110            0000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVV  620 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  620 (669)
                        ..++...+..+.+|+.+||+.||++|||++|++
T Consensus       227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence              112222345688999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-48  Score=395.06  Aligned_cols=251  Identities=23%  Similarity=0.349  Sum_probs=206.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      +.|++.++||+|+||+||+|+.. +++.||||++........+.|.+|+.++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56889999999999999999975 58999999998777777889999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++|+|.+++.+.  ...+++.++..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++......  
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            999999998543  345999999999999999999999998   9999999999999999999999999997643211  


Q ss_pred             cCcccccccCCccCchhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcc
Q 005933          509 ANTDRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELID  583 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (669)
                      .......||+.|+|||++.     +..++.++|||||||+||||++|+.|+......   ..+......    ..     
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~~----~~-----  232 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAKS----EP-----  232 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHHS----CC-----
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcC----CC-----
Confidence            1223467999999999984     456899999999999999999999997543221   111111000    00     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          584 KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       584 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        .....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       233 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 --PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000112233467889999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=393.96  Aligned_cols=247  Identities=27%  Similarity=0.421  Sum_probs=197.8

Q ss_pred             CeeeecCccceEEEEeCC---CcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeecCC
Q 005933          356 NKLGEGGFGPVYRGMLTE---GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYLPN  430 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  430 (669)
                      ++||+|+||+||+|.+.+   ++.||||+++...  ....++|.+|+.++++++|||||+++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998643   5689999996532  3345789999999999999999999999864 567899999999


Q ss_pred             CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC-c
Q 005933          431 KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE-A  509 (669)
Q Consensus       431 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  509 (669)
                      |+|.+++..   ...+++..++.++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999854   345999999999999999999999998   999999999999999999999999999876543322 2


Q ss_pred             CcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccCC
Q 005933          510 NTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLDG  588 (669)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (669)
                      ......||+.|+|||++.+..++.++|||||||++|||++ |+.|+......   .+.             ..+......
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~-------------~~i~~~~~~  229 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT-------------AMLEKGERM  229 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH-------------HHHHTTCCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHH-------------HHHHcCCCC
Confidence            2334678999999999999999999999999999999998 89886532211   111             111111111


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          589 SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       589 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ..+...+..+.+|+.+||+.||++|||+++|+++|+.
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            2233345678899999999999999999999998853

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-48  Score=393.19  Aligned_cols=254  Identities=27%  Similarity=0.440  Sum_probs=205.5

Q ss_pred             cCCCccC-eeeecCccceEEEEeC---CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKN-KLGEGGFGPVYRGMLT---EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|.+.+ +||+|+||+||+|.+.   ++..||||+++... ....++|.+|+.+|++++|||||+++|++.. +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 5999999999999864   35579999997543 3446789999999999999999999999864 568999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999999843  3456999999999999999999999998   99999999999999999999999999998754


Q ss_pred             Ccc-CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          505 DQT-EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       505 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ... ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||......   .+...             +
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~-------------i  225 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF-------------I  225 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH-------------H
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH-------------H
Confidence            332 222334568999999999999999999999999999999998 89997543221   11111             1


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ........+...+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus       226 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1111112233445678899999999999999999999998864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=394.95  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=193.9

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEec--CCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--RDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV  424 (669)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....  ....+.+.+|+.++++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999975 58999999987543  3345679999999999999999999999865  4557899


Q ss_pred             EeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          425 YEYLPNKSLEQFIFDV-TRTKFLDWSKRCQIIEGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      |||+++|+|.+++.+. .....+++..++.++.||+.||.|||+.+  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998643 23456999999999999999999999865  23599999999999999999999999999987


Q ss_pred             cCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          502 FGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      +....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...    ...      
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~----i~~------  228 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGK----IRE------  228 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH----HHH------
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHH----HHc------
Confidence            64322  2233467899999999999999999999999999999999999997532211   11111    000      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                        ... ...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       229 --~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         229 --GKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              000 1122233457889999999999999999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=399.44  Aligned_cols=263  Identities=22%  Similarity=0.319  Sum_probs=204.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.+|+.++|||||++++++.++++.+||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            568999999999999999999975 58999999997653 3345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      |+++|+|.+++.+.   +.+++..+..++.||+.||.|||+. +   |+||||||+||||++++.+||+|||+|+.+.. 
T Consensus        85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence            99999999999643   4589999999999999999999974 7   99999999999999999999999999987532 


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh---------------
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW---------------  570 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~---------------  570 (669)
                         ......+||+.|+|||++.+..++.++||||+||++|||++|+.||................               
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence               22234689999999999999999999999999999999999999976432211100000000               


Q ss_pred             --------hhcccccchhhcccccCC---CCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          571 --------RLWTEDRSLELIDKSLDG---SYS-LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       571 --------~~~~~~~~~~~~~~~~~~---~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                              .........+..+.....   ..+ ...+..+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                    000000000111110000   000 112356789999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-47  Score=394.15  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=210.6

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccCc-cchHHHHHHHHHHHHhCCCceeEEEEEEecCCc
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  420 (669)
                      ..++|++.++||+|+||+||+|++.      +++.||||++..... ...++|.+|+.++++++||||+++++++...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            4578999999999999999999964      357899999975443 345789999999999999999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCC
Q 005933          421 RMLIYEYLPNKSLEQFIFDVT---------------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLK  479 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dik  479 (669)
                      .++||||+++|+|.+++....                     ....+++..++.++.||+.||+|||+.+   ++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            999999999999999996422                     1234899999999999999999999998   9999999


Q ss_pred             CCCEEEcCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCC
Q 005933          480 ASNVLLDNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYH  558 (669)
Q Consensus       480 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~-p~~~~~  558 (669)
                      |+||||+.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||++|.. |+....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            9999999999999999999987654444344445678899999999999999999999999999999999964 543321


Q ss_pred             CCCccchhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          559 ADHHHNLLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ..   .+....    ...         .....+...+.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus       248 ~~---e~~~~v----~~~---------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HE---EVIYYV----RDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HH---HHHHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HH---HHHHHH----HcC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            11   111111    000         111223334467889999999999999999999999998764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-47  Score=393.20  Aligned_cols=259  Identities=23%  Similarity=0.340  Sum_probs=193.2

Q ss_pred             HhcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          348 ATDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       348 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ..+.|++.+.||+|+||+||+|... +++.||||++.+.. ......+.+|+.+++.++|||||++++++.+++..+|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3467999999999999999999975 58999999997543 233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc---CCcceEEeecCCCccc
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NDMNPKISDFGMARAF  502 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~---~~~~~kl~Dfgla~~~  502 (669)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999943   456999999999999999999999998   99999999999995   5789999999999865


Q ss_pred             CCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ....   ......||+.|+|||++.+..++.++|||||||+||||++|+.||......   .+.....+   .       
T Consensus       161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~---~-------  224 (307)
T d1a06a_         161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQILK---A-------  224 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHT---T-------
T ss_pred             cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHhc---c-------
Confidence            3322   233467999999999999999999999999999999999999997532211   11111000   0       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HhcCCCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGERS  628 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  628 (669)
                      ............+..+.+|+.+||+.||++|||++|+++  .+.+...
T Consensus       225 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  272 (307)
T d1a06a_         225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA  272 (307)
T ss_dssp             CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred             CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence            000111111223457889999999999999999999998  3554433

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=380.33  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=194.0

Q ss_pred             CccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEec----CCcceEEE
Q 005933          353 SWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL----RDERMLIY  425 (669)
Q Consensus       353 ~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~  425 (669)
                      .+.++||+|+||+||+|+.. +++.||||++...  .....+.|.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45678999999999999975 4889999998654  33446789999999999999999999999865    34578999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc-CCcceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NDMNPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~-~~~~~kl~Dfgla~~~~~  504 (669)
                      ||+++|+|.+++.+   ...+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999954   345899999999999999999999876 3499999999999997 578999999999976432


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      .    ......||+.|+|||++.+ .++.++|||||||+||||++|+.||.....  ...+...    ........    
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~----i~~~~~~~----  232 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRR----VTSGVKPA----  232 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHH----HTTTCCCG----
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHH----HHcCCCCc----
Confidence            2    2234679999999998865 699999999999999999999999753211  1111111    11000000    


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                          ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus       233 ----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                011112345789999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-47  Score=389.39  Aligned_cols=245  Identities=28%  Similarity=0.404  Sum_probs=199.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      +.|++.++||+|+||+||+|+.. +++.||||++.....   ...+.+.+|+.++++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45888999999999999999964 588999999976432   33467899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||++..... 
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999999877633   356999999999999999999999998   99999999999999999999999999986532 


Q ss_pred             ccCcCcccccccCCccCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                           .....||+.|+|||++.+   ..|+.++|||||||++|||++|+.|+......   ..+   ...         .
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~---~~i---------~  227 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL---YHI---------A  227 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHH---------H
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHH---HHH---------H
Confidence                 223579999999999864   46899999999999999999999996532111   111   010         0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ........+...+..+.+|+.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            000000111223457889999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-46  Score=392.94  Aligned_cols=253  Identities=22%  Similarity=0.321  Sum_probs=207.5

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999975 5899999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC--CcceEEeecCCCcccCCC
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--DMNPKISDFGMARAFGVD  505 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~--~~~~kl~Dfgla~~~~~~  505 (669)
                      +++|+|.+++.+  ....+++..+..++.||+.||.|||+++   |+||||||+||||+.  ++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999843  3456999999999999999999999999   999999999999964  678999999999876432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..+......          ...
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~----------~~~  243 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSC----------DWN  243 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT----------CCC
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhC----------CCC
Confidence            2   223467899999999999999999999999999999999999997532211   111111000          000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      .........+..+.+|+.+||+.||++|||++|+++-
T Consensus       244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000111223568899999999999999999999983

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=389.14  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=202.8

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-Cc----EEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ----EIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      ++|++.++||+|+||+||+|.+.. |+    +||||++... .....++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            468899999999999999999653 43    6899988653 345678899999999999999999999999864 5678


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ++||+.+|+|.+++..  ....+++..+++++.|||+||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999998854  3456999999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      ............||..|+|||++.++.++.++|||||||+||||+| |.+|+.......   +             ...+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~-------------~~~i  226 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I-------------SSIL  226 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---H-------------HHHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---H-------------HHHH
Confidence            5444444445678999999999999999999999999999999998 777765332211   1             1111


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ........+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus       227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            11111223334456788999999999999999999999988754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-46  Score=380.10  Aligned_cols=247  Identities=22%  Similarity=0.326  Sum_probs=203.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC------ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS------GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDER  421 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  421 (669)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.+..      ....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999974 58999999986532      22467899999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc----ceEEeecC
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM----NPKISDFG  497 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~----~~kl~Dfg  497 (669)
                      +|||||+++|+|.+++...   +.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999999543   46999999999999999999999999   99999999999998776    59999999


Q ss_pred             CCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          498 MARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       498 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ++.......   ......+|+.|+|||++.+..++.++|||||||+||||++|+.||......   .......       
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~-------  229 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVS-------  229 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-------
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHHHHH-------
Confidence            998764332   223457899999999999999999999999999999999999996532211   1110000       


Q ss_pred             chhhcccccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLELIDKSLDGSYSL----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                           ..  ....+.    ..+..+.+|+.+||+.||++|||++|+++
T Consensus       230 -----~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         230 -----AV--NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -----TT--CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----hc--CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 00  001111    12346789999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=378.49  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=197.4

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecC-CcceEEEeec
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-DERMLIYEYL  428 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~~  428 (669)
                      ++|++.++||+|+||.||+|.++ |+.||||++++.  ...+.|.+|+.++++++||||++++|++.+. +..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            56788899999999999999996 789999999653  3457899999999999999999999998654 5689999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++|+|.++|... ....+++..+++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999999642 2235899999999999999999999998   999999999999999999999999999865322   


Q ss_pred             cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhcccccC
Q 005933          509 ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSLD  587 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (669)
                        .....++..|+|||++.+..++.++|||||||++|||+| |++|+......   .+...             +.....
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~-------------i~~~~~  218 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR-------------VEKGYK  218 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH-------------HTTTCC
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH-------------HHcCCC
Confidence              223467889999999999999999999999999999998 67665432211   11111             111112


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          588 GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       588 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ...+...+..+.+|+.+||+.||++||||.+|+++|+.+
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            233334446788999999999999999999999999764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=383.98  Aligned_cols=260  Identities=27%  Similarity=0.376  Sum_probs=198.9

Q ss_pred             hcCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccC-ccchHHHHHHHHHHHHh-CCCceeEEEEEEecC-C
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR-D  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~  419 (669)
                      .++|++.++||+|+||.||+|...      +++.||||++.... ....+.+..|+.++.++ +|+||+.+++++... .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            468999999999999999999953      24689999997543 33456788899888887 689999999998665 4


Q ss_pred             cceEEEeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVT-------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD  486 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~  486 (669)
                      ..++||||+++|+|.+++....             ....+++.+++.++.||++||.|||+++   |+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            6899999999999999996432             1345899999999999999999999998   99999999999999


Q ss_pred             CCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCccch
Q 005933          487 NDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-RNRGFYHADHHHNL  565 (669)
Q Consensus       487 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~-~p~~~~~~~~~~~~  565 (669)
                      +++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. +|+......  ..+
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence            99999999999998765554444455578999999999999999999999999999999999975 454322211  111


Q ss_pred             hhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          566 LGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      ..             .+........+...+..+.+|+.+||+.||++|||++||++.|+.+
T Consensus       247 ~~-------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         247 CR-------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HH-------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH-------------HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            10             1111111122223345788999999999999999999999999754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.6e-46  Score=389.62  Aligned_cols=252  Identities=22%  Similarity=0.277  Sum_probs=207.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999974 5999999999876655667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEc--CCcceEEeecCCCcccCCC
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~--~~~~~kl~Dfgla~~~~~~  505 (669)
                      +++|+|.+++..  ....+++.++..++.||+.||.|||+.+   |+||||||+||||+  .++.+||+|||++..+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999988742  3445999999999999999999999998   99999999999998  6789999999999876432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .   ......+|+.|+|||++.+..++.++|||||||+||||++|+.||......   ..+......          ...
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~----------~~~  246 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRC----------DWE  246 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHC----------CCC
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC----------CCC
Confidence            2   233467899999999999999999999999999999999999997532211   111111000          000


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .........+..+.+|+.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111223456789999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-46  Score=382.17  Aligned_cols=261  Identities=27%  Similarity=0.386  Sum_probs=209.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC--------CcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeEEEEEEecC
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLR  418 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  418 (669)
                      .++|++.++||+|+||.||+|+...        +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578889999999999999998532        34799999976543 3467899999999998 799999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTR-------------TKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                      +..++||||+++|+|.++|.....             ...+++.++++++.||+.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999964331             345899999999999999999999999   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  564 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~  564 (669)
                      +.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |.+|+......   .
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence            9999999999999998766555555566788999999999999999999999999999999998 67775432211   1


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                          ...         .+........+...+..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus       246 ----~~~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 ----LFK---------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ----HHH---------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHH---------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                111         111111112222334578899999999999999999999999987543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-46  Score=384.08  Aligned_cols=260  Identities=25%  Similarity=0.398  Sum_probs=212.0

Q ss_pred             hcCCCccCeeeecCccceEEEEe------CCCcEEEEEEecccCc-cchHHHHHHHHHHHHh-CCCceeEEEEEEecCCc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML------TEGQEIAVKRLSKSSG-QGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  420 (669)
                      .++|++.++||+|+||.||+|++      .+++.||||+++.... ....+|.+|+.+++++ +|||||+++|++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            36888899999999999999985      2367899999976443 3456799999999999 69999999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEE
Q 005933          421 RMLIYEYLPNKSLEQFIFDVT---------------RTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLL  485 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll  485 (669)
                      .++||||+++|+|.+++....               ....+++..+..++.||++||+|||+++   ++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999997532               2335899999999999999999999999   9999999999999


Q ss_pred             cCCcceEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCccc
Q 005933          486 DNDMNPKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHN  564 (669)
Q Consensus       486 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG-~~p~~~~~~~~~~~  564 (669)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+|+ .+++......   .
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---~  255 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---S  255 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---H
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---H
Confidence            99999999999999987655444445567889999999999999999999999999999999995 4443322111   0


Q ss_pred             hhhHhhhhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          565 LLGHAWRLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .            ..+++........+...+..+.+|+.+||+.||++||||++|+++|+..
T Consensus       256 ~------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         256 K------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             H------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            0            1111222222222333456788999999999999999999999999753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-46  Score=377.36  Aligned_cols=255  Identities=24%  Similarity=0.338  Sum_probs=195.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeCC----CcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERML  423 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  423 (669)
                      .++|++.+.||+|+||.||+|++..    +..||||++.... ....+.|.+|+.++++++||||++++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3578899999999999999999643    4568999986543 334678999999999999999999999996 467899


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccC
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFG  503 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~  503 (669)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999998754  3456899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchhhc
Q 005933          504 VDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLELI  582 (669)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (669)
                      .... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+|+......   .+.....            
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~------------  223 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE------------  223 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH------------
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHHH------------
Confidence            3322 22334568999999999999999999999999999999998 78886543221   1111110            


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          583 DKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       583 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                       .......+...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         224 -NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             0011122333456788999999999999999999999988653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=380.24  Aligned_cols=255  Identities=27%  Similarity=0.371  Sum_probs=196.0

Q ss_pred             cCCCccCeeeecCccceEEEEeCC----CcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE----GQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      ++|++.+.||+|+||.||+|++..    ...||||++.+.   .....++|.+|+.++++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568899999999999999998642    237899998653   33446789999999999999999999999965 4678


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||||+++|+|.+++..  +...+++..++.++.|||+||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999998854  3345999999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCccC-cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCccchhhHhhhhcccccchh
Q 005933          503 GVDQTE-ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWTEDRSLE  580 (669)
Q Consensus       503 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  580 (669)
                      ...... .......++..|+|||++.+..++.++|||||||++|||+| |+.|+......   ......           
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i-----------  227 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI-----------  227 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH-----------
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHH-----------
Confidence            544332 22334567889999999999999999999999999999998 88886432211   111111           


Q ss_pred             hcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          581 LIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       581 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                       .........+...+..+.+|+.+||+.||++||||.||++.|.+
T Consensus       228 -~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         228 -DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             -HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence             11111112222334578899999999999999999999999865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=384.28  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=206.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEE
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      .++|++.+.||+|+||.||+++.. +|+.||||++.+.   .....+.+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            357999999999999999999974 5999999999754   344568899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999854   345899999999999999999999999   99999999999999999999999999986533


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|++|+......   .+....            ...
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i------------~~~  220 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELI------------LME  220 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH------------HHC
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHHHH------------hcC
Confidence            22  2334478999999999999999999999999999999999999996543211   111110            000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      .  ..++...+..+.+|+.+||+.||++||+     ++|+++
T Consensus       221 ~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         221 E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            0  1122233456789999999999999995     788875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-46  Score=382.80  Aligned_cols=256  Identities=27%  Similarity=0.446  Sum_probs=203.5

Q ss_pred             cCCCccCeeeecCccceEEEEeCC-Cc--EEEEEEeccc-CccchHHHHHHHHHHHHh-CCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTE-GQ--EIAVKRLSKS-SGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|++.++||+|+||.||+|++++ +.  .||||++... .....+.|.+|+.+|.++ +|||||+++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578888999999999999999754 44  5788888643 344567899999999999 799999999999999999999


Q ss_pred             EeecCCCCHHHHhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcce
Q 005933          425 YEYLPNKSLEQFIFDV-------------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNP  491 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~  491 (669)
                      |||+++|+|.++|...             .....+++..+++++.|||.||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999643             23466999999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCCccchhhHhh
Q 005933          492 KISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAW  570 (669)
Q Consensus       492 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~-p~~~~~~~~~~~~~~~~~  570 (669)
                      ||+|||+++......   ......+|..|+|||.+.+..++.++|||||||++|||++|.. |+....   ...+.    
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~----  236 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELY----  236 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHH----
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHH----
Confidence            999999998643222   2233568999999999999999999999999999999999765 433211   11111    


Q ss_pred             hhcccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          571 RLWTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                               +.+........+...+..+.+|+.+||+.||++||||+||++.|+.+.
T Consensus       237 ---------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         237 ---------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             ---------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                     111111112233344567889999999999999999999999988763

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=381.60  Aligned_cols=260  Identities=26%  Similarity=0.398  Sum_probs=211.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC------CCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT------EGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      ++|++.++||+|+||+||+|.++      +++.||||+++... ......|.+|+.++++++||||++++|++...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            67888999999999999999864      25789999997543 334567999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEee
Q 005933          423 LIYEYLPNKSLEQFIFDV-------TRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISD  495 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  495 (669)
                      +||||+++|+|.+++...       .....+++..+.+++.|||+||.|||+.+   |+||||||+||||+.++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence            999999999999998632       22345799999999999999999999998   99999999999999999999999


Q ss_pred             cCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCccchhhHhhhhcc
Q 005933          496 FGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-RNRGFYHADHHHNLLGHAWRLWT  574 (669)
Q Consensus       496 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~-~p~~~~~~~~~~~~~~~~~~~~~  574 (669)
                      ||+++.+.............+|+.|+|||.+.+..++.++||||||++||||++|. +|+.....   ...+...     
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~~~~i-----  248 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFV-----  248 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHH-----
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---HHHHHHH-----
Confidence            99998775544444445567899999999999999999999999999999999985 55432111   1111111     


Q ss_pred             cccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 005933          575 EDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  628 (669)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  628 (669)
                             .+. .....+...+..+.+|+.+||+.+|++||||++|+++|+...+
T Consensus       249 -------~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         249 -------MEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -------HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------HhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                   010 0111222334678999999999999999999999999987533

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.9e-45  Score=379.44  Aligned_cols=244  Identities=23%  Similarity=0.303  Sum_probs=203.7

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.++||+|+||+||+|+.. +|+.||||++++.   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57899999999999999999975 5999999999653   2345678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+++|+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998843   445788999999999999999999998   999999999999999999999999999876432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                           .....||+.|+|||++.+..++.++|||||||+||||++|+.||......   .+...            +....
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~------------i~~~~  217 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEK------------ILNAE  217 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH------------HHHCC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHHH------------HHcCC
Confidence                 23468999999999999999999999999999999999999997532211   11100            01110


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  621 (669)
                        ...+...+..+.+++.+||+.||.+||     |++++++
T Consensus       218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              112222345688999999999999996     8999985

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-45  Score=382.13  Aligned_cols=244  Identities=20%  Similarity=0.245  Sum_probs=204.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  425 (669)
                      ++|++.++||+|+||.||+|+.. +|+.||||++.+.   .....+.+.+|+.+|+.++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 5999999998643   2345678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVD  505 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~  505 (669)
                      ||+.+|+|..++...   +.+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999998543   45899999999999999999999999   999999999999999999999999999876432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                           .....||+.|+|||++.+..++.++|||||||+||||++|+.||.....   ..+....            ....
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i------------~~~~  254 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKI------------VSGK  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH------------HHCC
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHH------------hcCC
Confidence                 2346799999999999999999999999999999999999999753211   1111110            0111


Q ss_pred             cCCCCCHHHHHHHHHHHHHhccCCCCCC-----CCHHHHHH
Q 005933          586 LDGSYSLSEALRCIQVGLLCVQQRPEDR-----PNMSSVVL  621 (669)
Q Consensus       586 ~~~~~~~~~~~~l~~li~~cl~~dP~~R-----Ps~~evl~  621 (669)
                      .  ..+...+..+.+++.+||+.||.+|     ||++++++
T Consensus       255 ~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 V--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1  1122234578899999999999999     48999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-45  Score=379.80  Aligned_cols=247  Identities=26%  Similarity=0.382  Sum_probs=202.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHHHHHHH-HhCCCceeEEEEEEecCCcceEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNEVLLIA-KLQHRNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV  424 (669)
                      ++|.+.+.||+|+||+||+|+.. +++.||||++++.   .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999975 5899999999753   2345567778887765 68999999999999999999999


Q ss_pred             EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCC
Q 005933          425 YEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGV  504 (669)
Q Consensus       425 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~  504 (669)
                      |||+++|+|.+++..   ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999954   345899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccc
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDK  584 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (669)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+.....            ..
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~------------~~  218 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIR------------MD  218 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH------------HC
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHH------------cC
Confidence            22  2334468999999999999999999999999999999999999997532211   1111100            00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 005933          585 SLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMS-SVVL  621 (669)
Q Consensus       585 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  621 (669)
                        ....+...+..+.+|+.+||+.||++||++. ++++
T Consensus       219 --~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 --NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence              1112222345688999999999999999996 6753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-45  Score=375.43  Aligned_cols=253  Identities=26%  Similarity=0.360  Sum_probs=201.5

Q ss_pred             cCeeeecCccceEEEEeCCC----cEEEEEEeccc-CccchHHHHHHHHHHHHhCCCceeEEEEEEecC-CcceEEEeec
Q 005933          355 KNKLGEGGFGPVYRGMLTEG----QEIAVKRLSKS-SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-DERMLIYEYL  428 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~~  428 (669)
                      .++||+|+||+||+|++.++    ..||||++++. .....++|.+|++++++++||||++++|++... ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            47899999999999997542    25899999753 444568899999999999999999999998764 5789999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      ++|+|.+++..  ....+++..+++++.||++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999854  3445788999999999999999999998   999999999999999999999999999876543322


Q ss_pred             --cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhccccc
Q 005933          509 --ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKSL  586 (669)
Q Consensus       509 --~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (669)
                        .......||..|+|||.+.+..++.++||||||+++|||++|..|+......  .........             ..
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~-------------g~  251 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQ-------------GR  251 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT-------------TC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc-------------CC
Confidence              2223457899999999999999999999999999999999988774422111  111111100             00


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 005933          587 DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  627 (669)
Q Consensus       587 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  627 (669)
                      ....+...+..+.+|+.+||+.||++||+|.||++.|+.+.
T Consensus       252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            11122233457889999999999999999999999998763

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=377.84  Aligned_cols=271  Identities=21%  Similarity=0.262  Sum_probs=197.1

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCC----cceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----ERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~  425 (669)
                      +.|.+.++||+|+||.||+|+++ |+.||||+++.... ....+..|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            45677899999999999999974 89999999864321 1222334555556789999999999998754    478999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      ||+++|+|.+++.+    ..++|..+++++.|+|.||+|||+..     ..+|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999964    24899999999999999999999741     2349999999999999999999999999998


Q ss_pred             ccCCCcc--CcCcccccccCCccCchhhccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          501 AFGVDQT--EANTDRVVGTYGYMSPEYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       501 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      .......  ........||+.|+|||++.+..      ++.++|||||||+||||+||..|+..................
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            7644322  22334578999999999987653      677999999999999999998876532222110000000000


Q ss_pred             cccccchhhcccccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 005933          573 WTEDRSLELIDKSLDGSY-----SLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  626 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  626 (669)
                      .............+.+..     +.+.+..+.+|+.+||+.||++||||.||++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            000000111111222222     223455788999999999999999999999999754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.4e-45  Score=370.39  Aligned_cols=258  Identities=24%  Similarity=0.321  Sum_probs=198.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc---cchHHHHHHHHHHHHhCCCceeEEEEEEecCCc----
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG---QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDE----  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----  420 (669)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++....   ...+.|.+|+.+++.++||||+++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999964 699999999975432   335679999999999999999999999876543    


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .+|||||+++++|.+++..   .+.+++.++..++.||++||.|||+.+   |+||||||+||||+.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999998854   345899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCcc-CcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch
Q 005933          501 AFGVDQT-EANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL  579 (669)
Q Consensus       501 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  579 (669)
                      ....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...   .+........
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~---~~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVA---YQHVREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHHHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---HHH---HHHHhcCCCC
Confidence            6543322 22334567999999999999999999999999999999999999997532211   111   1111100000


Q ss_pred             hhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhcC
Q 005933          580 ELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRP-NMSSVVLMLSG  625 (669)
Q Consensus       580 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~  625 (669)
                         .    .......+..+.+++.+||+.||++|| |+++++..|..
T Consensus       234 ---~----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 ---P----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ---G----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---C----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence               0    001112235688999999999999999 89999887754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-44  Score=367.42  Aligned_cols=250  Identities=22%  Similarity=0.301  Sum_probs=202.3

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCcc---------chHHHHHHHHHHHHhC-CCceeEEEEEEecC
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQ---------GVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLR  418 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~  418 (669)
                      ++|++.+.||+|+||+||+++.. +|+.||||++.+....         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999974 5899999999754321         2346889999999997 99999999999999


Q ss_pred             CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCC
Q 005933          419 DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGM  498 (669)
Q Consensus       419 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgl  498 (669)
                      +..+|||||+++|+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999954   346999999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhh
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  572 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~  572 (669)
                      ++.+....   ......||..|+|||++.+      ..++.++||||+||+||||++|+.||......   ......   
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~~~~i---  227 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLRMI---  227 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HHHHHH---
Confidence            98765432   2234679999999999863      35788999999999999999999997643211   111100   


Q ss_pred             cccccchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          573 WTEDRSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      .. ...      ..........+..+.+|+.+||+.||++|||+.||++
T Consensus       228 ~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MS-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HH-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Hh-CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00 000      0011111233457889999999999999999999865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=373.50  Aligned_cols=245  Identities=19%  Similarity=0.296  Sum_probs=202.6

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      .++|++.+.||+|+||+||+|... +++.||||+++... .....+.+|+.+|+.++|||||++++++.+.+..+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999975 58899999996543 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCC--cceEEeecCCCcccCCC
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDND--MNPKISDFGMARAFGVD  505 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~--~~~kl~Dfgla~~~~~~  505 (669)
                      +++|+|.+++..  ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999943  2345899999999999999999999998   9999999999999854  58999999999875432


Q ss_pred             ccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhhcccc
Q 005933          506 QTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLELIDKS  585 (669)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (669)
                      .   ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||......   ..                +...
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~----------------~~~i  215 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QI----------------IENI  215 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH----------------HHHH
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HH----------------HHHH
Confidence            2   223357899999999999999999999999999999999999997543211   11                1111


Q ss_pred             cCC--CCCHH----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          586 LDG--SYSLS----EALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       586 ~~~--~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...  .++..    .+..+.+|+.+||+.||++|||+.|+++
T Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111  11111    2346789999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=369.57  Aligned_cols=256  Identities=23%  Similarity=0.279  Sum_probs=194.8

Q ss_pred             cCeeeecCccceEEEEeC-CCcEEEEEEecccCc-----cchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEeec
Q 005933          355 KNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG-----QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEYL  428 (669)
Q Consensus       355 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  428 (669)
                      .++||+|+||+||+|+.. +|+.||||+++....     ...+.+.+|+.++++++|||||++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999975 589999999865322     12457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCccC
Q 005933          429 PNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQTE  508 (669)
Q Consensus       429 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~~  508 (669)
                      .++++..++   .....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            988777665   34556899999999999999999999999   99999999999999999999999999987543322 


Q ss_pred             cCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccch------hh
Q 005933          509 ANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSL------EL  581 (669)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~  581 (669)
                       ......||+.|+|||++... .++.++|||||||++|||++|++||......   ..+....+........      ..
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhcc
Confidence             22345789999999998755 6799999999999999999999987543221   1111111111000000      00


Q ss_pred             cccc---cCCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          582 IDKS---LDGSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       582 ~~~~---~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ....   .....+.     .....+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000   0001111     12346889999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.1e-44  Score=378.89  Aligned_cols=248  Identities=24%  Similarity=0.293  Sum_probs=197.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc---CccchHHHHHH---HHHHHHhCCCceeEEEEEEecCCcce
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS---SGQGVEEFKNE---VLLIAKLQHRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E---~~~l~~l~h~niv~l~g~~~~~~~~~  422 (669)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++.+.   .......+.+|   +.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999975 5999999998643   12233444454   55666678999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      +||||+++|+|.++|..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999954   345889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCccCcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccchhh
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRSLEL  581 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  581 (669)
                      ...    ......||+.|+|||++.. ..++.++|||||||+||||++|+.||..........+..   ..         
T Consensus       158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~---------  221 (364)
T d1omwa3         158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MT---------  221 (364)
T ss_dssp             SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---HS---------
T ss_pred             CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc---------
Confidence            433    2334679999999999975 568999999999999999999999976433221111100   00         


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          582 IDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       582 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                      ..  .....+...+..+.+|+.+||+.||++|||     ++|+++
T Consensus       222 ~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         222 LT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             cc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            00  001112223456889999999999999999     688874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=368.65  Aligned_cols=250  Identities=20%  Similarity=0.242  Sum_probs=196.3

Q ss_pred             hcCCCccC-eeeecCccceEEEEe-CCCcEEEEEEecccCccchHHHHHHHHHHHHh-CCCceeEEEEEEec----CCcc
Q 005933          349 TDNFSWKN-KLGEGGFGPVYRGML-TEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKL-QHRNLVRLLGCCTL----RDER  421 (669)
Q Consensus       349 ~~~~~~~~-~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~  421 (669)
                      .++|.+.+ .||+|+||.||+|.. .+++.||||++++     ...+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788775 599999999999996 4589999999853     35678899987665 89999999999865    4568


Q ss_pred             eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEeecCC
Q 005933          422 MLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGM  498 (669)
Q Consensus       422 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~Dfgl  498 (669)
                      ++||||+++|+|.++|... ....+++.++..++.||+.||+|||+.+   |+||||||+|||+++   .+.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999999642 2346999999999999999999999999   999999999999985   55799999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      ++......   ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+   ..       
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~-------  227 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT-------  227 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred             eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HH-------
Confidence            98764332   233467999999999999999999999999999999999999997533221110000   00       


Q ss_pred             hhhcccccCCCCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 LELIDKSLDGSYS--LSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 ~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                       .+.........+  ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       228 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 -RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             000000000111  122457889999999999999999999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=363.81  Aligned_cols=263  Identities=23%  Similarity=0.334  Sum_probs=199.1

Q ss_pred             cCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.++||+|+||+||+|+. .+|+.||||++....  ....+++.+|+.++++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999996 458999999996543  2346789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      |+.++.+. ++.. .....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 4422 34456999999999999999999999999   9999999999999999999999999998764322


Q ss_pred             cCcCcccccccCCccCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc------ch
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR------SL  579 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~  579 (669)
                        .......||+.|+|||++.... ++.++|||||||++|+|++|+.||......   ..+....+......      ..
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGG
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhccccc
Confidence              2333467999999999987765 578999999999999999999997643211   11111111000000      00


Q ss_pred             hhccc--cc-C-CCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          580 ELIDK--SL-D-GSYS-----LSEALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       580 ~~~~~--~~-~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ...+.  .. . ....     ......+.+|+.+||+.||++|||+.|+++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000  00 0 0000     0112467899999999999999999999873

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-43  Score=363.25  Aligned_cols=261  Identities=23%  Similarity=0.350  Sum_probs=200.5

Q ss_pred             cCCCccCeeeecCccceEEEEeCCCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEee
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYEY  427 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  427 (669)
                      ++|++.++||+|+||+||+|+.++|+.||||++...  .....+.+.+|+.+|++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578999999999999999999999999999999654  233467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCcc
Q 005933          428 LPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQT  507 (669)
Q Consensus       428 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~~  507 (669)
                      +.++.+..+.   ...+.+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9887777766   34466999999999999999999999998   99999999999999999999999999987643322


Q ss_pred             CcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc------chh
Q 005933          508 EANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR------SLE  580 (669)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~  580 (669)
                        ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......   ..+...........      ...
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhh
Confidence              22335689999999999765 5789999999999999999999997543211   11111111000000      000


Q ss_pred             hc--ccccC--C-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          581 LI--DKSLD--G-----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       581 ~~--~~~~~--~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..  .....  .     .........+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  00000  0     011122357789999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-43  Score=357.57  Aligned_cols=239  Identities=25%  Similarity=0.392  Sum_probs=195.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc------cchHHHHHHHHHHHHhC--CCceeEEEEEEecCCc
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG------QGVEEFKNEVLLIAKLQ--HRNLVRLLGCCTLRDE  420 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~  420 (669)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.+...      ....++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999965 589999999865321      12345778999999997  8999999999999999


Q ss_pred             ceEEEeecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-CcceEEeecCC
Q 005933          421 RMLIYEYLPN-KSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-DMNPKISDFGM  498 (669)
Q Consensus       421 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-~~~~kl~Dfgl  498 (669)
                      .++||||+.+ +++.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+||||+. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 577777743   345899999999999999999999998   999999999999985 57999999999


Q ss_pred             CcccCCCccCcCcccccccCCccCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc
Q 005933          499 ARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR  577 (669)
Q Consensus       499 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  577 (669)
                      ++.....    ......||+.|+|||++.+..+ +.++|||||||+||||++|+.|+....     .             
T Consensus       158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------------  215 (273)
T d1xwsa_         158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------------  215 (273)
T ss_dssp             CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------------
T ss_pred             ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-------------
Confidence            9865322    2334679999999999988765 567899999999999999999965311     0             


Q ss_pred             chhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          578 SLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       578 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         +.....  ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus       216 ---i~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         216 ---IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ---HHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---Hhhccc--CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence               000000  111122356889999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-43  Score=360.98  Aligned_cols=262  Identities=22%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-C-CcEEEEEEecccC--ccchHHHHHHHHHHHHh---CCCceeEEEEEEec----
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-E-GQEIAVKRLSKSS--GQGVEEFKNEVLLIAKL---QHRNLVRLLGCCTL----  417 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~----  417 (669)
                      .++|++.++||+|+||+||+|+.. + ++.||||++....  ......+.+|+.+++.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999963 4 6779999986532  23345677888887776   79999999999853    


Q ss_pred             -CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeec
Q 005933          418 -RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDF  496 (669)
Q Consensus       418 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  496 (669)
                       ....+++|||++++++.....  .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             345789999999887765542  34456899999999999999999999998   999999999999999999999999


Q ss_pred             CCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          497 GMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       497 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      |++......   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......   .+..........
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~  234 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP  234 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence            998864322   23345689999999999999999999999999999999999999976433211   111111100000


Q ss_pred             cch------hhccccc--C-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          577 RSL------ELIDKSL--D-----GSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       577 ~~~------~~~~~~~--~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...      .......  .     ..........+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000      0000000  0     0011122346789999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-42  Score=354.44  Aligned_cols=268  Identities=21%  Similarity=0.322  Sum_probs=197.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEeccc--CccchHHHHHHHHHHHHhCCCceeEEEEEEec--------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKS--SGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTL--------  417 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------  417 (669)
                      .++|++.++||+|+||+||+|+.. +|+.||||++...  ......++.+|+.+|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            368999999999999999999974 6999999998644  33456789999999999999999999998855        


Q ss_pred             CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecC
Q 005933          418 RDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFG  497 (669)
Q Consensus       418 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfg  497 (669)
                      ....++||||+.++.+....   .....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            34578999999888776554   34456899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccC--cCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc
Q 005933          498 MARAFGVDQTE--ANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT  574 (669)
Q Consensus       498 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~  574 (669)
                      ++..+......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99876543322  223345799999999999765 689999999999999999999999753322111111111100000


Q ss_pred             cc--------cchhhcccccCCCCCHHH-------HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          575 ED--------RSLELIDKSLDGSYSLSE-------ALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       575 ~~--------~~~~~~~~~~~~~~~~~~-------~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                      ..        ..................       ...+++|+.+||+.||++|||++|+++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00        000001111111111111       2356789999999999999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=358.56  Aligned_cols=258  Identities=21%  Similarity=0.266  Sum_probs=192.9

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCceeEEEEEEecC------CcceE
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------DERML  423 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l  423 (669)
                      +|+..++||+|+||+||+|+.. +|+.||||++.+...    .+.+|+.+|++++||||+++++++...      ...+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5777899999999999999975 599999999965432    234799999999999999999998543      23689


Q ss_pred             EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeecCCCccc
Q 005933          424 IYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAF  502 (669)
Q Consensus       424 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla~~~  502 (669)
                      ||||++++.+..+.........+++.++..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987655554433345567999999999999999999999998   99999999999999775 8999999999876


Q ss_pred             CCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc---c
Q 005933          503 GVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR---S  578 (669)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  578 (669)
                      ....   ......|+..|+|||.+.+. .++.++||||+||++|||++|+.||.......   .+....+......   .
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~---~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCCHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH---HHHHHHHHhCCChHHhh
Confidence            4332   22335789999999988754 78999999999999999999999976433211   1111110000000   0


Q ss_pred             hhh----ccccc--------CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          579 LEL----IDKSL--------DGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       579 ~~~----~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...    .....        ...........+.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000    00000        00011123456889999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.6e-41  Score=343.78  Aligned_cols=260  Identities=20%  Similarity=0.247  Sum_probs=196.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCCCce-eEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E  426 (669)
                      .++|++.++||+|+||.||+|+.. +|+.||||++....  ...++..|+++++.++|+|+ +.+.++..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            357999999999999999999964 58999999986543  23568899999999987664 555666677888899999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC---CcceEEeecCCCcccC
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---DMNPKISDFGMARAFG  503 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~---~~~~kl~Dfgla~~~~  503 (669)
                      |+ +++|...+..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.   +..+||+|||+++.+.
T Consensus        84 ~~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             Ec-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            99 4566666533  3345899999999999999999999999   999999999999864   4579999999999875


Q ss_pred             CCccC-----cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          504 VDQTE-----ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       504 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+........................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            43221     1233467999999999999999999999999999999999999997654433222211111110000000


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       579 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                           +.+..    ..+..+.+++..||+.+|++||+++++.+.|+.
T Consensus       238 -----~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         238 -----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             -----HHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             -----hHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                 01111    123567899999999999999999999888864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-40  Score=339.36  Aligned_cols=260  Identities=17%  Similarity=0.200  Sum_probs=204.7

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhCC-CceeEEEEEEecCCcceEEEe
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH-RNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E  426 (669)
                      .++|.+.++||+|+||+||+|+.. +|+.||||++....  ....+.+|+++++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999965 58999999986543  23567889999999975 899999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcC-----CcceEEeecCCCcc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----DMNPKISDFGMARA  501 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~Dfgla~~  501 (669)
                      |+ +++|.+++...  ...+++.++..++.|++.||+|||+.+   |+||||||+||||+.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 68999988543  345899999999999999999999999   999999999999974     57899999999987


Q ss_pred             cCCCccC-----cCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccc
Q 005933          502 FGVDQTE-----ANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTED  576 (669)
Q Consensus       502 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  576 (669)
                      +......     .......||+.|+|||++.+..++.++|||||||++|||++|+.|+......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6433221     12334679999999999999999999999999999999999999976544332222111111100000


Q ss_pred             cchhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 005933          577 RSLELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  625 (669)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  625 (669)
                      ...+     +....    +..+.+++..|++.+|++||+++.+.+.|+.
T Consensus       236 ~~~~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         236 PLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             CHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ChHH-----hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            1111     11112    3467889999999999999999998887765

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=356.28  Aligned_cols=264  Identities=20%  Similarity=0.307  Sum_probs=197.4

Q ss_pred             hcCCCccCeeeecCccceEEEEe-CCCcEEEEEEecccC-ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC----cce
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGML-TEGQEIAVKRLSKSS-GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD----ERM  422 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~  422 (669)
                      +++|++.++||+|+||+||+|+. .+|+.||||++.+.. ....+++++|+.+|+.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999996 469999999997543 334678999999999999999999999986654    345


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCccc
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAF  502 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~  502 (669)
                      ++++++.+|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+||||++++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            66677889999999953    24899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCcc-CcCcccccccCCccCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc--
Q 005933          503 GVDQT-EANTDRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS--  578 (669)
Q Consensus       503 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  578 (669)
                      ..... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||........   .............  
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED  236 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhh
Confidence            44332 223445679999999999854 4678999999999999999999999754322111   1110000000000  


Q ss_pred             ---------hhhccccc-CCCCCHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005933          579 ---------LELIDKSL-DGSYSLS-----EALRCIQVGLLCVQQRPEDRPNMSSVVLM  622 (669)
Q Consensus       579 ---------~~~~~~~~-~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~  622 (669)
                               ........ ....+..     ....+.+|+.+||+.||++|||++|+++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     00000000 0111111     12467899999999999999999999973

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-41  Score=342.66  Aligned_cols=262  Identities=22%  Similarity=0.286  Sum_probs=202.6

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCCcceEEEe
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  426 (669)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...  .....++.+|+.+++.++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999964 58999999986543  3446789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCcccCCCc
Q 005933          427 YLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMARAFGVDQ  506 (669)
Q Consensus       427 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~~~~~~  506 (669)
                      ++.+++|..++.   ..+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988874   3456899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cCcCcccccccCCccCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhccccc---c---h
Q 005933          507 TEANTDRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDR---S---L  579 (669)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~  579 (669)
                      .  ......++..|+|||++.... ++.++|||||||++|||++|+.|+-.  ...................   .   .
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            2  223346788899999988765 68999999999999999999998532  1111111111111111000   0   0


Q ss_pred             hhcccc---------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          580 ELIDKS---------LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       580 ~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ...+..         ............+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000         000111222356789999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-41  Score=354.54  Aligned_cols=265  Identities=20%  Similarity=0.299  Sum_probs=194.2

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecCC------
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLRD------  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------  419 (669)
                      .++|++.++||+|+||+||+|... +|+.||||++++..  ....+.+.+|+.+|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999965 59999999997542  234568899999999999999999999997665      


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      +.++||||+ +.+|..++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 5677777642    35999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh--------h
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------W  570 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~--------~  570 (669)
                      +.....     .....+|+.|+|||++.+. .++.++||||+||++|||++|+.|+...............        +
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            875432     2346789999999998764 5789999999999999999999997543221110000000        0


Q ss_pred             hhcccccchhhccc--ccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 005933          571 RLWTEDRSLELIDK--SLDG----SYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGE  626 (669)
Q Consensus       571 ~~~~~~~~~~~~~~--~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~  626 (669)
                      ..............  ....    .........+.+|+.+||+.||++|||+.|+++-  |+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            00000000000000  0000    0011223467899999999999999999999973  5543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.2e-40  Score=345.70  Aligned_cols=255  Identities=18%  Similarity=0.283  Sum_probs=195.8

Q ss_pred             cCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecC--CcceEEE
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLR--DERMLIY  425 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~  425 (669)
                      ++|++.++||+|+||+||+|+.. +|+.||||+++..   ..+++.+|+.+|..++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999974 5899999998643   3568899999999995 99999999998754  4588999


Q ss_pred             eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCc-ceEEeecCCCcccCC
Q 005933          426 EYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDM-NPKISDFGMARAFGV  504 (669)
Q Consensus       426 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~-~~kl~Dfgla~~~~~  504 (669)
                      ||+++++|..+.      +.+++..+..++.||+.||.|||+++   |+||||||+||||+.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997764      34899999999999999999999999   99999999999998655 699999999987643


Q ss_pred             CccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcc---------
Q 005933          505 DQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWT---------  574 (669)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------  574 (669)
                      ..   ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+........  ..........         
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHH
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhh
Confidence            32   23346789999999998876 479999999999999999999999754332211  1000000000         


Q ss_pred             ---ccc---chhhcc--------cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          575 ---EDR---SLELID--------KSLDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       575 ---~~~---~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                         ...   ......        ..............+.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000   000000        00011111122356789999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=345.81  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=201.1

Q ss_pred             cCCCccCeeeecCccceEEEEeC----CCcEEEEEEeccc----CccchHHHHHHHHHHHHhCC-CceeEEEEEEecCCc
Q 005933          350 DNFSWKNKLGEGGFGPVYRGMLT----EGQEIAVKRLSKS----SGQGVEEFKNEVLLIAKLQH-RNLVRLLGCCTLRDE  420 (669)
Q Consensus       350 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~  420 (669)
                      ++|++.++||+|+||+||+|...    +|+.||||++.+.    .....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            57999999999999999999852    4789999998643    22346778999999999976 899999999999999


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++||||+.+|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999998543   34678899999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhhhhcccccc
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWTEDRS  578 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  578 (669)
                      .+...... ......+++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........+....        
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--------  248 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--------  248 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--------
Confidence            76433222 23346789999999999765  47889999999999999999999976443322211111100        


Q ss_pred             hhhcccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 005933          579 LELIDKSLDGSYSLSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL  621 (669)
Q Consensus       579 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  621 (669)
                         ..  .....+...+..+.+++.+||+.||++|||     ++|+++
T Consensus       249 ---~~--~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 ---LK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---cc--CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence               00  011222334567889999999999999994     788875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-40  Score=346.48  Aligned_cols=261  Identities=22%  Similarity=0.248  Sum_probs=189.0

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccC--ccchHHHHHHHHHHHHhCCCceeEEEEEEecC------C
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSS--GQGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR------D  419 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~  419 (669)
                      .++|++.++||+|+||+||+|+.. +|+.||||++.+..  .....++.+|+.++++++||||+++++++...      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999976 59999999997543  23456789999999999999999999999643      5


Q ss_pred             cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCC
Q 005933          420 ERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMA  499 (669)
Q Consensus       420 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla  499 (669)
                      ..++||||+.++.+..+.      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            779999999766554432      34899999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhH--------hhh
Q 005933          500 RAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH--------AWR  571 (669)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~--------~~~  571 (669)
                      +.....   .......+|+.|+|||++.+..+++++||||+||+++||++|+.||...+.......+..        .+.
T Consensus       167 ~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            865432   233345789999999999999999999999999999999999999753321111000000        000


Q ss_pred             hc--------------ccccchhhcccccCCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005933          572 LW--------------TEDRSLELIDKSLDGSY---SLSEALRCIQVGLLCVQQRPEDRPNMSSVVL  621 (669)
Q Consensus       572 ~~--------------~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  621 (669)
                      ..              .................   .......+.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00              00000111111111111   1223557899999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-40  Score=345.00  Aligned_cols=265  Identities=22%  Similarity=0.299  Sum_probs=196.4

Q ss_pred             hcCCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCc--cchHHHHHHHHHHHHhCCCceeEEEEEEecC-----Cc
Q 005933          349 TDNFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSG--QGVEEFKNEVLLIAKLQHRNLVRLLGCCTLR-----DE  420 (669)
Q Consensus       349 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~  420 (669)
                      .++|++.++||+|+||+||+|+.. +|+.||||++++...  ...+++.+|+.+|+.++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999964 699999999975432  3456789999999999999999999998643     34


Q ss_pred             ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEeecCCCc
Q 005933          421 RMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKISDFGMAR  500 (669)
Q Consensus       421 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~  500 (669)
                      .++|++|+.+|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            5778888999999999832    35999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCccCcCcccccccCCccCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHhh--------h
Q 005933          501 AFGVDQTEANTDRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW--------R  571 (669)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~~--------~  571 (669)
                      ....     ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||...........+....        .
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            6432     22345789999999987765 46899999999999999999999975432211111110000        0


Q ss_pred             hcccccchhhcccccC-CCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH--HhcC
Q 005933          572 LWTEDRSLELIDKSLD-GSYSL-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSG  625 (669)
Q Consensus       572 ~~~~~~~~~~~~~~~~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~  625 (669)
                      ................ .....     .....+.+|+.+||+.||++|||++|+++  .+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence            0000000000000000 01111     12346789999999999999999999997  4544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-35  Score=314.58  Aligned_cols=262  Identities=21%  Similarity=0.231  Sum_probs=192.0

Q ss_pred             CCCccCeeeecCccceEEEEeC-CCcEEEEEEecccCccchHHHHHHHHHHHHhC-----------CCceeEEEEEEecC
Q 005933          351 NFSWKNKLGEGGFGPVYRGMLT-EGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-----------HRNLVRLLGCCTLR  418 (669)
Q Consensus       351 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~  418 (669)
                      +|++.++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.+++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5999999999999999999974 69999999996542 23467888999998875           57899999887653


Q ss_pred             --CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceeccCCCCCEEEcCCcc-----
Q 005933          419 --DERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNDMN-----  490 (669)
Q Consensus       419 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dikp~NIll~~~~~-----  490 (669)
                        ...++++++...+..............+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence              4566777777666554444445566678999999999999999999998 66   999999999999986653     


Q ss_pred             -eEEeecCCCcccCCCccCcCcccccccCCccCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCccchhhHh
Q 005933          491 -PKISDFGMARAFGVDQTEANTDRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  569 (669)
Q Consensus       491 -~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwS~G~~l~elltG~~p~~~~~~~~~~~~~~~~  569 (669)
                       ++++|||.+.....     ......+|+.|+|||++....++.++||||+||+++||++|+.||...............
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             99999999976432     223467899999999999999999999999999999999999997644332211111110


Q ss_pred             h---hhccc------------------ccchhhcccc----------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 005933          570 W---RLWTE------------------DRSLELIDKS----------LDGSYSLSEALRCIQVGLLCVQQRPEDRPNMSS  618 (669)
Q Consensus       570 ~---~~~~~------------------~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  618 (669)
                      .   .....                  ......+...          ............+.+|+.+||+.||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            0   00000                  0000000000          011233455678899999999999999999999


Q ss_pred             HHH
Q 005933          619 VVL  621 (669)
Q Consensus       619 vl~  621 (669)
                      +++
T Consensus       325 ~L~  327 (362)
T d1q8ya_         325 LVN  327 (362)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=2.9e-22  Score=190.57  Aligned_cols=164  Identities=19%  Similarity=0.216  Sum_probs=121.0

Q ss_pred             CccCeeeecCccceEEEEeCCCcEEEEEEecccCc------------------cchHHHHHHHHHHHHhCCCceeEEEEE
Q 005933          353 SWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSG------------------QGVEEFKNEVLLIAKLQHRNLVRLLGC  414 (669)
Q Consensus       353 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g~  414 (669)
                      .+.++||+|+||+||+|+..+|+.||||+++....                  .....+..|+..+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999998899999998753210                  012334568889999999999988865


Q ss_pred             EecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceeccCCCCCEEEcCCcceEEe
Q 005933          415 CTLRDERMLIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSRLRIIHRDLKASNVLLDNDMNPKIS  494 (669)
Q Consensus       415 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dikp~NIll~~~~~~kl~  494 (669)
                      .    ..+++|||+++..+..          ++......++.|++++|+|||+.+   |+||||||+|||+++++ ++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence            3    3479999998866543          233445689999999999999998   99999999999999754 8999


Q ss_pred             ecCCCcccCCCccCcCcccccccCCccCc------hhhccCCCCchhhHHHHHHHHH
Q 005933          495 DFGMARAFGVDQTEANTDRVVGTYGYMSP------EYAIDGLFSVKSDVFSFGVLVL  545 (669)
Q Consensus       495 Dfgla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~t~~sDVwS~G~~l~  545 (669)
                      |||+|.....+...          .|...      +. ....|..++|+||..--+.
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            99999764322111          11111      11 1345778899999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.65  E-value=7e-08  Score=94.30  Aligned_cols=149  Identities=15%  Similarity=0.100  Sum_probs=107.8

Q ss_pred             HHHHHhcCCCccCeeeecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhC-CCceeEEEEEEecCCcce
Q 005933          344 TIADATDNFSWKNKLGEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQ-HRNLVRLLGCCTLRDERM  422 (669)
Q Consensus       344 ~l~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~  422 (669)
                      ++....+.|+..+..+.++.+.||+... +++.++||+...........+.+|..++..+. +--+.+++.+...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4555566777666555555578998865 46778899887665556667888999988884 444677888888888899


Q ss_pred             EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--------------------------------
Q 005933          423 LIYEYLPNKSLEQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQDSR--------------------------------  470 (669)
Q Consensus       423 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--------------------------------  470 (669)
                      +||+++++.++.+.....        .....++.++++.++.||+...                                
T Consensus        87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999998887654211        1133456666777777775321                                


Q ss_pred             ------------------------CCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          471 ------------------------LRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       471 ------------------------~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                                              ..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                    1379999999999999877778999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=4.7e-06  Score=80.36  Aligned_cols=131  Identities=18%  Similarity=0.169  Sum_probs=88.3

Q ss_pred             eeeecCc-cceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCC--CceeEEEEEEecCCcceEEEeecCCCCH
Q 005933          357 KLGEGGF-GPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQH--RNLVRLLGCCTLRDERMLIYEYLPNKSL  433 (669)
Q Consensus       357 ~lg~G~f-g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~~~~gsL  433 (669)
                      .+..|.. ..||+....++..+++|......   ...+..|+..++.+..  -.+.+++.+..+++..++|||++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455553 57899998888889999764332   3456778888887743  3466788888888889999999998765


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 005933          434 EQFIFDVTRTKFLDWSKRCQIIEGIARGLLYLHQD---------------------------------------------  468 (669)
Q Consensus       434 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------------  468 (669)
                      .+..        +..   ...+.++++.|+-||+.                                             
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        111   11222333333344321                                             


Q ss_pred             ----------CCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          469 ----------SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       469 ----------~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                                .+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                      112379999999999999887788999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.59  E-value=7.8e-05  Score=76.62  Aligned_cols=75  Identities=13%  Similarity=0.181  Sum_probs=50.8

Q ss_pred             CeeeecCccceEEEEeCC-CcEEEEEEeccc-------CccchHHHHHHHHHHHHhC-C--CceeEEEEEEecCCcceEE
Q 005933          356 NKLGEGGFGPVYRGMLTE-GQEIAVKRLSKS-------SGQGVEEFKNEVLLIAKLQ-H--RNLVRLLGCCTLRDERMLI  424 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~lV  424 (669)
                      +.||.|....||+....+ ++.|+||.-...       .....++...|++.|..+. +  ..+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            578999999999998755 678999964321       1223456677888888773 2  345566654  45677899


Q ss_pred             EeecCCCC
Q 005933          425 YEYLPNKS  432 (669)
Q Consensus       425 ~E~~~~gs  432 (669)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.84  E-value=0.0015  Score=64.84  Aligned_cols=136  Identities=13%  Similarity=0.158  Sum_probs=78.4

Q ss_pred             ccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCce--eEEEE-----EEecCCcceEEEeecCCCCHHH
Q 005933          363 FGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL--VRLLG-----CCTLRDERMLIYEYLPNKSLEQ  435 (669)
Q Consensus       363 fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lV~E~~~~gsL~~  435 (669)
                      --.||+....+|+.+++|+.+. .....+++..|...+..|....+  +..+.     .....+..+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            4579999999999999998753 33456778889999988853222  11111     1233455678899988643221


Q ss_pred             -----H---------hhc------cCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCC
Q 005933          436 -----F---------IFD------VTRTKFLDWS----------------------KRCQIIEGIARGLLYL-HQDSRLR  472 (669)
Q Consensus       436 -----~---------l~~------~~~~~~l~~~----------------------~~~~i~~~ia~~L~yL-H~~~~~~  472 (669)
                           +         ++.      ......+++.                      .....+.++...+.-+ .+..+..
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                 0         110      0011112211                      1112222232222222 1222345


Q ss_pred             ceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          473 IIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       473 iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ++|+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.78  E-value=0.0014  Score=67.03  Aligned_cols=72  Identities=18%  Similarity=0.313  Sum_probs=50.2

Q ss_pred             CeeeecCccceEEEEeCC--------CcEEEEEEecccCccchHHHHHHHHHHHHhCCCce-eEEEEEEecCCcceEEEe
Q 005933          356 NKLGEGGFGPVYRGMLTE--------GQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL-VRLLGCCTLRDERMLIYE  426 (669)
Q Consensus       356 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E  426 (669)
                      +.|+.|-.-.+|+....+        .+.|++++... . ...-...+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            678889999999998654        34677776642 2 233455689999998853344 477887743    68999


Q ss_pred             ecCCCCH
Q 005933          427 YLPNKSL  433 (669)
Q Consensus       427 ~~~~gsL  433 (669)
                      |+++.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=96.21  E-value=0.013  Score=48.24  Aligned_cols=92  Identities=13%  Similarity=0.139  Sum_probs=55.5

Q ss_pred             EEEeecCCCCC--------------CCCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeee
Q 005933           14 FMSSWKSADDP--------------AQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVS   79 (669)
Q Consensus        14 ~L~Sw~s~~DP--------------s~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~   79 (669)
                      .|-||.+.++|              +.|.|+|.|..+|.  ++++++..++|.++...... .-...+....  ++...+
T Consensus         3 ~~~s~~~~~~~~~~l~~~q~l~~~~~~~~y~l~mQ~DGN--LVLy~~~~~vWssnt~~~~~-~~~l~l~~dG--nLvL~d   77 (119)
T d1b2pa_           3 IIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN--LVLYDNNNPIWATNTGGLGN-GCRAVLQPDG--VLVVIT   77 (119)
T ss_dssp             EEECSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC--EEEEETTEEEEECCCTTSCS-SCEEEECTTS--CEEEEC
T ss_pred             EEEeeecCCCCCCEEeCCCeEEEecCCceEEEEECCCCc--EEEEECCeEEEEecCCCCCc-ceEEEEEeCC--CEEEEC
Confidence            35566666555              57999999999986  57899999999987643110 0011122211  122223


Q ss_pred             cCCeeEEEEEeecCCeeeeEEEccCCCeEEE
Q 005933           80 NENEVFYRFNLIKSSVLTMMVINPQGEPQRL  110 (669)
Q Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~  110 (669)
                      ......++..........+++|+.||++..|
T Consensus        78 ~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlY  108 (119)
T d1b2pa_          78 NENVTVWQSPVAGKAGHYVLVLQPDRNVVIY  108 (119)
T ss_dssp             TTCCEEEECSCCCCSSCEEEEECTTSCEEEE
T ss_pred             CCCcEEEECCCcCCCCceEEEEcCCCCEEEE
Confidence            3333434433333444568999999999998

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.17  E-value=0.043  Score=53.31  Aligned_cols=159  Identities=15%  Similarity=0.078  Sum_probs=85.1

Q ss_pred             ccHHHHHHHhcCCCccCee-----eecCccceEEEEeCCCcEEEEEEecccCccchHHHHHHHHHHHHhCCCce--eEEE
Q 005933          340 FDWNTIADATDNFSWKNKL-----GEGGFGPVYRGMLTEGQEIAVKRLSKSSGQGVEEFKNEVLLIAKLQHRNL--VRLL  412 (669)
Q Consensus       340 ~~~~~l~~~~~~~~~~~~l-----g~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~  412 (669)
                      .+.+++.....+|.+++..     ..|---+.|+...++| .+++|+....  ...+++..|+.++..|...++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence            3556788888889876554     3555677899887765 5899988543  123455667777777743222  1111


Q ss_pred             E------EEecCCcceEEEeecCCCCHHH--------------HhhccCC------CCCCCH------------------
Q 005933          413 G------CCTLRDERMLIYEYLPNKSLEQ--------------FIFDVTR------TKFLDW------------------  448 (669)
Q Consensus       413 g------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~------~~~l~~------------------  448 (669)
                      .      +.........++.++.+.....              .++....      ......                  
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      1122334556666666543211              0000000      000000                  


Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCCceeccCCCCCEEEcCCcceEEeecCCCcc
Q 005933          449 SKRCQIIEGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNDMNPKISDFGMARA  501 (669)
Q Consensus       449 ~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dikp~NIll~~~~~~kl~Dfgla~~  501 (669)
                      ......+..+...+...+.. -+.++||+|+.+.||+++.+...-|+||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            01112222233333333322 234599999999999999988889999998853

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=94.82  E-value=0.032  Score=45.90  Aligned_cols=81  Identities=15%  Similarity=0.147  Sum_probs=47.8

Q ss_pred             CCCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccC
Q 005933           25 AQDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQ  104 (669)
Q Consensus        25 s~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  104 (669)
                      ..|.|+|.|..+|.  ++++.+..++|.++-- +....-...+....  ++-..+...+..+...........+++|+.|
T Consensus        33 ~~g~y~L~~q~DGN--LvL~~~~~~vW~s~t~-~~~~~~~~~l~~~G--nLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~D  107 (120)
T d1dlpa2          33 QLSPYRLSMETDCN--LVLFDRDDRVWSTNTA-GKGTGCRAVLQPNG--RMDVLTNQNIAVWTSGNSRSAGRYVFVLQPD  107 (120)
T ss_dssp             BCSSCEEEEETTTE--EEEEBTTBCCSCCCCC-SSCSSCEEEEETTT--EEEEEETTTEEEEECCCCCSSSCCEEEECSS
T ss_pred             EcCCEEEEEcCCCc--EEEecCCcEEEEEccc-cCCCcEEEEEeCCe--eEEEEcCCCCEEEEeCCCCCCCcEEEEECCC
Confidence            67999999999885  4888888899976532 11111111222211  2222233444444333333333468999999


Q ss_pred             CCeEEE
Q 005933          105 GEPQRL  110 (669)
Q Consensus       105 G~l~~~  110 (669)
                      |+++.|
T Consensus       108 GnlvlY  113 (120)
T d1dlpa2         108 RNLAIY  113 (120)
T ss_dssp             SCEEEE
T ss_pred             CcEEEe
Confidence            999998

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=94.74  E-value=0.047  Score=43.89  Aligned_cols=80  Identities=6%  Similarity=-0.023  Sum_probs=47.8

Q ss_pred             CCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccCC
Q 005933           26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG  105 (669)
Q Consensus        26 ~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G  105 (669)
                      .|.|+|.|..+|.  ++||++..++|.++..+...-. .-.+....  ++...+.......+........-.+++|..||
T Consensus        18 ng~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~~~-~l~l~~~G--nlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddG   92 (108)
T d1jpca_          18 YGSFVFIMQEDCN--LVLYDVDKPIWATNTGGLSRSC-FLSMQTDG--NLVVYNPSNKPIWASNTGGQNGNYVCILQKDR   92 (108)
T ss_dssp             ETTEEEEECTTSC--EEEEETTEEEEECCCTTSCSSC-EEEECTTS--CEEEECTTCCEEEECCCCCSCSCEEEEECTTS
T ss_pred             cCCEEEEECCCCe--EEEEeCCceeeEeCCCCCCCcc-EEEEeccc--eEEEECCCccceEEccccCCCCcEEEEEcCCC
Confidence            5999999999886  5889999999987754311000 01122111  22222333334344333333444578999999


Q ss_pred             CeEEE
Q 005933          106 EPQRL  110 (669)
Q Consensus       106 ~l~~~  110 (669)
                      ++..|
T Consensus        93 NlVly   97 (108)
T d1jpca_          93 NVVIY   97 (108)
T ss_dssp             CEEEE
T ss_pred             CEEEe
Confidence            99998

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=94.64  E-value=0.12  Score=41.75  Aligned_cols=80  Identities=6%  Similarity=0.078  Sum_probs=47.6

Q ss_pred             CCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccCC
Q 005933           26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG  105 (669)
Q Consensus        26 ~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G  105 (669)
                      .|.|+|.|..+|.  ++++....++|.++.-+...-..+ .+...-.  +.. .+.....+.......+...+++|..+|
T Consensus        18 ~g~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~~~~l-~l~~dGn--Lvl-~~~~~~~w~s~t~~~~~~~~l~L~ddG   91 (112)
T d1xd5a_          18 EGGYLFIIQNDCN--LVLYDNNRAVWASGTNGKASGCVL-KMQNDGN--LVI-YSGSRAIWASNTNRQNGNYYLILQRDR   91 (112)
T ss_dssp             ETTEEEEECTTSC--EEEEETTEEEEECCCTTSCSSEEE-EECTTSC--EEE-EETTEEEEECCCCCSCCCCEEEECTTS
T ss_pred             ECCEEEEEcCCCC--EEEEcCCcEEEEccCccCCCCcEE-EEecccc--EEE-EecCCeEEEEeeccCCCceEEEEcCCC
Confidence            3999999999886  588999999998775432110000 1221111  111 122333333333334445689999999


Q ss_pred             CeEEEE
Q 005933          106 EPQRLT  111 (669)
Q Consensus       106 ~l~~~~  111 (669)
                      ++..|.
T Consensus        92 Nlvly~   97 (112)
T d1xd5a_          92 NVVIYD   97 (112)
T ss_dssp             CEEEEC
T ss_pred             CEEEEC
Confidence            999984

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.62  E-value=0.0063  Score=37.01  Aligned_cols=34  Identities=32%  Similarity=0.708  Sum_probs=27.2

Q ss_pred             ccCCCCCCCCCCCccccCCCCCCcccccCCCccCC
Q 005933          130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVPKS  164 (669)
Q Consensus       130 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~  164 (669)
                      .|+|.+-..|| +|.|+.--..-.|.|-.||+|..
T Consensus         1 tdECsignpCG-nGTCtNviGgFec~C~~GFepgp   34 (39)
T d1emoa2           1 TDECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CCGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred             CCccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence            37899999998 79997543445799999999854

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=92.87  E-value=0.29  Score=39.08  Aligned_cols=80  Identities=13%  Similarity=0.137  Sum_probs=44.7

Q ss_pred             CCccEEEEccCCCCeEEEEeCCEEEEeecCCC-CcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccC
Q 005933           26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWN-GLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQ  104 (669)
Q Consensus        26 ~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~-g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  104 (669)
                      .|.|+|.|..+|.  ++++.+..++|.++.=+ +..-. .-.+....  ++...+................-.+++|..|
T Consensus        18 ~g~~~l~~q~dgn--Lvl~~~~~~vW~ant~~~~~~~~-~l~l~~dG--nLvl~~~~g~~vW~s~t~~~~~~~~l~L~dd   92 (109)
T d1kj1a_          18 VEPYHFIMQEDCN--LVLYDHSTSVWASNTGILGKKGC-KAVLQSDG--NFVVYDAEGRSLWASHSVRGNGNYVLVLQED   92 (109)
T ss_dssp             ETTEEEEECTTSC--EEEEETTEEEEECCCCCTTCCCC-EEEECTTS--CEEEECSSSCEEEECCCCCCSSCCEEEECTT
T ss_pred             eCCEEEEecCCCe--EEEEeCCEEEEEeCCCCCCceeE-EEEEcCCc--eEEEEeCCCcEEEEEeeECCCCCEEEEEeCC
Confidence            4999999998876  58899999999864311 00000 00122211  1211222223333332222333468999999


Q ss_pred             CCeEEE
Q 005933          105 GEPQRL  110 (669)
Q Consensus       105 G~l~~~  110 (669)
                      |++..|
T Consensus        93 GNlvly   98 (109)
T d1kj1a_          93 GNVVIY   98 (109)
T ss_dssp             SCEEEE
T ss_pred             CcEEEE
Confidence            999988

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=90.76  E-value=0.18  Score=40.75  Aligned_cols=79  Identities=9%  Similarity=0.075  Sum_probs=44.9

Q ss_pred             CCccEEEEccCCCCeEEEEeCCEEEEeecCCCCcceeccccCCCCCceeEEeeecCCeeEEEEEeecCCeeeeEEEccCC
Q 005933           26 QDNYIYEVDPRGVPQAVFRKGSKIKFRAGPWNGLHWTGTPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVLTMMVINPQG  105 (669)
Q Consensus        26 ~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~w~g~~f~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~G  105 (669)
                      .|.|+|.|..+|.  ++++++..++|.++.=+.  ......+...-.  +.+.+......+...........+++|+.||
T Consensus        25 ~g~~~l~~q~DGN--LvL~~~~~~vW~s~t~~~--~~~~l~l~~dGN--Lvl~d~~~~~vWsS~t~~~~g~y~l~Lq~DG   98 (115)
T d1dlpa1          25 LSSFRFTMQSDCN--LVLFDSDVRVWASNTAGA--TGCRAVLQSDGL--LVILTAQNTIRWSSGTKGSIGNYVLVLQPDR   98 (115)
T ss_dssp             STTEEEEECTTSC--EEEEESSSEEECCCCCSC--SCCBCCBCSSSC--BCCBCTTTCCSCCCCCCCCSSCCEEEECSSS
T ss_pred             cCCEEEEECCCCe--EEEEcCCeeEEEcccCCC--CceEEEEeccCC--EEEEccCCCEEEEcCCCCCCCCEEEEECCCC
Confidence            6899999999986  478888899998763211  111112222211  1112222222222222223334578999999


Q ss_pred             CeEEE
Q 005933          106 EPQRL  110 (669)
Q Consensus       106 ~l~~~  110 (669)
                      ++..|
T Consensus        99 NlvlY  103 (115)
T d1dlpa1          99 TVTIY  103 (115)
T ss_dssp             CEEEE
T ss_pred             cEEEe
Confidence            99988

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.43  E-value=0.051  Score=35.33  Aligned_cols=33  Identities=27%  Similarity=0.653  Sum_probs=26.8

Q ss_pred             ccCCCC-CCCCCCCccccCCCCCCcccccCCCcc
Q 005933          130 LDQCDN-YALCGAYAICNMNSNSARCECLEGFVP  162 (669)
Q Consensus       130 ~~~C~~-~~~CG~~g~C~~~~~~~~C~C~~gf~~  162 (669)
                      .|+|.. ...|...|.|.....+-.|.|++||+.
T Consensus         3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G   36 (42)
T d2vj3a1           3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYTG   36 (42)
T ss_dssp             CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred             CccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence            367876 568999999987656678999999974

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.31  E-value=0.11  Score=33.06  Aligned_cols=32  Identities=38%  Similarity=0.781  Sum_probs=25.3

Q ss_pred             cCCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 005933          131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPK  163 (669)
Q Consensus       131 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  163 (669)
                      |+|. ...|...|.|......-.|.|++||+.+
T Consensus         1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~   32 (39)
T d1xkba1           1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK   32 (39)
T ss_dssp             CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred             CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence            4566 4779999999876567789999999854

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.52  E-value=0.13  Score=33.59  Aligned_cols=36  Identities=19%  Similarity=0.376  Sum_probs=26.1

Q ss_pred             ccCCCCCCCCCCCccccCCCCCCcccccCCCccCCc
Q 005933          130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVPKSP  165 (669)
Q Consensus       130 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~~~  165 (669)
                      .|+|.....+-.++.|.....+-.|.|++||+...+
T Consensus         3 idEC~~~~~~C~~~~C~Nt~Gsy~C~C~~Gy~~~~~   38 (44)
T d1lmja1           3 IDECRISPDLCGRGQCVNTPGDFECKCDEGYESGFM   38 (44)
T ss_dssp             CCTTTTCSSTTTTSCEEEETTEEEECCCSSEEECTT
T ss_pred             ccccCCCCCCCCCCEeEcCCCCeEEeCCCCCccCCC
Confidence            378987544335799977656678999999986543

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.35  E-value=0.12  Score=32.84  Aligned_cols=33  Identities=36%  Similarity=0.545  Sum_probs=26.7

Q ss_pred             ccCCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 005933          130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVPK  163 (669)
Q Consensus       130 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  163 (669)
                      .|+|. ...|-..|.|....+.-+|.|++||+.+
T Consensus         3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G~   35 (39)
T d1edmb_           3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEGK   35 (39)
T ss_dssp             CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred             cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCCC
Confidence            46787 5779999999876567789999999754

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.09  E-value=0.26  Score=31.95  Aligned_cols=32  Identities=28%  Similarity=0.607  Sum_probs=25.4

Q ss_pred             ccCCCCCCCCCCCccccCCCCCCcccccCCCcc
Q 005933          130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVP  162 (669)
Q Consensus       130 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~  162 (669)
                      .|+|.... |+..+.|.....+-.|.|++||+.
T Consensus         5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~   36 (43)
T d1emoa1           5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL   36 (43)
T ss_dssp             CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred             eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence            48898654 557899987666778999999985

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.91  E-value=0.15  Score=32.35  Aligned_cols=32  Identities=22%  Similarity=0.527  Sum_probs=25.1

Q ss_pred             cCCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 005933          131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPK  163 (669)
Q Consensus       131 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  163 (669)
                      |+|. ..-|...|.|.....+-.|.|++||..+
T Consensus         2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G~   33 (39)
T d2vj3a2           2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEGV   33 (39)
T ss_dssp             CTTT-TCCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred             cCCc-CCCCCCCCEEECCCCCEEEeCCCCCccC
Confidence            5564 3679999999876567789999999854

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.69  E-value=0.25  Score=31.67  Aligned_cols=31  Identities=29%  Similarity=0.752  Sum_probs=24.5

Q ss_pred             cCCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 005933          131 DQCDNYALCGAYAICNMNSNSARCECLEGFVPK  163 (669)
Q Consensus       131 ~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  163 (669)
                      |+|...+.|  ..+|.....+-.|.|++||...
T Consensus         2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~   32 (41)
T d1i0ua2           2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD   32 (41)
T ss_dssp             CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred             ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence            678877777  4689776567789999999863

>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.77  E-value=0.28  Score=30.19  Aligned_cols=31  Identities=29%  Similarity=0.616  Sum_probs=23.6

Q ss_pred             CCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 005933          132 QCDNYALCGAYAICNMNSNSARCECLEGFVPK  163 (669)
Q Consensus       132 ~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  163 (669)
                      +|. ...|...|.|....+.-+|.|++||..+
T Consensus         2 ~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G~   32 (35)
T d2vj3a3           2 ECA-SSPCLHNGRCLDKINEFQCECPTGFTGH   32 (35)
T ss_dssp             TTT-TCCSTTTCEEEECSSCEEEECCTTEESS
T ss_pred             CCC-CCCCCCCcEEECCCCCeEEECCCCCCCC
Confidence            453 4678889999766566789999999753

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=80.66  E-value=0.68  Score=37.14  Aligned_cols=36  Identities=17%  Similarity=0.341  Sum_probs=29.0

Q ss_pred             EeecCCCCCCCCccEEEEccCCCCeEEEEeCCEEEEeecC
Q 005933           16 SSWKSADDPAQDNYIYEVDPRGVPQAVFRKGSKIKFRAGP   55 (669)
Q Consensus        16 ~Sw~s~~DPs~G~~s~~~d~~g~~~~~~~~~~~~y~~sg~   55 (669)
                      +-|.|..+.++|.|.+.|+++|..  +++  +.++|.+|.
T Consensus        77 ~vWsS~t~~~~g~y~l~Lq~DGNl--vlY--~~~~Wssgt  112 (115)
T d1dlpa1          77 IRWSSGTKGSIGNYVLVLQPDRTV--TIY--GPGLWDSGT  112 (115)
T ss_dssp             CSCCCCCCCCSSCCEEEECSSSCE--EEE--CSEEEECSC
T ss_pred             EEEEcCCCCCCCCEEEEECCCCcE--EEe--CCCeecCCC
Confidence            349999999999999999999874  666  347888774

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=80.24  E-value=0.19  Score=32.63  Aligned_cols=33  Identities=21%  Similarity=0.513  Sum_probs=25.7

Q ss_pred             ccCCCCCCCCCCCccccCCCCCCcccccCCCccC
Q 005933          130 LDQCDNYALCGAYAICNMNSNSARCECLEGFVPK  163 (669)
Q Consensus       130 ~~~C~~~~~CG~~g~C~~~~~~~~C~C~~gf~~~  163 (669)
                      .|+|.....| -.+.|.....+-.|.|++||+..
T Consensus         3 idEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~   35 (43)
T d1uzka1           3 VNECLDPTTC-ISGNCVNTPGSYICDCPPDFELN   35 (43)
T ss_dssp             CCGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred             ccccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence            3789887666 57899776556789999999864